Clustering O 0 0.013133365660905838
of O 0 0.0027686485555022955
missense O 0 0.005522540770471096
mutations O 0 0.0006420172867365181
in O 0 0.00024261834914796054
the O 0 0.020662011578679085
ataxia B-Disease 1 0.9999998807907104
- I-Disease 1 0.9998464584350586
telangiectasia I-Disease 1 0.9998617172241211
gene O 0 0.00047493824968114495
in O 0 0.00022047491802368313
a O 0 0.0007978365756571293
sporadic B-Disease 0 0.18451179563999176
T I-Disease 1 0.9999113082885742
- I-Disease 1 0.9198177456855774
cell I-Disease 0 0.0830768495798111
leukaemia I-Disease 1 0.9946377873420715
. O 0 0.0013559096259996295

Ataxia B-Disease 1 0.999998927116394
- I-Disease 1 0.9998587369918823
telangiectasia I-Disease 1 0.9999949932098389
( O 1 0.8204589486122131
A B-Disease 1 0.9999916553497314
- I-Disease 1 0.9998816251754761
T I-Disease 1 0.9998621940612793
) O 0 0.0001547666179249063
is O 0 7.76232554926537e-05
a O 0 0.00029832826112397015
recessive B-Disease 0 0.025618765503168106
multi I-Disease 1 0.999893307685852
- I-Disease 1 0.9999786615371704
system I-Disease 1 0.9995137453079224
disorder I-Disease 1 0.9999998807907104
caused O 1 0.9999289512634277
by O 0 0.00023130413319449872
mutations O 0 0.00011135824024677277
in O 0 6.117045995779335e-05
the O 0 0.00012922490714117885
ATM O 0 0.0006525008357129991
gene O 0 0.00013178889639675617
at O 0 0.0004241264541633427
11q22 O 0 0.21275928616523743
- O 0 0.0019350482616573572
q23 O 0 0.09110639989376068
( O 0 0.0005913694621995091
ref O 0 0.004449691157788038
. O 0 0.00015089826774783432
3 O 0 0.00048712361603975296
) O 0 0.00037237966898828745
. O 0 0.0006641719373874366

The O 0 0.006139441393315792
risk O 0 0.011150998994708061
of O 1 0.6734594106674194
cancer B-Disease 1 0.9999808073043823
, O 0 0.0018378706881776452
especially O 0 0.018705280497670174
lymphoid B-Disease 1 0.999991774559021
neoplasias I-Disease 1 0.9999926090240479
, O 0 0.0004503070085775107
is O 0 0.00014055983047001064
substantially O 0 0.0005134900566190481
elevated O 1 0.5302724242210388
in O 0 0.0005243076011538506
A B-Disease 1 0.9999853372573853
- I-Disease 1 0.9999872446060181
T I-Disease 1 0.9999970197677612
patients O 0 0.0002623463806230575
and O 0 5.5710766901029274e-05
has O 0 4.8717229219619185e-05
long O 0 0.00012603912909980863
been O 0 0.0001447114918846637
associated O 0 0.00018240435747429729
with O 0 0.000480436923680827
chromosomal O 1 0.9999959468841553
instability O 1 0.9999986886978149
. O 0 0.019735049456357956

By O 0 0.0027100606821477413
analysing O 0 0.01834132708609104
tumour B-Disease 1 0.999992847442627
DNA O 0 0.0029970731120556593
from O 0 0.0005782121443189681
patients O 0 0.0004711703222710639
with O 0 0.00028833362739533186
sporadic B-Disease 1 0.6626148223876953
T I-Disease 1 0.9999109506607056
- I-Disease 1 0.6516398787498474
cell I-Disease 0 0.2999448776245117
prolymphocytic I-Disease 1 0.999915599822998
leukaemia I-Disease 1 0.9999911785125732
( O 0 0.029265226796269417
T B-Disease 1 0.9997277855873108
- I-Disease 0 0.10153073072433472
PLL I-Disease 1 0.9880489706993103
) O 0 0.00016223023703787476
, O 0 0.00010951013973681256
a O 0 0.00022143221576698124
rare O 0 0.0005926085286773741
clonal B-Disease 0 0.019826237112283707
malignancy I-Disease 1 0.9534687995910645
with O 0 0.00010853914136532694
similarities O 0 0.00024428730830550194
to O 0 0.0001360205205855891
a O 0 0.00046676554484292865
mature B-Disease 0 0.004063945729285479
T I-Disease 1 0.9991655349731445
- I-Disease 0 0.04245875030755997
cell I-Disease 0 0.0021432500798255205
leukaemia I-Disease 1 0.8768463730812073
seen O 0 0.0003652870946098119
in O 0 0.00019341352162882686
A B-Disease 1 0.9994592070579529
- I-Disease 1 0.9949020147323608
T I-Disease 1 0.9956918358802795
, O 0 8.018795779207721e-05
we O 0 3.470110459602438e-05
demonstrate O 0 8.2607519289013e-05
a O 0 7.200410618679598e-05
high O 0 0.00011982665455434471
frequency O 0 5.381006849347614e-05
of O 0 0.00010882071364903823
ATM O 0 0.0012157612945884466
mutations O 0 0.0002697336603887379
in O 0 0.0005603949539363384
T B-Disease 1 0.9986839890480042
- I-Disease 0 0.01707611232995987
PLL I-Disease 1 0.9423588514328003
. O 0 0.0017583969747647643

In O 0 0.0015871865907683969
marked O 0 0.0017705793725326657
contrast O 0 0.00030948015046305954
to O 0 0.00010579957597656175
the O 0 0.0002301327622262761
ATM O 0 0.0013277851976454258
mutation O 0 0.00020743483037222177
pattern O 0 0.000364972569514066
in O 0 0.00024452872457914054
A B-Disease 1 0.9998694658279419
- I-Disease 1 0.9977013468742371
T I-Disease 1 0.9981889128684998
, O 0 6.881324952701107e-05
the O 0 7.06088321749121e-05
most O 0 3.51299240719527e-05
frequent O 0 7.716685649938881e-05
nucleotide O 0 0.00015417361282743514
changes O 0 6.787366874050349e-05
in O 0 7.408965757349506e-05
this O 0 0.0001510396396042779
leukaemia B-Disease 1 0.928680956363678
were O 0 0.000517176347784698
missense O 0 0.004986180923879147
mutations O 0 0.001248666550964117
. O 0 0.0009596425807103515

These O 0 0.0008462007972411811
clustered O 0 0.0010308611672371626
in O 0 0.0001624615106265992
the O 0 0.00015201751375570893
region O 0 0.00012124914064770564
corresponding O 0 7.832233677618206e-05
to O 0 5.3182793635642156e-05
the O 0 0.00010813345579663292
kinase O 0 0.0002600289590191096
domain O 0 0.0001345358177786693
, O 0 5.4454198107123375e-05
which O 0 2.6012789021478966e-05
is O 0 2.4923483579186723e-05
highly O 0 7.108147110557184e-05
conserved O 0 0.00011174362589372322
in O 0 9.812288772081956e-05
ATM O 0 0.0008544139564037323
- O 0 0.00044300640001893044
related O 0 0.00012832116044592112
proteins O 0 0.00012030499783577397
in O 0 0.00014322667266242206
mouse O 0 0.00043073869892396033
, O 0 0.00015567033551633358
yeast O 0 0.0004922771477140486
and O 0 0.00026900219381786883
Drosophila O 0 0.0019124281825497746
. O 0 0.0006729095475748181

The O 0 0.0026760606560856104
resulting O 0 0.0025088987313210964
amino O 0 0.0009958456503227353
- O 0 0.0022319378331303596
acid O 0 0.000743808806873858
substitutions O 0 0.0003508748486638069
are O 0 2.2938244001124986e-05
predicted O 0 0.00011350702698109671
to O 0 3.108062446699478e-05
interfere O 0 0.00014383434609044343
with O 0 0.00011098307732027024
ATP O 1 0.9536572098731995
binding O 0 0.0004555214545689523
or O 0 0.0002848115982487798
substrate O 0 0.0010974303586408496
recognition O 0 0.0010508071864023805
. O 0 0.0007417775923386216

Two O 0 0.0007255268283188343
of O 0 0.0009306085994467139
seventeen O 0 0.004947204142808914
mutated O 1 0.5657482743263245
T B-Disease 1 0.9993847608566284
- I-Disease 0 0.0035368723329156637
PLL I-Disease 0 0.20941774547100067
samples O 0 0.00019105910905636847
had O 0 0.00010581895185168833
a O 0 0.00012294687621761113
previously O 0 0.0001900953211588785
reported O 0 0.00039306189864873886
A B-Disease 1 0.9602438807487488
- I-Disease 1 0.9426924586296082
T I-Disease 1 0.9982206225395203
allele O 0 0.0030217994935810566
. O 0 0.0010837652953341603

In O 0 0.0013916688039898872
contrast O 0 0.0008910129545256495
, O 0 0.00022693513892591
no O 0 0.0001157268270617351
mutations O 0 0.00010896858293563128
were O 0 6.847208715043962e-05
detected O 0 0.00020961867994628847
in O 0 5.4590735089732334e-05
the O 0 0.00015160191105678678
p53 O 0 0.0004683872393798083
gene O 0 8.639215229777619e-05
, O 0 4.268449265509844e-05
suggesting O 0 0.0001153530174633488
that O 0 4.4431442802306265e-05
this O 0 0.00017360122001264244
tumour B-Disease 1 0.9999998807907104
suppressor O 1 0.9959773421287537
is O 0 0.00018065526091959327
not O 0 5.0649447075556964e-05
frequently O 0 8.636240818304941e-05
altered O 0 0.00025610800366848707
in O 0 0.0002028041344601661
this O 0 0.0003209147835150361
leukaemia B-Disease 1 0.9966709017753601
. O 0 0.0016661530826240778

Occasional O 0 0.010805876925587654
missense O 0 0.007438128814101219
mutations O 0 0.000875817728228867
in O 0 0.00037205981789156795
ATM O 0 0.0011053186608478427
were O 0 0.0001214419025927782
also O 0 6.371984636643901e-05
found O 0 9.49558088905178e-05
in O 0 0.0002552326477598399
tumour B-Disease 1 0.9999877214431763
DNA O 0 0.0008062104461714625
from O 0 0.00027100808802060783
patients O 0 0.00018173284479416907
with O 0 0.0001366706856060773
B B-Disease 0 0.25803443789482117
- I-Disease 0 0.030080603435635567
cell I-Disease 0 0.004881151486188173
non I-Disease 0 0.004443786572664976
- I-Disease 1 0.9555311799049377
Hodgkins I-Disease 1 0.9999996423721313
lymphomas I-Disease 1 0.9996374845504761
( O 0 0.000880147737916559
B B-Disease 0 0.005718443542718887
- I-Disease 0 0.0005859765806235373
NHL I-Disease 0 0.0006321423570625484
) O 0 6.30599315627478e-05
and O 0 6.864350143587217e-05
a O 0 0.0002573860401753336
B B-Disease 0 0.0029902870301157236
- I-Disease 0 0.0028630909509956837
NHL I-Disease 0 0.006829657591879368
cell O 0 0.0018246364779770374
line O 0 0.001870197942480445
. O 0 0.000759298971388489

The O 0 0.0013982573291286826
evidence O 0 0.0005851402529515326
of O 0 0.00030987252830527723
a O 0 0.00015636686293873936
significant O 0 0.00011635234841378406
proportion O 0 7.422217458952218e-05
of O 0 0.0001683404261711985
loss O 1 0.7403436899185181
- O 0 0.0008969234186224639
of O 0 0.0004544729308690876
- O 0 0.021569008007645607
function O 0 0.00012623975635506213
mutations O 0 8.104804874164984e-05
and O 0 5.4311371059156954e-05
a O 0 0.00011353300942573696
complete O 0 0.00022232836636248976
absence O 0 0.0002954251249320805
of O 0 0.00015507238276768476
the O 0 0.0001945180119946599
normal O 0 0.00012661829532589763
copy O 0 0.00012561412586364895
of O 0 0.00010442680650157854
ATM O 0 0.0002725607482716441
in O 0 2.6752131816465408e-05
the O 0 5.516197416000068e-05
majority O 0 3.7324236473068595e-05
of O 0 0.00019332078227307647
mutated O 0 0.0057111093774437904
tumours B-Disease 1 0.9999350309371948
establishes O 0 0.005264949053525925
somatic O 0 0.0018166881054639816
inactivation O 0 0.006088408175855875
of O 0 0.00024085679615382105
this O 0 5.5180495110107586e-05
gene O 0 5.820794103783555e-05
in O 0 3.6569166695699096e-05
the O 0 0.00013253647193778306
pathogenesis O 0 0.0709507018327713
of O 0 0.001618982758373022
sporadic B-Disease 1 0.9782278537750244
T I-Disease 1 0.9999511241912842
- I-Disease 0 0.17534741759300232
PLL I-Disease 1 0.9303231239318848
and O 0 0.00015499551955144852
suggests O 0 0.0001744243927532807
that O 0 5.9135581977898255e-05
ATM O 0 0.0004945723921991885
acts O 0 0.00032889452995732427
as O 0 0.0004738416173495352
a O 0 0.005452808924019337
tumour B-Disease 1 0.9999995231628418
suppressor O 1 0.998869001865387
. O 0 0.0023164749145507812

As O 0 0.0014219825388863683
constitutional O 0 0.0012944652698934078
DNA O 0 0.0007144986884668469
was O 0 0.000534089223947376
not O 0 5.40468463441357e-05
available O 0 2.8185599148855545e-05
, O 0 4.318614082876593e-05
a O 0 0.00017210125224664807
putative O 0 0.0037030174862593412
hereditary O 1 0.9995707869529724
predisposition O 1 0.9999052286148071
to O 1 0.7252751588821411
T B-Disease 1 0.9999978542327881
- I-Disease 1 0.9716980457305908
PLL I-Disease 1 0.9868183135986328
will O 0 9.584926010575145e-05
require O 0 5.2177772886352614e-05
further O 0 8.89261209522374e-05
investigation O 0 0.0003580268530640751
. O 0 0.0001380604226142168
. O 0 0.00038757993024773896

Myotonic B-Disease 1 0.9999995231628418
dystrophy I-Disease 1 0.9999997615814209
protein O 0 0.08969266712665558
kinase O 0 0.003730304306373
is O 0 0.00027281083748675883
involved O 0 0.0002094343217322603
in O 0 7.057758921291679e-05
the O 0 0.00013033024151809514
modulation O 0 0.0004029874107800424
of O 0 0.0002460934338159859
the O 0 0.001548000262118876
Ca2 O 1 0.8865677118301392
+ O 0 0.3817319869995117
homeostasis O 1 0.9975451827049255
in O 0 0.011692403815686703
skeletal O 1 0.9999986886978149
muscle O 1 0.999997615814209
cells O 1 0.7167945504188538
. O 0 0.0016541664954274893

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999535083770752
DM B-Disease 1 1.0
) O 0 0.001404122798703611
, O 0 0.00040786905447021127
the O 0 0.0003916742280125618
most O 0 0.0004869488184340298
prevalent O 1 0.9999138116836548
muscular B-Disease 1 1.0
disorder I-Disease 1 1.0
in O 1 0.9248431921005249
adults O 0 0.0005308401305228472
, O 0 0.00011895187344634905
is O 0 7.766982889734209e-05
caused O 0 0.00103003007825464
by O 0 6.523854244733229e-05
( O 0 0.00014029350131750107
CTG O 0 0.21595768630504608
) O 0 0.00010540211951592937
n O 0 0.00020760179904755205
- O 0 0.00022207816073205322
repeat O 0 0.00023901321401353925
expansion O 0 0.00021667458349838853
in O 0 4.0885490307118744e-05
a O 0 9.022479207487777e-05
gene O 0 6.643920642090961e-05
encoding O 0 5.749562114942819e-05
a O 0 0.00012725096894428134
protein O 0 0.000251313264016062
kinase O 0 0.0007661225972697139
( O 0 0.00037373806117102504
DM B-Disease 1 0.9997133612632751
protein O 0 0.0008606853662058711
kinase O 0 0.0012560185277834535
; O 0 0.000186458884854801
DMPK O 1 0.9899328947067261
) O 0 0.0001447279064450413
and O 0 0.00011635811097221449
involves O 0 0.00025212016771547496
changes O 0 0.00023458183568436652
in O 0 0.00043550474219955504
cytoarchitecture O 1 0.9987899661064148
and O 0 0.0014700839528813958
ion O 1 0.8071090579032898
homeostasis O 1 0.9977432489395142
. O 0 0.001888083410449326

To O 0 0.0008748109685257077
obtain O 0 0.0004446364473551512
clues O 0 0.000855214602779597
to O 0 0.00016688319738022983
the O 0 0.00022234022617340088
normal O 0 0.00035797321470454335
biological O 0 0.0004158368974458426
role O 0 0.0004212465137243271
of O 0 0.0007358388975262642
DMPK O 1 0.9999250173568726
in O 0 0.0010940202046185732
cellular O 0 0.10053189843893051
ion O 0 0.01759565807878971
homeostasis O 0 0.2112179696559906
, O 0 0.00010965926776407287
we O 0 4.785547935171053e-05
have O 0 1.740908555802889e-05
compared O 0 5.836541095050052e-05
the O 0 0.00012128404341638088
resting O 0 0.016261372715234756
[ O 0 0.00136214355006814
Ca2 O 0 0.002641606144607067
+ O 0 0.0008737305761314929
] O 0 0.00041161454282701015
i O 0 0.0001119274747907184
, O 0 3.4466516808606684e-05
the O 0 6.558279710588977e-05
amplitude O 0 0.00016918621258810163
and O 0 8.694257849128917e-05
shape O 0 0.0003027031780220568
of O 0 0.001620327471755445
depolarization O 1 0.9997032284736633
- O 1 0.9698605537414551
induced O 1 0.9990986585617065
Ca2 O 0 0.23702536523342133
+ O 0 0.0026012170128524303
transients O 0 0.0020347656682133675
, O 0 0.00010593748447718099
and O 0 5.290579065331258e-05
the O 0 9.384599252371117e-05
content O 0 6.916021084180102e-05
of O 0 0.00025176562485285103
ATP O 1 0.9981495141983032
- O 0 0.003593554487451911
driven O 0 0.002234719693660736
ion O 0 0.0027230484411120415
pumps O 0 0.003436524420976639
in O 0 0.0004947885172441602
cultured O 0 0.35228613018989563
skeletal O 1 0.9999656677246094
muscle O 1 0.9996007084846497
cells O 0 0.0005980893038213253
of O 0 0.00040984927909448743
wild O 0 0.0007453375146724284
- O 0 0.0007497321930713952
type O 0 0.00038967723958194256
and O 0 0.00020277281873859465
DMPK O 1 0.9985717535018921
[ O 0 0.0026582451537251472
- O 0 0.003990855999290943
/ O 0 0.0062372502870857716
- O 0 0.003652736311778426
] O 0 0.004204153548926115
knockout O 0 0.26792460680007935
mice O 0 0.0032185139134526253
. O 0 0.0010205177823081613

In O 0 0.0034802129957824945
vitro O 0 0.006941921543329954
- O 0 0.0031927605159580708
differentiated O 0 0.003215605625882745
DMPK O 1 0.9996628761291504
[ O 0 0.013204020448029041
- O 0 0.011765667237341404
/ O 0 0.0035942052491009235
- O 0 0.001526418374851346
] O 0 0.0009993783896788955
myotubes O 0 0.003990476951003075
exhibit O 0 0.0004937480553053319
a O 0 0.000294261088129133
higher O 0 0.0003052226093132049
resting O 0 0.002649052534252405
[ O 0 0.0009602883947081864
Ca2 O 0 0.0024576294235885143
+ O 0 0.0008415438351221383
] O 0 0.00029379999614320695
i O 0 9.066793427336961e-05
than O 0 3.1776417017681524e-05
do O 0 2.399330878688488e-05
wild O 0 0.00013959161879029125
- O 0 0.0003477965947240591
type O 0 0.00039477107929997146
myotubes O 0 0.06243887171149254
because O 0 8.174491085810587e-05
of O 0 0.00010085719986818731
an O 0 8.990256174001843e-05
altered O 0 0.00016778723511379212
open O 0 0.000124750382383354
probability O 0 4.331135642132722e-05
of O 0 0.00014693116827402264
voltage O 0 0.0008376464829780161
- O 0 0.0004904032684862614
dependent O 0 0.0002002023538807407
l O 0 0.0009023782331496477
- O 0 0.0006240900256671011
type O 0 0.0005761079373769462
Ca2 O 0 0.0018604578217491508
+ O 0 0.0007955092587508261
and O 0 0.00027759181102737784
Na O 0 0.08719100803136826
+ O 0 0.0015256119659170508
channels O 0 0.0005653419648297131
. O 0 0.0005118271801620722

The O 0 0.006190865766257048
mutant O 0 0.0743495523929596
myotubes O 1 0.8793319463729858
exhibit O 0 0.0018529396038502455
smaller O 0 0.0004259736742824316
and O 0 0.00016651679470669478
slower O 0 0.0006817367393523455
Ca2 O 0 0.0012642653891816735
+ O 0 0.00043845162144862115
responses O 0 0.00014213162648957223
upon O 0 0.00017069706518668681
triggering O 0 0.0014910316094756126
by O 0 0.000163796721608378
acetylcholine O 0 0.001833007438108325
or O 0 0.00024531196686439216
high O 0 0.0008553865482099354
external O 0 0.0007100982475094497
K O 0 0.004086543805897236
+ O 0 0.0022414536215364933
. O 0 0.0007257972029037774

In O 0 0.0017393170855939388
addition O 0 0.0007599080563522875
, O 0 0.00018315024499315768
we O 0 0.0001020791387418285
observed O 0 0.00010500875941943377
that O 0 4.4526412239065394e-05
these O 0 5.375498585635796e-05
Ca2 O 0 0.0019988862331956625
+ O 0 0.0020330012775957584
transients O 0 0.0033845228608697653
partially O 0 0.0006710481829941273
result O 0 0.00010472096619196236
from O 0 5.9773305110866204e-05
an O 0 8.290930418297648e-05
influx O 0 0.0005115031381137669
of O 0 0.000316495425067842
extracellular O 0 0.0013696488458663225
Ca2 O 0 0.0014975771773606539
+ O 0 0.0003741843975149095
through O 0 0.00010984282562276348
the O 0 0.00027306066476739943
l O 0 0.0019206609576940536
- O 0 0.0008658480364829302
type O 0 0.0008151569636538625
Ca2 O 0 0.0030423428397625685
+ O 0 0.0013821370666846633
channel O 0 0.0007806538487784564
. O 0 0.0005241830367594957

Neither O 0 0.004536982625722885
the O 0 0.001191119896247983
content O 0 0.00028052052948623896
nor O 0 0.00033824777347035706
the O 0 0.0002461338008288294
activity O 0 0.0003075708809774369
of O 0 0.000526388525031507
Na O 1 0.999183714389801
+ O 0 0.007581207901239395
/ O 0 0.0034720643889158964
K O 0 0.003716746810823679
+ O 0 0.0021774345077574253
ATPase O 0 0.006508011370897293
and O 0 0.0007452321005985141
sarcoplasmic O 1 0.9587097764015198
reticulum O 1 0.9164089560508728
Ca2 O 0 0.3956386148929596
+ O 0 0.012357528321444988
- O 0 0.003039875067770481
ATPase O 0 0.003249627770856023
are O 0 0.00010736122931120917
affected O 0 0.00046140284393914044
by O 0 0.0003317352675367147
DMPK O 1 0.9996781349182129
absence O 0 0.16915397346019745
. O 0 0.00187769066542387

In O 0 0.0013490249402821064
conclusion O 0 0.001233172370120883
, O 0 0.00024456786923110485
our O 0 0.00018436586833558977
data O 0 6.041732194717042e-05
suggest O 0 0.00014988439215812832
that O 0 9.012161171995103e-05
DMPK O 1 0.9969037175178528
is O 0 0.00014189181092660874
involved O 0 0.0001345645432593301
in O 0 6.8209323217161e-05
modulating O 0 0.00044156573130749166
the O 0 0.00015583312779199332
initial O 0 0.0001310846710111946
events O 0 0.00010894355364143848
of O 0 0.00035564994323067367
excitation O 0 0.0778181180357933
- O 0 0.10757551342248917
contraction O 1 0.8264498114585876
coupling O 0 0.012568308971822262
in O 0 0.0012869082856923342
skeletal O 1 0.9999970197677612
muscle O 1 0.9999593496322632
. O 0 0.0008400952210649848
. O 0 0.0009686802513897419

Constitutional O 0 0.414482444524765
RB1 O 1 0.9999879598617554
- O 1 0.9665387272834778
gene O 0 0.0019130372675135732
mutations O 0 0.0007890794076956809
in O 0 0.0003844721941277385
patients O 0 0.0005880343378521502
with O 0 0.00022863177582621574
isolated O 0 0.08545742183923721
unilateral B-Disease 0 0.1945239007472992
retinoblastoma I-Disease 1 0.9996634721755981
. O 0 0.0029223449528217316

In O 0 0.0027222211938351393
most O 0 0.0007963834214024246
patients O 0 0.0007298854179680347
with O 0 0.00021313797333277762
isolated O 0 0.018574897199869156
unilateral B-Disease 1 0.7562129497528076
retinoblastoma I-Disease 1 0.9999960660934448
, O 0 0.3783118426799774
tumor B-Disease 1 0.9999439716339111
development O 0 0.0009778920793905854
is O 0 0.00017622666200622916
initiated O 0 0.00047086412087082863
by O 0 9.438517008675262e-05
somatic O 0 0.0005674543790519238
inactivation O 0 0.0014694533310830593
of O 0 0.00027202669298276305
both O 0 9.92832938209176e-05
alleles O 0 0.0002435751521261409
of O 0 0.00040264680865220726
the O 0 0.0021709753200411797
RB1 O 1 0.9998904466629028
gene O 0 0.002038773614913225
. O 0 0.000930176058318466

However O 0 0.001240292564034462
, O 0 0.00024257905897684395
some O 0 9.671543375588953e-05
of O 0 0.00033011811319738626
these O 0 9.96320231934078e-05
patients O 0 0.00048078480176627636
can O 0 0.00012188890104880556
transmit O 0 0.003542138496413827
retinoblastoma B-Disease 1 0.9988096952438354
predisposition O 1 0.7339430451393127
to O 0 0.00031757596298120916
their O 0 0.0002787133271340281
offspring O 0 0.00153758330270648
. O 0 0.0006767893792130053

To O 0 0.0009246146073564887
determine O 0 0.00030913809314370155
the O 0 0.00032502252724952996
frequency O 0 0.00015140458708629012
and O 0 7.191147597040981e-05
nature O 0 0.00018770164751913399
of O 0 0.00042137340642511845
constitutional O 0 0.11457743495702744
RB1 O 1 0.999998927116394
- O 1 0.8685307502746582
gene O 0 0.00030544353649020195
mutations O 0 0.0001456125610275194
in O 0 9.018349373945966e-05
patients O 0 0.00010592202306725085
with O 0 6.154869333840907e-05
isolated O 0 0.0010315940016880631
unilateral B-Disease 0 0.0024115063715726137
retinoblastoma I-Disease 1 0.9845060706138611
, O 0 0.00016433863493148237
we O 0 0.0001136144419433549
analyzed O 0 0.00017409687279723585
DNA O 0 0.0002985188621096313
from O 0 0.0002779753122013062
peripheral O 1 0.9832586050033569
blood O 1 0.5801928639411926
and O 0 0.0017706763464957476
from O 1 0.902064859867096
tumor B-Disease 1 0.9999994039535522
tissue O 1 0.9995641112327576
. O 0 0.0015743379481136799

The O 0 0.00158072414342314
analysis O 0 0.0004174504429101944
of O 0 0.0008308248943649232
tumors B-Disease 1 0.9930504560470581
from O 0 0.00023092157789506018
54 O 0 0.0004429274413269013
( O 0 0.00013049239350948483
71 O 0 0.0003487920621410012
% O 0 6.371226481860504e-05
) O 0 5.285642691887915e-05
of O 0 0.0001242481084773317
76 O 0 0.0007199287065304816
informative O 0 0.0005480392137542367
patients O 0 0.00033968110801652074
showed O 0 0.0003577061288524419
loss O 0 0.0006175554590299726
of O 0 0.0005551938083954155
constitutional O 0 0.020906897261738777
heterozygosity O 1 0.9999728202819824
( O 1 0.5726401805877686
LOH O 1 0.9999921321868896
) O 0 0.0005646615754812956
at O 0 0.002213413594290614
intragenic O 0 0.359190434217453
loci O 0 0.0042006876319646835
. O 0 0.0011641507735475898

Three O 0 0.0016829298110678792
of O 0 0.002073720097541809
13 O 0 0.0037929757963865995
uninformative O 1 0.9458805918693542
patients O 0 0.002584979869425297
had O 0 0.0016035126755014062
constitutional O 0 0.0027318422216922045
deletions O 0 0.008617361076176167
. O 0 0.002086845925077796

For O 0 0.0011538007529452443
39 O 0 0.0013638654490932822
randomly O 0 0.0007531428127549589
selected O 0 0.0018296001944690943
tumors B-Disease 1 0.9995580315589905
, O 0 0.0010651746997609735
SSCP O 1 0.9998107552528381
, O 0 0.0016917112516239285
hetero O 0 0.16307830810546875
- O 0 0.0018018827540799975
duplex O 0 0.0035835872404277325
analysis O 0 0.00014754780568182468
, O 0 0.0001156925136456266
sequencing O 0 0.0001866587990662083
, O 0 4.9234949983656406e-05
and O 0 5.6823479098966345e-05
Southern O 0 0.0002737300528679043
blot O 0 0.0011160748545080423
analysis O 0 9.550667891744524e-05
were O 0 8.628897921880707e-05
used O 0 6.993202259764075e-05
to O 0 0.00012267283455003053
identify O 0 0.0005131302168592811
mutations O 0 0.0010619057575240731
. O 0 0.0006904690526425838

Mutations O 0 0.0023061407264322042
were O 0 0.00041745181079022586
detected O 0 0.0005172670353204012
in O 0 0.00011939392425119877
21 O 0 0.0002730705600697547
( O 0 0.0001205878725158982
91 O 0 0.00026552658528089523
% O 0 7.718099368503317e-05
) O 0 7.284252933459356e-05
of O 0 0.00031347296317107975
23 O 0 0.1556997299194336
tumors B-Disease 1 0.9999920129776001
with O 0 0.07001937180757523
LOH O 1 0.9999991655349731
. O 0 0.0022572888992726803

In O 0 0.0008340853382833302
6 O 0 0.00077289022738114
( O 0 0.00019198864174541086
38 O 0 0.0002413986949250102
% O 0 6.837061664555222e-05
) O 0 5.3871990530751646e-05
of O 0 0.00022224652639124542
16 O 0 0.12220286577939987
tumors B-Disease 1 0.9999978542327881
without O 0 0.037467047572135925
LOH O 1 0.999998927116394
, O 0 0.00014809526328463107
one O 0 9.332747868029401e-05
mutation O 0 0.00015983523917384446
was O 0 0.00025893794372677803
detected O 0 0.0001669185294304043
, O 0 3.448972347541712e-05
and O 0 1.8356473447056487e-05
in O 0 2.2490039555123076e-05
9 O 0 8.592146332375705e-05
( O 0 3.374330481165089e-05
56 O 0 0.00010730882786447182
% O 0 3.40186852554325e-05
) O 0 2.763776501524262e-05
of O 0 0.00012767869338858873
the O 0 0.003906359430402517
tumors B-Disease 1 0.9999992847442627
without O 0 0.3163060247898102
LOH O 1 0.9999997615814209
, O 0 0.00022675258514937013
both O 0 9.949862578650936e-05
mutations O 0 0.00020503094128798693
were O 0 0.00017813076556194574
found O 0 0.00038625134038738906
. O 0 0.0006382256979122758

Thus O 0 0.0010163882980123162
, O 0 0.00018434476805850863
a O 0 0.00012892496306449175
total O 0 0.00011584949970711023
of O 0 0.00012117330334149301
45 O 0 0.000292526267003268
mutations O 0 0.0001617174712009728
were O 0 8.083895227173343e-05
identified O 0 0.0001635340740904212
in O 0 0.0002301997010363266
tumors B-Disease 1 0.9924736022949219
of O 0 0.0012778205564245582
36 O 0 0.0065377806313335896
patients O 0 0.0022742568980902433
. O 0 0.0007275122334249318

Thirty O 0 0.004904027562588453
- O 0 0.0013090599095448852
nine O 0 0.0003232244052924216
of O 0 0.0002320215426152572
the O 0 0.0002835384802892804
mutations O 0 0.00023430463625118136
- O 0 0.0002560242428444326
including O 0 6.87784850015305e-05
34 O 0 0.00017229269724339247
small O 0 0.00010780975571833551
mutations O 0 8.152725058607757e-05
, O 0 7.205974543467164e-05
2 O 0 0.00016029219841584563
large O 0 0.00017807168478611857
structural O 0 0.08693480491638184
alterations O 0 0.060266558080911636
, O 0 0.00018753689073491842
and O 0 0.000141220138175413
hypermethylation O 0 0.1786222755908966
in O 0 0.00034293881617486477
3 O 0 0.05583598092198372
tumors O 1 0.9999219179153442
- O 0 0.00039362700772471726
were O 0 4.433549111126922e-05
not O 0 1.819584758777637e-05
detected O 0 6.190793646965176e-05
in O 0 3.54589028574992e-05
the O 0 0.00012848229380324483
corresponding O 0 0.0007805731729604304
peripheral O 1 0.9996042847633362
blood O 1 0.992017388343811
DNA O 0 0.0057434262707829475
. O 0 0.0007879564655013382

In O 0 0.0010068853152915835
6 O 0 0.0008591772639192641
( O 0 0.0002761186915449798
17 O 0 0.0002384941908530891
% O 0 4.3766664020949975e-05
) O 0 1.9778968635364436e-05
of O 0 5.28638374817092e-05
the O 0 0.0001052794759743847
36 O 0 0.00023607254843227565
patients O 0 0.0001325111952610314
, O 0 5.491665069712326e-05
a O 0 0.00011607308260863647
mutation O 0 0.00014388358977157623
was O 0 0.00025581149384379387
detected O 0 0.00012789118045475334
in O 0 5.513468204298988e-05
constitutional O 0 0.00013572459283750504
DNA O 0 0.0001193034477182664
, O 0 3.670640944619663e-05
and O 0 3.061045572394505e-05
1 O 0 6.041098095010966e-05
of O 0 6.926898640813306e-05
these O 0 2.8319178454694338e-05
mutations O 0 8.05576128186658e-05
is O 0 4.6456625568680465e-05
known O 0 7.64291689847596e-05
to O 0 4.286229159333743e-05
be O 0 5.721098932554014e-05
associated O 0 0.00010057790495920926
with O 0 0.00014170237409416586
reduced O 0 0.0009486636845394969
expressivity O 1 0.6408542394638062
. O 0 0.000985400634817779

The O 0 0.0012380281696096063
presence O 0 0.0006425378960557282
of O 0 0.0003191801661159843
a O 0 0.0002994726528413594
constitutional O 0 0.000790528254583478
mutation O 0 0.00033983055618591607
was O 0 0.0003640826034825295
not O 0 3.486519926809706e-05
associated O 0 4.162995901424438e-05
with O 0 2.1621388441417366e-05
an O 0 7.200554682640359e-05
early O 0 0.00033461939892731607
age O 0 0.000724817393347621
at O 0 0.006182198878377676
treatment O 0 0.01673259399831295
. O 0 0.0008708497625775635

In O 0 0.002125502098351717
1 O 0 0.002044210908934474
patient O 0 0.0025074672885239124
, O 0 0.0005420793313533068
somatic O 0 0.00993211381137371
mosaicism O 1 0.9972143769264221
was O 0 0.002563090994954109
demonstrated O 0 0.00043299325625412166
by O 0 5.1089824410155416e-05
molecular O 0 0.00010105406545335427
analysis O 0 4.1485182009637356e-05
of O 0 0.00011018272198271006
DNA O 0 0.00031522466451860964
and O 0 0.0001649035548325628
RNA O 0 0.0010686676250770688
from O 0 0.0009022888261824846
peripheral O 1 0.9978272318840027
blood O 1 0.7966742515563965
. O 0 0.0012967902002856135

In O 0 0.0014198336284607649
2 O 0 0.0014592116931453347
patients O 0 0.0005121590220369399
without O 0 0.00013639769167639315
a O 0 0.0003193277807440609
detectable O 0 0.031968310475349426
mutation O 0 0.0006659802747890353
in O 0 0.0004807816294487566
peripheral O 1 0.9998784065246582
blood O 1 0.9811493158340454
, O 0 0.00059552735183388
mosaicism O 1 0.9839228987693787
was O 0 0.0010215392103418708
suggested O 0 0.00014236911374609917
because O 0 3.4003020118689165e-05
1 O 0 7.656784873688594e-05
of O 0 0.00010828019003383815
the O 0 0.000625010346993804
patients O 0 0.2849745750427246
showed O 1 0.9986822009086609
multifocal O 1 1.0
tumors B-Disease 1 0.9999997615814209
and O 0 0.000624642358161509
the O 0 0.0004147881700191647
other O 0 0.00011981180432485417
later O 0 0.0004480500938370824
developed O 0 0.0008300370536744595
bilateral B-Disease 0 0.0063534569926559925
retinoblastoma I-Disease 1 0.9977608919143677
. O 0 0.0022974221501499414

In O 0 0.0017559294356033206
conclusion O 0 0.0013053568545728922
, O 0 0.00028805885813198984
our O 0 0.000202466020709835
results O 0 0.0001147942675743252
emphasize O 0 0.00028880630270577967
that O 0 8.825233089737594e-05
the O 0 0.00027910154312849045
manifestation O 1 0.9542620778083801
and O 0 0.0004736538103315979
transmissibility O 1 0.9160069227218628
of O 0 0.0013975250767543912
retinoblastoma B-Disease 0 0.41700223088264465
depend O 0 8.019009692361578e-05
on O 0 5.0512073357822374e-05
the O 0 6.170317647047341e-05
nature O 0 7.59818940423429e-05
of O 0 5.6046847021207213e-05
the O 0 0.0001004703517537564
first O 0 0.00012384144065435976
mutation O 0 7.090882718330249e-05
, O 0 1.788807458069641e-05
its O 0 1.5034408534120303e-05
time O 0 1.9590625015553087e-05
in O 0 3.0789604352321476e-05
development O 0 0.00010635572107275948
, O 0 4.510064536589198e-05
and O 0 3.4499200410209596e-05
the O 0 6.758863310096785e-05
number O 0 2.9808401450281963e-05
and O 0 4.900804196950048e-05
types O 0 6.370230403263122e-05
of O 0 0.00026537218946032226
cells O 0 0.0003781454870477319
that O 0 4.557224383461289e-05
are O 0 2.186775964219123e-05
affected O 0 0.00015507770876865834
. O 0 0.00012269530270714313
. O 0 0.0003714753838721663

Hereditary B-Disease 1 0.9999943971633911
deficiency I-Disease 1 0.9999985694885254
of I-Disease 1 0.5399707555770874
the I-Disease 0 0.4800621271133423
fifth I-Disease 1 0.9992520213127136
component I-Disease 0 0.15382911264896393
of I-Disease 0 0.00155619066208601
complement I-Disease 0 0.001506297616288066
in O 0 0.0004622414708137512
man O 0 0.0029800974298268557
. O 0 0.0008301289053633809

I O 0 0.07283447682857513
. O 0 0.006086042616516352

Clinical O 0 0.24087898433208466
, O 0 0.0034665879793465137
immunochemical O 1 0.9986624717712402
, O 0 0.0007199475658126175
and O 0 0.0005186880589462817
family O 0 0.00125241803470999
studies O 0 0.0005350045976229012
. O 0 0.0009184001246467233

The O 0 0.002278068568557501
first O 0 0.0010480553610250354
recognized O 0 0.0008753800066187978
human O 0 0.001173025812022388
kindred O 1 0.9873819947242737
with O 0 0.011540546081960201
hereditary B-Disease 1 0.9999995231628418
deficiency I-Disease 1 0.9999998807907104
of I-Disease 1 0.9907078742980957
the I-Disease 1 0.9529695510864258
fifth I-Disease 1 0.999535083770752
component I-Disease 0 0.1098882332444191
of I-Disease 0 0.0013718962436541915
complement I-Disease 0 0.0033698955085128546
( O 0 0.0008384598768316209
C5 O 1 0.9995681643486023
) O 0 0.00016180184320546687
is O 0 0.0001563407713547349
described O 0 0.0006752183544449508
. O 0 0.0004200701368972659

The O 0 0.0036840513348579407
proband O 0 0.034664906561374664
, O 0 0.0003039698058273643
a O 0 0.0003346385492477566
20 O 0 0.00031897996086627245
- O 0 0.0007214255747385323
year O 0 0.000340404047165066
- O 0 0.0009179871412925422
old O 0 0.0017124270088970661
black O 0 0.007490432821214199
female O 0 0.2735650837421417
with O 1 0.9838907122612
systemic B-Disease 1 1.0
lupus I-Disease 1 1.0
erythematosus I-Disease 1 1.0
since O 1 0.9999076128005981
age O 1 0.9949771761894226
11 O 1 0.6630591750144958
, O 0 0.0007214503712020814
lacked O 1 0.7647895812988281
serum O 1 0.9997519850730896
hemolytic O 1 0.9999991655349731
complement O 0 0.012018331326544285
activity O 0 0.0008824671967886388
, O 0 0.0001871067943284288
even O 0 0.00014977298269513994
during O 0 0.0013177908258512616
remission O 0 0.01649037003517151
. O 0 0.0014514565700665116

C5 O 1 0.9999250173568726
was O 1 0.5643311142921448
undetectable O 0 0.36505505442619324
in O 0 0.0008350213756784797
her O 0 0.0011366397375240922
serum O 0 0.11020147800445557
by O 0 0.0003297161019872874
both O 0 0.0004761680611409247
immunodiffusion O 1 0.999446451663971
and O 0 0.008859807625412941
hemolytic O 1 0.9999995231628418
assays O 0 0.006677120458334684
. O 0 0.002063957741484046

Other O 0 0.0017300902400165796
complement O 0 0.0023988147731870413
components O 0 0.0010030899429693818
were O 0 0.0002238026645500213
normal O 0 0.00046135266893543303
during O 0 0.0010224846191704273
remission O 0 0.3308506906032562
of O 1 0.772250771522522
lupus O 1 0.9999998807907104
, O 0 0.0041846237145364285
but O 0 0.0008762450306676328
C1 O 1 0.9999392032623291
, O 0 0.0008850396261550486
C4 O 1 0.9998300075531006
, O 0 0.0008958025719039142
C2 O 1 0.996751070022583
, O 0 0.00035099629894830287
and O 0 0.0004137795476708561
C3 O 1 0.999619722366333
levels O 0 0.004621323198080063
fell O 0 0.3539459705352783
during O 0 0.005074882414191961
exacerbations O 1 0.9864199757575989
. O 0 0.0013844456989318132

A O 0 0.007451631128787994
younger O 0 0.003191109746694565
half O 0 0.0008649307419545949
- O 0 0.00168223783839494
sister O 0 0.0007698007975704968
, O 0 9.766063885763288e-05
who O 0 0.00011610674118855968
had O 0 0.00038717742427252233
no O 0 0.0015073911054059863
underlying O 1 0.9999943971633911
disease O 1 0.9999998807907104
, O 0 0.012712978757917881
was O 0 0.24507442116737366
also O 0 9.347051673103124e-05
found O 0 0.00011819173232652247
to O 0 0.00016778962162788957
lack O 0 0.00247364048846066
immunochemically O 1 0.9998308420181274
detectable O 1 0.9974088072776794
C5 O 1 0.9997857213020325
. O 0 0.002504701493307948

By O 0 0.012393690645694733
hemolytic O 1 0.9999982118606567
assay O 0 0.01807290129363537
, O 0 0.00045790677540935576
she O 0 0.0002624371845740825
exhibited O 0 0.0006228841375559568
1 O 0 0.00029660845757462084
- O 0 0.000281777698546648
2 O 0 0.00013028127432335168
% O 0 4.224737494951114e-05
of O 0 0.00011571844515856355
the O 0 0.0003549609682522714
normal O 0 0.0010199220851063728
serum O 1 0.9073821306228638
C5 O 1 0.9981045722961426
level O 0 0.00040824757888913155
and O 0 8.859939407557249e-05
normal O 0 0.0001170126924989745
concentrations O 0 0.00024841123376972973
of O 0 0.00015861699648667127
other O 0 0.0001596274960320443
complement O 0 0.001186374225653708
components O 0 0.0020268247462809086
. O 0 0.0007499172352254391

C5 O 1 0.9991512298583984
levels O 0 0.0012748341541737318
of O 0 0.00030091055668890476
other O 0 6.0027949075447395e-05
family O 0 0.0001225814048666507
members O 0 3.899052171618678e-05
were O 0 3.80282144760713e-05
either O 0 4.45897712779697e-05
normal O 0 7.59949252824299e-05
or O 0 4.135728158871643e-05
approximately O 0 0.0001070897706085816
half O 0 0.00010227000166196376
- O 0 0.000269382813712582
normal O 0 0.00014227195060811937
, O 0 4.96377469971776e-05
consistent O 0 0.0001549375883769244
with O 0 0.00011268116941209882
autosomal O 0 0.00116692204028368
codominant O 1 0.9924984574317932
inheritance O 0 0.001747987000271678
of O 0 0.0012415548553690314
the O 0 0.02910178154706955
gene O 0 0.007440558169037104
determining O 1 0.7196863293647766
C5 B-Disease 1 0.9999998807907104
deficiency I-Disease 1 1.0
. O 0 0.005245682783424854

Normal O 1 0.9084798097610474
hemolytic O 1 0.9999973773956299
titers O 1 0.9916146993637085
were O 0 0.0008608218631707132
restored O 0 0.0022207784932106733
to O 0 0.0002700269687920809
both O 0 0.0004217842943035066
homozygous O 0 0.06296709179878235
C5 B-Disease 1 0.9999997615814209
- I-Disease 1 0.999885082244873
deficient I-Disease 1 0.9999924898147583
( O 0 0.025484832003712654
C5D B-Disease 1 0.9999992847442627
) O 0 0.0005905910511501133
sera O 0 0.00385655602440238
by O 0 0.00010728734923759475
addition O 0 0.00017117217066697776
of O 0 0.00036966026527807117
highly O 0 0.0015174571890383959
purified O 1 0.8323052525520325
human O 0 0.0098276287317276
C5 O 1 0.9996234178543091
. O 0 0.0018266801489517093

In O 0 0.003627557773143053
specific O 0 0.0021702460944652557
C5 O 1 0.9999347925186157
titrations O 1 0.8702346086502075
, O 0 0.00035269485670141876
however O 0 0.00014069797180127352
, O 0 5.843898543389514e-05
it O 0 2.9214255846454762e-05
was O 0 0.00018986199575010687
noted O 0 6.9716690632049e-05
that O 0 1.987331415875815e-05
when O 0 4.659963087760843e-05
limited O 0 3.8084472180344164e-05
amounts O 0 6.277739157667384e-05
of O 0 0.00023468742438126355
C5 O 1 0.9379013776779175
were O 0 0.00011664484190987423
assayed O 0 0.0004832535341847688
in O 0 5.968569530523382e-05
the O 0 8.949010953074321e-05
presence O 0 0.00014433360775001347
of O 0 0.0001552635512780398
low O 0 0.0002602234308142215
dilutions O 0 0.002154350746423006
of O 0 0.000719367410056293
either O 0 0.001533208996988833
C5D B-Disease 1 0.9999997615814209
serum O 1 0.9648426175117493
, O 0 0.00024316213966812938
curving O 0 0.0007577260839752853
rather O 0 7.698310218984261e-05
than O 0 4.859449836658314e-05
linear O 0 0.00017757352907210588
dose O 0 0.0006634184392169118
- O 0 0.000453250075224787
response O 0 0.00010950878640869632
plots O 0 0.000155112924403511
were O 0 6.230011058505625e-05
consistently O 0 9.162356582237408e-05
obtained O 0 8.4145154687576e-05
, O 0 5.881502147531137e-05
suggesting O 0 0.00014042978000361472
some O 0 0.00012089770461898297
inhibitory O 0 0.0016778127755969763
effect O 0 0.0012854149099439383
. O 0 0.0008024330018088222

Further O 0 0.0017624828033149242
studies O 0 0.0005479018436744809
suggested O 0 0.0003240098594687879
that O 0 0.00013656140072271228
low O 0 0.00046519419993273914
dilutions O 0 0.004843349568545818
of O 0 0.0038003972731530666
C5D B-Disease 1 0.9999997615814209
serum O 1 0.9787655472755432
contain O 0 0.00040017502033151686
a O 0 0.00040058413287624717
factor O 0 0.0005457284860312939
( O 0 9.398694965057075e-05
or O 0 5.0677666877163574e-05
factors O 0 6.205344834597781e-05
) O 0 4.5746750402031466e-05
interfering O 0 0.00013238641258794814
at O 0 0.00010794038826134056
some O 0 2.5371862648171373e-05
step O 0 0.00012772153422702104
in O 0 6.808701436966658e-05
the O 0 0.00033297864138148725
hemolytic O 1 0.999997615814209
assay O 0 0.003189872484654188
of O 0 0.11561862379312515
C5 O 1 0.999977707862854
, O 0 0.00013178889639675617
rather O 0 6.249766738619655e-05
than O 0 5.842538666911423e-05
a O 0 0.00019579134823288769
true O 0 0.0012439661659300327
C5 O 1 0.9999443292617798
inhibitor O 1 0.9850649237632751
or O 0 0.0012919282307848334
inactivator O 1 0.9397101402282715
. O 0 0.002468538237735629

Of O 0 0.0036642393097281456
clinical O 0 0.0020996148232370615
interest O 0 0.0002816194901242852
are O 0 4.533902756520547e-05
( O 0 6.978667079238221e-05
a O 0 0.00014662383182439953
) O 0 4.830020770896226e-05
the O 0 0.00011029120651073754
documentation O 0 0.00040716768126003444
of O 0 0.017507966607809067
membranous O 1 0.9999994039535522
glomerulonephritis B-Disease 1 1.0
, O 1 0.9999788999557495
vasculitis B-Disease 1 1.0
, O 1 0.9953243136405945
and O 1 0.9931894540786743
arthritis B-Disease 1 1.0
in O 0 0.003405304392799735
an O 0 0.002036578254774213
individual O 0 0.00041270683868788183
lacking O 1 0.9077871441841125
C5 O 1 0.9999895095825195
( O 0 0.0001764555199770257
and O 0 5.5524018534924835e-05
its O 0 3.876003756886348e-05
biologic O 0 0.005154740065336227
functions O 0 6.805416342103854e-05
) O 0 3.6795143387280405e-05
, O 0 2.4510871298843995e-05
and O 0 3.1155530450632796e-05
( O 0 5.9409041568869725e-05
b O 0 9.65508515946567e-05
) O 0 3.317323717055842e-05
a O 0 6.909559306222945e-05
remarkable O 0 0.0006390908383764327
propensity O 0 0.0028188007418066263
to O 0 0.0006616289610974491
bacterial B-Disease 1 0.9999964237213135
infections I-Disease 1 0.999983549118042
in O 0 0.000589523115195334
the O 0 0.004121085163205862
proband O 1 0.9984269142150879
, O 0 0.00011995583918178454
even O 0 5.471341501106508e-05
during O 0 0.0001405957737006247
periods O 0 0.00019160569354426116
of O 0 0.00015270149742718786
low O 0 0.00032002569059841335
- O 0 0.0004289745120331645
dose O 0 0.00036960880970582366
or O 0 9.7768432169687e-05
alternate O 0 0.00035053264582529664
- O 0 0.0013999450020492077
day O 0 0.0024451492354273796
corticosteroid O 1 0.9662529230117798
therapy O 0 0.09583453834056854
. O 0 0.0014182612067088485

Other O 0 0.0004988298751413822
observations O 0 0.0004941934603266418
indicate O 0 0.0003434749669395387
that O 0 9.544174827169627e-05
the O 0 0.0003305867430754006
C5D B-Disease 1 0.9999872446060181
state O 0 0.00020479512750171125
is O 0 0.00014695414574816823
compatible O 0 0.00018548803927842528
with O 0 0.00015325519780162722
normal O 0 0.0006723146652802825
coagulation O 0 0.2068866640329361
function O 0 0.00019569914729800075
and O 0 7.210566400317475e-05
the O 0 0.00016659381799399853
capacity O 0 0.0003638560592662543
to O 0 0.00011060473480029032
mount O 0 0.005751925986260176
a O 0 0.001860963529907167
neutrophilic O 1 0.9997746348381042
leukocytosis O 1 0.999729573726654
during O 1 0.9943884015083313
pyogenic B-Disease 1 0.999971866607666
infection I-Disease 1 0.9993289709091187
. O 0 0.0005081872805021703
. O 0 0.0006902315653860569

Susceptibility O 1 0.9961041212081909
to O 0 0.39664426445961
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
in O 1 0.9816438555717468
twins O 1 0.9679876565933228
: O 0 0.00021373752679210156
the O 0 0.00010984513210132718
role O 0 0.0001970679295482114
of O 0 0.000247725285589695
genes O 0 0.0003098175802733749
, O 0 0.00026790265110321343
HLA O 1 0.9998732805252075
, O 0 0.0001429649710189551
and O 0 0.00010481548815732822
the O 0 0.0002899589599110186
environment O 0 0.000631094619166106
. O 0 0.0006784286233596504

OBJECTIVE O 0 0.004705845844000578
To O 0 0.00039380002999678254
determine O 0 0.0002031842595897615
the O 0 0.00023482755932491273
relative O 0 0.0004604908754117787
effects O 0 0.0005555321113206446
of O 0 0.0004945363034494221
genetic O 0 0.0007715619867667556
and O 0 0.0001506035914644599
environmental O 0 0.00036457754322327673
factors O 0 0.0001346754579572007
in O 0 0.00030346945277415216
susceptibility O 1 0.9613511562347412
to O 1 0.6687766909599304
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
( O 1 0.9998550415039062
AS B-Disease 1 0.9998306035995483
) O 0 0.0008996434626169503
. O 0 0.0010578316869214177

METHODS O 0 0.005927171092480421
Twins O 0 0.01023738645017147
with O 0 0.0003483282052911818
AS B-Disease 0 0.0029427260160446167
were O 0 9.88710016827099e-05
identified O 0 7.658770482521504e-05
from O 0 8.211821841541678e-05
the O 0 0.00022458548482973129
Royal O 0 0.24528078734874725
National O 1 0.987505316734314
Hospital O 1 0.9999983310699463
for O 1 0.9973145127296448
Rheumatic B-Disease 1 1.0
Diseases I-Disease 1 1.0
database O 0 0.12765589356422424
. O 0 0.002252289094030857

Clinical O 0 0.01517054345458746
and O 0 0.0014322365168482065
radiographic O 0 0.06625755876302719
examinations O 0 0.0010376243153586984
were O 0 0.00018093646212946624
performed O 0 0.00029130009352229536
to O 0 0.00010528932034503669
establish O 0 0.0007948557031340897
diagnoses O 1 0.8396487832069397
, O 0 0.0007642497657798231
and O 0 0.004852416459470987
disease O 1 0.9999939203262329
severity O 1 0.9994908571243286
was O 1 0.7682880759239197
assessed O 0 0.0003284893755335361
using O 0 7.32930566300638e-05
a O 0 0.00014924720744602382
combination O 0 0.00020642284653149545
of O 0 0.00024260496138595045
validated O 0 0.0011936897644773126
scoring O 0 0.0007833305280655622
systems O 0 0.0009904527105391026
. O 0 0.000676466675940901

HLA O 1 0.9952050447463989
typing O 0 0.010825706645846367
for O 0 0.0017527103191241622
HLA O 1 0.9999711513519287
- O 0 0.3601822257041931
B27 O 1 0.997056245803833
, O 0 0.0016596871428191662
HLA O 1 0.9998816251754761
- O 0 0.01365553680807352
B60 O 1 0.8972856998443604
, O 0 0.00039135420229285955
and O 0 0.0003975762228947133
HLA O 1 0.9999721050262451
- O 0 0.34680965542793274
DR1 O 1 0.9952394962310791
was O 0 0.0012874457752332091
performed O 0 0.0003203581436537206
by O 0 0.00014195323456078768
polymerase O 0 0.0008271835977211595
chain O 0 0.0003556770388968289
reaction O 0 0.0001570590102346614
with O 0 3.509259840939194e-05
sequence O 0 9.620364289730787e-05
- O 0 0.0001743598550092429
specific O 0 6.401139398803934e-05
primers O 0 0.0003204470267519355
, O 0 0.00010759233555290848
and O 0 0.00012197600881336257
zygosity O 0 0.0960429459810257
was O 0 0.001301819458603859
assessed O 0 0.0008992356015369296
using O 0 0.0005910765612497926
microsatellite O 0 0.009350155480206013
markers O 0 0.004979202523827553
. O 0 0.0012807765742763877

Genetic O 0 0.0031473450362682343
and O 0 0.0004187912563793361
environmental O 0 0.000623389205429703
variance O 0 0.00019169304869137704
components O 0 0.0004260200366843492
were O 0 7.838180317776278e-05
assessed O 0 0.0001186265581054613
with O 0 5.353603046387434e-05
the O 0 0.00016685263835825026
program O 0 0.00016344443429261446
Mx O 0 0.0022140953224152327
, O 0 4.524154428509064e-05
using O 0 1.5358911696239375e-05
data O 0 9.695745575299952e-06
from O 0 1.481728395447135e-05
this O 0 1.1955789886997081e-05
and O 0 2.405521627224516e-05
previous O 0 5.6276396207977086e-05
studies O 0 5.4756113968323916e-05
of O 0 0.00019256319501437247
twins O 0 0.0024502070154994726
with O 0 0.00033326190896332264
AS B-Disease 0 0.2236083447933197
. O 0 0.0010487354593351483

RESULTS O 0 0.0017834835452958941
Six O 0 0.0005029572057537735
of O 0 0.0006015724502503872
8 O 0 0.0019227799493819475
monozygotic O 1 0.7919250130653381
( O 0 0.0027811205945909023
MZ O 1 0.9998456239700317
) O 0 0.0005896989605389535
twin O 0 0.003994182217866182
pairs O 0 0.00042062110151164234
were O 0 0.0005721153574995697
disease O 1 0.9908170700073242
concordant O 0 0.0056842416524887085
, O 0 0.00013953066081739962
compared O 0 5.553481969400309e-05
with O 0 2.6107425583177246e-05
4 O 0 0.00010309542994946241
of O 0 0.00016224122373387218
15 O 0 0.0003851955116260797
B27 O 0 0.4022549092769623
- O 0 0.0007734619430266321
positive O 0 0.0002914264623541385
dizygotic O 0 0.0037099625915288925
( O 0 0.0003481990424916148
DZ O 1 0.9334002733230591
) O 0 0.00013833992125000805
twin O 0 0.000525681534782052
pairs O 0 8.066499140113592e-05
( O 0 5.694916762877256e-05
27 O 0 0.00013108029088471085
% O 0 4.056524267070927e-05
) O 0 2.3951495677465573e-05
and O 0 3.0147797588142566e-05
4 O 0 7.926279795356095e-05
of O 0 0.00014254434790927917
32 O 0 0.00048020019312389195
DZ O 1 0.9955543875694275
twin O 0 0.0014722755877301097
pairs O 0 0.00014027958968654275
overall O 0 0.00020106128067709506
( O 0 8.297637396026403e-05
12 O 0 9.009822679217905e-05
. O 0 4.088400964974426e-05
5 O 0 0.00013432225387077779
% O 0 0.00012874623644165695
) O 0 0.00015319179510697722
. O 0 0.0002870852767955512

Nonsignificant O 1 0.9926313161849976
increases O 0 0.0013881782069802284
in O 0 0.00022279564291238785
similarity O 0 0.00022233938216231763
with O 0 5.216891804593615e-05
regard O 0 0.00015122957120183855
to O 0 9.45221763686277e-05
age O 0 0.02264345809817314
at O 1 0.9994719624519348
disease O 1 0.9999967813491821
onset O 1 0.9999792575836182
and O 0 0.0001310944207943976
all O 0 4.735009861178696e-05
of O 0 0.0003404185699764639
the O 0 0.08402802795171738
disease O 1 0.999966025352478
severity O 1 0.753209114074707
scores O 0 0.0003730069729499519
assessed O 0 0.00013089767890051007
were O 0 6.113074050517753e-05
noted O 0 0.00016296513786073774
in O 0 0.00025332634686492383
disease O 1 0.9998103976249695
- O 0 0.25330641865730286
concordant O 1 0.9230446815490723
MZ O 1 0.9999709129333496
twins O 0 0.01045181043446064
compared O 0 0.0005652449908666313
with O 0 0.00037075276486575603
concordant O 0 0.25432080030441284
DZ O 1 0.9999606609344482
twins O 1 0.6279871463775635
. O 0 0.0024962113238871098

HLA O 1 0.9999823570251465
- O 1 0.9851996898651123
B27 O 1 0.9968987703323364
and O 0 0.0013669469626620412
B60 O 1 0.8532021641731262
were O 0 0.00028086546808481216
associated O 0 0.00018351244216319174
with O 0 0.00010280308924848214
the O 0 0.011545701883733273
disease O 1 0.9999896287918091
in O 0 0.0038871269207447767
probands O 1 0.9998725652694702
, O 0 8.92596654011868e-05
and O 0 3.3163240004796535e-05
the O 0 7.73888168623671e-05
rate O 0 8.91878516995348e-05
of O 0 0.00017952181224245578
disease O 1 0.9952147006988525
concordance O 0 0.0016802872996777296
was O 0 0.001843081321567297
significantly O 0 0.000179188689799048
increased O 0 0.00012145024084020406
among O 0 0.00015149339742492884
DZ O 1 0.9953625202178955
twin O 0 0.0017720541218295693
pairs O 0 0.00011500902473926544
in O 0 6.599333573831245e-05
which O 0 5.100473208585754e-05
the O 0 0.0001429296680726111
co O 0 0.001213987241499126
- O 0 0.0012654176680371165
twin O 0 0.004149795509874821
was O 0 0.000878862221725285
positive O 0 0.0001541842066217214
for O 0 9.814348595682532e-05
both O 0 0.00019976188195869327
B27 O 1 0.9936906099319458
and O 0 0.002065288368612528
DR1 O 1 0.9986943602561951
. O 0 0.00188262399751693

Additive O 0 0.02481774613261223
genetic O 0 0.002682248130440712
effects O 0 0.0014763505896553397
were O 0 0.0001933093590196222
estimated O 0 0.0001901703653857112
to O 0 7.466259557986632e-05
contribute O 0 0.00010655955702532083
97 O 0 0.00021915996330790222
% O 0 3.1187093554763123e-05
of O 0 7.245788583531976e-05
the O 0 8.906071161618456e-05
population O 0 8.589762001065537e-05
variance O 0 0.00021548580843955278
. O 0 0.00037775601958855987

CONCLUSION O 0 0.019320879131555557
Susceptibility O 0 0.020963067188858986
to O 0 0.0005794181488454342
AS B-Disease 0 0.0888514444231987
is O 0 0.00021662683866452426
largely O 0 0.0003086704236920923
genetically O 0 0.00022421233006753027
determined O 0 0.00010909064440056682
, O 0 5.507241075974889e-05
and O 0 4.043069202452898e-05
the O 0 0.00014022263349033892
environmental O 0 0.0005025869468227029
trigger O 0 0.001237200223840773
for O 0 0.00014148189802654088
the O 0 0.060801878571510315
disease O 1 0.999995231628418
is O 0 0.0011213964316993952
probably O 0 0.0024135697167366743
ubiquitous O 0 0.00381082808598876
. O 0 0.0005582189187407494

HLA O 1 0.9999324083328247
- O 0 0.029746878892183304
B27 O 0 0.017160044983029366
accounts O 0 0.00023258944565895945
for O 0 6.719065277138725e-05
a O 0 0.00010005857620853931
minority O 0 7.319165160879493e-05
of O 0 0.00012357307423371822
the O 0 0.00032617038232274354
overall O 0 0.029686225578188896
genetic O 0 0.0036425278522074223
susceptibility O 0 0.15013760328292847
to O 0 0.00036907114554196596
AS B-Disease 0 0.40721365809440613
. O 0 0.0009173383587040007

Cell O 0 0.18855294585227966
cycle O 0 0.030666688457131386
- O 0 0.003382357070222497
dependent O 0 0.0012354524806141853
colocalization O 0 0.11514998972415924
of O 0 0.003198169404640794
BARD1 O 1 0.9999958276748657
and O 0 0.0017703442135825753
BRCA1 O 0 0.07745207101106644
proteins O 0 0.00017343000217806548
in O 0 0.00019162322860211134
discrete O 0 0.000791357655543834
nuclear O 0 0.002048472873866558
domains O 0 0.0016437888843938708
. O 0 0.0006264391704462469

Germ O 1 0.9998137354850769
- O 0 0.08494606614112854
line O 0 0.0025277184322476387
mutations O 0 0.00033835272188298404
of O 0 0.00041676510591059923
the O 0 0.0017281066393479705
BRCA1 O 1 0.9969353675842285
gene O 0 0.0006047892384231091
predispose O 0 0.00255197542719543
women O 0 0.00014066402218304574
to O 0 0.00014060421381145716
early O 0 0.003246324136853218
- O 1 0.9988002777099609
onset O 1 0.9999997615814209
breast B-Disease 1 0.9999998807907104
and I-Disease 1 0.9999929666519165
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
by O 0 0.0007653083303011954
compromising O 0 0.004082020837813616
the O 0 0.0005438308580778539
genes O 0 0.00023638609854970127
presumptive O 0 0.22080719470977783
function O 0 0.000276639882940799
as O 0 0.00038619685801677406
a O 0 0.001981798792257905
tumor B-Disease 1 0.999944806098938
suppressor O 1 0.9826801419258118
. O 0 0.001426491653546691

Although O 0 0.0015383491991087794
the O 0 0.0008755823946557939
biochemical O 0 0.002685972722247243
properties O 0 0.0009471105295233428
of O 0 0.005313084926456213
BRCA1 O 1 0.9948437213897705
polypeptides O 0 0.0006707785651087761
are O 0 2.8581238439073786e-05
not O 0 2.9582501156255603e-05
understood O 0 0.00015416377573274076
, O 0 4.674919182434678e-05
their O 0 3.26426925312262e-05
expression O 0 0.00015034260286483914
pattern O 0 0.0005624067271128297
and O 0 0.00014583072334062308
subcellular O 0 0.002164768986403942
localization O 0 0.0015147740487009287
suggest O 0 0.00013301073340699077
a O 0 0.00014495580398943275
role O 0 0.00028729281621053815
in O 0 0.00019069983682129532
cell O 0 0.001963674323633313
- O 0 0.0020232717506587505
cycle O 0 0.002462653210386634
regulation O 0 0.0009181914501823485
. O 0 0.0005826334236189723

When O 0 0.010823691263794899
resting O 1 0.9877274036407471
cells O 0 0.0023737563751637936
are O 0 0.00012231727305334061
induced O 0 0.002151578664779663
to O 0 0.00013986328849568963
proliferate O 0 0.0004708430205937475
, O 0 8.340985368704423e-05
the O 0 0.0001227185712195933
steady O 0 0.00036548476782627404
- O 0 0.00021398729586508125
state O 0 6.529661186505109e-05
levels O 0 0.00011393948807381094
of O 0 0.00017554895021021366
BRCA1 O 0 0.001507660374045372
increase O 0 0.00010985015251208097
in O 0 0.00010293706873198971
late O 0 0.0004989348235540092
G1 O 0 0.02478739060461521
and O 0 6.624782690778375e-05
reach O 0 8.51462027640082e-05
a O 0 0.00010924824891844764
maximum O 0 0.0001416811574017629
during O 0 0.0006218581693246961
S O 0 0.006611502263695002
phase O 0 0.00564982183277607
. O 0 0.0011707397643476725

Moreover O 0 0.0038781051989644766
, O 0 0.0005518668331205845
in O 0 0.000556983461137861
S O 1 0.6894936561584473
phase O 1 0.9706990122795105
cells O 0 0.003383318427950144
, O 0 0.0004020177584607154
BRCA1 O 0 0.005961226765066385
polypeptides O 0 0.0005951500497758389
are O 0 6.986630614846945e-05
hyperphosphorylated O 0 0.006384000182151794
and O 0 0.00016290205530822277
accumulate O 0 0.000422244134824723
into O 0 0.00041770085226744413
discrete O 0 0.0015817169332876801
subnuclear O 1 0.8764334321022034
foci O 0 0.07225187867879868
termed O 0 0.12014589458703995
" O 0 0.003667958313599229
BRCA1 O 1 0.5396485328674316
nuclear O 0 0.010076246224343777
dots O 0 0.006143385544419289
. O 0 0.0016889383550733328

" O 0 0.022221077233552933
BRCA1 O 0 0.37621089816093445
associates O 0 0.0025157195050269365
in O 0 0.0004754378751385957
vivo O 0 0.0010569990845397115
with O 0 0.0001436337042832747
a O 0 0.00039621227188035846
structurally O 0 0.008538194000720978
related O 0 0.0007267083856277168
protein O 0 0.0023852738086134195
termed O 1 0.7901484370231628
BARD1 O 1 0.9999366998672485
. O 0 0.002215705346316099

Here O 0 0.001693866914138198
we O 0 0.00022635860659647733
show O 0 0.00020022793614771217
that O 0 3.765855944948271e-05
the O 0 0.00010856347216758877
steady O 0 0.0003480024170130491
- O 0 0.00019145941769238561
state O 0 9.423606388736516e-05
levels O 0 0.00016788291395641863
of O 0 0.00026879479992203414
BARD1 O 1 0.9995390176773071
, O 0 0.00015394503134302795
unlike O 0 8.336039900314063e-05
those O 0 3.2627442124066874e-05
of O 0 0.00027934086392633617
BRCA1 O 0 0.4564487040042877
, O 0 0.0001249986671609804
remain O 0 0.00010871607082663104
relatively O 0 0.00013722569565288723
constant O 0 0.0003987445088569075
during O 0 0.002650482812896371
cell O 0 0.015261688269674778
cycle O 0 0.010967900976538658
progression O 0 0.15279807150363922
. O 0 0.0011186465853825212

However O 0 0.004440442658960819
, O 0 0.001833333051763475
immunostaining O 1 0.8753235340118408
revealed O 0 0.003610279643908143
that O 0 0.0006401765858754516
BARD1 O 1 0.9992992877960205
resides O 0 0.0038108481094241142
within O 0 0.0008871335303410888
BRCA1 O 0 0.12673267722129822
nuclear O 0 0.0015547703951597214
dots O 0 0.0007630250183865428
during O 0 0.0006140946061350405
S O 0 0.0025042921770364046
phase O 0 0.0007223660359159112
of O 0 0.00017053958436008543
the O 0 0.0003329621395096183
cell O 0 0.0015970348613336682
cycle O 0 0.000643832259811461
, O 0 7.814954733476043e-05
but O 0 3.6077264667255804e-05
not O 0 4.193772474536672e-05
during O 0 0.0004052545700687915
the O 0 0.0007447759853675961
G1 O 1 0.9930441975593567
phase O 0 0.011597656644880772
. O 0 0.000959177385084331

Nevertheless O 0 0.024115830659866333
, O 0 0.0027853213250637054
BARD1 O 1 0.997018575668335
polypeptides O 0 0.0017298489110544324
are O 0 5.892100671189837e-05
found O 0 6.572128768311813e-05
exclusively O 0 5.8003693993669e-05
in O 0 4.0605413232697174e-05
the O 0 7.526593981310725e-05
nuclear O 0 0.0002503657015040517
fractions O 0 0.00022158386127557606
of O 0 0.00011162519513163716
both O 0 0.00013096035399939865
G1 O 1 0.9837210178375244
- O 0 0.0005904652643948793
and O 0 0.0001824045175453648
S O 0 0.23318719863891602
- O 0 0.0036858823150396347
phase O 0 0.042390044778585434
cells O 0 0.0016645507421344519
. O 0 0.0006685082335025072

Therefore O 0 0.003437703475356102
, O 0 0.0007218237733468413
progression O 0 0.002291956217959523
to O 0 0.00019732475630007684
S O 0 0.05396744981408119
phase O 0 0.0016301646828651428
is O 0 8.095551311271265e-05
accompanied O 0 0.0002499916881788522
by O 0 3.5874705645255744e-05
the O 0 8.548545883968472e-05
aggregation O 0 0.00015598590834997594
of O 0 0.0002375183830736205
nuclear O 0 0.0019331244984641671
BARD1 O 1 0.9875319600105286
polypeptides O 0 0.0008488197345286608
into O 0 0.0007480087224394083
BRCA1 O 0 0.19787947833538055
nuclear O 0 0.0032747641671448946
dots O 0 0.002470126375555992
. O 0 0.0010671709896996617

This O 0 0.0030034761875867844
cell O 0 0.006484391633421183
cycle O 0 0.0044443728402256966
- O 0 0.0016769837820902467
dependent O 0 0.0006974920979700983
colocalization O 0 0.0744030624628067
of O 0 0.0024940476287156343
BARD1 O 1 0.999990701675415
and O 0 0.000999965937808156
BRCA1 O 0 0.020783958956599236
indicates O 0 0.0004523182287812233
a O 0 0.00022954828455112875
role O 0 0.000426270067691803
for O 0 0.00020486151333898306
BARD1 O 1 0.999561607837677
in O 0 0.0015565560897812247
BRCA1 O 1 0.9996205568313599
- O 1 0.909447968006134
mediated O 1 0.9873215556144714
tumor B-Disease 1 0.9999904632568359
suppression O 1 0.9997009038925171
. O 0 0.002283888403326273

Ethnic O 0 0.002480817958712578
differences O 0 0.0012009277706965804
in O 0 0.0004459459742065519
the O 0 0.0012281687231734395
HFE O 1 0.9897655248641968
codon O 0 0.004164171405136585
282 O 0 0.007533285301178694
( O 0 0.001458410290069878
Cys O 1 0.9935042262077332
/ O 0 0.055149223655462265
Tyr O 1 0.8429039716720581
) O 0 0.0008167314808815718
polymorphism O 0 0.0018300339579582214
. O 0 0.0009801806882023811

Recent O 0 0.0017182888695970178
studies O 0 0.00037358346162363887
have O 0 0.00011861841630889103
shown O 0 0.00034584334935061634
that O 0 0.0004543163231573999
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
( O 1 0.9999971389770508
HH B-Disease 1 1.0
) O 0 0.0006828831974416971
is O 0 0.00013179228699300438
likely O 0 9.003605373436585e-05
to O 0 4.1221243009204045e-05
be O 0 3.897137503372505e-05
caused O 0 0.00031773923547007143
by O 0 7.083213131409138e-05
homozygosity O 0 0.00917909387499094
for O 0 7.373990956693888e-05
a O 0 0.0002809128782246262
Cys282Tyr O 1 0.885008692741394
mutation O 0 0.00016949688142631203
in O 0 0.00010359803127357736
the O 0 0.00038445863174274564
HFE O 1 0.8778600692749023
gene O 0 0.0004462034266907722
located O 0 0.000663453247398138
4 O 0 0.0008532969513908029
. O 0 0.0006478707655332983

5 O 0 0.007409786339849234
Mb O 0 0.021122446283698082
telomeric O 0 0.04420975223183632
to O 0 0.0035179532133042812
HLA O 1 0.999931812286377
- O 0 0.06620513647794724
A O 0 0.008275498636066914
. O 0 0.0014401223743334413

Population O 0 0.000498831330332905
studies O 0 0.00015929117216728628
of O 0 0.0001995121274376288
this O 0 7.99797780928202e-05
polymorphism O 0 0.0001548414584249258
are O 0 2.046923509624321e-05
facilitated O 0 0.00023577340471092612
by O 0 3.760903928196058e-05
the O 0 8.294061990454793e-05
fact O 0 8.242278272518888e-05
that O 0 4.4584328861674294e-05
the O 0 0.0002865187416318804
Cys282Tyr O 1 0.9611234664916992
mutation O 0 0.0007112245657481253
creates O 0 0.0008715346921235323
a O 0 0.0007378616137430072
Rsal O 1 0.9085796475410461
restriction O 0 0.0010753297246992588
site O 0 0.0019109988352283835
. O 0 0.0007207005983218551

We O 0 0.0007580203237012029
have O 0 0.0001033363732858561
studied O 0 0.00019210620666854084
the O 0 0.0002121619036188349
codon O 0 0.0012542359763756394
282 O 0 0.00310868164524436
( O 0 0.0007866360829211771
Cys O 1 0.9836533069610596
/ O 0 0.04712055251002312
Tyr O 0 0.48777487874031067
) O 0 0.00022635342611465603
polymorphism O 0 0.0003485464258119464
in O 0 6.829926860518754e-05
different O 0 2.5821536837611347e-05
ethnic O 0 0.0001477305340813473
groups O 0 0.00014136619574856013
. O 0 0.0005012705805711448

In O 0 0.0010511906584724784
agreement O 0 0.0005044240970164537
with O 0 0.0001306968624703586
previous O 0 0.0002892165502998978
observations O 0 0.0003633041924331337
the O 0 0.00043819446000270545
Tyr O 1 0.9333352446556091
allele O 0 0.0007024987135082483
appeared O 0 0.00027876938111148775
to O 0 6.509580271085724e-05
be O 0 5.759148552897386e-05
rare O 0 0.0001596415095264092
or O 0 8.686822548042983e-05
absent O 0 0.0002748469414655119
in O 0 0.00010131613089470193
Asiatic O 0 0.005385642405599356
( O 0 0.00014504815044347197
Indian O 0 0.00032116484362632036
, O 0 0.00011050596367567778
Chinese O 0 0.0005801566876471043
) O 0 0.0001323907054029405
populations O 0 0.00019057697500102222
. O 0 0.00030130412778817117

The O 0 0.0013406062498688698
highest O 0 0.0010524953249841928
allele O 0 0.0002668951347004622
frequency O 0 9.696456982055679e-05
( O 0 3.9104466850403696e-05
7 O 0 7.055902824504301e-05
. O 0 1.8117823856300674e-05
5 O 0 4.471879583434202e-05
% O 0 3.268405998824164e-05
) O 0 2.403909275017213e-05
was O 0 0.00013593690528068691
found O 0 8.757661998970434e-05
in O 0 0.00015664937382098287
Swedes O 0 0.001813249196857214
. O 0 0.0008452775655314326

Saamis O 1 0.8459492921829224
( O 0 0.001086664036847651
2 O 0 0.0005380769143812358
% O 0 0.00015839542902540416
) O 0 7.958582864375785e-05
and O 0 9.828600741457194e-05
Mordvinians O 0 0.04797789826989174
( O 0 0.00014929375902283937
1 O 0 0.0001061215007212013
. O 0 2.9883367460570298e-05
8 O 0 8.428778528468683e-05
% O 0 3.3489825000287965e-05
) O 0 3.0213766876840964e-05
had O 0 8.657143189338967e-05
significantly O 0 0.00011645157792372629
lower O 0 9.246361150871962e-05
frequencies O 0 6.490124360425398e-05
of O 0 0.00014455674681812525
the O 0 0.000591393793001771
Tyr O 1 0.6860248446464539
allele O 0 0.0014832314336672425
. O 0 0.0008635452250018716

Comparisons O 0 0.0020702453330159187
with O 0 0.0003833552182186395
allele O 0 0.0005326140089891851
frequencies O 0 0.0001528996363049373
based O 0 5.1417398935882375e-05
on O 0 0.00012739239900838584
prevalence O 0 0.0005134436069056392
estimates O 0 0.00014474708586931229
of O 0 0.00035632087383419275
HH B-Disease 1 0.9999490976333618
showed O 0 0.000542577647138387
some O 0 8.032756159082055e-05
disagreements O 0 0.00026876767515204847
with O 0 7.202375127235427e-05
the O 0 0.0004849546530749649
RFLP O 0 0.04653540998697281
data O 0 0.00013439630856737494
, O 0 0.00010239228140562773
particularly O 0 0.00017117625975515693
in O 0 0.0001515639160061255
Finns O 0 0.002319395774975419
. O 0 0.0006932347314432263

The O 0 0.003917271271348
newly O 0 0.006972901988774538
described O 0 0.004904593341052532
HFE O 1 0.9994624257087708
marker O 0 0.0035216156393289566
provides O 0 0.00015118172450456768
a O 0 0.0001042704752762802
new O 0 7.362383621511981e-05
approach O 0 7.219317922135815e-05
to O 0 3.092682527494617e-05
the O 0 9.472040983382612e-05
screening O 0 0.0001448346156394109
of O 0 0.00039696425665169954
HH B-Disease 1 0.9999499320983887
as O 0 0.00025954697048291564
well O 0 4.863298454438336e-05
as O 0 4.211760460748337e-05
studies O 0 1.824836181185674e-05
of O 0 4.7024084778968245e-05
the O 0 0.00011901654215762392
relationship O 0 0.00020929115999024361
between O 0 0.00028861028840765357
the O 0 0.0489453449845314
HFE O 1 0.9999983310699463
Tyr O 1 0.9998741149902344
allele O 0 0.0018943831091746688
and O 0 0.0005047432496212423
different O 0 0.00048065994633361697
disorders O 1 0.9999887943267822
including O 1 0.9618868231773376
cancer B-Disease 1 0.9999903440475464

Autosomal B-Disease 1 0.9996684789657593
dominant I-Disease 1 0.999991774559021
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 0.9999911785125732
associated O 0 0.0013572836760431528
with O 0 0.00020551614579744637
a O 0 0.0004731526714749634
missense O 0 0.0013896741438657045
mutation O 0 0.0002886119473259896
encoding O 0 0.0002518827677704394
Gly23 O 1 0.9627587199211121
- O 0 0.0038757866714149714
- O 0 0.001565590500831604
> O 0 0.0013094096211716533
Val O 0 0.009486313909292221
in O 0 0.0008118064724840224
neurophysin O 1 0.9952670335769653
II O 1 0.9998020529747009
. O 0 0.002455623121932149

Autosomal B-Disease 1 0.9996660947799683
dominant I-Disease 1 0.9999938011169434
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 0.9999998807907104
( O 1 0.9996059536933899
ADNDI B-Disease 1 0.9999998807907104
) O 0 0.0006625092355534434
is O 0 0.0002959088596981019
an O 0 0.056516289710998535
inherited B-Disease 1 1.0
disease I-Disease 1 1.0
caused O 1 1.0
by O 1 0.998102605342865
progressive O 1 0.9999996423721313
degeneration O 1 1.0
of O 1 0.9991660118103027
the O 1 0.9976673126220703
magnocellular O 1 0.9999593496322632
neurons O 0 0.0020812973380088806
of O 0 0.00039459599065594375
the O 0 0.0010524753015488386
hypothalamus O 0 0.23932327330112457
leading O 0 0.0009105578064918518
to O 0 0.0001204140207846649
decreased O 0 0.0006658888305537403
ability O 0 8.54218887980096e-05
to O 0 5.016074646846391e-05
produce O 0 0.0001617412199266255
the O 0 0.0005031178006902337
hormone O 0 0.0601939782500267
arginine O 0 0.007548998575657606
vasopressin O 0 0.20168381929397583
( O 0 0.0014839456416666508
AVP O 1 0.9869383573532104
) O 0 0.001014229259453714
. O 0 0.0007954688044264913

Affected O 0 0.004677602555602789
individuals O 0 0.00027485008467920125
are O 0 6.57316340948455e-05
not O 0 0.00013545180263463408
symptomatic O 1 0.9971011281013489
at O 1 0.7033870220184326
birth O 0 0.12570272386074066
, O 0 0.00022682224516756833
but O 0 0.00014837199705652893
usually O 0 0.00018903071759268641
develop O 0 0.002295702463015914
diabetes B-Disease 1 0.9998335838317871
insipidus I-Disease 1 0.9901475310325623
at O 0 0.0024714635219424963
1 O 0 0.000565267342608422
- O 0 0.0008066407754085958
6 O 0 0.0007337742135860026
yr O 0 0.006759124808013439
of O 0 0.0006115494761615992
age O 0 0.0012740300735458732
. O 0 0.0008283028146252036

The O 0 0.002538388129323721
genetic O 0 0.0011466918513178825
locus O 0 0.002544255228713155
of O 0 0.0014030360616743565
the O 0 0.44359615445137024
disease O 1 0.9999772310256958
is O 0 0.000648026296403259
the O 0 0.06449951976537704
AVP O 1 0.9999988079071045
- O 1 0.987506628036499
neurophysin O 1 0.9999167919158936
II O 1 0.9999966621398926
( O 0 0.002562381559982896
NPII O 1 0.9998751878738403
) O 0 0.00023011276789475232
gene O 0 0.00023757977760396898
, O 0 0.00010460220801178366
and O 0 8.465945575153455e-05
mutations O 0 0.0002413448237348348
that O 0 0.00013255668454803526
cause O 1 0.9687771201133728
ADNDI B-Disease 1 0.9999923706054688
have O 0 7.094413012964651e-05
been O 0 4.866174640483223e-05
found O 0 3.3985030313488096e-05
in O 0 3.175061283400282e-05
both O 0 2.1404981453088112e-05
the O 0 7.293838280020282e-05
signal O 0 0.00032144668512046337
peptide O 0 0.00024899691925384104
of O 0 0.0001507185079390183
the O 0 0.0005456746439449489
prepro O 1 0.9986842274665833
- O 0 0.388194739818573
AVP O 1 0.9998887777328491
- O 0 0.06075175106525421
NPII O 1 0.9989913105964661
precursor O 0 0.005506641231477261
and O 0 0.0002891931217163801
within O 0 0.0005578080308623612
NPII O 1 0.9997020363807678
itself O 0 0.0025094239972531796
. O 0 0.0009711407474242151

An O 0 0.003148827701807022
affected O 0 0.0016850902466103435
girl O 0 0.0023595148231834173
who O 0 0.0002553020021878183
presented O 0 0.0002993253874592483
at O 0 0.0002748162660282105
9 O 0 0.00021476790425367653
months O 0 0.00011199835716979578
of O 0 0.00013012000999879092
age O 0 0.0002758749760687351
and O 0 9.504931222181767e-05
her O 0 0.0002617430000100285
similarly O 0 0.000252908852417022
affected O 0 0.0004463559598661959
younger O 0 0.0006817422690801322
brother O 0 0.0025128473062068224
and O 0 7.351229578489438e-05
father O 0 0.0005327381659299135
were O 0 4.410402470966801e-05
all O 0 1.929803693201393e-05
found O 0 2.012541335716378e-05
to O 0 2.1183674107305706e-05
have O 0 1.5152540072449483e-05
a O 0 8.479502139380202e-05
novel O 0 0.00019926310051232576
missense O 0 0.0006341931293718517
mutation O 0 0.0003158428589813411
( O 0 0.0003157717874273658
G1758 O 1 0.9723765850067139
- O 0 0.010639753192663193
- O 0 0.0015099720330908895
> O 0 0.0015546949580311775
T O 0 0.001230455469340086
) O 0 4.4352786062518135e-05
encoding O 0 6.278774526435882e-05
the O 0 8.922594861360267e-05
amino O 0 0.00021170522086322308
acid O 0 0.0005577567499130964
substitution O 0 0.0012723990948870778
Gly23 O 1 0.9865728616714478
- O 0 0.008144460618495941
- O 0 0.0028107946272939444
> O 0 0.0021387171000242233
Val O 0 0.01245869044214487
within O 0 0.0010398895246908069
NPII O 1 0.995557963848114
. O 0 0.002119670622050762

The O 0 0.0026929534506052732
mutation O 0 0.0013912221184000373
was O 0 0.0009797305101528764
confirmed O 0 0.00048533990047872066
by O 0 0.00016731514187995344
restriction O 0 0.0008092514472082257
endonuclease O 0 0.003682743990793824
analysis O 0 0.0005828827852383256
. O 0 0.0009430907084606588

A O 0 0.047213681042194366
T1 O 1 0.9974310994148254
- O 0 0.005325909238308668
weighted O 0 0.0018014927627518773
magnetic O 0 0.0018365764990448952
resonance O 0 0.001563532743602991
imaging O 0 0.0010327218333259225
of O 0 0.000575019686948508
the O 0 0.00375874200835824
fathers O 1 0.9929857850074768
pituitary O 1 0.9999972581863403
gland O 1 0.9999550580978394
demonstrates O 0 0.36923083662986755
an O 0 0.007763933390378952
attenuated O 1 0.9961283206939697
posterior O 1 0.9996463060379028
pituitary O 1 0.9999914169311523
bright O 1 0.9596037268638611
spot O 0 0.02268737368285656
. O 0 0.001862343167886138

This O 0 0.001639251597225666
mutation O 0 0.0011098983231931925
may O 0 0.0003105317009612918
be O 0 0.0001081214941223152
valuable O 0 0.0003287779400125146
for O 0 6.360505358316004e-05
developing O 0 0.0002052576601272449
models O 0 0.000284364476101473
of O 0 0.0014437743229791522
dominantly B-Disease 1 0.9999593496322632
inherited I-Disease 1 0.9999997615814209
neurodegeneration I-Disease 1 1.0
, O 0 0.0007338899304158986
as O 0 0.0001261708966922015
the O 0 0.00014438621292356402
early O 0 0.00018023083976004273
age O 0 0.00016419529856648296
of O 0 0.0004143915430177003
onset O 1 0.9999444484710693
of O 1 0.9871542453765869
symptoms O 1 0.9999892711639404
suggests O 0 0.0006906329654157162
that O 0 6.0316808230709285e-05
this O 0 4.112006354262121e-05
mutation O 0 9.320581011706963e-05
may O 0 6.326906441245228e-05
be O 0 4.19532043451909e-05
particularly O 0 0.00011733526480384171
deleterious O 0 0.0003822184808086604
to O 0 0.00011145821190439165
the O 0 0.0007227158057503402
magnocellular O 1 0.9989228844642639
neuron O 1 0.948665201663971
. O 0 0.000708347768522799
. O 0 0.0011173089733347297

Frequent O 0 0.0083804065361619
inactivation O 0 0.16056384146213531
of O 0 0.18387244641780853
PTEN O 1 0.9999947547912598
/ O 1 0.9981155395507812
MMAC1 O 1 0.999982476234436
in O 0 0.34685203433036804
primary O 1 0.9998906850814819
prostate B-Disease 1 1.0
cancer I-Disease 1 0.9999995231628418
. O 0 0.00569984270259738

Sporadic B-Disease 1 0.9999717473983765
prostate I-Disease 1 1.0
carcinoma I-Disease 1 1.0
is O 0 0.0039773182943463326
the O 0 0.000762550684157759
most O 0 0.00013972452143207192
common O 0 0.0005076327361166477
male B-Disease 0 0.39696046710014343
cancer I-Disease 1 0.9741036891937256
in O 0 9.584122017258778e-05
the O 0 0.000176379136973992
Western O 0 0.00032629171619191766
world O 0 0.0002632568939588964
, O 0 4.229421028867364e-05
yet O 0 2.8797241611755453e-05
many O 0 1.2563295058498625e-05
of O 0 5.635221896227449e-05
the O 0 9.550056711304933e-05
major O 0 0.0004955037729814649
genetic O 0 0.00015210856508929282
events O 0 0.0001331998355453834
involved O 0 7.541623199358582e-05
in O 0 5.713782593375072e-05
the O 0 0.00014392845332622528
progression O 0 0.019531454890966415
of O 0 0.0006263251998461783
this O 0 0.00029964689747430384
often O 0 0.0007492786389775574
fatal O 1 0.9999983310699463
cancer B-Disease 1 0.9997879862785339
remain O 0 0.0004966926062479615
to O 0 0.00019863387569785118
be O 0 0.00024708628188818693
elucidated O 0 0.005924861412495375
. O 0 0.0010239297989755869

Numerous O 0 0.00872885249555111
cytogenetic O 1 0.9745702743530273
and O 0 0.0014448348665609956
allelotype O 1 0.9966275095939636
studies O 0 0.00020792153372894973
have O 0 8.684478962095454e-05
reported O 0 0.00020074464555364102
frequent O 0 0.00026429680292494595
loss O 0 0.0009134049178101122
of O 0 0.0011403847020119429
heterozygosity O 1 0.9997262358665466
on O 0 0.023799298331141472
chromosomal O 1 0.9995100498199463
arm O 1 0.9997996687889099
10q O 1 0.9999511241912842
in O 0 0.31312307715415955
sporadic B-Disease 1 0.9999774694442749
prostate I-Disease 1 1.0
cancer I-Disease 1 0.9999995231628418
. O 0 0.004369319882243872

Deletion O 0 0.00859028473496437
mapping O 0 0.001857403782196343
studies O 0 0.0003032713430002332
have O 0 7.35289795557037e-05
unambiguously O 0 0.000488065998069942
identified O 0 0.00021119271696079522
a O 0 0.0001803209015633911
region O 0 0.0002940092817880213
of O 0 0.00048574208631180227
chromosome O 0 0.0031109137926250696
10q23 O 1 0.8261890411376953
to O 0 0.00010870269761653617
be O 0 4.447442552191205e-05
the O 0 7.621569966431707e-05
minimal O 0 0.00022140666260384023
area O 0 0.00022547156549990177
of O 0 0.0004689213237725198
loss O 0 0.15435336530208588
. O 0 0.0007973614847287536

A O 0 0.00827011652290821
new O 0 0.00342072662897408
tumor B-Disease 1 0.9999420642852783
suppressor O 1 0.9993211030960083
gene O 0 0.002367798238992691
, O 0 0.001109583885408938
PTEN O 1 0.9999791383743286
/ O 1 0.9528719186782837
MMAC1 O 1 0.9999221563339233
, O 0 0.00033754677860997617
was O 0 0.0007708608754910529
isolated O 0 0.00042705339728854597
recently O 0 0.00021198335161898285
at O 0 0.00012424608576111495
this O 0 3.616175672505051e-05
region O 0 0.00010452383867232129
of O 0 0.00018593495769891888
chromosome O 0 0.0011281194165349007
10q23 O 1 0.820959210395813
and O 0 6.534133717650548e-05
found O 0 4.375790013000369e-05
to O 0 2.5352730517624877e-05
be O 0 3.4546672395663336e-05
inactivated O 0 0.00035816009039990604
by O 0 5.1004099077545106e-05
mutation O 0 0.0001475525787100196
in O 0 0.000230035133427009
three O 0 0.006062826607376337
prostate B-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
cell O 1 0.9835281372070312
lines O 0 0.0030763435643166304
. O 0 0.0008298789616674185

We O 0 0.0033196196891367435
screened O 0 0.008591298945248127
80 O 1 0.6572312712669373
prostate B-Disease 1 0.999997615814209
tumors I-Disease 1 0.9999395608901978
by O 0 0.0005085915909148753
microsatellite O 0 0.004822791088372469
analysis O 0 0.00016022802446968853
and O 0 0.00010114864562638104
found O 0 0.0001975730701815337
chromosome O 0 0.0005467385053634644
10q23 O 0 0.07133204489946365
to O 0 8.980787970358506e-05
be O 0 6.923067849129438e-05
deleted O 0 0.0001912477455334738
in O 0 0.0001244192972080782
23 O 0 0.0006340556428767741
cases O 0 0.00038415566086769104
. O 0 0.0004993238835595548

We O 0 0.0011931275948882103
then O 0 0.0005317757022567093
proceeded O 0 0.0007890414563007653
with O 0 7.012823334662244e-05
sequence O 0 0.00010105127876158804
analysis O 0 5.9408364904811606e-05
of O 0 0.00013808190124109387
the O 0 0.0002933954820036888
entire O 0 0.07614042609930038
PTEN O 1 0.9999788999557495
/ O 0 0.35477760434150696
MMAC1 O 1 0.999338686466217
coding O 0 0.0009051093365997076
region O 0 0.0002631743554957211
and O 0 0.00011860133236041293
tested O 0 0.0002208597434218973
for O 0 7.045172242214903e-05
homozygous O 0 0.0001975199847947806
deletion O 0 0.00027211697306483984
with O 0 7.680903217988089e-05
new O 0 0.0001845744700403884
intragenic O 1 0.7703272700309753
markers O 0 0.0006140293553471565
in O 0 9.265197877539322e-05
these O 0 2.9243858080008067e-05
23 O 0 0.00019099029304925352
cases O 0 9.065116319106892e-05
with O 0 0.00019471748964861035
10q23 O 1 0.9958672523498535
loss O 0 0.2969244420528412
of O 0 0.0059775300323963165
heterozygosity O 1 0.9993207454681396
. O 0 0.002276079496368766

The O 0 0.0011042177211493254
identification O 0 0.0003929730737581849
of O 0 0.0002998189302161336
the O 0 0.0004306342452764511
second O 0 0.0013183570699766278
mutational O 0 0.0064264824613928795
event O 0 0.00037575940950773656
in O 0 7.786331116221845e-05
10 O 0 7.555415504612029e-05
( O 0 4.214636646793224e-05
43 O 0 0.00014996576646808535
% O 0 0.0001327130157733336
) O 0 0.0003064606571570039
tumors B-Disease 1 0.999365508556366
establishes O 0 0.24369071424007416
PTEN O 1 0.9999802112579346
/ O 0 0.30920693278312683
MMAC1 O 1 0.9937130808830261
as O 0 0.0002916187804657966
a O 0 0.00020120800763834268
main O 0 0.00046655486221425235
inactivation O 0 0.0015623338986188173
target O 0 0.0002723521611187607
of O 0 0.00039538892451673746
10q O 1 0.9988561868667603
loss O 1 0.9731718301773071
in O 0 0.00963666383177042
sporadic B-Disease 1 0.9999867677688599
prostate I-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
. O 0 0.0013297770638018847
. O 0 0.0009456677362322807

Risk O 0 0.011165177449584007
reversals O 0 0.01268234197050333
in O 0 0.001425115973688662
predictive O 0 0.004123122896999121
testing O 0 0.011928829364478588
for O 0 0.05620980262756348
Huntington B-Disease 1 0.9999998807907104
disease I-Disease 1 0.9999995231628418
. O 0 0.00491481414064765

The O 0 0.0020173341035842896
first O 0 0.0013801619643345475
predictive O 0 0.0020651263184845448
testing O 0 0.0013988001737743616
for O 0 0.0016748879570513964
Huntington B-Disease 1 0.9999998807907104
disease I-Disease 1 1.0
( O 0 0.10919928550720215
HD B-Disease 1 0.6571513414382935
) O 0 7.100707443896681e-05
was O 0 0.00013142770330887288
based O 0 2.0773439246113412e-05
on O 0 2.847635914804414e-05
analysis O 0 3.6355111660668626e-05
of O 0 0.00012263411190360785
linked O 0 0.0005048216553404927
polymorphic O 0 0.0009106315555982292
DNA O 0 0.0003370260528754443
markers O 0 0.00028765294700860977
to O 0 4.218988033244386e-05
estimate O 0 5.519960177480243e-05
the O 0 5.550273272092454e-05
likelihood O 0 0.0001183768326882273
of O 0 0.00011521857231855392
inheriting O 0 0.002634954871609807
the O 0 0.0004892369615845382
mutation O 0 0.0005249419482424855
for O 0 0.0004005793889518827
HD B-Disease 0 0.010289432480931282
. O 0 0.0007671499042771757

Limits O 0 0.0013241568813100457
to O 0 0.000216572530916892
accuracy O 0 0.0003486747154965997
included O 0 0.00018444219313096255
recombination O 0 0.00032638534321449697
between O 0 0.00012317193613853306
the O 0 0.00019470506231300533
DNA O 0 0.0003926933859474957
markers O 0 0.0006096828146837652
and O 0 7.787578942952678e-05
the O 0 0.00016679457621648908
mutation O 0 0.0001405669463565573
, O 0 6.072496034903452e-05
pedigree O 0 0.00044400247861631215
structure O 0 0.00021581251348834485
, O 0 5.217916623223573e-05
and O 0 2.614539880596567e-05
whether O 0 2.3625188987352885e-05
DNA O 0 6.622944783885032e-05
samples O 0 4.298620478948578e-05
were O 0 4.058029662701301e-05
available O 0 2.1412861315184273e-05
from O 0 6.850186036899686e-05
family O 0 0.00018169352551922202
members O 0 0.000200960086658597
. O 0 0.0005873697227798402

With O 0 0.0005752333672717214
direct O 0 0.0003805059823207557
tests O 0 0.00019646457803901285
for O 0 9.34005729504861e-05
the O 0 0.0002949872286990285
HD B-Disease 1 0.5352597832679749
mutation O 0 0.00022529881971422583
, O 0 5.697855885955505e-05
we O 0 3.676792766782455e-05
have O 0 1.0789864063553978e-05
assessed O 0 3.6278197512729093e-05
the O 0 4.5393233449431136e-05
accuracy O 0 9.646572289057076e-05
of O 0 0.000118291522085201
results O 0 6.238762580323964e-05
obtained O 0 6.205138197401538e-05
by O 0 4.968055509380065e-05
linkage O 0 0.00043770059710368514
approaches O 0 0.000227088836254552
when O 0 9.68298627412878e-05
requested O 0 5.5913387768669054e-05
to O 0 2.4167446099454537e-05
do O 0 2.2558995624422096e-05
so O 0 1.7386473700753413e-05
by O 0 2.3481232346966863e-05
the O 0 9.263819083571434e-05
test O 0 0.0002826909185387194
individuals O 0 0.00013704797311220318
. O 0 0.00038748147198930383

For O 0 0.0008138158591464162
six O 0 0.0004062776861246675
such O 0 0.00011443011317169294
individuals O 0 9.327461884822696e-05
, O 0 9.146355296252295e-05
there O 0 0.00010813634435180575
was O 0 0.0005319275078363717
significant O 0 0.00033648620592430234
disparity O 0 0.001124827191233635
between O 0 0.0002737994655035436
the O 0 0.0004841964691877365
tests O 0 0.0006160346092656255
. O 0 0.0005416994099505246

Three O 0 0.0010378941660746932
went O 0 0.0009864497696980834
from O 0 0.000253328267717734
a O 0 0.0003786468878388405
decreased O 0 0.002084152540192008
risk O 0 6.676036718999967e-05
to O 0 2.716003655223176e-05
an O 0 8.598892600275576e-05
increased O 0 0.00018739157530944794
risk O 0 8.981121936812997e-05
, O 0 3.0129458536976017e-05
while O 0 2.057083838735707e-05
in O 0 2.670538378879428e-05
another O 0 7.855705916881561e-05
three O 0 6.475904228864238e-05
the O 0 0.00019715889357030392
risk O 0 0.0005108682089485228
was O 0 0.0048223198391497135
decreased O 0 0.008109774440526962
. O 0 0.0006435770774260163

Knowledge O 0 0.0032193216029554605
of O 0 0.0009383001597598195
the O 0 0.0005381164373829961
potential O 0 0.00041997668449766934
reasons O 0 0.00013557379133999348
for O 0 5.251512266113423e-05
these O 0 1.8946891941595823e-05
changes O 0 5.340773714124225e-05
in O 0 6.311058677965775e-05
results O 0 5.504757791641168e-05
and O 0 3.645759716164321e-05
impact O 0 0.00010723456216510385
of O 0 0.00010331410157959908
these O 0 4.353953409008682e-05
risk O 0 0.00015191143029369414
reversals O 0 0.017136946320533752
on O 0 0.00020312810374889523
both O 0 9.111586405197158e-05
patients O 0 9.857651457423344e-05
and O 0 4.8464135034009814e-05
the O 0 0.00019302348664496094
counseling O 0 0.0005755091551691294
team O 0 0.0001424715155735612
can O 0 2.0608047634596005e-05
assist O 0 5.112939834361896e-05
in O 0 2.433498048048932e-05
the O 0 5.508549293153919e-05
development O 0 8.245342905865982e-05
of O 0 8.523068390786648e-05
strategies O 0 9.93738358374685e-05
for O 0 4.3229239963693544e-05
the O 0 0.00017073645722121
prevention O 0 0.2962268590927124
and O 0 5.97311336605344e-05
, O 0 3.0895633244654164e-05
where O 0 3.5745313653023914e-05
necessary O 0 5.5407497711712494e-05
, O 0 3.8374117139028385e-05
management O 0 6.218489579623565e-05
of O 0 6.282429239945486e-05
a O 0 0.0001649867626838386
risk O 0 0.000164296172442846
reversal O 0 0.0007175501668825746
in O 0 7.800496678100899e-05
any O 0 6.923787441337481e-05
predictive O 0 0.0003561575140338391
testing O 0 0.00027736322954297066
program O 0 0.0002121346042258665
. O 0 0.00012147572851972654
. O 0 0.00032003395608626306

A O 0 0.0080629987642169
novel O 0 0.0036426656879484653
common O 0 0.0008322193170897663
missense O 0 0.002697974443435669
mutation O 0 0.0005567297921516001
G301C O 0 0.0036285831592977047
in O 0 0.00016583861724939197
the O 0 0.00031509637483395636
N O 0 0.0017015119083225727
- O 0 0.0013682342832908034
acetylgalactosamine O 0 0.12965942919254303
- O 0 0.0020203900057822466
6 O 0 0.0015050225192680955
- O 0 0.0026859675999730825
sulfate O 0 0.10381869971752167
sulfatase O 1 0.9331267476081848
gene O 0 0.0008927384042181075
in O 0 0.0008413096657022834
mucopolysaccharidosis B-Disease 1 0.9994094371795654
IVA I-Disease 1 0.9999053478240967
. O 0 0.002989212516695261

Mucopolysaccharidosis B-Disease 1 0.9999253749847412
IVA I-Disease 1 0.9999934434890747
( O 0 0.4570316970348358
MPS B-Disease 1 0.9993162155151367
IVA I-Disease 1 0.999997615814209
) O 0 0.0008657804573886096
is O 0 0.000341549253789708
an O 0 0.0006028934731148183
autosomal B-Disease 1 0.9945439100265503
recessive I-Disease 1 0.9999971389770508
lysosomal I-Disease 1 1.0
storage I-Disease 1 1.0
disorder I-Disease 1 1.0
caused O 1 0.999997615814209
by O 0 0.0014048691373318434
a O 0 0.09400034695863724
genetic B-Disease 1 0.9335800409317017
defect I-Disease 1 0.9999659061431885
in O 0 0.0005680632311850786
N O 0 0.01876588724553585
- O 0 0.0016762654995545745
acetylgalactosamine O 0 0.13889282941818237
- O 0 0.0014550613705068827
6 O 0 0.0012505846098065376
- O 0 0.004749473184347153
sulfate O 1 0.7329421639442444
sulfatase O 1 0.9973863959312439
( O 0 0.0026012270245701075
GALNS O 1 0.9989829659461975
) O 0 0.0016367532080039382
. O 0 0.0010254267835989594

In O 0 0.001266642240807414
previous O 0 0.0006411352078430355
studies O 0 0.00016909377882257104
, O 0 0.00012124682689318433
we O 0 5.716648593079299e-05
have O 0 2.2428550437325612e-05
found O 0 3.489609662210569e-05
two O 0 3.9409198507200927e-05
common O 0 0.00013946708349976689
mutations O 0 0.00016732995572965592
in O 0 0.0001950787554960698
Caucasians O 0 0.0025732130743563175
and O 0 0.0002124088496202603
Japanese O 0 0.004582641180604696
, O 0 0.00029783177888020873
respectively O 0 0.0006544545176438987
. O 0 0.0005988177144899964

To O 0 0.0014496386284008622
characterize O 0 0.0029007666744291782
the O 0 0.0008460910758003592
mutational O 0 0.021040823310613632
spectrum O 0 0.00039478670805692673
in O 0 0.00010531381121836603
various O 0 6.29232163191773e-05
ethnic O 0 7.543479296145961e-05
groups O 0 4.0244813135359436e-05
, O 0 4.7931662265909836e-05
mutations O 0 6.329754978651181e-05
in O 0 6.178656622068956e-05
the O 0 0.0004073577292729169
GALNS O 1 0.9997319579124451
gene O 0 0.00026916226488538086
in O 0 0.0002598965947981924
Colombian O 0 0.007884184829890728
MPS B-Disease 1 0.9982848763465881
IVA I-Disease 1 0.9999996423721313
patients O 0 0.005099467467516661
were O 0 0.00019304780289530754
investigated O 0 0.000742527365218848
, O 0 0.0001377060980303213
and O 0 8.967891335487366e-05
genetic O 0 0.00011106055899290368
backgrounds O 0 0.00013399732415564358
were O 0 8.156675903592259e-05
extensively O 0 0.0001651114143896848
analyzed O 0 8.817450725473464e-05
to O 0 4.33671084465459e-05
identify O 0 7.8862693044357e-05
racial O 0 0.0002942425780929625
origin O 0 8.33567391964607e-05
, O 0 5.450880416901782e-05
based O 0 3.39445068675559e-05
on O 0 8.334688027389348e-05
mitochondrial O 0 0.000440024072304368
DNA O 0 0.00036730177816934884
( O 0 0.00018243111844640225
mtDNA O 0 0.00030136300483718514
) O 0 0.00017406351980753243
lineages O 0 0.0008137511322274804
. O 0 0.0005737363244406879

Three O 0 0.002366066677495837
novel O 0 0.0023611788637936115
missense O 0 0.005250284913927317
mutations O 0 0.0003300554526504129
never O 0 0.00025955686578527093
identified O 0 0.00010043625661637634
previously O 0 8.543606963939965e-05
in O 0 2.88663650280796e-05
other O 0 1.974707811314147e-05
populations O 0 1.6608189980615862e-05
and O 0 1.621830051590223e-05
found O 0 1.9574174075387418e-05
in O 0 2.6778780011227354e-05
16 O 0 6.429691711673513e-05
out O 0 5.5081862228689715e-05
of O 0 0.00011402393283788115
19 O 0 0.0005116542452014983
Colombian O 0 0.002401184756308794
MPS B-Disease 0 0.35318002104759216
IVA I-Disease 1 0.9999649524688721
unrelated O 0 0.001676618936471641
alleles O 0 0.000321477884426713
account O 0 0.0002187003119615838
for O 0 0.00022055271256249398
84 O 0 0.002010201569646597
. O 0 0.0010569235309958458

2 O 0 0.0013806457864120603
% O 0 0.00024502724409103394
of O 0 0.00028180531808175147
the O 0 0.0002903708955273032
alleles O 0 0.0002444126585032791
in O 0 0.00012914951366838068
this O 0 0.00012006753968307748
study O 0 0.000301852123811841
. O 0 0.00035570215550251305

The O 0 0.010206751525402069
G301C O 1 0.9924349188804626
and O 0 0.0017301932675763965
S162F O 1 0.9805065393447876
mutations O 0 0.0007176234503276646
account O 0 0.00018477275443729013
for O 0 0.00019930434064008296
68 O 0 0.00143900653347373
. O 0 0.0010301523143425584

4 O 0 0.0026568446774035692
% O 0 0.0006602482753805816
and O 0 0.00047538208309561014
10 O 0 0.0009544561617076397
. O 0 0.0009241979569196701

5 O 0 0.0011564482701942325
% O 0 0.00026548150344751775
of O 0 0.00044092978350818157
mutations O 0 0.00033711810829117894
, O 0 0.00012461630103643984
respectively O 0 0.0002439549280097708
, O 0 0.00011083573917858303
whereas O 0 0.00012428578338585794
the O 0 0.000152164269820787
remaining O 0 0.00042511205538176
F69V O 1 0.9970360994338989
is O 0 0.00011843756510643288
limited O 0 7.05827769706957e-05
to O 0 4.268318662070669e-05
a O 0 0.00020199861319269985
single O 0 0.0004811245307791978
allele O 0 0.0009324236307293177
. O 0 0.0006046307389624417

The O 0 0.002624726854264736
skewed O 0 0.002774439752101898
prevalence O 0 0.0027002755086869
of O 0 0.001591512351296842
G301C O 1 0.9869798421859741
in O 0 0.00037218042416498065
only O 0 0.00016992147720884532
Colombian O 0 0.0011870615417137742
patients O 0 0.00027256255270913243
and O 0 0.00012782460544258356
haplotype O 0 0.000409140920965001
analysis O 0 7.652711065020412e-05
by O 0 8.432999311480671e-05
restriction O 0 0.00023370180861093104
fragment O 0 0.0003253539325669408
length O 0 0.00021771498722955585
polymorphisms O 0 0.0002684751234482974
in O 0 9.482867608312517e-05
the O 0 0.00031949314870871603
GALNS O 1 0.9997267127037048
gene O 0 0.0003298727096989751
suggest O 0 0.00016855436842888594
that O 0 7.380780152743682e-05
G301C O 0 0.0026312924455851316
originated O 0 0.00028231978649273515
from O 0 0.00013604399282485247
a O 0 0.0002699237666092813
common O 0 0.0003616379399318248
ancestor O 0 0.0030658687464892864
. O 0 0.001103367074392736

Investigation O 0 0.0026588484179228544
of O 0 0.0006223942036740482
the O 0 0.000442363292677328
genetic O 0 0.0003380190464667976
background O 0 0.00021775900677312165
by O 0 7.236935925902799e-05
means O 0 0.00010754854883998632
of O 0 0.00011947570601478219
mtDNA O 0 0.00013639457756653428
lineages O 0 0.00014320264745038003
indicate O 0 9.935687558026984e-05
that O 0 2.5446595827816054e-05
all O 0 2.0433410099940374e-05
our O 0 7.556323544122279e-05
patients O 0 6.08479676884599e-05
are O 0 1.819508361222688e-05
probably O 0 0.0001394442078890279
of O 0 0.0002062064886558801
native O 0 0.0006168963154777884
American O 0 0.0014394992031157017
descent O 0 0.007407068274915218

Low O 0 0.003659168491140008
frequency O 0 0.0011994745582342148
of O 0 0.0009459334542043507
BRCA1 O 1 0.8216484189033508
germline O 0 0.01713535562157631
mutations O 0 0.0002502320858184248
in O 0 0.00014860420196782798
45 O 0 0.0006271644961088896
German O 1 0.9995506405830383
breast B-Disease 1 1.0
/ I-Disease 1 0.9999998807907104
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999994039535522
families O 0 0.003577420487999916
. O 0 0.0011327685788273811

In O 0 0.000790117890574038
this O 0 0.00017583223234396428
study O 0 0.00013464104267768562
we O 0 7.21257456461899e-05
investigated O 0 0.0002975190000142902
45 O 0 0.0005200451705604792
German O 1 0.9960435628890991
breast B-Disease 1 0.9999998807907104
/ I-Disease 1 0.9999997615814209
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999943971633911
families O 0 0.0003448252391535789
for O 0 0.0002337372425245121
germline O 0 0.4750397503376007
mutations O 0 0.0002235003194073215
in O 0 0.00017755049339029938
the O 0 0.0010690254857763648
BRCA1 O 1 0.8830510377883911
gene O 0 0.0008047720184549689
. O 0 0.0005950533086434007

We O 0 0.0010309047065675259
identified O 0 0.0007948409183882177
four O 0 0.00045796920312568545
germline O 0 0.006541644223034382
mutations O 0 0.0002506882301531732
in O 0 0.0001928075507748872
three O 0 0.0006534112035296857
breast B-Disease 1 0.9999319314956665
cancer I-Disease 1 0.9934005737304688
families O 0 0.00010920460772467777
and O 0 0.00010869461402762681
in O 0 0.00029150923364795744
one O 0 0.13220806419849396
breast B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999998807907104
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
family O 0 0.0049201687797904015
. O 0 7.597869989695027e-05
among O 0 3.335124711156823e-05
these O 0 1.2687998605542816e-05
were O 0 3.182579530403018e-05
one O 0 7.257945981109515e-05
frameshift O 0 0.002935169730335474
mutation O 0 0.0002147447521565482
, O 0 4.86356730107218e-05
one O 0 6.710939487675205e-05
nonsense O 0 0.0013010776601731777
mutation O 0 0.00019539243658073246
, O 0 7.440501940436661e-05
one O 0 7.96807580627501e-05
novel O 0 0.0002962583093903959
splice O 0 0.0009913905523717403
site O 0 0.0005023286212235689
mutation O 0 0.00017496240616310388
, O 0 8.01806163508445e-05
and O 0 9.400971612194553e-05
one O 0 0.00024695132742635906
missense O 0 0.005130532197654247
mutation O 0 0.002293916419148445
. O 0 0.0010698242112994194

The O 0 0.004075734876096249
missense O 0 0.009535139426589012
mutation O 0 0.0008898917003534734
was O 0 0.0007101635565049946
also O 0 0.00012375068035908043
found O 0 7.774533150950447e-05
in O 0 0.00015126561629585922
2 O 0 0.0005181290907785296
. O 0 0.0006115571013651788

8 O 0 0.0016146592097356915
% O 0 0.0002571174700278789
of O 0 0.00021797337103635073
the O 0 0.00025875752908177674
general O 0 0.0004250549536664039
population O 0 7.835132419131696e-05
, O 0 8.834528125589713e-05
suggesting O 0 0.00014325698430184275
that O 0 4.424911458045244e-05
it O 0 5.552888978854753e-05
is O 0 0.00011908375017810613
not O 0 0.0002316762402188033
disease O 1 0.9992005228996277
associated O 0 0.0013008007081225514
. O 0 0.0010283308802172542

The O 0 0.0017717343289405107
average O 0 0.001070185098797083
age O 0 0.000956146395765245
of O 0 0.16059638559818268
disease O 1 0.9999992847442627
onset O 1 0.9999985694885254
in O 0 0.0016518310876563191
those O 0 0.00018226177780888975
families O 0 0.0002809560392051935
harbouring O 1 0.999659538269043
causative O 1 0.9963200092315674
mutations O 0 0.0010001775808632374
was O 0 0.001424318295903504
between O 0 0.00047181325498968363
32 O 0 0.001131625846028328
. O 0 0.00069168716436252

3 O 0 0.005142510868608952
and O 0 0.0012089809169992805
37 O 0 0.0029385595116764307
. O 0 0.0014117371756583452

4 O 0 0.00284750759601593
years O 0 0.00112207664642483
, O 0 0.0003112487029284239
whereas O 0 0.00035046596894972026
the O 0 0.0003120887267868966
family O 0 0.0006220375653356314
harbouring O 1 0.911514401435852
the O 0 0.0008409478468820453
missense O 0 0.0022492497228085995
mutation O 0 0.00017804790695663542
had O 0 0.00010973771713906899
an O 0 6.827953620813787e-05
average O 0 0.00011879498924827203
age O 0 0.00012239602801855654
of O 0 0.00026540865655988455
onset O 1 0.9936756491661072
of O 0 0.008847517892718315
51 O 0 0.007493769284337759
. O 0 0.0011124563170596957

2 O 0 0.008455684408545494
years O 0 0.0038475575856864452
. O 0 0.0022069853730499744

These O 0 0.0008041200344450772
findings O 0 0.0007491935975849628
show O 0 0.000611861702054739
that O 0 0.0001944836985785514
BRCA1 O 0 0.017039718106389046
is O 0 0.00019204028649255633
implicated O 0 0.0008881424437277019
in O 0 8.239369344664738e-05
a O 0 0.00015557357983198017
small O 0 0.00011843937681987882
fraction O 0 0.0005260795005597174
of O 1 0.7957555651664734
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999957084655762
families O 0 0.0002081335842376575
suggesting O 0 0.00021588147501461208
the O 0 0.00011900451499968767
involvement O 0 0.0002703283680602908
of O 0 0.0005479582468979061
another O 0 0.01756109856069088
susceptibility O 1 0.8805959224700928
gene O 0 0.00102959293872118
( O 0 0.0008038335363380611
s O 0 0.0036134386900812387
) O 0 0.0009620915516279638

Paternal O 1 0.9956263303756714
transmission O 1 0.9999580383300781
of O 1 0.999996542930603
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 1 0.9991807341575623

We O 0 0.0013690685154870152
report O 0 0.0006954411510378122
a O 0 0.0005597827257588506
rare O 0 0.0008598020649515092
case O 0 0.0008612608653493226
of O 0 0.43697652220726013
paternally O 1 0.9999984502792358
transmitted O 1 0.9999997615814209
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999995231628418
DM B-Disease 1 1.0
) O 0 0.006225613411515951
. O 0 0.002084940206259489

The O 0 0.0025407460052520037
proband O 0 0.1254618912935257
is O 0 0.00026508799055591226
a O 0 0.0002779742644634098
23 O 0 0.0005430468590930104
year O 0 0.00043580459896475077
old O 0 0.025450661778450012
, O 0 0.004971676506102085
mentally B-Disease 1 0.9999986886978149
retarded I-Disease 1 0.9999982118606567
male O 1 0.9982079267501831
who O 1 0.9995262622833252
suffers O 1 1.0
severe O 1 1.0
muscular B-Disease 1 1.0
weakness I-Disease 1 1.0
. O 1 0.9993711113929749

He O 0 0.003796723671257496
presented O 0 0.004557739943265915
with O 0 0.03140655532479286
respiratory O 1 0.9999998807907104
and O 1 0.6708132028579712
feeding O 1 0.9858127236366272
difficulties O 1 0.999497652053833
at O 1 0.9929640293121338
birth O 0 0.33320462703704834
. O 0 0.0010723215527832508

His O 0 0.008784935809671879
two O 0 0.00364769552834332
sibs O 1 0.9997119307518005
suffer O 1 0.9962518811225891
from O 0 0.08156844228506088
childhood O 1 0.9999942779541016
onset O 1 1.0
DM B-Disease 1 1.0
. O 0 0.15105915069580078

Their O 0 0.001130752032622695
late O 0 0.0019167534774169326
father O 0 0.0011751289712265134
had O 0 0.0003141751803923398
the O 0 0.00021678098710253835
adult O 0 0.00018551366520114243
type O 0 0.0005086500896140933
of O 0 0.02012336440384388
DM B-Disease 1 0.9999998807907104
, O 0 0.0002711502311285585
with O 0 9.662618685979396e-05
onset O 1 0.9718501567840576
around O 0 0.000599635299295187
30 O 0 0.0005651973187923431
years O 0 0.0005769588169641793
. O 0 0.0004971639136783779

Only O 0 0.0007163375266827643
six O 0 0.0005545464809983969
other O 0 0.00012238680210430175
cases O 0 0.00014016407658345997
of O 0 0.0006291886675171554
paternal O 1 0.9985359907150269
transmission O 1 0.999995231628418
of O 1 0.9999986886978149
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
have O 0 0.0029419800266623497
been O 0 0.0006838854751549661
reported O 0 0.0005866599967703223
recently O 0 0.0009799499530345201
. O 0 0.0006138058961369097

We O 0 0.0011047484586015344
review O 0 0.0005161042208783329
the O 0 0.0003009412612300366
sex O 0 0.0004906492540612817
related O 0 0.0005230864626355469
effects O 0 0.0031883823685348034
on O 0 0.001511253067292273
transmission O 1 0.9988746047019958
of O 1 0.9998830556869507
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 0 0.33935245871543884

Decreased O 0 0.33295029401779175
fertility O 0 0.005768405739217997
of O 0 0.0006680856458842754
males O 0 0.00016636746295262128
with O 0 0.00015649797569494694
adult O 0 0.0009586684172973037
onset O 1 0.9999974966049194
DM B-Disease 1 1.0
and O 0 0.0011448010336607695
contraction O 0 0.010368695482611656
of O 0 0.00028859186568297446
the O 0 0.0003603807417675853
repeat O 0 0.0006343164714053273
upon O 0 0.0002796755579765886
male O 0 0.0004858916800003499
transmission O 0 0.0005711446865461767
contribute O 0 8.006676944205537e-05
to O 0 3.2311025279341266e-05
the O 0 0.0001111771198338829
almost O 0 0.0001170330069726333
absent O 0 0.0004144743434153497
occurrence O 0 0.00042772863525897264
of O 0 0.00045040957047604024
paternal O 0 0.299047589302063
transmission O 1 0.999478280544281
of O 1 0.9998866319656372
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 0 0.4674900472164154

Also O 0 0.000789846817497164
the O 0 0.00047494913451373577
fathers O 0 0.0005899761454202235
of O 0 0.0002484310825821012
the O 0 0.0013142989482730627
reported O 0 0.00653922138735652
congenitally O 1 0.9898597598075867
affected O 0 0.0006789503386244178
children O 0 0.0001874642912298441
showed O 0 0.0002468148013576865
, O 0 5.005509956390597e-05
on O 0 0.000108642183477059
average O 0 0.00019451968546491116
, O 0 0.0001513692259322852
shorter O 0 0.0007526205736212432
CTG O 1 0.6375550627708435
repeat O 0 0.0018805499421432614
lengths O 0 0.0011329979170113802
and O 0 0.00019709119806066155
hence O 0 0.0005012208712287247
less O 0 0.00044073539902456105
severe O 1 0.999688982963562
clinical O 1 0.9768650531768799
symptoms O 1 0.9997264742851257
than O 0 0.00039568907232023776
the O 0 0.0008318824111483991
mothers O 0 0.0005953889340162277
of O 0 0.0007132125901989639
children O 0 0.007200275082141161
with O 1 0.9650915861129761
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 1 0.9383167624473572

We O 0 0.0017658929573372006
conclude O 0 0.0021162531338632107
that O 0 0.00044853382860310376
paternal O 0 0.006007779855281115
transmission O 1 0.9988806843757629
of O 1 0.9999786615371704
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
is O 1 0.9933888912200928
rare O 0 0.11320473253726959
and O 0 0.00019237933156546205
preferentially O 0 0.00025376511621288955
occurs O 0 0.00018762756371870637
with O 0 9.35612988541834e-05
onset O 1 0.5405825972557068
of O 0 0.00782510545104742
DM B-Disease 1 0.9999986886978149
past O 0 0.00037891880492679775
30 O 0 0.00017674242553766817
years O 0 7.12939363438636e-05
in O 0 5.1791106670862064e-05
the O 0 0.00022122454538475722
father O 0 0.000860037631355226
. O 0 0.00024927814956754446
. O 0 0.0005726974923163652

The O 0 0.013276509940624237
RB1 O 1 0.9995026588439941
gene O 0 0.001354502746835351
mutation O 0 0.0004034732701256871
in O 0 0.00020638015121221542
a O 0 0.0007636669906787574
child O 0 0.008472498506307602
with O 0 0.004584508016705513
ectopic B-Disease 1 0.9999922513961792
intracranial I-Disease 1 0.9999983310699463
retinoblastoma I-Disease 1 0.9999767541885376
. O 0 0.005076765548437834

The O 0 0.01180217694491148
RB1 O 1 0.9998156428337097
gene O 0 0.0016835314454510808
mutation O 0 0.0005480726831592619
was O 0 0.0006974103744141757
investigated O 0 0.0005436906358227134
in O 0 0.0001382183691021055
a O 0 0.0003081746690440923
child O 0 0.001116097206249833
with O 0 0.0005337978946045041
ectopic B-Disease 1 0.9998952150344849
intracranial I-Disease 1 0.9999899864196777
retinoblastoma I-Disease 1 0.9987836480140686
using O 0 0.00022695267398376018
DNA O 0 0.0002011536998907104
obtained O 0 7.398432353511453e-05
from O 0 8.311409328598529e-05
both O 0 9.873382077785209e-05
the O 0 0.0006307376897893846
pineal B-Disease 1 0.9996721744537354
and I-Disease 0 0.004269363358616829
retinal I-Disease 1 0.9999953508377075
tumours I-Disease 1 0.9999992847442627
of O 1 0.9288384914398193
the O 1 0.9939919114112854
patient O 1 0.8235296607017517
. O 0 0.0011740666814148426

A O 0 0.008481573313474655
nonsense O 0 0.009155639447271824
mutation O 0 0.0006572419661097229
in O 0 0.0002966495230793953
exon O 0 0.0015299508813768625
17 O 0 0.0006196088506840169
( O 0 0.00023664651962462813
codon O 0 0.0007040234049782157
556 O 0 0.0008349358686245978
) O 0 8.387469279114157e-05
of O 0 0.00017080779070965946
the O 0 0.0005003191181458533
RB1 O 1 0.9998114705085754
gene O 0 0.000321223953505978
was O 0 0.0003103624621871859
found O 0 5.894685455132276e-05
to O 0 3.652863233583048e-05
be O 0 4.205471122986637e-05
present O 0 0.00014356564497575164
homozygously O 0 0.009007330052554607
in O 0 0.0001382473565172404
both O 0 9.235116885975003e-05
the O 0 0.0005028881714679301
retinal B-Disease 1 0.9994924068450928
and I-Disease 0 0.0012506844941526651
the I-Disease 1 0.947541356086731
pineal I-Disease 1 0.9999980926513672
tumours I-Disease 1 0.9999991655349731
. O 0 0.0033069627825170755

The O 0 0.0019838795997202396
same O 0 0.0006425651372410357
mutation O 0 0.0005280111217871308
was O 0 0.000647169363219291
present O 0 0.0002780214126687497
heterozygously O 0 0.007378345355391502
in O 0 0.00010455992742208764
the O 0 9.18726364034228e-05
DNA O 0 0.00010897191532421857
from O 0 4.0197253838414326e-05
the O 0 9.20325837796554e-05
constitutional O 0 0.00018754563643597066
cells O 0 0.00010880680929403752
of O 0 8.547110337531194e-05
the O 0 0.00022011659166309983
patient O 0 0.0004878947511315346
, O 0 8.310941484523937e-05
proving O 0 0.00040104417712427676
it O 0 2.4928593120421283e-05
to O 0 2.003955523832701e-05
be O 0 4.503754826146178e-05
of O 0 0.00027920081629417837
germline O 0 0.006016089115291834
origin O 0 0.000441055279225111
. O 0 0.0005530904163606465

The O 0 0.0018544604536145926
initial O 0 0.0010966194095090032
mutation O 0 0.0005831895396113396
was O 0 0.0005547965411096811
shown O 0 9.434253297513351e-05
to O 0 4.044210436404683e-05
have O 0 3.547398227965459e-05
occurred O 0 0.00026883400278165936
in O 0 0.00015329291636589915
the O 0 0.0005009426386095583
paternally O 0 0.014833077788352966
derived O 0 0.0031997368205338717
RB1 O 1 0.9960628151893616
allele O 0 0.0035648064222186804
. O 0 0.001264188322238624

The O 0 0.0026956505607813597
mutation O 0 0.0003708287258632481
is O 0 9.204539674101397e-05
in O 0 4.116593117942102e-05
an O 0 3.2709380320739e-05
area O 0 8.460376557195559e-05
of O 0 8.383135718759149e-05
the O 0 0.00013731980288866907
gene O 0 5.416820204118267e-05
that O 0 1.688986230874434e-05
encodes O 0 5.6175751524278894e-05
the O 0 6.022668821970001e-05
protein O 0 0.00011484004789963365
- O 0 0.00013401763862930238
binding O 0 5.430417149909772e-05
region O 0 0.00011166650074301288
known O 0 0.00011291673581581563
as O 0 0.0001020745694404468
the O 0 0.00023275005514733493
pocket O 0 0.002139458665624261
region O 0 0.000183354684850201
and O 0 5.7258806918980554e-05
has O 0 3.772721902350895e-05
been O 0 3.5883636883227155e-05
detected O 0 8.215864363592118e-05
in O 0 2.8164316972834058e-05
other O 0 2.7038056941819377e-05
cases O 0 6.821862189099193e-05
of O 0 0.0005244136555120349
retinoblastoma B-Disease 1 0.9996324777603149
. O 0 0.0005201743333600461
. O 0 0.0006445014150813222

Low O 0 0.003985560033470392
levels O 0 0.0008163280435837805
of O 0 0.0006229033460840583
beta O 0 0.0011737344320863485
hexosaminidase O 0 0.17038263380527496
A O 0 0.0010400301543995738
in O 0 0.00018968901713378727
healthy O 0 0.00026298846933059394
individuals O 0 3.556517185643315e-05
with O 0 0.00013646637671627104
apparent O 1 0.9999390840530396
deficiency O 1 1.0
of O 1 0.996127188205719
this O 0 0.023316744714975357
enzyme O 0 0.004832043778151274
. O 0 0.0006686181295663118

Appreciable O 0 0.1346193104982376
beta O 0 0.007471972145140171
hexosaminidase O 1 0.6305550336837769
A O 0 0.0032924942206591368
( O 0 0.00043803537846542895
hex O 0 0.0017807597760111094
A O 0 0.0006751977489329875
) O 0 9.797488019103184e-05
activity O 0 0.00014483986888080835
has O 0 6.516684516100213e-05
been O 0 9.502084867563099e-05
detected O 0 0.0005809100111946464
in O 0 0.0004943649400956929
cultured O 1 0.9950626492500305
skin O 1 0.9999933242797852
fibroblasts O 1 0.9999823570251465
and O 1 0.9972659349441528
melanoma B-Disease 1 1.0
tissue O 1 0.9999871253967285
from O 0 0.00814384501427412
healthy O 0 0.0010254473891109228
individuals O 0 3.4447915822966024e-05
previously O 0 0.00010190659668296576
reported O 0 0.0001256038376595825
as O 0 0.00010084921814268455
having O 0 0.00046129024121910334
deficiency B-Disease 1 0.9999691247940063
of I-Disease 0 0.07574532926082611
hex I-Disease 1 0.9634675979614258
A I-Disease 0 0.003595139365643263
activity O 0 0.00014977912360336632
indistinguishable O 0 0.00015401052951347083
from O 0 3.120470864814706e-05
that O 0 2.2084310330683365e-05
of O 0 0.00014784156519453973
patients O 0 0.0032918821088969707
with O 1 0.6288982629776001
Tay B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
Sachs I-Disease 1 0.9999998807907104
disease I-Disease 1 0.9999997615814209
( O 1 0.7285674214363098
TSD B-Disease 1 0.9999915361404419
) O 0 0.0009993364801630378
. O 0 0.0007658668328076601

Identification O 0 0.0023681598249822855
and O 0 0.0007504025707021356
quantitation O 0 0.009755776263773441
of O 0 0.0014497918309643865
hex O 0 0.009600335732102394
A O 0 0.0020936380606144667
, O 0 0.0001946785196196288
amounting O 0 0.0007371577084995806
to O 0 0.00018818513490259647
3 O 0 0.0005781653453595936
. O 0 0.0004519445647019893

5 O 0 0.002672482281923294
% O 0 0.001275875372812152
- O 0 0.0028839409351348877
6 O 0 0.0026414741296321154
. O 0 0.0013503669761121273

9 O 0 0.0018170269904658198
% O 0 0.00020934247004333884
of O 0 0.00022499740589410067
total O 0 0.00035075697815045714
beta O 0 0.0012623763177543879
hexosaminidase O 1 0.6102513670921326
activity O 0 0.00029085713322274387
, O 0 6.3567582401447e-05
has O 0 4.505180913838558e-05
been O 0 4.497060217545368e-05
obtained O 0 7.806984649505466e-05
by O 0 0.00015590681869070977
cellulose O 0 0.40833523869514465
acetate O 1 0.7756543755531311
gel O 0 0.4020210802555084
electrophoresis O 0 0.0032881484366953373
, O 0 0.00047586674918420613
DEAE O 1 0.9995521903038025
- O 0 0.004826839547604322
cellulose O 0 0.02413003332912922
ion O 0 0.0017430831212550402
- O 0 0.001114017330110073
exchange O 0 0.0006301491521298885
chromatography O 0 0.004881987813860178
, O 0 0.0004709505883511156
radial O 0 0.44613245129585266
immunodiffusion O 1 0.999504804611206
, O 0 0.0008452888578176498
and O 0 0.0008123922161757946
radioimmunoassay O 1 0.9971311092376709
. O 0 0.001822141231968999

Previous O 0 0.0033517018891870975
family O 0 0.0011844160035252571
studies O 0 0.0002172413660446182
suggested O 0 0.0002170035004382953
that O 0 8.093621727311984e-05
these O 0 3.814705996774137e-05
individuals O 0 5.324764788383618e-05
may O 0 9.31161775952205e-05
be O 0 8.770565909799188e-05
compound O 0 0.0040926323272287846
heterozygotes O 0 0.0017116526141762733
for O 0 0.00013132047024555504
the O 0 0.0003648647107183933
common O 0 0.0004943256499245763
mutant O 0 0.4420905113220215
TSD B-Disease 1 0.9998202919960022
gene O 0 0.0003109900571871549
and O 0 0.00013086647959426045
a O 0 0.00023812949075363576
rare O 0 0.0008121573482640088
( O 0 0.0004616142250597477
allelic O 0 0.0051033711060881615
) O 0 0.000438014481915161
mutant O 0 0.0025782256852835417
gene O 0 0.0009151803096756339
. O 0 0.0007936409674584866

Thus O 0 0.002275007776916027
, O 0 0.0006661066436208785
the O 0 0.000630955386441201
postulated O 0 0.0029097034130245447
rate O 0 0.0005598142161034048
mutant O 0 0.0013103460660204291
gene O 0 0.0002336416655452922
appears O 0 0.00011992496001766995
to O 0 3.685087722260505e-05
code O 0 5.498005702975206e-05
for O 0 3.4804736060323194e-05
the O 0 8.756985334912315e-05
expression O 0 0.00016721466090530157
of O 0 0.00021694910537917167
low O 0 0.0002835696213878691
amounts O 0 0.000185577358934097
of O 0 0.00045503495493903756
hex O 0 0.004118854645639658
A O 0 0.0018644585506990552
. O 0 0.0008821606752462685

Heterozygotes O 0 0.017921019345521927
for O 0 0.000737262365873903
the O 0 0.000803471717517823
rare O 0 0.0026005643885582685
mutant O 0 0.06033231317996979
may O 0 0.00029760017059743404
be O 0 7.529621507273987e-05
indistinguishable O 0 0.0004182299308013171
from O 0 0.00023327927920036018
heterozygotes O 0 0.0010106906993314624
for O 0 0.0001009096231427975
the O 0 0.0005012562032788992
common O 0 0.001284885685890913
TSD B-Disease 1 0.9999271631240845
mutant O 0 0.14946328103542328
. O 0 0.0010214048670604825

However O 0 0.0016113927122205496
, O 0 0.0005414147744886577
direct O 0 0.00032061844831332564
visualization O 0 0.0014230587985366583
and O 0 0.00029259687289595604
quantitation O 0 0.009893709793686867
of O 0 0.0011592308292165399
hex O 0 0.011872443370521069
A O 0 0.0006379240076057613
by O 0 5.678323213942349e-05
the O 0 8.227451326092705e-05
methods O 0 8.802858064882457e-05
described O 0 0.0002680199104361236
may O 0 0.00011877551878569648
prevent O 0 0.00037060078466311097
false O 0 0.0007571377791464329
- O 0 0.00176213716622442
positive O 0 0.0006198430783115327
prenatal O 0 0.013238223269581795
diagnosis O 0 0.015157582238316536
of O 0 0.015833869576454163
TSD B-Disease 1 0.9999969005584717
in O 0 0.001122788293287158
fetuses O 0 0.0031589018180966377
having O 0 0.0001632572093512863
the O 0 0.0001404404902132228
incomplete O 0 0.0009073279215954244
hex B-Disease 0 0.12966877222061157
A I-Disease 0 0.4377900958061218
deficiency I-Disease 1 0.9999372959136963
of O 0 0.000641359481960535
the O 0 0.0008744101505726576
type O 0 0.0013106613187119365
described O 0 0.00020412798039615154
in O 0 6.711528112646192e-05
the O 0 0.00013231120829004794
four O 0 0.00027988204965367913
healthy O 0 0.000980897108092904
individuals O 0 0.0004211125778965652

The O 0 0.06112831458449364
tumor B-Disease 1 0.9999872446060181
suppressor O 1 0.9990813732147217
gene O 0 0.02140093594789505
Smad4 O 1 0.9998818635940552
/ O 1 0.7137612700462341
Dpc4 O 1 0.9918320775032043
is O 0 0.0002117231924785301
required O 0 0.00012823236465919763
for O 0 7.886690582381561e-05
gastrulation O 0 0.0687725618481636
and O 0 0.0002138015115633607
later O 0 0.0003234645409975201
for O 0 0.00014550653577316552
anterior O 0 0.09941864013671875
development O 0 0.0005517584504559636
of O 0 0.0010821986943483353
the O 0 0.0049904813058674335
mouse O 0 0.005543919745832682
embryo O 0 0.0022402978502213955
. O 0 0.0006469549844041467

Mutations O 0 0.0027335546910762787
in O 0 0.0010682502761483192
the O 0 0.0026898302603513002
SMAD4 O 1 0.9999948740005493
/ O 1 0.9997437596321106
DPC4 O 1 0.9999995231628418
tumor B-Disease 1 0.999997615814209
suppressor O 1 0.9762242436408997
gene O 0 0.00037272722693160176
, O 0 0.00011557750258361921
a O 0 0.00021981584723107517
key O 0 0.000327909248881042
signal O 0 0.0004790366510860622
transducer O 0 0.0010311375372111797
in O 0 0.00012935363338328898
most O 0 0.00014104493311606348
TGFbeta O 1 0.9994057416915894
- O 0 0.057348351925611496
related O 0 0.0004446372913662344
pathways O 0 0.002486374694854021
, O 0 5.6497930927434936e-05
are O 0 9.603654689271934e-06
involved O 0 3.115576691925526e-05
in O 0 3.454795660218224e-05
50 O 0 0.0001421252527507022
% O 0 0.00016479179612360895
of O 0 0.14302775263786316
pancreatic B-Disease 1 0.9999998807907104
cancers I-Disease 1 0.9999536275863647
. O 0 0.0019134568283334374

Homozygous O 0 0.07522634416818619
Smad4 O 1 0.9992007613182068
mutant O 1 0.9796308279037476
mice O 0 0.006038016639649868
die O 0 0.00267393933609128
before O 0 0.0005194410332478583
day O 0 0.0008782490622252226
7 O 0 0.0013106318656355143
. O 0 0.0007190137403085828

5 O 0 0.006436547264456749
of O 0 0.004323143977671862
embryogenesis O 0 0.31510981917381287
. O 0 0.002566948300227523

Mutant O 0 0.02154652215540409
embryos O 0 0.001709281699731946
have O 0 0.00018059690773952752
reduced O 0 0.00032364929211325943
size O 0 0.00023567270545754582
, O 0 0.00010788071085698903
fail O 0 0.00025061052292585373
to O 0 0.0001228053297381848
gastrulate O 0 0.12260790169239044
or O 0 0.0002753405715338886
express O 0 0.00035355769796296954
a O 0 0.0006018358981236815
mesodermal O 1 0.9136884808540344
marker O 1 0.5583142638206482
, O 0 0.0005422441172413528
and O 0 0.00045286049135029316
show O 0 0.0016601778334006667
abnormal O 1 0.619143009185791
visceral O 1 0.9993687272071838
endoderm O 1 0.999923825263977
development O 0 0.016488414257764816
. O 0 0.002113035414367914

Growth B-Disease 1 0.9989051818847656
retardation I-Disease 1 0.9999022483825684
of O 0 0.014100302010774612
the O 1 0.6155126690864563
Smad4 O 1 0.9999972581863403
- O 1 0.9944226145744324
deficient O 0 0.1801033765077591
embryos O 0 0.0004981069942004979
results O 0 0.00012051327212247998
from O 0 0.00015245068061631173
reduced O 0 0.00040247791912406683
cell O 0 0.0005474970093928277
proliferation O 0 0.0005384709220379591
rather O 0 8.563950541429222e-05
than O 0 0.00010466606181580573
increased O 0 0.00041510298615321517
apoptosis O 0 0.004901524633169174
. O 0 0.0006147832609713078

Aggregation O 0 0.005731227342039347
of O 0 0.0023152846843004227
mutant O 1 0.7950835824012756
Smad4 O 1 0.9999727010726929
ES O 1 0.999744713306427
cells O 0 0.0007207933231256902
with O 0 0.000155112924403511
wild O 0 0.0005858978256583214
- O 0 0.001215210766531527
type O 0 0.0013050109846517444
tetraploid O 0 0.011026318185031414
morulae O 1 0.9527871012687683
rescues O 0 0.10113655775785446
the O 0 0.00675960723310709
gastrulation B-Disease 1 0.9997194409370422
defect I-Disease 1 0.9998260140419006
. O 0 0.003116474486887455

These O 0 0.0006615697056986392
results O 0 0.0004362961044535041
indicate O 0 0.00029162128339521587
that O 0 0.0001294280227739364
Smad4 O 1 0.6791645288467407
is O 0 9.93738358374685e-05
initially O 0 8.828649151837453e-05
required O 0 3.425411705393344e-05
for O 0 2.6261597668053582e-05
the O 0 8.99326623766683e-05
differentiation O 0 0.00027099516591988504
of O 0 0.0003362195857334882
the O 0 0.0013313383096829057
visceral O 1 0.9993566870689392
endoderm O 1 0.9991877675056458
and O 0 0.0001513149618403986
that O 0 6.0876634961459786e-05
the O 0 0.00033052085200324655
gastrulation B-Disease 1 0.9975860118865967
defect I-Disease 1 0.9904136061668396
in O 0 0.00033338964567519724
the O 0 0.0008881776011548936
epiblast O 1 0.998357355594635
is O 0 0.00025912417913787067
secondary O 0 0.0005920890835113823
and O 0 0.00020910607418045402
non O 0 0.0007055914611555636
- O 0 0.001555134542286396
cell O 0 0.000832463672850281
autonomous O 0 0.0011761928908526897
. O 0 0.0006589549011550844

Rescued O 1 0.5521522164344788
embryos O 0 0.019882502034306526
show O 0 0.010711969807744026
severe O 1 0.9998623132705688
anterior O 1 0.9999642372131348
truncations O 1 0.99996018409729
, O 0 0.0026191554497927427
indicating O 0 0.0014778332551941276
a O 0 0.0003243962419219315
second O 0 0.00046029427903704345
important O 0 0.00026056700153276324
role O 0 0.00039452221244573593
for O 0 0.00032583909342065454
Smad4 O 1 0.9940705895423889
in O 0 0.0014599470887333155
anterior O 1 0.9999023675918579
patterning O 1 0.9998440742492676
during O 1 0.9814229011535645
embryogenesis O 1 0.9951163530349731
. O 0 0.001973258564248681

Prevalence O 0 0.017539113759994507
of O 0 0.004469674080610275
p16 O 1 0.9809853434562683
and O 0 0.002955372678115964
CDK4 O 1 0.999990701675415
germline O 1 0.9786199927330017
mutations O 0 0.0006213285378180444
in O 0 0.0004881874192506075
48 O 0 0.14676909148693085
melanoma B-Disease 1 0.9999996423721313
- O 1 0.9243612289428711
prone O 0 0.2286917120218277
families O 0 0.00039239361649379134
in O 0 0.0003869353677146137
France O 0 0.0016843235353007913
. O 0 0.0010287176119163632

The O 0 0.012452947907149792
French O 1 0.9213405847549438
Familial B-Disease 1 0.9999856948852539
Melanoma I-Disease 1 0.9999998807907104
Study O 0 0.011531486175954342
Group O 0 0.0035562682896852493
. O 0 0.0017277274746447802

Germline O 1 0.9018305540084839
mutations O 0 0.002061419887468219
in O 0 0.00059385976055637
the O 0 0.0011103294091299176
p16 O 1 0.5739652514457703
and O 0 0.0008392011513933539
CDK4 O 1 0.9999473094940186
genes O 0 0.00021506032499019057
have O 0 4.8647129005985335e-05
been O 0 6.381527055054903e-05
reported O 0 4.327279020799324e-05
in O 0 3.136249870294705e-05
a O 0 8.91240852070041e-05
subset O 0 0.00030869280453771353
of O 0 0.0027196952141821384
melanoma B-Disease 1 0.9999990463256836
pedigrees O 0 0.07476643472909927
, O 0 0.00010303586896043271
but O 0 5.6216103985207155e-05
their O 0 4.631361662177369e-05
prevalence O 0 0.0004608200106304139
is O 0 7.104798714863136e-05
not O 0 4.4609845645027235e-05
well O 0 0.00010430777911096811
known O 0 0.0003896593989338726
. O 0 0.0005116218235343695

We O 0 0.0013622960541397333
searched O 0 0.0016093840822577477
for O 0 0.00024440098786726594
such O 0 0.00018411781638860703
germline O 0 0.0037448955699801445
mutations O 0 0.00020606712496373802
in O 0 0.00017616651894059032
48 O 0 0.001037397887557745
French O 1 0.8372682332992554
melanoma B-Disease 1 0.9999997615814209
- O 1 0.7405399084091187
prone O 0 0.0070450701750814915
families O 0 8.220801100833341e-05
selected O 0 8.055722719291225e-05
according O 0 2.8963400836801156e-05
to O 0 2.0045001292601228e-05
two O 0 2.4662807845743373e-05
major O 0 0.00016301237337756902
criteria O 0 5.663753836415708e-05
families O 0 5.0427559472154826e-05
with O 0 3.6277746403357014e-05
at O 0 0.0001327056816080585
least O 0 3.357616515131667e-05
three O 0 2.6914211048278958e-05
affected O 0 4.253082079230808e-05
members O 0 1.883729601104278e-05
( O 0 3.9667400415055454e-05
n O 0 0.0001359113521175459
= O 0 0.000177095687831752
20 O 0 0.0001013630026136525
) O 0 3.34557298629079e-05
or O 0 2.0698333173641004e-05
families O 0 1.8573697161627933e-05
with O 0 1.588372833793983e-05
two O 0 2.1792977349832654e-05
affected O 0 7.149791781557724e-05
members O 0 2.7008831239072606e-05
, O 0 2.725291960814502e-05
one O 0 2.85296391666634e-05
of O 0 5.3334453696152195e-05
them O 0 2.4458591724396683e-05
affected O 0 6.740583921782672e-05
before O 0 5.656736539094709e-05
the O 0 5.0472543080104515e-05
age O 0 4.410974361235276e-05
of O 0 6.962780025787652e-05
50 O 0 7.204312714748085e-05
( O 0 4.6934746933402494e-05
n O 0 0.00010064314847113565
= O 0 0.0001501587830716744
28 O 0 0.00013932352885603905
) O 0 2.444518577249255e-05
, O 0 2.6426956537761725e-05
and O 0 2.874977326428052e-05
one O 0 5.3689822379965335e-05
additional O 0 0.00015792415069881827
minor O 0 0.0027066795155406
criterion O 0 0.0041662221774458885
. O 0 0.0011758024338632822

Sixteen O 0 0.00993693433701992
different O 0 0.0009730281890369952
p16 O 0 0.4058206081390381
germline O 0 0.07813961058855057
mutations O 0 0.0003218916244804859
were O 0 8.757929754210636e-05
found O 0 5.743046131101437e-05
in O 0 4.5333843445405364e-05
21 O 0 0.00018532360263634473
families O 0 5.596139817498624e-05
, O 0 4.3003914470318705e-05
while O 0 5.5330565373878926e-05
one O 0 0.00011491715849842876
germline O 0 0.05044153705239296
mutation O 0 0.00037324349978007376
, O 0 0.00013722294534090906
Arg24His O 1 0.8484029769897461
, O 0 0.00020113817299716175
was O 0 0.0006629807176068425
detected O 0 0.0003874469839502126
in O 0 0.00014887709403410554
the O 0 0.0005883505218662322
CDK4 O 1 0.9997872710227966
gene O 0 0.0011490926844999194
. O 0 0.0009523531189188361

The O 0 0.002119125099852681
frequency O 0 0.0008019082597456872
of O 0 0.0006285604904405773
p16 O 0 0.00797366350889206
gene O 0 0.00031809654319658875
mutation O 0 0.0001302568125538528
in O 0 4.018207619083114e-05
our O 0 3.939807720598765e-05
sample O 0 2.7494861569721252e-05
( O 0 3.7687699659727514e-05
44 O 0 8.17089166957885e-05
% O 0 4.7329467633971944e-05
) O 0 2.8771935831173323e-05
is O 0 2.5219309463864192e-05
among O 0 2.5353843739139847e-05
the O 0 7.793908298481256e-05
highest O 0 0.0002614873228594661
rates O 0 4.887157410848886e-05
yet O 0 3.731943070306443e-05
reported O 0 6.36804397800006e-05
and O 0 3.962687333114445e-05
the O 0 0.00015116267604753375
CDK4 O 1 0.9994204044342041
mutation O 0 0.00020854019385296851
is O 0 6.885788752697408e-05
the O 0 0.00011299535253783688
second O 0 0.0004570781602524221
mutation O 0 0.00017786194803193212
detected O 0 0.00032158734393306077
in O 0 0.00011466889554867521
this O 0 0.00011614262621151283
gene O 0 0.00045450564357452095
worldwide O 0 0.000538117194082588
. O 0 0.0006735367351211607

In O 0 0.002173101995140314
summary O 0 0.0012443370651453733
, O 0 0.00029109211754985154
our O 0 0.00033962668385356665
results O 0 0.00015240909124258906
show O 0 0.00019939974299632013
frequent O 0 0.00013217702507972717
involvement O 0 0.00030712023726664484
of O 0 0.00043711811304092407
the O 0 0.0016876477748155594
p16 O 1 0.7464643120765686
gene O 0 0.0003698816290125251
in O 0 0.0002663521736394614
familial B-Disease 1 0.9996106028556824
melanoma I-Disease 1 0.9999997615814209
and O 0 0.0006126687512733042
confirm O 0 0.00019408062507864088
the O 0 0.00010710026981541887
role O 0 0.00012273342872504145
of O 0 0.00013997763744555414
the O 0 0.0004950208822265267
CDK4 O 1 0.9998244643211365
gene O 0 0.00031331012723967433
as O 0 0.0002767649421002716
a O 0 0.001987252151593566
melanoma B-Disease 1 0.9999988079071045
- O 1 0.8197620511054993
predisposing O 0 0.4652036428451538
gene O 0 0.0007537915953435004
. O 0 0.0003387151809874922
. O 0 0.0005363987875171006

Progression O 0 0.30412885546684265
of O 0 0.007297677919268608
somatic O 1 0.7672749757766724
CTG O 1 0.9983964562416077
repeat O 0 0.0031594892498105764
length O 0 0.00035745673812925816
heterogeneity O 0 0.0006099696038290858
in O 0 0.0002719416515901685
the O 0 0.0011147434124723077
blood O 1 0.9947998523712158
cells O 1 0.8371520638465881
of O 1 0.9992448091506958
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 0.9997928738594055
. O 0 0.0026641034055501223

The O 0 0.002507508033886552
genetic O 0 0.0013180871028453112
basis O 0 0.0006712403264828026
of O 1 0.9381781220436096
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999715089797974
DM B-Disease 1 1.0
) O 0 0.0002712352725211531
is O 0 8.399948274018243e-05
the O 0 8.290740515803918e-05
expansion O 0 0.0002741463540587574
of O 0 0.00014228226791601628
an O 0 0.00021141434262972325
unstable O 1 0.8351355791091919
CTG O 1 0.9972594976425171
repeat O 0 0.0007335431291721761
in O 0 7.791574171278626e-05
the O 0 0.0001308884529862553
34 O 0 0.0003102636255789548
UTR O 0 0.0023726103827357292
of O 0 0.0003490052476990968
the O 0 0.0006496854475699365
DM B-Disease 1 0.9999510049819946
protein O 0 0.0007331115775741637
kinase O 0 0.0008045430877245963
gene O 0 0.0002933222276624292
on O 0 0.0002518311084713787
chromosome O 0 0.0008488897001370788
19 O 0 0.001339124864898622
. O 0 0.0010461484780535102

One O 0 0.0015288165304809809
of O 0 0.0007169732707552612
the O 0 0.00042574756662361324
principal O 0 0.0005560836289077997
features O 0 0.00020751434203702956
of O 0 0.0004007099778391421
the O 0 0.23237764835357666
DM B-Disease 1 0.9999998807907104
mutation O 0 0.0004665731103159487
is O 0 7.43814671295695e-05
an O 0 7.938572525745258e-05
extraordinarily O 0 0.0005480910185724497
high O 0 0.0002937896060757339
level O 0 0.0002042152191279456
of O 0 0.000347062770742923
somatic O 0 0.023228105157613754
mosaicism O 1 0.9953669309616089
, O 0 0.0001783381012501195
due O 0 0.00010420200123917311
to O 0 4.564295522868633e-05
an O 0 8.0543861258775e-05
extremely O 0 0.00012525006604846567
high O 0 0.00021535968699026853
degree O 0 0.00025908512179739773
of O 0 0.00046948192175477743
somatic O 0 0.019543085247278214
instability O 0 0.0567823126912117
both O 0 7.315633411053568e-05
within O 0 8.381265797652304e-05
and O 0 9.598537144483998e-05
between O 0 0.00028335012029856443
different O 0 0.00019448036618996412
tissues O 0 0.004574033431708813
. O 0 0.0005604035686701536

This O 0 0.0022438340820372105
instability O 0 0.19313454627990723
appears O 0 0.0008963437867350876
to O 0 0.00010959758947137743
be O 0 6.837133696535602e-05
biased O 0 0.00011517155508045107
towards O 0 0.00023206823971122503
further O 0 0.00015504666953347623
expansion O 0 0.00032433500746265054
and O 0 6.041847518645227e-05
continuous O 0 0.00014929944882169366
throughout O 0 7.390605605905876e-05
the O 0 0.00011617573181865737
life O 0 0.0001375635911244899
of O 0 0.00010365317575633526
an O 0 7.282085425686091e-05
individual O 0 4.8123565647983924e-05
, O 0 6.06752946623601e-05
features O 0 7.411213300656527e-05
that O 0 2.9063365218462422e-05
could O 0 4.4102129322709516e-05
be O 0 2.528958793845959e-05
associated O 0 3.721047687577084e-05
with O 0 3.7502377381315455e-05
the O 0 0.0001830898254411295
progressive O 0 0.11782379448413849
nature O 0 0.0006661684601567686
of O 0 0.22741831839084625
the O 1 0.9980927109718323
disease O 1 0.9999943971633911
. O 0 0.0017467826837673783

Although O 0 0.0016699256375432014
increasing O 0 0.0008031722973100841
measured O 0 0.00047482666559517384
allele O 0 0.00031314973603002727
size O 0 0.00018889954662881792
between O 0 0.0002899954852182418
patients O 0 0.00023648481874261051
clearly O 0 0.0001718182465992868
correlates O 0 0.0003025447658728808
with O 0 3.760333493119106e-05
an O 0 9.99833137029782e-05
increased O 0 0.00023599108681082726
severity O 0 0.09408875554800034
of O 0 0.2730540633201599
symptoms O 1 0.999214768409729
and O 0 9.700822556624189e-05
an O 0 9.891144145512953e-05
earlier O 0 0.00013609406596515328
age O 0 0.00012138009333284572
of O 0 0.0005176330450922251
onset O 1 0.9998773336410522
, O 0 8.129536581691355e-05
this O 0 3.5630553611554205e-05
correlation O 0 7.201399421319366e-05
is O 0 3.479371662251651e-05
not O 0 1.4560298041033093e-05
precise O 0 7.422932685585693e-05
and O 0 5.3631942137144506e-05
measured O 0 0.00012261832307558507
allele O 0 0.0001031003484968096
length O 0 6.966565706534311e-05
cannot O 0 2.8984703021706082e-05
be O 0 1.743472421367187e-05
used O 0 2.054251126537565e-05
as O 0 3.595097587094642e-05
an O 0 5.4756790632382035e-05
accurate O 0 0.00021369184833019972
predictor O 0 0.0009730555466376245
of O 0 0.0004205080331303179
age O 0 0.0009552552946843207
of O 0 0.013442046009004116
onset O 1 0.9999874830245972
. O 0 0.004043186083436012

In O 0 0.0011323209619149566
order O 0 0.0003783225256484002
to O 0 8.653957775095478e-05
further O 0 0.000211864520679228
characterize O 0 0.0008007392170839012
the O 0 0.0005757457111030817
dynamics O 0 0.0033406566362828016
of O 0 0.10767894983291626
DM B-Disease 1 1.0
CTG O 1 0.9999908208847046
repeat O 1 0.9298123717308044
somatic O 0 0.26694756746292114
instability O 0 0.3437187373638153
, O 0 0.00011086080485256389
we O 0 4.976595664629713e-05
have O 0 1.8616115994518623e-05
studied O 0 8.769863052293658e-05
repeat O 0 0.0001805448846425861
length O 0 7.61642586439848e-05
changes O 0 4.4450003770180047e-05
over O 0 4.863057256443426e-05
time O 0 8.335927850566804e-05
in O 0 0.0002587178023532033
111 O 1 0.9654985666275024
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 0 0.39344707131385803
with O 0 0.0003685307747218758
varying O 0 0.0005970015190541744
clinical O 0 0.19396193325519562
severity O 1 0.9813754558563232
and O 0 0.0007252513896673918
CTG O 1 0.9945583343505859
repeat O 0 0.0004294857499189675
size O 0 7.48247402952984e-05
over O 0 2.8918440875713713e-05
time O 0 1.8913311578216963e-05
intervals O 0 4.457565228221938e-05
of O 0 6.565588410012424e-05
1 O 0 0.00014824329991824925
- O 0 0.0002930326445493847
7 O 0 0.00035732777905650437
years O 0 0.00033680442720651627
. O 0 0.00036808697041124105

We O 0 0.0005200493615120649
have O 0 9.152575512416661e-05
found O 0 7.104242831701413e-05
a O 0 9.685958502814174e-05
direct O 0 0.000103090911579784
progression O 0 0.0007339409785345197
of O 0 0.000174870336195454
the O 0 0.00014234741684049368
size O 0 0.0001187030429719016
heterogeneity O 0 0.00017984150326810777
over O 0 5.7909135648515075e-05
time O 0 3.871057560900226e-05
related O 0 5.9306581533746794e-05
to O 0 3.704964547068812e-05
initial O 0 0.00027024021255783737
CTG O 0 0.08242939412593842
repeat O 0 0.0007971617160364985
size O 0 0.00018627673853188753
and O 0 6.307881267275661e-05
the O 0 6.506489444291219e-05
time O 0 0.00012724185944534838
interval O 0 0.00024441382265649736
and O 0 6.622401269851252e-05
always O 0 0.00014087342424318194
biased O 0 0.00020720729662571102
towards O 0 0.00037536773015744984
further O 0 0.0004461921926122159
expansion O 0 0.0023356913588941097
. O 0 0.00103371508885175

Attempts O 0 0.0017910950118675828
to O 0 0.00034832555684261024
mathematically O 0 0.0006912308163009584
model O 0 0.00036783755058422685
the O 0 0.0002596756676211953
dynamics O 0 0.0015805306611582637
have O 0 7.998009095899761e-05
proved O 0 0.0005839887890033424
only O 0 9.562595369061455e-05
partially O 0 0.0006217295886017382
successful O 0 0.00023582373978570104
suggesting O 0 0.00016255168884526938
that O 0 2.32340935326647e-05
individual O 0 3.0798710213275626e-05
specific O 0 3.3833559427876025e-05
genetic O 0 0.0002050577022600919
and O 0 0.0002810693404171616
/ O 0 0.10843454301357269
or O 0 0.00023196182155515999
environmental O 0 0.0005348266568034887
factors O 0 9.491427044849843e-05
also O 0 4.674112278735265e-05
play O 0 7.268322224263102e-05
a O 0 0.00012969809176865965
role O 0 0.00036515318788588047
in O 0 0.00039276634925045073
somatic O 0 0.0967235192656517
mosaicism O 1 0.9985666871070862
. O 0 0.0007327399798668921
. O 0 0.00103942200075835

Aspartylglucosaminuria B-Disease 1 0.9994043111801147
among O 0 0.004411321599036455
Palestinian O 0 0.02093448117375374
Arabs O 0 0.013816937804222107
. O 0 0.00182378722820431

Aspartylglucosaminuria B-Disease 1 0.9999954700469971
( O 1 0.9894378185272217
AGU B-Disease 1 0.9999949932098389
) O 0 0.0007752410601824522
is O 0 0.00033375664497725666
a O 0 0.0006197931943461299
rare O 0 0.3436983525753021
disorder B-Disease 1 0.9999978542327881
of I-Disease 1 0.9998631477355957
glycoprotein I-Disease 1 0.9999996423721313
metabolism I-Disease 1 0.9999666213989258
caused O 1 0.9825096130371094
by O 0 0.00013035000301897526
the O 0 0.0010050992714241147
deficiency B-Disease 1 0.9999680519104004
of I-Disease 0 0.004797632340341806
the I-Disease 1 0.616611897945404
lysosomal I-Disease 1 0.999974250793457
enzyme I-Disease 1 0.8964970707893372
aspartylglucosaminidase I-Disease 1 0.9998754262924194
( O 0 0.0011474534403532743
AGA O 1 0.9893844723701477
) O 0 0.0007635323563590646
. O 0 0.0007237441022880375

AGU B-Disease 1 0.9999966621398926
is O 0 0.00841598492115736
inherited O 1 0.9983499050140381
as O 0 0.0021534531842917204
an O 0 0.014120846055448055
autosomal O 1 0.9992234706878662
recessive O 1 0.9999535083770752
trait O 1 0.9975538849830627
and O 0 0.000856158381793648
occurs O 0 0.0002599650470074266
with O 0 4.821056791115552e-05
a O 0 0.00015880375576671213
high O 0 0.00023322011111304164
frequency O 0 4.3820913560921326e-05
in O 0 2.6256888304487802e-05
Finland O 0 0.00011632794485194609
because O 0 2.6211380827589892e-05
of O 0 8.98831058293581e-05
a O 0 0.000396550603909418
founder O 0 0.00760730542242527
effect O 0 0.0008908198215067387
. O 0 0.0007124578696675599

While O 0 0.002482699230313301
very O 0 0.0006665269611403346
few O 0 0.0006726389983668923
patients O 0 0.0012827737955376506
with O 0 0.0005318316980265081
AGU B-Disease 1 0.9999971389770508
have O 0 0.00011574792006285861
been O 0 7.660844858037308e-05
reported O 0 8.97026839083992e-05
from O 0 0.00011545446614036337
non O 0 0.00035555637441575527
- O 0 0.0005426662974059582
Finnish O 0 0.0012814078945666552
origin O 0 0.0001325357152381912
, O 0 0.00011143726442242041
we O 0 0.00020341861818451434
diagnosed O 1 0.9991698265075684
the O 0 0.006509673316031694
disorder O 1 0.9999819993972778
in O 0 0.0010078238556161523
8 O 0 0.002208506455644965
patients O 0 0.00015766099386382848
originating O 0 0.0001333470136160031
from O 0 9.689839498605579e-05
3 O 0 0.0001841097546275705
unrelated O 0 0.0002515232772566378
families O 0 6.429655331885442e-05
, O 0 3.968139935750514e-05
all O 0 2.949745612568222e-05
Palestinian O 0 0.0002032311458606273
Arabs O 0 0.00016210685134865344
from O 0 4.330202500568703e-05
the O 0 8.626981434645131e-05
region O 0 0.00018236554751638323
of O 0 0.00043099294998683035
Jerusalem O 0 0.07995173335075378
. O 0 0.0011284041684120893

The O 0 0.00598704069852829
clinical O 0 0.3543242812156677
diagnosis O 1 0.9995039701461792
of O 1 0.9998692274093628
AGU B-Disease 1 1.0
is O 0 0.0015088336076587439
often O 0 8.665088535053656e-05
difficult O 0 9.18358564376831e-05
, O 0 3.4045813663396984e-05
in O 0 2.26552347157849e-05
particular O 0 3.232326344004832e-05
early O 0 7.495078898500651e-05
in O 0 2.087133725581225e-05
the O 0 4.558758155326359e-05
course O 0 0.00014467256551142782
of O 0 0.00015219736087601632
the O 0 0.27398982644081116
disease O 1 0.999954104423523
, O 0 5.641685493174009e-05
and O 0 2.164019679185003e-05
most O 0 2.0819172277697362e-05
of O 0 7.142990943975747e-05
the O 0 0.0008618041756562889
patients O 0 0.0014600027352571487
are O 0 4.8130907089216635e-05
diagnosed O 1 0.6290687322616577
after O 0 0.00021829511388204992
the O 0 0.00013087346451357007
age O 0 0.00017225361079908907
of O 0 0.0002420204400550574
5 O 0 0.00037017339491285384
years O 0 0.0003783231077250093
. O 0 0.0005436828942038119

However O 0 0.0015428117476403713
, O 0 0.0004503545933403075
since O 0 0.00045287495595403016
these O 0 0.0001477434707339853
patients O 0 0.0002662572078406811
excrete O 0 0.001281565404497087
early O 0 0.00027102435706183314
large O 0 0.00012174314178992063
amounts O 0 0.00011259340681135654
of O 0 0.0002426384889986366
aspartylglucosamine O 1 0.8500129580497742
in O 0 0.00025467865634709597
urine O 0 0.00045853230403736234
, O 0 0.00011958808318013325
biochemical O 0 0.0005182222230359912
screening O 0 0.00016070356650743634
is O 0 7.996468048077077e-05
easy O 0 0.00014606703189201653
by O 0 0.00013246267917566001
urine O 0 0.0015431327046826482
chromatography O 0 0.022274073213338852
. O 0 0.000509737292304635
. O 0 0.0006801062263548374

Detection O 0 0.007349547930061817
of O 0 0.0012752125039696693
heterozygous O 0 0.0009002305450849235
carriers O 0 0.00035782891791313887
of O 0 0.00031086229137144983
the O 0 0.02953701838850975
ataxia B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999740123748779
telangiectasia I-Disease 1 0.9999942779541016
( O 0 0.003991269506514072
ATM O 0 0.005294617265462875
) O 0 0.00014664632908534259
gene O 0 0.00013973971363157034
by O 0 0.00015670357970520854
G2 O 1 0.9638288021087646
phase O 0 0.18042998015880585
chromosomal O 1 0.8617985844612122
radiosensitivity O 1 0.9997562766075134
of O 1 0.9949433207511902
peripheral O 1 0.9999980926513672
blood O 1 0.9999778270721436
lymphocytes O 1 0.99903404712677
. O 0 0.0014529970940202475

In O 0 0.08175323158502579
ataxia B-Disease 1 0.9999988079071045
- I-Disease 1 0.9999071359634399
telangiectasia I-Disease 1 0.999996542930603
( O 1 0.9411214590072632
A B-Disease 1 0.999998927116394
- I-Disease 1 0.9999969005584717
T I-Disease 1 0.999998927116394
) O 0 0.0003869010542985052
patients O 0 0.0002602904278319329
, O 0 8.242529293056577e-05
mutations O 0 6.753477646270767e-05
in O 0 3.689602453960106e-05
a O 0 0.000118938711239025
single O 0 0.00013484431838151067
gene O 0 9.970567771233618e-05
, O 0 8.345743117388338e-05
ATM O 0 0.0005619533476419747
, O 0 7.128946162993088e-05
result O 0 7.421467307722196e-05
in O 0 0.0001297736744163558
an O 0 0.05823192000389099
autosomal B-Disease 1 0.9999998807907104
recessive I-Disease 1 1.0
syndrome I-Disease 1 1.0
that O 0 0.3328748345375061
embraces O 1 0.5756154656410217
a O 0 0.0004942179657518864
variety O 0 0.00015610287664458156
of O 0 0.0004897199105471373
clinical O 0 0.003156817052513361
features O 0 0.0003886240301653743
and O 0 0.00018556584836915135
manifests O 0 0.0029033690225332975
extreme O 0 0.2213321477174759
radiosensitivity O 1 0.9963755011558533
and O 0 0.0001499647623859346
a O 0 0.00020966806914657354
strong O 0 0.00028607816784642637
pre O 0 0.0033169325906783342
- O 0 0.0018521846504881978
disposition O 0 0.008332117460668087
to O 0 0.0006715178024023771
malignancy B-Disease 1 0.9974191188812256
. O 0 0.001850617816671729

Heterozygotes O 0 0.021357592195272446
for O 0 0.0008270047837868333
the O 0 0.0006511756801046431
ATM O 0 0.0029420487117022276
gene O 0 0.0001639292313484475
have O 0 2.9935281418147497e-05
no O 0 5.059142495156266e-05
clinical O 0 0.0001281949516851455
expression O 0 0.00013941708311904222
of O 0 0.0011840052902698517
A B-Disease 1 0.999997615814209
- I-Disease 1 0.9999790191650391
T I-Disease 1 0.9999910593032837
but O 0 0.00010437323362566531
may O 0 0.000144986915984191
be O 0 0.00011032759357476607
cancer B-Disease 0 0.15926703810691833
prone O 0 0.0013957554474473
with O 0 7.943359378259629e-05
a O 0 0.00020710003445856273
moderate O 0 0.0004770273808389902
increase O 0 0.00012731274182442576
in O 0 8.899949170881882e-05
in O 0 0.00018231113790534437
vitro O 0 0.0014784919330850244
radiosensitivity O 0 0.47908684611320496
. O 0 0.0011829202994704247

We O 0 0.001839664881117642
performed O 0 0.00158974330406636
a O 0 0.0011178582208231091
blind O 0 0.00210997904650867
chromosomal O 0 0.0015828770119696856
analysis O 0 0.00016415822028648108
on O 0 0.00037750237970612943
G2 O 1 0.9996160268783569
- O 0 0.0017364457016810775
phase O 0 0.0019494829466566443
lymphocytes O 0 0.0008494071080349386
from O 0 0.00013020167534705251
7 O 0 0.0003487046342343092
unrelated O 0 0.0009363238350488245
A B-Disease 1 0.9995859265327454
- I-Disease 1 0.999800980091095
T I-Disease 1 0.9999685287475586
patients O 0 0.00028809596551582217
, O 0 0.00012500880984589458
13 O 0 0.00039087675395421684
obligate O 0 0.0017863119719550014
A B-Disease 1 0.9997387528419495
- I-Disease 1 0.9995737671852112
T I-Disease 1 0.9999210834503174
heterozygotes O 0 0.0026249552611261606
( O 0 0.0001008144099614583
parents O 0 5.9311107179382816e-05
of O 0 0.00011651599197648466
the O 0 0.0003469326184131205
patients O 0 0.00036155557609163225
) O 0 4.959251236869022e-05
, O 0 3.1017232686281204e-05
and O 0 3.319734969409183e-05
14 O 0 0.0001089933211915195
normal O 0 6.674751784885302e-05
controls O 0 5.695400614058599e-05
following O 0 7.22156255505979e-05
X O 0 0.00036028766771778464
- O 0 0.00022496563906315714
irradiation O 0 0.00023154439986683428
with O 0 3.298635783721693e-05
1 O 0 0.00012894438987132162
Gy O 0 0.0010196709772571921
in O 0 3.130473487544805e-05
order O 0 3.3236054150620475e-05
to O 0 2.4395088985329494e-05
evaluate O 0 7.798644219292328e-05
this O 0 6.040545122232288e-05
cytogenetic O 0 0.0008499693358317018
method O 0 9.766091534402221e-05
as O 0 7.155576895456761e-05
a O 0 0.00013902016507927328
tool O 0 0.0005518973339349031
for O 0 0.00015427877951879054
detection O 0 0.0006343848071992397
of O 0 0.0005686591030098498
ATM O 0 0.0186610110104084
carriers O 0 0.0018181958002969623
. O 0 0.0007893558358773589

Both O 0 0.004373422358185053
A B-Disease 1 0.9998886585235596
- I-Disease 1 0.9999055862426758
T I-Disease 1 0.9999645948410034
homozygotes O 0 0.41458064317703247
and O 0 0.0005064408760517836
heterozygotes O 0 0.004210800863802433
showed O 0 0.0006084912456572056
significantly O 0 0.00014346053649205714
increased O 0 0.000105244544101879
levels O 0 0.00018353518680669367
of O 0 0.00043678254587575793
radiation O 1 0.9987727999687195
- O 1 0.511172890663147
induced O 1 0.9965983033180237
chromatid O 1 0.9967556595802307
damage O 0 0.20676596462726593
relative O 0 0.0002989073400385678
to O 0 4.8270732804667205e-05
that O 0 5.18470915267244e-05
of O 0 0.00027422973653301597
normal O 0 0.0005455157370306551
controls O 0 0.0008402293897233903
. O 0 0.0006345706642605364

These O 0 0.0007123468676581979
results O 0 0.000251711840974167
show O 0 0.00027758997748605907
that O 0 9.167625830741599e-05
the O 0 0.00039456135709770024
G2 O 1 0.9995879530906677
- O 0 0.008574526757001877
phase O 0 0.12520262598991394
chromosomal O 1 0.721980631351471
radiosensitivity O 1 0.9983798265457153
assay O 0 0.0007646121666766703
can O 0 4.700444333138876e-05
be O 0 1.906293982756324e-05
used O 0 2.234539351775311e-05
for O 0 1.758883081492968e-05
the O 0 7.387265213765204e-05
detection O 0 0.0002909525646828115
of O 0 0.0005641311290673912
A B-Disease 1 0.999977707862854
- I-Disease 1 0.9998762607574463
T I-Disease 1 0.9998923540115356
heterozygotes O 0 0.013036333955824375
. O 0 0.0009784068679437041

In O 0 0.0017153427470475435
combination O 0 0.0014327863464131951
with O 0 0.00021499101421795785
molecular O 0 0.0006654399912804365
genetic O 0 0.00031398830469697714
analyses O 0 0.00012770768080372363
, O 0 4.6059525629971176e-05
this O 0 3.734065103344619e-05
test O 0 9.381251584272832e-05
may O 0 2.6289608285878785e-05
be O 0 1.4413136341318022e-05
of O 0 4.233053186908364e-05
value O 0 4.119734512642026e-05
in O 0 4.843396891374141e-05
studies O 0 6.803625728935003e-05
of O 0 0.00020941173715982586
familial B-Disease 0 0.39756932854652405
and I-Disease 0 0.002116080839186907
sporadic I-Disease 1 0.993126630783081
cancers I-Disease 1 0.9979007244110107
aimed O 0 0.0008670782553963363
at O 0 0.00027468689950183034
determination O 0 0.00017780919733922929
of O 0 0.00014801505312789232
the O 0 0.00014691335672978312
potential O 0 0.0001456372847314924
involvement O 0 0.000362563063390553
of O 0 0.0005020576063543558
ATM O 0 0.2579618990421295
mutations O 0 0.000580520078074187
in O 0 0.0010346214985474944
tumor B-Disease 1 0.9999935626983643
risk O 0 0.0033803069964051247
or O 0 0.0003151315322611481
development O 0 0.000964442384429276
. O 0 0.00033638114109635353
. O 0 0.0006810678751207888

Ataxia B-Disease 1 0.9999997615814209
- I-Disease 1 0.9999499320983887
telangiectasia I-Disease 1 0.9999699592590332
: O 0 0.0007153588812798262
identification O 0 0.00023766882077325135
and O 0 0.00012754603812936693
detection O 0 0.0004520996881183237
of O 0 0.0005288628162816167
founder O 1 0.9775905609130859
- O 0 0.012634092941880226
effect O 0 0.0001885540405055508
mutations O 0 6.210573337739334e-05
in O 0 4.1753526602406055e-05
the O 0 0.00014490328612737358
ATM O 0 0.0009423631126992404
gene O 0 0.0001323440228588879
in O 0 7.669646583963186e-05
ethnic O 0 0.00026369348051957786
populations O 0 0.0003584639634937048
. O 0 0.0004699106211774051

To O 0 0.000852518598549068
facilitate O 0 0.0009986386867240071
the O 0 0.0004808116646017879
evaluation O 0 0.0007607742445543408
of O 0 0.0006313337944447994
ATM O 0 0.059937089681625366
heterozygotes O 0 0.005918207112699747
for O 0 0.0002672890550456941
susceptibility O 0 0.0035057279746979475
to O 0 0.0001345083728665486
other O 0 0.00019728168263100088
diseases O 1 0.9999585151672363
, O 0 0.0002995155518874526
such O 0 0.00033668821561150253
as O 1 0.9881107807159424
breast B-Disease 1 0.9999996423721313
cancer I-Disease 1 0.9999797344207764
, O 0 0.00013100894284434617
we O 0 3.8033111195545644e-05
have O 0 1.173520831798669e-05
attempted O 0 7.886939420131966e-05
to O 0 2.3283111659111455e-05
define O 0 6.551491242134944e-05
the O 0 8.46913389977999e-05
most O 0 6.837074761278927e-05
common O 0 8.123174484353513e-05
mutations O 0 7.485950482077897e-05
and O 0 3.2291925890604034e-05
their O 0 3.1119481718633324e-05
frequencies O 0 0.00012990590767003596
in O 0 0.00022699702822137624
ataxia B-Disease 1 0.9999839067459106
- I-Disease 1 0.9932321310043335
telangiectasia I-Disease 1 0.9999818801879883
( O 0 0.016860445961356163
A B-Disease 1 0.9999687671661377
- I-Disease 1 0.9958757758140564
T I-Disease 1 0.9984594583511353
) O 0 0.00013239575491752476
homozygotes O 0 0.0006815060623921454
from O 0 8.954902295954525e-05
10 O 0 0.00011776795145124197
ethnic O 0 0.0001569275773363188
populations O 0 0.0001921596995089203
. O 0 0.00026360503397881985

Both O 0 0.0024801415856927633
genomic O 0 0.0028472926933318377
mutations O 0 0.0007457780302502215
and O 0 0.0001628458412596956
their O 0 0.00010164931154577062
effects O 0 0.0006075571291148663
on O 0 0.0003525451465975493
cDNA O 0 0.001957305008545518
were O 0 0.0007263622246682644
characterized O 0 0.0016560070216655731
. O 0 0.000794513092841953

Protein O 0 0.0038091090973466635
- O 0 0.0027003376744687557
truncation O 0 0.0022799724247306585
testing O 0 0.00023845232499297708
of O 0 0.00014728997484780848
the O 0 0.0001566384598845616
entire O 0 0.000564797141123563
ATM O 0 0.0006959374295547605
cDNA O 0 0.0005195809062570333
detected O 0 0.00024613735149614513
92 O 0 0.00033794203773140907
( O 0 0.00010627521260175854
66 O 0 0.0003167870454490185
% O 0 0.00010848545207409188
) O 0 0.00011065632861573249
truncating O 0 0.0010180998360738158
mutations O 0 0.0001967387943295762
in O 0 0.00016215290816035122
140 O 0 0.0012317793443799019
mutant O 0 0.0021980057936161757
alleles O 0 0.0010992367751896381
screened O 0 0.0016961527289822698
. O 0 0.0011219109874218702

The O 0 0.004864119924604893
haplotyping O 1 0.9942084550857544
of O 0 0.0039194561541080475
patients O 0 0.0017486120341345668
with O 0 0.00014588635531254113
identical O 0 0.00028428612858988345
mutations O 0 0.0001540443190606311
indicates O 0 0.00011477117368485779
that O 0 1.7177593690576032e-05
almost O 0 2.3936790967127308e-05
all O 0 8.93836568138795e-06
of O 0 2.6633664674591273e-05
these O 0 1.4648487194790505e-05
represent O 0 3.822065264103003e-05
common O 0 6.147342355689034e-05
ancestry O 0 9.353060886496678e-05
and O 0 7.634030771441758e-05
that O 0 4.9210630095331e-05
very O 0 8.50180076668039e-05
few O 0 0.0001968827418750152
spontaneously O 0 0.0032374057918787003
recurring O 1 0.6189258694648743
ATM O 0 0.38970184326171875
mutations O 0 0.0012067793868482113
exist O 0 0.0007026474340818822
. O 0 0.0007286135805770755

Assays O 0 0.004376675002276897
requiring O 0 0.0006867811316624284
minimal O 0 0.0006056405836716294
amounts O 0 0.0001905686076497659
of O 0 0.00015870654897298664
genomic O 0 0.00030888061155565083
DNA O 0 0.0002582185552455485
were O 0 7.992929749889299e-05
designed O 0 0.00019615047494880855
to O 0 4.975860065314919e-05
allow O 0 6.761713302694261e-05
rapid O 0 0.000525117211509496
screening O 0 0.00019486236851662397
for O 0 7.30092215235345e-05
common O 0 0.0001793423289200291
ethnic O 0 0.0003169236006215215
mutations O 0 0.001099979504942894
. O 0 0.0008353050798177719

These O 0 0.0008285661460831761
rapid O 0 0.0026133025530725718
assays O 0 0.0008061028202064335
detected O 0 0.0004951289156451821
mutations O 0 0.0001545451086713001
in O 0 6.492258398793638e-05
76 O 0 0.00026209885254502296
% O 0 5.9744808822870255e-05
of O 0 0.00014835884212516248
Costa O 0 0.0004715528921224177
Rican O 0 0.0016136742196977139
patients O 0 0.00015309177979361266
( O 0 5.6536635383963585e-05
3 O 0 7.684008596697822e-05
) O 0 2.1779989765491337e-05
, O 0 1.5980544048943557e-05
50 O 0 2.434979069221299e-05
% O 0 1.5486959455301985e-05
of O 0 7.124398689484224e-05
Norwegian O 0 0.0005097883404232562
patients O 0 0.00012354175851214677
( O 0 5.73982106288895e-05
1 O 0 6.476973067037761e-05
) O 0 2.1335406927391887e-05
, O 0 1.8925113181467168e-05
25 O 0 3.593309156713076e-05
% O 0 2.691826921363827e-05
of O 0 8.677144796820357e-05
Polish O 1 0.6726107597351074
patients O 0 0.000549084972590208
( O 0 9.095743735088035e-05
4 O 0 0.00011902437108801678
) O 0 2.9847939003957435e-05
, O 0 1.753948708937969e-05
and O 0 9.511378266324755e-06
14 O 0 3.209865462849848e-05
% O 0 1.7594953533262014e-05
of O 0 6.705003761453554e-05
Italian O 0 0.0019459817558526993
patients O 0 0.00044763766345568
( O 0 0.00010335075785405934
1 O 0 8.925268048187718e-05
) O 0 3.429994103498757e-05
, O 0 3.031599408132024e-05
as O 0 3.483409091131762e-05
well O 0 3.0031409551156685e-05
as O 0 4.6902536269044504e-05
in O 0 6.930658128112555e-05
patients O 0 0.00012083972978871316
of O 0 0.0003523535851854831
Amish O 1 0.6950059533119202
/ O 0 0.004823763854801655
Mennonite O 0 0.00405013095587492
and O 0 0.0003274778136983514
Irish O 0 0.0008740872726775706
English O 0 0.0007991589955054224
backgrounds O 0 0.0007528041605837643
. O 0 0.0006179154734127223

Additional O 0 0.0021090733353048563
mutations O 0 0.0007986286655068398
were O 0 0.00023207973572425544
observed O 0 0.00017530038894619793
in O 0 0.00013104730169288814
Japanese O 0 0.0007406417280435562
, O 0 0.0001726762275211513
Utah O 0 0.0012016822583973408
Mormon O 0 0.001713682897388935
, O 0 0.0003117464657407254
and O 0 0.00023581564892083406
African O 0 0.0013280905550345778
American O 0 0.00613335520029068
patients O 0 0.004042556043714285
. O 0 0.0011151161743327975

These O 0 0.0007748562493361533
assays O 0 0.0006677075871266425
should O 0 0.00014982896391302347
facilitate O 0 0.00027788415900431573
screening O 0 0.00024300777295138687
for O 0 0.0001553682523081079
A B-Disease 1 0.998416543006897
- I-Disease 1 0.9973951578140259
T I-Disease 1 0.9997361302375793
heterozygotes O 0 0.001315578236244619
in O 0 0.00010366225615143776
the O 0 0.00012626081297639757
populations O 0 6.795260560465977e-05
studied O 0 0.00022883416386321187
. O 0 0.00012054522812832147
. O 0 0.0003009659412782639

The O 0 0.007386647164821625
von B-Disease 1 0.9015010595321655
Hippel I-Disease 1 0.9997950196266174
- I-Disease 1 0.9994245767593384
Lindau I-Disease 1 0.9999842643737793
tumor I-Disease 1 0.9999979734420776
suppressor O 1 0.9968949556350708
gene O 0 0.0005015188362449408
is O 0 0.00010133111209142953
required O 0 6.229749851627275e-05
for O 0 0.00010184045095229521
cell O 0 0.00043517170706763864
cycle O 0 0.0007246728055179119
exit O 0 0.0008745868690311909
upon O 0 0.0009554041898809373
serum O 0 0.046361323446035385
withdrawal O 0 0.00643320893868804
. O 0 0.0014672504039481282

The O 0 0.002488573081791401
inactivation O 0 0.0076968129724264145
of O 0 0.0008697145385667682
the O 0 0.0015108479419723153
von B-Disease 1 0.9384037852287292
Hippel I-Disease 1 0.9997521042823792
- I-Disease 1 0.9900726079940796
Lindau I-Disease 1 0.9996185302734375
( I-Disease 0 0.08263391256332397
VHL I-Disease 1 0.9999915361404419
) I-Disease 0 0.03539993613958359
tumor I-Disease 1 0.9999912977218628
suppressor O 1 0.9994561076164246
gene O 0 0.0026235575787723064
predisposes O 0 0.44171610474586487
affected O 0 0.0003917567082680762
individuals O 0 5.799794234917499e-05
to O 0 0.00010375265264883637
the O 0 0.13123567402362823
human O 1 0.9999914169311523
VHL B-Disease 1 1.0
cancer I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 1 0.771085262298584
is O 0 0.0008791294530965388
associated O 0 0.0005999062559567392
with O 0 0.0007899506599642336
sporadic B-Disease 1 0.999913215637207
renal I-Disease 1 1.0
cell I-Disease 1 0.9999998807907104
carcinomas I-Disease 1 1.0
( O 1 0.9999253749847412
RCC B-Disease 1 1.0
) O 0 0.0015062139136716723
and O 0 0.001481050974689424
brain B-Disease 1 0.998370349407196
hemangioblastomas I-Disease 1 0.9977357387542725
. O 0 0.0018197534373030066

VHL O 1 0.9963739514350891
- O 0 0.009552818723022938
negative O 0 0.0014713850105181336
786 O 1 0.7120422720909119
- O 0 0.277859628200531
0 O 0 0.0035225730389356613
RCC B-Disease 1 0.9999946355819702
cells O 0 0.0015048169298097491
are O 0 8.599877037340775e-05
tumorigenic O 0 0.12408258765935898
in O 0 0.0004952941089868546
nude O 0 0.22317254543304443
mice O 0 0.0006336334045045078
which O 0 6.988389941398054e-05
is O 0 0.00010318059503333643
suppressed O 0 0.0003791034978348762
by O 0 6.391831993823871e-05
the O 0 0.00028102940996177495
reintroduction O 0 0.003494455711916089
of O 0 0.002784969052299857
VHL B-Disease 1 0.9999101161956787
. O 0 0.0018923976458609104

Remarkably O 0 0.012691169045865536
, O 0 0.0008087492315098643
this O 0 0.00027167785447090864
occurs O 0 0.00039070163620635867
without O 0 9.256665362045169e-05
affecting O 0 0.0003000771685037762
the O 0 0.00029239023569971323
growth O 0 0.00046695576747879386
rate O 0 9.193697769660503e-05
and O 0 7.288755296031013e-05
cell O 0 0.00025595881743356586
cycle O 0 0.0002580074069555849
profile O 0 0.00013191702601034194
of O 0 0.00012257952766958624
these O 0 5.052941924077459e-05
cells O 0 0.0003071134851779789
in O 0 0.00019147309649270028
culture O 0 0.0010072706500068307
. O 0 0.0006008695927448571

The O 0 0.003259624121710658
786 O 0 0.04082942754030228
- O 0 0.0036125583574175835
0 O 0 0.0009449143544770777
cell O 0 0.0013312350492924452
line O 0 0.0008230656385421753
, O 0 0.00017124351870734245
like O 0 0.0003376876120455563
many O 0 0.000293125951429829
cancer B-Disease 1 0.9996581077575684
cells O 0 0.001586584490723908
, O 0 0.00013184822455514222
fails O 0 0.00022063391224946827
to O 0 5.042967677582055e-05
exit O 0 0.00029744274797849357
the O 0 0.0002247396914754063
cell O 0 0.0006531989201903343
cycle O 0 0.0008488345774821937
upon O 0 0.000771496444940567
serum O 0 0.043085627257823944
withdrawal O 0 0.003568655112758279
. O 0 0.0009139410685747862

Here O 0 0.0019546872936189175
, O 0 0.0003359071852173656
it O 0 0.00012808962492272258
is O 0 5.9552883612923324e-05
shown O 0 5.192601020098664e-05
that O 0 2.244185634481255e-05
reintroduction O 0 0.00018733475008048117
of O 0 0.00010618061060085893
the O 0 0.0002089531917590648
wild O 0 0.0005831494927406311
- O 0 0.0008581675938330591
type O 0 0.000673603848554194
VHL B-Disease 1 0.9967888593673706
gene O 0 0.000270549557171762
restores O 0 0.0006844709278084338
the O 0 0.00010594435298116878
ability O 0 0.00011055023060180247
of O 0 0.0005593571113422513
VHL O 1 0.9999970197677612
- O 1 0.9920245409011841
negative O 0 0.042851660400629044
RCC B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9995237588882446
cells O 0 0.0002173685934394598
to O 0 6.225641118362546e-05
exit O 0 0.00027022245922125876
the O 0 0.00024189078249037266
cell O 0 0.0005261405021883547
cycle O 0 0.0005914639914408326
and O 0 0.00017366695101372898
enter O 0 0.0008181537850759923
G0 O 1 0.9907638430595398
/ O 0 0.0034439461305737495
quiescence O 0 0.007476747967302799
in O 0 0.0005571401561610401
low O 0 0.001802874612621963
serum O 0 0.010306019335985184
. O 0 0.0008757885079830885

Both O 0 0.0053773862309753895
VHL O 1 0.9999159574508667
- O 0 0.14325203001499176
positive O 0 0.0012711823219433427
and O 0 0.0010742320446297526
VHL O 1 0.999985933303833
- O 1 0.914054274559021
negative O 0 0.0019365710904821754
RCC B-Disease 1 0.9999926090240479
cells O 0 0.0009603330981917679
exit O 0 0.0009004484163597226
the O 0 0.000699685828294605
cell O 0 0.001361211878247559
cycle O 0 0.001033460022881627
by O 0 0.00026370654813945293
contact O 0 0.0009157332824543118
inhibition O 0 0.0034146723337471485
. O 0 0.0013542306842282414

The O 0 0.006382723804563284
cyclin O 0 0.015299816615879536
- O 0 0.002980841090902686
dependent O 0 0.0014005175326019526
kinase O 0 0.003343313466757536
inhibitor O 0 0.17837108671665192
, O 0 0.0004045786918140948
p27 O 0 0.03752543404698372
, O 0 0.0002046781883109361
accumulates O 0 0.0014031616738066077
upon O 0 0.0005377026391215622
serum O 0 0.037802357226610184
withdrawal O 0 0.001246346510015428
, O 0 7.219675899250433e-05
only O 0 2.714602669584565e-05
in O 0 2.8385855330270715e-05
the O 0 5.3423380450112745e-05
presence O 0 0.00013636387302540243
of O 0 0.0004764681507367641
VHL B-Disease 1 0.9999402761459351
, O 0 0.0001060007416526787
as O 0 5.292274727253243e-05
a O 0 5.374345346353948e-05
result O 0 3.534202915034257e-05
of O 0 7.08954394212924e-05
the O 0 0.00012940644228365272
stabilization O 0 0.0010057493345811963
of O 0 0.0003023025637958199
the O 0 0.0006277547217905521
protein O 0 0.0008955507655628026
. O 0 0.0004499504284467548

We O 0 0.0009260455262847245
propose O 0 0.0006791725754737854
that O 0 0.00012297593639232218
the O 0 0.00020144622249063104
loss O 0 0.0006525496137328446
of O 0 0.0004506638506427407
wild O 0 0.003308225190266967
- O 0 0.0896524116396904
type O 0 0.027162272483110428
VHL B-Disease 1 0.9997137188911438
gene O 0 0.00024619154282845557
results O 0 8.8383378169965e-05
in O 0 5.292870628181845e-05
a O 0 0.00015147376689128578
specific O 0 0.0001354910637019202
cellular O 0 0.003037022426724434
defect O 1 0.9876489043235779
in O 0 0.0014944494469091296
serum O 1 0.9979844093322754
- O 0 0.008203692734241486
dependent O 0 0.0002469975152052939
growth O 0 0.0003266356361564249
control O 0 0.0002786612312775105
, O 0 9.008319466374815e-05
which O 0 9.560170292388648e-05
may O 0 0.00024395770742557943
initiate O 0 0.0024136914871633053
tumor B-Disease 1 0.9996726512908936
formation O 1 0.8220506906509399
. O 0 0.0012993060518056154

This O 0 0.0013167164288461208
is O 0 0.0005784136010333896
corrected O 0 0.0010806038044393063
by O 0 8.553258521715179e-05
the O 0 0.00011816920596174896
reintroduction O 0 0.000728952931240201
of O 0 0.00037222864921204746
wild O 0 0.0013200091198086739
- O 0 0.00756132323294878
type O 0 0.008540421724319458
VHL B-Disease 1 0.9999170303344727
, O 0 0.000789100828114897
implicating O 1 0.9679625034332275
VHL B-Disease 1 0.9990615248680115
as O 0 0.00024295400362461805
the O 0 0.0003398158005438745
first O 0 0.00223382655531168
tumor B-Disease 1 0.9996762275695801
suppressor O 0 0.006419273093342781
involved O 0 0.00017385219689458609
in O 0 6.537636363646016e-05
the O 0 0.00010436109005240723
regulation O 0 0.0001117462816182524
of O 0 0.00019212964980397373
cell O 0 0.0009095211862586439
cycle O 0 0.0007488011033274233
exit O 0 0.00043758045649155974
, O 0 5.779642015113495e-05
which O 0 2.543710797908716e-05
is O 0 2.5555935280863196e-05
consistent O 0 3.44042491633445e-05
with O 0 2.633377334859688e-05
its O 0 4.989753506379202e-05
gatekeeper O 0 0.32841986417770386
function O 0 0.0002130869688699022
in O 0 0.00016400645836256444
the O 0 0.005263023544102907
kidney O 1 0.9999896287918091
. O 0 0.00041535234777256846
. O 0 0.0005379928043112159

Piebaldism B-Disease 1 0.9999909400939941
with O 1 0.7590570449829102
deafness B-Disease 1 1.0
: O 0 0.0018543456681072712
molecular O 0 0.0008231307147070765
evidence O 0 0.00044120894744992256
for O 0 0.00016622853581793606
an O 0 0.00036856066435575485
expanded O 0 0.09835656732320786
syndrome O 1 0.9999969005584717
. O 0 0.001279893098399043

In O 0 0.0012265967670828104
a O 0 0.0008675279095768929
South O 0 0.0014117083046585321
African O 0 0.0009744949056766927
girl O 0 0.002211003564298153
of O 0 0.0012729080626741052
Xhosa O 1 0.9978777170181274
stock O 0 0.006889050360769033
with O 0 0.0008820064831525087
severe O 1 0.9999994039535522
piebaldism B-Disease 1 0.9999998807907104
and O 1 0.9999306201934814
profound O 1 1.0
congenital O 1 1.0
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
we O 0 0.34868061542510986
identified O 0 0.0005128378397785127
a O 0 0.0002959765843115747
novel O 0 0.00027811049949377775
missense O 0 0.000410919456044212
substitution O 0 0.0002585343609098345
at O 0 0.00016816971765365452
a O 0 8.111408533295617e-05
highly O 0 8.415430784225464e-05
conserved O 0 0.0001339406007900834
residue O 0 0.00036760407965630293
in O 0 6.330473115667701e-05
the O 0 0.00011024766718037426
intracellular O 0 0.00039775477489456534
kinase O 0 0.00020971184130758047
domain O 0 0.00012555786815937608
of O 0 0.00019276437524240464
the O 0 0.0007359791779890656
KIT O 1 0.923861026763916
proto O 1 0.9672846794128418
- O 0 0.18462029099464417
oncogene O 1 0.9784747362136841
, O 0 0.0010950262658298016
R796G O 0 0.19654390215873718
. O 0 0.0018498147837817669

Though O 0 0.006881577428430319
auditory B-Disease 1 0.9752964973449707
anomalies I-Disease 0 0.10203331708908081
have O 0 0.00010141114762518555
been O 0 0.0001772250689100474
observed O 0 0.00015737232752144337
in O 0 0.00010818523151101544
mice O 0 0.00020537117961794138
with O 0 7.248539623105898e-05
dominant O 0 0.0014135829405859113
white O 0 0.01620587520301342
spotting O 1 0.9245092868804932
( O 0 0.0007609950844198465
W O 0 0.42076149582862854
) O 0 9.931085514836013e-05
due O 0 0.0001552392786834389
to O 0 0.0001761033636284992
KIT O 1 0.999087929725647
mutations O 0 0.0027557529974728823
, O 0 0.0008095723460428417
deafness B-Disease 1 0.9999994039535522
is O 0 0.0001729616487864405
not O 0 5.974736995995045e-05
typical O 0 0.00026738157612271607
in O 0 0.000230879319133237
human O 0 0.0009907159255817533
piebaldism B-Disease 1 0.9933615922927856
. O 0 0.0012687031412497163

Thus O 0 0.0020523855928331614
, O 0 0.0007084739627316594
the O 0 0.0006046370835974813
occurrence O 0 0.0026919187512248755
of O 1 0.8879613280296326
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
in O 0 0.17283861339092255
this O 0 0.00040749990148469806
patient O 0 0.0005590335349552333
extends O 0 0.0005307727842591703
considerably O 0 0.0002627410867717117
the O 0 0.00014654721599072218
phenotypic O 0 0.000257712381426245
range O 0 0.00010102312808157876
of O 0 0.00022152722522150725
piebaldism B-Disease 0 0.25049281120300293
due O 0 0.00038512260653078556
to O 0 0.00019190700550097972
KIT O 0 0.1705220341682434
gene O 0 0.0002833849866874516
mutation O 0 0.0001580014213686809
in O 0 7.445235678460449e-05
humans O 0 9.004257299238816e-05
and O 0 7.388772792182863e-05
tightens O 0 0.00046346531598828733
the O 0 0.00014745243242941797
clinical O 0 0.0002630611998029053
similarity O 0 0.00029059883672744036
between O 0 0.0003682724782265723
piebaldism B-Disease 1 0.9843653440475464
and O 0 0.00016558817878831178
the O 0 0.00017078530800063163
various O 0 0.0001336298300884664
forms O 0 0.0006368551403284073
of O 1 0.9995658993721008
Waardenburg B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 0.009830054827034473
. O 0 0.0020173860248178244

Cycloheximide O 1 0.9154195189476013
facilitates O 0 0.00463572284206748
the O 0 0.0005008464213460684
identification O 0 0.0004134156333748251
of O 0 0.00042840218520723283
aberrant O 0 0.0036131914239376783
transcripts O 0 0.0006665345863439143
resulting O 0 0.00027391855837777257
from O 0 8.514247019775212e-05
a O 0 0.00019905382941942662
novel O 0 0.00022327390615828335
splice O 0 0.0010673750657588243
- O 0 0.000406515144277364
site O 0 0.00035600477713160217
mutation O 0 0.00019615795463323593
in O 0 0.00018676546460483223
COL17A1 O 1 0.9783631563186646
in O 0 0.0003320257819723338
a O 0 0.0008133193477988243
patient O 0 0.0030042058788239956
with O 0 0.0011960417032241821
generalized O 1 0.9998284578323364
atrophic B-Disease 1 1.0
benign I-Disease 1 0.9999998807907104
epidermolysis I-Disease 1 0.9999997615814209
bullosa I-Disease 1 0.9999896287918091
. O 0 0.011750496923923492

Patients O 1 0.6873325705528259
with O 0 0.013355676084756851
generalized O 1 0.9999697208404541
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 0.9999998807907104
bullosa I-Disease 1 0.9999973773956299
often O 0 0.0011200550943613052
show O 0 0.0009098610025830567
decreased O 0 0.0008774306625127792
expression O 0 0.0002071110939141363
of O 0 0.00048059149412438273
type O 1 0.9657241106033325
XVII O 1 0.9999998807907104
collagen O 1 0.9998992681503296
, O 0 0.0002755004388745874
a O 0 0.00035941749229095876
transmembrane O 0 0.0018268097192049026
hemidesmosomal O 0 0.02992553636431694
protein O 0 0.00043927953811362386
encoded O 0 0.00024689530255272985
by O 0 0.0002990672364830971
COL17A1 O 1 0.9138303399085999
. O 0 0.0013232050696387887

This O 0 0.0009439816931262612
report O 0 0.0004872058052569628
documents O 0 0.000346575427101925
a O 0 0.0003973022976424545
novel O 0 0.0004825112991966307
splice O 0 0.0028953184373676777
- O 0 0.0012416684767231345
site O 0 0.0008074235520325601
mutation O 0 0.0002791701990645379
in O 0 0.00014022197865415365
COL17A1 O 1 0.9884203672409058
in O 0 0.00021696275507565588
a O 0 0.00043226167326793075
patient O 0 0.0017721639014780521
with O 0 0.0005364187527447939
generalized O 1 0.999903678894043
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 0.9999998807907104
bullosa I-Disease 1 0.999997615814209
, O 0 0.0006486464408226311
and O 0 0.00013163241965230554
applies O 0 9.013037924887612e-05
a O 0 8.028282172745094e-05
new O 0 7.75288644945249e-05
methodology O 0 0.0001454536832170561
to O 0 5.2767332817893475e-05
define O 0 0.00012377263919916004
and O 0 0.00011240300227655098
characterize O 0 0.0007575375493615866
the O 0 0.0004443786747287959
resulting O 0 0.0011616216506808996
mRNA O 0 0.0008936056401580572
splice O 0 0.0030765016563236713
variants O 0 0.0008083281572908163
. O 0 0.0005749815609306097

Mutational O 0 0.033305320888757706
analysis O 0 0.001187704037874937
of O 0 0.001535890274681151
COL17A1 O 1 0.9982725381851196
identified O 0 0.0012314579216763377
a O 0 0.0010266447206959128
maternally O 0 0.009556746110320091
inherited O 1 0.9788030982017517
G O 1 0.7004162669181824
- O 0 0.0017094396753236651
to O 0 0.00019629286543931812
- O 0 0.0015806043520569801
T O 0 0.0032523691188544035
transversion O 0 0.0038440609350800514
at O 0 0.0002941483398899436
the O 0 0.00014615787949878722
- O 0 0.0002469136379659176
1 O 0 0.00011337763862684369
position O 0 0.00016582265379838645
of O 0 0.00026057547074742615
exon O 0 0.002113811671733856
32 O 0 0.0009938343428075314
. O 0 0.0006209799321368337

This O 0 0.0012650627177208662
acceptor O 0 0.002375571755692363
splice O 0 0.00845242291688919
- O 0 0.002050976734608412
site O 0 0.0007476246100850403
mutation O 0 0.00023528945166617632
led O 0 0.00021441026183310896
to O 0 5.6234381190733984e-05
the O 0 0.00014074317004997283
formation O 0 0.0007745528710074723
of O 0 0.00034268226590938866
aberrant O 0 0.0024809897877275944
transcripts O 0 0.0003832291404251009
present O 0 0.0002384859835729003
at O 0 0.0003589083207771182
extremely O 0 0.0003697123902384192
low O 0 0.0007231030031107366
levels O 0 0.0006099987076595426
. O 0 0.00045749274431727827

Based O 0 0.0012481752783060074
on O 0 0.0004877933824900538
our O 0 0.0005564478342421353
recent O 0 0.00025514140725135803
finding O 0 0.00040779836126603186
that O 0 0.0003751572221517563
cycloheximide O 1 0.9536070227622986
stabilized O 1 0.7704042196273804
mutant O 0 0.11874064058065414
COL17A1 O 1 0.9993190765380859
transcripts O 0 0.0014501900877803564
in O 0 0.00027669762494042516
keratinocytes O 0 0.002015357604250312
homozygous O 0 0.00043270448804832995
for O 0 9.304685227107257e-05
a O 0 0.0002497782406862825
frameshift O 0 0.003932542633265257
mutation O 0 0.00021955484407953918
, O 0 7.696005195612088e-05
the O 0 9.737320215208456e-05
effects O 0 0.00016954132297541946
of O 0 0.00014206346531864256
the O 0 0.0002851370663847774
splice O 0 0.003361637005582452
- O 0 0.00044131409958936274
site O 0 0.0002998191921506077
mutation O 0 9.490448428550735e-05
on O 0 6.393868534360081e-05
splicing O 0 0.0002478840760886669
of O 0 0.00017918508092407137
COL17A1 O 1 0.9499922394752502
transcripts O 0 0.0004812745610252023
were O 0 8.328570402227342e-05
determined O 0 9.919302101479843e-05
using O 0 5.986405449220911e-05
reverse O 0 0.00029175312374718487
transcriptase O 0 0.0006462187157012522
polymerase O 0 0.00046523462515324354
chain O 0 0.00019413945847190917
reaction O 0 6.565074727404863e-05
of O 0 5.985800817143172e-05
total O 0 0.00010084430687129498
RNA O 0 0.0003128597163595259
from O 0 0.00017126294551417232
keratinocytes O 0 0.0014700194587931037
incubated O 0 0.0007664015865884721
for O 0 0.00016408621740993112
2 O 0 0.0007287702756002545
. O 0 0.0007197835948318243

5 O 0 0.0032103657722473145
h O 0 0.002009460236877203
in O 0 0.00026475530466996133
the O 0 0.000321756029734388
presence O 0 0.00041519643855281174
or O 0 0.00015379877004306763
absence O 0 0.0004335558332968503
of O 0 0.000492801598738879
10 O 0 0.0011709548998624086
microg O 1 0.991061806678772
cycloheximide O 1 0.9714368581771851
per O 0 0.001428130199201405
ml O 0 0.0077317580580711365
. O 0 0.0011419664369896054

Using O 0 0.0008762634242884815
this O 0 0.00030568387592211366
approach O 0 0.00043888064101338387
, O 0 0.00018350771279074252
an O 0 0.00020916189532727003
abnormally O 0 0.0021740244701504707
spliced O 0 0.0009675213368609548
transcript O 0 0.0007687957840971649
was O 0 0.0002892311895266175
identified O 0 5.607133061857894e-05
that O 0 1.9101809812127613e-05
contains O 0 2.1074021788081154e-05
an O 0 2.2802454623160884e-05
extra O 0 6.993282295297831e-05
264 O 0 0.00020231590315233916
bases O 0 0.00011144034942844883
upstream O 0 0.0002179012808483094
from O 0 6.70065637677908e-05
exon O 0 0.0004994547925889492
32 O 0 0.00017887286958284676
, O 0 9.006945037981495e-05
resulting O 0 0.00015939859440550208
in O 0 6.753065099474043e-05
a O 0 0.00027714751195162535
premature O 0 0.001335954642854631
termination O 0 0.0013701870338991284
codon O 0 0.0012659752974286675
27 O 0 0.000804950250312686
bp O 0 0.0016814538976177573
downstream O 0 0.0005508732865564525
from O 0 0.00018402373825665563
the O 0 0.0003640949435066432
cryptic O 0 0.003430310869589448
splice O 0 0.008580847643315792
site O 0 0.0039502293802797794
. O 0 0.0012263742974027991

Three O 0 0.001200548023916781
other O 0 0.0003076025459449738
splice O 0 0.0029925231356173754
variants O 0 0.0004966086125932634
, O 0 0.0001302665041293949
including O 0 6.083914922783151e-05
one O 0 5.78328144911211e-05
derived O 0 7.912589353509247e-05
from O 0 4.524098403635435e-05
the O 0 9.55031209741719e-05
skipping O 0 0.0006276009371504188
of O 0 0.00021593087876681238
exon O 0 0.0011840328807011247
32 O 0 0.00029569031903520226
, O 0 9.107972437050194e-05
were O 0 8.336619794135913e-05
also O 0 0.00013264038716442883
identified O 0 0.0003301338292658329
. O 0 0.000602872809395194

These O 0 0.0006728258449584246
results O 0 0.00033820117823779583
indicate O 0 0.0002498787653166801
the O 0 0.00025960191851481795
usefulness O 0 0.0008906908333301544
of O 0 0.000697592506185174
cycloheximide O 1 0.9989940524101257
treatment O 0 0.002533051185309887
in O 0 0.00011350140266586095
evaluating O 0 0.0001801189937395975
the O 0 0.00019779813010245562
abnormal O 0 0.0005456442013382912
processing O 0 0.00021634716540575027
of O 0 0.00017870002193376422
mRNA O 0 0.0001784166815923527
due O 0 9.313100599683821e-05
to O 0 5.652660547639243e-05
splice O 0 0.001030992134474218
- O 0 0.0005659304442815483
site O 0 0.00042503245640546083
mutations O 0 0.00013753787789028138
, O 0 6.923873297637329e-05
because O 0 6.530857353936881e-05
( O 0 0.0001265754399355501
i O 0 0.00022134525352157652
) O 0 8.966591121861711e-05
aberrant O 0 0.0006542596383951604
splicing O 0 0.00027604997740127146
often O 0 6.491205567726865e-05
generates O 0 0.00013488133845385164
a O 0 0.00017629758804105222
premature O 0 0.0010706568136811256
termination O 0 0.0012400728883221745
codon O 0 0.0007268496556207538
, O 0 0.00014368000847753137
( O 0 0.00019576445629354566
ii O 0 0.0034821100998669863
) O 0 0.0001214224539580755
transcripts O 0 0.0002742446376942098
with O 0 0.00011844976688735187
premature O 0 0.0014298433670774102
termination O 0 0.0018151841359212995
codons O 0 0.0004502894007600844
can O 0 4.1201903513865545e-05
occur O 0 8.064783469308168e-05
at O 0 0.00025715571246109903
low O 0 0.0003984416543971747
or O 0 0.00017413556633982807
undetectable O 0 0.005338681396096945
levels O 0 0.00015310884919017553
due O 0 0.00012499699369072914
to O 0 6.718045915476978e-05
nonsense O 0 0.0008224266930483282
- O 0 0.00041926681296899915
mediated O 0 0.0005152946687303483
mRNA O 0 0.00033688213443383574
decay O 0 0.0006204447126947343
, O 0 6.714204209856689e-05
and O 0 3.951366670662537e-05
( O 0 0.00010179267701460049
iii O 0 0.0025020407047122717
) O 0 5.0066177209373564e-05
the O 0 6.863918679300696e-05
levels O 0 6.981102342251688e-05
of O 0 4.608571180142462e-05
these O 0 2.2567643100046553e-05
transcripts O 0 0.00014019683294463903
can O 0 2.9209855711087584e-05
be O 0 3.9821396057959646e-05
increased O 0 0.00011532947246450931
by O 0 0.00016359379515051842
cycloheximide O 0 0.25512218475341797
. O 0 0.0007255582604557276

A O 0 0.009270237758755684
deletion O 0 0.00768176419660449
mutation O 0 0.0010277281980961561
in O 0 0.0004470760468393564
COL17A1 O 1 0.9988012313842773
in O 0 0.00036092361551709473
five O 0 0.0003056448476854712
Austrian O 0 0.0020865052938461304
families O 0 0.0005339393974281847
with O 0 0.0005654821288771927
generalized O 1 0.9993182420730591
atrophic B-Disease 1 1.0
benign I-Disease 1 0.9999996423721313
epidermolysis I-Disease 1 0.9999994039535522
bullosa I-Disease 1 0.9999785423278809
represents O 0 0.0059378482401371
propagation O 0 0.001893056440167129
of O 0 0.0005946754245087504
an O 0 0.0005491187330335379
ancestral O 0 0.04756263643503189
allele O 0 0.0020227066706866026
. O 0 0.0008408568101003766

Patients O 0 0.1651502549648285
with O 0 0.006862149108201265
generalized O 1 0.9999139308929443
atrophic B-Disease 1 1.0
benign I-Disease 1 0.9999998807907104
epidermolysis I-Disease 1 0.9999998807907104
bullosa I-Disease 1 0.9999979734420776
, O 0 0.0014717353042215109
a O 0 0.0005908309831283987
usually O 0 0.0003066962235607207
nonlethal O 0 0.0017968760803341866
form O 0 0.00038795769796706736
of O 0 0.003101160516962409
junctional B-Disease 1 0.9999973773956299
epidermolysis I-Disease 1 0.9999979734420776
bullosa I-Disease 1 0.999977707862854
, O 0 0.0007484450470656157
have O 0 0.00015750595775898546
generalized O 0 0.0034352049697190523
blistering B-Disease 1 0.9996142387390137
, O 1 0.5778809189796448
nail B-Disease 1 1.0
dystrophy I-Disease 1 1.0
, O 1 0.9950096607208252
patchy B-Disease 1 0.9999994039535522
alopecia I-Disease 1 1.0
, O 1 0.9975792765617371
and O 1 0.9930277466773987
dental B-Disease 1 0.9999995231628418
abnormalities I-Disease 1 0.9999970197677612
. O 0 0.004429162014275789

Skin B-Disease 1 0.9999837875366211
fragility I-Disease 1 0.9999349117279053
in O 0 0.001129735610447824
most O 0 0.000302638829452917
cases O 0 0.0001407488016411662
is O 0 8.414467447437346e-05
due O 0 0.00014373233716469258
to O 0 6.15317330812104e-05
mutations O 0 5.6611403124406934e-05
in O 0 5.35202088940423e-05
the O 0 0.00017479597590863705
gene O 0 0.00023258323199115694
encoding O 0 0.0004963594255968928
type O 0 0.3075385093688965
XVII O 1 0.9999994039535522
collagen O 1 0.9999947547912598
( O 0 0.04379454255104065
COL17A1 O 1 0.9999254941940308
) O 0 0.0006506750360131264
. O 0 0.0006697869393974543

Recently O 0 0.004806268494576216
, O 0 0.0005396308843046427
we O 0 0.00019443586643319577
reported O 0 0.0002026645961450413
five O 0 0.0001464137021685019
Austrian O 0 0.001671779085882008
families O 0 0.0002750128332991153
with O 0 0.0008373683667741716
generalized O 1 0.9999251365661621
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 0.9999997615814209
bullosa I-Disease 1 0.9999727010726929
who O 0 0.0014828996500000358
share O 0 0.00034758911351673305
the O 0 0.0006186073296703398
same O 0 0.0006260936497710645
COL17A1 O 1 0.999931812286377
mutation O 0 0.004123209044337273
. O 0 0.0015793782658874989

Affected O 0 0.004145047161728144
individuals O 0 0.00020111729099880904
in O 0 0.00015221259673126042
three O 0 0.00014285567158367485
families O 0 0.00010712887888075784
are O 0 3.879194991895929e-05
homozygous O 0 0.0002731176500674337
for O 0 0.00012219627387821674
4003delTC O 1 0.7488719820976257
, O 0 0.00014102474960964173
whereas O 0 9.457816486246884e-05
those O 0 2.201302777393721e-05
in O 0 4.181488839094527e-05
two O 0 4.234700099914335e-05
others O 0 9.624630911275744e-05
are O 0 7.28157174307853e-05
compound O 0 0.006510579958558083
heterozygotes O 0 0.009584791958332062
. O 0 0.0010138622019439936

To O 0 0.0007239255355671048
determine O 0 0.000284131383523345
if O 0 0.00015586965309921652
the O 0 0.0001781599858077243
occurrence O 0 0.00047868426190689206
of O 0 0.00038330620736815035
4003delTC O 1 0.8845257759094238
in O 0 0.00016242153651546687
these O 0 4.142999023315497e-05
unrelated O 0 0.00032560373074375093
families O 0 0.0001005542217171751
signifies O 0 0.0010074400343000889
propagation O 0 0.0004330820229370147
of O 0 0.0001421778288204223
an O 0 0.0001369756064377725
ancestral O 0 0.0014468478038907051
allele O 0 0.0002498182584531605
or O 0 0.0001075726468116045
a O 0 0.00024346556165255606
mutational O 0 0.014511036686599255
hot O 0 0.0039712549187242985
spot O 0 0.0011090671177953482
, O 0 0.00015735687338747084
haplotypes O 0 0.0003037736751139164
were O 0 8.96265046321787e-05
determined O 0 0.00014409048890229315
for O 0 0.00011020688543794677
polymorphisms O 0 0.00038399454206228256
both O 0 0.00011615623225225136
within O 0 0.0002914422657340765
and O 0 0.0006007790798321366
flanking O 1 0.9952219128608704
COL17A1 O 1 0.9999802112579346
. O 0 0.004520384594798088

Five O 0 0.005750088021159172
intragenic O 1 0.9124739766120911
polymorphisms O 0 0.002261386252939701
were O 0 0.0002756646426860243
chosen O 0 0.00028374724206514657
based O 0 0.00011799726053141057
on O 0 0.00022443433408625424
their O 0 0.00036563878529705107
informativeness O 0 0.4132455885410309
. O 0 0.0018606845987960696

One O 0 0.0007586010615341365
of O 0 0.00038046823465265334
these O 0 5.9837173466803506e-05
, O 0 6.225664401426911e-05
not O 0 2.9518048904719763e-05
previously O 0 0.00010480649507371709
reported O 0 8.612202509539202e-05
, O 0 5.706528827431612e-05
was O 0 0.0005256131989881396
2988 O 0 0.3130621016025543
A O 0 0.0011570971691980958
or O 0 0.00016420298197772354
C O 0 0.0003240732476115227
that O 0 3.7332105421228334e-05
introduces O 0 0.00019303859153296798
a O 0 8.32674340927042e-05
new O 0 7.745333277853206e-05
restriction O 0 0.0001710847282083705
site O 0 0.0002768945414572954
for O 0 0.00019031493866350502
Eco0109 O 1 0.804560124874115
I O 0 0.007454103324562311
. O 0 0.0012324764393270016

All O 0 0.0008074328070506454
the O 0 0.0011623295722529292
4003delTC O 0 0.2982080578804016
alleles O 0 0.0006784713477827609
showed O 0 0.00040642876410856843
the O 0 0.00025119251222349703
same O 0 0.00016347233031410724
haplotype O 0 0.00040454897680319846
for O 0 8.073617937043309e-05
these O 0 4.6420449507422745e-05
five O 0 0.00031438280711881816
polymorphic O 0 0.0026002894155681133
markers O 0 0.006047358736395836
. O 0 0.001491739647462964

Fourteen O 0 0.017689282074570656
microsatellite O 0 0.025274910032749176
polymorphisms O 0 0.002970141125842929
were O 0 0.00029843096854165196
selected O 0 0.00012804321886505932
based O 0 5.5192391300806776e-05
on O 0 4.298620478948578e-05
their O 0 5.539856283576228e-05
high O 0 0.0005758615443482995
heterozygosity O 0 0.050323911011219025
and O 0 9.064131154445931e-05
their O 0 3.965253563364968e-05
location O 0 0.00024174555437639356
within O 0 0.0004191008338239044
10q23 O 1 0.9307913184165955
- O 0 0.010566080920398235
q25 O 1 0.8535428643226624
near O 0 0.1654021441936493
COL17A1 O 1 0.9984379410743713
. O 0 0.002165023237466812

Three O 0 0.001261844881810248
families O 0 0.0007119864458218217
shared O 0 0.0008486308506689966
microsatellite O 0 0.01787189207971096
polymorphisms O 0 0.001997602405026555
covering O 0 0.0017922481056302786
at O 0 0.0008775987080298364
most O 0 8.771837747190148e-05
19 O 0 0.00041298975702375174
cM O 0 0.00041281190351583064
, O 0 0.00010305836622137576
whereas O 0 8.874703053152189e-05
the O 0 8.364712994080037e-05
others O 0 5.339266135706566e-05
shared O 0 7.752028614049777e-05
smaller O 0 6.765621219528839e-05
regions O 0 5.289035107125528e-05
consistent O 0 0.00010446485975990072
with O 0 6.788894097553566e-05
cross O 0 0.00035456527257338166
- O 0 0.0003324774734210223
over O 0 8.110804628813639e-05
events O 0 0.00011284557695034891
during O 0 0.0001214085568790324
passage O 0 9.571810369379818e-05
of O 0 9.093080007005483e-05
this O 0 3.721984103322029e-05
mutation O 0 9.882650192594156e-05
through O 0 7.616702350787818e-05
several O 0 0.00011441374954301864
generations O 0 0.0007896489114500582
. O 0 0.0006501633324660361

These O 0 0.000602373038418591
results O 0 0.0003177137696184218
indicate O 0 0.000243747781496495
that O 0 0.00012865173630416393
4003delTC O 0 0.005467298440635204
occurs O 0 0.0002574569662101567
on O 0 0.00013475534797180444
a O 0 0.0002627776993904263
single O 0 0.00035520264646038413
ancestral O 0 0.0023157065734267235
allele O 0 0.0008817212074063718
. O 0 0.00023377533943857998
. O 0 0.00045906557352282107

The O 0 0.005643727723509073
haptoglobin O 1 0.6843762993812561
- O 0 0.009539640508592129
gene O 0 0.00113171327393502
deletion O 0 0.0014342853100970387
responsible O 0 0.001089216792024672
for O 0 0.0007713765953667462
anhaptoglobinemia B-Disease 1 0.9936271905899048
. O 0 0.0016744198510423303

We O 0 0.0009839794365689158
have O 0 0.00011986619210802019
found O 0 0.0001048194826580584
an O 0 0.00011417049245210364
allelic O 0 0.0011262863408774137
deletion O 0 0.00041900237556546926
of O 0 0.0002948044566437602
the O 0 0.0005218214937485754
haptoglobin O 1 0.8183568120002747
( O 0 0.0003059512819163501
Hp O 0 0.0011204018956050277
) O 0 6.140007462818176e-05
gene O 0 5.8139263273915276e-05
from O 0 4.004222500952892e-05
an O 0 9.053471148945391e-05
individual O 0 9.755387145560235e-05
with O 0 0.00034457369474694133
anhaptoglobinemia B-Disease 1 0.9982275366783142
. O 0 0.0016529621789231896

The O 0 0.0054858834482729435
Hp O 0 0.011091615073382854
gene O 0 0.0007041864446364343
cluster O 0 0.0007980471709743142
consists O 0 0.0001340757735306397
of O 0 0.00017566600581631064
coding O 0 0.00022264952713157982
regions O 0 8.569782949052751e-05
of O 0 0.00016387029609177262
the O 0 0.00040049347444437444
alpha O 0 0.0005338312475942075
chain O 0 0.00025678181555122137
and O 0 6.194856541696936e-05
beta O 0 0.00016865081852301955
chain O 0 0.00014443286636378616
of O 0 0.00010782280151033774
the O 0 0.00023241831513587385
haptoglobin O 0 0.020188961178064346
gene O 0 0.00021456855756696314
( O 0 0.00014384860696736723
Hp O 0 0.0005468320450745523
) O 0 4.505207107285969e-05
and O 0 3.506472785375081e-05
of O 0 8.708079985808581e-05
the O 0 0.00019567376875784248
alpha O 0 0.0005445246351882815
chain O 0 0.00034429936204105616
and O 0 8.826655539451167e-05
beta O 0 0.00019081533537246287
chain O 0 0.0001416106679243967
of O 0 8.488661114824936e-05
the O 0 0.00020066827710252255
haptoglobin O 0 0.4162279963493347
- O 0 0.0009676232002675533
related O 0 0.00025400888989679515
gene O 0 0.00016835231508594006
( O 0 0.00012602614879142493
Hpr O 0 0.0023776721209287643
) O 0 6.75879928166978e-05
, O 0 5.3589148592436686e-05
in O 0 7.182018453022465e-05
tandem O 0 0.00038637069519609213
from O 0 0.00014036228822078556
the O 0 0.0002959274861495942
5 O 0 0.0006831714999862015
side O 0 0.001066349446773529
. O 0 0.0007595341885462403

Southern O 0 0.01749591901898384
blot O 0 0.04452865198254585
and O 0 0.001132303150370717
PCR O 0 0.0025949133560061455
analyses O 0 0.0003207642585039139
have O 0 4.8203484766418114e-05
indicated O 0 0.00011277167504886165
that O 0 2.1349287635530345e-05
the O 0 4.2465289880055934e-05
individual O 0 3.729047239175998e-05
with O 0 9.551095718052238e-05
anhaptoglobinemia B-Disease 1 0.9980745315551758
was O 0 0.002578694373369217
homozygous O 0 0.00020424382819328457
for O 0 5.926265657762997e-05
the O 0 0.0001242112775798887
gene O 0 0.00013252244389150292
deletion O 0 0.00018058106070384383
and O 0 3.5516095522325486e-05
that O 0 2.742771539487876e-05
the O 0 8.035283826757222e-05
gene O 0 7.201371772680432e-05
deletion O 0 0.00017073092749342322
was O 0 0.000162818658282049
included O 0 5.610282823909074e-05
at O 0 0.00010239725088467821
least O 0 3.385789750609547e-05
from O 0 6.265663978410885e-05
the O 0 8.831664308672771e-05
promoter O 0 0.0010901369387283921
region O 0 0.0002853799087461084
of O 0 0.0003751230542548001
Hp O 0 0.0022135653998702765
to O 0 0.00020273531845305115
Hpr O 0 0.00525993388146162
alpha O 0 0.00042490343912504613
but O 0 3.727728108060546e-05
not O 0 1.5460780559806153e-05
to O 0 5.754366429755464e-05
Hpr O 0 0.004372257739305496
beta O 0 0.0014917509397491813
( O 0 0.0006133646238595247
Hpdel O 1 0.7438851594924927
) O 0 0.0005011059693060815
. O 0 0.0007753751706331968

In O 0 0.0010863913921639323
addition O 0 0.00039856397779658437
, O 0 0.00011975217057624832
we O 0 5.574365786742419e-05
found O 0 4.2868265154538676e-05
seven O 0 7.004842336755246e-05
individuals O 0 3.6476238165050745e-05
with O 0 5.526064342120662e-05
hypohaptoglobinemia B-Disease 0 0.2258618026971817
in O 0 0.00011920758697669953
three O 0 7.033866859273985e-05
families O 0 3.880633812514134e-05
, O 0 3.254733019275591e-05
and O 0 3.200359424226917e-05
the O 0 6.169964763103053e-05
genotypes O 0 0.00017076413496397436
of O 0 7.429908873746172e-05
six O 0 5.726284871343523e-05
of O 0 8.89272996573709e-05
the O 0 7.662116695428267e-05
seven O 0 8.047944720601663e-05
individuals O 0 1.717148370516952e-05
were O 0 2.9990225812071003e-05
found O 0 5.6200991821242496e-05
to O 0 8.483481360599399e-05
be O 0 0.00024886734900064766
Hp2 O 1 0.9965372085571289
/ O 0 0.22206833958625793
Hpdel O 1 0.9891409873962402
. O 0 0.002560678170993924

The O 0 0.007791955955326557
phenotypes O 0 0.008586134761571884
and O 0 0.0005194955156184733
genotypes O 0 0.0012148235691711307
in O 0 0.00013400510943029076
one O 0 8.404956315644085e-05
of O 0 0.00012498829164542258
these O 0 2.29355318879243e-05
three O 0 4.03407248086296e-05
families O 0 5.463323032017797e-05
showed O 0 0.00019368888752069324
the O 0 0.00011933360656257719
father O 0 0.00032402254873886704
to O 0 8.40191132738255e-05
be O 0 8.930265175877139e-05
hypohaptoglobinemic B-Disease 0 0.41615918278694153
( O 0 0.0005005340790376067
Hp2 O 1 0.8361698985099792
) O 0 0.00019664596766233444
and O 0 0.00022712216014042497
Hp2 O 1 0.9987583160400391
/ O 0 0.11704229563474655
Hpdel O 1 0.9679782390594482
, O 0 0.00011545050801942125
the O 0 0.0001165742360171862
mother O 0 0.0002171047090087086
to O 0 5.092531500849873e-05
be O 0 7.218918472062796e-05
Hp2 O 0 0.08623696118593216
- O 0 0.0006163074285723269
1 O 0 0.00020573769870679826
and O 0 0.00016145709378179163
Hp1 O 1 0.9980142116546631
/ O 0 0.09259422868490219
Hp2 O 1 0.9686135649681091
, O 0 9.833552030613646e-05
one O 0 5.707737000193447e-05
of O 0 8.60723594087176e-05
the O 0 9.547689842293039e-05
two O 0 3.5836616007145494e-05
children O 0 4.965677362633869e-05
to O 0 3.7680907553294674e-05
be O 0 7.13533881935291e-05
hypohaptoglobinemic B-Disease 1 0.934419572353363
( O 0 0.00048094321391545236
Hp2 O 1 0.8495423793792725
) O 0 0.00025445708888582885
and O 0 0.00028027858934365213
Hp2 O 1 0.9996285438537598
/ O 1 0.8910666108131409
Hpdel O 1 0.9994497895240784
, O 0 0.00017572262731846422
and O 0 6.88804138917476e-05
the O 0 7.304995961021632e-05
other O 0 3.58057368430309e-05
child O 0 0.00013811190729029477
to O 0 7.695198291912675e-05
be O 0 0.00012766601867042482
Hp1 O 1 0.9674669504165649
and O 0 0.0005989118944853544
Hp1 O 1 0.9999279975891113
/ O 1 0.7749762535095215
Hpdel O 1 0.997585654258728
, O 0 0.00034292659256607294
showing O 0 0.0004284456081222743
an O 0 0.00015165672812145203
anomalous O 0 0.0017352014547213912
inheritance O 0 0.0009517626604065299
of O 0 0.0016830507665872574
Hp O 1 0.717747151851654
phenotypes O 0 0.0008218016009777784
in O 0 0.00014807831030339003
the O 0 0.00034002424217760563
child O 0 0.0008925138972699642
with O 0 0.00035783095518127084
Hp1 O 1 0.9991810917854309
. O 0 0.0013398678274825215

The O 0 0.011751620098948479
Hp2 O 1 0.9999524354934692
/ O 1 0.9949746131896973
Hpdel O 1 0.9980226755142212
individuals O 0 0.0002306355454493314
had O 0 0.00022500641352962703
an O 0 0.0001310767838731408
extremely O 0 0.00015963587793521583
low O 0 0.0001602017437107861
level O 0 0.00014027611177880317
of O 0 0.00021158716117497534
Hp O 0 0.0013795063132420182
( O 0 0.00012657218030653894
mean O 0 0.0001674482336966321
+ O 0 0.00029354379512369633
/ O 0 0.0003134000289719552
- O 0 0.0003615965833887458
SD O 0 0.0012625891249626875
= O 0 0.0003629289276432246
0 O 0 0.00017910462338477373
. O 0 8.43257294036448e-05
049 O 0 0.002641398925334215
+ O 0 0.00060550298076123
/ O 0 0.0006173236179165542
- O 0 0.0003557381278369576
0 O 0 0.00019242848793510348
. O 0 0.00010607758304104209
043 O 0 0.003422150854021311
mg O 0 0.0022984652314335108
/ O 0 0.0010401034960523248
ml O 0 0.0008349959389306605
; O 0 9.869013592833653e-05
n O 0 0.00021700040088035166
= O 0 0.00019439583411440253
6 O 0 0.0001438689068891108
) O 0 4.000253102276474e-05
, O 0 3.427992851356976e-05
compared O 0 3.1825489713810384e-05
with O 0 1.5201532733044587e-05
the O 0 5.0910071877297014e-05
level O 0 9.070546366274357e-05
( O 0 4.982982136425562e-05
1 O 0 5.248388697509654e-05
. O 0 3.224915053579025e-05
64 O 0 0.0001732095261104405
+ O 0 0.0003316995862405747
/ O 0 0.0003573175927158445
- O 0 0.00031871951068751514
1 O 0 0.0001674103841651231
. O 0 9.19756421353668e-05
07 O 0 0.0019630726892501116
mg O 0 0.0024827125016599894
/ O 0 0.0008815436158329248
ml O 0 0.0010358059080317616
) O 0 6.836657848907635e-05
obtained O 0 7.820889732101932e-05
from O 0 0.00011952139175264165
52 O 0 0.0006225555553101003
healthy O 0 0.0006328445742838085
volunteers O 0 0.0007956764893606305
having O 0 0.0006857180851511657
phenotype O 0 0.002695272210985422
Hp2 O 1 0.989829957485199
, O 0 0.000250570650678128
whereas O 0 0.0002497113309800625
the O 0 0.0004703813756350428
serum O 0 0.005110971629619598
Hp O 0 0.0007441878551617265
level O 0 0.0001380113244522363
of O 0 7.242376887006685e-05
an O 0 5.945420707575977e-05
individual O 0 5.19830864504911e-05
with O 0 0.0001184060747618787
Hp1 O 1 0.9995699524879456
/ O 0 0.3022812306880951
Hpdel O 1 0.996479332447052
was O 0 0.004408605862408876
0 O 0 0.0008980107377283275
. O 0 0.0005560250137932599

50 O 0 0.005773419048637152
mg O 0 0.10705451667308807
/ O 0 0.005549574736505747
ml O 0 0.0025124335661530495
, O 0 0.00012870693171862513
which O 0 3.749801544472575e-05
was O 0 0.0001256313844351098
approximately O 0 6.655404285993427e-05
half O 0 4.423902646522038e-05
the O 0 7.324471516767517e-05
level O 0 0.00010202853445662186
of O 0 0.0001256128161912784
Hp O 0 0.0005390799487940967
in O 0 9.726815187605098e-05
control O 0 0.00024177318846341223
sera O 0 0.002065598964691162
from O 0 0.0001241070858668536
the O 0 0.00026557367527857423
Hp1 O 1 0.6304453611373901
phenotype O 0 0.0005685571813955903
( O 0 9.630396380089223e-05
1 O 0 8.008372242329642e-05
. O 0 3.2602372812107205e-05
26 O 0 0.00015729040023870766
+ O 0 0.00023114628857001662
/ O 0 0.0002531457575969398
- O 0 0.0001317072456004098
0 O 0 6.207896512933075e-05
. O 0 3.6665824154624715e-05
33 O 0 0.00020012773165944964
mg O 0 0.0005827272543683648
/ O 0 0.00034037543809972703
ml O 0 0.0005009862943552434
; O 0 5.566307663684711e-05
n O 0 0.0002065181324724108
= O 0 0.00018321172683499753
9 O 0 0.00016739941202104092
) O 0 3.8222256989683956e-05
, O 0 4.896132668363862e-05
showing O 0 0.00015732475731056184
a O 0 0.0002174500550609082
gene O 0 0.00039127786294557154
- O 0 0.0012551770778372884
dosage O 0 0.0020626699551939964
effect O 0 0.0008219416486099362
. O 0 0.0005461713881231844

The O 0 0.002054814016446471
other O 0 0.0004855527658946812
allele O 0 0.0013104659738019109
( O 0 0.0005018633673898876
Hp2 O 0 0.1286640465259552
) O 0 0.0001352798572042957
of O 0 0.00017670501256361604
individuals O 0 6.986390508245677e-05
with O 0 0.00026460393564775586
Hp2 O 1 0.9999939203262329
/ O 1 0.999453604221344
Hpdel O 1 0.9999123811721802
was O 0 0.002275572856888175
found O 0 8.39628919493407e-05
to O 0 4.036312020616606e-05
have O 0 1.5570838513667695e-05
, O 0 2.7817335649160668e-05
in O 0 2.6434214305481873e-05
all O 0 2.8473345082602464e-05
exons O 0 0.000302162574371323
, O 0 6.0225193010410294e-05
no O 0 6.458973803091794e-05
mutation O 0 0.00011229350639041513
, O 0 6.527419463964179e-05
by O 0 9.30408132262528e-05
DNA O 0 0.000489719386678189
sequencing O 0 0.0010785767808556557
. O 0 0.0005129160126671195

On O 0 0.0010276810498908162
the O 0 0.0002530825149733573
basis O 0 5.663273259415291e-05
of O 0 0.00010924762318609282
the O 0 0.00014168277266435325
present O 0 9.817745012696832e-05
study O 0 5.3459818445844576e-05
, O 0 6.112887058407068e-05
the O 0 9.71703339018859e-05
mechanism O 0 0.00025197883951477706
of O 0 0.00032363139325752854
anhaptoglobinemia B-Disease 1 0.7946255207061768
and O 0 0.00011312095011817291
the O 0 0.00015605140652041882
mechanism O 0 0.00020671221136581153
of O 0 0.0002896895457524806
anomalous O 0 0.004685178864747286
inheritance O 0 0.001862772274762392
of O 0 0.038037288933992386
Hp O 1 0.9971643090248108
phenotypes O 0 0.004071595147252083
were O 0 0.00028656842187047005
well O 0 0.0002744695811998099
explained O 0 0.0010787288192659616
. O 0 0.0006362796993926167

However O 0 0.0017656903946772218
, O 0 0.0005318773328326643
the O 0 0.0006183634977787733
mechanism O 0 0.0010092492448166013
of O 0 0.0022844173945486546
hypohaptoglobinemia B-Disease 1 0.9998346567153931
remains O 0 0.43703240156173706
unknown O 0 0.011453096754848957

ATM O 0 0.41934430599212646
mutations O 0 0.003578035393729806
and O 0 0.001225506654009223
phenotypes O 0 0.018291812390089035
in O 0 0.07522432506084442
ataxia B-Disease 1 0.9999998807907104
- I-Disease 1 0.999880313873291
telangiectasia I-Disease 1 0.9999309778213501
families O 0 0.0002999481512233615
in O 0 0.0002305084781255573
the O 0 0.0003540542093105614
British O 0 0.0008049476309679449
Isles O 0 0.0008418024517595768
: O 0 0.00015621648344676942
expression O 0 9.385797602590173e-05
of O 0 0.000186777557246387
mutant O 0 0.002273532096296549
ATM O 0 0.001149038434959948
and O 0 7.691560313105583e-05
the O 0 0.00020008650608360767
risk O 0 0.0007408754318021238
of O 1 0.9769778251647949
leukemia B-Disease 1 1.0
, O 1 0.9999966621398926
lymphoma B-Disease 1 1.0
, O 1 0.9992499947547913
and O 1 0.9996857643127441
breast B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999977350234985
. O 0 0.0025539423804730177

We O 0 0.0011153467930853367
report O 0 0.00031221192330121994
the O 0 0.00015835963131394237
spectrum O 0 0.00024484089226461947
of O 0 0.00027782056713476777
59 O 0 0.0013357556890696287
ATM O 0 0.0037361884023994207
mutations O 0 0.0002763327502179891
observed O 0 0.0003625204262789339
in O 0 0.0005288572865538299
ataxia B-Disease 1 0.9999972581863403
- I-Disease 1 0.9993728995323181
telangiectasia I-Disease 1 0.9999867677688599
( O 0 0.025437980890274048
A B-Disease 1 0.9999845027923584
- I-Disease 1 0.9999228715896606
T I-Disease 1 0.999976634979248
) O 0 0.00012846136814914644
patients O 0 9.23404295463115e-05
in O 0 6.57031123409979e-05
the O 0 0.0002953603689093143
British O 0 0.0012114858254790306
Isles O 0 0.002639445010572672
. O 0 0.0009822292486205697

Of O 0 0.0030990808736532927
51 O 0 0.004430028609931469
ATM O 0 0.01266585011035204
mutations O 0 0.00032695182017050683
identified O 0 0.000145938407513313
in O 0 5.07888435095083e-05
families O 0 4.370664100861177e-05
native O 0 6.481550371972844e-05
to O 0 3.0061384677537717e-05
the O 0 8.953168435255066e-05
British O 0 0.0002551725192461163
Isles O 0 0.00038627011235803366
, O 0 9.307845175499097e-05
11 O 0 0.00015337903460022062
were O 0 8.767355029704049e-05
founder O 0 0.002157762413844466
mutations O 0 0.00010828721133293584
, O 0 4.239265763317235e-05
and O 0 3.7769121263409033e-05
2 O 0 8.289184188470244e-05
of O 0 0.0001184845605166629
these O 0 3.088762241532095e-05
11 O 0 0.0001372211117995903
conferred O 0 0.0005306068924255669
a O 0 0.0003291319590061903
milder O 0 0.0015549124218523502
clinical O 0 0.001269135857000947
phenotype O 0 0.0007180653046816587
with O 0 0.00011298942263238132
respect O 0 0.00029493236797861755
to O 0 0.00022178550716489553
both O 0 0.0016684207366779447
cerebellar B-Disease 1 1.0
degeneration I-Disease 1 1.0
and O 1 0.9971635937690735
cellular O 1 0.9964244961738586
features O 0 0.0015131601830944419
. O 0 0.0007291912334039807

We O 0 0.0010139395017176867
report O 0 0.0002580922737251967
, O 0 9.327568841399625e-05
in O 0 7.940686191432178e-05
two O 0 0.00011481245019240305
A B-Disease 1 0.8876186013221741
- I-Disease 1 0.6066063642501831
T I-Disease 1 0.8689990639686584
families O 0 7.791797543177381e-05
, O 0 6.507047510240227e-05
an O 0 7.98480978119187e-05
ATM O 0 0.0010095364414155483
mutation O 0 0.00022095809981692582
( O 0 0.00021643629588652402
7271T O 1 0.6810528635978699
- O 0 0.003739146748557687
- O 0 0.0013548060087487102
> O 0 0.0013801094610244036
G O 0 0.0027447177562862635
) O 0 6.377620593411848e-05
that O 0 4.972511305822991e-05
may O 0 4.9616926844464615e-05
be O 0 2.4189235773519613e-05
associated O 0 2.9802487915731035e-05
with O 0 2.2490619812742807e-05
an O 0 7.972225284902379e-05
increased O 0 0.0003264936385676265
risk O 0 0.001608818070963025
of O 1 0.9908088445663452
breast B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999793767929077
in O 0 0.0003321432159282267
both O 0 0.00024214923905674368
homozygotes O 0 0.009336045011878014
and O 0 0.00013731549552176148
heterozygotes O 0 0.001014364999718964
( O 0 9.224036330124363e-05
relative O 0 0.00012408649490680546
risk O 0 7.177253428380936e-05
12 O 0 8.553959924029186e-05
. O 0 3.362711504450999e-05
7 O 0 0.00010814820416271687
; O 0 4.8347301344620064e-05
P O 0 0.000929449568502605
= O 0 0.0004030170093756169
. O 0 9.417741239303723e-05
0025 O 0 0.0048266565427184105
) O 0 8.047338633332402e-05
, O 0 4.883337169303559e-05
although O 0 2.6932417313219048e-05
there O 0 2.8964697776245885e-05
is O 0 3.153328725602478e-05
a O 0 0.00011840641673188657
less O 0 0.00021211638522800058
severe O 1 0.9999268054962158
A B-Disease 1 0.9999982118606567
- I-Disease 1 0.9999747276306152
T I-Disease 1 0.9999284744262695
phenotype O 0 0.00038715085247531533
in O 0 7.267406908795238e-05
terms O 0 5.154838436283171e-05
of O 0 0.00011666498176055029
the O 0 0.00020335755834821612
degree O 0 0.0015095350099727511
of O 1 0.9918644428253174
cerebellar B-Disease 1 1.0
degeneration I-Disease 1 1.0
. O 1 0.7006078958511353

This O 0 0.0017928206361830235
mutation O 0 0.001272697700187564
( O 0 0.0009039431461133063
7271T O 1 0.9245293736457825
- O 0 0.035288386046886444
- O 0 0.003910809755325317
> O 0 0.0015850713243708014
G O 0 0.001170152216218412
) O 0 8.204652112908661e-05
also O 0 4.6171709982445464e-05
allows O 0 3.277463838458061e-05
expression O 0 6.20105056441389e-05
of O 0 9.85790611593984e-05
full O 0 0.0002370663423789665
- O 0 0.00033220683690160513
length O 0 0.00012432551011443138
ATM O 0 0.00037818404962308705
protein O 0 9.074613626580685e-05
at O 0 0.0001103934773709625
a O 0 9.816658712225035e-05
level O 0 9.164863877231255e-05
comparable O 0 0.00011524504952831194
with O 0 3.67248612747062e-05
that O 0 4.1699247958604246e-05
in O 0 0.00014044021372683346
unaffected O 0 0.0013573321048170328
individuals O 0 0.0002754996530711651
. O 0 0.0004956559278070927

In O 0 0.0009903049794957042
addition O 0 0.0004078881465829909
, O 0 9.403893636772409e-05
we O 0 4.199628165224567e-05
have O 0 2.2341175281326286e-05
studied O 0 8.877250365912914e-05
18 O 0 0.0004113085742574185
A B-Disease 1 0.9996781349182129
- I-Disease 1 0.9998633861541748
T I-Disease 1 0.9999896287918091
patients O 0 0.00014686393842566758
, O 0 3.151952114421874e-05
in O 0 3.062487667193636e-05
15 O 0 5.8196619647787884e-05
families O 0 4.815152351511642e-05
, O 0 7.065341924317181e-05
who O 0 0.0002376941847614944
developed O 1 0.8136175870895386
leukemia B-Disease 1 1.0
, O 1 0.9996016621589661
lymphoma B-Disease 1 1.0
, O 1 0.9845127463340759
preleukemic O 1 0.9999994039535522
T O 1 0.9999964237213135
- O 1 0.9741831421852112
cell O 0 0.15765193104743958
proliferation O 1 0.8236722946166992
, O 0 0.0012366981245577335
or O 1 0.9979762434959412
Hodgkin B-Disease 1 1.0
lymphoma I-Disease 1 1.0
, O 0 0.014674936421215534
mostly O 0 0.0004334591212682426
in O 0 0.0007385865319520235
childhood O 1 0.575801432132721
. O 0 0.0010231120977550745

A O 0 0.00653234776109457
wide O 0 0.0016649533063173294
variety O 0 0.00047418460599146783
of O 0 0.0006227455451153219
ATM O 0 0.02386130765080452
mutation O 0 0.0003734047058969736
types O 0 0.00015799237007740885
, O 0 8.113837247947231e-05
including O 0 7.60822367738001e-05
missense O 0 0.0006599585176445544
mutations O 0 8.858123328536749e-05
and O 0 5.5757111113052815e-05
in O 0 0.00012779842654708773
- O 0 0.0006128504173830152
frame O 0 0.0013437995221465826
deletions O 0 0.0004181440453976393
, O 0 6.41375154373236e-05
were O 0 9.188542753690854e-05
seen O 0 0.00022907690436113626
in O 0 0.00016215693904086947
these O 0 0.00017632298113312572
patients O 0 0.0006462423480115831
. O 0 0.0006625200039707124

We O 0 0.0011909010354429483
also O 0 0.0003622941148933023
show O 0 0.0002156950649805367
that O 0 3.793379437411204e-05
25 O 0 7.593205373268574e-05
% O 0 3.502348772599362e-05
of O 0 9.306193533120677e-05
all O 0 0.00015189798432402313
A B-Disease 1 0.9998956918716431
- I-Disease 1 0.9997493624687195
T I-Disease 1 0.9999474287033081
patients O 0 0.00020001575467176735
carried O 0 0.00021270148863550276
in O 0 0.00011785793321905658
- O 0 0.000671443238388747
frame O 0 0.0013309745118021965
deletions O 0 0.0009769636671990156
or O 0 0.00016934583254624158
missense O 0 0.0008047427982091904
mutations O 0 0.00010678904800442979
, O 0 3.724597627297044e-05
many O 0 1.5365416402346455e-05
of O 0 8.034165512071922e-05
which O 0 4.406080915941857e-05
were O 0 3.38011777785141e-05
also O 0 4.152235123910941e-05
associated O 0 5.887596125830896e-05
with O 0 6.757026858394966e-05
expression O 0 0.0002709388791117817
of O 0 0.0007150419987738132
mutant O 0 0.02776353619992733
ATM O 0 0.007571370340883732
protein O 0 0.0012361352564767003
. O 0 0.0007614205242134631

The O 0 0.013694963417947292
DMPK O 1 0.9998406171798706
gene O 0 0.008187209255993366
of O 1 0.6568467020988464
severely O 1 0.9999971389770508
affected O 1 0.9999942779541016
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 0.9999899864196777
is O 1 0.950714647769928
hypermethylated O 1 0.9999830722808838
proximal O 1 0.9994462132453918
to O 0 0.0004623037821147591
the O 0 0.0006630461430177093
largely O 0 0.0009877914562821388
expanded O 0 0.0020928620360791683
CTG O 1 0.8728659152984619
repeat O 0 0.006550153251737356
. O 0 0.0012898884015157819

Using O 0 0.0020420649088919163
methylation O 0 0.00298841274343431
- O 0 0.002705170074477792
sensitive O 0 0.0012596305459737778
restriction O 0 0.0006472658715210855
enzymes O 0 0.0003079884627368301
, O 0 8.625369082437828e-05
we O 0 6.673236930510029e-05
characterized O 0 0.00018085745978169143
the O 0 0.00010036253661382943
methylation O 0 0.00019177970534656197
pattern O 0 0.00020295697322580963
on O 0 0.00011082083801738918
the O 0 0.00014290280523709953
5 O 0 0.00012402969878166914
side O 0 0.00015055476978886873
of O 0 0.0001877363829407841
the O 0 0.000385211780667305
CTG O 1 0.651231050491333
repeat O 0 0.0007317045237869024
in O 0 0.00010949342686217278
the O 0 0.0002083823928842321
DMPK O 1 0.9993293285369873
gene O 0 0.00018280862423125654
of O 0 0.00014614184328820556
normal O 0 0.00017549440963193774
individuals O 0 3.150954216835089e-05
and O 0 5.9157697251066566e-05
of O 0 0.0024675989989191294
patients O 1 0.8029559850692749
affected O 1 0.8911870121955872
with O 1 0.9908555746078491
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
, O 0 0.003162987297400832
showing O 0 0.0012786983279511333
expansions O 0 0.0009730689343996346
of O 0 0.00034978872281499207
the O 0 0.00038998271338641644
repetitive O 0 0.0027120483573526144
sequence O 0 0.0007570717134512961
. O 0 0.0006589241093024611

The O 0 0.003452915931120515
gene O 0 0.0013662265846505761
segment O 0 0.0011305984808132052
analyzed O 0 0.00024984945775941014
corresponds O 0 0.00025334832025691867
to O 0 7.166857540141791e-05
the O 0 0.000246881420025602
genomic O 0 0.0009968907106667757
SacI O 0 0.24495992064476013
- O 0 0.0019354581600055099
HindIII O 0 0.010131951421499252
fragment O 0 0.0010495745809748769
carrying O 0 0.0006320801912806928
exons O 0 0.0007466028910130262
11 O 0 0.0006707831053063273
- O 0 0.0009017559932544827
15 O 0 0.0007720201392658055
. O 0 0.0006065498455427587

There O 0 0.0020318638999015093
is O 0 0.0007804403430782259
constitutive O 0 0.0028444849886000156
methylation O 0 0.00047964794794097543
in O 0 0.0002969259221572429
intron O 0 0.002709709806367755
12 O 0 0.0004003755166195333
at O 0 0.0003627034311648458
restriction O 0 0.00016793944814708084
sites O 0 0.00011157794506289065
of O 0 0.00027385217254050076
SacII O 1 0.8794662952423096
and O 0 0.00035480179940350354
HhaI O 1 0.6542421579360962
, O 0 0.00019339121354278177
localized O 0 0.00031335646053776145
1 O 0 0.00013742237933911383
, O 0 6.102531551732682e-05
159 O 0 0.00020438857609406114
- O 0 0.00022383767645806074
1 O 0 0.0001507783163106069
, O 0 7.667788304388523e-05
232 O 0 0.00044059049105271697
bp O 0 0.0006318321102298796
upstream O 0 0.0003856080584228039
of O 0 0.00017190034850500524
the O 0 0.00029336445732042193
CTG O 1 0.9936046004295349
repeat O 0 0.0014979671686887741
, O 0 0.00012064941256539896
whereas O 0 9.512184624327347e-05
most O 0 3.076057691941969e-05
, O 0 2.7551477614906617e-05
if O 0 1.7551032215123996e-05
not O 0 9.932526154443622e-06
all O 0 1.097139738703845e-05
, O 0 2.3307371520786546e-05
of O 0 3.1200124794850126e-05
the O 0 4.7181383706629276e-05
other O 0 2.5950794224627316e-05
sites O 0 5.809337380924262e-05
of O 0 0.00024460660642944276
SacII O 1 0.9996999502182007
, O 0 0.0005411368911154568
HhaI O 1 0.996177077293396
, O 0 0.00020284745551180094
and O 0 0.00012817430251743644
HpaII O 0 0.3268122673034668
in O 0 0.00012395024532452226
this O 0 6.357407255563885e-05
region O 0 0.00016765273176133633
are O 0 2.2154996258905157e-05
unmethylated O 0 0.0016626635333523154
, O 0 0.00010655833466444165
in O 0 7.993433246156201e-05
normal O 0 0.00015413539949804544
individuals O 0 2.6076870199176483e-05
and O 0 4.282058580429293e-05
most O 0 5.495814548339695e-05
of O 0 0.00027016911190003157
the O 0 0.0184087585657835
patients O 0 0.008355667814612389
. O 0 0.0008067291346378624

In O 0 0.0011497812811285257
a O 0 0.0004927208065055311
number O 0 0.00011161220754729584
of O 0 0.00040847729542292655
young O 0 0.004909636918455362
and O 0 0.0033682736102491617
severely O 1 0.9999598264694214
affected O 1 0.6629576086997986
patients O 0 0.008438984863460064
, O 0 0.00010921616922132671
however O 0 4.354236079961993e-05
, O 0 4.44153010903392e-05
complete O 0 0.0001335997658316046
methylation O 0 0.00011014007031917572
of O 0 7.912936416687444e-05
these O 0 2.3260698071680963e-05
restriction O 0 5.598659117822535e-05
sites O 0 3.8619207771262154e-05
was O 0 0.0001231660571647808
found O 0 4.8615544073982164e-05
in O 0 8.328077819896862e-05
the O 0 0.00034185219556093216
mutated O 0 0.0009704399853944778
allele O 0 0.0008554253145121038
. O 0 0.0005247964290902019

In O 0 0.0011272878618910909
most O 0 0.00020220519218128175
of O 0 0.00024814752396196127
these O 0 7.66644297982566e-05
patients O 0 0.00026438754866831005
, O 0 6.943048356333748e-05
the O 0 0.00031917437445372343
onset O 1 0.9999074935913086
of O 1 0.9963696002960205
the O 1 0.9999960660934448
disease O 1 1.0
was O 1 0.9999997615814209
congenital O 1 1.0
. O 0 0.3493114709854126

Preliminary O 0 0.0044554779306054115
in O 0 0.0017165811732411385
vivo O 0 0.005256210919469595
footprinting O 0 0.009432788006961346
data O 0 0.00013465517258737236
gave O 0 0.00019503486691974103
evidence O 0 0.0001129219017457217
for O 0 6.932858377695084e-05
protein O 0 0.0001558613294037059
- O 0 0.00024021166609600186
DNA O 0 0.0001485244429204613
contact O 0 0.00011006658314727247
in O 0 8.975514356279746e-05
normal O 0 0.00010193839261773974
genes O 0 6.320116517599672e-05
at O 0 0.00016125923139043152
an O 0 0.00014694209676235914
Sp1 O 0 0.003643311560153961
consensus O 0 0.00021396343072410673
binding O 0 9.700387454358861e-05
site O 0 0.0002041836705757305
upstream O 0 0.00035765839857049286
of O 0 0.0001533829781692475
the O 0 0.00034259085077792406
CTG O 1 0.974968671798706
repeat O 0 0.0005480193649418652
and O 0 5.033973138779402e-05
for O 0 2.8462947739171796e-05
a O 0 7.04073827364482e-05
significant O 0 7.777188875479624e-05
reduction O 0 0.00012972023978363723
of O 0 0.00010551989544183016
this O 0 5.248638990451582e-05
interaction O 0 8.117846300592646e-05
in O 0 8.554678061045706e-05
cells O 0 0.00012038486602250487
with O 0 6.735564966220409e-05
a O 0 0.0006875693215988576
hypermethylated O 1 0.9994157552719116
DMPK O 1 0.9999614953994751
gene O 0 0.0008831248851493001
. O 0 0.0002950009948108345
. O 0 0.0006851321086287498

The O 0 0.4485146105289459
hemochromatosis B-Disease 1 0.9999997615814209
gene O 0 0.003953960724174976
product O 0 0.0010737900156527758
complexes O 0 0.0014064682181924582
with O 0 0.00017439677321817726
the O 0 0.0009103630436584353
transferrin O 1 0.9884470105171204
receptor O 0 0.0005953809595666826
and O 0 0.00012265294208191335
lowers O 0 0.00045555815449915826
its O 0 6.872131052659824e-05
affinity O 0 0.00024825683794915676
for O 0 0.0001446107926312834
ligand O 0 0.0013517097104340792
binding O 0 0.0006077505531720817
. O 0 0.0005301614874042571

We O 0 0.001619079033844173
recently O 0 0.0010975913610309362
reported O 0 0.0005213979166001081
the O 0 0.000302262807963416
positional O 0 0.0014282852644100785
cloning O 0 0.0005339317722246051
of O 0 0.00015516793064307421
a O 0 0.0002475699584465474
candidate O 0 0.00045169537770561874
gene O 0 0.0004494218446779996
for O 0 0.0005645850906148553
hereditary B-Disease 1 0.9999998807907104
hemochromatosis I-Disease 1 1.0
called O 1 0.9999872446060181
HFE O 1 0.9999979734420776
. O 0 0.0038184626027941704

The O 0 0.0026743891648948193
gene O 0 0.0007692368817515671
product O 0 0.0003609101986512542
, O 0 6.716598727507517e-05
a O 0 9.448639320908114e-05
member O 0 9.789326577447355e-05
of O 0 0.0001779029844328761
the O 0 0.00037534552393481135
major O 0 0.27429530024528503
histocompatibility O 1 0.9999971389770508
complex O 1 0.9623977541923523
class O 0 0.22826094925403595
I O 0 0.30436912178993225
- O 0 0.0005746432580053806
like O 0 8.454280032310635e-05
family O 0 8.951819472713396e-05
, O 0 4.0583894588053226e-05
was O 0 0.00010681847925297916
found O 0 2.9750010071438737e-05
to O 0 2.27007367357146e-05
have O 0 2.2415100829675794e-05
a O 0 0.00010842875781236216
mutation O 0 0.000179533104528673
, O 0 0.00013410928659141064
Cys O 0 0.21537670493125916
- O 0 0.001424218062311411
282 O 0 0.0036784671247005463
- O 0 0.002993160393089056
- O 0 0.001305813668295741
> O 0 0.001551388413645327
Tyr O 0 0.07700297981500626
( O 0 0.0003494810371194035
C282Y O 0 0.004253948573023081
) O 0 8.780742064118385e-05
, O 0 4.381585677037947e-05
in O 0 3.0694998713443056e-05
85 O 0 0.0001317231944995001
% O 0 7.617566006956622e-05
of O 0 0.00029455975163728
patient O 0 0.0020332373678684235
chromosomes O 0 0.001390149351209402
. O 0 0.0007898897747509181

This O 0 0.0017450748709961772
mutation O 0 0.0021075827535241842
eliminates O 0 0.0018226121319457889
the O 0 0.00035557601950131357
ability O 0 0.0003239774378016591
of O 0 0.0005771995638497174
HFE O 1 0.9943884015083313
to O 0 0.00018614089640323073
associate O 0 0.00040236476343125105
with O 0 0.0002554103557486087
beta2 O 1 0.9987146854400635
- O 0 0.18659338355064392
microglobulin O 1 0.994952917098999
( O 0 0.0008331524441018701
beta2m O 1 0.928423285484314
) O 0 0.00022792679374106228
and O 0 0.0002542342117521912
prevents O 0 0.002476026536896825
cell O 0 0.01679648831486702
- O 0 0.003492984687909484
surface O 0 0.0021335240453481674
expression O 0 0.0014405326219275594
. O 0 0.0009264863329008222

A O 0 0.004561839159578085
second O 0 0.0016020751791074872
mutation O 0 0.0002598951105028391
that O 0 5.596673145191744e-05
has O 0 4.9410577048547566e-05
no O 0 6.198963819770142e-05
effect O 0 0.0001548123691463843
on O 0 0.00021781338728033006
beta2m O 1 0.9904362559318542
association O 0 0.0007881851634010673
, O 0 0.0002737621252890676
H63D O 1 0.999527096748352
, O 0 0.0001711723452899605
was O 0 0.0002894493518397212
found O 0 3.7259615055518225e-05
in O 0 3.262069003540091e-05
eight O 0 6.272969767451286e-05
out O 0 5.619509829557501e-05
of O 0 0.00011859917867695913
nine O 0 0.00028834189288318157
patients O 0 0.000221496622543782
heterozygous O 0 0.000181507712113671
for O 0 8.787745900917798e-05
the O 0 0.0007121608941815794
C282Y O 1 0.9964523315429688
mutant O 0 0.011979314498603344
. O 0 0.001142044784501195

In O 0 0.0008497507660649717
this O 0 0.00021413566719274968
report O 0 0.00012838971451856196
, O 0 5.4673255363013595e-05
we O 0 5.199776205699891e-05
demonstrate O 0 0.00020037424110341817
in O 0 0.00015202142822090536
cultured O 0 0.0012632296420633793
293 O 0 0.004248511046171188
cells O 0 0.0010054786689579487
overexpressing O 0 0.004777371417731047
wild O 0 0.0004840568290092051
- O 0 0.0006715274066664279
type O 0 0.0004551590245682746
or O 0 0.0002496222732588649
mutant O 0 0.0032701946329325438
HFE O 1 0.9356074929237366
proteins O 0 0.00011572716175578535
that O 0 3.902980824932456e-05
both O 0 3.449657015153207e-05
the O 0 0.00011930197069887072
wild O 0 0.0005263120401650667
- O 0 0.0015476009575650096
type O 0 0.0012540090829133987
and O 0 0.0007340543088503182
H63D O 1 0.9999889135360718
HFE O 1 0.9998757839202881
proteins O 0 0.0005479279789142311
form O 0 0.0004020158667117357
stable O 0 0.0012506573693826795
complexes O 0 0.000773569627199322
with O 0 0.00010440201731398702
the O 0 0.0005090126651339233
transferrin O 1 0.9934588074684143
receptor O 0 0.0018696398474276066
( O 0 0.0007155432831496
TfR O 0 0.2645924687385559
) O 0 0.000531422789208591
. O 0 0.0006364458822645247

The O 0 0.0063573685474693775
C282Y O 1 0.9943997263908386
mutation O 0 0.001953541301190853
nearly O 0 0.0009186311508528888
completely O 0 0.0009366700542159379
prevents O 0 0.00039040527190081775
the O 0 0.000178899455931969
association O 0 0.00013286140165291727
of O 0 0.00013814956764690578
the O 0 0.0003734039783012122
mutant O 0 0.015097933821380138
HFE O 1 0.9945595860481262
protein O 0 0.00032181155984289944
with O 0 0.00010191291949013248
the O 0 0.0005557778058573604
TfR O 1 0.9907079935073853
. O 0 0.0013619380770251155

Studies O 0 0.0011347713880240917
on O 0 0.0011592291994020343
cell O 0 0.0021748479921370745
- O 0 0.00093203189317137
associated O 0 0.0003476693236734718
transferrin O 0 0.005409089848399162
at O 0 0.0003317046503070742
37 O 0 0.0002717721799854189
degrees O 0 0.00018475337128620595
C O 0 0.0003881804004777223
suggest O 0 8.643582259537652e-05
that O 0 3.655058389995247e-05
the O 0 0.00012110239185858518
overexpressed O 0 0.0012059943983331323
wild O 0 0.0004164059355389327
- O 0 0.0007658237591385841
type O 0 0.0008667965303175151
HFE O 1 0.7277907729148865
protein O 0 0.00027597942971624434
decreases O 0 0.00027347516152076423
the O 0 0.000113438640255481
affinity O 0 0.00016454637807328254
of O 0 0.00021432031644508243
the O 0 0.0006106924265623093
TfR O 1 0.9899342656135559
for O 0 0.0006717728683724999
transferrin O 1 0.8085868954658508
. O 0 0.0014078511158004403

The O 0 0.010749533772468567
overexpressed O 1 0.9671542048454285
H63D O 1 0.999901533126831
protein O 0 0.0008702893974259496
does O 0 0.00010456969903316349
not O 0 2.6445208277436905e-05
have O 0 1.6157197023858316e-05
this O 0 2.29662600759184e-05
effect O 0 5.4796593758510426e-05
, O 0 2.5110355636570603e-05
providing O 0 3.050013219763059e-05
the O 0 4.33914756285958e-05
first O 0 7.799320883350447e-05
direct O 0 5.5823245929786935e-05
evidence O 0 8.031637116800994e-05
for O 0 4.6388675400521606e-05
a O 0 0.0001727918570395559
functional O 0 0.00024487331393174827
consequence O 0 0.0007189390598796308
of O 0 0.0005952963838353753
the O 0 0.030653562396764755
H63D O 1 0.9999901056289673
mutation O 0 0.0021828035824000835
. O 0 0.0008209245861507952

Addition O 0 0.0022439644671976566
of O 0 0.0020418125204741955
soluble O 0 0.016732703894376755
wild O 0 0.0026563694700598717
- O 0 0.010279002599418163
type O 0 0.02828352339565754
HFE O 1 0.9999486207962036
/ O 1 0.7158477306365967
beta2m O 1 0.9829903841018677
heterodimers O 0 0.02095862478017807
to O 0 0.0006482480675913393
cultured O 0 0.008461598306894302
cells O 0 0.0005618695286102593
also O 0 0.00014580125571228564
decreased O 0 0.00027900710119865835
the O 0 0.00010043395741377026
apparent O 0 0.00047782837646082044
affinity O 0 0.00015339936362579465
of O 0 0.000187456957064569
the O 0 0.0002930150367319584
TfR O 0 0.08986472338438034
for O 0 5.748465264332481e-05
its O 0 4.599179737851955e-05
ligand O 0 0.0002611860691104084
under O 0 0.00014659055159427226
steady O 0 0.0004606524598784745
- O 0 0.0002207883371738717
state O 0 4.888150215265341e-05
conditions O 0 0.00012953137047588825
, O 0 3.98211668652948e-05
both O 0 3.774898868869059e-05
in O 0 9.798580867936835e-05
293 O 0 0.002541045658290386
cells O 0 0.0005362603114917874
and O 0 0.00020834583847317845
in O 0 0.000750832143239677
HeLa O 1 0.999354898929596
cells O 0 0.0023159810807555914
. O 0 0.0006617847830057144

Furthermore O 0 0.001545623759739101
, O 0 0.00035081966780126095
at O 0 0.0003046623896807432
4 O 0 0.0002576828992459923
degrees O 0 0.0002540272835176438
C O 0 0.0007010895060375333
, O 0 9.543410851620138e-05
the O 0 0.00015119985619094223
added O 0 0.00026335654547438025
soluble O 0 0.0004559949738904834
complex O 0 0.0007221148116514087
of O 0 0.0013360012089833617
HFE O 1 0.9999465942382812
/ O 0 0.06775758415460587
beta2m O 0 0.40980538725852966
inhibited O 0 0.0012963288463652134
binding O 0 0.00028504847432486713
of O 0 0.00044400457409210503
transferrin O 0 0.13774476945400238
to O 0 0.0005553606315515935
HeLa O 1 0.9858106374740601
cell O 0 0.001748806913383305
TfR O 0 0.0077869524247944355
in O 0 0.00015328604786191136
a O 0 0.0003338177630212158
concentration O 0 0.13413061201572418
- O 0 0.0012905026087537408
dependent O 0 0.00029566267039626837
manner O 0 0.00041250011418014765
. O 0 0.0004544180992525071

Scatchard O 0 0.016289612278342247
plots O 0 0.001996781211346388
of O 0 0.00045262317871674895
these O 0 6.171000859467313e-05
data O 0 5.78984763706103e-05
indicate O 0 7.243957952596247e-05
that O 0 5.194939149077982e-05
the O 0 0.00018953751714434475
added O 0 0.0006045301561243832
heterodimer O 0 0.003292783861979842
substantially O 0 0.0006328384624794126
reduced O 0 0.00027174572460353374
the O 0 0.00016699079424142838
affinity O 0 0.000366340100299567
of O 0 0.0008671468822285533
TfR O 1 0.9923111200332642
for O 0 0.001693440368399024
transferrin O 1 0.9363978505134583
. O 0 0.0023220619186758995

These O 0 0.00045632373075932264
results O 0 0.0003072077815886587
establish O 0 0.00029469290166161954
a O 0 0.00037470346433110535
molecular O 0 0.0005266258958727121
link O 0 0.0006161955534480512
between O 0 0.0005824229447171092
HFE O 1 0.9990231990814209
and O 0 0.00020119399414397776
a O 0 0.0002436973445583135
key O 0 0.0003511244722176343
protein O 0 0.00013962757657282054
involved O 0 0.00012198670447105542
in O 0 0.00013279631093610078
iron O 1 0.9999481439590454
transport O 0 0.005285463761538267
, O 0 0.00010428152017993852
the O 0 0.00022742338478565216
TfR O 1 0.9906260967254639
, O 0 9.715134365251288e-05
and O 0 3.598555122152902e-05
raise O 0 6.075345663703047e-05
the O 0 5.6536635383963585e-05
possibility O 0 0.00011993342195637524
that O 0 4.0509305108571425e-05
alterations O 0 0.0003454549878370017
in O 0 6.520079477922991e-05
this O 0 4.991219248040579e-05
regulatory O 0 0.00017816746549215168
mechanism O 0 0.00022765356698073447
may O 0 7.903539517428726e-05
play O 0 8.18073094706051e-05
a O 0 9.340475662611425e-05
role O 0 0.0001863561337813735
in O 0 0.00015618403267581016
the O 0 0.0004400521866045892
pathogenesis O 1 0.9998900890350342
of O 1 0.999653697013855
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 1 0.9214488863945007
. O 0 0.0024290692526847124

Genomic O 0 0.0031879746820777655
organization O 0 0.0007145957206375897
of O 0 0.0005780807696282864
the O 0 0.002042800886556506
UBE3A O 1 0.999980092048645
/ O 1 0.9827584624290466
E6 O 1 0.999889612197876
- O 0 0.15090501308441162
AP O 0 0.002436508657410741
gene O 0 0.00046138791367411613
and O 0 0.00019029407121706754
related O 0 0.0006648615235462785
pseudogenes O 0 0.006219618488103151
. O 0 0.0014687279472127557

The O 0 0.00750336516648531
UBE3A O 1 0.8079723119735718
gene O 0 0.0010677583049982786
encodes O 0 0.0005991436773911119
the O 0 0.0006016693077981472
E6 O 1 0.9912179112434387
- O 0 0.006206251680850983
AP O 0 0.002596871228888631
ubiquitin O 0 0.006252229679375887
- O 0 0.0013560052029788494
protein O 0 0.0003565655497368425
ligase O 0 0.0014927340671420097
and O 0 0.00010151117749046534
has O 0 7.009186083450913e-05
recently O 0 0.00012875653919763863
been O 0 7.148359873099253e-05
shown O 0 5.510887422133237e-05
to O 0 5.058891838416457e-05
be O 0 0.0001208058456541039
mutated O 0 0.009902494959533215
in O 1 0.9351633787155151
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 1 0.9999266862869263
who O 0 0.23894985020160675
lack O 1 0.9945963025093079
15q11 O 1 0.9999986886978149
- O 1 0.9927945733070374
q13 O 1 0.9959731698036194
deletions O 0 0.002338046208024025
or O 0 0.0003602158685680479
chromosome O 0 0.0007308163330890238
15 O 0 0.0007692819344811141
paternal O 0 0.021529944613575935
uniparental B-Disease 1 0.9999558925628662
disomy I-Disease 1 0.9998032450675964
. O 0 0.004002195317298174

Previous O 0 0.011410331353545189
UBE3A O 1 0.5234026908874512
cDNA O 0 0.004331641830503941
analysis O 0 0.00033141320454888046
has O 0 0.00012019812857033685
shown O 0 0.00011989237100351602
a O 0 0.00015043366875033826
coding O 0 0.0002755926689133048
region O 0 0.00014761253260076046
of O 0 0.00019355540280230343
approximately O 0 0.0004337567661423236
2 O 0 0.000754698587115854
. O 0 0.0005849436274729669

6 O 0 0.004963151179254055
kb O 0 0.004649987444281578
and O 0 0.00028480071341618896
a O 0 0.00038429375854320824
3 O 0 0.0004639491089619696
- O 0 0.0006558918976224959
untranslated O 0 0.002065625274553895
region O 0 0.00045951371430419385
( O 0 0.00028300995472818613
UTR O 0 0.0037481188774108887
) O 0 8.666361100040376e-05
of O 0 0.00025601571542210877
< O 0 0.001086249016225338
50 O 0 0.000287646078504622
bp O 0 0.001007842249237001
, O 0 9.285574924433604e-05
whereas O 0 6.610192212974653e-05
Northern O 0 8.590884681325406e-05
analysis O 0 4.6124223445076495e-05
has O 0 3.260716039221734e-05
indicated O 0 6.684988329652697e-05
mRNA O 0 9.619079355616122e-05
sizes O 0 2.912760101025924e-05
of O 0 7.916800677776337e-05
5 O 0 0.00020535552175715566
- O 0 0.0005327266990207136
8 O 0 0.000788032659329474
kb O 0 0.003373571438714862
. O 0 0.0007494307355955243

We O 0 0.000989864463917911
have O 0 0.0001366656069876626
analyzed O 0 0.0001841901830630377
additional O 0 0.00016277984832413495
cDNA O 0 0.0014946095179766417
clones O 0 0.0010097903432324529
and O 0 6.569521792698652e-05
provide O 0 5.2101902838330716e-05
evidence O 0 8.484824502374977e-05
for O 0 5.14226958330255e-05
an O 0 0.00010669082985259593
additional O 0 0.00034998118644580245
0 O 0 0.0005111604696139693
. O 0 0.0006841697031632066

5 O 0 0.002939170226454735
kb O 0 0.0041443658992648125
of O 0 0.0010355939157307148
5 O 0 0.0010585366981104016
- O 0 0.002023607725277543
UTR O 0 0.006630048621445894
and O 0 0.0002557824773248285
> O 0 0.0007522060768678784
2 O 0 0.0003073636326007545
kb O 0 0.0009204925154335797
of O 0 0.0004059039056301117
3 O 0 0.0014842812670394778
- O 0 0.003908402752131224
UTR O 0 0.05345454439520836
. O 0 0.0018678904743865132

We O 0 0.000724515994079411
have O 0 0.00011807728151325136
established O 0 0.0002602286112960428
the O 0 0.00022360433649737388
genomic O 0 0.0003788144385907799
organization O 0 0.0002544325543567538
of O 0 0.00041127216536551714
UBE3A O 1 0.9919376969337463
and O 0 0.0001844210783019662
the O 0 0.00020203560416121036
sequence O 0 0.00019078096374869347
of O 0 0.000487982266349718
intron O 0 0.49157026410102844
- O 0 0.0043099420145154
exon O 0 0.004879641812294722
borders O 0 0.0012374394573271275
. O 0 0.0009400459821335971

We O 0 0.0013358911965042353
have O 0 0.00016052316641435027
also O 0 0.00015131251711864024
mapped O 0 0.0002496301312930882
two O 0 0.0001029443446896039
highly O 0 0.0004034459707327187
homologous O 0 0.0009038617718033493
processed O 0 0.0004996255738660693
pseudogenes O 0 0.0016089114360511303
, O 0 0.0002671204274520278
UBE3AP1 O 1 0.9995861649513245
and O 0 0.00035044492688030005
UBE3AP2 O 1 0.9986976385116577
, O 0 0.0001381163892801851
to O 0 4.7866655222605914e-05
chromosomes O 0 9.09292430151254e-05
2 O 0 9.58675445872359e-05
and O 0 4.2380288505228236e-05
21 O 0 0.00014785003440920264
, O 0 6.046787166269496e-05
respectively O 0 7.832965638954192e-05
, O 0 5.1677823648788035e-05
and O 0 4.515305772656575e-05
determined O 0 7.036241731839254e-05
their O 0 5.370579310692847e-05
genomic O 0 0.0005429837619885802
organization O 0 0.00039462075801566243
. O 0 0.0005441735847853124

These O 0 0.0006609565461985767
results O 0 0.0003004962927661836
will O 0 8.393150346819311e-05
form O 0 6.141062476672232e-05
the O 0 9.561009210301563e-05
basis O 0 4.6522822231054306e-05
for O 0 3.6061301216250286e-05
studies O 0 3.667687269626185e-05
of O 0 0.00013040407793596387
mutation O 0 0.00027584683266468346
and O 0 0.00016919475456234068
imprinting O 0 0.008630284108221531
of O 0 0.007228991016745567
UBE3A O 1 0.9998643398284912
. O 0 0.0023195247631520033

Mutation O 0 0.008108934387564659
spectrum O 0 0.003949328791350126
and O 0 0.0009918680880218744
genotype O 0 0.0068874419666826725
- O 0 0.010755049996078014
phenotype O 0 0.0017307921079918742
analyses O 0 0.0008014365448616445
in O 0 0.0021294085308909416
Cowden B-Disease 1 0.9999991655349731
disease I-Disease 1 0.9999996423721313
and O 1 0.9920980930328369
Bannayan B-Disease 1 1.0
- I-Disease 1 0.9999996423721313
Zonana I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 0.0022184806875884533
two O 0 0.0016551149310544133
hamartoma B-Disease 1 0.9999990463256836
syndromes I-Disease 1 0.9999995231628418
with O 1 0.996525228023529
germline O 1 0.999998927116394
PTEN O 1 0.9999985694885254
mutation O 0 0.011721102520823479
. O 0 0.001675951760262251

The O 1 0.7792860269546509
tumour B-Disease 1 0.9999998807907104
suppressor O 1 0.9999614953994751
gene O 1 0.7552134990692139
PTEN O 1 0.9998905658721924
, O 0 0.00040929304668679833
which O 0 0.0001349701196886599
maps O 0 0.00038709273212589324
to O 0 0.00031989329727366567
10q23 O 0 0.1678560972213745
. O 0 0.0014535103691741824

3 O 0 0.001776326447725296
and O 0 0.00028655011556111276
encodes O 0 0.00040678479126654565
a O 0 0.0002472024643793702
403 O 0 0.0007331080851145089
amino O 0 0.0002658016455825418
acid O 0 0.0005446434370242059
dual O 0 0.00038483523530885577
specificity O 0 0.00038344875792972744
phosphatase O 0 0.006762306671589613
( O 0 0.00023580575361847878
protein O 0 0.000303880573483184
tyrosine O 0 0.0012142788618803024
phosphatase O 0 0.02924477867782116
; O 0 0.00017643262981437147
PTPase O 1 0.5345456004142761
) O 0 0.00011417266796343029
, O 0 8.134196832543239e-05
was O 0 0.00030582325416617095
shown O 0 0.00011938640818698332
recently O 0 9.100645547732711e-05
to O 0 3.550335532054305e-05
play O 0 0.0001000878619379364
a O 0 0.00010721289436332881
broad O 0 0.00031561290961690247
role O 0 0.0008395482436753809
in O 0 0.0007753082318231463
human O 0 0.009086568839848042
malignancy B-Disease 1 0.9999490976333618
. O 0 0.0024257726036012173

Somatic O 1 0.995124876499176
PTEN O 1 0.9997475743293762
deletions O 0 0.01308224257081747
and O 0 0.0005811231676489115
mutations O 0 0.00029653412639163435
were O 0 0.0001378293236484751
observed O 0 0.00025816590641625226
in O 0 0.00033432641066610813
sporadic B-Disease 1 0.9076222777366638
breast I-Disease 1 0.9999955892562866
, I-Disease 1 0.814784824848175
brain I-Disease 1 0.9999960660934448
, I-Disease 1 0.8998578190803528
prostate I-Disease 1 1.0
and I-Disease 1 0.9999833106994629
kidney I-Disease 1 1.0
cancer I-Disease 1 1.0
cell O 1 0.9996021389961243
lines O 0 0.0007838999736122787
and O 0 7.199656101875007e-05
in O 0 7.933244341984391e-05
several O 0 0.00010114478209288791
primary O 0 0.0015366143779829144
tumours B-Disease 1 0.9999675750732422
such O 0 0.0009673456661403179
as O 1 0.9862783551216125
endometrial B-Disease 1 0.9999998807907104
carcinomas I-Disease 1 1.0
, O 1 0.999998927116394
malignant B-Disease 1 1.0
melanoma I-Disease 1 1.0
and O 1 1.0
thyroid B-Disease 1 1.0
tumours I-Disease 1 1.0
. O 1 0.9094043970108032

In O 0 0.0019363886676728725
addition O 0 0.0010875863954424858
, O 0 0.0007130787125788629
PTEN O 1 0.996001660823822
was O 0 0.0011848531430587173
identified O 0 0.0002254971768707037
as O 0 0.00014844191900920123
the O 0 0.00025419978192076087
susceptibility O 0 0.0010305390460416675
gene O 0 0.00023860015789978206
for O 0 0.00020830966241192073
two O 0 0.0008846542914398015
hamartoma B-Disease 1 0.9999997615814209
syndromes I-Disease 1 1.0
Cowden B-Disease 1 1.0
disease I-Disease 1 1.0
( O 1 0.9984973669052124
CD B-Disease 1 0.9895281195640564
; O 0 0.0004930834984406829
MIM O 1 0.9986988306045532
158350 O 1 0.8803519606590271
) O 0 0.00039698128239251673
and O 0 0.00043388723861426115
Bannayan B-Disease 1 0.9766356945037842
- I-Disease 0 0.00769804697483778
Zonana I-Disease 1 0.9730010628700256
( I-Disease 0 0.0009515436249785125
BZS I-Disease 1 0.5228303670883179
) I-Disease 0 0.0002817771746776998
or I-Disease 0 0.00046140633639879525
Ruvalcaba I-Disease 1 0.9693958759307861
- I-Disease 0 0.08586091548204422
Riley I-Disease 1 0.9974351525306702
- I-Disease 1 0.9967556595802307
Smith I-Disease 1 0.9983611702919006
syndrome I-Disease 1 0.9999998807907104
( O 1 0.8231587409973145
MIM O 1 0.9999946355819702
153480 O 1 0.9999293088912964
) O 0 0.0016401292523369193
. O 0 0.001025813864544034

Constitutive O 0 0.021473176777362823
DNA O 0 0.0014572844374924898
from O 0 0.0004525552212726325
37 O 0 0.0008553169318474829
CD B-Disease 0 0.0012193711008876562
families O 0 0.00012902385788038373
and O 0 0.00011510940385051072
seven O 0 0.0003842845617327839
BZS B-Disease 1 0.5475939512252808
families O 0 0.0007403536001220345
was O 0 0.001862968085333705
screened O 0 0.0017526878509670496
for O 0 0.0009543583728373051
germline O 1 0.9989149570465088
PTEN O 1 0.9999604225158691
mutations O 0 0.0035249674692749977
. O 0 0.0014030373422428966

PTEN O 1 0.9990159273147583
mutations O 0 0.0012219527270644903
were O 0 0.0002174054825445637
identified O 0 0.00011161923612235114
in O 0 3.647130142780952e-05
30 O 0 6.751623732270673e-05
of O 0 6.68215798214078e-05
37 O 0 0.0001543889957247302
( O 0 8.639198495075107e-05
81 O 0 0.00025090103736147285
% O 0 7.024221849860623e-05
) O 0 9.502674947725609e-05
CD B-Disease 0 0.00044512737076729536
families O 0 6.250183650990948e-05
, O 0 6.41171500319615e-05
including O 0 6.343665154417977e-05
missense O 0 0.0005082059651613235
and O 0 0.00012862731819041073
nonsense O 0 0.005696125328540802
point O 0 0.000792508595623076
mutations O 0 0.00018832855857908726
, O 0 9.649984713178128e-05
deletions O 0 0.000353823765181005
, O 0 0.00010517311602598056
insertions O 0 0.0006038722349330783
, O 0 0.00011779557826230302
a O 0 0.0002993673551827669
deletion O 0 0.0012243458768352866
/ O 0 0.0014697108417749405
insertion O 0 0.002189650433138013
and O 0 0.0003326746809761971
splice O 0 0.009025165811181068
site O 0 0.0034290303010493517
mutations O 0 0.0013475508894771338
. O 0 0.000851038726978004

These O 0 0.0005900385440327227
mutations O 0 0.00044360265019349754
were O 0 9.273452451452613e-05
scattered O 0 0.00018747823196463287
over O 0 8.65692927618511e-05
the O 0 0.00013100332580506802
entire O 0 0.0003476477868389338
length O 0 0.00015328092558775097
of O 0 0.0003412117366679013
PTEN O 1 0.9985522627830505
, O 0 8.540015551261604e-05
with O 0 2.7437812605057843e-05
the O 0 4.661421189666726e-05
exception O 0 5.877419971511699e-05
of O 0 6.850669888081029e-05
the O 0 0.00015703267126809806
first O 0 0.00024708136334083974
, O 0 8.638917643111199e-05
fourth O 0 0.0003903222386725247
and O 0 0.00010184686107095331
last O 0 0.00048158864956349134
exons O 0 0.0020227336790412664
. O 0 0.0005750826094299555

A O 0 0.008037417195737362
hot O 0 0.00790831632912159
spot O 0 0.003466519294306636
for O 0 0.0007058463525027037
PTEN O 1 0.9960671067237854
mutation O 0 0.0004611093318089843
in O 0 0.0002041599218500778
CD B-Disease 0 0.0008250726968981326
was O 0 0.0004983508260920644
identified O 0 0.00011929718311876059
in O 0 7.714522507740185e-05
exon O 0 0.0004711092624347657
5 O 0 8.192002860596403e-05
that O 0 2.1254054445307702e-05
contains O 0 5.649189915857278e-05
the O 0 0.00011098286631749943
PTPase O 0 0.348957896232605
core O 0 0.001835203031077981
motif O 0 0.0004719335411209613
, O 0 3.700713568832725e-05
with O 0 1.814649294828996e-05
13 O 0 7.164138514781371e-05
of O 0 5.9828216762980446e-05
30 O 0 8.524384611519054e-05
( O 0 4.9890586524270475e-05
43 O 0 0.00018367804295849055
% O 0 8.961752610048279e-05
) O 0 7.36919027986005e-05
CD B-Disease 0 0.00035826890962198377
mutations O 0 9.926833445206285e-05
identified O 0 9.801534906728193e-05
in O 0 0.00010301397560397163
this O 0 0.0001291184889851138
exon O 0 0.0026114373467862606
. O 0 0.0007632675115019083

Seven O 0 0.0009695866028778255
of O 0 0.0003893341345246881
30 O 0 0.00031691844924353063
( O 0 0.00010433384159114212
23 O 0 0.00015481577429454774
% O 0 4.266312680556439e-05
) O 0 2.0253602997399867e-05
were O 0 1.6386829884140752e-05
within O 0 3.2454317988594994e-05
the O 0 0.00010153064067708328
core O 0 0.000465753284515813
motif O 0 0.0002736084279604256
, O 0 3.89330780308228e-05
the O 0 4.8989299102686346e-05
majority O 0 2.607035457913298e-05
( O 0 1.956596133823041e-05
five O 0 2.0230188965797424e-05
of O 0 4.700318822870031e-05
seven O 0 4.9332185881212354e-05
) O 0 2.6369860279373825e-05
of O 0 5.5004918976919726e-05
which O 0 3.0579991289414465e-05
were O 0 6.657930498477072e-05
missense O 0 0.000592121621593833
mutations O 0 0.00015224990784190595
, O 0 7.138809451134875e-05
possibly O 0 0.00013783642498310655
pointing O 0 0.0001840521872509271
to O 0 5.053775748820044e-05
the O 0 9.826239693211392e-05
functional O 0 0.000190794060472399
significance O 0 0.0002423458208795637
of O 0 0.0003028838546015322
this O 0 0.00019705291197169572
region O 0 0.000801023852545768
. O 0 0.0005133376689627767

Germline O 1 0.9994608759880066
PTEN O 1 0.9995429515838623
mutations O 0 0.0009142612107098103
were O 0 0.00014141284918878227
identified O 0 8.394799806410447e-05
in O 0 2.87662296614144e-05
four O 0 3.999360342277214e-05
of O 0 9.900089935399592e-05
seven O 0 0.00013905410014558583
( O 0 9.928442887030542e-05
57 O 0 0.0003581275523174554
% O 0 0.00015029772475827485
) O 0 0.00022049846302252263
BZS B-Disease 0 0.012404096312820911
families O 0 0.0004156431241426617
studied O 0 0.0010733762755990028
. O 0 0.0007548241410404444

Interestingly O 0 0.007581646088510752
, O 0 0.0005922201089560986
none O 0 0.0002617866557557136
of O 0 0.0002467244921717793
these O 0 8.974666707217693e-05
mutations O 0 0.00022401615569833666
was O 0 0.00042033690260723233
observed O 0 0.00017234297411050647
in O 0 0.00014166008622851223
the O 0 0.00042824618867598474
PTPase O 1 0.9966835379600525
core O 0 0.1854218989610672
motif O 0 0.011254845187067986
. O 0 0.0013153019826859236

It O 0 0.000689808395691216
is O 0 0.0002552976366132498
also O 0 0.00013763835886493325
worthy O 0 0.0004784695920534432
of O 0 0.0002222664625151083
note O 0 0.0001249211054528132
that O 0 4.118273500353098e-05
a O 0 0.00010022233618656173
single O 0 0.00019194252672605217
nonsense O 0 0.0008546049357391894
point O 0 0.0003430196375120431
mutation O 0 0.00016947908443398774
, O 0 0.00010788976942421868
R233X O 0 0.023313185200095177
, O 0 8.652992255520076e-05
was O 0 0.00014725516666658223
observed O 0 5.7587916671764106e-05
in O 0 2.888266863010358e-05
the O 0 0.00013104041863698512
germline O 0 0.0011479078093543649
DNA O 0 0.00013390459935180843
from O 0 6.08146729064174e-05
two O 0 7.263153383973986e-05
unrelated O 0 0.00045999098801985383
CD B-Disease 0 0.000862969842273742
families O 0 0.00010332938109058887
and O 0 0.00014120370906312019
one O 0 0.0004383391933515668
BZS B-Disease 1 0.9810346961021423
family O 0 0.0017570615746080875
. O 0 0.0013976269401609898

Genotype O 0 0.351520836353302
- O 0 0.02822689153254032
phenotype O 0 0.0016497515607625246
studies O 0 0.0001268150081159547
were O 0 6.834174564573914e-05
not O 0 3.149368421873078e-05
performed O 0 0.000113169830001425
on O 0 7.910068961791694e-05
this O 0 4.6656419726787135e-05
small O 0 7.989729783730581e-05
group O 0 8.517087553627789e-05
of O 0 0.0003414554812479764
BZS B-Disease 1 0.9923961758613586
families O 0 0.0008849810692481697
. O 0 0.000954956456553191

However O 0 0.002756376750767231
, O 0 0.0012019346468150616
genotype O 0 0.0033257375471293926
- O 0 0.002114252420142293
phenotype O 0 0.0008206113707274199
analysis O 0 0.00018069059296976775
inthe O 0 0.0025146668776869774
group O 0 0.00021002361609134823
of O 0 0.0004114089533686638
CD B-Disease 0 0.0015317825600504875
families O 0 0.00010718324483605102
revealed O 0 0.00024449609918519855
two O 0 3.622512667789124e-05
possible O 0 5.8131608966505155e-05
associations O 0 7.174591155489907e-05
worthy O 0 0.00028101468342356384
of O 0 0.00022613642795477062
follow O 0 0.00018773440388031304
- O 0 0.00026314749266020954
up O 0 0.00014208976062946022
in O 0 9.132811101153493e-05
independent O 0 0.00018598034512251616
analyses O 0 0.0003879540308844298
. O 0 0.0004063755040988326

The O 0 0.0015131314285099506
first O 0 0.0007701602880842984
was O 0 0.0007830962422303855
an O 0 0.0001751473464537412
association O 0 0.00019897111633326858
noted O 0 8.495649672113359e-05
in O 0 4.3671356252161786e-05
the O 0 8.641077147331089e-05
group O 0 7.984467083588243e-05
of O 0 0.0001894175511552021
CD B-Disease 0 0.003363492665812373
families O 0 0.00028051488334313035
with O 0 0.037272676825523376
breast B-Disease 1 0.9999995231628418
disease I-Disease 1 0.9999992847442627
. O 0 0.004327210132032633

A O 0 0.004177972674369812
correlation O 0 0.0010155723430216312
was O 0 0.000681775389239192
observed O 0 0.0001734870602376759
between O 0 0.00013365151244215667
the O 0 0.00019429872918408364
presence O 0 0.0004022404900752008
/ O 0 0.00045854627387598157
absence O 0 0.00032825395464897156
of O 0 0.0002725999802350998
a O 0 0.0025621599052101374
PTEN O 1 0.9998043179512024
mutation O 0 0.00023653623065911233
and O 0 4.108416032977402e-05
the O 0 8.928655734052882e-05
type O 0 0.00027580137248151004
of O 0 0.0033920297864824533
breast O 1 0.997962236404419
involvement O 0 0.297570139169693
( O 0 0.0014430609298869967
unaffected O 0 0.09533942490816116
versus O 1 0.9325281381607056
benign O 1 0.999943733215332
versus O 1 0.9997232556343079
malignant O 1 0.999998927116394
) O 0 0.0010500685311853886
. O 0 0.0011159408604726195

Specifically O 0 0.0012900074943900108
and O 0 0.00024160776229109615
more O 0 6.0510497860377654e-05
directly O 0 7.758167339488864e-05
, O 0 6.17397963651456e-05
an O 0 0.00010369963274570182
association O 0 0.0003178607439622283
was O 0 0.00036313041346147656
also O 0 5.904835052206181e-05
observed O 0 4.893938239547424e-05
between O 0 5.44159920536913e-05
the O 0 9.50686153373681e-05
presence O 0 0.000173501786775887
of O 0 0.0002762816729955375
a O 0 0.014669063501060009
PTEN O 1 0.9999985694885254
mutation O 1 0.9806926846504211
and O 1 0.9878526926040649
malignant B-Disease 1 1.0
breast I-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 0.14254578948020935

Secondly O 0 0.02678557112812996
, O 0 0.0005757298204116523
there O 0 0.00017843200475908816
appeared O 0 0.00021102564642205834
to O 0 5.98917540628463e-05
be O 0 5.6986220442922786e-05
an O 0 0.00011626451305346563
interdependent O 0 0.003374821972101927
association O 0 0.00042137762648053467
between O 0 0.00029327665106393397
mutations O 0 0.00023622767184861004
upstream O 0 0.000763172225560993
and O 0 0.00011574680684134364
within O 0 0.00013469369150698185
the O 0 0.00043988018296658993
PTPase O 1 0.989591658115387
core O 0 0.010793807916343212
motif O 0 0.0011275851866230369
, O 0 0.00015008349146228284
the O 0 0.00019837553554680198
core O 0 0.0008454177877865732
motif O 0 0.0006545979995280504
containing O 0 0.0002055169316008687
the O 0 0.00011952812201343477
majority O 0 9.311165194958448e-05
of O 0 0.00023302830231841654
missense O 0 0.0031123277731239796
mutations O 0 0.00026756315492093563
, O 0 7.67866222304292e-05
and O 0 4.273605009075254e-05
the O 0 8.730230911169201e-05
involvement O 0 0.00023577609681524336
of O 0 0.0002200725139118731
all O 0 0.00011345723760314286
major O 1 0.7128613591194153
organ O 1 0.9999425411224365
systems O 1 0.7435542345046997
( O 0 0.0004985730047337711
central O 0 0.0016947798430919647
nervous O 1 0.7721909880638123
system O 0 0.003590076696127653
, O 0 0.014635667204856873
thyroid O 1 1.0
, O 1 0.8714551329612732
breast O 1 0.9999990463256836
, O 1 0.98487788438797
skin O 1 0.9999997615814209
and O 1 0.9999191761016846
gastrointestinal O 1 1.0
tract O 1 1.0
) O 0 0.02060512825846672
. O 0 0.0011271096300333738

However O 0 0.0017882719403132796
, O 0 0.000349787762388587
these O 0 7.983286923263222e-05
observations O 0 0.00019387566135264933
would O 0 6.662522355327383e-05
need O 0 4.5657849113922566e-05
to O 0 2.4997343643917702e-05
be O 0 2.138670242857188e-05
confirmed O 0 4.650454502552748e-05
by O 0 1.624700234970078e-05
studying O 0 5.30482575413771e-05
a O 0 6.769339233869687e-05
larger O 0 5.996273102937266e-05
number O 0 4.08659216191154e-05
of O 0 0.00020971502817701548
CD B-Disease 0 0.001370635349303484
families O 0 0.0003884036559611559
. O 0 0.0005989113124087453

Molecular O 1 0.9851509928703308
defects O 1 0.9998748302459717
leading O 0 0.041521020233631134
to O 0 0.0008514868095517159
human O 0 0.0031296084634959698
complement B-Disease 1 0.9607369899749756
component I-Disease 1 0.9999986886978149
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 0.0005550949135795236
an O 0 0.0005494831129908562
African O 0 0.004131404682993889
- O 0 0.0016141743399202824
American O 0 0.0005662771291099489
family O 0 0.0006166079547256231
. O 0 0.0006012390367686749

Complement B-Disease 1 0.9874774217605591
component I-Disease 1 0.9999960660934448
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 1 0.9974485039710999
C6D B-Disease 1 0.9999988079071045
) O 0 0.0007323686149902642
was O 0 0.012402040883898735
diagnosed O 0 0.4420967698097229
in O 0 9.419870184501633e-05
a O 0 0.00020800363563466817
16 O 0 0.00035290629602968693
- O 0 0.0005394989275373518
year O 0 0.00015948570217005908
- O 0 0.0003302017867099494
old O 0 0.0006149904220364988
African O 0 0.000913260446395725
- O 0 0.0010197043884545565
American O 0 0.0010690530762076378
male O 0 0.0024541704915463924
with O 0 0.007227560970932245
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 0.9999998807907104
. O 0 0.015509959310293198

The O 0 0.014655141159892082
patients O 0 0.004852491896599531
father O 0 0.003193856682628393
and O 0 0.00014664226910099387
two O 0 0.00014773882867302746
brothers O 0 0.0018868964398279786
also O 0 0.00016868718375917524
had O 0 0.0008859458612278104
C6D B-Disease 1 0.9999121427536011
, O 0 0.00016774532559793442
but O 0 4.0883151086745784e-05
gave O 0 9.976464207284153e-05
no O 0 6.586017843801528e-05
history O 0 0.00023834459716454148
of O 0 0.0339304618537426
meningitis B-Disease 1 0.9999997615814209
or O 0 0.08706457167863846
other O 0 0.001315706642344594
neisserial B-Disease 1 0.9999971389770508
infection I-Disease 1 0.9999179840087891
. O 0 0.001643049530684948

By O 0 0.0009874582756310701
using O 0 0.0004644808068405837
exon O 0 0.0021003244910389185
- O 0 0.0007084155804477632
specific O 0 0.00023220921866595745
polymerase O 0 0.0010807146318256855
chain O 0 0.0006145117804408073
reaction O 0 0.00036904425360262394
( O 0 0.00014625434414483607
PCR O 0 0.0006236649351194501
) O 0 0.0001010761407087557
/ O 0 0.00036927350447513163
single O 0 0.00022705766605213284
- O 0 0.000441230833530426
strand O 0 0.0005027634906582534
conformation O 0 0.00033862280542962253
polymorphism O 0 0.00025955538148991764
as O 0 0.00010239686525892466
a O 0 0.00011318794713588431
screening O 0 0.00012228880950715393
step O 0 0.00014608402852900326
and O 0 5.529680129257031e-05
nucleotide O 0 8.897074440028518e-05
sequencing O 0 8.110541966743767e-05
of O 0 6.167542596813291e-05
target O 0 0.00011551591887837276
exons O 0 0.00022959821217227727
, O 0 4.914713281323202e-05
we O 0 2.571118420746643e-05
determined O 0 4.772349711856805e-05
that O 0 2.8940068659721874e-05
the O 0 0.0001280810683965683
proband O 0 0.008121350780129433
was O 0 0.0005203967448323965
a O 0 0.00029860655195079744
compound O 0 0.0030998559668660164
heterozygote O 0 0.0018577644368633628
for O 0 0.00023746315855532885
two O 0 0.00037042860640212893
C6 O 1 0.9999139308929443
gene O 0 0.0019296068930998445
mutations O 0 0.0013375417329370975
. O 0 0.0007886953535489738

The O 0 0.0022857023868709803
first O 0 0.0009658060153014958
, O 0 0.00035533239133656025
1195delC O 0 0.00329453032463789
located O 0 0.000547267438378185
in O 0 0.00017706528888083994
exon O 0 0.0008172336383722723
7 O 0 0.0003108750388491899
, O 0 6.99567754054442e-05
is O 0 4.651900599128567e-05
a O 0 8.100416016532108e-05
novel O 0 0.0001894619781523943
mutation O 0 6.110672984505072e-05
, O 0 3.221174483769573e-05
while O 0 1.8487813576939516e-05
the O 0 5.197025166125968e-05
second O 0 0.0002408113214187324
, O 0 0.00012018827692372724
1936delG O 0 0.00186497054528445
in O 0 0.00010883648792514578
exon O 0 0.0007478240877389908
12 O 0 0.00014489969180431217
, O 0 4.9948666855925694e-05
has O 0 3.081107570324093e-05
been O 0 5.1269042160129175e-05
described O 0 0.00010419404861750081
before O 0 0.00015024642925709486
to O 0 0.0001189982722280547
cause O 0 0.20934340357780457
C6D B-Disease 1 0.9998553991317749
in O 0 0.00025607357383705676
an O 0 0.0001506248372606933
unrelated O 0 0.0007666448364034295
African O 0 0.0021864022128283978
- O 0 0.002433682791888714
American O 0 0.0006205755053088069
individual O 0 0.00039587245555594563
. O 0 0.0007612452609464526

Both O 0 0.0015831106575205922
mutations O 0 0.0011371076107025146
result O 0 0.0007029413245618343
in O 0 0.0005575101240538061
premature O 0 0.3056885004043579
termination O 1 0.5846147537231445
codons O 0 0.006355275399982929
and O 0 0.0012169383699074388
C6 O 1 0.9999082088470459
null O 0 0.006924419663846493
alleles O 0 0.0026190222706645727
. O 0 0.001074311789125204

Allele O 0 0.006917926482856274
- O 0 0.002510594204068184
specific O 0 0.0003285927523393184
PCR O 0 0.001059754635207355
indicated O 0 0.0002236597501905635
that O 0 5.528113979380578e-05
the O 0 0.00015812258061487228
probands O 0 0.06023849919438362
two O 0 0.00015637579781468958
brothers O 0 0.0009334355127066374
also O 0 0.00014854755136184394
inherited O 0 0.22544270753860474
the O 0 0.0022564611863344908
1195delC O 1 0.9996488094329834
mutation O 0 0.0003974841092713177
from O 0 0.00014689753879792988
their O 0 7.049486157484353e-05
heterozygous O 0 0.00013625547580886632
mother O 0 0.0003007410268764943
and O 0 7.257863762788475e-05
the O 0 0.00018975921557284892
1936delG O 1 0.7763590812683105
mutation O 0 0.00023906287970021367
from O 0 9.13974508875981e-05
their O 0 8.353338489541784e-05
homozygous O 0 0.0007781864842399955
father O 0 0.0018618255853652954
. O 0 0.0004792124673258513
. O 0 0.0008108781767077744

PAX6 O 1 0.9979020357131958
mutations O 0 0.012794271111488342
reviewed O 0 0.007960857823491096
. O 0 0.0035012448206543922

Mutations O 0 0.005275229457765818
in O 0 0.0011900137178599834
PAX6 O 1 0.9966536164283752
are O 0 0.00012960389722138643
responsible O 0 0.0004656542732845992
for O 0 0.00022305322636384517
human O 0 0.008747479878365993
aniridia B-Disease 1 0.9999983310699463
and O 0 0.00023433280875906348
have O 0 4.677313700085506e-05
also O 0 3.686359923449345e-05
been O 0 2.9763516067760065e-05
found O 0 4.3515708966879174e-05
in O 0 7.496851321775466e-05
patients O 0 0.0002613068791106343
with O 0 0.00034161043004132807
Peters B-Disease 1 0.999998927116394
anomaly I-Disease 1 0.9999998807907104
, O 1 0.9814183712005615
with O 1 0.9999402761459351
congenital B-Disease 1 1.0
cataracts I-Disease 1 1.0
, O 1 0.9999566078186035
with O 1 0.9977632761001587
autosomal B-Disease 1 0.9999896287918091
dominant I-Disease 1 0.9999990463256836
keratitis I-Disease 1 1.0
, O 0 0.1474231630563736
and O 0 0.0006574690924026072
with O 0 0.0014880456728860736
isolated B-Disease 1 0.9997966885566711
foveal I-Disease 1 0.9999998807907104
hypoplasia I-Disease 1 0.9999997615814209
. O 0 0.012739789672195911

No O 0 0.002500873291864991
locus O 0 0.002579591004177928
other O 0 0.00020754443539772183
than O 0 0.00029073486803099513
chromosome O 0 0.0015601841732859612
11p13 O 1 0.9919517040252686
has O 0 0.00023656510165892541
been O 0 0.0002104511804645881
implicated O 0 0.030667701736092567
in O 0 0.0015724045224487782
aniridia B-Disease 1 0.9999986886978149
, O 0 0.0005643265321850777
and O 0 0.00032845709938555956
PAX6 O 1 0.9998241066932678
is O 0 0.0001375024439767003
clearly O 0 0.00011910658213309944
the O 0 0.00010293078958056867
major O 0 0.0003199353814125061
, O 0 4.550258017843589e-05
if O 0 2.0611860236385837e-05
not O 0 1.38423210955807e-05
only O 0 2.85296391666634e-05
, O 0 7.419996109092608e-05
gene O 0 0.00020138687978032976
responsible O 0 0.0007664957665838301
. O 0 0.000895816192496568

Twenty O 0 0.007818412035703659
- O 0 0.001900551957078278
eight O 0 0.0004412297857925296
percent O 0 0.0002033083001151681
of O 0 0.00025310085038654506
identified O 0 0.00042276227031834424
PAX6 O 1 0.9965440630912781
mutations O 0 0.0003109298995696008
are O 0 5.6968998251250014e-05
C O 0 0.001733954530209303
- O 0 0.0011671308893710375
T O 0 0.0012466599000617862
changes O 0 0.00010624766582623124
at O 0 0.00031020271126180887
CpG O 0 0.0014057436492294073
dinucleotides O 0 0.004893632140010595
, O 0 0.00010120836668647826
20 O 0 8.910223550628871e-05
% O 0 4.7413039283128455e-05
are O 0 1.883077493403107e-05
splicing O 0 0.00023091236653272063
errors O 0 0.0001861769414972514
, O 0 3.62754290108569e-05
and O 0 1.8192480638390407e-05
more O 0 1.610071922186762e-05
than O 0 3.280152668594383e-05
30 O 0 6.483287870651111e-05
% O 0 4.1952807805500925e-05
are O 0 1.831852387113031e-05
deletion O 0 0.0004379952442832291
or O 0 0.0003079767047893256
insertion O 0 0.002206771168857813
events O 0 0.0014241398312151432
. O 0 0.0008382528903894126

There O 0 0.001604523858986795
is O 0 0.0006561708287335932
a O 0 0.0006610046839341521
noticeably O 0 0.004045390523970127
elevated O 0 0.15619006752967834
level O 0 0.00045135687105357647
of O 0 0.00025333455414511263
mutation O 0 8.974273077910766e-05
in O 0 4.263530718162656e-05
the O 0 7.09943487890996e-05
paired O 0 0.00014079043467063457
domain O 0 7.189070311142132e-05
compared O 0 4.699475903180428e-05
with O 0 1.8344258933211677e-05
the O 0 5.603476893156767e-05
rest O 0 0.0001306968624703586
of O 0 0.0001759352016961202
the O 0 0.00043125497177243233
gene O 0 0.0008213380351662636
. O 0 0.0004918798804283142

Increased O 0 0.0035770584363490343
mutation O 0 0.000533019716385752
in O 0 0.0002723954967223108
the O 0 0.00040059996536001563
homeodomain O 0 0.002964399755001068
is O 0 0.00011081365664722398
accounted O 0 0.00015890493523329496
for O 0 3.4382541343802586e-05
by O 0 5.697959568351507e-05
the O 0 0.00029033326427452266
hypermutable O 1 0.7872666716575623
CpG O 0 0.008415850810706615
dinucleotide O 0 0.013710469007492065
in O 0 0.0006414497038349509
codon O 0 0.0025221125688403845
240 O 0 0.0023409107234328985
. O 0 0.0009612678550183773

Very O 0 0.001018146867863834
nearly O 0 0.0007332282839342952
all O 0 0.00016147342103067786
mutations O 0 0.00018934386025648564
appear O 0 0.0001225004089064896
to O 0 0.00011508668831083924
cause O 0 0.009460781700909138
loss O 0 0.0017374230083078146
of O 0 0.0003493951226118952
function O 0 0.00010398272570455447
of O 0 0.00020151727949269116
the O 0 0.0002602958702482283
mutant O 0 0.0011171716032549739
allele O 0 0.0001110898083425127
, O 0 2.3507314836024307e-05
and O 0 1.2777099982486106e-05
more O 0 6.512167146865977e-06
than O 0 1.1748847100534476e-05
80 O 0 5.607668208540417e-05
% O 0 4.339904626249336e-05
of O 0 0.0001621148840058595
exonic O 0 0.06957313418388367
substitutions O 0 0.00080231943866238
result O 0 0.00028186984127387404
in O 0 0.00036931224167346954
nonsense O 0 0.0035114965867251158
codons O 0 0.002535113599151373
. O 0 0.0008578540873713791

In O 0 0.001205773325636983
a O 0 0.0007965872064232826
gene O 0 0.0003154242585878819
with O 0 0.0001055658794939518
such O 0 9.625025268178433e-05
extraordinarily O 0 0.0009482530294917524
high O 0 0.000369809364201501
sequence O 0 0.00014713643759023398
conservation O 0 0.0001669610064709559
throughout O 0 9.66704246820882e-05
evolution O 0 0.00017966737505048513
, O 0 6.735046190442517e-05
there O 0 7.100639777490869e-05
are O 0 3.524711064528674e-05
presumed O 0 0.0006042916793376207
undiscovered O 0 0.19312459230422974
missense O 0 0.0054809534922242165
mutations O 0 0.0004375608405098319
, O 0 9.079901064978912e-05
these O 0 3.103217386524193e-05
are O 0 1.3626120562548749e-05
hypothesized O 0 0.00017026497516781092
to O 0 5.818075078423135e-05
exist O 0 9.600478369975463e-05
in O 0 9.672401210991666e-05
as O 0 0.00020829416462220252
- O 0 0.0006843177834525704
yet O 0 0.00034477721783332527
unidentified O 0 0.0019235297804698348
phenotypes O 0 0.002597438171505928
. O 0 0.0003889345971401781
. O 0 0.0007839678437449038

Genetic O 0 0.00678651500493288
heterogeneity O 0 0.006176184397190809
and O 0 0.0008240179158747196
penetrance O 0 0.004752118140459061
analysis O 0 0.00020719427266158164
of O 0 0.0005205656634643674
the O 0 0.0029693704564124346
BRCA1 O 1 0.997721254825592
and O 0 0.0009269883157685399
BRCA2 O 1 0.9779992699623108
genes O 0 0.0010149823501706123
in O 0 0.01329971756786108
breast B-Disease 1 0.9999964237213135
cancer I-Disease 1 0.9999207258224487
families O 0 0.0011007939465343952
. O 0 0.0010629916796460748

The O 1 0.9992357492446899
Breast B-Disease 1 0.9999998807907104
Cancer I-Disease 1 0.9999995231628418
Linkage O 1 0.999672532081604
Consortium O 0 0.04118752107024193
. O 0 0.002109878696501255

The O 0 0.0024950469378381968
contribution O 0 0.0024909628555178642
of O 0 0.0035701526794582605
BRCA1 O 1 0.9987425208091736
and O 0 0.0015558116137981415
BRCA2 O 1 0.9990324974060059
to O 0 0.0809599831700325
inherited B-Disease 1 1.0
breast I-Disease 1 1.0
cancer I-Disease 1 1.0
was O 1 0.9996016621589661
assessed O 0 0.0009629311389289796
by O 0 8.608894131612033e-05
linkage O 0 0.0006810084450989962
and O 0 7.815118442522362e-05
mutation O 0 6.521696195704862e-05
analysis O 0 2.4387809389736503e-05
in O 0 3.298066076240502e-05
237 O 0 0.00018816502415575087
families O 0 2.390115878370125e-05
, O 0 2.2172709577716887e-05
each O 0 7.951986845000647e-06
with O 0 1.14925696834689e-05
at O 0 5.249820605968125e-05
least O 0 2.864995622076094e-05
four O 0 3.760337131097913e-05
cases O 0 5.121176582179032e-05
of O 0 0.0548565499484539
breast B-Disease 1 0.9999980926513672
cancer I-Disease 1 0.9998393058776855
, O 0 0.00011486237053759396
collected O 0 8.046156290220097e-05
by O 0 0.00010130037844646722
the O 0 0.010207300074398518
Breast B-Disease 1 0.9999997615814209
Cancer I-Disease 1 0.9999994039535522
Linkage O 1 0.9990354776382446
Consortium O 0 0.005963391624391079
. O 0 0.001225436688400805

Families O 0 0.0012933070538565516
were O 0 0.00025702136917971075
included O 0 0.00019122898811474442
without O 0 7.322781311813742e-05
regard O 0 0.00012357000377960503
to O 0 4.647732203011401e-05
the O 0 0.00019629529560916126
occurrence O 0 0.0031691393814980984
of O 1 0.968380331993103
ovarian B-Disease 1 0.9999998807907104
or I-Disease 0 0.2890551686286926
other I-Disease 0 0.0014319365145638585
cancers I-Disease 1 0.9989099502563477
. O 0 0.0010362638859078288

Overall O 1 0.9830021262168884
, O 0 0.38145729899406433
disease O 1 0.9999878406524658
was O 1 0.8530778288841248
linked O 0 0.012423058971762657
to O 0 0.00021425921295303851
BRCA1 O 0 0.00217280606739223
in O 0 5.604556281468831e-05
an O 0 3.696523344842717e-05
estimated O 0 6.579815817531198e-05
52 O 0 0.00010366542119299993
% O 0 2.6061579774250276e-05
of O 0 6.208802369656041e-05
families O 0 5.7376651966478676e-05
, O 0 3.4270324249519035e-05
to O 0 3.8315251003950834e-05
BRCA2 O 0 0.00044824209180660546
in O 0 5.095339656691067e-05
32 O 0 9.718747605802491e-05
% O 0 3.446237315074541e-05
of O 0 6.543723429786041e-05
families O 0 5.174765828996897e-05
, O 0 4.760768206324428e-05
and O 0 2.6259316655341536e-05
to O 0 3.248512075515464e-05
neither O 0 0.00010898874461418018
gene O 0 5.2882689487887546e-05
in O 0 2.7614370992523618e-05
16 O 0 6.528378435177729e-05
% O 0 3.280055898358114e-05
( O 0 3.848387495963834e-05
95 O 0 0.00011741562775569037
% O 0 6.049653165973723e-05
confidence O 0 0.000307899754261598
interval O 0 0.0003579752519726753
[ O 0 0.00034554817830212414
CI O 0 0.004738172050565481
] O 0 0.00025225189165212214
6 O 0 0.00012965740461368114
% O 0 4.173799970885739e-05
- O 0 0.00010438598837936297
28 O 0 0.00014453910989686847
% O 0 5.7907422160496935e-05
) O 0 6.41721417196095e-05
, O 0 8.024647831916809e-05
suggesting O 0 0.00023634078388568014
other O 0 0.00013366603525355458
predisposition O 0 0.25004395842552185
genes O 0 0.0011330561246722937
. O 0 0.001062047784216702

The O 0 0.001449624658562243
majority O 0 0.0003588335821405053
( O 0 0.00020674924599006772
81 O 0 0.0005390460719354451
% O 0 8.857286593411118e-05
) O 0 9.308839071309194e-05
of O 0 0.0003529289679136127
the O 1 0.7070938944816589
breast B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999953508377075
families O 0 0.00023930096358526498
were O 0 0.00011374962195986882
due O 0 0.00023523606068920344
to O 0 0.0001132042525568977
BRCA1 O 0 0.03125016763806343
, O 0 5.09967103425879e-05
with O 0 2.394526200077962e-05
most O 0 2.241381662315689e-05
others O 0 2.5773564630071633e-05
( O 0 3.2133750210050493e-05
14 O 0 0.00010833451233338565
% O 0 5.662036710418761e-05
) O 0 7.817742880433798e-05
due O 0 0.00028387687052600086
to O 0 0.0004173276829533279
BRCA2 O 0 0.02685064636170864
. O 0 0.001000220887362957

Conversely O 0 0.005434009712189436
, O 0 0.0003672800667118281
the O 0 0.00021382597333285958
majority O 0 8.312860154546797e-05
of O 0 0.0001348769583273679
families O 0 7.049257692415267e-05
with O 0 8.866404823493212e-05
male B-Disease 0 0.0029375231824815273
and I-Disease 0 0.0013747730990871787
female I-Disease 1 0.9997891783714294
breast I-Disease 1 0.9999994039535522
cancer I-Disease 1 0.9999206066131592
were O 0 0.00023570236226078123
due O 0 0.00036743891541846097
to O 0 0.00012856393004767597
BRCA2 O 0 0.003410337259992957
( O 0 0.00013835166464559734
76 O 0 0.0006922289030626416
% O 0 0.00021305526024661958
) O 0 0.0002828535216394812
. O 0 0.0004321026790421456

The O 0 0.0016022177878767252
largest O 0 0.001296555739827454
proportion O 0 0.00025364779867231846
( O 0 0.000126902581541799
67 O 0 0.00025645396090112627
% O 0 5.141014116816223e-05
) O 0 2.7737334676203318e-05
of O 0 6.540717004099861e-05
families O 0 5.456975850393064e-05
due O 0 7.955715409480035e-05
to O 0 3.446099435677752e-05
other O 0 2.3893504476291128e-05
genes O 0 3.369028490851633e-05
was O 0 0.00011615369294304401
found O 0 2.425051570753567e-05
in O 0 1.9225150026613846e-05
families O 0 1.744340443110559e-05
with O 0 1.592252192494925e-05
four O 0 2.68614458036609e-05
or O 0 3.9771872252458706e-05
five O 0 5.6532695452915505e-05
cases O 0 7.976149208843708e-05
of O 0 0.001560690812766552
female O 1 0.9998063445091248
breast B-Disease 1 0.9999991655349731
cancer I-Disease 1 0.9999408721923828
only O 0 0.0006431011715903878
. O 0 0.0008134057279676199

These O 0 0.00037043477641418576
estimates O 0 0.0002051065966952592
were O 0 0.00011661648750305176
not O 0 5.960163616691716e-05
substantially O 0 0.00020151077478658408
affected O 0 8.205451013054699e-05
either O 0 3.8399160985136405e-05
by O 0 4.2775525798788294e-05
changing O 0 0.00011770149285439402
the O 0 0.0001795697316993028
assumed O 0 0.000862973160110414
penetrance O 0 0.004808312281966209
model O 0 0.00045321654761210084
for O 0 0.00019021317712031305
BRCA1 O 0 0.003566888626664877
or O 0 0.0001344268093816936
by O 0 6.34083480690606e-05
including O 0 0.00014530854241456836
or O 0 0.00027996156131848693
excluding O 0 0.0015623369254171848
BRCA1 O 1 0.7956966161727905
mutation O 0 0.0011848390568047762
data O 0 0.0003337935486342758
. O 0 0.00043207115959376097

Among O 0 0.0013549337163567543
those O 0 0.0002631951938383281
families O 0 0.0003829588822554797
with O 0 0.000887781148776412
disease O 1 0.9999923706054688
due O 1 0.8407524824142456
to O 0 0.0009436003747396171
BRCA1 O 1 0.9056103229522705
that O 0 7.505070243496448e-05
were O 0 5.08466073370073e-05
tested O 0 8.082222484517843e-05
by O 0 2.1526824639295228e-05
one O 0 2.6142904971493408e-05
of O 0 4.65182529296726e-05
the O 0 9.95954469544813e-05
standard O 0 0.0001087578566512093
screening O 0 9.42340848268941e-05
methods O 0 6.322636909317225e-05
, O 0 5.696209700545296e-05
mutations O 0 4.210318729747087e-05
were O 0 3.971873229602352e-05
detected O 0 0.00011118729889858514
in O 0 3.634422682807781e-05
the O 0 8.076374797383323e-05
coding O 0 0.00012281305680517107
sequence O 0 9.569200483383611e-05
or O 0 5.620618685497902e-05
splice O 0 0.0003370024205651134
sites O 0 5.40979890502058e-05
in O 0 2.3733784473733976e-05
an O 0 2.1659605408785865e-05
estimated O 0 2.7514059183886275e-05
63 O 0 8.939416875364259e-05
% O 0 2.663528903212864e-05
( O 0 3.126938463537954e-05
95 O 0 8.440287638222799e-05
% O 0 4.38559873146005e-05
CI O 0 0.0012994558783248067
51 O 0 0.0001948943390743807
% O 0 7.27421574993059e-05
- O 0 0.0003340119437780231
77 O 0 0.00041565066203475
% O 0 0.00021290805307216942
) O 0 0.00021655025193467736
. O 0 0.00046772422501817346

The O 0 0.002183401957154274
estimated O 0 0.001037325826473534
sensitivity O 0 0.0009391324711032212
was O 0 0.0005100514972582459
identical O 0 0.00012119179882574826
for O 0 5.326445898390375e-05
direct O 0 0.00012153319403296337
sequencing O 0 0.0002822436217684299
and O 0 9.43937266129069e-05
other O 0 9.122645860770717e-05
techniques O 0 0.0009190159034915268
. O 0 0.00043210142757743597

The O 0 0.003456283360719681
penetrance O 0 0.0449763685464859
of O 0 0.0031589805148541927
BRCA2 O 1 0.7380997538566589
was O 0 0.0017253810074180365
estimated O 0 0.0003481039311736822
by O 0 7.169469608925283e-05
maximizing O 0 0.00041464861715212464
the O 0 0.0002475265064276755
LOD O 0 0.09058694541454315
score O 0 0.0003894146648235619
in O 0 0.0003747704322449863
BRCA2 O 0 0.4219835698604584
- O 0 0.0008326056995429099
mutation O 0 0.00014128479233477265
families O 0 6.720532837789506e-05
, O 0 4.235241067362949e-05
over O 0 6.330902397166938e-05
all O 0 8.792413427727297e-05
possible O 0 0.00027250018320046365
penetrance O 0 0.013323762454092503
functions O 0 0.0008441661484539509
. O 0 0.0006876639672555029

The O 0 0.002307940972968936
estimated O 0 0.0012619764311239123
cumulative O 0 0.0018614756409078836
risk O 0 0.0010827678488567472
of O 0 0.11737978458404541
breast B-Disease 1 0.9999949932098389
cancer I-Disease 1 0.9993001222610474
reached O 0 0.0011998781701549888
28 O 0 0.00023547055025119334
% O 0 4.4808526581618935e-05
( O 0 4.278539927327074e-05
95 O 0 8.489599713357165e-05
% O 0 4.862194327870384e-05
CI O 0 0.0015280952211469412
9 O 0 0.0001791515969671309
% O 0 4.0803228330332786e-05
- O 0 0.0001090679652406834
44 O 0 6.932660471647978e-05
% O 0 3.288242805865593e-05
) O 0 2.2310727217700332e-05
by O 0 2.3894872356322594e-05
age O 0 5.720706030842848e-05
50 O 0 7.911094144219533e-05
years O 0 6.545097130583599e-05
and O 0 4.1141283873002976e-05
84 O 0 0.00019725385936908424
% O 0 5.967186370980926e-05
( O 0 5.498855534824543e-05
95 O 0 0.00012644912931136787
% O 0 8.023063855944201e-05
CI O 0 0.001915906323119998
43 O 0 0.00020556630624923855
% O 0 5.2719598897965625e-05
- O 0 0.00012492990936152637
95 O 0 8.638514555059373e-05
% O 0 3.9810802263673395e-05
) O 0 2.9078448278596625e-05
by O 0 3.100664616795257e-05
age O 0 0.00019013593555428088
70 O 0 0.00041259409044869244
years O 0 0.0003745327121578157
. O 0 0.0005954137886874378

The O 0 0.030751094222068787
corresponding O 1 0.99982088804245
ovarian B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
risks O 1 0.7467111349105835
were O 0 0.0008698620949871838
0 O 0 0.001135482918471098
. O 0 0.0008527080644853413

4 O 0 0.002094411291182041
% O 0 0.00032039228244684637
( O 0 0.0001837968302424997
95 O 0 0.00036302139051258564
% O 0 0.0001320646406384185
CI O 0 0.002171927597373724
0 O 0 0.00014046457363292575
% O 0 5.113515362609178e-05
- O 0 9.465387120144442e-05
1 O 0 6.312719051493332e-05
% O 0 2.5420398742426187e-05
) O 0 1.091776903194841e-05
by O 0 1.4595444554288406e-05
age O 0 4.6051973185967654e-05
50 O 0 3.924987686332315e-05
years O 0 3.32132403855212e-05
and O 0 2.611978015920613e-05
27 O 0 8.737792813917622e-05
% O 0 3.0758081265958026e-05
( O 0 4.4024523958796635e-05
95 O 0 0.00013202107220422477
% O 0 4.944932879880071e-05
CI O 0 0.0013795614941045642
0 O 0 7.553253817604855e-05
% O 0 3.9281847421079874e-05
- O 0 0.00010744071187218651
47 O 0 0.00011407407146180049
% O 0 3.680518057080917e-05
) O 0 3.090517930104397e-05
by O 0 3.6786725104320794e-05
age O 0 0.00022322429867926985
70 O 0 0.0004713033267762512
years O 0 0.0006431027431972325
. O 0 0.0007465694798156619

The O 0 0.003729368792846799
lifetime O 0 0.012018409557640553
risk O 0 0.02595292404294014
of O 1 0.9976645708084106
breast B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999967813491821
appears O 0 0.001161016640253365
similar O 0 8.571171929361299e-05
to O 0 4.5479635446099564e-05
the O 0 0.00017550944176036865
risk O 0 0.00021951926464680582
in O 0 0.00015328005247283727
BRCA1 O 1 0.7402732372283936
carriers O 0 0.00015487379278056324
, O 0 2.7822827178169973e-05
but O 0 2.1530582671402954e-05
there O 0 3.160099367960356e-05
was O 0 0.00010750895307864994
some O 0 3.542766717146151e-05
suggestion O 0 0.00020118709653615952
of O 0 0.00014501812984235585
a O 0 0.0003348673926666379
lower O 0 0.0009861669968813658
risk O 0 0.00030129204969853163
in O 0 0.0002389917935943231
BRCA2 O 0 0.004749473184347153
carriers O 0 0.0002993462258018553
< O 0 0.0006958018057048321
50 O 0 0.00022098803310655057
years O 0 0.00018856879614759237
of O 0 0.000498622830491513
age O 0 0.0013808594085276127
. O 0 0.0010028998367488384

Eye B-Disease 1 0.9999428987503052
movement I-Disease 1 0.9973536729812622
abnormalities I-Disease 1 0.9993228912353516
correlate O 0 0.0032337799202650785
with O 0 0.0006644833483733237
genotype O 0 0.011131346225738525
in O 0 0.0022531140130013227
autosomal O 1 0.9991021156311035
dominant O 1 0.9999963045120239
cerebellar B-Disease 1 1.0
ataxia I-Disease 1 1.0
type I-Disease 1 0.9999997615814209
I I-Disease 1 0.999983549118042
. O 0 0.0031621831003576517

We O 0 0.003959455993026495
compared O 0 0.0030824183486402035
horizontal O 0 0.06482730060815811
eye O 1 0.8888792991638184
movements O 0 0.0019052430288866162
( O 0 0.0007313582464121282
visually O 0 0.003010983346030116
guided O 0 0.004310629330575466
saccades O 1 0.9960702657699585
, O 0 0.0008905520662665367
antisaccades O 1 0.93132084608078
, O 0 0.0002490812330506742
and O 0 0.00012134212738601491
smooth O 0 0.0008571469807066023
pursuit O 0 0.0028208929579705
) O 0 7.873060530982912e-05
in O 0 5.511286872206256e-05
control O 0 0.0001136018690885976
subjects O 0 0.00013540608051698655
( O 0 9.808050526771694e-05
n O 0 0.00024258854682557285
= O 0 0.00026632979279384017
14 O 0 0.00014725250366609544
) O 0 4.7948211431503296e-05
and O 0 4.465742676984519e-05
patients O 0 4.9877464334713295e-05
with O 0 3.4728680475382134e-05
three O 0 6.312105688266456e-05
forms O 0 0.00023793976288288832
of O 0 0.04810646176338196
autosomal O 1 0.9992679953575134
dominant O 1 0.9999648332595825
cerebellar B-Disease 1 1.0
ataxias I-Disease 1 0.9999997615814209
type I-Disease 1 0.999861478805542
I I-Disease 1 0.9995916485786438
spinocerebellar B-Disease 1 0.9999715089797974
ataxias I-Disease 1 0.9948652386665344
1 I-Disease 0 0.0003206138499081135
and I-Disease 0 7.860771438572556e-05
2 I-Disease 0 0.00020715851860586554
( O 0 0.00013641174882650375
SCA1 B-Disease 0 0.04469851776957512
, O 0 0.0001259187702089548
n O 0 0.00025931053096428514
= O 0 0.0002307919494342059
11 O 0 0.00016224014689214528
; O 0 7.989890582393855e-05
SCA2 B-Disease 0 0.014792105183005333
, O 0 9.881255391519517e-05
n O 0 0.00023216936097014695
= O 0 0.00021180679323151708
10 O 0 0.00010047207615571097
) O 0 6.235681939870119e-05
and O 0 0.00018669976270757616
SCA3 B-Disease 1 0.9999796152114868
/ O 0 0.06781173497438431
Machado B-Disease 1 0.6547625064849854
- I-Disease 0 0.29901978373527527
Joseph I-Disease 1 0.9503229260444641
disease I-Disease 1 0.9999769926071167
( O 0 0.004193694330751896
MJD B-Disease 1 0.9999979734420776
) O 0 0.00034763169242069125
( O 0 0.00020211865194141865
n O 0 0.0004758146242238581
= O 0 0.00047285982873290777
16 O 0 0.0005162565503269434
) O 0 0.00022015857393853366
. O 0 0.00039705014205537736

In O 0 0.007990308105945587
SCA1 B-Disease 1 0.996620774269104
, O 0 0.0015297118807211518
saccade O 0 0.00877081323415041
amplitude O 0 0.001601928728632629
was O 0 0.0008349079871550202
significantly O 0 0.0002756260510068387
increased O 0 0.00016934856830630451
, O 0 0.00010618284431984648
resulting O 0 0.00035711185773834586
in O 0 0.0003028038772754371
hypermetria B-Disease 1 0.9754586815834045
. O 0 0.0011114876251667738

The O 0 0.00711607001721859
smooth O 0 0.011024831794202328
pursuit O 0 0.04781518876552582
gain O 0 0.007090624887496233
was O 0 0.05260968580842018
decreased O 0 0.02265475131571293
. O 0 0.0013435980072245002

In O 0 0.003157973987981677
SCA2 B-Disease 1 0.9983988404273987
, O 0 0.001858208328485489
saccade O 0 0.014263457618653774
velocity O 0 0.003320252289995551
was O 0 0.0055381786078214645
markedly O 0 0.011644632555544376
decreased O 0 0.0059880586341023445
. O 0 0.0013239779509603977

The O 0 0.0014556865207850933
percentage O 0 0.0007373586413450539
of O 0 0.0005613145185634494
errors O 0 0.0016717948019504547
in O 0 0.0007798117585480213
antisaccades O 1 0.9998359680175781
was O 0 0.26021429896354675
greatly O 0 0.0007395953871309757
increased O 0 0.00014250099775381386
and O 0 5.4303087381413206e-05
was O 0 0.0003842767036985606
significantly O 0 0.00011759714834624901
correlated O 0 0.00021732033928856254
with O 0 0.00011900588287971914
age O 0 0.006121072452515364
at O 1 0.9951085448265076
disease O 1 0.999995231628418
onset O 1 0.9999904632568359
. O 0 0.0029971476178616285

In O 0 0.0010346653871238232
addition O 0 0.0003288584703113884
, O 0 0.0001397675514454022
a O 0 0.00023258899454958737
correlation O 0 0.00020539076649583876
between O 0 0.00021417038806248456
smooth O 0 0.001405712217092514
pursuit O 0 0.0033314053434878588
gain O 0 0.00035157398087903857
and O 0 6.621637294301763e-05
the O 0 8.278243331005797e-05
number O 0 4.534175241133198e-05
of O 0 0.0002030370815191418
trinucleotide O 1 0.9217934608459473
repeats O 0 0.0011829891009256244
was O 0 0.001074117491953075
found O 0 0.0004611597105395049
. O 0 0.0005213333060964942

In O 0 0.009674984961748123
SCA3 B-Disease 1 0.9999973773956299
, O 0 0.0042971963994205
gaze B-Disease 1 0.9944292306900024
- I-Disease 1 0.9700846076011658
evoked I-Disease 1 0.9982247948646545
nystagmus I-Disease 1 0.9980683922767639
was O 0 0.0023327930830419064
often O 0 0.00011193088721483946
present O 0 0.00019884649373125285
as O 0 0.0002817010972648859
was O 0 0.0027223804499953985
saccade O 0 0.1888258159160614
hypometria O 1 0.8246131539344788
and O 0 0.0004561058303806931
smooth O 0 0.0015152898849919438
pursuit O 0 0.011582416482269764
gain O 0 0.0017581022111698985
was O 0 0.009442964568734169
markedly O 0 0.011943845078349113
decreased O 0 0.004580993205308914
. O 0 0.0009594726725481451

Three O 0 0.0019145783735439181
major O 0 0.0024865842424333096
criteria O 0 0.0007445346564054489
, O 0 0.0005166091723367572
saccade O 0 0.007643877528607845
amplitude O 0 0.001178800011985004
, O 0 0.00031322738504968584
saccade O 0 0.0025040856562554836
velocity O 0 0.0005166481714695692
, O 0 9.7426884167362e-05
and O 0 8.013383921934292e-05
presence O 0 0.00021655167802236974
of O 0 0.0004899337072856724
gaze B-Disease 1 0.9050162434577942
- I-Disease 1 0.5388661026954651
evoked I-Disease 1 0.9298675656318665
nystagmus I-Disease 0 0.16227713227272034
, O 0 0.00013760110596194863
permitted O 0 0.00011223452020203695
the O 0 8.910139149520546e-05
correct O 0 0.00017327228852082044
assignment O 0 0.00016165889974217862
of O 0 7.615880895173177e-05
90 O 0 8.410784357693046e-05
% O 0 2.7908183255931363e-05
of O 0 8.817846537567675e-05
the O 0 0.00024673601728864014
SCA1 B-Disease 1 0.9383370280265808
, O 0 7.965842087287456e-05
90 O 0 5.7703462516656145e-05
% O 0 2.169077743019443e-05
of O 0 7.535268377978355e-05
the O 0 0.00024377428053412586
SCA2 B-Disease 1 0.9995686411857605
, O 0 0.0001256417017430067
and O 0 5.625836274703033e-05
93 O 0 0.0001981027889996767
% O 0 5.129897181177512e-05
of O 0 8.651812095195055e-05
the O 0 0.0002613547258079052
patients O 0 0.0002261098998133093
with O 0 0.00011214637197554111
SCA3 B-Disease 1 0.9999988079071045
to O 0 0.0001600788236828521
their O 0 6.450418732129037e-05
genetically O 0 0.00016329581558238715
confirmed O 0 0.00014056720829103142
patient O 0 0.0002060661354335025
group O 0 6.138725439086556e-05
and O 0 4.903936496702954e-05
, O 0 4.8068162868730724e-05
therefore O 0 4.669269037549384e-05
, O 0 4.266845280653797e-05
may O 0 7.394384010694921e-05
help O 0 0.00016121510998345912
orient O 0 0.003392223035916686
diagnoses O 0 0.003389931283891201
of O 0 0.027433518320322037
SCA1 B-Disease 1 0.9999997615814209
, O 0 0.0033992785029113293
SCA2 B-Disease 1 0.9999785423278809
, O 0 0.0003906743077095598
and O 0 0.00020839786157011986
SCA3 B-Disease 1 0.9999771118164062
at O 0 0.0007193632191047072
early O 0 0.0002244189236080274
clinical O 0 0.00033117501880042255
stages O 0 0.0006092776311561465
of O 0 0.0012705763801932335
the O 1 0.6690784096717834
diseases O 1 0.9999771118164062
. O 0 0.0004880650667473674
. O 0 0.0005337928305380046

Genetic O 0 0.0022516543976962566
basis O 0 0.0005656157736666501
and O 0 0.00037163510569371283
molecular O 0 0.006624940782785416
mechanism O 1 0.9164407849311829
for O 1 0.9843425750732422
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
. O 1 0.980549156665802

Ventricular B-Disease 1 0.9999998807907104
fibrillation I-Disease 1 0.9999996423721313
causes O 1 0.9902385473251343
more O 0 0.00018059415742754936
than O 0 0.00010562801617197692
300 O 0 0.0001724396279314533
, O 0 5.637296271743253e-05
000 O 0 0.0002842866815626621
sudden O 0 0.0005462051485665143
deaths O 0 0.00016196933574974537
each O 0 2.0083578419871628e-05
year O 0 6.114753341535106e-05
in O 0 3.758329330594279e-05
the O 0 0.00021428476611617953
USA O 0 0.001607546117156744
alone O 0 0.0006384303560480475
. O 0 0.000677936477586627

In O 0 0.0006359792896546423
approximately O 0 0.0004043388762511313
5 O 0 0.00028934533474966884
- O 0 0.0002517156535759568
12 O 0 9.142230555880815e-05
% O 0 2.6019984943559393e-05
of O 0 5.7747831306187436e-05
these O 0 2.0084537027287297e-05
cases O 0 2.6164530936512165e-05
, O 0 2.6946163416141644e-05
there O 0 4.3051022657891735e-05
are O 0 1.8524575352785178e-05
no O 0 0.0001414468279108405
demonstrable O 1 0.9991998076438904
cardiac O 1 0.9999980926513672
or O 1 0.6658728718757629
non O 1 0.9991710186004639
- O 1 0.9999520778656006
cardiac O 1 0.9999966621398926
causes O 0 0.025418007746338844
to O 0 5.387183409766294e-05
account O 0 2.3425160179613158e-05
for O 0 1.8576638467493467e-05
the O 0 7.496321632061154e-05
episode O 0 0.00038848011172376573
, O 0 4.378185622044839e-05
which O 0 2.85930436803028e-05
is O 0 6.202654185472056e-05
therefore O 0 0.00010872591519728303
classified O 0 0.0008939424296841025
as O 1 0.5183761715888977
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
( O 1 0.9999899864196777
IVF B-Disease 1 0.9999964237213135
) O 0 0.0013718106783926487
. O 0 0.0010734510142356157

A O 0 0.0040667373687028885
distinct O 0 0.0006269367877393961
group O 0 0.0006477250135503709
of O 0 0.31853583455085754
IVF B-Disease 1 0.9999995231628418
patients O 0 0.01351581234484911
has O 0 0.00011061074474127963
been O 0 4.660950435209088e-05
found O 0 3.172815195284784e-05
to O 0 2.420846067252569e-05
present O 0 7.025903323665261e-05
with O 0 5.4749223636463284e-05
a O 0 0.0005370963481254876
characteristic O 0 0.07227352261543274
electrocardiographic O 1 0.9998646974563599
pattern O 0 0.17235073447227478
. O 0 0.0013822561595588923

Because O 0 0.0006972000701352954
of O 0 0.00044708437053486705
the O 0 0.00030413854983635247
small O 0 0.00013701818534173071
size O 0 0.0001099504588637501
of O 0 0.00012390592019073665
most O 0 7.114222535165027e-05
pedigrees O 0 0.00035755441058427095
and O 0 5.9886384406127036e-05
the O 0 0.00016064642113633454
high O 0 0.001230478985235095
incidence O 0 0.0385124646127224
of O 0 0.008864181116223335
sudden B-Disease 1 0.999955415725708
death I-Disease 1 0.9596002101898193
, O 0 8.764346421230584e-05
however O 0 2.9357755920500495e-05
, O 0 2.714770926104393e-05
molecular O 0 6.672333256574348e-05
genetic O 0 5.95712881477084e-05
studies O 0 4.022835855721496e-05
of O 0 0.00043951303814537823
IVF B-Disease 1 0.9998571872711182
have O 0 4.124113547732122e-05
not O 0 2.7965112167294137e-05
yet O 0 8.661999163450673e-05
been O 0 0.00011605548206716776
done O 0 0.00035219526034779847
. O 0 0.00047243182780221105

Because O 1 0.9295759797096252
IVF B-Disease 1 0.9999991655349731
causes O 1 0.9999984502792358
cardiac O 1 1.0
rhythm O 1 0.9999998807907104
disturbance O 1 0.9999994039535522
, O 0 0.0011910644825547934
we O 0 0.00018081330927088857
investigated O 0 0.00045718622277490795
whether O 0 0.00012483417231123894
malfunction O 0 0.4001317024230957
of O 0 0.0005080390255898237
ion O 0 0.0023991488851606846
channels O 0 0.00017645282787270844
could O 0 0.00014228226791601628
cause O 0 0.009732689708471298
the O 0 0.0011365868849679828
disorder O 1 0.999919056892395
by O 0 0.00012319025699980557
studying O 0 0.0002683715138118714
mutations O 0 0.00014092877972871065
in O 0 0.0001053527812473476
the O 0 0.00042566764750517905
cardiac O 1 0.9990092515945435
sodium O 0 0.004413701128214598
channel O 0 0.0012389358598738909
gene O 0 0.0013104629470035434
SCN5A O 1 0.9290054440498352
. O 0 0.0014039836823940277

We O 0 0.000830153760034591
have O 0 0.00010523149830987677
now O 0 0.00012628115655388683
identified O 0 0.00013633813068736345
a O 0 0.00023432499438058585
missense O 0 0.0013834242708981037
mutation O 0 0.00034767595934681594
, O 0 0.00011425925185903907
a O 0 0.00020947123994119465
splice O 0 0.0045510511845350266
- O 0 0.001786623033694923
donor O 0 0.00047040742356330156
mutation O 0 0.0002578725980129093
, O 0 6.860607390990481e-05
and O 0 8.029033051570877e-05
a O 0 0.00019427668303251266
frameshift O 0 0.0021528045181185007
mutation O 0 0.00013191034668125212
in O 0 7.88210381870158e-05
the O 0 0.00014457947690971196
coding O 0 0.0003979383618570864
region O 0 0.00021521640883293003
of O 0 0.00031753903022035956
SCN5A O 1 0.9996371269226074
in O 0 0.0005948653561063111
three O 0 0.0005791368312202394
IVF B-Disease 1 0.924462616443634
families O 0 0.0007094606989994645
. O 0 0.0009658889030106366

We O 0 0.001373720820993185
show O 0 0.0008298037573695183
that O 0 0.00012994495045859367
sodium O 0 0.00029730211826972663
channels O 0 6.457348354160786e-05
with O 0 4.7052428271854296e-05
the O 0 0.00024276183103211224
missense O 0 0.0014991816133260727
mutation O 0 0.00038309599040076137
recover O 0 0.0011554290540516376
from O 0 0.00013649227912537754
inactivation O 0 0.005509817507117987
more O 0 7.092789746820927e-05
rapidly O 0 0.0002752685977611691
than O 0 4.311684097046964e-05
normal O 0 0.00011163113958900794
and O 0 3.48971298080869e-05
that O 0 3.0944993341108784e-05
the O 0 0.00012923686881549656
frameshift O 0 0.004249253310263157
mutation O 0 0.0002130591165041551
causes O 0 0.0003152370045427233
the O 0 0.00018818944226950407
sodium O 0 0.00039324595127254725
channel O 0 0.00012859604612458497
to O 0 4.4393666030373424e-05
be O 0 6.01138781348709e-05
non O 0 0.000274805526714772
- O 0 0.0007765330956317484
functional O 0 0.0009003385785035789
. O 0 0.0008574180537834764

Our O 0 0.00244280812330544
results O 0 0.00042306166142225266
indicate O 0 0.0003501921019051224
that O 0 9.38654993660748e-05
mutations O 0 0.00020686874631792307
in O 0 0.00022625505516771227
cardiac O 1 0.9998849630355835
ion O 0 0.09638681262731552
- O 0 0.0016062931390479207
channel O 0 0.0001420314802089706
genes O 0 3.853907765005715e-05
contribute O 0 5.33578495378606e-05
to O 0 2.6035970222437754e-05
the O 0 9.870048961602151e-05
risk O 0 0.0001905273529700935
of O 0 0.0008596391417086124
developing O 1 0.5065832734107971
IVF B-Disease 1 0.9999438524246216
. O 0 0.0007824579952284694
. O 0 0.0007122287061065435

Molecular O 0 0.011590453796088696
heterogeneity O 0 0.00945554580539465
in O 0 0.001935266423970461
mucopolysaccharidosis B-Disease 1 0.9997873902320862
IVA I-Disease 1 0.9998730421066284
in O 0 0.00045754353050142527
Australia O 0 0.00022156337217893451
and O 0 7.02138859196566e-05
Northern O 0 0.00022057921160012484
Ireland O 0 0.00023772001441102475
: O 0 8.287990203825757e-05
nine O 0 0.0001393947604810819
novel O 0 0.00020451821910683066
mutations O 0 0.00017666493658907712
including O 0 0.00012213090667501092
T312S O 1 0.9349441528320312
, O 0 0.00019377921125851572
a O 0 0.00024238391779363155
common O 0 0.00020107891759835184
allele O 0 0.00022664993593934923
that O 0 8.267608063761145e-05
confers O 0 0.0013530574506148696
a O 0 0.0019217508379369974
mild O 1 0.9850642085075378
phenotype O 0 0.03681834414601326
. O 0 0.001280099037103355

Mucopolysaccharidosis B-Disease 1 0.9999701976776123
IVA I-Disease 1 0.9999960660934448
( O 1 0.898029625415802
MPS B-Disease 1 0.9998273849487305
IVA I-Disease 1 0.999998927116394
) O 0 0.0010069122072309256
is O 0 0.0003915444831363857
an O 0 0.0007513703894801438
autosomal B-Disease 1 0.9987987279891968
recessive I-Disease 1 0.9999983310699463
lysosomal I-Disease 1 1.0
storage I-Disease 1 1.0
disorder I-Disease 1 1.0
caused O 1 0.9999985694885254
by O 0 0.0037222106475383043
a O 0 0.03513851389288902
genetic B-Disease 1 0.6663959622383118
defect I-Disease 1 0.9998953342437744
in O 0 0.00043441986781544983
N O 0 0.007066796068102121
- O 0 0.0019148909486830235
acetylgalactosamine O 0 0.4740656912326813
- O 0 0.0017445990815758705
6 O 0 0.0014973246725276113
- O 0 0.0033161600586026907
sulfate O 1 0.9557215571403503
sulfatase O 1 0.9993894100189209
( O 0 0.0031514992006123066
GALNS O 1 0.9998262524604797
) O 0 0.0008539666887372732
. O 0 0.0008987057954072952

Previous O 0 0.002313978737220168
studies O 0 0.0004693974042311311
of O 0 0.000563296431209892
patients O 0 0.00034405881888233125
from O 0 0.0001343665790045634
a O 0 0.00040279689710587263
British O 0 0.001662099501118064
- O 0 0.000688800704665482
Irish O 0 0.0004357208381406963
population O 0 6.487264909083024e-05
showed O 0 0.00010126647975994274
that O 0 3.741864566109143e-05
the O 0 0.00013959042553324252
I113F O 1 0.7176276445388794
mutation O 0 0.00016440746549051255
is O 0 5.439020605990663e-05
the O 0 6.802678399253637e-05
most O 0 5.801265797344968e-05
common O 0 7.606887811562046e-05
single O 0 0.00016982380475383252
mutation O 0 0.00032122820266522467
among O 0 0.0005214856355451047
MPS B-Disease 1 0.9998373985290527
IVA I-Disease 1 1.0
patients O 0 0.44802728295326233
and O 0 0.0005654260166920722
produces O 0 0.002594877267256379
a O 0 0.012293975800275803
severe O 1 0.9999918937683105
clinical O 1 0.9989824891090393
phenotype O 1 0.9865966439247131
. O 0 0.0016061378410086036

We O 0 0.0010111805750057101
studied O 0 0.0007651256746612489
mutations O 0 0.00019068839901592582
in O 0 9.850510832620785e-05
the O 0 0.0003219008503947407
GALNS O 1 0.9994912147521973
gene O 0 0.0001707459014141932
from O 0 0.0001109369404730387
23 O 0 0.0002799410140141845
additional O 0 0.0002589391660876572
MPS B-Disease 1 0.6003383994102478
IVA I-Disease 1 0.9999958276748657
patients O 0 0.0005324246594682336
( O 0 9.780517575563863e-05
15 O 0 8.893374615581706e-05
from O 0 5.619552393909544e-05
Australia O 0 8.246129436884075e-05
, O 0 3.211307557648979e-05
8 O 0 7.840722537366673e-05
from O 0 5.1956125389551744e-05
Northern O 0 0.00014004104014020413
Ireland O 0 0.00020010255684610456
) O 0 4.154226917307824e-05
, O 0 4.009301119367592e-05
with O 0 3.6311383155407384e-05
various O 0 7.309455395443365e-05
clinical O 0 0.004982832819223404
phenotypes O 1 0.5618399977684021
( O 0 0.0031628385186195374
severe O 1 0.999869704246521
, O 0 0.00015042275481391698
16 O 0 0.00015987077495083213
cases O 0 4.676908065448515e-05
; O 0 2.739456613198854e-05
intermediate O 0 0.0002179010771214962
, O 0 3.827011096291244e-05
4 O 0 0.00010650105832610279
cases O 0 8.144885214278474e-05
; O 0 6.088081863708794e-05
mild O 0 0.0007207837770693004
, O 0 0.00010305688920198008
3 O 0 0.0002249077515443787
cases O 0 0.000182006842806004
) O 0 0.00022082205396145582
. O 0 0.0004366595530882478

We O 0 0.001002043136395514
found O 0 0.00024213630240410566
two O 0 9.274018520954996e-05
common O 0 0.00015615587471984327
mutations O 0 0.00011134772648802027
that O 0 2.5497069145785645e-05
together O 0 4.251776044839062e-05
accounted O 0 7.31107356841676e-05
for O 0 2.188628241128754e-05
32 O 0 5.489916293299757e-05
% O 0 2.08025194297079e-05
of O 0 6.31845323368907e-05
the O 0 0.00016306959150824696
44 O 0 0.00036445105797611177
unrelated O 0 0.0005337258917279541
alleles O 0 0.0003541497571859509
in O 0 0.00025162880774587393
these O 0 0.0002464682038407773
patients O 0 0.0007251020870171487
. O 0 0.0006870688521303236

One O 0 0.0011709955288097262
is O 0 0.0003888052306137979
the O 0 0.0006067767972126603
T312S O 1 0.9961488246917725
mutation O 0 0.0005800474318675697
, O 0 0.0001584489073138684
a O 0 0.0002665152424015105
novel O 0 0.0005913377390243113
mutation O 0 0.00025805464247241616
found O 0 0.0001369803212583065
exclusively O 0 0.00022232752235140651
in O 0 0.0002519420813769102
milder O 0 0.003985435701906681
patients O 0 0.0016429424285888672
. O 0 0.000669183034915477

The O 0 0.0019513345323503017
other O 0 0.0002741411153692752
is O 0 0.00017790398851502687
the O 0 0.00026490859454497695
previously O 0 0.00042463577119633555
described O 0 0.000812805665191263
I113F O 1 0.9125730395317078
that O 0 0.0003185903769917786
produces O 0 0.000805796415079385
a O 0 0.0021198331378400326
severe O 1 0.999884843826294
phenotype O 1 0.810794472694397
. O 0 0.0021366714499890804

The O 0 0.007515779696404934
I113F O 1 0.9372255206108093
and O 0 0.0011573914671316743
T312S O 1 0.7309213280677795
mutations O 0 0.00036136258859187365
accounted O 0 0.00031404310720972717
for O 0 4.446179445949383e-05
8 O 0 0.00011896004434674978
( O 0 4.763020115206018e-05
18 O 0 7.41805779398419e-05
% O 0 3.570749322534539e-05
) O 0 2.4916947950259782e-05
and O 0 2.8542865038616583e-05
6 O 0 0.00010133458999916911
( O 0 4.934597745887004e-05
14 O 0 8.539909322280437e-05
% O 0 2.8981194191146642e-05
) O 0 2.9907600037404336e-05
of O 0 0.0001178072634502314
44 O 0 0.0002985615865327418
unrelated O 0 0.0005386141128838062
alleles O 0 0.0005552287911996245
, O 0 0.0002657200675457716
respectively O 0 0.000928802415728569
. O 0 0.000557287537958473

The O 0 0.003415571292862296
relatively O 0 0.0017934631323441863
high O 0 0.001880139228887856
residual O 0 0.09689527004957199
GALNS O 1 0.9998089671134949
activity O 0 0.0008957530371844769
seen O 0 0.0003636673791334033
when O 0 0.00011680635361699387
the O 0 0.0002784312528092414
T312S O 0 0.023684851825237274
mutant O 0 0.0016296189278364182
cDNA O 0 0.001162789762020111
is O 0 0.0001797684672055766
overexpressed O 0 0.0016787113854661584
in O 0 0.00020241043239366263
mutant O 0 0.0015008964110165834
cells O 0 0.0002432240144116804
provides O 0 5.140768917044625e-05
an O 0 4.520907532423735e-05
explanation O 0 0.00014114960504230112
for O 0 7.090260623954237e-05
the O 0 0.0003996412851847708
mild O 1 0.8693810105323792
phenotype O 0 0.00360347842797637
in O 0 0.0003188799601048231
patients O 0 0.0002853100304491818
with O 0 8.953732321970165e-05
this O 0 0.00025476558948867023
mutation O 0 0.0007438597967848182
. O 0 0.0006075507262721658

The O 0 0.0020771408453583717
distribution O 0 0.0006452601519413292
and O 0 0.00015045619511511177
relative O 0 0.00030740321381017566
frequencies O 0 0.00013175825006328523
of O 0 0.0001842896017478779
the O 0 0.0004486612742766738
I113F O 1 0.9841355681419373
and O 0 0.000386379542760551
T312S O 1 0.8562734723091125
mutations O 0 0.0001627163728699088
in O 0 5.917721500736661e-05
Australia O 0 0.00011376231850590557
corresponded O 0 0.0001261205179616809
to O 0 2.89242307189852e-05
those O 0 2.100303754559718e-05
observed O 0 4.44121214968618e-05
in O 0 3.7179470382397994e-05
Northern O 0 0.00016349679208360612
Ireland O 0 0.00013145529374014586
and O 0 3.766006921068765e-05
are O 0 1.006860111374408e-05
unique O 0 2.1630748960888013e-05
to O 0 1.743399116094224e-05
these O 0 1.222627906827256e-05
two O 0 1.8139053281629458e-05
populations O 0 2.5800642106332816e-05
, O 0 2.25339645112399e-05
suggesting O 0 7.220295810839161e-05
that O 0 1.975046870938968e-05
both O 0 3.1024184863781556e-05
mutations O 0 4.898154656984843e-05
were O 0 5.20159192092251e-05
probably O 0 0.00014509879110846668
introduced O 0 8.175551192834973e-05
to O 0 2.0015128029626794e-05
Australia O 0 5.592223897110671e-05
by O 0 3.167367322021164e-05
Irish O 0 0.00017746722733136266
migrants O 0 0.00011501429253257811
during O 0 0.00022726903262082487
the O 0 0.00025686167646199465
19th O 0 0.002172002336010337
century O 0 0.0031471371185034513
. O 0 0.0010478812037035823

Haplotype O 0 0.005952626466751099
analysis O 0 0.00035945503623224795
using O 0 0.0002066810557153076
6 O 0 0.0005719240289181471
RFLPs O 0 0.005406391806900501
provides O 0 0.00018975595594383776
additional O 0 0.00010835558350663632
data O 0 3.872083834721707e-05
that O 0 2.9225626349216327e-05
the O 0 0.0001533951290184632
I113F O 0 0.07421917468309402
mutation O 0 0.0002773304586298764
originated O 0 0.00039125775219872594
from O 0 0.00013892818242311478
a O 0 0.0003226034459657967
common O 0 0.00046101241605356336
ancestor O 0 0.00400230148807168
. O 0 0.0016001140465959907

The O 0 0.0013509863056242466
other O 0 0.00024014206428546458
9 O 0 0.0007422839989885688
novel O 0 0.00046735742944292724
mutations O 0 0.00016341297305189073
identified O 0 8.423924737144262e-05
in O 0 6.626905087614432e-05
these O 0 3.640479553723708e-05
23 O 0 0.0003064516349695623
patients O 0 0.00013064865197520703
were O 0 4.4537919166032225e-05
each O 0 1.845645601861179e-05
limited O 0 4.076134064234793e-05
to O 0 3.732063851202838e-05
a O 0 0.00018368680321145803
single O 0 0.00032380546326749027
family O 0 0.0006337047088891268
. O 0 0.0005529461777769029

These O 0 0.0005712041165679693
data O 0 0.00022481472115032375
provide O 0 0.0001316334237344563
further O 0 9.894229879137129e-05
evidence O 0 0.00011954077490372583
for O 0 5.377939305617474e-05
extensive O 0 0.0003627683036029339
allelic O 0 0.0032900776714086533
heterogeneity O 0 0.0017650667577981949
in O 0 0.0005525494925677776
MPS B-Disease 1 0.9848430156707764
IVA I-Disease 1 0.9999881982803345
in O 0 0.00043300940888002515
British O 0 0.005145099945366383
- O 0 0.010247759521007538
Irish O 0 0.0017201064620167017
patients O 0 0.0001661482237977907
and O 0 4.244205047143623e-05
provide O 0 5.382448944146745e-05
evidence O 0 6.835543899796903e-05
for O 0 3.8259022403508425e-05
their O 0 3.7620724469888955e-05
transmission O 0 0.00015835222438909113
to O 0 2.464501085341908e-05
Australia O 0 8.225050987675786e-05
by O 0 4.926764086121693e-05
British O 0 0.0003183744556736201
- O 0 0.000502388458698988
Irish O 0 0.0006050578085705638
migrants O 0 0.0002807642740663141
. O 0 0.00015218037879094481
. O 0 0.00030314933974295855

Identification O 0 0.0022514937445521355
of O 0 0.00237432774156332
constitutional O 0 0.1797807216644287
WT1 O 1 0.9999933242797852
mutations O 0 0.002065887674689293
, O 0 0.00030591944232583046
in O 0 0.00037308729952201247
patients O 0 0.0008695803117007017
with O 0 0.0004613698401954025
isolated O 1 0.9998624324798584
diffuse B-Disease 1 0.9999998807907104
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
, O 0 0.0033389804884791374
and O 0 0.0001615886139916256
analysis O 0 0.00011421219824114814
of O 0 0.00039405631832778454
genotype O 0 0.004344242159277201
/ O 0 0.006995396688580513
phenotype O 0 0.00048763558152131736
correlations O 0 0.00015544251073151827
by O 0 3.675656989798881e-05
use O 0 3.135654696961865e-05
of O 0 8.637220889795572e-05
a O 0 0.000292655429802835
computerized O 0 0.0010706965113058686
mutation O 0 0.000438149378169328
database O 0 0.0003847383486572653
. O 0 0.0004213388601783663

Constitutional O 0 0.004630628041923046
mutations O 0 0.0011743673821911216
of O 0 0.0008075921214185655
the O 0 0.0012789530446752906
WT1 O 1 0.9996765851974487
gene O 0 0.0002723100478760898
, O 0 0.0001021761418087408
encoding O 0 0.00013501272769644856
a O 0 0.0002972017682623118
zinc O 1 0.9768914580345154
- O 0 0.0020460588857531548
finger O 0 0.006115928292274475
transcription O 0 0.0016280373092740774
factor O 0 0.0009105530916713178
involved O 0 0.0007419882458634675
in O 0 0.008236530236899853
renal O 1 1.0
and O 1 0.8817936778068542
gonadal O 1 0.9999997615814209
development O 1 0.9102453589439392
, O 0 0.00013530103024095297
are O 0 1.6570031220908277e-05
found O 0 4.7795550926821306e-05
in O 0 5.4589381761616096e-05
most O 0 7.221590203698725e-05
patients O 0 0.0001985768903978169
with O 0 0.00033305134274996817
Denys B-Disease 1 0.9999992847442627
- I-Disease 1 0.9999992847442627
Drash I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9977807402610779
DDS B-Disease 1 0.9999997615814209
) O 0 0.0007781790336593986
, O 0 0.0006707767024636269
or O 0 0.005678450223058462
diffuse B-Disease 1 0.9999772310256958
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
( O 1 0.9999552965164185
DMS B-Disease 1 0.9999996423721313
) O 0 0.0003667318378575146
associated O 0 0.00022414690465666354
with O 0 0.0002200141898356378
pseudohermaphroditism B-Disease 1 0.9999451637268066
and O 0 0.0020002068486064672
/ O 1 0.9876833558082581
or O 1 0.6223827004432678
Wilms B-Disease 1 0.9999998807907104
tumor I-Disease 1 0.9999994039535522
( O 0 0.05659419670701027
WT B-Disease 1 0.9999105930328369
) O 0 0.0018029209459200501
. O 0 0.0013277212856337428

Most O 0 0.0033692840952426195
mutations O 0 0.0036597631406039
in O 0 0.0018674273742362857
DDS B-Disease 1 0.9999850988388062
patients O 0 0.0014911789912730455
lie O 0 0.001369125209748745
in O 0 0.0002996648836415261
exon O 0 0.0013874797150492668
8 O 0 0.00027378040249459445
or O 0 0.0001572295295773074
exon O 0 0.000487939192680642
9 O 0 0.00023239680740516633
, O 0 8.506762969773263e-05
encoding O 0 0.00016381374734919518
zinc O 0 0.00302108027972281
finger O 0 0.0019074033480137587
2 O 0 0.000443501427071169
or O 0 0.00023493079061154276
zinc O 1 0.9628793597221375
finger O 0 0.007985509000718594
3 O 0 0.00021320930682122707
, O 0 6.7030472564511e-05
respectively O 0 5.401644011726603e-05
, O 0 2.6394292945042253e-05
with O 0 1.9627519577625208e-05
a O 0 0.0001029820487019606
hot O 0 0.000877448997925967
spot O 0 0.001095685875043273
( O 0 0.00029126950539648533
R394W O 0 0.0031418874859809875
) O 0 0.00012783400597982109
in O 0 0.00020086430595256388
exon O 0 0.001912937848828733
9 O 0 0.001312325126491487
. O 0 0.0007777116261422634

We O 0 0.0005323906661942601
analyzed O 0 0.0002073727227980271
a O 0 0.00011942091077798977
series O 0 0.00012011436047032475
of O 0 0.00011369767889846116
24 O 0 0.0005548462504521012
patients O 0 0.0001735500991344452
, O 0 5.126845644554123e-05
10 O 0 8.864798292052001e-05
with O 0 8.903234265744686e-05
isolated B-Disease 0 0.03875063359737396
DMS I-Disease 1 0.9999916553497314
( O 0 0.0020214328542351723
IDMS B-Disease 1 0.9997013211250305
) O 0 0.00010908024705713615
, O 0 6.629098788835108e-05
10 O 0 0.00012144838547101244
with O 0 0.00011105377780040726
DDS B-Disease 1 0.9998288154602051
, O 0 0.00021667499095201492
and O 0 0.00012713659089058638
4 O 0 0.000746383098885417
with O 0 0.000912973249796778
urogenital B-Disease 1 0.9999992847442627
abnormalities I-Disease 1 0.999998927116394
and O 1 0.5357905626296997
/ O 1 0.9980693459510803
or O 0 0.05281694978475571
WT B-Disease 1 0.9997702240943909
. O 0 0.001895521185360849

We O 0 0.0026405348908156157
report O 0 0.001974256942048669
WT1 O 1 0.8623780012130737
heterozygous O 0 0.0006699219229631126
mutations O 0 0.00022774496756028384
in O 0 0.00017207629571203142
16 O 0 0.0006073006079532206
patients O 0 0.0002482156560290605
, O 0 8.735359733691439e-05
4 O 0 0.0002247662632726133
of O 0 0.00034439092269167304
whom O 0 0.0006823298172093928
presented O 0 0.0014379640342667699
with O 0 0.001441874774172902
IDMS B-Disease 1 0.9998552799224854
. O 0 0.003369745099917054

One O 0 0.0016581283416599035
male O 0 0.0011669463710859418
and O 0 0.0004623850982170552
two O 0 0.00048228687955997884
female O 1 0.8789721727371216
IDMS B-Disease 1 0.9999991655349731
patients O 1 0.9231423139572144
with O 0 0.16094264388084412
WT1 O 1 0.9999998807907104
mutations O 1 0.8953908681869507
underwent O 1 0.9999895095825195
normal O 1 0.5079053640365601
puberty O 1 0.9902763366699219
. O 0 0.0011881226673722267

Two O 0 0.003172857454046607
mutations O 0 0.0026972098276019096
associated O 0 0.0012076193233951926
with O 0 0.00045091912033967674
IDMS B-Disease 1 0.999810516834259
are O 0 6.232186569832265e-05
different O 0 3.2220897992374375e-05
from O 0 7.956141053000465e-05
those O 0 6.531884719152004e-05
described O 0 0.0005411252495832741
in O 0 0.0021536005660891533
DDS B-Disease 1 0.9999988079071045
patients O 0 0.05412491038441658
. O 0 0.0012042520102113485

No O 0 0.010229408740997314
WT1 O 1 0.9990854263305664
mutations O 0 0.0007807208457961679
were O 0 0.00018136586004402488
detected O 0 0.0002726545790210366
in O 0 9.034256072482094e-05
the O 0 0.0001445410307496786
six O 0 0.00034098117612302303
other O 0 0.0002829139120876789
IDMS B-Disease 1 0.9999974966049194
patients O 0 0.002567407675087452
, O 0 0.00014409187133423984
suggesting O 0 0.00040074458229355514
genetic O 0 0.0003058765723835677
heterogeneity O 0 0.0017709300154820085
of O 0 0.015831170603632927
this O 0 0.011455824598670006
disease O 1 0.9999737739562988
. O 0 0.0012096835998818278

We O 0 0.0017034928314387798
analyzed O 0 0.0015519557055085897
genotype O 0 0.003263272810727358
/ O 0 0.0023927425500005484
phenotype O 0 0.0011208555661141872
correlations O 0 0.000258473475696519
, O 0 4.823571725864895e-05
on O 0 4.015480226371437e-05
the O 0 5.3083484090166166e-05
basis O 0 2.553493504819926e-05
of O 0 6.0728092648787424e-05
the O 0 0.00011495584476506338
constitution O 0 0.00011157071276102215
of O 0 0.000190456717973575
a O 0 0.0003820786077994853
WT1 O 1 0.9816193580627441
mutation O 0 0.00016517186304554343
database O 0 7.182353874668479e-05
of O 0 0.00012319587403908372
84 O 0 0.0021606816444545984
germ O 1 0.9999614953994751
- O 0 0.0684276893734932
line O 0 0.0004837888991460204
mutations O 0 7.25293139112182e-05
, O 0 3.066959834541194e-05
to O 0 2.503795076336246e-05
compare O 0 4.6159912017174065e-05
the O 0 5.1471062761265785e-05
distribution O 0 4.0649818402016535e-05
and O 0 3.862244921037927e-05
type O 0 0.00016013607091736048
of O 0 0.0003161025233566761
mutations O 0 0.00013356140698306262
, O 0 4.951681330567226e-05
according O 0 2.765511453617364e-05
to O 0 3.092646875302307e-05
the O 0 0.000147620405186899
different O 0 0.0001478584745200351
symptoms O 1 0.581861674785614
. O 0 0.0006243129028007388

This O 0 0.0009623702499084175
demonstrated O 0 0.0019449504325166345
( O 0 0.00030410749604925513
1 O 0 0.00030445997253991663
) O 0 9.964979108190164e-05
the O 0 0.0001762028259690851
association O 0 0.0001463945663999766
between O 0 9.783259883988649e-05
mutations O 0 8.773042645771056e-05
in O 0 7.127151911845431e-05
exons O 0 0.00025292744976468384
8 O 0 0.000204827927518636
and O 0 8.031744073377922e-05
9 O 0 0.0002558634150773287
and O 0 0.00013991676678415388
DMS B-Disease 1 0.9902656674385071
; O 0 7.941624062368646e-05
( O 0 0.00010658151586540043
2 O 0 0.00017874788318295032
) O 0 8.969925693236291e-05
among O 0 7.917662151157856e-05
patients O 0 0.00011496437946334481
with O 0 8.572782826377079e-05
DMS B-Disease 1 0.9993590712547302
, O 0 0.0001297363342018798
a O 0 0.00011200177686987445
higher O 0 8.798477938398719e-05
frequency O 0 4.623560016625561e-05
of O 0 5.4551492212340236e-05
exon O 0 0.00036888153408654034
8 O 0 0.0001258778211195022
mutations O 0 0.00010321662557544187
among O 0 7.393277337541804e-05
46 O 0 0.00024904843303374946
, O 0 0.0003074333944823593
XY O 1 0.9931742548942566
patients O 0 0.00039476071833632886
with O 0 0.00010840623144758865
female O 0 0.0008510156185366213
phenotype O 0 0.0004483171214815229
than O 0 5.936497836955823e-05
among O 0 8.278399764094502e-05
46 O 0 0.0003471831150818616
, O 0 0.0002872837649192661
XY O 1 0.9972988963127136
patients O 0 0.0003574238799046725
with O 0 0.00012357636296655983
sexual O 0 0.0006871726945973933
ambiguity O 0 0.011120051145553589
or O 0 0.0017133858054876328
male O 0 0.018319278955459595
phenotype O 0 0.0011383779346942902
; O 0 3.831875801552087e-05
and O 0 4.783366966876201e-05
( O 0 6.451316585298628e-05
3 O 0 8.112104114843532e-05
) O 0 3.495415148790926e-05
statistically O 0 3.9448379538953304e-05
significant O 0 6.33404852123931e-05
evidence O 0 6.31051734671928e-05
that O 0 2.7202031560591422e-05
mutations O 0 6.088900045142509e-05
in O 0 6.965555803617463e-05
exons O 0 0.0002932609640993178
8 O 0 0.00016670441254973412
and O 0 5.850706293131225e-05
9 O 0 0.0002296249003848061
preferentially O 0 0.00025284758885391057
affect O 0 0.0001340203161817044
amino O 0 9.2302929260768e-05
acids O 0 6.547743396367878e-05
with O 0 3.0414972570724785e-05
different O 0 2.9581682611024007e-05
functions O 0 0.00011511742195580155
. O 0 0.00018165644723922014
. O 0 0.00045722941285930574

The O 0 0.008739649318158627
185delAG O 1 0.9951764345169067
BRCA1 O 0 0.4952370226383209
mutation O 0 0.0007658989052288234
originated O 0 0.00041546026477590203
before O 0 0.00017281212785746902
the O 0 0.0001292498200200498
dispersion O 0 0.0003685553674586117
of O 0 0.00012985985085833818
Jews O 0 0.00021125315106473863
in O 0 7.975814514793456e-05
the O 0 0.00012335670180618763
diaspora O 0 0.00015183597861323506
and O 0 5.4461204854305834e-05
is O 0 3.934247433790006e-05
not O 0 2.9127324523869902e-05
limited O 0 7.231741619762033e-05
to O 0 0.0001503126259194687
Ashkenazim O 0 0.004805782809853554
. O 0 0.0009304016712121665

The O 0 0.004700287710875273
185delAG O 1 0.9875301122665405
mutation O 0 0.0021146023645997047
in O 0 0.0005937109817750752
BRCA1 O 0 0.2675463855266571
is O 0 0.00029100748361088336
detected O 0 0.00042984288302250206
in O 0 0.000147831131471321
Ashkenazi O 0 0.0006196319591253996
Jews O 0 0.0002913350472226739
both O 0 0.00011856796481879428
in O 0 0.0004297738487366587
familial B-Disease 1 0.9999916553497314
breast I-Disease 1 1.0
and I-Disease 1 0.9999988079071045
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 0.0008900791290216148
in O 0 0.00021827744785696268
the O 0 0.0002991679357364774
general O 0 0.0007252652430906892
population O 0 0.00026547492598183453
. O 0 0.00048586734919808805

All O 0 0.0027477878611534834
tested O 0 0.003420609515160322
Ashkenazi O 0 0.003974799066781998
mutation O 0 0.0006219708593562245
carriers O 0 0.0002567783812992275
share O 0 0.00010205023136222735
the O 0 0.00019005635112989694
same O 0 0.00018544768681749701
allelic O 0 0.0022378466092050076
pattern O 0 0.002220843220129609
at O 0 0.0020540456753224134
the O 0 0.0021526888012886047
BRCA1 O 1 0.6504178047180176
locus O 0 0.009670504368841648
. O 0 0.002174444729462266

Our O 0 0.002012362703680992
previous O 0 0.0009973039850592613
study O 0 0.00018341133545618504
showed O 0 0.00025147435371764004
that O 0 5.7229110097978264e-05
this O 0 6.33323288639076e-05
Ashkenazi O 0 0.0007169979508034885
mutation O 0 0.00019375333795323968
also O 0 8.719903416931629e-05
occurs O 0 0.00010106274567078799
in O 0 5.106547541799955e-05
Iraqi O 0 0.00029147896566428244
Jews O 0 0.00016717208200134337
with O 0 4.2263003706466407e-05
a O 0 0.0002270712866447866
similar O 0 0.000208289799047634
allelic O 0 0.0048153093084692955
pattern O 0 0.003919700160622597
. O 0 0.0011768568074330688

We O 0 0.0009523794869892299
extended O 0 0.0007129557197913527
our O 0 0.00022012414410710335
analysis O 0 7.173831545514986e-05
to O 0 4.269292185199447e-05
other O 0 4.309439464122988e-05
non O 0 0.0002360403595957905
- O 0 0.00030628949753008783
Ashkenazi O 0 0.000669752829708159
subsets O 0 0.0005855957861058414
354 O 0 0.0009417859837412834
of O 0 0.0003403086157049984
Moroccan O 0 0.0010119949001818895
origin O 0 0.0002601606538519263
, O 0 0.00017676939023658633
200 O 0 0.0004486092657316476
Yemenites O 0 0.004566694609820843
and O 0 0.0002870494208764285
150 O 0 0.0006777804810553789
Iranian O 0 0.0010214400244876742
Jews O 0 0.0013989281142130494
. O 0 0.0011613330570980906

Heteroduplex O 0 0.2164837121963501
analysis O 0 0.0007504638051614165
complemented O 0 0.0011576870456337929
by O 0 0.0001250381174031645
direct O 0 0.00016576857888139784
DNA O 0 0.0004923754604533315
sequencing O 0 0.0005664271302521229
of O 0 0.000439879804616794
abnormally O 0 0.0045413062907755375
migrating O 0 0.0006378607940860093
bands O 0 0.0006906379712745547
were O 0 0.00024981016758829355
employed O 0 0.0009292698232457042
. O 0 0.0005495752557180822

Four O 0 0.0006791116902604699
of O 0 0.0005034869536757469
Moroccan O 0 0.0009334272472187877
origin O 0 0.0001601745461812243
( O 0 8.540869748685509e-05
1 O 0 6.412356742657721e-05
. O 0 2.624922854010947e-05
1 O 0 5.681236871168949e-05
% O 0 3.277523137512617e-05
) O 0 2.0408013369888067e-05
and O 0 3.111790647380985e-05
none O 0 6.129757821327075e-05
of O 0 9.391571074957028e-05
the O 0 0.00019180128583684564
Yemenites O 0 0.10744696855545044
or O 0 0.00011122813157271594
Iranians O 0 0.00026916354545392096
was O 0 0.00021820334950461984
a O 0 0.00012254562170710415
carrier O 0 0.00027186700026504695
of O 0 0.0001907096739159897
the O 0 0.0005301100318320096
185delAG O 1 0.9975937008857727
mutation O 0 0.0025076367892324924
. O 0 0.0007148406002670527

BRCA1 O 1 0.9844016432762146
allelic O 0 0.02848692797124386
patterns O 0 0.0008517863461747766
were O 0 0.00013504980597645044
determined O 0 0.00012225779937580228
for O 0 4.3526579247554764e-05
four O 0 4.354260818217881e-05
of O 0 6.195937748998404e-05
these O 0 1.8214803276350722e-05
individuals O 0 1.284918198507512e-05
and O 0 2.8306167223490775e-05
for O 0 2.285356640641112e-05
12 O 0 9.215728641720489e-05
additional O 0 9.598811448086053e-05
non O 0 0.0002591226948425174
- O 0 0.0005636877031065524
Ashkenazi O 0 0.001152506796643138
185delAG O 0 0.11341153085231781
mutation O 0 0.0006115075666457415
carriers O 0 0.0004027892427984625
who O 0 0.00044519040966406465
had O 1 0.5558896064758301
breast B-Disease 1 0.9999998807907104
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
. O 0 0.010083705186843872

Six O 0 0.0034215105697512627
non O 0 0.0035305223427712917
- O 0 0.0021771311294287443
Ashkenazi O 0 0.0008893661433830857
individuals O 0 0.00010062377259600908
shared O 0 0.00023661970044486225
the O 0 0.0002621858147904277
common O 0 0.0003022838500328362
Ashkenazi O 0 0.003473724937066436
haplotype O 0 0.0008256503497250378
, O 0 9.102537296712399e-05
four O 0 8.474441710859537e-05
had O 0 9.950868115993217e-05
a O 0 0.0001059205096680671
closely O 0 8.559410343877971e-05
related O 0 0.00015943961625453085
pattern O 0 0.0005258321762084961
, O 0 0.00011096867820015177
and O 0 6.831229984527454e-05
the O 0 0.0001464860251871869
rest O 0 0.0002524910669308156
( O 0 9.610883716959506e-05
n O 0 0.0001934284664457664
= O 0 0.00022715616796631366
6 O 0 0.00013757958367932588
) O 0 5.228316877037287e-05
displayed O 0 0.00030000164406374097
a O 0 0.0002212764520663768
distinct O 0 0.0004941734950989485
BRCA1 O 0 0.22573651373386383
allelic O 0 0.045296695083379745
pattern O 0 0.03664759173989296
. O 0 0.0019492119317874312

We O 0 0.0013414595741778612
conclude O 0 0.0015348060987889767
that O 0 0.00016950494318734854
the O 0 0.0005782601074315608
185delAG O 1 0.996971845626831
BRCA1 O 1 0.9549436569213867
mutation O 0 0.00043463046313263476
occurs O 0 0.00015570165123790503
in O 0 5.8908979553962126e-05
some O 0 6.82008612784557e-05
non O 0 0.0002444061101414263
- O 0 0.00043128026300109923
Ashkenazi O 0 0.0005412227474153042
populations O 0 6.134821160230786e-05
at O 0 0.00015892281953711063
rates O 0 4.9321413825964555e-05
comparable O 0 0.00011008189176209271
with O 0 3.76680436602328e-05
that O 0 6.432260852307081e-05
of O 0 0.00048116009566001594
Ashkenazim O 0 0.20718514919281006
. O 0 0.001639945083297789

The O 0 0.0014317142777144909
majority O 0 0.0003871637745760381
of O 0 0.00039942457806319
Jewish O 0 0.0027477319817990065
185delAG O 1 0.9996115565299988
mutation O 0 0.00100901466794312
carriers O 0 0.00037478990270756185
have O 0 4.1801886254688725e-05
a O 0 0.00010229906911263242
common O 0 0.00016684182628523558
allelic O 0 0.002654467709362507
pattern O 0 0.0013341504381969571
, O 0 0.00010982366075040773
supporting O 0 0.000160744326421991
the O 0 0.00023533229250460863
founder O 0 0.022828713059425354
effect O 0 0.00022888784587848932
notion O 0 0.00023010486620478332
, O 0 4.3609386921161786e-05
but O 0 2.433883310004603e-05
dating O 0 0.0001224356092279777
the O 0 7.236784585984424e-05
mutations O 0 3.155741796945222e-05
origin O 0 2.6933574190479703e-05
to O 0 1.5848685507080518e-05
an O 0 3.1945230148267e-05
earlier O 0 9.61951955105178e-05
date O 0 9.445109026273713e-05
than O 0 5.431655154097825e-05
currently O 0 0.00013240017869975418
estimated O 0 0.0003507855290081352
. O 0 0.0004948255373165011

However O 0 0.001114527927711606
, O 0 0.00026445029652677476
the O 0 0.0001496236800448969
different O 0 6.030714575899765e-05
allelic O 0 0.0012771610636264086
pattern O 0 0.0011061871191486716
at O 0 0.0011786691611632705
the O 0 0.000661024241708219
BRCA1 O 0 0.1709846705198288
locus O 0 0.0005155752296559513
even O 0 4.798415830009617e-05
in O 0 3.0469667763100006e-05
some O 0 2.8855796699644998e-05
Jewish O 0 0.00020927441073581576
mutation O 0 0.00019293592777103186
carriers O 0 0.00016482513456139714
, O 0 5.378349669626914e-05
might O 0 5.628691360470839e-05
suggest O 0 5.251246693660505e-05
that O 0 2.8371403459459543e-05
the O 0 0.00012507199426181614
mutation O 0 0.00022210503811948001
arose O 0 0.0005841790116392076
independently O 0 0.00021194719010964036
. O 0 0.00016699047409929335
. O 0 0.00040409283246845007

Crystal O 0 0.19263337552547455
structure O 0 0.0031240228563547134
of O 0 0.002902856795117259
the O 1 0.6290767788887024
hemochromatosis B-Disease 1 1.0
protein O 1 0.7717501521110535
HFE O 1 0.9998281002044678
and O 0 0.0004854127764701843
characterization O 0 0.0010191206820309162
of O 0 0.0003964179486501962
its O 0 0.00021989444212522358
interaction O 0 0.000312994874548167
with O 0 0.0003688537981361151
transferrin O 1 0.9521465301513672
receptor O 0 0.002572180237621069
. O 0 0.000938276934903115

HFE O 1 0.9980631470680237
is O 0 0.0013002000050619245
an O 0 0.0006401097634807229
MHC O 1 0.8762966394424438
- O 0 0.002187068108469248
related O 0 0.0002424264675937593
protein O 0 0.00012578316091094166
that O 0 3.931903120246716e-05
is O 0 5.287058593239635e-05
mutated O 0 0.00020171204232610762
in O 0 0.00011125337186967954
the O 0 0.0033448326867073774
iron B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
overload I-Disease 1 1.0
disease I-Disease 1 1.0
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 1 0.9968568086624146

HFE O 1 0.8965784907341003
binds O 0 0.004788365680724382
to O 0 0.001342647592537105
transferrin O 1 0.9879819750785828
receptor O 0 0.0038661607541143894
( O 0 0.0009840900311246514
TfR O 1 0.7396240830421448
) O 0 0.0001930492726387456
and O 0 0.00011489534517750144
reduces O 0 0.0003106329822912812
its O 0 5.666547076543793e-05
affinity O 0 0.0002542109286878258
for O 0 0.00020740872423630208
iron O 1 0.9999665021896362
- O 0 0.08171367645263672
loaded O 0 0.005209736526012421
transferrin O 1 0.7631945610046387
, O 0 0.0006436019320972264
implicating O 1 0.9944925308227539
HFE O 1 0.9999746084213257
in O 0 0.25267085433006287
iron O 1 0.9999983310699463
metabolism O 1 0.9978152513504028
. O 0 0.0026339213363826275

The O 0 0.006298154126852751
2 O 0 0.006764356512576342
. O 0 0.0029010865837335587

6 O 0 0.010631593875586987
A O 0 0.013656320050358772
crystal O 0 0.32096508145332336
structure O 0 0.003960174508392811
of O 0 0.004654447548091412
HFE O 1 0.9996742010116577
reveals O 0 0.0024423571303486824
the O 0 0.00036613026168197393
locations O 0 0.0003001020522788167
of O 0 0.00886548776179552
hemochromatosis B-Disease 1 1.0
mutations O 0 0.0010365344351157546
and O 0 0.0001926524710142985
a O 0 0.000763474905397743
patch O 1 0.9992530941963196
of O 0 0.018099628388881683
histidines O 1 0.999683141708374
that O 0 6.510710227303207e-05
could O 0 6.445032340707257e-05
be O 0 2.3257658540387638e-05
involved O 0 9.598847827874124e-05
in O 0 0.00023114164650905877
pH O 0 0.009551998227834702
- O 0 0.0015708077698946
dependent O 0 0.0007930505671538413
interactions O 0 0.0007470790296792984
. O 0 0.0005671929684467614

We O 0 0.0021207125391811132
also O 0 0.0007011740235611796
demonstrate O 0 0.001473746495321393
that O 0 0.0003857715055346489
soluble O 0 0.11730921268463135
TfR O 1 0.9975549578666687
and O 0 0.0007862066850066185
HFE O 1 0.9981117248535156
bind O 0 0.0006687278510071337
tightly O 0 0.0003954372077714652
at O 0 0.0003429437638260424
the O 0 0.00015654649178031832
basic O 0 0.00030578355654142797
pH O 0 0.0005193012184463441
of O 0 0.00019652619084808975
the O 0 0.0004646433226298541
cell O 0 0.0009389243205077946
surface O 0 0.0003826483152806759
, O 0 5.60172411496751e-05
but O 0 2.4060054784058593e-05
not O 0 2.1461561118485406e-05
at O 0 0.00015486552729271352
the O 0 0.00027928606141358614
acidic O 0 0.0018439242849126458
pH O 0 0.0018675002502277493
of O 0 0.0014872595202177763
intracellular O 0 0.19692359864711761
vesicles O 0 0.07238844782114029
. O 0 0.0017528997268527746

TfR O 1 0.9932458996772766
HFE O 1 0.991939127445221
stoichiometry O 0 0.013400967232882977
( O 0 0.0006971412803977728
2 O 0 0.0004959257785230875
1 O 0 0.00036357619683258235
) O 0 0.00014619006833527237
differs O 0 0.00029054758488200605
from O 0 0.00019640236860141158
TfR O 0 0.02117059752345085
transferrin O 0 0.008604839444160461
stoichiometry O 0 0.001306399004533887
( O 0 0.00014524011930916458
2 O 0 0.0001595021312823519
2 O 0 0.00014797864423599094
) O 0 4.721383811556734e-05
, O 0 3.307354563730769e-05
implying O 0 0.00012367374438326806
a O 0 4.980250741937198e-05
different O 0 2.5513609216432087e-05
mode O 0 0.0001444297085981816
of O 0 0.0001001352138700895
binding O 0 0.00014065355935599655
for O 0 0.00015414862718898803
HFE O 1 0.9988721013069153
and O 0 0.0004351273237261921
transferrin O 1 0.6216258406639099
to O 0 0.0004215989902149886
TfR O 1 0.8769125938415527
, O 0 0.00018005150195676833
consistent O 0 0.00019307136244606227
with O 0 8.118666301015764e-05
our O 0 0.00018129531235899776
demonstration O 0 0.0019999078940600157
that O 0 0.0001601942494744435
HFE O 1 0.9998351335525513
, O 0 0.00042204896453768015
transferrin O 1 0.7929581999778748
, O 0 0.000207175689865835
and O 0 0.0002683840284589678
TfR O 0 0.376276433467865
form O 0 0.0003491946554277092
a O 0 0.0009651027503423393
ternary O 0 0.042592015117406845
complex O 0 0.013972872868180275
. O 0 0.001363300601951778

Identification O 0 0.0013708437327295542
of O 0 0.0009439163841307163
three O 0 0.0004481386858969927
novel O 0 0.0007674788939766586
mutations O 0 0.0001369358942611143
and O 0 5.500124825630337e-05
a O 0 0.00011999106936855242
high O 0 0.0001674413651926443
frequency O 0 6.764975842088461e-05
of O 0 8.379698556382209e-05
the O 0 0.0002658178855199367
Arg778Leu O 1 0.9944136738777161
mutation O 0 0.0002314581215614453
in O 0 0.00020421872613951564
Korean O 1 0.8594050407409668
patients O 0 0.0029540208633989096
with O 0 0.0007861354970373213
Wilson B-Disease 1 0.9998877048492432
disease I-Disease 1 0.9999761581420898
. O 0 0.0015331818722188473

Four O 0 0.00327604659833014
mutations O 0 0.0035666211042553186
- O 0 0.014230470173060894
- O 0 0.01163554284721613
R778L O 1 0.9905335903167725
, O 0 0.0005457256338559091
A874V O 1 0.9676324725151062
, O 0 0.00036867131711915135
L1083F O 0 0.2101573348045349
, O 0 0.00015363020065706223
and O 0 0.0001326828933088109
2304delC O 0 0.44700589776039124
- O 0 0.0009262025123462081
- O 0 0.0003184245724696666
in O 0 8.815593173494563e-05
the O 0 0.00017886911518871784
copper O 0 0.4423252046108246
- O 0 0.0008477716473862529
transporting O 0 0.0010816719150170684
enzyme O 0 0.00036533092497847974
, O 0 0.00011571856157388538
P O 0 0.0011635664850473404
- O 0 0.000387591018807143
type O 0 0.0006265634438022971
ATPase O 0 0.005282197613269091
( O 0 0.00046426968765445054
ATP7B O 1 0.9974530339241028
) O 0 0.00010568281140876934
, O 0 6.497845606645569e-05
were O 0 3.932645631721243e-05
identified O 0 9.334155038231984e-05
in O 0 0.0001746298949001357
Korean O 1 0.9175082445144653
Patients O 0 0.04322266951203346
with O 0 0.006374413147568703
Wilson B-Disease 1 0.9999707937240601
disease I-Disease 1 0.9999960660934448
. O 0 0.0023783657234162092

Arg778Leu O 1 0.9945914149284363
, O 0 0.0012481308076530695
the O 0 0.00034821793087758124
most O 0 0.00012017015978926793
frequently O 0 0.00012313904881011695
reported O 0 0.00010210960317635909
mutation O 0 6.3056439103093e-05
of O 0 0.00010726216714829206
this O 0 6.708379805786535e-05
enzyme O 0 0.0002061011182377115
, O 0 4.182565680821426e-05
was O 0 0.0001075610562111251
found O 0 2.323068110854365e-05
in O 0 2.23377446673112e-05
six O 0 4.951761366100982e-05
of O 0 0.00010553227184573188
eight O 0 0.00017353818111587316
unrelated O 0 0.0004355881828814745
patients O 0 0.00012000366405118257
studied O 0 0.00013395899441093206
, O 0 6.243179086595774e-05
an O 0 6.76346171530895e-05
allele O 0 0.00014148783520795405
frequency O 0 0.00010184686107095331
of O 0 0.0002724090008996427
37 O 0 0.0008594834362156689
. O 0 0.0005554495146498084

5 O 0 0.0015452668303623796
% O 0 0.00039226911030709743
, O 0 0.00020526470325421542
which O 0 6.546956865349784e-05
is O 0 5.406539639807306e-05
considerably O 0 8.917271043173969e-05
higher O 0 5.011298708268441e-05
than O 0 2.1123438273207285e-05
those O 0 1.4841352822259068e-05
in O 0 4.4511602027341723e-05
other O 0 5.496679659700021e-05
Asian O 0 0.0006411379436030984
populations O 0 0.0002828680444508791
. O 0 0.00041597685776650906

The O 0 0.0020223092287778854
novel O 0 0.0013073786394670606
single O 0 0.0006364185828715563
nucleotide O 0 0.0009481695597060025
deletion O 0 0.0008804720710031688
, O 0 0.00023784766381140798
2304delC O 0 0.09399347752332687
, O 0 0.00016220919496845454
was O 0 0.00036705427919514477
found O 0 8.238049485953525e-05
in O 0 0.00013289181515574455
one O 0 0.0002975499664898962
patient O 0 0.0017236268613487482
. O 0 0.0009907603962346911

Since O 0 0.002589736133813858
a O 0 0.001081988331861794
mutation O 0 0.0005407406133599579
at O 0 0.0006683445535600185
cDNA O 0 0.0018707053968682885
nucleotide O 0 0.001477431389503181
2302 O 0 0.10400578379631042
( O 0 0.00042999431025236845
2302insC O 0 0.007630668580532074
) O 0 9.949369268724695e-05
had O 0 0.00012236183101776987
been O 0 6.045905320206657e-05
previously O 0 7.226736488519236e-05
described O 0 9.060173033503816e-05
, O 0 3.8956699427217245e-05
this O 0 2.273232166771777e-05
region O 0 7.537547207903117e-05
of O 0 0.00020783432410098612
the O 0 0.00394511828199029
ATP7B O 1 0.9999986886978149
gene O 0 0.0008315067389048636
may O 0 0.00016189661982934922
be O 0 6.366537127178162e-05
susceptible O 0 0.00048398031503893435
to O 0 0.00024129603116307408
gene O 0 0.0014785496750846505
rearrangements O 1 0.9989711046218872
causing O 1 0.9999951124191284
Wilson B-Disease 1 0.9999912977218628
disease I-Disease 1 0.9999980926513672
. O 0 0.0023906605783849955

Disruption O 0 0.022582916542887688
of O 0 0.0013322674203664064
splicing O 0 0.0014777409378439188
regulated O 0 0.00037112776772119105
by O 0 0.00012571312254294753
a O 0 0.0004192388732917607
CUG O 1 0.9990087151527405
- O 0 0.0026975548826158047
binding O 0 0.0008117692777886987
protein O 0 0.002019773004576564
in O 0 0.0033037643879652023
myotonic B-Disease 1 0.9999996423721313
dystrophy I-Disease 1 0.9999997615814209
. O 0 0.00995879527181387

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999275207519531
DM B-Disease 1 1.0
) O 0 0.002810030011460185
is O 0 0.00040874446858651936
caused O 0 0.0022286144085228443
by O 0 0.00014349556295201182
a O 0 0.0005533548537641764
CTG O 1 0.5390985012054443
expansion O 0 0.00044727299246005714
in O 0 0.0001014732479234226
the O 0 0.00013148286961950362
3 O 0 0.0002116119721904397
untranslated O 0 0.0010428205132484436
region O 0 0.00027720461366698146
of O 0 0.0003190557472407818
the O 0 0.002594616962596774
DM B-Disease 1 0.9999997615814209
gene O 0 0.002122105797752738
. O 0 0.0008678899612277746

One O 0 0.0034274125937372446
model O 0 0.004108766559511423
of O 0 0.018766270950436592
DM B-Disease 1 0.9999997615814209
pathogenesis O 1 0.9999158382415771
suggests O 0 0.0021179968025535345
that O 0 0.0001502960076322779
RNAs O 0 0.0005304344813339412
from O 0 0.00013193550694268197
the O 0 0.00018101822934113443
expanded O 0 0.00018805831496138126
allele O 0 0.0001192585114040412
create O 0 8.378388884011656e-05
a O 0 0.00010876532905967906
gain O 0 0.00021761163952760398
- O 0 0.00026734796119853854
of O 0 0.00021518724679481238
- O 0 0.0005208118236623704
function O 0 9.635282913222909e-05
mutation O 0 5.6982906244229525e-05
by O 0 2.9043805625406094e-05
the O 0 7.724666647845879e-05
inappropriate O 0 0.00016781890008132905
binding O 0 7.008959073573351e-05
of O 0 8.446012361673638e-05
proteins O 0 8.242466719821095e-05
to O 0 0.00010585549171082675
the O 0 0.0004349488008301705
CUG O 1 0.9984065890312195
repeats O 0 0.00290039274841547
. O 0 0.0007487155380658805

Data O 0 0.0011312098940834403
presented O 0 0.0006458714487962425
here O 0 0.0002864984853658825
indicate O 0 0.0001654504012549296
that O 0 3.622153235482983e-05
the O 0 0.0001278387353522703
conserved O 0 0.0003932830586563796
heterogeneous O 0 0.0017748414538800716
nuclear O 0 0.003989289049059153
ribonucleoprotein O 1 0.9087626338005066
, O 0 0.0003024536417797208
CUG O 1 0.9393141269683838
- O 0 0.0004829192184843123
binding O 0 0.00014487192675005645
protein O 0 0.00036456016823649406
( O 0 0.0003537623560987413
CUG O 1 0.999645471572876
- O 0 0.009976079687476158
BP O 0 0.09836170822381973
) O 0 0.00010119620856130496
, O 0 8.742626960156485e-05
may O 0 8.948447793954983e-05
mediate O 0 0.0003838397387880832
the O 0 0.0003460872685536742
trans O 0 0.003245818428695202
- O 0 0.0008437828510068357
dominant O 0 0.0006006356561556458
effect O 0 0.00024858914548531175
of O 0 0.00024306037812493742
the O 0 0.0006086179637350142
RNA O 0 0.0017108836909756064
. O 0 0.0006501373718492687

CUG O 1 0.9999550580978394
- O 1 0.6976691484451294
BP O 1 0.5334743857383728
was O 0 0.001089919009245932
found O 0 0.00011890945461345837
to O 0 5.761273860116489e-05
bind O 0 0.00018422002904117107
to O 0 8.247812365880236e-05
the O 0 0.00037348002661019564
human O 0 0.04731365665793419
cardiac O 1 0.9999995231628418
troponin O 1 0.9999996423721313
T O 1 0.9999352693557739
( O 0 0.0007680587004870176
cTNT O 0 0.1004544049501419
) O 0 0.00025175214977934957
pre O 0 0.0012860401766374707
- O 0 0.000944992178119719
messenger O 0 0.000900388287845999
RNA O 0 0.00024130709061864763
and O 0 7.082537194946781e-05
regulate O 0 0.00022477353923022747
its O 0 0.0001577798102516681
alternative O 0 0.00040402865852229297
splicing O 0 0.002145430538803339
. O 0 0.0008074328070506454

Splicing O 0 0.009303725324571133
of O 0 0.004585749004036188
cTNT O 1 0.9991298317909241
was O 1 0.8212717771530151
disrupted O 1 0.989098310470581
in O 0 0.11371758580207825
DM B-Disease 1 1.0
striated O 1 0.9999971389770508
muscle O 1 0.999881386756897
and O 0 0.0004890159470960498
in O 0 0.00030302483355626464
normal O 0 0.0006906767375767231
cells O 0 0.00024845334701240063
expressing O 0 0.00025691211340017617
transcripts O 0 0.0003833592345472425
that O 0 0.00012323583359830081
contain O 0 0.0007703122682869434
CUG O 1 0.9936442375183105
repeats O 0 0.0029970447067171335
. O 0 0.0008260800968855619

Altered O 0 0.005659522023051977
expression O 0 0.0008681699982844293
of O 0 0.00043545456719584763
genes O 0 0.0004139828961342573
regulated O 0 0.0004323084722273052
posttranscriptionally O 0 0.4542793929576874
by O 0 0.0005124889430589974
CUG O 1 0.9999867677688599
- O 1 0.6562772989273071
BP O 0 0.2884901762008667
therefore O 0 0.00025998582714237273
may O 0 0.00021964487677905709
contribute O 0 0.00039807113353163004
to O 0 0.0005295408191159368
DM B-Disease 1 0.9999995231628418
pathogenesis O 1 0.9999444484710693
. O 0 0.0011233316035941243
. O 0 0.0011661963071674109

Identification O 0 0.0019970498979091644
of O 0 0.0010914375307038426
a O 0 0.0009336802177131176
novel O 0 0.0013862652704119682
nonsense O 0 0.006783696822822094
mutation O 0 0.00024704268435016274
and O 0 9.292147296946496e-05
a O 0 0.00012748427980113775
missense O 0 0.0006011969526298344
substitution O 0 0.0003501029859762639
in O 0 0.00010675076191546395
the O 0 0.00032593481591902673
vasopressin O 0 0.13132447004318237
- O 0 0.003575865412130952
neurophysin O 1 0.9648786783218384
II O 1 0.9989008903503418
gene O 0 0.00023698320728726685
in O 0 0.00011109859769931063
two O 0 0.00011794595775427297
Spanish O 0 0.000904024695046246
kindreds O 0 0.0066781737841665745
with O 0 0.0014184239553287625
familial B-Disease 1 0.9999923706054688
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 0.999998927116394
. O 0 0.026475900784134865

Familial B-Disease 1 0.9999954700469971
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 0.9999998807907104
( O 1 0.9998441934585571
FNDI B-Disease 1 1.0
) O 0 0.0013909948756918311
is O 0 0.00039139241562224925
an O 0 0.0005366809200495481
autosomal B-Disease 1 0.9951249957084656
dominant I-Disease 1 0.9999986886978149
disease I-Disease 1 1.0
caused O 1 1.0
by O 1 0.9999278783798218
deficiency O 1 1.0
in O 1 0.8055469393730164
the O 1 0.9957312941551208
antidiuretic O 1 0.9999719858169556
hormone O 1 0.9611594080924988
arginine O 0 0.01542197447270155
vasopressin O 0 0.03753681853413582
( O 0 0.0004765524063259363
AVP O 0 0.018714386969804764
) O 0 0.00012572738341987133
encoded O 0 6.58881981507875e-05
by O 0 6.854303501313552e-05
the O 0 0.00040923303458839655
AVP O 1 0.9988446235656738
- O 0 0.07040563970804214
neurophysin O 1 0.999255359172821
II O 1 0.9999839067459106
( O 0 0.008494840934872627
AVP O 1 0.9998248219490051
- O 0 0.03829379379749298
NPII O 1 0.9908084273338318
) O 0 0.00034751323983073235
gene O 0 0.0003867093182634562
on O 0 0.0005161226727068424
chromosome O 0 0.002588137984275818
20p13 O 1 0.6945996284484863
. O 0 0.001840424258261919

In O 0 0.0016101183136925101
this O 0 0.00032700516749173403
study O 0 0.0001497415651101619
, O 0 7.487607217626646e-05
we O 0 3.7086691008880734e-05
analyzed O 0 5.742032954003662e-05
two O 0 3.8127240259200335e-05
families O 0 6.345747533487156e-05
with O 0 0.00010155329800909385
FNDI B-Disease 1 0.9997640252113342
using O 0 0.00017148991173598915
direct O 0 0.00019084574887529016
automated O 0 0.0009059690055437386
fluorescent O 0 0.0013919067569077015
, O 0 0.0001132248726207763
solid O 0 0.0003321922558825463
phase O 0 0.0005937200621701777
, O 0 7.815774733899161e-05
single O 0 9.65773724601604e-05
- O 0 0.00016481694183312356
stranded O 0 0.00031033967388793826
DNA O 0 0.00014807915431447327
sequencing O 0 0.00012495266855694354
of O 0 0.0002377381460973993
PCR O 0 0.001747997011989355
- O 0 0.0013296491233631968
amplified O 0 0.0031775934621691704
AVP O 1 0.9985164999961853
- O 0 0.024383842945098877
NPII O 1 0.9949700236320496
DNA O 0 0.0038203925359994173
. O 0 0.0015014696400612593

In O 0 0.00065152149181813
one O 0 0.0001991681201616302
of O 0 0.0001987714204005897
the O 0 0.00024215754820033908
families O 0 0.00014233980618882924
, O 0 0.00010461008787387982
affected O 0 0.00012884766329079866
individuals O 0 3.329195533297025e-05
presented O 0 0.00016718418919481337
a O 0 0.000199302623514086
novel O 0 0.00028376647969707847
nonsense O 0 0.0007547832210548222
mutation O 0 9.558493184158579e-05
in O 0 4.464878293219954e-05
exon O 0 0.00024927291087806225
3 O 0 5.861691170139238e-05
of O 0 6.719429802615196e-05
the O 0 8.503301069140434e-05
gene O 0 6.325784488581121e-05
, O 0 3.591791391954757e-05
consisting O 0 3.324147837702185e-05
in O 0 4.202171476208605e-05
a O 0 0.00013453196152113378
G O 0 0.0004993141046725214
to O 0 9.149678226094693e-05
T O 0 0.0013604270061478019
transition O 0 0.0005574197275564075
at O 0 0.00040340868872590363
nucleotide O 0 0.000563561508897692
2101 O 0 0.004426097497344017
, O 0 9.826268069446087e-05
which O 0 4.537077620625496e-05
produces O 0 6.0577418480534106e-05
a O 0 9.00530576473102e-05
stop O 0 0.00017094465147238225
signal O 0 0.0002222435869043693
in O 0 0.00010890002158703282
codon O 0 0.0006192988948896527
82 O 0 0.0010368337389081717
( O 0 0.0005231696995906532
Glu O 0 0.029925622045993805
) O 0 0.000388406275305897
of O 0 0.0012247487902641296
NPII O 1 0.9982535243034363
. O 0 0.002451614011079073

The O 0 0.0050947885029017925
premature O 0 0.08353078365325928
termination O 0 0.006704418919980526
eliminates O 0 0.002037250669673085
part O 0 0.00046836421824991703
of O 0 0.0002855489728972316
the O 0 0.0004234972002450377
C O 0 0.002503198804333806
- O 0 0.0005862245452590287
terminal O 0 0.0005566226318478584
domain O 0 0.00014474378258455545
of O 0 0.00021714693866670132
NPII O 1 0.9978576302528381
, O 0 7.74913132772781e-05
including O 0 5.141779183759354e-05
a O 0 9.200028580380604e-05
cysteine O 0 0.00018612509302329272
residue O 0 0.00037031169631518424
in O 0 6.551254045916721e-05
position O 0 0.00012699181388597935
85 O 0 0.00014673305850010365
, O 0 4.328488648752682e-05
which O 0 2.2676333173876628e-05
could O 0 2.0626293917302974e-05
be O 0 1.7858075807453133e-05
involved O 0 4.179080860922113e-05
in O 0 5.3562693210551515e-05
the O 0 0.00015785114374011755
correct O 0 0.0005456827348098159
folding O 0 0.00330680375918746
of O 0 0.000927465851418674
the O 0 0.002660225611180067
prohormone O 1 0.9957519769668579
. O 0 0.0024392735213041306

In O 0 0.0011416994966566563
the O 0 0.0006402586586773396
second O 0 0.0007350388914346695
family O 0 0.00031152451992966235
, O 0 0.00011433348117861897
a O 0 0.00026360349147580564
G279A O 0 0.004559263586997986
substitution O 0 0.00037378116394393146
at O 0 0.00022019489551894367
position O 0 0.00010897056199610233
- O 0 9.539745224174112e-05
1 O 0 4.3266027205390856e-05
of O 0 4.635356162907556e-05
the O 0 8.323298970935866e-05
signal O 0 0.0003641560033429414
peptide O 0 0.00034463198971934617
was O 0 0.00022553092276211828
observed O 0 4.93896659463644e-05
in O 0 5.2241903176764026e-05
all O 0 5.189037256059237e-05
affected O 0 0.0002405118866590783
individuals O 0 0.0001217456956510432
. O 0 0.00042793177999556065

This O 0 0.0017862864769995213
missense O 0 0.006248814053833485
mutation O 0 0.001515932846814394
, O 0 0.0003158467879984528
which O 0 0.0002399571385467425
replaces O 0 0.3968102037906647
Ala O 1 0.980225145816803
with O 0 0.0004858675820287317
Thr O 1 0.9997206330299377
, O 0 0.00030251190764829516
is O 0 0.00014158418343868107
frequent O 0 0.00028956751339137554
among O 0 0.002229347126558423
FNDI B-Disease 1 1.0
patients O 1 0.602567732334137
and O 0 0.00019584959954954684
is O 0 9.34333584154956e-05
thought O 0 0.00011063459533033893
to O 0 4.190374238532968e-05
reduce O 0 8.664395136293024e-05
the O 0 0.00011802573862951249
efficiency O 0 0.0003281169047113508
of O 0 0.00027936618425883353
cleavage O 0 0.0056491573341190815
by O 0 0.0003362612333148718
signal O 0 0.002293851226568222
peptidases O 0 0.00908922404050827
. O 0 0.0005639550508931279
. O 0 0.0007646190351806581

Genetic O 0 0.008871938101947308
heterogeneity O 0 0.009851442649960518
of O 0 0.3089897632598877
Saethre B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999990463256836
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 0.0011622848687693477
due O 0 0.002101181074976921
to O 0 0.0006339637911878526
TWIST O 1 0.9986398816108704
and O 0 0.004197722766548395
FGFR O 1 0.9999935626983643
mutations O 0 0.004085583612322807
. O 0 0.001672144397161901

Thirty O 0 0.013590656220912933
- O 0 0.004399333614856005
two O 0 0.00032996456138789654
unrelated O 0 0.0016421048203483224
patients O 0 0.00027074539684690535
with O 0 0.00010627754818415269
features O 0 0.0003843290905933827
of O 1 0.7665808200836182
Saethre B-Disease 1 1.0
- I-Disease 1 0.9999995231628418
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 0.000577707018237561
a O 0 0.0009423152077943087
common O 0 0.000775656255427748
autosomal B-Disease 0 0.33248406648635864
dominant I-Disease 1 0.9981017708778381
condition I-Disease 1 0.9999394416809082
of O 1 0.9999864101409912
craniosynostosis B-Disease 1 1.0
and O 1 0.9999921321868896
limb B-Disease 1 1.0
anomalies I-Disease 1 0.9999933242797852
, O 0 0.00046780583215877414
were O 0 0.00018990601529367268
screened O 0 0.0002586837799753994
for O 0 6.583846698049456e-05
mutations O 0 0.00011643925245152786
in O 0 0.00018339524103794247
TWIST O 1 0.8608464002609253
, O 0 0.0007279306882992387
FGFR2 O 1 0.9999555349349976
, O 0 0.0007863425998948514
and O 0 0.0009397490648552775
FGFR3 O 1 0.9996587038040161
. O 0 0.0026360242627561092

Nine O 0 0.004937504883855581
novel O 0 0.002467803191393614
and O 0 0.000367393164196983
three O 0 0.00046113328426145017
recurrent O 1 0.9884025454521179
TWIST O 1 0.9996102452278137
mutations O 0 0.0005788292037323117
were O 0 0.00010310103243682534
found O 0 7.781349268043414e-05
in O 0 9.621235221857205e-05
12 O 0 0.00036028146860189736
families O 0 0.0003536881704349071
. O 0 0.0005314582376740873

Seven O 0 0.0015921222511678934
families O 0 0.0003052697575185448
were O 0 0.00012405595043674111
found O 0 8.056260412558913e-05
to O 0 5.4434571211459115e-05
have O 0 6.241779192350805e-05
the O 0 0.00035334815038368106
FGFR3 O 1 0.9999942779541016
P250R O 1 0.9999321699142456
mutation O 0 0.0007273187511600554
, O 0 7.261241262312979e-05
and O 0 3.7687448639189824e-05
one O 0 3.8154921639943495e-05
individual O 0 3.671732702059671e-05
was O 0 0.00019043237261939794
found O 0 5.455076097860001e-05
to O 0 3.431371442275122e-05
have O 0 4.519777940004133e-05
an O 0 0.0001500618818681687
FGFR2 O 1 0.9989761114120483
VV269 O 1 0.9953997731208801
- O 0 0.003343440592288971
270 O 0 0.002757999813184142
deletion O 0 0.0034706820733845234
. O 0 0.0011820641811937094

To O 0 0.000982577446848154
date O 0 0.0009592604474164546
, O 0 0.00023919602972455323
our O 0 0.00023775175213813782
detection O 0 0.0004108159919269383
rate O 0 9.328868327429518e-05
for O 0 5.5410509958164766e-05
TWIST O 0 0.019686514511704445
or O 0 0.00032274468685500324
FGFR O 1 0.9995139837265015
mutations O 0 0.00014451293100137264
is O 0 5.077043897472322e-05
68 O 0 0.00013870818656869233
% O 0 3.936033681384288e-05
in O 0 7.939451461425051e-05
our O 0 0.0004837902670260519
Saethre B-Disease 1 0.9999977350234985
- I-Disease 1 0.9999926090240479
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 1 0.6894522309303284
, O 0 0.00018297361384611577
including O 0 0.00015346051077358425
our O 0 0.00026134224026463926
five O 0 0.0002072960342047736
patients O 0 0.00026687528588809073
elsewhere O 0 0.00022304710000753403
reported O 0 0.0002436153299640864
with O 0 0.00017622766608837992
TWIST O 1 0.9818099737167358
mutations O 0 0.00145726150367409
. O 0 0.0009865452302619815

More O 0 0.0005069040926173329
than O 0 0.00023347373644355685
35 O 0 0.00029267973150126636
different O 0 0.00011963997530983761
TWIST O 0 0.010117575526237488
mutations O 0 0.00020800047786906362
are O 0 4.161209290032275e-05
now O 0 0.0001328296202700585
known O 0 0.00022380480368155986
in O 0 0.00013299600686877966
the O 0 0.0004052433359902352
literature O 0 0.0007654669461771846
. O 0 0.0007306452607735991

The O 0 0.0026836718898266554
most O 0 0.0004014362639281899
common O 0 0.0003670660371426493
phenotypic O 0 0.001011492102406919
features O 0 0.0001996739156311378
, O 0 5.407745993579738e-05
present O 0 4.957615237799473e-05
in O 0 2.313137702003587e-05
more O 0 8.52760422276333e-06
than O 0 1.4303021089290269e-05
a O 0 3.625457247835584e-05
third O 0 0.00010981224477291107
of O 0 9.17964571272023e-05
our O 0 0.00019575140322558582
patients O 0 0.00018694184836931527
with O 0 0.00010674953955458477
TWIST O 1 0.9935328960418701
mutations O 0 0.0003659402427729219
, O 0 0.0001123551992350258
are O 0 6.276307976804674e-05
coronal B-Disease 1 0.9176440238952637
synostosis I-Disease 1 0.998582124710083
, O 0 0.0005707169766537845
brachycephaly B-Disease 1 0.9968733191490173
, O 0 0.0014035473577678204
low B-Disease 0 0.25167790055274963
frontal I-Disease 1 0.9999911785125732
hairline I-Disease 1 1.0
, O 1 0.9975211024284363
facial B-Disease 1 0.9999998807907104
asymmetry I-Disease 1 0.999998927116394
, O 1 0.9843027591705322
ptosis B-Disease 1 0.9999985694885254
, O 0 0.01563451811671257
hypertelorism B-Disease 1 0.9993343949317932
, O 0 0.0007312008528970182
broad B-Disease 0 0.00384350772947073
great I-Disease 1 0.9838162064552307
toes I-Disease 1 0.9991542100906372
, O 0 0.0009347522864118218
and O 0 0.0011395257897675037
clinodactyly B-Disease 1 0.9957636594772339
. O 0 0.0021384127903729677

Significant O 0 0.010741119273006916
intra O 1 0.9529175758361816
- O 0 0.027709675952792168
and O 0 0.0009624802623875439
interfamilial O 1 0.9233567118644714
phenotypic O 0 0.003313652239739895
variability O 0 0.0009066339698620141
is O 0 9.963058982975781e-05
present O 0 0.00014482384722214192
for O 0 9.888400381896645e-05
either O 0 0.00027995355776511133
TWIST O 1 0.8863474130630493
mutations O 0 0.0012426652247086167
or O 0 0.0015827020397409797
FGFR O 1 0.9999655485153198
mutations O 0 0.002171867759898305
. O 0 0.0009535584831610322

The O 0 0.0016174644697457552
overlap O 0 0.0006264030816964805
in O 0 0.0002886986476369202
clinical O 0 0.0005436248029582202
features O 0 0.00015050625370349735
and O 0 7.454698788933456e-05
the O 0 0.00012163440987933427
presence O 0 0.0001296476402785629
, O 0 2.5449264285271056e-05
in O 0 2.6883020836976357e-05
the O 0 4.3245239794487134e-05
same O 0 3.7607889680657536e-05
genes O 0 3.760573599720374e-05
, O 0 2.4653520085848868e-05
of O 0 5.478379171108827e-05
mutations O 0 4.978042488801293e-05
for O 0 2.1601807020488195e-05
more O 0 2.1691934307455085e-05
than O 0 3.615813693613745e-05
one O 0 0.00011361986253177747
craniosynostotic B-Disease 1 0.9044003486633301
condition I-Disease 0 0.04639169201254845
- O 0 0.0005743409274145961
such O 0 9.14829142857343e-05
as O 0 0.0003227015840820968
Saethre B-Disease 1 0.9999443292617798
- I-Disease 1 0.8049519658088684
Chotzen I-Disease 1 0.9996461868286133
, I-Disease 0 0.0006728091975674033
Crouzon I-Disease 1 0.9986929297447205
, I-Disease 0 0.0004993968177586794
and I-Disease 0 0.0007338913273997605
Pfeiffer I-Disease 1 0.9999969005584717
syndromes I-Disease 1 0.9999902248382568
- O 0 0.01612793654203415
support O 0 0.00025294936494901776
the O 0 0.0002663404738996178
hypothesis O 0 0.00028207225841470063
that O 0 7.025729428278282e-05
TWIST O 0 0.009420040063560009
and O 0 0.00015679089119657874
FGFRs O 0 0.20228658616542816
are O 0 4.03322592319455e-05
components O 0 0.00014083150017540902
of O 0 9.248512651538476e-05
the O 0 0.00011991363862762228
same O 0 8.40502034407109e-05
molecular O 0 0.0002342353982385248
pathway O 0 0.00026733725098893046
involved O 0 9.023924940265715e-05
in O 0 5.38578096893616e-05
the O 0 0.00018151705444324762
modulation O 0 0.0008885504794307053
of O 0 0.02814277447760105
craniofacial O 1 1.0
and O 1 0.9963879585266113
limb O 1 0.9999998807907104
development O 1 0.8189663887023926
in O 0 0.0014668088406324387
humans O 0 0.0008495519286952913
. O 0 0.00025402900064364076
. O 0 0.000323026004480198

Mutation O 0 0.002935593482106924
analysis O 0 0.0009017104748636484
of O 0 0.004710497800260782
UBE3A O 1 0.9999984502792358
in O 1 0.9999901056289673
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 1 0.9999924898147583
. O 0 0.14748291671276093

Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9994725584983826
AS B-Disease 1 0.999963641166687
) O 0 0.00043320009717717767
is O 0 0.00019382430764380842
caused O 0 0.021920710802078247
by O 0 0.0003105512587353587
chromosome O 0 0.019373230636119843
15q11 O 1 0.999761164188385
- O 0 0.05158735066652298
q13 O 1 0.5887542963027954
deletions O 0 0.0009967396035790443
of O 0 0.0004437244788277894
maternal O 0 0.00147281214594841
origin O 0 0.000245107599766925
, O 0 0.0001647244207561016
by O 0 0.00021525273041334003
paternal O 0 0.004744404926896095
uniparental B-Disease 1 0.999964714050293
disomy I-Disease 1 0.9999911785125732
( O 0 0.18150320649147034
UPD B-Disease 1 0.999976396560669
) O 0 0.0001806597429094836
15 O 0 0.00020644825417548418
, O 0 0.00013068641419522464
by O 0 0.00019298230472486466
imprinting O 1 0.9973445534706116
defects O 1 0.9999884366989136
, O 0 0.0002980414137709886
and O 0 0.00014847134298179299
by O 0 0.00011889754387084395
mutations O 0 0.00018526635540183634
in O 0 0.0001853112189564854
the O 0 0.0011587765766307712
UBE3A O 1 0.9998764991760254
gene O 0 0.0014957956736907363
. O 0 0.0005945388693362474

UBE3A O 1 0.6383127570152283
encodes O 0 0.005059462506324053
a O 0 0.0023391051217913628
ubiquitin O 0 0.013548173010349274
- O 0 0.002409368986263871
protein O 0 0.0008919328101910651
ligase O 0 0.003646339988335967
and O 0 0.00036721702781505883
shows O 0 0.0010573893086984754
brain O 1 0.8954757452011108
- O 0 0.0012634829618036747
specific O 0 0.00031436962308362126
imprinting O 0 0.00722593255341053
. O 0 0.0010926416143774986

Here O 0 0.003170090029016137
we O 0 0.0007676142267882824
describe O 0 0.001402697991579771
UBE3A O 1 0.9637849926948547
coding O 0 0.002912771189585328
- O 0 0.0016215413343161345
region O 0 0.00039968910277821124
mutations O 0 0.0003438524145167321
detected O 0 0.00036016336525790393
by O 0 8.654535486130044e-05
SSCP O 1 0.7588167190551758
analysis O 0 6.374774966388941e-05
in O 0 7.393594569293782e-05
13 O 0 0.0002660501340869814
AS B-Disease 0 0.0012189686531201005
individuals O 0 0.00016108251293189824
or O 0 0.00025357428239658475
families O 0 0.0004628265160135925
. O 0 0.0007323172758333385

Two O 0 0.0011760343331843615
identical O 0 0.0009783182758837938
de O 0 0.0023353570140898228
novo O 0 0.0038883236702531576
5 O 0 0.0011080153053626418
- O 0 0.0012461879523470998
bp O 0 0.0016528582200407982
duplications O 0 0.0018659880151972175
in O 0 0.00023895349295344204
exon O 0 0.0013379176380112767
16 O 0 0.00039270645356737077
were O 0 0.00025221004034392536
found O 0 0.00039204966742545366
. O 0 0.0006288107251748443

Among O 0 0.001001051627099514
the O 0 0.00037920649629086256
other O 0 9.687474084785208e-05
11 O 0 0.00022374828404281288
unique O 0 0.00019350058573763818
mutations O 0 0.00015943581820465624
, O 0 7.999931403901428e-05
8 O 0 0.00013799396401736885
were O 0 6.773155473638326e-05
small O 0 7.351509702857584e-05
deletions O 0 0.0005484384601004422
or O 0 0.00015149760292842984
insertions O 0 0.0009765257709659636
predicted O 0 0.00042468152241781354
to O 0 0.00010297595144947991
cause O 0 0.001997310435399413
frameshifts O 1 0.7849373817443848
, O 0 0.00012767856242135167
1 O 0 0.0001435848098481074
was O 0 0.000244420807575807
a O 0 9.985143697122112e-05
mutation O 0 6.223622767720371e-05
to O 0 2.7757869247579947e-05
a O 0 8.62831439008005e-05
stop O 0 0.00019889825489372015
codon O 0 0.0002828295109793544
, O 0 4.672316208598204e-05
1 O 0 7.06918362993747e-05
was O 0 0.0001962196984095499
a O 0 0.00018825441657099873
missense O 0 0.0007600818644277751
mutation O 0 0.00017049229063559324
, O 0 4.453019209904596e-05
and O 0 4.5028529711999e-05
1 O 0 0.00010423995991004631
was O 0 0.0002308973780600354
predicted O 0 0.00021888095943722874
to O 0 6.163132638903335e-05
cause O 0 0.0003069568774662912
insertion O 0 0.00041570051689632237
of O 0 0.00022719409025739878
an O 0 0.0002223656774731353
isoleucine O 0 0.006720187608152628
in O 0 9.764610877027735e-05
the O 0 0.00012034698738716543
hect O 0 0.0017995291855186224
domain O 0 0.00011316832387819886
of O 0 0.0001473717566113919
the O 0 0.0003868284111376852
UBE3A O 1 0.9977213740348816
protein O 0 0.0002625693450681865
, O 0 7.367342186626047e-05
which O 0 4.5602235331898555e-05
functions O 0 7.076797919580713e-05
in O 0 9.378246613778174e-05
E2 O 0 0.009150605648756027
binding O 0 0.00029776134761050344
and O 0 0.00021920471044722944
ubiquitin O 0 0.0026841035578399897
transfer O 0 0.0009625164675526321
. O 0 0.0005142922163940966

Eight O 0 0.0015468185301870108
of O 0 0.0005587682244367898
the O 0 0.000502286886330694
cases O 0 0.0002283979847561568
were O 0 0.0002310964628122747
familial O 0 0.12590157985687256
, O 0 0.0002303384244441986
and O 0 0.00019718107068911195
five O 0 0.00030781698296777904
were O 0 0.00031761746504344046
sporadic O 0 0.0027048715855926275
. O 0 0.0008350774878636003

In O 0 0.0014073477359488606
two O 0 0.0005838758079335093
familial O 0 0.014980470761656761
cases O 0 0.0004433217109180987
and O 0 0.0002599575964268297
one O 0 0.00028209216543473303
sporadic O 0 0.002382809529080987
case O 0 0.0008365868125110865
, O 0 0.0003737640508916229
mosaicism O 1 0.9473915100097656
for O 0 0.00034433018299750984
UBE3A O 1 0.9996888637542725
mutations O 0 0.0003980931069236249
was O 0 0.0004479315539356321
detected O 0 0.00012070302909705788
in O 0 3.435923281358555e-05
the O 0 5.660984243149869e-05
mother O 0 0.00011800423089880496
of O 0 7.484950765501708e-05
three O 0 7.485507376259193e-05
AS B-Disease 0 0.04588335007429123
sons O 0 0.0007624191348440945
, O 0 5.167802737560123e-05
in O 0 4.1181086999131367e-05
the O 0 0.0001209235197165981
maternal O 0 0.0007414178689941764
grandfather O 0 0.0021573377307504416
of O 0 0.00020450007286854088
two O 0 0.00011584728781599551
AS B-Disease 0 0.06479258835315704
first O 0 0.00027002260321751237
cousins O 0 0.0003202896914444864
, O 0 3.700667730299756e-05
and O 0 3.076515349675901e-05
in O 0 3.915073466487229e-05
the O 0 0.00012422690633684397
mother O 0 0.00026447250274941325
of O 0 0.00031836627749726176
an O 0 0.0006192894652485847
AS B-Disease 1 0.9845927357673645
daughter O 0 0.21918009221553802
. O 0 0.0009265471599064767

The O 0 0.0017416027840226889
frequencies O 0 0.0004946552799083292
with O 0 0.00014103295688983053
which O 0 7.255606760736555e-05
we O 0 7.684404408792034e-05
detected O 0 0.0001443221844965592
mutations O 0 3.7135174352442846e-05
were O 0 2.8521775675471872e-05
5 O 0 5.2153642172925174e-05
( O 0 3.7146295653656125e-05
14 O 0 5.971905920887366e-05
% O 0 1.696585059107747e-05
) O 0 1.3310906979313586e-05
of O 0 2.9686187190236524e-05
35 O 0 6.923609180375934e-05
in O 0 5.420401066658087e-05
sporadic O 0 0.00019809351942967623
cases O 0 3.803644722211175e-05
and O 0 4.1345170757267624e-05
8 O 0 8.180964505299926e-05
( O 0 4.0702496335143223e-05
80 O 0 6.946716166567057e-05
% O 0 2.4162054614862427e-05
) O 0 1.8336771972826682e-05
of O 0 3.69923873222433e-05
10 O 0 6.238096102606505e-05
in O 0 9.946865611709654e-05
familial O 0 0.0025124887470155954
cases O 0 0.0005418917862698436
. O 0 0.00035802923957817256
. O 0 0.0007355650886893272

The O 0 0.0185585655272007
hemochromatosis B-Disease 1 0.999998927116394
845 O 1 0.9995512366294861
G O 1 0.998616099357605
- O 0 0.07942495495080948
- O 0 0.0010131786111742258
> O 0 0.00036348297726362944
A O 0 0.00018306364654563367
and O 0 9.938549919752404e-05
187 O 0 0.0003420331049710512
C O 0 0.000889306771568954
- O 0 0.0008800513460300863
- O 0 0.0009249437134712934
> O 0 0.001535410643555224
G O 0 0.0023831971921026707
mutations O 0 0.00034270811011083424
: O 0 0.00014719620230607688
prevalence O 0 0.0005842098616994917
in O 0 0.00021841356647200882
non O 0 0.001183661282993853
- O 0 0.0022600882221013308
Caucasian O 0 0.0034713156055659056
populations O 0 0.0009438620763830841
. O 0 0.0008136177202686667

Hemochromatosis B-Disease 1 0.9999972581863403
, O 0 0.004652705043554306
the O 1 0.9165775775909424
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
of I-Disease 1 0.9999998807907104
iron I-Disease 1 1.0
metabolism I-Disease 1 0.9999998807907104
, O 0 0.040787748992443085
leads O 0 0.08375555276870728
, O 0 0.00015780147805344313
if O 0 0.0001464206725358963
untreated O 1 0.9642897248268127
, O 0 0.00015734082262497395
to O 0 0.00022434363199863583
progressive O 1 0.9998052716255188
iron B-Disease 1 1.0
overload I-Disease 1 0.9999997615814209
and O 0 0.4505915939807892
premature B-Disease 1 0.9995242357254028
death I-Disease 1 0.7498449683189392
. O 0 0.0010296866530552506

The O 1 0.8227089047431946
hemochromatosis B-Disease 1 1.0
gene O 0 0.38511359691619873
, O 0 0.002521401271224022
HFE O 1 0.9999685287475586
, O 0 0.0003364385920576751
recently O 0 0.0003279233060311526
has O 0 7.827483932487667e-05
been O 0 4.867121242568828e-05
identified O 0 5.698887980543077e-05
, O 0 3.502669642330147e-05
and O 0 3.589849438867532e-05
characterization O 0 0.0002470924227964133
of O 0 0.00013303889136295766
this O 0 7.069601269904524e-05
gene O 0 6.626589311053976e-05
has O 0 3.391001882846467e-05
shown O 0 2.7749161745305173e-05
that O 0 1.0470153029018547e-05
it O 0 8.15852308733156e-06
contains O 0 1.4726126210007351e-05
two O 0 1.3040863450441975e-05
mutations O 0 2.253220372949727e-05
that O 0 1.6107842384371907e-05
result O 0 4.9139871407533064e-05
in O 0 5.676753062289208e-05
amino O 0 9.944835619535297e-05
acid O 0 0.00017535689403302968
substitutions O 0 0.0002841416862793267
- O 0 0.00023632387456018478
cDNA O 0 0.00039958892739377916
nucleotides O 0 0.0002717630995903164
845 O 0 0.0015263609820976853
G O 0 0.0012655098689720035
- O 0 0.000608451256994158
- O 0 0.0004367665678728372
> O 0 0.0004414138675201684
A O 0 0.0004322031745687127
( O 0 0.0001618800888536498
C282Y O 0 0.0017749241087585688
) O 0 5.866081119165756e-05
and O 0 6.5503605583217e-05
187 O 0 0.0003735015634447336
C O 0 0.0011634750990197062
- O 0 0.0009086134377866983
- O 0 0.0015061257872730494
> O 0 0.0020828447304666042
G O 0 0.0063117980025708675
( O 0 0.0010775158880278468
H63D O 1 0.9859974384307861
) O 0 0.0006245833355933428
. O 0 0.0008666202775202692

Although O 0 0.023075537756085396
hemochromatosis B-Disease 1 0.9999995231628418
is O 0 0.001557165291160345
common O 0 0.0006402006838470697
in O 0 0.0003505363129079342
Caucasians O 0 0.007607859559357166
, O 0 0.00026184110902249813
affecting O 0 0.0005989010678604245
> O 0 0.0008181424927897751
= O 0 0.0003894863184541464
1 O 0 0.00016298533591907471
/ O 0 0.00023583677830174565
300 O 0 8.82100939634256e-05
individuals O 0 1.326784331467934e-05
of O 0 4.279176573618315e-05
northern O 0 9.240421059075743e-05
European O 0 4.9320475227432325e-05
origin O 0 4.721747973235324e-05
, O 0 3.5241122532170266e-05
it O 0 1.865486046881415e-05
has O 0 2.211887294834014e-05
not O 0 1.398870790580986e-05
been O 0 3.7744201108580455e-05
recognized O 0 8.305071241920814e-05
in O 0 8.058542152866721e-05
other O 0 0.00010561592353042215
populations O 0 0.00035499141085892916
. O 0 0.0005324464873410761

The O 0 0.001820559031330049
present O 0 0.0006735665956512094
study O 0 0.0002732528664637357
used O 0 0.00022110647114459425
PCR O 0 0.0007756456034258008
and O 0 0.00016087865515146405
restriction O 0 0.0004871466080658138
- O 0 0.0005643362528644502
enzyme O 0 0.0003552761918399483
digestion O 0 0.0004430977860465646
to O 0 4.03565754822921e-05
analyze O 0 7.326595368795097e-05
the O 0 5.283717473503202e-05
frequency O 0 3.7913610867690295e-05
of O 0 4.2315030441386625e-05
the O 0 0.00012145695654908195
845 O 0 0.0042527406476438046
G O 0 0.005211888812482357
- O 0 0.000616630248259753
- O 0 0.00029205530881881714
> O 0 0.00026393469306640327
A O 0 0.00017952419875655323
and O 0 7.596102659590542e-05
187 O 0 0.0003705815179273486
C O 0 0.0009455933468416333
- O 0 0.0006402891594916582
- O 0 0.0006943987100385129
> O 0 0.0010637656087055802
G O 0 0.001500269747339189
mutations O 0 0.00028562001534737647
in O 0 0.00020559494441840798
HLA O 1 0.7918475270271301
- O 0 0.0005167273920960724
typed O 0 0.00017550709890201688
samples O 0 8.564016752643511e-05
from O 0 0.00011156262189615518
non O 0 0.00036438886309042573
- O 0 0.00040052441181614995
Caucasian O 0 0.0008051386685110629
populations O 0 9.61602563620545e-05
, O 0 6.298793596215546e-05
comprising O 0 0.00014410506992135197
Australian O 0 0.0008550997590646148
Aboriginal O 0 0.0009147060918621719
, O 0 0.0001676078245509416
Chinese O 0 0.00042268229299224913
, O 0 0.00014035587082616985
and O 0 0.00015995599096640944
Pacific O 0 0.001863995217718184
Islanders O 0 0.001892164582386613
. O 0 0.0007140313973650336

Results O 0 0.0021267596166580915
showed O 0 0.000896681216545403
that O 0 0.0001225601154146716
the O 0 0.0002478004607837647
845 O 0 0.014361179433763027
G O 0 0.13330014050006866
- O 0 0.0022353874519467354
- O 0 0.0008656620630063117
> O 0 0.0004674924712162465
A O 0 0.0004925061948597431
mutation O 0 0.0001246631145477295
was O 0 0.00021140709577593952
present O 0 6.915387348271906e-05
in O 0 2.7930867872782983e-05
these O 0 1.8292252207174897e-05
populations O 0 2.456816037010867e-05
( O 0 3.750738687813282e-05
allele O 0 7.256589742610231e-05
frequency O 0 3.289428059360944e-05
0 O 0 2.4300979930558242e-05
. O 0 1.1389179235266056e-05
32 O 0 3.6590794479707256e-05
% O 0 3.096335058216937e-05
) O 0 3.034219662367832e-05
, O 0 3.867744089802727e-05
and O 0 4.284521492081694e-05
, O 0 5.585220787907019e-05
furthermore O 0 0.00014191167429089546
, O 0 4.730775981443003e-05
it O 0 3.676757842185907e-05
was O 0 0.0002301369240740314
always O 0 9.83592399279587e-05
seen O 0 0.00013509784184861928
in O 0 6.942948675714433e-05
conjunction O 0 0.0003843699232675135
with O 0 0.0003207792469765991
HLA O 1 0.9998414516448975
haplotypes O 0 0.0015059449942782521
common O 0 0.00019342218001838773
in O 0 0.00013780487643089145
Caucasians O 0 0.0009691321756690741
, O 0 9.173493890557438e-05
suggesting O 0 0.0001401034096488729
that O 0 5.9147540014237165e-05
845 O 0 0.007880507968366146
G O 0 0.481832355260849
- O 0 0.01056358776986599
- O 0 0.0010962150990962982
> O 0 0.0005246733780950308
A O 0 0.0004115274059586227
may O 0 7.450960401911288e-05
have O 0 2.022997614403721e-05
been O 0 3.317709706607275e-05
introduced O 0 6.366950401570648e-05
into O 0 6.941909668967128e-05
these O 0 3.8840589695610106e-05
populations O 0 9.27288638195023e-05
by O 0 0.00017763281357474625
Caucasian O 0 0.005302163772284985
admixture O 0 0.011840488761663437
. O 0 0.0020512433256953955

187 O 0 0.008308935910463333
C O 0 0.009866365231573582
- O 0 0.0033150857780128717
- O 0 0.00124127056915313
> O 0 0.00136462168302387
G O 0 0.0013842196203768253
was O 0 0.00039343751268461347
present O 0 0.00010766777995740995
at O 0 0.00021024461602792144
an O 0 9.046350896824151e-05
allele O 0 0.0001463900989620015
frequency O 0 0.00011072388588218018
of O 0 0.00023652089294046164
2 O 0 0.0006086864741519094
. O 0 0.0004160991811659187

68 O 0 0.0031493802089244127
% O 0 0.0002602710446808487
in O 0 0.0001192987838294357
the O 0 0.00015984149649739265
two O 0 8.06191674200818e-05
populations O 0 6.67652057018131e-05
analyzed O 0 0.00012665476242545992
( O 0 0.00014785397797822952
Australian O 0 0.0007090481230989099
Aboriginal O 0 0.0010157919023185968
and O 0 0.00018727403949014843
Chinese O 0 0.0010200090473517776
) O 0 0.0004030765558127314
. O 0 0.0005935171502642334

In O 0 0.0012904031900689006
the O 0 0.0009769119787961245
Australian O 0 0.0016768721397966146
Aboriginal O 0 0.0009397576213814318
samples O 0 0.00016505662642885
, O 0 7.765168993500993e-05
187 O 0 0.00031567367841489613
C O 0 0.0007949670543894172
- O 0 0.0005255079595372081
- O 0 0.00047871615970507264
> O 0 0.0005377557245083153
G O 0 0.0006905907648615539
was O 0 0.0001613528875168413
found O 0 5.168699499336071e-05
to O 0 3.1919957109494135e-05
be O 0 4.5246593799674883e-05
associated O 0 0.00010089414718095213
with O 0 0.00017249028314836323
HLA O 1 0.9999797344207764
haplotypes O 0 0.0023805934470146894
common O 0 0.00033719249768182635
in O 0 0.00029932995676063
Caucasians O 0 0.004639042541384697
, O 0 0.00014751515118405223
suggesting O 0 0.00018483336316421628
that O 0 4.060255014337599e-05
it O 0 3.8608050090260804e-05
was O 0 0.0002503719297237694
introduced O 0 0.00018707163690123707
by O 0 0.00015100478776730597
recent O 0 0.00041330212843604386
admixture O 0 0.003624256933107972
. O 0 0.0011579440906643867

In O 0 0.001055851229466498
the O 0 0.00042453155037947
Chinese O 0 0.0004645348235499114
samples O 0 0.00011765457747969776
analyzed O 0 9.98503019218333e-05
, O 0 4.9272806791123e-05
187 O 0 0.0002309689298272133
C O 0 0.00048748153494670987
- O 0 0.0004202107375022024
- O 0 0.0004927055560983717
> O 0 0.0005342639051377773
G O 0 0.0005830539157614112
was O 0 0.0002439274830976501
present O 0 9.337635128758848e-05
in O 0 6.542600749526173e-05
association O 0 9.172714635496959e-05
with O 0 2.6623656594892964e-05
a O 0 0.00011685670324368402
wide O 0 0.00020025638514198363
variety O 0 0.00024819080135785043
of O 0 0.002999468008056283
HLA O 1 0.9999909400939941
haplotypes O 0 0.0023126560263335705
, O 0 0.0001528597204014659
showing O 0 0.00019530692952685058
this O 0 6.156507151899859e-05
mutation O 0 8.364130917470902e-05
to O 0 4.033476216136478e-05
be O 0 4.2008574382634833e-05
widespread O 0 0.0002074906078632921
and O 0 9.519416198600084e-05
likely O 0 0.00010110699076903984
to O 0 7.081422518240288e-05
predate O 0 0.000528738833963871
the O 0 0.00013378512812778354
more O 0 5.209658411331475e-05
genetically O 0 0.0002327749243704602
restricted O 0 0.00018057416309602559
845 O 0 0.004821716342121363
G O 0 0.043777089565992355
- O 0 0.004333126824349165
- O 0 0.0017561609856784344
> O 0 0.0012380193220451474
A O 0 0.001405062503181398
mutation O 0 0.0009335983777418733
. O 0 0.0006019389256834984

Genotype O 0 0.18423910439014435
- O 0 0.02227330580353737
phenotype O 0 0.00774336326867342
correlations O 0 0.004564468748867512
in O 0 0.004245349206030369
attenuated B-Disease 1 0.9998341798782349
adenomatous I-Disease 1 0.9999998807907104
polyposis I-Disease 1 0.9999998807907104
coli I-Disease 1 0.9999974966049194
. O 0 0.014012345112860203

Germ O 1 0.9996432065963745
- O 0 0.01765464060008526
line O 0 0.002654770854860544
mutations O 0 0.00035408392432145774
of O 0 0.0004888299736194313
the O 0 0.25351402163505554
tumor B-Disease 1 0.9999996423721313
suppressor O 1 0.9999703168869019
APC O 1 0.9990105628967285
are O 0 0.00015852249634917825
implicated O 0 0.017855435609817505
in O 0 0.002124861814081669
attenuated B-Disease 1 0.99986732006073
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
( O 1 0.9995869994163513
AAPC B-Disease 1 0.9999988079071045
) O 0 0.00036772340536117554
, O 0 0.0002594252582639456
a O 0 0.0005500162951648235
variant O 0 0.0015152350533753633
of O 0 0.005358390975743532
familial B-Disease 1 0.9999997615814209
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 1 0.9999769926071167
FAP B-Disease 1 0.9999984502792358
) O 0 0.0027846102602779865
. O 0 0.0016390832606703043

AAPC B-Disease 1 0.9996631145477295
is O 0 0.0009819397237151861
recognized O 0 0.00034628211869858205
by O 0 0.00011220981104997918
the O 0 0.00020480391685850918
occurrence O 0 0.0004836699226871133
of O 0 0.0005573376547545195
< O 0 0.06281868368387222
100 O 0 0.00185010873246938
colonic B-Disease 1 0.9987428784370422
adenomas I-Disease 0 0.06614841520786285
and O 0 0.00010011535050580278
a O 0 0.0001945256080944091
later O 0 0.0004304113972466439
onset O 1 0.9998797178268433
of O 1 0.9999727010726929
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 0.02981044352054596
age O 0 0.0011339006014168262
> O 0 0.0008387418929487467
40 O 0 0.0003371768107172102
years O 0 0.0002406605490250513
) O 0 0.00023752586275804788
. O 0 0.0004283981106709689

The O 0 0.002033649478107691
aim O 0 0.0010245036100968719
of O 0 0.00031069963006302714
this O 0 8.63107925397344e-05
study O 0 9.939715528162196e-05
was O 0 0.00024288870918098837
to O 0 8.987118053482845e-05
assess O 0 0.00037409632932394743
genotype O 0 0.002094856696203351
- O 0 0.001925833523273468
phenotype O 0 0.001373485429212451
correlations O 0 0.0011245415080338717
in O 0 0.0010283401934430003
AAPC B-Disease 1 0.99993896484375
families O 0 0.002080559730529785
. O 0 0.001370748970657587

By O 0 0.0012794608483090997
protein O 0 0.0013554403558373451
- O 0 0.0012267488054931164
truncation O 0 0.004177230875939131
test O 0 0.0007629101746715605
( O 0 0.00033725553657859564
PTT O 0 0.0027626226656138897
) O 0 0.00011256540165049955
assay O 0 0.0002602407766971737
, O 0 6.004409442539327e-05
the O 0 8.964898734120652e-05
entire O 0 0.0002852074976544827
coding O 0 0.00024735150509513915
region O 0 0.00010323768947273493
of O 0 0.00013077068433631212
the O 0 0.0007795317796990275
APC B-Disease 1 0.9992963075637817
gene O 0 0.00030997241265140474
was O 0 0.00048615020932629704
screened O 0 0.00016430995310656726
in O 0 5.6732136727077886e-05
affected O 0 9.14925112738274e-05
individuals O 0 3.54391559085343e-05
from O 0 0.00014072921476326883
11 O 0 0.027904221788048744
AAPC B-Disease 1 0.9999971389770508
kindreds O 1 0.8663145899772644
, O 0 0.000250828277785331
and O 0 0.00011831361916847527
their O 0 9.411518112756312e-05
phenotypic O 0 0.0008564211311750114
differences O 0 0.0003352292696945369
were O 0 0.0004763600882142782
examined O 0 0.0016232110792770982
. O 0 0.0009523831540718675

Five O 0 0.0055872593075037
novel O 0 0.011828968301415443
germ O 1 0.9999301433563232
- O 1 0.7719238996505737
line O 0 0.021062148734927177
APC B-Disease 1 0.9296683073043823
mutations O 0 0.0004883921938017011
were O 0 0.0001584461861057207
identified O 0 0.00020526096341200173
in O 0 0.00016062297800090164
seven O 0 0.0005829728324897587
kindreds O 0 0.011430719867348671
. O 0 0.0012415064265951514

Mutations O 0 0.0016348983626812696
were O 0 0.00027845962904393673
located O 0 0.00025241257390007377
in O 0 6.382677383953705e-05
three O 0 3.858246418531053e-05
different O 0 9.762418812897522e-06
regions O 0 2.7353791665518656e-05
of O 0 8.31793513498269e-05
the O 0 0.00038849920383654535
APC B-Disease 1 0.9826357364654541
gene O 0 0.00012564504868350923
( O 0 4.578743391903117e-05
1 O 0 5.212943869992159e-05
) O 0 1.6980031432467513e-05
at O 0 3.7450026866281405e-05
the O 0 2.557299922045786e-05
5 O 0 4.3215841287747025e-05
end O 0 9.435854008188471e-05
spanning O 0 0.00024275209580082446
exons O 0 0.00023011431039776653
4 O 0 0.00010373543773312122
and O 0 4.1455637983744964e-05
5 O 0 7.797164289513603e-05
, O 0 3.739210296771489e-05
( O 0 3.6900630220770836e-05
2 O 0 7.771124364808202e-05
) O 0 3.3498257835162804e-05
within O 0 4.551239180727862e-05
exon O 0 0.00032673586974851787
9 O 0 0.00015324263949878514
, O 0 3.556429146556184e-05
and O 0 3.171750722685829e-05
( O 0 4.056090983795002e-05
3 O 0 6.884094909764826e-05
) O 0 2.8450625904952176e-05
at O 0 8.539509872207418e-05
the O 0 9.641781070968136e-05
3 O 0 0.00018454914970789105
distal O 0 0.0009827455505728722
end O 0 0.0004376388096716255
of O 0 0.0002841652894858271
the O 0 0.0007314423564821482
gene O 0 0.00079476332757622
. O 0 0.0005421490641310811

Variability O 0 0.003945972770452499
in O 0 0.0004254992527421564
the O 0 0.00038280378794297576
number O 0 0.00029746288782916963
of O 1 0.9947302341461182
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
was O 1 0.9964324235916138
most O 0 0.00016232338384725153
apparent O 0 0.000801876129116863
in O 0 5.39365028089378e-05
individuals O 0 2.4051063519436866e-05
with O 0 2.7103660613647662e-05
mutations O 0 4.280510620446876e-05
in O 0 3.2733780244598165e-05
region O 0 0.0001786952343536541
1 O 0 0.00021114680566824973
, O 0 8.422959945164621e-05
and O 0 0.00015004441956989467
upper O 1 0.9971823692321777
- O 1 0.9994783997535706
gastrointestinal O 1 0.9999452829360962
manifestations O 1 0.993834376335144
were O 0 0.0004910754505544901
more O 0 0.0001818437740439549
severe O 1 0.9076870679855347
in O 0 0.0002741136704571545
them O 0 0.00020878948271274567
. O 0 0.0006009858916513622

In O 0 0.001373410108499229
individuals O 0 0.00017125869635492563
with O 0 0.00017328353715129197
mutations O 0 0.00013024054351262748
in O 0 7.687241304665804e-05
either O 0 3.8109425076982006e-05
region O 0 9.521077299723402e-05
2 O 0 8.280311158159748e-05
or O 0 3.960450703743845e-05
region O 0 6.36115946690552e-05
3 O 0 7.711359648965299e-05
, O 0 3.219319478375837e-05
the O 0 4.845419971388765e-05
average O 0 5.8515659475233406e-05
number O 0 4.3019135773647577e-05
of O 0 0.0001980493398150429
adenomas B-Disease 0 0.09597782045602798
tended O 0 0.0002839661610778421
to O 0 3.952135011786595e-05
be O 0 3.555218791007064e-05
lower O 0 7.048370753182098e-05
than O 0 1.2302233699301723e-05
those O 0 8.069643627095502e-06
in O 0 1.7463993572164327e-05
individuals O 0 1.6442463675048202e-05
with O 0 2.531139944039751e-05
mutations O 0 5.1306407840456814e-05
in O 0 3.377643588464707e-05
region O 0 8.213780529331416e-05
1 O 0 0.00010876987653318793
, O 0 4.62911011709366e-05
although O 0 4.641681880457327e-05
age O 0 0.0001515220064902678
at O 0 0.0004741468874271959
diagnosis O 0 0.010451307520270348
was O 0 0.0016914971638470888
similar O 0 0.00036288262344896793
. O 0 0.0004205385339446366

In O 0 0.003578057512640953
all O 0 0.0023640268482267857
AAPC B-Disease 1 0.9997352957725525
kindreds O 0 0.015210561454296112
, O 0 0.0003791522467508912
a O 0 0.0006322254776023328
predominance O 0 0.010258735157549381
of O 0 0.051211193203926086
right O 1 0.9990696310997009
- O 1 0.9999767541885376
sided O 1 0.9999985694885254
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and O 1 0.9992049336433411
rectal B-Disease 1 0.9999997615814209
polyp I-Disease 1 0.9999992847442627
sparing O 1 0.9969594478607178
was O 0 0.23693831264972687
observed O 0 0.0017795608146116138
. O 0 0.0007822976913303137

No O 0 0.3440797030925751
desmoid B-Disease 1 0.9999886751174927
tumors I-Disease 1 0.9999697208404541
were O 0 0.000747540092561394
found O 0 0.00037369923666119576
in O 0 0.00030845185392536223
these O 0 0.00026365931262262166
kindreds O 0 0.010791899636387825
. O 0 0.0017730437684804201

Our O 0 0.002082532737404108
data O 0 0.00042798559297807515
suggest O 0 0.00032096588984131813
that O 0 9.743218834046274e-05
, O 0 0.0001349394879071042
in O 0 0.000201404545805417
AAPC B-Disease 1 0.999241828918457
families O 0 0.00017207434575539082
, O 0 5.1117844122927636e-05
the O 0 9.212881559506059e-05
location O 0 0.00021027888578828424
of O 0 0.00027405511355027556
the O 0 0.0026975946966558695
APC B-Disease 1 0.9999510049819946
mutation O 0 0.002157952869310975
may O 0 0.0002761444775387645
partially O 0 0.0011104404693469405
predict O 0 0.00043970855767838657
specific O 0 0.00015547066868748516
phenotypic O 0 0.0016004691133275628
expression O 0 0.0008992236689664423
. O 0 0.00048474277718923986

This O 0 0.0009245264227502048
should O 0 0.00029584538424387574
help O 0 0.00018653481674846262
in O 0 9.885647887131199e-05
the O 0 0.00018169039685744792
design O 0 0.00038418604526668787
of O 0 0.0004296382248867303
tailored O 0 0.0008520606206730008
clinical O 0 0.003961110953241587
- O 0 0.002465013647451997
management O 0 0.0003926454810425639
protocols O 0 0.00026339548639953136
in O 0 7.830650429241359e-05
this O 0 5.51456687389873e-05
subset O 0 0.0003887892817147076
of O 0 0.0016621887916699052
FAP B-Disease 1 0.9999850988388062
patients O 0 0.010423953644931316
. O 0 0.0004217481182422489
. O 0 0.0006355748628266156

Wilms B-Disease 1 0.9999879598617554
' I-Disease 1 0.9673654437065125
tumor I-Disease 1 0.9989114999771118
1 O 0 0.0012629872653633356
and O 0 0.00047227804316207767
Dax O 1 0.9957693815231323
- O 0 0.0015028928173705935
1 O 0 0.00047244623419828713
modulate O 0 0.0010949632851406932
the O 0 0.0003542024060152471
orphan O 0 0.003293897956609726
nuclear O 0 0.0017242340836673975
receptor O 0 0.0008608276257291436
SF O 1 0.7735947966575623
- O 0 0.00035501952515915036
1 O 0 0.00014169966743793339
in O 0 6.398343975888565e-05
sex O 0 0.00018112493853550404
- O 0 0.0002561289875302464
specific O 0 9.4301336503122e-05
gene O 0 0.00035448718699626625
expression O 0 0.0006932264659553766
. O 0 0.0006031101220287383

Products O 0 0.0033754718024283648
of O 0 0.0016681140987202525
steroidogenic O 1 0.9901319742202759
factor O 0 0.0034184257965534925
1 O 0 0.0009053279063664377
( O 0 0.0007043663063086569
SF O 1 0.9936816692352295
- O 0 0.0005972898798063397
1 O 0 0.000289404415525496
) O 0 0.00016078143380582333
and O 0 0.000249985750997439
Wilms B-Disease 1 0.9999902248382568
tumor I-Disease 1 0.9999552965164185
1 O 0 0.0026133295614272356
( O 0 0.0007060061325319111
WT1 O 1 0.9951444268226624
) O 0 0.00018074264517053962
genes O 0 7.855414150981233e-05
are O 0 2.3795675588189624e-05
essential O 0 0.0001296188565902412
for O 0 7.976651977514848e-05
mammalian O 0 0.0006945381173864007
gonadogenesis O 0 0.09658179432153702
prior O 0 0.00045102377771399915
to O 0 0.0002511398633942008
sexual O 0 0.0012343127746134996
differentiation O 0 0.00873116496950388
. O 0 0.0009300780948251486

In O 0 0.0014364916132763028
males O 0 0.0008350420976057649
, O 0 0.0008151286747306585
SF O 1 0.999243974685669
- O 0 0.0015311460010707378
1 O 0 0.00036533494130708277
participates O 0 0.0003978711611125618
in O 0 0.00010802102769957855
sexual O 0 0.00021390752226579934
development O 0 0.00021331891184672713
by O 0 6.468571518780664e-05
regulating O 0 0.00028429398662410676
expression O 0 0.000174830318428576
of O 0 0.00026101406547240913
the O 0 0.0020664287731051445
polypeptide O 1 0.9959033131599426
hormone O 1 0.9950042366981506
Mullerian O 1 0.9997625946998596
inhibiting O 1 0.9637630581855774
substance O 1 0.9975537657737732
( O 0 0.0038306580390781164
MIS O 1 0.9978249073028564
) O 0 0.0006019535358063877
. O 0 0.0008554387604817748

Here O 0 0.0031072015408426523
, O 0 0.0006773320492357016
we O 0 0.0003076413122471422
show O 0 0.0005574458045884967
that O 0 0.0003176759055349976
WT1 O 1 0.9980283379554749
- O 0 0.014748036861419678
KTS O 1 0.9935164451599121
isoforms O 0 0.0009716192143969238
associate O 0 0.0007039523334242404
and O 0 0.00034958269679918885
synergize O 0 0.0064333584159612656
with O 0 0.0006000821013003588
SF O 1 0.9999107122421265
- O 0 0.0014491541078314185
1 O 0 0.0003302257682662457
to O 0 0.00024104653857648373
promote O 0 0.0014078523963689804
MIS O 1 0.9906326532363892
expression O 0 0.001996194012463093
. O 0 0.0011426964774727821

In O 0 0.003795962780714035
contrast O 0 0.0033331250306218863
, O 0 0.001551376422867179
WT1 O 1 0.9996665716171265
missense O 0 0.03380965813994408
mutations O 0 0.000631347531452775
, O 0 0.0001746224006637931
associated O 0 0.0002169300860259682
with O 0 0.00016832051915116608
male B-Disease 0 0.004126495216041803
pseudohermaphroditism I-Disease 1 0.9999970197677612
in O 0 0.41719919443130493
Denys B-Disease 1 0.9999994039535522
- I-Disease 1 0.9999983310699463
Drash I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 0.0009699345100671053
fail O 0 0.0007461519562639296
to O 0 0.00024306916748173535
synergize O 0 0.3937264680862427
with O 0 0.0016090652206912637
SF O 1 0.9999842643737793
- O 0 0.010928344912827015
1 O 0 0.0014021344250068069
. O 0 0.0007236600504256785

Additionally O 0 0.0035070895683020353
, O 0 0.0004970661248080432
the O 0 0.0005489556351676583
X O 0 0.03766060248017311
- O 0 0.002397016854956746
linked O 0 0.0005242943880148232
, O 0 0.00011857158096972853
candidate O 0 0.00023546471493318677
dosage O 0 0.0010634874925017357
- O 0 0.0004909888957627118
sensitive O 0 0.00039234093856066465
sex O 0 0.000255297141848132
- O 0 0.0004795213753823191
reversal O 0 0.0011423552641645074
gene O 0 0.00016183842672035098
, O 0 9.521831088932231e-05
Dax O 1 0.9780519604682922
- O 0 0.0006504314369522035
1 O 0 0.00020893587497994304
, O 0 0.00019019702449440956
antagonizes O 0 0.0020269057713449
synergy O 0 0.0022572383750230074
between O 0 0.000846714130602777
SF O 1 0.9999803304672241
- O 0 0.0030379476957023144
1 O 0 0.0003898916475009173
and O 0 0.00023529550526291132
WT1 O 1 0.9913262724876404
, O 0 9.158853208646178e-05
most O 0 2.9862912924727425e-05
likely O 0 5.022848563385196e-05
through O 0 3.113812636001967e-05
a O 0 6.96946881362237e-05
direct O 0 7.31200780137442e-05
interaction O 0 0.00011359872587490827
with O 0 0.0002327185356989503
SF O 1 0.9999604225158691
- O 0 0.004132535308599472
1 O 0 0.001045374432578683
. O 0 0.0005447602597996593

We O 0 0.0020125762093812227
propose O 0 0.002770455554127693
that O 0 0.0006165733211673796
WT1 O 1 0.976146399974823
and O 0 0.0006763393175788224
Dax O 1 0.9996102452278137
- O 0 0.003490033093839884
1 O 0 0.0005950655322521925
functionally O 0 0.0004731845110654831
oppose O 0 0.00015215438907034695
each O 0 2.7761310775531456e-05
other O 0 2.828126343956683e-05
in O 0 0.00012975784193258733
testis O 0 0.03830958530306816
development O 0 0.0005767761031165719
by O 0 0.00036112600355409086
modulating O 1 0.9345263838768005
SF O 1 0.9999399185180664
- O 0 0.005399812012910843
1 O 0 0.0008597758132964373
- O 0 0.0012112268013879657
mediated O 0 0.002394953975453973
transactivation O 0 0.011406348086893559
. O 0 0.0004965073894709349
. O 0 0.0005797844496555626

A O 0 0.012893985025584698
mouse O 0 0.00636464124545455
model O 0 0.0020835574250668287
for O 0 0.0017420871881768107
Prader B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999996423721313
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
imprinting O 1 0.9999990463256836
- O 1 0.9999637603759766
centre O 1 0.9962318539619446
mutations O 0 0.002174346474930644
. O 0 0.001197216217406094

Imprinting O 0 0.017770148813724518
in O 0 0.0010233212960883975
the O 0 0.0019188208971172571
15q11 O 1 0.9986011385917664
- O 0 0.009744263254106045
q13 O 0 0.07187340408563614
region O 0 0.0006958741578273475
involves O 0 0.0005431793979369104
an O 0 0.0002361342340009287
imprinting O 0 0.028319112956523895
centre O 0 0.20121319591999054
( O 0 0.0007401983020827174
IC O 1 0.91828453540802
) O 0 0.00010757643030956388
, O 0 4.717814226751216e-05
mapping O 0 8.948465256253257e-05
in O 0 3.3911539503606036e-05
part O 0 5.26263247593306e-05
to O 0 3.344462675158866e-05
the O 0 0.00012048971257172525
promoter O 0 0.003529653185978532
and O 0 0.0001427369425073266
first O 0 0.0002940799167845398
exon O 0 0.0022830592934042215
of O 0 0.0012063466710969806
SNRPN O 1 0.9999228715896606
. O 0 0.0013520083157345653

Deletion O 0 0.008462334983050823
of O 0 0.001968537922948599
this O 0 0.001347985933534801
IC O 1 0.9709661602973938
abolishes O 0 0.01683889701962471
local O 0 0.0007218131213448942
paternally O 0 0.0040862043388187885
derived O 0 0.0005662075127474964
gene O 0 0.00034248619340360165
expression O 0 0.00023992647766135633
and O 0 0.00010988683061441407
results O 0 0.0002689675602596253
in O 0 0.0020245988853275776
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9999964237213135
PWS B-Disease 1 1.0
) O 0 0.011147565208375454
. O 0 0.0016345434123650193

We O 0 0.001315632602199912
have O 0 0.00017347581160720438
created O 0 0.0002806141274049878
two O 0 0.0001457835896871984
deletion O 0 0.0010212758788838983
mutations O 0 0.00033059620182029903
in O 0 0.0001815127325244248
mice O 0 0.00038982773548923433
to O 0 0.00012886918557342142
understand O 0 0.0006057560676708817
PWS B-Disease 1 0.9999892711639404
and O 0 0.00023802326177246869
the O 0 0.00029129008180461824
mechanism O 0 0.0003758468374144286
of O 0 0.0004236938548274338
this O 0 0.0005563704180531204
IC O 1 0.9705800414085388
. O 0 0.0013966833939775825

Mice O 0 0.0417281910777092
harbouring O 1 0.830485999584198
an O 0 0.002828180091455579
intragenic O 1 0.9946854114532471
deletion O 0 0.014094934798777103
in O 0 0.0013631138717755675
Snrpn O 1 0.9992167949676514
are O 0 0.00015197171887848526
phenotypically O 0 0.004504268057644367
normal O 0 0.000394829228753224
, O 0 9.007451444631442e-05
suggesting O 0 0.00019967601110693067
that O 0 4.969642759533599e-05
mutations O 0 8.284213254228234e-05
of O 0 0.000204659256269224
SNRPN O 1 0.999923825263977
are O 0 3.7714842619607225e-05
not O 0 3.323656346765347e-05
sufficient O 0 0.00013506950926966965
to O 0 0.00019581896776799113
induce O 0 0.08466191589832306
PWS B-Disease 1 0.9999982118606567
. O 0 0.0016456297598779202

Mice O 0 0.004280104301869869
with O 0 0.0003341998963151127
a O 0 0.000431603315519169
larger O 0 0.000329266011249274
deletion O 0 0.0007195532089099288
involving O 0 0.0004450193664524704
both O 0 0.00017970539920497686
Snrpn O 1 0.9840421676635742
and O 0 0.0002252983977086842
the O 0 0.0006174659938551486
putative O 1 0.9973843693733215
PWS O 1 1.0
- O 1 0.9958968162536621
IC O 1 0.9922745823860168
lack O 0 0.0005125577445141971
expression O 0 0.00024150413810275495
of O 0 0.00020100572146475315
the O 0 0.00035381870111450553
imprinted O 0 0.01975199021399021
genes O 0 0.0004932202864438295
Zfp127 O 1 0.9741070866584778
( O 0 0.0003371845232322812
mouse O 0 0.0006090703536756337
homologue O 0 0.0015455289976671338
of O 0 0.0006510674138553441
ZNF127 O 1 0.9999173879623413
) O 0 0.0003843660815618932
, O 0 0.0002977415279019624
Ndn O 0 0.40837588906288147
and O 0 0.0004385279316920787
Ipw O 1 0.8700087666511536
, O 0 0.0004251970094628632
and O 0 0.0002409195149084553
manifest O 0 0.001580503536388278
several O 0 0.00035605431185103953
phenotypes O 0 0.0043235961347818375
common O 0 0.0016949709970504045
to O 0 0.004062322899699211
PWS B-Disease 1 0.9999998807907104
infants O 1 0.999502420425415
. O 0 0.0024972669780254364

These O 0 0.0007957780035212636
data O 0 0.00030685652745887637
demonstrate O 0 0.0003910694213118404
that O 0 5.231508475844748e-05
both O 0 4.0349266782868654e-05
the O 0 7.09845990058966e-05
position O 0 0.0001458507467759773
of O 0 0.0002448084414936602
the O 0 0.0005133518134243786
IC O 1 0.9739402532577515
and O 0 7.325924525503069e-05
its O 0 5.6411794503219426e-05
role O 0 8.624373731436208e-05
in O 0 2.8109363483963534e-05
the O 0 7.275922689586878e-05
coordinate O 0 0.00011406124394852668
expression O 0 7.492377335438505e-05
of O 0 9.230688738171011e-05
genes O 0 6.638131890213117e-05
is O 0 3.770873081521131e-05
conserved O 0 0.0001665836462052539
between O 0 0.00015652706497348845
mouse O 0 0.00046976172598078847
and O 0 8.102053834591061e-05
human O 0 9.30997557588853e-05
, O 0 4.44993311248254e-05
and O 0 2.4378972739214078e-05
indicate O 0 4.9180700443685055e-05
that O 0 2.9688311769859865e-05
the O 0 7.318802090594545e-05
mouse O 0 0.00019596205675043166
is O 0 4.944518150296062e-05
a O 0 7.686258322792128e-05
suitable O 0 0.00013799843145534396
model O 0 0.0001564145932206884
system O 0 5.5916374549269676e-05
in O 0 3.6583955079549924e-05
which O 0 1.682178844930604e-05
to O 0 2.2616333808400668e-05
investigate O 0 0.00010503480734769255
the O 0 9.496332495473325e-05
molecular O 0 0.00013623156701214612
mechanisms O 0 0.0001174133867607452
of O 0 0.0001701114815659821
imprinting O 0 0.0008519892580807209
in O 0 7.241644198074937e-05
this O 0 2.6717740183812566e-05
region O 0 5.4937707318458706e-05
of O 0 9.567036613589153e-05
the O 0 0.00025836238637566566
genome O 0 0.00036315794568508863
. O 0 0.00018945836927741766
. O 0 0.00033018289832398295

Mutations O 0 0.0021709224674850702
of O 0 0.0012199716875329614
the O 0 0.0007229220937006176
ATM O 0 0.006885371636599302
gene O 0 0.0003762361593544483
detected O 0 0.0006578796892426908
in O 0 0.00035284977639093995
Japanese O 1 0.9916554689407349
ataxia B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999927282333374
telangiectasia I-Disease 1 0.9999985694885254
patients O 0 0.012450768612325191
: O 0 0.0001106139097828418
possible O 0 9.267847053706646e-05
preponderance O 0 0.00099656218662858
of O 0 0.00013203216076362878
the O 0 0.00017484099953435361
two O 0 0.0001657243410591036
founder O 0 0.02186804823577404
mutations O 0 0.0006962594925425947
4612del165 O 1 0.9358080625534058
and O 0 0.0009899247670546174
7883del5 O 1 0.9951220154762268
. O 0 0.0021411017514765263

The O 0 0.0038589013274759054
ATM O 0 0.029828200116753578
( O 0 0.0022995672188699245
A O 1 0.998323380947113
- O 1 0.9978463649749756
T O 1 0.9995068311691284
, O 0 0.0002608279755804688
mutated O 0 0.00041517068166285753
) O 0 9.822342690313235e-05
gene O 0 0.0001857074530562386
on O 0 0.00020678395230788738
human O 0 0.0007419431349262595
chromosome O 0 0.003085717326030135
11q22 O 1 0.9638997912406921
. O 0 0.001689032418653369

3 O 0 0.002210036851465702
has O 0 0.0003737296792678535
recently O 0 0.00036713163717649877
been O 0 0.00011309064575470984
identified O 0 8.784234523773193e-05
as O 0 6.461450539063662e-05
the O 0 0.0001247681211680174
gene O 0 0.00012121630425099283
responsible O 0 0.00014326217933557928
for O 0 6.980583566473797e-05
the O 0 0.0007864138460718095
human O 1 0.9873989820480347
recessive B-Disease 1 0.9999996423721313
disease I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 1 0.9996919631958008
A B-Disease 1 0.9999992847442627
- I-Disease 1 0.9999669790267944
T I-Disease 1 0.9998887777328491
) O 0 0.0005376780172809958
. O 0 0.0007010420667938888

In O 0 0.0010244669392704964
order O 0 0.00031548531842418015
to O 0 0.0001080878937500529
define O 0 0.0001538299984531477
the O 0 0.00019222054106649011
types O 0 0.00021723308600485325
of O 1 0.7594243288040161
disease O 1 1.0
- O 1 0.999956488609314
causing O 1 0.9996440410614014
ATM O 0 0.02133619226515293
mutations O 0 0.00013224108261056244
in O 0 0.00010536956688156351
Japanese O 0 0.002436490263789892
A B-Disease 1 0.9998589754104614
- I-Disease 1 0.999860405921936
T I-Disease 1 0.9999792575836182
patients O 0 0.00020843047241214663
as O 0 6.0503916756715626e-05
well O 0 3.655302134575322e-05
as O 0 3.1415507692145184e-05
to O 0 2.808808676491026e-05
look O 0 8.651853568153456e-05
for O 0 4.454904774320312e-05
possible O 0 0.0002576146216597408
mutational O 0 0.014230985194444656
hotspots O 0 0.00847409013658762
, O 0 0.0001789327507140115
reverse O 0 0.0006233196472749114
- O 0 0.0003710191522259265
transcribed O 0 0.00021938093414064497
RNA O 0 0.00015167608216870576
derived O 0 4.359711965662427e-05
from O 0 3.9654765714658424e-05
ten O 0 9.134859283221886e-05
patients O 0 7.802742766216397e-05
belonging O 0 0.0001272547378903255
to O 0 5.424366827355698e-05
eight O 0 0.00018916703993454576
unrelated O 0 0.00047014470328576863
Japanese O 0 0.007396138738840818
A B-Disease 1 0.9997255206108093
- I-Disease 1 0.9742377400398254
T I-Disease 1 0.9686126708984375
families O 0 9.194223821396008e-05
was O 0 0.0001625244040042162
analyzed O 0 8.494037319906056e-05
for O 0 3.787656896747649e-05
mutations O 0 4.360951061244123e-05
by O 0 4.685286694439128e-05
the O 0 0.0001759196020429954
restriction O 0 0.00045667312224395573
endonuclease O 0 0.0030019243713468313
fingerprinting O 0 0.0017536190571263433
method O 0 0.0005602652672678232
. O 0 0.0006967447116039693

As O 0 0.002176310634240508
has O 0 0.0004148822627030313
been O 0 0.0001723268796922639
reported O 0 0.00018343406554777175
by O 0 5.4471649491460994e-05
others O 0 8.505789446644485e-05
, O 0 7.862885831855237e-05
mutations O 0 8.303605864057317e-05
that O 0 3.0258370316005312e-05
lead O 0 0.00016222713747993112
to O 0 0.0001299889263464138
exon O 0 0.00136746175121516
skipping O 0 0.001651566824875772
or O 0 0.0002812266757246107
premature O 0 0.0013907161774113774
protein O 0 0.00035228425986133516
truncation O 0 0.0013228541938588023
were O 0 0.0001236205716850236
also O 0 0.00010078662307932973
predominant O 0 0.00043112837010994554
in O 0 0.00020954136562068015
our O 0 0.0006561251357197762
mutants O 0 0.0034370175562798977
. O 0 0.0009101097821258008

Six O 0 0.0011021957034245133
different O 0 0.00013017177116125822
mutations O 0 0.00011919075768673792
were O 0 3.953039777115919e-05
identified O 0 4.937968333251774e-05
on O 0 3.870031287078746e-05
12 O 0 7.97648390289396e-05
of O 0 9.129093086812645e-05
the O 0 0.0002606738416943699
16 O 0 0.0006716598873026669
alleles O 0 0.0008233292028307915
examined O 0 0.0017235915875062346
. O 0 0.0007952929008752108

Four O 0 0.0010668340837582946
were O 0 0.00045099001727066934
deletions O 0 0.0008231119718402624
involving O 0 0.00036388167063705623
a O 0 0.00021815719082951546
loss O 0 0.0008056160295382142
of O 0 0.00019003624038305134
a O 0 0.0002744130324572325
single O 0 0.00031334240338765085
exon O 0 0.0012387300375849009
exon O 0 0.0008508817991241813
7 O 0 0.00026371460990048945
, O 0 0.00011080731928814203
exon O 0 0.0005668252124451101
16 O 0 0.0002717301540542394
, O 0 0.00014821307559031993
exon O 0 0.0013300938298925757
33 O 0 0.0007177239749580622
or O 0 0.0005095769301988184
exon O 0 0.0028389799408614635
35 O 0 0.0018321867100894451
. O 0 0.0015199837507680058

The O 0 0.0019404126796871424
others O 0 0.0005130363279022276
were O 0 0.000315161858452484
minute O 0 0.0004179320822004229
deletions O 0 0.0009790624026209116
, O 0 0.00028388388454914093
4649delA O 0 0.004091725219041109
in O 0 0.0003596613823901862
exon O 0 0.001746159279718995
33 O 0 0.0007957086781971157
and O 0 0.00024336019123438746
7883del5 O 0 0.009443646296858788
in O 0 0.0006369613693095744
exon O 0 0.006092596333473921
55 O 0 0.0032354509457945824
. O 0 0.001322672120295465

The O 0 0.005629302002489567
mutations O 0 0.0036510725039988756
4612del165 O 1 0.97649085521698
and O 0 0.0005186796188354492
7883del5 O 1 0.5561308860778809
were O 0 0.00013529599527828395
found O 0 4.913354496238753e-05
in O 0 3.013681634911336e-05
more O 0 1.475749013479799e-05
than O 0 1.9100098143098876e-05
two O 0 1.8350434402236715e-05
unrelated O 0 6.563972419826314e-05
families O 0 2.1384785213740543e-05
; O 0 1.639870970393531e-05
44 O 0 6.698330980725586e-05
% O 0 3.2671749067958444e-05
( O 0 3.741032924153842e-05
7 O 0 7.784727495163679e-05
of O 0 8.070623880485073e-05
16 O 0 0.00010666854359442368
) O 0 2.9458968128892593e-05
of O 0 6.247550481930375e-05
the O 0 0.00010397322330391034
mutant O 0 0.0005954978987574577
alleles O 0 9.838156984187663e-05
had O 0 7.722736336290836e-05
one O 0 4.409695611684583e-05
of O 0 9.981459879782051e-05
the O 0 0.0002255175932077691
two O 0 0.00017720615142025054
mutations O 0 0.0006462867022491992
. O 0 0.0005698995082639158

The O 0 0.00646396167576313
4612del165 O 1 0.9876872897148132
mutations O 0 0.0006093829870223999
in O 0 8.859517402015626e-05
three O 0 4.7881403588689864e-05
different O 0 2.075126212730538e-05
families O 0 3.679942528833635e-05
were O 0 3.374179141246714e-05
all O 0 2.4735403712838888e-05
ascribed O 0 0.0001683320733718574
to O 0 3.6436260415939614e-05
the O 0 0.00014875931083224714
same O 0 0.000216216008993797
T O 0 0.35377824306488037
- O 0 0.0006519059534184635
- O 0 0.00038414023583754897
> O 0 0.0003071696846745908
A O 0 0.00024337737704627216
substitution O 0 0.00037425110349431634
at O 0 0.00023360512568615377
the O 0 0.00023009807046037167
splice O 0 0.0010613782797008753
donor O 0 0.0003423978923819959
site O 0 0.0004782815231010318
in O 0 0.00025439835735596716
intron O 0 0.004197400063276291
33 O 0 0.001986529678106308
. O 0 0.0009508617222309113

Microsatellite O 0 0.05640295147895813
genotyping O 0 0.01228143461048603
around O 0 0.0014168695779517293
the O 0 0.0008310612174682319
ATM O 0 0.003662180621176958
locus O 0 0.0013271997449919581
also O 0 0.00015165441436693072
indicated O 0 0.00010627765004755929
that O 0 2.3792386855348013e-05
a O 0 7.940602517919615e-05
common O 0 8.873958722688258e-05
haplotype O 0 0.0006017297273501754
was O 0 0.0004158132942393422
shared O 0 0.00014731161354575306
by O 0 6.49608628009446e-05
the O 0 0.00023330638941843063
mutant O 0 0.001312342006713152
alleles O 0 0.0003177240723744035
in O 0 0.00015749424346722662
both O 0 0.0002830485755112022
mutations O 0 0.0008497976814396679
. O 0 0.000706101767718792

This O 0 0.001145174610428512
suggests O 0 0.0005864643026143312
that O 0 7.30333777028136e-05
these O 0 4.103384344489314e-05
two O 0 8.61243242979981e-05
founder O 0 0.0740763247013092
mutations O 0 0.0003276099159847945
may O 0 0.0001366775977658108
be O 0 0.00011882466787938029
predominant O 0 0.0006152595742605627
among O 0 0.0003308061568532139
Japanese O 0 0.0031194109469652176
ATM O 0 0.02416311390697956
mutant O 0 0.0060951667837798595
alleles O 0 0.0017379582859575748
. O 0 0.0006072966498322785

W474C O 1 0.7409733533859253
amino O 0 0.004849117249250412
acid O 0 0.0036903242580592632
substitution O 0 0.001995266182348132
affects O 0 0.0005964220035821199
early O 0 0.0002248897508252412
processing O 0 0.00011946112499572337
of O 0 9.357290400657803e-05
the O 0 0.00013587455032393336
alpha O 0 0.0002902303240261972
- O 0 0.00011307371460134163
subunit O 0 9.562322520650923e-05
of O 0 0.00011755814193747938
beta O 0 0.00043180203647352755
- O 0 0.00042215982102788985
hexosaminidase O 0 0.006813523825258017
A O 0 0.0005088338511995971
and O 0 8.14164595794864e-05
is O 0 7.983561226865277e-05
associated O 0 0.00017067264707293361
with O 0 0.0003413792874198407
subacute O 1 0.9999979734420776
G B-Disease 1 0.9999639987945557
( I-Disease 0 0.08610209077596664
M2 I-Disease 1 0.9995177984237671
) I-Disease 0 0.0009166044765152037
gangliosidosis I-Disease 0 0.035500288009643555
. O 0 0.0015602814964950085

Mutations O 0 0.0030849166214466095
in O 0 0.0007920510834082961
the O 0 0.0014708051458001137
HEXA O 1 0.9989111423492432
gene O 0 0.00032859586644917727
, O 0 9.377441165270284e-05
encoding O 0 8.159669960150495e-05
the O 0 0.00010398501763120294
alpha O 0 0.00022478040773421526
- O 0 0.0001043540469254367
subunit O 0 5.4797481425339356e-05
of O 0 0.00010929159179795533
beta O 0 0.0002818738576024771
- O 0 0.00041791671537794173
hexosaminidase O 0 0.0035774032585322857
A O 0 0.000714847759809345
( O 0 0.0002868425799533725
Hex O 0 0.0012727287830784917
A O 0 0.0005595101392827928
) O 0 5.962687646388076e-05
, O 0 5.122007496538572e-05
that O 0 4.384657586342655e-05
abolish O 0 0.0005832061870023608
Hex O 0 0.0018483255989849567
A O 0 0.0009832452051341534
enzyme O 0 0.001568442676216364
activity O 0 0.002843842376023531
cause O 1 0.9999494552612305
Tay B-Disease 1 1.0
- I-Disease 1 0.9999980926513672
Sachs I-Disease 1 0.9999990463256836
disease I-Disease 1 0.9999995231628418
( O 0 0.35258036851882935
TSD B-Disease 1 0.9999921321868896
) O 0 0.0001478741323808208
, O 0 9.143939678324386e-05
the O 0 0.000323132291669026
fatal O 1 0.9996500015258789
infantile B-Disease 1 0.999480664730072
form I-Disease 0 0.0007470470736734569
of I-Disease 0 0.15056592226028442
G I-Disease 1 0.9984617233276367
( I-Disease 0 0.0010867577511817217
M2 I-Disease 1 0.9432740807533264
) I-Disease 0 0.00028223529807291925
gangliosidosis I-Disease 0 0.007309597451239824
, I-Disease 0 0.00031736562959849834
Type I-Disease 0 0.0010573590407148004
1 I-Disease 0 0.0010534843895584345
. O 0 0.000839773565530777

Less O 0 0.010577083565294743
severe O 1 0.9999561309814453
, O 0 0.1213904395699501
subacute O 1 0.9999996423721313
( O 1 0.9898784160614014
juvenile O 1 0.9999881982803345
- O 1 0.9997382760047913
onset O 1 0.9999951124191284
) O 0 0.0008681886247359216
and O 0 0.0013532275334000587
chronic O 1 0.9999996423721313
( O 0 0.2114134430885315
adult O 0 0.012864354066550732
- O 1 0.9420472979545593
onset O 1 0.999779999256134
) O 0 0.0001303777244174853
variants O 0 8.128396439133212e-05
are O 0 1.3997570022183936e-05
characterized O 0 0.00010479750199010596
by O 0 3.292833571322262e-05
a O 0 0.00012357448576949537
broad O 0 0.0002546191681176424
spectrum O 0 0.00038299502921290696
of O 0 0.0012783134588971734
clinical O 0 0.3569556176662445
manifestations O 1 0.9984034895896912
and O 0 0.00021140224998816848
are O 0 2.475772998877801e-05
associated O 0 5.6906828831415623e-05
with O 0 5.1692910346901044e-05
residual O 0 0.0018150759860873222
levels O 0 0.00027515814872458577
of O 0 0.0004013641446363181
Hex O 0 0.0050079794600605965
A O 0 0.0017256323480978608
enzyme O 0 0.0015015109675005078
activity O 0 0.0005776585312560201
. O 0 0.0005052000633440912

We O 0 0.0011463030241429806
identified O 0 0.0007312172674573958
a O 0 0.0008686999208293855
1422 O 1 0.5669814944267273
G O 0 0.05662151798605919
- O 0 0.0028296501841396093
- O 0 0.0016130758449435234
> O 0 0.0012781261466443539
C O 0 0.0009776060469448566
( O 0 0.00022346217883750796
amino O 0 0.00033933427766896784
acid O 0 0.0006348671158775687
W474C O 0 0.0035429378040134907
) O 0 9.628265252104029e-05
substitution O 0 0.00021957118588034064
in O 0 4.089727008249611e-05
the O 0 6.771417974960059e-05
first O 0 7.492634904338047e-05
position O 0 8.307106327265501e-05
of O 0 0.00011294020077912137
exon O 0 0.0006113132112659514
13 O 0 0.0002615436678752303
of O 0 0.00023951687035150826
HEXA O 1 0.9808835387229919
of O 0 0.0003034787077922374
a O 0 0.0004299459687899798
non O 0 0.0005637611029669642
- O 0 0.0006469942163676023
Jewish O 0 0.0005656799185089767
proband O 1 0.7036287784576416
who O 0 0.0002920792903751135
manifested O 0 0.002573012374341488
a O 0 0.0008003448019735515
subacute O 1 0.9997780919075012
variant O 0 0.02938719093799591
of O 0 0.2720016837120056
G B-Disease 1 0.9996800422668457
( I-Disease 0 0.00490036653354764
M2 I-Disease 1 0.9984151124954224
) I-Disease 0 0.0009276155615225434
gangliosidosis I-Disease 0 0.052229225635528564
. O 0 0.0010801381431519985

On O 0 0.0020141408313065767
the O 0 0.0012061294401064515
second O 0 0.002423516707494855
maternally O 0 0.041810691356658936
inherited O 1 0.9714654684066772
allele O 0 0.0009188837138935924
, O 0 0.00016975015751086175
we O 0 6.438864511437714e-05
identified O 0 0.00010044717055279762
the O 0 0.00020960770780220628
common O 0 0.0024626965168863535
infantile O 1 0.9999997615814209
disease O 1 0.9999998807907104
- O 1 0.9992270469665527
causing O 1 0.9939649701118469
4 O 0 0.0011711792321875691
- O 0 0.0008723051869310439
bp O 0 0.001819743076339364
insertion O 0 0.000775761203840375
, O 0 0.0002120822318829596
+ O 0 0.001258715521544218
TATC O 1 0.9963809847831726
1278 O 0 0.3802977502346039
, O 0 0.0002682778867892921
in O 0 0.0003512701077852398
exon O 0 0.0025869233068078756
11 O 0 0.001137148356065154
. O 0 0.000980141805484891

Pulse O 0 0.11913954466581345
- O 0 0.0038496542256325483
chase O 0 0.001537127303890884
analysis O 0 0.00019097862241324037
using O 0 0.0002094560768455267
proband O 1 0.6358236074447632
fibroblasts O 0 0.004320698790252209
revealed O 0 0.0005353604210540652
that O 0 7.345931953750551e-05
the O 0 0.0002174050605390221
W474C O 0 0.038824986666440964
- O 0 0.00040736509254202247
containing O 0 0.00015469313075300306
alpha O 0 0.00035268848296254873
- O 0 0.00021423774887807667
subunit O 0 0.00023205384786706418
precursor O 0 0.00065875198924914
was O 0 0.00029614960658364
normally O 0 8.177626295946538e-05
synthesized O 0 0.00016958446940407157
, O 0 3.528962406562641e-05
but O 0 1.4347161595651414e-05
not O 0 1.8289932995685376e-05
phosphorylated O 0 0.00025660611572675407
or O 0 9.941223106579855e-05
secreted O 0 0.000422711978899315
, O 0 0.000101051467936486
and O 0 9.033756941789761e-05
the O 0 0.0001838445314206183
mature O 0 0.0005163699970580637
lysosomal O 0 0.016972266137599945
alpha O 0 0.0007382663316093385
- O 0 0.0005559825804084539
subunit O 0 0.0003899633593391627
was O 0 0.0005178755964152515
not O 0 0.0001091280864784494
detected O 0 0.0011513929348438978
. O 0 0.0005762557266280055

When O 0 0.00206805975176394
the O 0 0.001025829347781837
W474C O 0 0.06300840526819229
- O 0 0.0013771145604550838
containing O 0 0.0006385642336681485
alpha O 0 0.0007348550134338439
- O 0 0.0005762238870374858
subunit O 0 0.0003761131374631077
was O 0 0.0008037296938709915
transiently O 0 0.0021686917170882225
co O 0 0.0006660367362201214
- O 0 0.00018410377379041165
expressed O 0 6.539095193147659e-05
with O 0 2.2800366423325613e-05
the O 0 0.0001042998192133382
beta O 0 0.00019066639652010053
- O 0 0.0001240573765244335
subunit O 0 8.064284338615835e-05
to O 0 3.482399188214913e-05
produce O 0 0.00010784769256133586
Hex O 0 0.0006682098610326648
A O 0 0.00031745005981065333
( O 0 0.00017103120626416057
alphabeta O 0 0.002191266743466258
) O 0 0.00010132512397831306
in O 0 0.00015360221732407808
COS O 1 0.9792125225067139
- O 0 0.0013587729772552848
7 O 0 0.00047136127250269055
cells O 0 0.00015129678649827838
, O 0 3.878344432450831e-05
the O 0 7.723340968368575e-05
mature O 0 0.00019619686645455658
alpha O 0 0.0002466120640747249
- O 0 0.0001743545290082693
subunit O 0 0.0001230116031365469
was O 0 0.0002126714971382171
present O 0 6.0244554333621636e-05
, O 0 3.4506570955272764e-05
but O 0 1.2688943570537958e-05
its O 0 2.2288993932306767e-05
level O 0 6.709781155223027e-05
was O 0 0.00013485396630130708
much O 0 4.898444240097888e-05
lower O 0 5.171894372324459e-05
than O 0 1.488137695559999e-05
that O 0 1.3947280422144104e-05
from O 0 3.663423194666393e-05
normal O 0 0.0001265799073735252
alpha O 0 0.0002613564720377326
- O 0 0.00029018602799624205
subunit O 0 0.0003117098822258413
transfections O 0 0.001488066976889968
, O 0 7.000436016824096e-05
although O 0 4.41626543761231e-05
higher O 0 3.8030208088457584e-05
than O 0 2.3087035515345633e-05
in O 0 3.8993977796053514e-05
those O 0 4.499119313550182e-05
cells O 0 0.000198855806956999
transfected O 0 0.000793290906585753
with O 0 7.338747673202306e-05
an O 0 0.00012961267202626914
alpha O 0 0.0005808964488096535
- O 0 0.0004116367199458182
subunit O 0 0.0003633298329077661
associated O 0 0.0003023861791007221
with O 0 0.00036628314410336316
infantile O 1 0.999914288520813
TSD B-Disease 1 0.9999847412109375
. O 0 0.00316973146982491

Furthermore O 0 0.0025987704284489155
, O 0 0.0004346520290710032
the O 0 0.0003649089194368571
precursor O 0 0.001047134748660028
level O 0 0.00029289687518030405
of O 0 0.00017152198415715247
the O 0 0.00036057110992260277
W474C O 0 0.028256310150027275
alpha O 0 0.0005379771464504302
- O 0 0.00020653250976465642
subunit O 0 0.00011290294060017914
was O 0 8.758497278904542e-05
found O 0 2.6882969905273058e-05
to O 0 3.040975207113661e-05
accumulate O 0 6.980010948609561e-05
in O 0 3.590099368011579e-05
comparison O 0 5.0934399041580036e-05
to O 0 2.4275548639707267e-05
the O 0 0.00011305291263852268
normal O 0 0.00026693023391999304
alpha O 0 0.0005354333552531898
- O 0 0.00037124668597243726
subunit O 0 0.0006285755080170929
precursor O 0 0.0036630784161388874
levels O 0 0.0009434111998416483
. O 0 0.0004242477589286864

We O 0 0.0014160795835778117
conclude O 0 0.001319656614214182
that O 0 0.000159186078235507
the O 0 0.00046753830974921584
1422 O 1 0.8177005648612976
G O 0 0.2606632113456726
- O 0 0.005797725636512041
- O 0 0.001720620784908533
> O 0 0.0010542988311499357
C O 0 0.0005745252128690481
mutation O 0 6.813337677158415e-05
is O 0 3.0817063816357404e-05
the O 0 0.00010391601972514763
cause O 0 0.00035341328475624323
of O 0 0.0006889697979204357
Hex B-Disease 1 0.9840701818466187
A I-Disease 1 0.9994671940803528
enzyme I-Disease 1 0.9999474287033081
deficiency I-Disease 1 0.9999997615814209
in O 0 0.0005133314989507198
the O 0 0.004585765767842531
proband O 1 0.9988594055175781
. O 0 0.0012858050176873803

The O 0 0.007366599515080452
resulting O 0 0.009339926764369011
W474C O 1 0.7260411381721497
substitution O 0 0.0032447250559926033
clearly O 0 0.0008747380343265831
interferes O 0 0.0010514981113374233
with O 0 0.00012548676750157028
alpha O 0 0.00042650679824873805
- O 0 0.0001978364452952519
subunit O 0 0.00018211202404927462
processing O 0 9.655748726800084e-05
, O 0 2.7289956051390618e-05
but O 0 1.1974504559475463e-05
because O 0 1.746697489579674e-05
the O 0 3.882407327182591e-05
base O 0 0.00022171088494360447
substitution O 0 0.0003691621241159737
falls O 0 0.0008621233282610774
at O 0 0.00012366313603706658
the O 0 5.712512574973516e-05
first O 0 6.981995102250949e-05
position O 0 9.600203338777646e-05
of O 0 0.00011611869558691978
exon O 0 0.0010561937233433127
13 O 0 0.00032632157672196627
, O 0 0.0001687648764345795
aberrant O 0 0.001449835835956037
splicing O 0 0.0006787297315895557
may O 0 0.00013257793034426868
also O 0 9.487815987085924e-05
contribute O 0 0.00014712379197590053
to O 0 0.00014922245463822037
Hex B-Disease 0 0.33181801438331604
A I-Disease 1 0.992067813873291
deficiency I-Disease 1 0.9999970197677612
in O 0 0.0005046879523433745
this O 0 0.0002931849448941648
proband O 1 0.9770783185958862
. O 0 0.0005078797694295645
. O 0 0.0007207682356238365

Two O 0 0.002390987239778042
frequent O 0 0.0037806520704180002
missense O 0 0.041073624044656754
mutations O 0 0.021521443501114845
in O 1 0.7607021331787109
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 0.23379208147525787

Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 1 0.99468994140625
an O 1 0.999908447265625
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 1 1.0
by O 1 0.9999425411224365
early O 1 0.9999969005584717
childhood O 1 1.0
deafness B-Disease 1 1.0
and O 1 0.9999896287918091
goiter B-Disease 1 1.0
. O 1 0.8111107349395752

A O 0 0.004519427660852671
century O 0 0.0019506633980199695
after O 0 0.00045004565618000925
its O 0 0.0001126192873925902
recognition O 0 0.0003271819732617587
as O 0 0.0003455263504292816
a O 0 0.019001489505171776
syndrome O 1 0.9999995231628418
by O 0 0.000784927629865706
Vaughan O 1 0.9989483952522278
Pendred O 1 0.9999712705612183
, O 0 0.0006327830487862229
the O 0 0.009973447769880295
disease O 1 0.9999712705612183
gene O 0 0.001707924297079444
( O 0 0.0004856791056226939
PDS O 1 0.9987168312072754
) O 0 0.0001264040474779904
was O 0 0.0003430955111980438
mapped O 0 0.00042150416993536055
to O 0 0.0002508034522179514
chromosome O 0 0.0026788394898176193
7q22 O 1 0.9965387582778931
- O 0 0.08143067359924316
q31 O 1 0.8076202869415283
. O 0 0.002101300284266472

1 O 0 0.0019474567379802465
and O 0 0.0003137357416562736
, O 0 0.0001596271904418245
recently O 0 0.0002711481647565961
, O 0 6.601669156225398e-05
found O 0 5.6874167057685554e-05
to O 0 8.410680311499164e-05
encode O 0 0.00031537676113657653
a O 0 0.0006913641700521111
putative O 0 0.01372701209038496
sulfate O 1 0.9982902407646179
transporter O 1 0.966013491153717
. O 0 0.0017092867055907845

We O 0 0.0011723825009539723
performed O 0 0.0013033689465373755
mutation O 0 0.0002149338397430256
analysis O 0 5.07017903146334e-05
of O 0 0.00015179328329395503
the O 0 0.000659512123093009
PDS B-Disease 1 0.9999561309814453
gene O 0 0.00035789134562946856
in O 0 0.00013891176786273718
patients O 0 0.00010061647481052205
from O 0 0.00011150392674608156
14 O 0 0.0005675880238413811
Pendred B-Disease 0 0.3103429079055786
families O 0 8.925302245188504e-05
originating O 0 0.00012356317893136293
from O 0 5.433618571260013e-05
seven O 0 6.292597390711308e-05
countries O 0 1.6250627595582046e-05
and O 0 3.775147706619464e-05
identified O 0 0.00011199984874110669
all O 0 0.00012204301310703158
mutations O 0 0.0007163538248278201
. O 0 0.0006284203263930976

The O 0 0.0024449448101222515
mutations O 0 0.0005461556720547378
include O 0 0.00013689309707842767
three O 0 0.00015611179696861655
single O 0 0.00025791689404286444
base O 0 0.0006338622770272195
deletions O 0 0.0005601472803391516
, O 0 9.423067240277305e-05
one O 0 0.00010201793338637799
splice O 0 0.0008913759957067668
site O 0 0.00040954130236059427
mutation O 0 0.0002113149967044592
and O 0 0.0001428904215572402
10 O 0 0.0003431635268498212
missense O 0 0.0025514874141663313
mutations O 0 0.0007138524088077247
. O 0 0.0006288691074587405

One O 0 0.0028295975644141436
missense O 0 0.00760730542242527
mutation O 0 0.0012172231217846274
( O 0 0.0006426132167689502
L236P O 1 0.9109883904457092
) O 0 0.00021548580843955278
was O 0 0.00031381865846924484
found O 0 9.671303268987685e-05
in O 0 4.5218384912004694e-05
a O 0 0.00010334514081478119
homozygous O 0 0.0001618053938727826
state O 0 5.2494349802145734e-05
in O 0 4.685916792368516e-05
two O 0 5.010734457755461e-05
consanguineous O 0 0.0009015862597152591
families O 0 6.834435043856502e-05
and O 0 6.837303226348013e-05
in O 0 5.535362652153708e-05
a O 0 0.00010875100997509435
heterozygous O 0 6.589919939870015e-05
state O 0 2.4740311346249655e-05
in O 0 4.130056549911387e-05
five O 0 7.005911902524531e-05
additional O 0 0.0001550342421978712
non O 0 0.0006612721481360495
- O 0 0.0014448602451011539
consanguineous O 0 0.005838180426508188
families O 0 0.0005663688643835485
. O 0 0.0008314964361488819

Another O 0 0.006860062945634127
missense O 0 0.01161688007414341
mutation O 0 0.0025481039192527533
( O 0 0.0008395379409193993
T416P O 1 0.877945601940155
) O 0 0.00015107981744222343
was O 0 0.00020925684657413512
found O 0 4.7218924009939656e-05
in O 0 4.0739345422480255e-05
a O 0 7.492356235161424e-05
homozygous O 0 8.360910578630865e-05
state O 0 2.2764690584153868e-05
in O 0 2.4560522433603182e-05
one O 0 2.9382568754954264e-05
family O 0 4.3626732804114e-05
and O 0 2.443194534862414e-05
in O 0 3.4500779293011874e-05
a O 0 6.396965181920677e-05
heterozygous O 0 4.718867421615869e-05
state O 0 2.653610317793209e-05
in O 0 4.635422374121845e-05
four O 0 0.00010360396117903292
families O 0 0.00015987061487976462
. O 0 0.0004010233678855002

Pendred B-Disease 1 0.9991188645362854
patients O 0 0.002613374497741461
in O 0 0.0003100950561929494
three O 0 0.00028282302082516253
non O 0 0.0010946565307676792
- O 0 0.0014094830257818103
consanguineous O 0 0.0024954171385616064
families O 0 0.00013353915710467845
were O 0 8.481718396069482e-05
shown O 0 0.00011855439515784383
to O 0 6.734146154485643e-05
be O 0 0.00010005695366999134
compound O 0 0.002860176144167781
heterozygotes O 0 0.002310132374987006
for O 0 0.00032431585714221
L236P O 1 0.8433257937431335
and O 0 0.0016469775000587106
T416P O 1 0.9470757842063904
. O 0 0.002292404416948557

In O 0 0.0007516632904298604
total O 0 0.0003253179311286658
, O 0 8.719015022506937e-05
one O 0 7.733850361546502e-05
or O 0 4.9726055294740945e-05
both O 0 2.8152126105851494e-05
of O 0 9.04787884792313e-05
these O 0 3.212011870346032e-05
mutations O 0 4.977790740667842e-05
were O 0 3.196473699063063e-05
found O 0 3.045906123588793e-05
in O 0 4.019978587166406e-05
nine O 0 7.483266381314024e-05
of O 0 8.74105971888639e-05
the O 0 0.0001710049546090886
14 O 0 0.0003110378165729344
families O 0 0.00025155875482596457
analyzed O 0 0.000691734254360199
. O 0 0.0005157594569027424

The O 0 0.0014066429575905204
identification O 0 0.0004526732082013041
of O 0 0.00026490254094824195
two O 0 0.00020198280981276184
frequent O 0 0.0022335653193295
PDS B-Disease 1 0.9999877214431763
mutations O 0 0.0006473014364019036
will O 0 0.00016014247376006097
facilitate O 0 0.00036370792076922953
the O 0 0.0004827381344512105
molecular O 0 0.0041898926720023155
diagnosis O 1 0.9907515048980713
of O 1 0.9997501969337463
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 0.34226149320602417

Insertional O 1 0.9821135401725769
mutation O 0 0.003540558274835348
by O 0 0.0009273755713365972
transposable O 0 0.07083242386579514
element O 0 0.005388080142438412
, O 0 0.0006359738181345165
L1 O 0 0.018336012959480286
, O 0 0.00022132160665933043
in O 0 0.0001681360590737313
the O 0 0.0005362945375964046
DMD B-Disease 1 0.9999734163284302
gene O 0 0.0004495791217777878
results O 0 0.00022289720072876662
in O 0 0.00035388412652537227
X B-Disease 1 0.9882802963256836
- I-Disease 1 0.9936235547065735
linked I-Disease 1 0.9858192205429077
dilated I-Disease 1 0.9999769926071167
cardiomyopathy I-Disease 1 1.0
. O 0 0.021928604692220688

X B-Disease 1 0.9997171759605408
- I-Disease 1 0.9995444416999817
linked I-Disease 1 0.9996452331542969
dilated I-Disease 1 0.9999992847442627
cardiomyopathy I-Disease 1 1.0
( O 1 0.9999171495437622
XLDCM B-Disease 1 0.9999996423721313
) O 0 0.0006412882939912379
is O 0 0.0002402547252131626
a O 0 0.00028332232614047825
clinical O 0 0.0008148078923113644
phenotype O 0 0.0011748138349503279
of O 0 0.0015094142872840166
dystrophinopathy B-Disease 1 0.9999237060546875
which O 0 0.00031669915188103914
is O 0 0.0001543932594358921
characterized O 0 0.00060934730572626
by O 0 0.00023043858527671546
preferential O 0 0.08803845196962357
myocardial B-Disease 1 0.9999998807907104
involvement I-Disease 1 0.9684106111526489
without O 0 0.0005800563376396894
any O 0 0.0003185976529493928
overt O 0 0.016832472756505013
clinical O 1 0.5519173741340637
signs O 1 0.9978941082954407
of O 1 0.9998231530189514
skeletal B-Disease 1 1.0
myopathy I-Disease 1 1.0
. O 1 0.7994500994682312

To O 0 0.0009023790480569005
date O 0 0.0007298889104276896
, O 0 0.0001677913824096322
several O 0 0.00015674096357543021
mutations O 0 0.00024478649720549583
in O 0 0.0003426303737796843
the O 1 0.8996994495391846
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
gene O 1 0.9999740123748779
, O 1 0.9881667494773865
DMD O 1 0.9999998807907104
, O 0 0.00025341936270706356
have O 0 4.1366234654560685e-05
been O 0 5.164694084669463e-05
identified O 0 9.589370165485889e-05
in O 0 8.71544107212685e-05
patients O 0 0.0001867098908405751
with O 0 0.00020522554405033588
XLDCM B-Disease 1 0.9999985694885254
, O 0 0.00018732313765212893
but O 0 3.4244254493387416e-05
a O 0 9.036462142830715e-05
pathogenic O 0 0.00023777238675393164
correlation O 0 9.763539856066927e-05
of O 0 0.00014422849926631898
these O 0 0.00013586314162239432
cardiospecific O 1 0.9016780853271484
mutations O 0 0.0005228825029917061
in O 0 0.00038283877074718475
DMD O 1 0.9999674558639526
with O 0 0.0004845801740884781
the O 0 0.03789632022380829
XLDCM B-Disease 1 0.9999988079071045
phenotype O 0 0.024260343983769417
has O 0 0.0002765470708254725
remained O 0 0.000542491558007896
to O 0 0.0001626230077818036
be O 0 0.0002700014447327703
elucidated O 0 0.006582334171980619
. O 0 0.0009410720085725188

We O 0 0.0011643380858004093
report O 0 0.0003521123144309968
here O 0 0.00018475971592124552
the O 0 9.589588444214314e-05
identification O 0 9.914752445183694e-05
of O 0 0.0002090873458655551
a O 0 0.0003092312254011631
unique O 0 0.000531256664544344
de O 0 0.001954450039193034
novo O 0 0.003668655175715685
L1 O 0 0.005079921334981918
insertion O 0 0.0009504129993729293
in O 0 0.0001961396192200482
the O 0 0.00040031218668445945
muscle O 0 0.024724651128053665
exon O 0 0.0024746234994381666
1 O 0 0.0003770871553570032
in O 0 0.00027437700191512704
DMD O 1 0.999001681804657
in O 0 0.0001845850347308442
three O 0 0.00025189449661411345
XLDCM B-Disease 1 0.9999557733535767
patients O 0 0.0002827011630870402
from O 0 0.00010011124686570838
two O 0 0.00010250022023683414
unrelated O 0 0.0005893961642868817
Japanese O 0 0.0027080608997493982
families O 0 0.000469978986075148
. O 0 0.0007587948348373175

The O 0 0.0022214234340935946
insertion O 0 0.002943190513178706
was O 0 0.0008228703518398106
a O 0 0.00034402371966280043
5 O 0 0.0003780399274546653
- O 0 0.000336012220941484
truncated O 0 0.00039312109583988786
form O 0 0.00011782466026488692
of O 0 0.0002140731958206743
human O 0 0.00023866294941399246
L1 O 0 0.005081712268292904
inversely O 0 0.0006033456302247941
integrated O 0 0.0005704013165086508
in O 0 6.393514922820032e-05
the O 0 0.00010269187623634934
5 O 0 0.0001592788757989183
- O 0 0.00021342470427043736
untranslated O 0 0.0005367002449929714
region O 0 0.000152913635247387
in O 0 8.779762720223516e-05
the O 0 0.0002566470066085458
muscle O 0 0.1270473748445511
exon O 0 0.0023498334921896458
1 O 0 0.00018903956515714526
, O 0 5.317909017321654e-05
which O 0 3.949761958210729e-05
affected O 0 7.102698873495683e-05
the O 0 9.212257282342762e-05
transcription O 0 0.00022749233176000416
or O 0 6.303895497694612e-05
the O 0 0.00014049431774765253
stability O 0 0.0005289415130391717
of O 0 0.0004944700049236417
the O 0 0.002646756824105978
muscle O 1 0.9595713019371033
form O 0 0.00043605416431091726
of O 0 0.0026718878652900457
dystrophin O 1 0.8473173379898071
transcripts O 0 0.0004033709701616317
but O 0 2.87191887764493e-05
not O 0 1.3033701179665513e-05
that O 0 9.60458055487834e-06
of O 0 7.410888065351173e-05
the O 0 0.0027663116343319416
brain O 1 0.999941349029541
or O 0 0.16272231936454773
Purkinje O 1 0.9999992847442627
cell O 0 0.4164007604122162
form O 0 0.0002144580939784646
, O 0 7.691486098337919e-05
probably O 0 0.00011272533447481692
due O 0 6.224874960025772e-05
to O 0 2.1006724637118168e-05
its O 0 2.815620791807305e-05
unique O 0 9.403768490301445e-05
site O 0 0.0002895506622735411
of O 0 0.00026053370675072074
integration O 0 0.0013645198196172714
. O 0 0.0007372068357653916

We O 0 0.0017238958971574903
speculate O 0 0.001181539031676948
that O 0 9.313562622992322e-05
this O 0 8.092217467492446e-05
insertion O 0 0.0004458752227947116
of O 0 0.0001857198658399284
an O 0 0.00018839318363461643
L1 O 0 0.03573339432477951
sequence O 0 0.0003856531111523509
in O 0 0.00036271728458814323
DMD O 1 0.9999169111251831
is O 0 8.467357838526368e-05
responsible O 0 0.0001089193465304561
for O 0 2.6049030566355214e-05
some O 0 1.5499193978030235e-05
of O 0 6.0774662415497005e-05
the O 0 7.849767280276865e-05
population O 0 3.900145384250209e-05
of O 0 0.0001524745166534558
Japanese O 0 0.04282679036259651
patients O 0 0.0005702637718059123
with O 0 0.0002474344801157713
XLDCM B-Disease 1 0.9999823570251465
. O 0 0.0005862683756276965
. O 0 0.0005967890610918403

Severe O 1 0.9999047517776489
early O 1 0.996545135974884
- O 1 0.999993085861206
onset O 1 1.0
obesity B-Disease 1 1.0
, O 1 0.9999964237213135
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 1 0.999992847442627
red O 1 0.9999997615814209
hair O 1 0.9999983310699463
pigmentation O 1 0.9999988079071045
caused O 1 0.9999908208847046
by O 0 0.03864282742142677
POMC O 1 0.9999933242797852
mutations O 0 0.0007033625151962042
in O 0 0.0003085877688135952
humans O 0 0.0006432844675146043
. O 0 0.0006413482478819788

Sequential O 0 0.007253294810652733
cleavage O 0 0.006297327112406492
of O 0 0.0008685307111591101
the O 0 0.0006215382018126547
precursor O 0 0.005332724191248417
protein O 0 0.000773785577621311
pre O 0 0.002574003767222166
- O 0 0.00147622125223279
pro O 0 0.002871220000088215
- O 0 0.0027369498275220394
opiomelanocortin O 1 0.6228180527687073
( O 0 0.0012409011833369732
POMC O 1 0.7712265253067017
) O 0 0.0003075655840802938
generates O 0 0.0004997981595806777
the O 0 0.0006171988206915557
melanocortin O 0 0.3936784863471985
peptides O 0 0.0031729964539408684
adrenocorticotrophin O 1 0.9933348894119263
( O 0 0.0022071669809520245
ACTH O 1 0.9817633032798767
) O 0 0.0005705924704670906
, O 0 0.0006232513696886599
melanocyte O 1 0.9974958300590515
- O 1 0.5305243134498596
stimulating O 1 0.8526185750961304
hormones O 0 0.2535763680934906
( O 0 0.0007624671561643481
MSH O 1 0.7704532742500305
) O 0 0.00019489266560412943
alpha O 0 0.0002874462225008756
, O 0 7.744248432572931e-05
beta O 0 0.0001307350175920874
and O 0 4.04013590014074e-05
gamma O 0 0.00013242417480796576
as O 0 4.6697325160494074e-05
well O 0 3.38334939442575e-05
as O 0 5.428227814263664e-05
the O 0 0.00014004597323946655
opioid O 0 0.0024802747648209333
- O 0 0.0009302814723923802
receptor O 0 0.0006136976298876107
ligand O 0 0.002564144553616643
beta O 0 0.003035075031220913
- O 0 0.0037886416539549828
endorphin O 0 0.024684038013219833
. O 0 0.0012613083235919476

While O 0 0.00131357426289469
a O 0 0.0005750012351199985
few O 0 0.00021804736752528697
cases O 0 0.00021144983475096524
of O 0 0.014660051092505455
isolated O 1 0.999992847442627
ACTH B-Disease 1 1.0
deficiency I-Disease 1 0.9999998807907104
have O 0 0.00014666869537904859
been O 0 0.00015378717216663063
reported O 0 0.0002719922340475023
( O 0 0.00045695379958488047
OMIM O 1 0.9995145797729492
201400 O 1 0.9924511313438416
) O 0 0.00020718418818432838
, O 0 0.00013923905498813838
an O 0 0.0003680491936393082
inherited O 1 0.9999966621398926
POMC O 1 1.0
defect O 1 0.9999994039535522
has O 0 0.0005087489844299853
not O 0 7.612301124026999e-05
been O 0 0.00011247932707192376
described O 0 0.00018507901404518634
so O 0 7.354350236710161e-05
far O 0 0.0002768849954009056
. O 0 0.0003898224967997521

Recent O 0 0.002918304642662406
studies O 0 0.0005307159153744578
in O 0 0.0002466327860020101
animal O 0 0.0006689401343464851
models O 0 0.00027066670008935034
elucidated O 0 0.0010886394884437323
a O 0 0.00017500710964668542
central O 0 0.00021212104184087366
role O 0 0.00030616746516898274
of O 0 0.00037376725231297314
alpha O 0 0.00250679487362504
- O 0 0.0016774773830547929
MSH O 0 0.10364283621311188
in O 0 0.0001077460401575081
the O 0 0.00013138788926880807
regulation O 0 9.853027586359531e-05
of O 0 0.0001362083276035264
food O 0 0.0002888792660087347
intake O 0 0.0002730817359406501
by O 0 3.649259451776743e-05
activation O 0 8.290629921248183e-05
of O 0 0.00010866807133425027
the O 0 0.0003119361062999815
brain O 0 0.16515038907527924
melanocortin O 1 0.507745623588562
- O 0 0.00040841070585884154
4 O 0 0.00024726844276301563
- O 0 0.00043515159632079303
receptor O 0 0.00028846124769188464
( O 0 0.00023990932095330209
MC4 O 0 0.4391191899776459
- O 0 0.0008041387773118913
R O 0 0.0013045439263805747
; O 0 8.340531348949298e-05
refs O 0 0.0007765226764604449
3 O 0 0.00016422709450125694
- O 0 0.00019091852300334722
5 O 0 9.865936590358615e-05
) O 0 3.7245656130835414e-05
and O 0 2.4510474759154022e-05
the O 0 8.393694588448852e-05
linkage O 0 0.0005761772044934332
of O 0 0.0009971215622499585
human O 0 0.13388438522815704
obesity B-Disease 1 0.9998787641525269
to O 0 0.00010704586748033762
chromosome O 0 0.00013818172737956047
2 O 0 5.647175566991791e-05
in O 0 2.5953466320061125e-05
close O 0 7.108676072675735e-05
proximity O 0 9.226825932273641e-05
to O 0 4.1371600673301145e-05
the O 0 0.00023584665905218571
POMC O 1 0.9996059536933899
locus O 0 0.000942551763728261
, O 0 7.096950866980478e-05
led O 0 0.00013908499386161566
to O 0 3.951419057557359e-05
the O 0 5.86894057050813e-05
proposal O 0 5.584714745054953e-05
of O 0 6.380431295838207e-05
an O 0 9.949027298716828e-05
association O 0 0.0002598674036562443
of O 0 0.0015251566655933857
POMC O 1 0.9999958276748657
with O 0 0.00913385022431612
human O 1 0.9280962347984314
obesity B-Disease 1 0.9999847412109375
. O 0 0.001382680144160986

The O 0 0.0014898095978423953
dual O 0 0.00147648632992059
role O 0 0.0014970910269767046
of O 0 0.0020537329837679863
alpha O 0 0.08851596713066101
- O 0 0.050643302500247955
MSH O 1 0.9740468263626099
in O 0 0.000362288934411481
regulating O 0 0.0007330117514356971
food O 0 0.0006661433726549149
intake O 0 0.0008137332042679191
and O 0 0.0002577050181571394
influencing O 0 0.002322410000488162
hair O 1 0.7973310351371765
pigmentation O 1 0.9984996318817139
predicts O 0 0.0013836139114573598
that O 0 9.146215597866103e-05
the O 0 0.00020737350860144943
phenotype O 0 0.0005525657907128334
associated O 0 0.0001357633009320125
with O 0 0.00012142291234340519
a O 0 0.003378936555236578
defect O 1 0.9999626874923706
in O 0 0.018853167071938515
POMC O 1 0.999981164932251
function O 0 0.0005777213373221457
would O 0 0.00025425071362406015
include O 0 0.000501053174957633
obesity B-Disease 1 0.9996323585510254
, O 0 0.0006536933942697942
alteration O 1 0.9980514049530029
in O 0 0.40236279368400574
pigmentation O 1 0.9999990463256836
and O 1 0.999936580657959
ACTH B-Disease 1 0.9999998807907104
deficiency I-Disease 1 0.9999998807907104
. O 0 0.005858100019395351

The O 0 0.0019913578871637583
observation O 0 0.002966620260849595
of O 0 0.0009861333528533578
these O 0 0.00016584369586780667
symptoms O 0 0.15173110365867615
in O 0 0.00017912375915329903
two O 0 0.00014722988998983055
probands O 1 0.9480774402618408
prompted O 0 0.00043192022712901235
us O 0 0.00011693985288729891
to O 0 2.723769830481615e-05
search O 0 6.974449206609279e-05
for O 0 5.462447734316811e-05
mutations O 0 8.606891060480848e-05
within O 0 0.00011132956569781527
their O 0 0.00018817506497725844
POMC O 1 0.9988116025924683
genes O 0 0.000982706667855382
. O 0 0.0007108013960532844

Patient O 0 0.017292695119976997
1 O 0 0.001554782153107226
was O 0 0.001061226474121213
found O 0 0.0001288033090531826
to O 0 6.111045513534918e-05
be O 0 5.213450640439987e-05
a O 0 0.00018183927750214934
compound O 0 0.0012123534688726068
heterozygote O 0 0.0007982577662914991
for O 0 3.8796984881628305e-05
two O 0 2.582372871984262e-05
mutations O 0 6.297880463534966e-05
in O 0 9.11501920199953e-05
exon O 0 0.0009584506042301655
3 O 0 0.00038412760477513075
( O 0 0.00038898838101886213
G7013T O 0 0.4343358278274536
, O 0 0.00042937113903462887
C7133delta O 1 0.6389529705047607
) O 0 0.00013126640988048166
which O 0 8.555933891329914e-05
interfere O 0 0.00016136275371536613
with O 0 5.6033914006548e-05
appropriate O 0 0.00019282373250462115
synthesis O 0 0.0005888854502700269
of O 0 0.0012463298626244068
ACTH O 1 0.9991487264633179
and O 0 0.0008039227686822414
alpha O 0 0.00724745960906148
- O 0 0.01143492292612791
MSH O 1 0.9654009342193604
. O 0 0.001327376114204526

Patient O 0 0.007828419096767902
2 O 0 0.0011575151002034545
was O 0 0.0011256594443693757
homozygous O 0 0.00036477847606875
for O 0 5.842750397277996e-05
a O 0 0.00012518605217337608
mutation O 0 0.00016066709940787405
in O 0 0.00010042342910310254
exon O 0 0.001183822052553296
2 O 0 0.000386189843993634
( O 0 0.0004555908963084221
C3804A O 0 0.016059041023254395
) O 0 0.00035750260576605797
which O 0 0.000499367481097579
abolishes O 0 0.01595606468617916
POMC O 1 0.9952278137207031
translation O 0 0.0029772876296192408
. O 0 0.0010168981971219182

These O 0 0.0007150136516429484
findings O 0 0.00037565716775134206
represent O 0 0.00015050251386128366
the O 0 0.00016233576752711087
first O 0 0.00018597592134028673
examples O 0 0.00017741713963914663
of O 0 0.0002845529525075108
a O 0 0.0031373954843729734
genetic B-Disease 1 0.9761191606521606
defect I-Disease 1 0.9999841451644897
within O 0 0.0008745226659812033
the O 0 0.015450630336999893
POMC O 1 0.999961256980896
gene O 0 0.0001803659542929381
and O 0 3.973350612795912e-05
define O 0 0.00015850512136239558
a O 0 0.0004119878576602787
new O 0 0.0016012744745239615
monogenic B-Disease 1 0.9999997615814209
endocrine I-Disease 1 0.9999998807907104
disorder I-Disease 1 0.9999997615814209
resulting O 1 0.9322934746742249
in O 0 0.009494149126112461
early O 1 0.973851203918457
- O 1 0.9999314546585083
onset O 1 0.9999998807907104
obesity B-Disease 1 1.0
, O 1 0.9999246597290039
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 1 0.9999343156814575
red O 1 0.9999988079071045
hair O 1 0.9999914169311523
pigmentation O 1 0.9999465942382812
. O 0 0.000987796694971621
. O 0 0.00101054972037673

A O 0 0.007654906250536442
European O 0 0.002297653816640377
multicenter O 0 0.00648450804874301
study O 0 0.0009123559575527906
of O 0 0.0092272087931633
phenylalanine B-Disease 1 0.9999957084655762
hydroxylase I-Disease 1 0.9999940395355225
deficiency I-Disease 1 0.9999998807907104
: O 0 0.0003706645511556417
classification O 0 0.00026931503089144826
of O 0 0.00034015229903161526
105 O 0 0.0009623692603781819
mutations O 0 8.433424955001101e-05
and O 0 3.469845250947401e-05
a O 0 8.325347153004259e-05
general O 0 0.00018318726506549865
system O 0 9.980193863157183e-05
for O 0 5.0251572247361764e-05
genotype O 0 0.00033624327625148
- O 0 0.0003695332270581275
based O 0 0.0001281341101275757
prediction O 0 0.0007577423239126801
of O 0 0.0014467546716332436
metabolic O 1 0.9998860359191895
phenotype O 0 0.334667444229126
. O 0 0.0013054823502898216

Phenylketonuria B-Disease 1 0.99998939037323
( O 1 0.9830548763275146
PKU B-Disease 1 0.9999939203262329
) O 0 0.002363487146794796
and O 0 0.0032716155983507633
mild B-Disease 1 0.9999809265136719
hyperphenylalaninemia I-Disease 1 1.0
( O 1 0.9998626708984375
MHP B-Disease 1 1.0
) O 0 0.0016233958303928375
are O 0 0.00026358087779954076
allelic B-Disease 1 0.9995607733726501
disorders I-Disease 1 0.9999991655349731
caused O 1 0.9999301433563232
by O 0 0.0004346746136434376
mutations O 0 0.0001518856588518247
in O 0 7.578549411846325e-05
the O 0 0.00021691765869036317
gene O 0 0.00021645838569384068
encoding O 0 0.0004130055312998593
phenylalanine O 0 0.02758100815117359
hydroxylase O 1 0.9806711673736572
( O 0 0.011025924235582352
PAH O 1 0.9999960660934448
) O 0 0.0009212518925778568
. O 0 0.0011234531411901116

Previous O 0 0.002893430646508932
studies O 0 0.0003993782738689333
have O 0 8.636611892143264e-05
suggested O 0 0.0001937932538567111
that O 0 7.179485692176968e-05
the O 0 0.00024707993725314736
highly O 0 0.0005903991404920816
variable O 0 0.0009171164128929377
metabolic O 1 0.9997357726097107
phenotypes O 1 0.9927670955657959
of O 1 0.9999967813491821
PAH B-Disease 1 1.0
deficiency I-Disease 1 1.0
correlate O 1 0.9997703433036804
with O 1 0.9993801116943359
PAH O 1 1.0
genotypes O 1 0.9903944134712219
. O 0 0.0023883995600044727

We O 0 0.0013431214028969407
identified O 0 0.000871197902597487
both O 0 0.00030638909083791077
causative O 0 0.018412813544273376
mutations O 0 0.0006393001531250775
in O 0 0.00044493586756289005
686 O 1 0.9981618523597717
patients O 0 0.0008129458874464035
from O 0 0.00018006283789873123
seven O 0 0.00037412301753647625
European O 0 0.00041449174750596285
centers O 0 0.0008550764760002494
. O 0 0.0007613994530402124

On O 0 0.0010462806094437838
the O 0 0.00036430027103051543
basis O 0 0.00017824563838075846
of O 0 0.0002598292485345155
the O 0 0.000354035320924595
phenotypic O 0 0.0010108231799677014
characteristics O 0 0.0008757926407270133
of O 0 0.002570347161963582
297 O 1 0.9880744814872742
functionally O 1 0.9942903518676758
hemizygous O 1 0.9998999834060669
patients O 0 0.00022025012003723532
, O 0 4.901814099866897e-05
105 O 0 0.00016334286192432046
of O 0 0.00011376731708878651
the O 0 0.00010251322237309068
mutations O 0 5.481901825987734e-05
were O 0 2.2696234736940823e-05
assigned O 0 5.754750600317493e-05
to O 0 2.178377144446131e-05
one O 0 3.031998494407162e-05
of O 0 7.57489469833672e-05
four O 0 0.00010599144297884777
arbitrary O 0 0.000361003476427868
phenotype O 0 0.0011796295875683427
categories O 0 0.0006966331857256591
. O 0 0.000698624353390187

We O 0 0.0008805252728052437
proposed O 0 0.0006386993918567896
and O 0 0.00026116144726984203
tested O 0 0.00039383399416692555
a O 0 0.0001856699091149494
simple O 0 0.00016548289568163455
model O 0 0.00016883922216948122
for O 0 7.037799514364451e-05
correlation O 0 0.0001789585076039657
between O 0 0.0002462924749124795
genotype O 0 0.0005733293946832418
and O 0 0.0002620226296130568
phenotypic O 0 0.0018188769463449717
outcome O 0 0.001570618012920022
. O 0 0.0008884700364433229

The O 0 0.003695426043123007
observed O 0 0.0022633227054029703
phenotype O 0 0.002048127120360732
matched O 0 0.000614203279837966
the O 0 0.00031914940336719155
predicted O 0 0.0004923780215904117
phenotype O 0 0.0002814656472764909
in O 0 4.641465056920424e-05
79 O 0 0.00010737597767729312
% O 0 3.25685650750529e-05
of O 0 6.272138125495985e-05
the O 0 0.00012359736138023436
cases O 0 5.2968389354646206e-05
, O 0 3.182215368724428e-05
and O 0 1.4055731298867613e-05
in O 0 1.3341941667022184e-05
only O 0 1.5200647794699762e-05
5 O 0 2.915046934504062e-05
of O 0 7.080963405314833e-05
184 O 0 0.00047323518083430827
patients O 0 9.915064583765343e-05
was O 0 0.0001624175056349486
the O 0 8.272127161035314e-05
observed O 0 8.157080446835607e-05
phenotype O 0 7.377698057098314e-05
more O 0 8.096963938442059e-06
than O 0 1.167463960882742e-05
one O 0 2.2817679564468563e-05
category O 0 5.087871613795869e-05
away O 0 7.64518408686854e-05
from O 0 6.647183181485161e-05
that O 0 5.88951661484316e-05
expected O 0 0.000335742806782946
. O 0 0.0004965889384038746

Among O 0 0.001001794938929379
the O 0 0.0005810093716718256
seven O 0 0.0005473642377182841
contributing O 0 0.0008244927739724517
centers O 0 0.00036266198731027544
, O 0 8.275006985059008e-05
the O 0 0.00010458505857968703
proportion O 0 0.00010034952720161527
of O 0 0.0002368747373111546
patients O 0 0.0001201935374410823
for O 0 4.275260289432481e-05
whom O 0 0.00013665700680576265
the O 0 0.00017294581630267203
observed O 0 0.00022202054969966412
phenotype O 0 0.0003313443448860198
did O 0 5.644369593937881e-05
not O 0 2.187720383517444e-05
match O 0 6.359534745570272e-05
the O 0 7.587053551105782e-05
predicted O 0 0.00022458762396126986
phenotype O 0 0.0001648292236495763
was O 0 0.00016018493624869734
4 O 0 8.691090624779463e-05
% O 0 3.5072152968496084e-05
- O 0 0.0001093225582735613
23 O 0 0.00015638834156561643
% O 0 6.10416173003614e-05
( O 0 0.00011337937758071348
P O 0 0.0011492257472127676
< O 0 0.0009777789236977696
. O 0 9.867225162452087e-05
0001 O 0 0.0021299468353390694
) O 0 6.265658157644793e-05
, O 0 5.0038390327245e-05
suggesting O 0 6.0503341956064105e-05
that O 0 1.9146820704918355e-05
differences O 0 4.110975351068191e-05
in O 0 2.8384773031575605e-05
methods O 0 4.6849159843986854e-05
used O 0 5.9281261201249436e-05
for O 0 6.116491567809135e-05
mutation O 0 0.00023639194841962308
detection O 0 0.0006417740951292217
or O 0 0.00024684800882823765
phenotype O 0 0.0007336801500059664
classification O 0 0.000273688550805673
may O 0 7.985311822267249e-05
account O 0 3.8084872358012944e-05
for O 0 2.318440419912804e-05
a O 0 9.56602452788502e-05
considerable O 0 0.0001895384193630889
proportion O 0 0.00021847814787179232
of O 0 0.0006413109367713332
genotype O 0 0.06733445078134537
- O 0 0.07080258429050446
phenotype O 0 0.0035664145834743977
inconsistencies O 0 0.0034649609588086605
. O 0 0.0012982558691874146

Our O 0 0.002636243589222431
data O 0 0.00037429004441946745
indicate O 0 0.00037818352575413883
that O 0 0.00013946188846603036
the O 0 0.0026384899392724037
PAH O 1 1.0
- O 0 0.15729448199272156
mutation O 0 0.0003430497017689049
genotype O 0 0.00024091859813779593
is O 0 4.6642584493383765e-05
the O 0 9.30993992369622e-05
main O 0 0.0004908905830234289
determinant O 0 0.0041731661185622215
of O 0 0.026179393753409386
metabolic O 1 0.9999222755432129
phenotype O 0 0.005173808895051479
in O 0 0.0003917799040209502
most O 0 0.0006136203883215785
patients O 1 0.9074443578720093
with O 1 0.9998412132263184
PAH B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 0.12046752125024796

In O 0 0.001102892099879682
the O 0 0.0004515316104516387
present O 0 0.0002724970690906048
study O 0 9.679717186372727e-05
, O 0 6.897999264765531e-05
the O 0 0.00011110040213679895
classification O 0 0.00022568405256606638
of O 0 0.0018178800819441676
105 O 1 0.9993870258331299
PAH O 1 1.0
mutations O 0 0.00034645339474081993
may O 0 7.909375563031062e-05
allow O 0 3.527031003613956e-05
the O 0 6.366816523950547e-05
prediction O 0 0.00019196374341845512
of O 0 0.0001081617156160064
the O 0 0.00030293528106994927
biochemical O 0 0.0029589589685201645
phenotype O 0 0.00042958054109476507
in O 0 0.00012250099098309875
> O 0 0.00040305621223524213
10 O 0 0.00012304984556976706
, O 0 6.996351294219494e-05
000 O 0 0.00029227565391920507
genotypes O 0 0.0005004999693483114
, O 0 6.0795187891926616e-05
which O 0 4.3552910938160494e-05
may O 0 3.626560283009894e-05
be O 0 2.1068153728265315e-05
useful O 0 5.365440301829949e-05
for O 0 2.7187583327759057e-05
the O 0 9.898420103127137e-05
management O 0 0.00035752271651290357
of O 0 0.002214123262092471
hyperphenylalaninemia B-Disease 1 0.9999980926513672
in O 0 0.012889712117612362
newborns O 0 0.06570930033922195
. O 0 0.0008821880328468978

Somatic O 0 0.025364702567458153
instability O 0 0.013747970573604107
of O 0 0.0021948330104351044
the O 0 0.014739579521119595
CTG O 1 0.9999130964279175
repeat O 0 0.006992492824792862
in O 0 0.0004405176150612533
mice O 0 0.0004850642872042954
transgenic O 0 0.001003734301775694
for O 0 0.0001790325768524781
the O 0 0.0025821663439273834
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
region O 0 0.3660588264465332
is O 0 0.0004638949758373201
age O 0 0.00041009075357578695
dependent O 0 0.00013048294931650162
but O 0 2.9817696486134082e-05
not O 0 1.5420628187712282e-05
correlated O 0 4.50359184469562e-05
to O 0 2.953288822027389e-05
the O 0 0.00011431254824856296
relative O 0 0.0005204485496506095
intertissue O 1 0.9633424878120422
transcription O 0 0.008405479602515697
levels O 0 0.002006660448387265
and O 0 0.000837557076010853
proliferative O 1 0.9994713664054871
capacities O 0 0.03188563883304596
. O 0 0.0014900094829499722

A O 0 0.01806674525141716
( O 0 0.0037914575077593327
CTG O 1 0.8981131911277771
) O 0 0.0005820788792334497
nexpansion O 0 0.003663158742710948
in O 0 0.0002149592328350991
the O 0 0.00024108702200464904
3 O 0 0.0002846517018042505
- O 0 0.0004829977115150541
untranslated O 0 0.002315880497917533
region O 0 0.0003972628910560161
( O 0 0.00018639380868989974
UTR O 0 0.002508032601326704
) O 0 6.582860805792734e-05
of O 0 0.0001520553487353027
the O 0 0.0005665947683155537
DM O 1 0.9999843835830688
protein O 0 0.0014026686549186707
kinase O 0 0.0012367770541459322
gene O 0 0.0004692854708991945
( O 0 0.0003686270792968571
DMPK O 1 0.9964665174484253
) O 0 0.00020730789401568472
is O 0 0.00013176201900932938
responsible O 0 0.00040711049223318696
for O 0 0.0010655223159119487
causing O 1 0.9999990463256836
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999951124191284
DM B-Disease 1 1.0
) O 0 0.0030515259131789207
. O 0 0.0013994636246934533

Major O 1 0.9026212692260742
instability O 1 0.9903028607368469
, O 0 0.0006426095496863127
with O 0 0.00017571942589711398
very O 0 0.0001456545141991228
large O 0 0.0002460875839460641
expansions O 0 0.0009955926798284054
between O 0 0.00015803094720467925
generations O 0 0.00031136241159401834
and O 0 0.00010032120189862326
high O 0 0.0002842180838342756
levels O 0 0.00018307901336811483
of O 0 0.00024152804689947516
somatic O 0 0.010142507031559944
mosaicism O 1 0.9919875860214233
, O 0 0.0001469245762564242
is O 0 0.00010122178355231881
observed O 0 0.00014967760944273323
in O 0 0.0001924163952935487
patients O 0 0.0005373816238716245
. O 0 0.000417648465372622

There O 0 0.001064720214344561
is O 0 0.0002140944270649925
a O 0 0.00019296279060654342
good O 0 0.00016563807730562985
correlation O 0 0.00011815129255410284
between O 0 0.00010534485045354813
repeat O 0 0.00037844228791072965
size O 0 0.00017466604185756296
( O 0 8.03097864263691e-05
at O 0 0.0001149430318037048
least O 0 4.9725866119842976e-05
in O 0 7.048034603940323e-05
leucocytes O 0 0.1721029281616211
) O 0 7.500513311242685e-05
, O 0 7.661341805942357e-05
clinical O 0 0.0003292346082162112
severity O 0 0.0016124133253470063
and O 0 0.0001845318911364302
age O 0 0.0008231879910454154
of O 0 0.055153872817754745
onset O 1 0.9999916553497314
. O 0 0.0022589508444070816

The O 0 0.012420602142810822
trinucleotide O 1 0.999384880065918
repeat O 1 0.7344475388526917
instability O 1 0.9753680229187012
mechanisms O 0 0.0028886699583381414
involved O 0 0.0014332591090351343
in O 0 0.006650473922491074
DM B-Disease 1 1.0
and O 0 0.0012517310678958893
other O 0 0.0003126822703052312
human O 1 0.8588045835494995
genetic B-Disease 1 0.9999744892120361
diseases I-Disease 1 0.9999996423721313
are O 0 0.00022137205814942718
unknown O 0 0.0023829909041523933
. O 0 0.0006416239775717258

We O 0 0.001948213903233409
studied O 0 0.0024470193311572075
somatic O 0 0.0054961745627224445
instability O 0 0.004895764868706465
by O 0 0.00032496487256139517
measuring O 0 0.003464041044935584
the O 0 0.0015193622093647718
CTG O 1 0.9987071752548218
repeat O 0 0.0008448758162558079
length O 0 0.00010923013178398833
at O 0 0.00011894233466591686
several O 0 3.619929339038208e-05
ages O 0 8.069085015449673e-05
in O 0 4.953418465447612e-05
various O 0 6.980463513173163e-05
tissues O 0 0.0004013385041616857
of O 0 0.00039174669655039907
transgenic O 0 0.010914417915046215
mice O 0 0.00034721335396170616
carrying O 0 0.0003007843333762139
a O 0 0.00021397118689492345
( O 0 0.0002684247447177768
CTG O 0 0.12380464375019073
) O 0 0.00025355539401061833
55expansion O 0 0.0038300484884530306
surrounded O 0 0.0015292299212887883
by O 0 0.00010604785347823054
45 O 0 0.00030440051341429353
kb O 0 0.0012362548150122166
of O 0 0.0004224840959068388
the O 0 0.0006709372391924262
human O 0 0.004257947206497192
DM B-Disease 1 0.999997615814209
region O 0 0.0006711444002576172
, O 0 0.0001340179005637765
using O 0 0.00010523180390009657
small O 0 0.0002397545031271875
- O 0 0.0012168033281341195
pool O 0 0.002439135452732444
PCR O 0 0.003759515704587102
. O 0 0.0007562821847386658

These O 0 0.0020458486396819353
mice O 0 0.0017216014675796032
have O 0 8.726001397008076e-05
been O 0 0.00012179352779639885
shown O 0 0.00014424831897486
to O 0 8.604994945926592e-05
reproduce O 0 0.00021562475012615323
the O 0 0.0003137234889436513
intergenerational O 0 0.002528122626245022
and O 0 0.00022467585222329944
somatic O 0 0.001525026629678905
instability O 0 0.0023214600514620543
of O 0 0.0006624681409448385
the O 0 0.0011641401797533035
55 O 0 0.0016709084156900644
CTG O 1 0.9914618730545044
repeat O 0 0.0012376504018902779
suggesting O 0 0.00044706580229103565
that O 0 5.026106009609066e-05
surrounding O 0 0.0003772047348320484
sequences O 0 0.00013574866170529276
and O 0 7.671979255974293e-05
the O 0 0.00018513004761189222
chromatin O 0 0.0013566103298217058
environment O 0 0.00027974386466667056
are O 0 2.9347676900215447e-05
involved O 0 0.0002350262220716104
in O 0 0.0004110961453989148
instability O 1 0.8266106843948364
mechanisms O 0 0.014023682102560997
. O 0 0.0016118607018142939

As O 0 0.0017136909300461411
observed O 0 0.00045683534699492157
in O 0 0.00012646324466913939
some O 0 6.14312375546433e-05
of O 0 0.00017080322140827775
the O 0 0.000565572117920965
tissues O 1 0.7987215518951416
of O 1 0.9970477223396301
DM B-Disease 1 1.0
patients O 0 0.4085051417350769
, O 0 8.603517926530913e-05
there O 0 4.8098783736350015e-05
is O 0 4.5959266572026536e-05
a O 0 0.00010530408326303586
tendency O 0 0.00019439880270510912
for O 0 7.971145532792434e-05
repeat O 0 0.0004362381005194038
length O 0 0.00013610355381388217
and O 0 0.00013004051288589835
somatic O 0 0.0008402193780057132
mosaicism O 0 0.0076583330519497395
to O 0 6.312900222837925e-05
increase O 0 4.653879295801744e-05
with O 0 3.090188329224475e-05
the O 0 6.704722181893885e-05
age O 0 0.00015063403407111764
of O 0 0.00020029209554195404
the O 0 0.0006360608385875821
mouse O 0 0.0017129984917119145
. O 0 0.0007655504741705954

Furthermore O 0 0.0049964142963290215
, O 0 0.0006461514858528972
we O 0 0.0001419971085852012
observed O 0 0.00011873360926983878
no O 0 6.858383130747825e-05
correlation O 0 0.00010442521306686103
between O 0 0.00010189328895648941
the O 0 0.0002433660120004788
somatic O 0 0.002631856594234705
mutation O 0 0.0005792182637378573
rate O 0 0.0003754668578039855
and O 0 0.00046128983376547694
tissue O 1 0.9008386135101318
proliferation O 0 0.397930771112442
capacity O 0 0.003540544770658016
. O 0 0.0010606737341731787

The O 0 0.0038315479177981615
somatic O 0 0.0074352663941681385
mutation O 0 0.0005186283960938454
rates O 0 0.00012729695299640298
in O 0 7.054031448205933e-05
different O 0 2.593946373963263e-05
tissues O 0 0.0002902189444284886
were O 0 6.082708205212839e-05
also O 0 4.330309820943512e-05
not O 0 1.7983673387789167e-05
correlated O 0 6.370437040459365e-05
to O 0 2.7480022254167125e-05
the O 0 8.080341649474576e-05
relative O 0 0.0003496120043564588
inter O 0 0.011865799315273762
- O 0 0.014334739185869694
tissue O 0 0.0008246569777838886
difference O 0 0.00013743992894887924
in O 0 7.972970342962071e-05
transcriptional O 0 0.0003460187872406095
levels O 0 7.888239633757621e-05
of O 0 5.068781320005655e-05
the O 0 6.678278441540897e-05
three O 0 7.413601997541264e-05
genes O 0 0.00014893471961840987
( O 0 0.0002725924423430115
DMAHP O 1 0.9990072846412659
, O 0 0.0003780708648264408
DMPK O 1 0.991529107093811
and O 0 0.00021907096379436553
59 O 0 0.0005554966628551483
) O 0 9.181729546980932e-05
surrounding O 0 0.0004503276140894741
the O 0 0.0004888044204562902
repeat O 0 0.0017522640991955996
. O 0 0.00033820729004219174
. O 0 0.0005959339323453605

A O 0 0.00922400876879692
novel O 0 0.0041368394158780575
missense O 0 0.006490680389106274
mutation O 0 0.0006601992063224316
in O 0 0.00027831154875457287
patients O 0 0.0002590811636764556
from O 0 0.00019317005353514105
a O 0 0.0008709592511877418
retinoblastoma B-Disease 1 0.9957097768783569
pedigree O 0 0.006393291987478733
showing O 0 0.0007373951957561076
only O 0 0.00012166979286121204
mild O 0 0.0011710955295711756
expression O 0 0.00020912199397571385
of O 0 0.00046427323832176626
the O 0 0.2244672328233719
tumor B-Disease 1 0.999990701675415
phenotype O 0 0.022931749001145363
. O 0 0.0007767481147311628

We O 0 0.0009375825757160783
have O 0 0.0001379892200930044
used O 0 0.00014692696277052164
single O 0 0.00025928084505721927
strand O 0 0.000573421479202807
conformation O 0 0.0005344167002476752
polymorphism O 0 0.0001877716276794672
analysis O 0 3.472808384685777e-05
to O 0 2.6113402782357298e-05
study O 0 3.651898441603407e-05
the O 0 8.001074456842616e-05
27 O 0 0.00030405071447603405
exons O 0 0.0005041321855969727
of O 0 0.00028359334100969136
the O 0 0.0008973359363153577
RB1 O 1 0.9998133778572083
gene O 0 0.00022343764430843294
in O 0 7.007989916019142e-05
individuals O 0 2.9567183446488343e-05
from O 0 5.9973710449412465e-05
a O 0 0.00021648335678037256
family O 0 0.0003272699541412294
showing O 0 0.0012166207889094949
mild O 0 0.0071028247475624084
expression O 0 0.0003652398881968111
of O 0 0.000619026308413595
the O 0 0.009543506428599358
retinoblastoma B-Disease 1 0.9997032284736633
phenotype O 0 0.016414090991020203
. O 0 0.0012552404077723622

In O 0 0.0010821449104696512
this O 0 0.0002641594910528511
family O 0 0.0004892253200523555
affected O 0 0.0005922500276938081
individuals O 0 0.00015615618031006306
developed O 0 0.11689944565296173
unilateral B-Disease 1 0.9996342658996582
tumors I-Disease 1 0.9999997615814209
and O 0 0.0006667004199698567
, O 0 0.00013244475121609867
as O 0 8.679942402523011e-05
a O 0 9.14593692868948e-05
result O 0 7.902025390649214e-05
of O 0 0.00013455378939397633
linkage O 0 0.005083978641778231
analysis O 0 0.00014849059516564012
, O 0 0.00014328664110507816
unaffected O 0 0.001027539256028831
mutation O 0 0.00019545783288776875
carriers O 0 0.0001349737140117213
were O 0 4.017563696834259e-05
also O 0 3.420234133955091e-05
identified O 0 7.561744860140607e-05
within O 0 0.00010259331611450762
the O 0 0.0003925017372239381
pedigree O 0 0.003657673951238394
. O 0 0.0005970157799310982

A O 0 0.0071740662679076195
single O 0 0.0013833623379468918
band O 0 0.0013357155257835984
shift O 0 0.0008998257108032703
using O 0 0.00020954955834895372
SSCP O 1 0.9782636761665344
was O 0 0.0007503479137085378
identified O 0 0.00011303953942842782
in O 0 6.973704148549587e-05
exon O 0 0.0005804789252579212
21 O 0 0.00016006920486688614
which O 0 4.8566707846475765e-05
resulted O 0 0.00013249096809886396
in O 0 4.6140285121509805e-05
a O 0 0.00012480371515266597
missense O 0 0.0004321382730267942
mutation O 0 0.0001278100098716095
converting O 0 0.00028132478473708034
a O 0 0.00026126528973691165
cys O 0 0.019590098410844803
- O 0 0.0006614820449613035
- O 0 0.00041521896491758525
> O 0 0.00045329329441301525
arg O 0 0.0008257412118837237
at O 0 0.00020661049347836524
nucleotide O 0 0.0001760429295245558
position O 0 0.00017985797603614628
28 O 0 0.0003299658128526062
in O 0 0.0002129141503246501
the O 0 0.0004130890010856092
exon O 0 0.004903269466012716
. O 0 0.0011427286081016064

The O 0 0.003900231560692191
mutation O 0 0.0025370216462761164
destroyed O 0 0.01854517310857773
an O 0 0.0009820869890972972
NdeI O 1 0.9243287444114685
restriction O 0 0.002021751133725047
enzyme O 0 0.0020080942194908857
site O 0 0.0022761207073926926
. O 0 0.0009300342062488198

Analysis O 0 0.0010789273073896766
of O 0 0.0004916569450870156
all O 0 0.00014450354501605034
family O 0 0.00022528420959133655
members O 0 0.00010228658356936648
demonstrated O 0 0.00042329198913648725
that O 0 5.917135058552958e-05
the O 0 0.00021292467135936022
missense O 0 0.001845548045821488
mutation O 0 0.000722777156624943
co O 0 0.0024695880711078644
- O 0 0.001339132315479219
segregated O 0 0.001175505225546658
with O 0 0.00019006451475434005
patients O 0 0.04332927241921425
with O 0 0.05250677466392517
tumors B-Disease 1 0.9999998807907104
or O 0 0.0009181468049064279
who O 0 0.00011571933282539248
, O 0 5.4156320402398705e-05
as O 0 4.434551374288276e-05
a O 0 5.5294167395913973e-05
result O 0 6.935702549526468e-05
of O 0 9.118078742176294e-05
linkage O 0 0.0007371474639512599
analysis O 0 4.289737989893183e-05
had O 0 0.00010204975114902481
been O 0 8.784828969510272e-05
predicted O 0 0.00010872737038880587
to O 0 3.703347101691179e-05
carry O 0 0.00012682625674642622
the O 0 0.00031583354575559497
predisposing O 0 0.05391490086913109
mutation O 0 0.0017322427593171597
. O 0 0.0007454355363734066

These O 0 0.00030523454188369215
observations O 0 0.00031456537544727325
point O 0 0.000175946275703609
to O 0 7.510790601372719e-05
another O 0 0.00011262336920481175
region O 0 0.0001543474936624989
of O 0 0.0001621049887035042
the O 0 0.0019282996654510498
RB1 O 1 0.9999722242355347
gene O 0 0.00019159619114361703
where O 0 9.705995762487873e-05
mutations O 0 4.127721695112996e-05
only O 0 1.676029569352977e-05
modify O 0 3.9698057662462816e-05
the O 0 3.723660120158456e-05
function O 0 3.1925072107696906e-05
of O 0 7.114914478734136e-05
the O 0 0.00016799884906504303
gene O 0 0.00011077975068474188
and O 0 3.252154783695005e-05
raise O 0 5.174272519070655e-05
important O 0 3.915693378075957e-05
questions O 0 5.283047357806936e-05
for O 0 4.448146864888258e-05
genetic O 0 0.0001527815911686048
counseling O 0 0.0003955442807637155
in O 0 9.129467071034014e-05
families O 0 8.348951087100431e-05
with O 0 6.15060271229595e-05
these O 0 7.143154653022066e-05
distinctive O 0 0.0015917547279968858
phenotypes O 0 0.008213697001338005
. O 0 0.0003121797926723957
. O 0 0.0005950830527581275

Maternal B-Disease 1 0.9977989792823792
disomy I-Disease 1 0.9999542236328125
and O 1 0.9954284429550171
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
consistent O 1 0.9696650505065918
with O 0 0.004463300574570894
gamete O 1 0.9983943104743958
complementation O 1 0.9979919195175171
in O 0 0.00036984586040489376
a O 0 0.0002525394666008651
case O 0 0.00015491335943806916
of O 0 0.00016915846208576113
familial O 0 0.004504722077399492
translocation O 0 0.040110476315021515
( O 0 0.0001435240264981985
3 O 0 0.00010282346920575947
; O 0 3.306458893348463e-05
15 O 0 9.051969391293824e-05
) O 0 5.478499224409461e-05
( O 0 0.00011775986786233261
p25 O 0 0.003476208308711648
; O 0 0.00015571813855785877
q11 O 0 0.005369886290282011
. O 0 0.00017434357141610235
2 O 0 0.00034334350493736565
) O 0 0.00023765090736560524
. O 0 0.0005201490130275488

Maternal B-Disease 1 0.9984839558601379
uniparental I-Disease 1 0.999992847442627
disomy I-Disease 1 0.9999884366989136
( I-Disease 0 0.4301934540271759
UPD I-Disease 1 0.9999700784683228
) I-Disease 0 0.0002623843611218035
for I-Disease 0 0.00015743925177957863
chromosome I-Disease 0 0.0002439609816065058
15 I-Disease 0 0.0001474642485845834
is O 0 6.13877855357714e-05
responsible O 0 0.00010857547749765217
for O 0 2.9945787900942378e-05
an O 0 4.169308522250503e-05
estimated O 0 5.305757076712325e-05
30 O 0 7.17881484888494e-05
% O 0 2.9164706575102173e-05
of O 0 9.293875336879864e-05
cases O 0 0.00017757623572833836
of O 1 0.6313807368278503
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9999737739562988
PWS B-Disease 1 1.0
) O 0 0.0036324970424175262
. O 0 0.0017032218165695667

We O 0 0.0010938142659142613
report O 0 0.00028121727518737316
on O 0 0.00011398339847801253
an O 0 8.144799357978627e-05
unusual O 0 0.00014198220742400736
case O 0 0.00017439911607652903
of O 0 0.00040374454692937434
maternal B-Disease 1 0.762435257434845
disomy I-Disease 1 0.999755322933197
15 I-Disease 0 0.0021943298634141684
in O 0 0.0008441677200607955
PWS B-Disease 1 0.9999966621398926
that O 0 8.578850975027308e-05
is O 0 4.5336520997807384e-05
most O 0 2.3351445634034462e-05
consistent O 0 6.088499867473729e-05
with O 0 2.7714571842807345e-05
adjacent O 0 0.0004991531604900956
- O 0 0.00034296500962227583
1 O 0 0.00019769990467466414
segregation O 0 0.0005843652179464698
of O 0 0.0001413669961038977
a O 0 0.00022162421373650432
paternal O 0 0.0007889512926340103
t O 0 0.0004898524493910372
( O 0 6.626430695177987e-05
3 O 0 9.019080607686192e-05
; O 0 2.7531330488272943e-05
15 O 0 8.526913734385744e-05
) O 0 5.1263174100313336e-05
( O 0 0.00014608945639338344
p25 O 0 0.004734501242637634
; O 0 0.00020057265646755695
q11 O 0 0.0038969935849308968
. O 0 9.952025720849633e-05
2 O 0 0.00017082634440157562
) O 0 4.8454476200276986e-05
with O 0 5.1821978559019044e-05
simultaneous O 0 0.00040795968379825354
maternal O 0 0.004758244846016169
meiotic O 1 0.9991317391395569
nondisjunction O 1 0.9995811581611633
for O 0 0.0008547449833713472
chromosome O 0 0.0018368704477325082
15 O 0 0.0012742484686896205
. O 0 0.0007858164608478546

The O 0 0.005171468481421471
patient O 0 0.07238573580980301
( O 0 0.0018957204883918166
J O 1 0.9898109436035156
. O 0 0.00017157007823698223
B O 0 0.0005566122708842158
. O 0 5.125632742419839e-05
) O 0 2.9096396247041412e-05
, O 0 2.515771848266013e-05
a O 0 7.705346797592938e-05
17 O 0 0.000306879635900259
- O 0 0.00043760088738054037
year O 0 0.00019610747403930873
- O 0 0.0004692810762207955
old O 0 0.0006470706430263817
white O 0 0.0007457418250851333
male O 0 0.0004221660492476076
with O 0 0.0003677677595987916
PWS B-Disease 1 0.9999998807907104
, O 0 0.0004662374558392912
was O 0 0.0004964782274328172
found O 0 4.400042962515727e-05
to O 0 2.5798008209676482e-05
have O 0 1.872047687356826e-05
47 O 0 0.00011453382467152551
chromosomes O 0 8.507688471581787e-05
with O 0 5.5835706007201225e-05
a O 0 0.0003192078147549182
supernumerary O 1 0.7990349531173706
, O 0 0.0002951959613710642
paternal O 0 0.0017148912884294987
der O 0 0.010572896338999271
( O 0 0.00016382204194087535
15 O 0 0.00020464911358430982
) O 0 6.404668965842575e-05
consisting O 0 6.677680357825011e-05
of O 0 0.0001116403000196442
the O 0 0.00018264452228322625
short O 0 0.00025719936820678413
arm O 0 0.000926717184484005
and O 0 8.909843018045649e-05
the O 0 0.00022432010155171156
proximal O 1 0.9928953051567078
long O 0 0.0007689122576266527
arm O 0 0.01250766683369875
of O 0 0.0017310986295342445
chromosome O 0 0.002352586016058922
15 O 0 0.0007934437016956508
, O 0 0.00022099436318967491
and O 0 0.00040311075281351805
distal O 1 0.9791868925094604
chromosome O 1 0.7363178133964539
arm O 1 0.9981974959373474
3p O 1 0.9988003969192505
. O 0 0.0029026498086750507

The O 0 0.0024969272781163454
t O 0 0.0025445406790822744
( O 0 0.0002153559762518853
3 O 0 0.00020342830976005644
; O 0 4.3324907892383635e-05
15 O 0 6.546806980622932e-05
) O 0 3.627608748502098e-05
was O 0 0.00015270353469531983
present O 0 7.344572804868221e-05
in O 0 4.259381603333168e-05
the O 0 6.082198160584085e-05
balanced O 0 9.335667709819973e-05
state O 0 3.250994632253423e-05
in O 0 6.022105662850663e-05
the O 0 0.00017070518515538424
patients O 0 0.000408979132771492
father O 0 0.0014911224134266376
and O 0 0.0002866443828679621
a O 0 0.0012617426691576838
sister O 0 0.005321798380464315
. O 0 0.0017055300995707512

Fluorescent O 0 0.01127109955996275
in O 0 0.0010391075629740953
situ O 0 0.0035057016648352146
hybridization O 0 0.0008024390554055572
analysis O 0 0.00015657334006391466
demonstrated O 0 0.0006005592877045274
that O 0 9.736856009112671e-05
the O 0 0.0003753584169317037
PWS B-Disease 1 0.9999905824661255
critical O 0 0.0008495742222294211
region O 0 0.0002576131373643875
resided O 0 0.0005000776727683842
on O 0 0.00014894864580128342
the O 0 0.00023074244381859899
derivative O 0 0.000446525402367115
chromosome O 0 0.00025126535911113024
3 O 0 0.0001035379827953875
and O 0 4.9110400141216815e-05
that O 0 1.9344748579896986e-05
there O 0 4.309020732762292e-05
was O 0 0.00018224162340629846
no O 0 6.612449942622334e-05
deletion O 0 0.0002496415690984577
of O 0 0.00021055333490949124
the O 0 0.0014265096979215741
PWS B-Disease 1 0.9999985694885254
region O 0 0.0006068008369766176
on O 0 0.00019337591947987676
the O 0 0.00014467339497059584
normal O 0 0.00019382541358936578
pair O 0 0.00020200399740133435
of O 0 0.00026132483617402613
15s O 0 0.005084227304905653
present O 0 0.0005702697671949863
in O 0 0.0007298353011719882
J O 0 0.3049122393131256
. O 0 0.0011598217533901334

B O 0 0.1024734228849411
. O 0 0.008933871053159237

Methylation O 0 0.0025586646515876055
analysis O 0 0.0005607657949440181
at O 0 0.0006493873661383986
exon O 0 0.0015262373490259051
alpha O 0 0.0005165073089301586
of O 0 0.00014958872634451836
the O 0 0.00016353953105863184
small O 0 0.00024994692648760974
nuclear O 0 0.002023690612986684
ribonucleoprotein O 1 0.930262565612793
- O 0 0.001155799487605691
associated O 0 0.00024443966685794294
polypeptide O 0 0.001594038913026452
N O 0 0.0032104896381497383
( O 0 0.0005090002669021487
SNRPN O 1 0.9976344108581543
) O 0 0.00022116930631455034
gene O 0 0.00013263900473248214
showed O 0 0.0001530148583697155
a O 0 0.00012231843720655888
pattern O 0 0.0002576234401203692
characteristic O 0 0.0002986709005199373
of O 0 0.00019997189519926906
only O 0 8.384894317714497e-05
the O 0 0.00019266459275968373
maternal O 0 0.0008343044901266694
chromosome O 0 0.0002232579281553626
15 O 0 0.00023920195235405117
in O 0 0.00028118726913817227
J O 0 0.04409397020936012
. O 0 0.0009717640350572765

B O 0 0.16511160135269165
. O 0 0.0077924286015331745

Maternal B-Disease 1 0.7924900054931641
disomy I-Disease 1 0.9932418465614319
was O 0 0.004621217492967844
confirmed O 0 0.0007038295734673738
by O 0 0.0001833022542996332
polymerase O 0 0.0010248046601191163
chain O 0 0.0005587325431406498
reaction O 0 0.00021294094040058553
analysis O 0 6.504218617919832e-05
of O 0 0.00018375406216364354
microsatellite O 0 0.0013561394298449159
repeats O 0 0.0004625380679499358
at O 0 0.0003412849036976695
the O 0 0.0003730482130777091
gamma O 0 0.001112129888497293
- O 0 0.0008952615316957235
aminobutyric O 0 0.011481783352792263
acid O 0 0.0014112935168668628
receptor O 0 0.0007559063960798085
beta3 O 0 0.005055450834333897
subunit O 0 0.0010400668252259493
( O 0 0.0006601242930628359
GABRB3 O 1 0.9943028688430786
) O 0 0.0008052840712480247
locus O 0 0.003848087042570114
. O 0 0.0012153444113209844

A O 0 0.012537769041955471
niece O 1 0.5123887062072754
( O 0 0.0016345123294740915
B O 0 0.004170079715549946
. O 0 0.00025151800946332514
B O 0 0.0006142131169326603
. O 0 6.244298128876835e-05
) O 0 2.8932452551089227e-05
with O 0 2.3642092855880037e-05
45 O 0 7.511249714298174e-05
chromosomes O 0 0.00010412531264591962
and O 0 3.084552736254409e-05
the O 0 6.682419189019129e-05
derivative O 0 0.0001333810796495527
3 O 0 9.111291001318023e-05
but O 0 3.416322579141706e-05
without O 0 3.2700645533623174e-05
the O 0 0.0001240302954101935
der O 0 0.0010832517873495817
( O 0 9.496930579189211e-05
15 O 0 0.00012686278205364943
) O 0 6.27211993560195e-05
demonstrated O 0 0.00019455233996268362
a O 0 0.00015809849719516933
phenotype O 0 0.00025449320673942566
consistent O 0 9.895965922623873e-05
with O 0 2.714175388973672e-05
that O 0 2.8963317163288593e-05
reported O 0 7.052282307995483e-05
for O 0 6.507258513011038e-05
haploinsufficiency O 0 0.014689603820443153
of O 0 0.0009066123166121542
distal O 1 0.996414303779602
3 O 0 0.0029017406050115824
p O 0 0.004601968917995691
. O 0 0.0010993520263582468

Uniparental B-Disease 1 0.9999579191207886
disomy I-Disease 1 0.9998181462287903
associated O 0 0.0043072085827589035
with O 0 0.0008366458350792527
unbalanced O 0 0.07055569440126419
segregation O 1 0.9499184489250183
of O 0 0.08913975208997726
non O 1 0.9438451528549194
- O 1 0.9482929706573486
Robertsonian O 1 0.9995284080505371
translocations O 0 0.004055066034197807
has O 0 0.00011663671466521919
been O 0 6.0461010434664786e-05
reported O 0 0.00010550379374762997
previously O 0 7.187019946286455e-05
but O 0 2.2598525902139954e-05
has O 0 2.176433554268442e-05
not O 0 1.3225661859905813e-05
, O 0 3.412288424442522e-05
to O 0 3.967719749198295e-05
our O 0 0.00010554565960774198
knowledge O 0 0.0002408184518571943
, O 0 8.735109440749511e-05
been O 0 6.62667807773687e-05
observed O 0 6.249814759939909e-05
in O 0 5.779741331934929e-05
a O 0 0.0001652158098295331
case O 0 0.000473781576147303
of O 0 0.0027296957559883595
PWS B-Disease 1 0.999998927116394
. O 0 0.003308200044557452

Furthermore O 0 0.0039549339562654495
, O 0 0.0007117354543879628
our O 0 0.00039394680061377585
findings O 0 0.00019087377586402
are O 0 2.061087616311852e-05
best O 0 8.132962830131873e-05
interpreted O 0 0.00013994280016049743
as O 0 0.00015715100744273514
true O 0 0.00048693903954699636
gamete O 0 0.244730144739151
complementation O 1 0.9990980625152588
resulting O 0 0.027669640257954597
in O 0 0.0010840059258043766
maternal B-Disease 1 0.9971924424171448
UPD I-Disease 1 0.9999973773956299
15 I-Disease 0 0.010866254568099976
and O 0 0.0028564361855387688
PWS B-Disease 1 0.9999583959579468

Schwartz B-Disease 1 0.9944990873336792
- I-Disease 1 0.9995906949043274
Jampel I-Disease 1 0.999997615814209
syndrome I-Disease 1 0.9999995231628418
type I-Disease 1 0.7169952392578125
2 I-Disease 0 0.013452216982841492
and O 0 0.002144810976460576
Stuve B-Disease 1 0.9999980926513672
- I-Disease 1 0.9999620914459229
Wiedemann I-Disease 1 0.999996542930603
syndrome I-Disease 1 0.9999994039535522
: O 0 0.000322956417221576
a O 0 0.0002610697993077338
case O 0 0.00025158756761811674
for O 0 0.00015497009735554457
" O 0 0.0006664679385721684
lumping O 0 0.00410898681730032
" O 0 0.001661488669924438
. O 0 0.0006215778994373977

Recent O 0 0.001495664706453681
studies O 0 0.00036341921077109873
demonstrated O 0 0.0005005621933378279
the O 0 0.00018371327314525843
existence O 0 0.00016826690989546478
of O 0 0.00015142785559874028
a O 0 0.0003048410580959171
genetically O 0 0.00017342239152640104
distinct O 0 8.146461186697707e-05
, O 0 5.2793002396356314e-05
usually O 0 3.463818211457692e-05
lethal O 0 7.598521915497258e-05
form O 0 4.01215729652904e-05
of O 0 0.00012869662896264344
the O 0 0.0009128967649303377
Schwartz B-Disease 1 0.9865360856056213
- I-Disease 1 0.9997881054878235
Jampel I-Disease 1 0.9999996423721313
syndrome I-Disease 1 1.0
( O 0 0.4692051410675049
SJS B-Disease 1 0.9999507665634155
) O 0 0.00036994897527620196
of O 0 0.006619128864258528
myotonia B-Disease 1 0.9999995231628418
and O 1 0.9956088662147522
skeletal B-Disease 1 1.0
dysplasia I-Disease 1 1.0
, O 0 0.019142838194966316
which O 0 0.0001482006482547149
we O 0 0.00015550179523415864
called O 0 0.0004045995301567018
SJS B-Disease 1 0.9542098641395569
type I-Disease 0 0.0013480642810463905
2 I-Disease 0 0.0008675171411596239
. O 0 0.0006553995772264898

This O 0 0.00707964226603508
disorder O 1 0.9999545812606812
is O 0 0.000492195482365787
reminiscent O 0 0.16012850403785706
of O 0 0.0017970333574339747
another O 0 0.005730175878852606
rare O 0 0.02285885624587536
condition O 0 0.16087348759174347
, O 0 0.0001356091961497441
the O 0 0.0032434100285172462
Stuve B-Disease 1 0.9999990463256836
- I-Disease 1 0.9999812841415405
Wiedemann I-Disease 1 0.9999994039535522
syndrome I-Disease 1 1.0
( O 0 0.3573090732097626
SWS B-Disease 1 0.9996557235717773
) O 0 0.00017589125491213053
, O 0 0.00010153635230381042
which O 0 6.561070040334016e-05
comprises O 0 0.00043565008672885597
campomelia B-Disease 1 0.9413192868232727
at O 0 0.012873329222202301
birth O 0 0.3251573443412781
with O 0 0.019396483898162842
skeletal B-Disease 1 1.0
dysplasia I-Disease 1 1.0
, O 1 0.9993798732757568
contractures B-Disease 1 0.9999991655349731
, O 0 0.0011006874265149236
and O 0 0.0003619263006839901
early B-Disease 0 0.001507050939835608
death I-Disease 0 0.009030181914567947
. O 0 0.0008354368037544191

To O 0 0.0013421060284599662
test O 0 0.0008103143773041666
for O 0 0.000181477953447029
possible O 0 0.0003021054726559669
nosologic O 1 0.9485361576080322
identity O 0 0.0005727026727981865
between O 0 0.0018039270071312785
these O 0 0.0004378952144179493
disorders O 1 0.9999964237213135
, O 0 0.00021219834161456674
we O 0 5.4680349421687424e-05
reviewed O 0 7.298283890122548e-05
the O 0 4.653000723919831e-05
literature O 0 4.027011527796276e-05
and O 0 1.8578375602373853e-05
obtained O 0 2.1554043996729888e-05
a O 0 4.161967444815673e-05
follow O 0 3.159641346428543e-05
- O 0 7.669426850043237e-05
up O 0 3.757795275305398e-05
of O 0 3.9169779483927414e-05
the O 0 5.1520371926017106e-05
only O 0 2.6620229618856683e-05
two O 0 5.199419319978915e-05
surviving O 0 0.001584197860211134
patients O 0 0.00018293068569619209
, O 0 5.320947457221337e-05
one O 0 4.9439848226029426e-05
with O 0 9.408019832335413e-05
SJS B-Disease 1 0.6175516247749329
type I-Disease 0 0.00021464753081090748
2 I-Disease 0 9.072312241187319e-05
at O 0 0.00011965355224674568
age O 0 6.30168869975023e-05
10 O 0 4.269019336788915e-05
years O 0 3.605226083891466e-05
and O 0 2.4399392714258283e-05
another O 0 7.645884033991024e-05
with O 0 8.769613486947492e-05
SWS B-Disease 1 0.6711782813072205
at O 0 0.00046730643953196704
age O 0 0.0003009180072695017
7 O 0 0.000601435371208936
years O 0 0.0004909921553917229
. O 0 0.0005446356371976435

Patients O 0 0.015978656709194183
reported O 0 0.0011776624014601111
as O 0 0.00040613190503790975
having O 0 0.0006334646022878587
either O 0 0.001970750279724598
neonatal O 1 0.999997615814209
SJS B-Disease 1 0.9999839067459106
or O 0 0.0018393865320831537
SWS B-Disease 1 0.7109349966049194
presented O 0 0.0003924130869563669
a O 0 0.00020257376309018582
combination O 0 0.0002762545191217214
of O 0 0.00028843453037552536
a O 0 0.001916444394737482
severe O 1 0.9999849796295166
, O 1 0.8202775716781616
prenatal O 1 0.9999988079071045
- O 1 0.9999997615814209
onset O 1 1.0
neuromuscular B-Disease 1 1.0
disorder I-Disease 1 1.0
( O 1 0.9999988079071045
with O 1 0.999997615814209
congenital B-Disease 1 1.0
joint I-Disease 1 1.0
contractures I-Disease 1 1.0
, O 1 0.9999995231628418
respiratory O 1 1.0
and O 1 0.9988442659378052
feeding O 1 0.9989751577377319
difficulties O 1 0.9987724423408508
, O 0 0.0005343433585949242
tendency O 0 0.008065515197813511
to O 0 0.0008290435653179884
hyperthermia B-Disease 1 0.9999934434890747
, O 0 0.0002093191142193973
and O 0 9.369700273964554e-05
frequent O 0 0.00023221342416945845
death O 0 0.022116446867585182
in O 0 0.00029104441637173295
infancy O 0 0.002028824295848608
) O 0 6.835595559095964e-05
with O 0 5.8434026868781075e-05
a O 0 0.0003056693240068853
distinct O 0 0.0014261810574680567
campomelic B-Disease 1 0.9999971389770508
- I-Disease 1 0.9999727010726929
metaphyseal I-Disease 1 0.9999986886978149
skeletal I-Disease 1 0.9999995231628418
dysplasia I-Disease 1 0.9999997615814209
. O 0 0.013539274223148823

The O 0 0.0017122689168900251
similarity O 0 0.0008942176355049014
of O 0 0.0005267985980026424
the O 0 0.001123566646128893
clinical O 0 0.009288957342505455
and O 0 0.0004989834851585329
radiographic O 1 0.9378200173377991
findings O 0 0.00035321645555086434
is O 0 7.68429454183206e-05
so O 0 4.907341644866392e-05
extensive O 0 0.00017014943296089768
that O 0 9.402405703440309e-05
these O 0 9.891550871543586e-05
disorders O 1 0.999239444732666
appear O 0 0.0001352785766357556
to O 0 6.365031731547788e-05
be O 0 5.293991125654429e-05
a O 0 0.00020145160669926554
single O 0 0.0003503079933580011
entity O 0 0.0007694612140767276
. O 0 0.0007750198128633201

The O 0 0.0014190259389579296
follow O 0 0.0006012691301293671
- O 0 0.0005877751391381025
up O 0 0.00018529462977312505
observation O 0 0.0003272665198892355
of O 0 0.00014052996993996203
an O 0 0.00011223730689380318
identical O 0 0.00014585549070034176
and O 0 9.377746027894318e-05
unique O 0 0.0001655862870393321
pattern O 0 0.0024085245095193386
of O 1 0.989071249961853
progressive O 1 0.9999998807907104
bone B-Disease 1 1.0
dysplasia I-Disease 1 0.9999997615814209
in O 0 0.0018978186417371035
the O 0 0.0005749927368015051
two O 0 0.00011844694381579757
patients O 0 0.0001021056086756289
( O 0 4.2769734136527404e-05
one O 0 3.7639962101820856e-05
with O 0 7.155495404731482e-05
SJS B-Disease 1 0.994691789150238
type I-Disease 0 0.0006501797470264137
2 I-Disease 0 0.00016341047012247145
, O 0 4.728886051452719e-05
one O 0 4.4310043449513614e-05
with O 0 0.00011826648551505059
SWS B-Disease 0 0.3331337869167328
) O 0 0.00012218915799167007
surviving O 0 0.0005881304969079792
beyond O 0 0.0005604182370007038
infancy O 0 0.00070162583142519
adds O 0 0.0001354236446786672
to O 0 2.414063419564627e-05
the O 0 6.571038102265447e-05
evidence O 0 8.16122701507993e-05
in O 0 4.108748908038251e-05
favor O 0 5.4729334806324914e-05
of O 0 0.00016933144070208073
identity O 0 0.0005211691022850573
. O 0 0.0007017787429504097

The O 0 0.004305582027882338
hypothesis O 0 0.0026029946748167276
that O 0 0.0005155169637873769
SWS B-Disease 1 0.9870304465293884
and O 0 0.0008321444038301706
SJS B-Disease 1 0.9993964433670044
type I-Disease 0 0.0014336638851091266
2 I-Disease 0 0.00023451964079868048
are O 0 3.482874308247119e-05
the O 0 0.00012400015839375556
same O 0 0.00020479806698858738
disorder O 1 0.999544084072113
should O 0 0.00010943802044494078
be O 0 6.447619671234861e-05
testable O 0 0.00034950004192069173
by O 0 8.917185914469883e-05
molecular O 0 0.0003870120854116976
methods O 0 0.00024002647842280567
. O 0 0.0002856556966435164
. O 0 0.0005661175819113851

A O 0 0.01051299273967743
mouse O 0 0.005324178840965033
model O 0 0.0018200125778093934
of O 0 0.038895100355148315
severe O 1 1.0
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
: O 1 0.9999982118606567
defects O 1 1.0
in O 1 0.9994895458221436
hemostasis O 1 0.9999997615814209
and O 1 0.9954113364219666
thrombosis B-Disease 1 0.9999991655349731
. O 0 0.0071260519325733185

von B-Disease 1 0.9964725375175476
Willebrand I-Disease 1 0.9999873638153076
factor I-Disease 1 0.9987348914146423
( I-Disease 1 0.9834254384040833
vWf I-Disease 1 0.9999803304672241
) I-Disease 1 0.9995280504226685
deficiency I-Disease 1 1.0
causes O 1 1.0
severe O 1 1.0
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
in O 1 0.999884843826294
humans O 1 0.7123481035232544
. O 0 0.0011144408490508795

We O 0 0.0008227229700423777
generated O 0 0.0005929460749030113
a O 0 0.00036327465204522014
mouse O 0 0.0005256509175524116
model O 0 0.00018338965310249478
for O 0 7.385003846138716e-05
this O 0 0.00012873763625975698
disease O 1 0.5858863592147827
by O 0 0.0001184100256068632
using O 0 0.00015615364827681333
gene O 0 0.00026151625206694007
targeting O 0 0.0006328379386104643
. O 0 0.0004434889124240726

vWf B-Disease 1 0.998871386051178
- I-Disease 1 0.997919499874115
deficient I-Disease 1 0.9951776266098022
mice O 0 0.001502121682278812
appeared O 0 0.0005597085691988468
normal O 0 0.00031205068808048964
at O 0 0.000574688077904284
birth O 0 0.0003235184703953564
; O 0 3.6137142160441726e-05
they O 0 3.691034726216458e-05
were O 0 0.00010370695235906169
viable O 0 0.0004108934081159532
and O 0 0.0002627548819873482
fertile O 0 0.004387857858091593
. O 0 0.0010501272045075893

Neither O 0 0.02487221732735634
vWf O 0 0.18358154594898224
nor O 0 0.010159514844417572
vWf O 1 0.5221037268638611
propolypeptide O 1 0.9977846741676331
( O 0 0.0036756752524524927
von B-Disease 1 0.9906437993049622
Willebrand I-Disease 1 0.9999979734420776
antigen O 1 0.9993345141410828
II O 1 0.9999710321426392
) O 0 0.0003369100741110742
were O 0 0.0002179646398872137
detectable O 0 0.0007953193853609264
in O 0 0.0001817196753108874
plasma O 0 0.0022694922517985106
, O 0 0.0002561553556006402
platelets O 0 0.007364548742771149
, O 0 0.0001850156841101125
or O 0 0.00033758333302102983
endothelial O 1 0.6995571255683899
cells O 0 0.00023988712928257883
of O 0 0.00022712911595590413
the O 0 0.00046527915401384234
homozygous O 0 0.0015248240670189261
mutant O 0 0.009837386198341846
mice O 0 0.0013937326148152351
. O 0 0.0005195311969146132

The O 0 0.03229553997516632
mutant O 1 0.9986808896064758
mice O 1 0.9714111089706421
exhibited O 1 0.9958871006965637
defects O 1 0.9999878406524658
in O 0 0.014444987289607525
hemostasis O 1 0.9998995065689087
with O 0 0.0004119141958653927
a O 0 0.03354967013001442
highly O 1 0.956488311290741
prolonged O 1 0.9999971389770508
bleeding O 1 0.9999995231628418
time O 0 0.003382824594154954
and O 0 0.0006894715479575098
spontaneous O 1 0.5505569577217102
bleeding O 1 0.997298538684845
events O 0 0.00017473200568929315
in O 0 5.6113480241037905e-05
approximately O 0 7.441090565407649e-05
10 O 0 0.0001030453058774583
% O 0 8.408884605159983e-05
of O 0 0.0004774178669322282
neonates O 0 0.00570854265242815
. O 0 0.0008719890029169619

As O 0 0.0014341158093884587
in O 0 0.00044131703907623887
the O 0 0.001037720125168562
human O 1 0.5217809081077576
disease O 1 0.9999654293060303
, O 0 0.0002519202244002372
the O 0 0.0003715451166499406
factor O 0 0.0019524178933352232
VIII O 1 0.9971852898597717
level O 0 0.0003705825947690755
in O 0 7.286184700205922e-05
these O 0 3.5446799302008e-05
mice O 0 0.0001109555596485734
was O 0 0.00011469491437310353
reduced O 0 5.8709774748422205e-05
strongly O 0 2.969626621052157e-05
as O 0 2.7645832233247347e-05
a O 0 4.1123708797385916e-05
result O 0 3.5773344279732555e-05
of O 0 5.7601315347710624e-05
the O 0 0.00014046778960619122
lack O 0 0.0003306138387415558
of O 0 0.0005244085914455354
protection O 0 0.002204243326559663
provided O 0 0.0006623040535487235
by O 0 0.0004076831100974232
vWf O 0 0.0084823714569211
. O 0 0.0009418614790774882

Defective O 1 0.9999873638153076
thrombosis B-Disease 1 0.9999926090240479
in O 0 0.23125918209552765
mutant O 1 0.9994189739227295
mice O 0 0.08000770211219788
was O 0 0.0010454386938363314
also O 0 7.342416211031377e-05
evident O 0 0.0001478954218327999
in O 0 4.414871727931313e-05
an O 0 4.477200491237454e-05
in O 0 9.82291458058171e-05
vivo O 0 0.0009930534288287163
model O 0 0.0006859468412585557
of O 1 0.8650067448616028
vascular B-Disease 1 1.0
injury I-Disease 1 0.9999990463256836
. O 0 0.008527019061148167

In O 0 0.0016213738126680255
this O 0 0.00044389243703335524
model O 0 0.0004857097228523344
, O 0 0.00029567169258370996
the O 0 0.0005527567700482905
exteriorized O 1 0.911865770816803
mesentery O 1 0.9685067534446716
was O 0 0.17757806181907654
superfused O 1 0.9987898468971252
with O 0 0.001295505091547966
ferric O 1 0.9999984502792358
chloride O 1 0.9070892333984375
and O 0 0.00021776191715616733
the O 0 0.00045997477718628943
accumulation O 0 0.06712953746318817
of O 0 0.00741213234141469
fluorescently O 1 0.9984867572784424
labeled O 0 0.307488352060318
platelets O 0 0.15028606355190277
was O 0 0.0014204125618562102
observed O 0 0.0004406022490002215
by O 0 0.00034579570638015866
intravital O 0 0.04155125841498375
microscopy O 0 0.004384662955999374
. O 0 0.0011938477400690317

We O 0 0.0018319251248613
conclude O 0 0.0014213861431926489
that O 0 0.0002804271935019642
these O 0 0.00014799558266531676
mice O 0 0.00036816310603171587
very O 0 0.00021288816060405225
closely O 0 0.0003729674790520221
mimic O 1 0.9928550124168396
severe O 1 0.9999994039535522
human O 1 0.9999961853027344
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
and O 1 0.7231875061988831
will O 0 0.00015068231732584536
be O 0 4.287558112991974e-05
very O 0 3.1210096494760364e-05
useful O 0 2.4718570784898475e-05
for O 0 1.263680951524293e-05
investigating O 0 8.238167356466874e-05
the O 0 9.341108670923859e-05
role O 0 0.00021108644432388246
of O 0 0.00031128819682635367
vWf O 0 0.007006113883107901
in O 0 0.0003129504038952291
normal O 0 0.0009827511385083199
physiology O 0 0.4269164800643921
and O 0 0.00034365165629424155
in O 0 0.0013136869529262185
disease O 1 0.9999045133590698
models O 0 0.0006740899989381433
. O 0 0.000237880100030452
. O 0 0.0005832601455040276

Oral O 1 0.5904240608215332
contraceptives O 0 0.22534209489822388
and O 0 0.0006398041732609272
the O 0 0.001798733719624579
risk O 0 0.3853842616081238
of O 1 0.9998800754547119
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.7316623330116272

Hereditary B-Disease 1 1.0
Ovarian I-Disease 1 1.0
Cancer I-Disease 1 0.9999997615814209
Clinical O 1 0.9984555244445801
Study O 0 0.002850059885531664
Group O 0 0.0015028542838990688
. O 0 0.0008823503158055246

BACKGROUND O 0 0.01359096821397543
Women O 0 0.001276978524401784
with O 0 0.0001967086282093078
mutations O 0 0.0002251094119856134
in O 0 7.300623110495508e-05
either O 0 9.578256140230224e-05
the O 0 0.0003613119770307094
BRCA1 O 1 0.5949119925498962
or O 0 0.0002377222990617156
the O 0 0.0005889684543944895
BRCA2 O 0 0.010879701003432274
gene O 0 0.00014316521992441267
have O 0 3.2344938517780975e-05
a O 0 0.00016149927978403866
high O 0 0.000995541107840836
lifetime O 0 0.004020812921226025
risk O 0 0.0749773383140564
of O 1 0.9998962879180908
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.054645102471113205

Oral O 1 0.9163163900375366
contraceptives O 1 0.9984040856361389
protect O 1 0.9977020621299744
against O 1 0.9999924898147583
ovarian B-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
in O 0 0.007562725339084864
general O 0 0.005831359885632992
, O 0 0.00011751980491681024
but O 0 2.488460268068593e-05
it O 0 1.3598859368357807e-05
is O 0 2.408530781394802e-05
not O 0 1.7285507055930793e-05
known O 0 5.24971037521027e-05
whether O 0 4.162114055361599e-05
they O 0 2.6674126274883747e-05
also O 0 6.644491077167913e-05
protect O 0 0.00032410596031695604
against O 0 0.00027194528956897557
hereditary B-Disease 1 0.9974492192268372
forms I-Disease 1 0.9982625842094421
of I-Disease 1 0.9999998807907104
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.1411895900964737

METHODS O 0 0.003279781434684992
We O 0 0.0008318990585394204
enrolled O 0 0.001155885518528521
207 O 0 0.002595861442387104
women O 0 0.000773655076045543
with O 0 0.004702746868133545
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
and O 0 0.0016386976931244135
161 O 0 0.0016290931962430477
of O 0 0.0003830921486951411
their O 0 6.113458948675543e-05
sisters O 0 0.00023559450346510857
as O 0 5.158791827852838e-05
controls O 0 5.212516043684445e-05
in O 0 4.602102126227692e-05
a O 0 0.00012439758575055748
case O 0 0.0003317273803986609
- O 0 0.0007857801392674446
control O 0 0.0003808156761806458
study O 0 0.00035429871059022844
. O 0 0.0005362823139876127

All O 0 0.0009985942160710692
the O 0 0.000893372402060777
patients O 0 0.0003967104130424559
carried O 0 0.0002966707106679678
a O 0 0.0003061114111915231
pathogenic O 0 0.0011303869541734457
mutation O 0 0.00016318500274792314
in O 0 6.531753751914948e-05
either O 0 0.0001350731181446463
BRCA1 O 0 0.003666447475552559
( O 0 0.0001250269269803539
179 O 0 0.00037259573582559824
women O 0 0.00014508177991956472
) O 0 9.240262443199754e-05
or O 0 0.00022077154426369816
BRCA2 O 0 0.00874788872897625
( O 0 0.00029081033426336944
28 O 0 0.0008359293569810688
women O 0 0.0004273134109098464
) O 0 0.00030507889459840953
. O 0 0.0005589941283687949

The O 0 0.003831534879282117
control O 0 0.0015010136412456632
women O 0 0.0002531317586544901
were O 0 8.753362635616213e-05
enrolled O 0 0.0003095740103162825
regardless O 0 8.264125062851235e-05
of O 0 0.00016310068895108998
whether O 0 7.077574264258146e-05
or O 0 5.685551150236279e-05
not O 0 2.848923577403184e-05
they O 0 2.4251625291071832e-05
had O 0 0.00010207397281192243
either O 0 0.00015447822806891054
mutation O 0 0.0005398260545916855
. O 0 0.0005602827877737582

Lifetime O 0 0.009773330762982368
histories O 0 0.001813743612729013
of O 0 0.0012385825393721461
oral O 1 0.5333981513977051
- O 0 0.23488807678222656
contraceptive O 0 0.0022088908590376377
use O 0 6.333728379104286e-05
were O 0 6.294679769780487e-05
obtained O 0 6.021692752256058e-05
by O 0 3.857407864416018e-05
interview O 0 0.00014825319522060454
or O 0 3.688656579470262e-05
by O 0 2.1986888896208256e-05
written O 0 3.445842594373971e-05
questionnaire O 0 7.926794205559418e-05
and O 0 3.0650942790089175e-05
were O 0 4.6762746933382004e-05
compared O 0 0.0001732808887027204
between O 0 0.0002219018351752311
patients O 0 0.0002585799666121602
and O 0 7.846295193303376e-05
control O 0 0.0008065860602073371
women O 0 0.00022232964693102986
, O 0 7.459342305082828e-05
after O 0 0.0002148895728169009
adjustment O 0 0.00043173477752134204
for O 0 5.844667975907214e-05
year O 0 0.0001642806746531278
of O 0 0.0002874991623684764
birth O 0 0.0013371991226449609
and O 0 0.00041355902794748545
parity O 0 0.016472315415740013
. O 0 0.0010891000274568796

RESULTS O 0 0.0029270867817103863
The O 0 0.0011446690186858177
adjusted O 0 0.001521565834991634
odds O 0 0.0022275277879089117
ratio O 0 0.0025845214258879423
for O 0 0.054539937525987625
ovarian B-Disease 1 1.0
cancer I-Disease 1 0.9999992847442627
associated O 0 0.0007579781231470406
with O 0 0.00010147615103051066
any O 0 7.656478555873036e-05
past O 0 0.00011071120388805866
use O 0 6.701474922010675e-05
of O 0 0.0001781107421265915
oral O 0 0.0019101595971733332
contraceptives O 0 0.008792196400463581
was O 0 0.002012812765315175
0 O 0 0.0006994481082074344
. O 0 0.00045561566366814077

5 O 0 0.0011723366333171725
( O 0 0.0003122089838143438
95 O 0 0.00042855230276472867
percent O 0 0.00011738384637283161
confidence O 0 0.0002711693523451686
interval O 0 0.0001505929685663432
, O 0 3.663960887934081e-05
0 O 0 2.6364403311163187e-05
. O 0 1.0953583114314824e-05
3 O 0 2.7102470994577743e-05
to O 0 1.6372005120501854e-05
0 O 0 6.77603020449169e-05
. O 0 4.192756750853732e-05
8 O 0 0.00019972379959654063
) O 0 0.0001565037964610383
. O 0 0.0003826672909781337

The O 0 0.005305824335664511
risk O 0 0.0026165980380028486
decreased O 0 0.000867147755343467
with O 0 0.00010242918506264687
increasing O 0 0.00013016829325351864
duration O 0 0.0001488160341978073
of O 0 8.042221452342346e-05
use O 0 4.216124216327444e-05
( O 0 7.875417213654146e-05
P O 0 0.00041727774078026414
for O 0 5.3343599574873224e-05
trend O 0 0.00017062967526726425
, O 0 6.30557187832892e-05
< O 0 0.0003092064580414444
0 O 0 0.00010646784357959405
. O 0 5.4084270232124254e-05
001 O 0 0.0007223660359159112
) O 0 4.550961239147e-05
; O 0 2.0339000911917537e-05
use O 0 1.32528439280577e-05
for O 0 1.4776700481888838e-05
six O 0 3.509590897010639e-05
or O 0 2.6094779968843795e-05
more O 0 1.5266343325492926e-05
years O 0 4.614222052623518e-05
was O 0 0.00013695248344447464
associated O 0 3.285164711996913e-05
with O 0 1.4532275599776767e-05
a O 0 9.722566755954176e-05
60 O 0 0.00010233058128505945
percent O 0 0.0001240218844031915
reduction O 0 0.00037553845322690904
in O 0 0.00021713991009164602
risk O 0 0.0005063365679234266
. O 0 0.0002983891172334552

Oral O 0 0.09286782890558243
- O 0 0.01602400653064251
contraceptive O 0 0.006127240136265755
use O 0 0.0003088538069278002
protected O 0 0.03707447648048401
against O 1 0.9996150732040405
ovarian B-Disease 1 1.0
cancer I-Disease 1 0.999992847442627
both O 0 0.0001369250676361844
for O 0 9.647630213294178e-05
carriers O 0 9.565314394421875e-05
of O 0 0.00011692971747834235
the O 0 0.0005038229865022004
BRCA1 O 0 0.4416182339191437
mutation O 0 0.00018741516396403313
( O 0 8.50702344905585e-05
odds O 0 0.0002154623798560351
ratio O 0 0.00010974776523653418
, O 0 3.688466676976532e-05
0 O 0 3.080431997659616e-05
. O 0 1.4823489436821546e-05
5 O 0 3.252498936490156e-05
; O 0 1.3662501260114368e-05
95 O 0 7.108479621820152e-05
percent O 0 4.102688399143517e-05
confidence O 0 0.00013508986739907414
interval O 0 8.227491343859583e-05
, O 0 3.375730739207938e-05
0 O 0 2.7877696993527934e-05
. O 0 1.1109555998700671e-05
3 O 0 2.5703951905597933e-05
to O 0 1.6101625078590587e-05
0 O 0 3.531392940203659e-05
. O 0 2.143511301255785e-05
9 O 0 9.464564936934039e-05
) O 0 3.069639569730498e-05
and O 0 2.604535620776005e-05
for O 0 3.644877506303601e-05
carriers O 0 8.019575761863962e-05
of O 0 9.773860801942647e-05
the O 0 0.0003200760402251035
BRCA2 O 0 0.09778096526861191
mutation O 0 0.0002525396994315088
( O 0 8.345870446646586e-05
odds O 0 0.0001591830514371395
ratio O 0 8.35462924442254e-05
, O 0 3.042977004952263e-05
0 O 0 3.7842310121050104e-05
. O 0 1.6227861124207266e-05
4 O 0 3.554614886525087e-05
; O 0 1.4518547686748207e-05
95 O 0 7.193081546574831e-05
percent O 0 5.684477946488187e-05
confidence O 0 0.00014796822506468743
interval O 0 8.50189826451242e-05
, O 0 3.298465526313521e-05
0 O 0 2.7175583454663865e-05
. O 0 1.2822410099033732e-05
2 O 0 2.515402593417093e-05
to O 0 1.654195693845395e-05
1 O 0 5.895990034332499e-05
. O 0 4.733330206363462e-05
1 O 0 0.0001481613435316831
) O 0 0.00014786241808906198
. O 0 0.00035403395304456353

CONCLUSIONS O 0 0.01467733085155487
Oral O 0 0.046610377728939056
- O 0 0.018002966418862343
contraceptive O 0 0.007592977024614811
use O 0 0.00027106545167043805
may O 0 0.00019672096823342144
reduce O 0 0.00019084609812125564
the O 0 0.0004522242525126785
risk O 0 0.00881294533610344
of O 1 0.9997207522392273
ovarian B-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
in O 0 0.00297800125554204
women O 0 0.0003309121238999069
with O 0 0.00011762316717067733
pathogenic O 0 0.0018121808534488082
mutations O 0 0.00014988382463343441
in O 0 0.00013834070705343038
the O 0 0.0008164567989297211
BRCA1 O 1 0.9941078424453735
or O 0 0.0022990861907601357
BRCA2 O 1 0.8114134669303894
gene O 0 0.0037526923697441816

A O 0 0.007036879658699036
Japanese O 0 0.008680099621415138
family O 0 0.0012892559170722961
with O 0 0.0006982457125559449
adrenoleukodystrophy B-Disease 1 0.9999926090240479
with O 0 0.0004299348802305758
a O 0 0.0008207634673453867
codon O 0 0.001534903421998024
291 O 0 0.0009512206306681037
deletion O 0 0.0004248507902957499
: O 0 0.0001194406213471666
a O 0 0.00010818894224939868
clinical O 0 0.00034014711854979396
, O 0 0.00015952980902511626
biochemical O 0 0.04059582203626633
, O 0 0.00037988019175827503
pathological O 1 0.9879721999168396
, O 0 0.0003990380500908941
and O 0 0.00036977091804146767
genetic O 0 0.0007960473303683102
report O 0 0.00046255660708993673
. O 0 0.0005589568754658103

We O 0 0.0006430797511711717
report O 0 0.00023628557391930372
a O 0 0.00019530953431967646
Japanese O 0 0.0008275175932794809
family O 0 0.0004750401130877435
with O 0 0.0010763341560959816
adrenoleukodystrophy B-Disease 1 1.0
( O 1 0.9998185038566589
ALD B-Disease 1 1.0
) O 0 0.00012440138380043209
with O 0 2.5217144866473973e-05
a O 0 8.338018960785121e-05
three O 0 6.230890721781179e-05
base O 0 0.00025073118740692735
pair O 0 0.0002479126851540059
deletion O 0 0.0004026033857371658
( O 0 0.00014540611300617456
delGAG O 0 0.0038486847188323736
291 O 0 0.0007233069627545774
) O 0 7.495936733903363e-05
in O 0 0.00013682285498362035
the O 0 0.001069718273356557
ALD B-Disease 1 0.9999982118606567
gene O 0 0.0028472859412431717
. O 0 0.0015834188088774681

A O 0 0.002586192451417446
variety O 0 0.0006781173869967461
of O 0 0.0006133029237389565
phenotypes O 0 0.0010380424791947007
were O 0 0.00021076505072414875
observed O 0 0.00014000217197462916
within O 0 9.22346516745165e-05
this O 0 9.179996413877234e-05
family O 0 0.00041360838804394007
. O 0 0.0005977878463454545

While O 0 0.0018586268415674567
the O 0 0.001747793285176158
proband O 1 0.9976084232330322
( O 0 0.001254132017493248
patient O 0 0.0008589038625359535
1 O 0 0.00035720362211577594
) O 0 0.00010964524699375033
was O 0 0.00026995415100827813
classified O 0 0.00013004349602852017
as O 0 8.149009954649955e-05
having O 0 0.00013266669702716172
a O 0 0.000172521045897156
rare O 0 0.0003723213158082217
intermediate O 0 0.0014338972978293896
type O 0 0.0009865917963907123
of O 0 0.004154035355895758
adult O 0 0.002787512494251132
cerebral O 1 0.9999676942825317
and O 0 0.2890770733356476
cerebello O 1 0.9999998807907104
- O 1 0.9999849796295166
brain O 1 0.9998213648796082
stem O 0 0.0009024449391290545
forms O 0 0.00011420402734074742
, O 0 4.918717240798287e-05
his O 0 0.0001782942417776212
younger O 0 0.0005175590631552041
brother O 0 0.0029413620941340923
( O 0 0.0001680435671005398
patient O 0 0.00028381490847095847
2 O 0 0.00014749560796190053
) O 0 4.871857527177781e-05
and O 0 6.986497464822605e-05
nephew O 0 0.006879184860736132
( O 0 0.0001775672717485577
patient O 0 0.000340283993864432
3 O 0 0.00021341818501241505
) O 0 8.297637396026403e-05
had O 0 0.00017549574840813875
a O 0 0.0007238438702188432
childhood O 1 0.9991783499717712
ALD B-Disease 1 0.9999998807907104
type O 1 0.9958544969558716
. O 0 0.0030699975322932005

Another O 0 0.006463177502155304
nephew O 1 0.6491646766662598
( O 0 0.0011147742625325918
patient O 0 0.0007356958813033998
4 O 0 0.0002532457001507282
) O 0 5.571422298089601e-05
of O 0 0.00016325425531249493
patient O 0 0.000344903179211542
1 O 0 0.0002045266010100022
was O 0 0.0004690069181378931
classified O 0 0.0001857156166806817
as O 0 7.953098975121975e-05
having O 0 0.00015892494411673397
an O 0 0.0002276566083310172
adolescent O 0 0.027914196252822876
form O 0 0.0010225226869806647
. O 0 0.0009827365865930915

The O 0 0.0033646964002400637
tau O 0 0.008328237570822239
level O 0 0.0012264924589544535
in O 0 0.000611252908129245
the O 0 0.0014072523918002844
cerebrospinal O 1 0.9999513626098633
fluid O 1 0.9999226331710815
( O 0 0.1880388855934143
CSF O 1 0.9983343482017517
) O 0 0.00010970758739858866
in O 0 8.676995639689267e-05
patient O 0 0.0001775147975422442
1 O 0 0.00013877818128094077
was O 0 0.00021839984401594847
as O 0 6.0372749430825934e-05
high O 0 0.00014920681132934988
as O 0 5.0829738029278815e-05
that O 0 3.303631456219591e-05
of O 0 0.00026419703499414027
patients O 0 0.024303846061229706
with O 1 0.7187988758087158
Alzheimers B-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 0.16599790751934052
AD B-Disease 0 0.010054541751742363
) O 0 0.0004043211229145527
. O 0 0.0005295872688293457

His O 0 0.06664392352104187
brain O 1 0.99745112657547
magnetic O 0 0.0362178273499012
resonance O 0 0.01649647206068039
image O 0 0.2501806914806366
( O 0 0.003367577213793993
MRI O 1 0.9978744983673096
) O 0 0.00039535464020445943
showed O 0 0.0017100564436987042
abnormalities B-Disease 0 0.08430074155330658
in I-Disease 0 0.00018858839757740498
the I-Disease 0 0.0010867769597098231
bilateral I-Disease 1 0.9676898121833801
cerebellar I-Disease 1 0.9999997615814209
hemispheres I-Disease 1 0.9999082088470459
and O 1 0.9931094646453857
brain O 1 0.9999984502792358
stem O 1 0.9151654839515686
, O 0 0.00011483478738227859
but O 0 4.146655192016624e-05
not O 0 2.7501389922690578e-05
in O 0 7.778968574712053e-05
the O 0 0.0004189697792753577
cerebral O 1 0.9998096823692322
white O 0 0.12747438251972198
matter O 0 0.00030612776754423976
, O 0 0.00011321753117954358
where O 0 0.00014376331819221377
marked O 0 0.0004560532688628882
reductions O 0 0.0005300276097841561
of O 0 0.0003564551007002592
the O 0 0.1678958237171173
cerebral O 1 0.9999983310699463
blood O 1 0.9999204874038696
flow O 0 0.3560294508934021
and O 0 0.0020749846007674932
oxygen O 0 0.26918336749076843
metabolism O 0 0.0014279296156018972
were O 0 0.00013381139433477074
clearly O 0 0.00022624294797424227
demonstrated O 0 0.00033483895822428167
by O 0 8.650607196614146e-05
positron O 0 0.001234964351169765
emission O 0 0.0008425407577306032
tomography O 0 0.0011038080556318164
( O 0 0.0005609120125882328
PET O 0 0.003321831114590168
) O 0 0.00045457560918293893
. O 0 0.000705627491697669

In O 0 0.0013050652341917157
patients O 0 0.0007272613001987338
2 O 0 0.0003139945911243558
and O 0 0.00011111014464404434
3 O 0 0.00020001918892376125
, O 0 9.940322343027219e-05
the O 0 0.00017033188487403095
autopsy O 0 0.001214668620377779
findings O 0 0.00036421522963792086
showed O 0 0.0008433155016973615
massive O 1 0.91888028383255
demyelination B-Disease 1 0.9999985694885254
of I-Disease 1 0.9592549800872803
the I-Disease 1 0.9960854053497314
cerebral I-Disease 1 0.9999854564666748
white I-Disease 0 0.08922357857227325
matter I-Disease 0 0.00024161329201888293
with O 0 7.852230191929266e-05
sparing O 0 0.0003794183721765876
of O 0 0.00027349183801561594
the O 0 0.010553570464253426
U O 1 0.999992847442627
- O 1 0.9817430973052979
fibers O 1 0.5012044906616211
, O 0 0.00011685670324368402
compatible O 0 8.564089512219653e-05
with O 0 3.139706313959323e-05
the O 0 0.0001225718151545152
findings O 0 0.00035010799183510244
of O 0 0.001905368291772902
childhood O 1 0.9999234676361084
ALD B-Disease 1 0.9999998807907104
. O 0 0.006526817101985216

Oleic O 1 0.6796939969062805
and O 0 0.0038246107287704945
erucic O 1 0.9966957569122314
acids O 0 0.0016332382801920176
( O 0 0.000995587557554245
Lorenzos O 1 0.9668496251106262
Oil O 0 0.0022062023635953665
) O 0 9.610039705876261e-05
were O 0 5.994957609800622e-05
administered O 0 8.282696217065677e-05
to O 0 4.6741879486944526e-05
patients O 0 8.991310460260138e-05
1 O 0 8.927838644012809e-05
and O 0 4.997049109078944e-05
4 O 0 0.00016736907127778977
, O 0 5.7050980103667825e-05
but O 0 3.4544234949862584e-05
sufficient O 0 0.00022061329218558967
effectiveness O 0 0.00034631366725079715
was O 0 0.00041755769052542746
not O 0 9.657350165070966e-05
obtained O 0 0.000424800964538008
. O 0 0.0006254554609768093

The O 0 0.001896488480269909
findings O 0 0.0003426460607443005
in O 0 0.00016624155978206545
this O 0 6.512659456348047e-05
family O 0 0.00015452153456863016
suggest O 0 0.000191492450539954
that O 0 8.650673407828435e-05
delGAG291 O 0 0.004375921096652746
is O 0 0.0001014055305859074
part O 0 0.00016970417345874012
of O 0 0.00018570144311524928
the O 0 0.0004029124975204468
cause O 0 0.05113232880830765
of O 0 0.02231268584728241
Japanese O 1 0.9997766613960266
ALD B-Disease 1 0.9999997615814209
with O 0 0.0009562227642163634
phenotypic O 0 0.00428780447691679
variations O 0 0.001019204268231988
. O 0 0.0007243692525662482

Moreover O 0 0.004256108775734901
, O 0 0.0004358610894996673
although O 0 0.00015354453353211284
the O 0 0.00013532271259464324
scale O 0 0.0004644250147975981
of O 0 0.0002740177733357996
the O 0 0.00019831160898320377
study O 0 7.58080423111096e-05
is O 0 4.951728260493837e-05
limited O 0 4.465435995371081e-05
, O 0 3.6422850826056674e-05
there O 0 3.311204272904433e-05
is O 0 3.6257544707041234e-05
a O 0 0.00010328731150366366
possibility O 0 0.00022408325457945466
that O 0 8.054539648583159e-05
PET O 0 0.0011284557403996587
can O 0 6.798813410568982e-05
detect O 0 0.00025938768521882594
an O 0 0.00031267423764802516
insidious B-Disease 1 0.9994053840637207
lesion I-Disease 1 0.9999439716339111
which O 0 0.00038852603756822646
is O 0 0.00018899394490290433
undetectable O 0 0.0020106586162000895
by O 0 0.0001095112893381156
computed O 0 0.000395556737203151
tomogram O 1 0.5508198738098145
( O 0 0.00036218707100488245
CT O 0 0.00971499364823103
) O 0 0.00010716975521063432
or O 0 0.00010835910507012159
MRI O 0 0.0011883146362379193
analysis O 0 4.570872988551855e-05
, O 0 2.8401562303770334e-05
and O 0 2.205156306445133e-05
that O 0 1.604896351636853e-05
the O 0 4.2502440919633955e-05
higher O 0 4.714836904895492e-05
level O 0 8.104256266960874e-05
of O 0 8.587060438003391e-05
tau O 0 0.0010487539693713188
reflects O 0 0.00028816459234803915
the O 0 0.00013100281648803502
process O 0 0.00021139116142876446
of O 0 0.001562918652780354
neuronal B-Disease 1 0.9996839761734009
degeneration I-Disease 1 1.0
in O 1 0.9950762391090393
ALD B-Disease 1 0.9999998807907104
. O 0 0.005497300066053867

Lorenzos O 1 0.987330436706543
Oil O 0 0.004177153576165438
should O 0 0.00022479049221146852
be O 0 6.619036139454693e-05
given O 0 4.998784061172046e-05
in O 0 4.773687760462053e-05
the O 0 0.00012841542775277048
early O 0 0.00036574824480339885
stage O 0 0.0018184884684160352
. O 0 0.0003015889087691903
. O 0 0.0004371497198008001

Nonsense O 0 0.017954139038920403
mutation O 0 0.0008295029983855784
in O 0 0.000247434014454484
exon O 0 0.0018227942055091262
4 O 0 0.0003452133678365499
of O 0 0.0004135121707804501
human O 0 0.0006291994941420853
complement O 0 0.0017968963366001844
C9 O 1 0.9993908405303955
gene O 0 0.00025922845816239715
is O 0 9.440210124012083e-05
the O 0 0.00018900656141340733
major O 0 0.0007325675105676055
cause O 0 0.0021553412079811096
of O 0 0.003255972871556878
Japanese O 1 0.9990154504776001
complement B-Disease 1 0.9996433258056641
C9 I-Disease 1 0.9999997615814209
deficiency I-Disease 1 0.9999996423721313
. O 0 0.00441524526104331

Deficiency B-Disease 1 0.9999595880508423
of I-Disease 0 0.0061888182535767555
the I-Disease 0 0.010074172168970108
ninth I-Disease 1 0.9996813535690308
component I-Disease 0 0.3183898627758026
of I-Disease 0 0.001843525213189423
human I-Disease 0 0.001309993676841259
complement I-Disease 0 0.002432506764307618
( O 0 0.0008906309376470745
C9 O 1 0.9984318614006042
) O 0 8.222321048378944e-05
is O 0 4.612585325958207e-05
the O 0 8.590351353632286e-05
most O 0 6.084425695007667e-05
common O 0 0.0004665956075768918
complement B-Disease 1 0.9996639490127563
deficiency I-Disease 1 1.0
in O 0 0.0032307168003171682
Japan O 0 0.05345149710774422
but O 0 9.644190868129954e-05
is O 0 0.00010538654896663502
rare O 0 0.00018011846987064928
in O 0 9.737467917148024e-05
other O 0 8.291909762192518e-05
countries O 0 7.724652095930651e-05
. O 0 0.0004794009728357196

We O 0 0.0007040522759780288
studied O 0 0.0007191391196101904
the O 0 0.0003423907037358731
molecular O 0 0.0004779818409588188
basis O 0 0.00021949874644633383
of O 0 0.002451501088216901
C9 B-Disease 1 0.9999992847442627
deficiency I-Disease 1 0.9999983310699463
in O 0 0.00047533411998301744
four O 0 0.0006004510796628892
Japanese O 1 0.9908883571624756
C9 B-Disease 1 0.9999997615814209
- I-Disease 1 0.999874472618103
deficient I-Disease 1 0.9995715022087097
patients O 0 0.0011546341702342033
who O 0 0.0005921830888837576
had O 0 0.17029494047164917
suffered O 1 0.9999995231628418
from O 1 0.9999297857284546
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 1 0.6365734934806824

Direct O 0 0.003044057171791792
sequencing O 0 0.0036286194808781147
of O 0 0.0016919126501306891
amplified O 0 0.008488524705171585
C9 O 1 0.9706525206565857
cDNA O 0 0.003186591435223818
and O 0 0.00025244292919524014
DNA O 0 0.0005948103498667479
revealed O 0 0.0006201057112775743
a O 0 0.00032645510509610176
nonsense O 0 0.0014291947009041905
substitution O 0 0.0009169548284262419
( O 0 0.0004145351704210043
CGA O 0 0.0037521361373364925
- O 0 0.0014047740260139108
- O 0 0.00108360277954489
> O 0 0.001106592477299273
TGA O 0 0.0027659486513584852
) O 0 8.638736471766606e-05
at O 0 0.00017652347742114216
codon O 0 0.000304542452795431
95 O 0 0.0001782306790119037
in O 0 8.099720434984192e-05
exon O 0 0.0004852089914493263
4 O 0 0.00020659455913119018
in O 0 8.062070264713839e-05
the O 0 0.00026237787096761167
four O 0 0.000761199276894331
C9 B-Disease 1 0.9999881982803345
- I-Disease 1 0.946060299873352
deficient I-Disease 0 0.2713800370693207
individuals O 0 0.0003449179348535836
. O 0 0.0006344461580738425

An O 0 0.0022019643802195787
allele O 0 0.0018804945284500718
- O 0 0.0011190434452146292
specific O 0 0.00028240890242159367
polymerase O 0 0.002387416083365679
chain O 0 0.0013333254028111696
reaction O 0 0.000527208496350795
system O 0 0.0002222295879619196
designed O 0 0.00016227387823164463
to O 0 4.6799410483799875e-05
detect O 0 0.00011365237151039764
exclusively O 0 4.195508881821297e-05
only O 0 1.5433854059665464e-05
one O 0 1.9236887965234928e-05
of O 0 5.9705391322495416e-05
the O 0 0.00014489871682599187
normal O 0 0.00015681447985116392
and O 0 6.717220094287768e-05
mutant O 0 0.00043109626858495176
alleles O 0 9.232898446498439e-05
indicated O 0 7.622122939210385e-05
that O 0 1.7210519217769615e-05
all O 0 2.3339554900303483e-05
the O 0 7.528659625677392e-05
four O 0 0.00012005780445178971
patients O 0 8.865685958880931e-05
were O 0 4.9990369006991386e-05
homozygous O 0 0.00010441086487844586
for O 0 3.3837237424449995e-05
the O 0 7.528917922172695e-05
mutation O 0 8.517737296642736e-05
in O 0 6.170835695229471e-05
exon O 0 0.0006765439757145941
4 O 0 0.00013682285498362035
and O 0 4.279768472770229e-05
that O 0 2.221921386080794e-05
the O 0 6.833940278738737e-05
parents O 0 6.857997504994273e-05
of O 0 0.00024392282648477703
patient O 0 0.0010060732020065188
2 O 0 0.0005434134509414434
were O 0 0.00040864961920306087
heterozygous O 0 0.0008789459243416786
. O 0 0.0005512285861186683

The O 0 0.003471368458122015
common O 0 0.0009605290251784027
mutation O 0 0.000569143274333328
at O 0 0.0003654802276287228
codon O 0 0.0005543482839129865
95 O 0 0.00031887265504337847
in O 0 0.0001451185526093468
exon O 0 0.0008069121395237744
4 O 0 0.00024641980417072773
might O 0 8.308580436278135e-05
be O 0 3.411556099308655e-05
responsible O 0 0.00013218041567597538
for O 0 0.0001041992218233645
most O 0 0.00029179677949287
Japanese O 1 0.9975166320800781
C9 B-Disease 1 0.9999998807907104
deficiency I-Disease 1 1.0
. O 0 0.0011982310097664595
. O 0 0.0009580996120348573

BRCA1 O 0 0.023186542093753815
required O 0 0.0011114267399534583
for O 0 0.0005404397379606962
transcription O 0 0.0030427565798163414
- O 0 0.009606856852769852
coupled O 0 0.017737919464707375
repair O 1 0.998843789100647
of O 1 0.9512956738471985
oxidative O 1 0.9999946355819702
DNA O 1 0.966235339641571
damage O 1 0.9990345239639282
. O 0 0.0011850890005007386

The O 1 0.898263692855835
breast B-Disease 1 0.9999972581863403
and I-Disease 1 0.999919056892395
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
susceptibility O 1 0.9999951124191284
gene O 0 0.13167519867420197
BRCA1 O 0 0.42452874779701233
encodes O 0 0.0005470489268191159
a O 0 0.0006668465211987495
zinc O 1 0.9582263827323914
finger O 0 0.003588301595300436
protein O 0 0.0003219772479496896
of O 0 0.0005261597689241171
unknown O 0 0.0013023540377616882
function O 0 0.0007805210771039128
. O 0 0.0006982616032473743

Association O 0 0.002791684353724122
of O 0 0.0008747201645746827
the O 0 0.0008907383307814598
BRCA1 O 0 0.05284842848777771
protein O 0 0.00019592839817050844
with O 0 9.644429519539699e-05
the O 0 0.0003050448140129447
DNA O 0 0.002453660359606147
repair O 1 0.9977868795394897
protein O 0 0.001101724454201758
Rad51 O 0 0.26729902625083923
and O 0 8.317641186295077e-05
changes O 0 6.982514605624601e-05
in O 0 5.64576439501252e-05
the O 0 0.00012151210830779746
phosphorylation O 0 0.00021219225891400129
and O 0 8.319839253090322e-05
cellular O 0 0.000359130761353299
localization O 0 0.0004051916184835136
of O 0 0.00011103926954092458
the O 0 0.00011274973076069728
protein O 0 0.00011261466715950519
after O 0 0.00018462727894075215
exposure O 0 0.0003247905115131289
to O 0 0.00010815408313646913
DNA O 0 0.0006525726639665663
- O 0 0.0007416015723720193
damaging O 0 0.0014910208992660046
agents O 0 0.00010023610229836777
are O 0 1.2448645975382533e-05
consistent O 0 5.401386442827061e-05
with O 0 3.745581125258468e-05
a O 0 0.00012484703620430082
role O 0 0.0002766773395705968
for O 0 0.00020977744134142995
BRCA1 O 0 0.48233920335769653
in O 0 0.0007352815009653568
DNA O 0 0.004930627066642046
repair O 1 0.9970701932907104
. O 0 0.0010990670416504145

Here O 0 0.002158713759854436
, O 0 0.0004218920657876879
it O 0 0.0001240178826265037
is O 0 9.062748722499236e-05
shown O 0 0.00015021205763332546
that O 0 0.0001631120394449681
mouse O 0 0.0020522275008261204
embryonic O 0 0.043822113424539566
stem O 0 0.20406503975391388
cells O 0 0.015150445513427258
deficient B-Disease 0 0.3684803247451782
in I-Disease 0 0.0002783033123705536
BRCA1 I-Disease 0 0.20466282963752747
are O 0 3.8182115531526506e-05
defective O 0 0.001602674718014896
in O 0 7.640228432137519e-05
the O 0 8.688306115800515e-05
ability O 0 5.960845737718046e-05
to O 0 2.940729245892726e-05
carry O 0 5.979068373562768e-05
out O 0 7.704112795181572e-05
transcription O 0 0.0006900336593389511
- O 0 0.001365882926620543
coupled O 0 0.0018095736159011722
repair O 1 0.9329522848129272
of O 0 0.23720413446426392
oxidative O 1 0.9999864101409912
DNA O 1 0.9720591306686401
damage O 1 0.9994978904724121
, O 0 0.00020085740834474564
and O 0 0.00010058538464363664
are O 0 5.042919292463921e-05
hypersensitive O 0 0.005390952806919813
to O 0 0.0005320461350493133
ionizing O 1 0.9843406081199646
radiation O 1 0.5337382555007935
and O 0 0.0005980046698823571
hydrogen O 0 0.0037226052954792976
peroxide O 0 0.008882103487849236
. O 0 0.0010572049068287015

These O 0 0.0011765043018385768
results O 0 0.0008003119146451354
suggest O 0 0.00038498049252666533
that O 0 0.00020479552040342242
BRCA1 O 0 0.022250238806009293
participates O 0 0.0006269773584790528
, O 0 0.0001719545980449766
directly O 0 0.0001659691333770752
or O 0 0.00013445463264361024
indirectly O 0 0.00025980346254073083
, O 0 0.00011095714580733329
in O 0 0.00015645007079001516
transcription O 0 0.0014956260565668344
- O 0 0.0020887788850814104
coupled O 0 0.002846171846613288
repair O 1 0.9885998964309692
of O 1 0.7035461664199829
oxidative O 1 0.9999873638153076
DNA O 1 0.9672695994377136
damage O 1 0.9992144107818604
. O 0 0.00044974719639867544
. O 0 0.0006501289899460971

Truncation O 0 0.17795774340629578
mutations O 0 0.001319295959547162
in O 0 0.000308331596897915
the O 0 0.0004798714362550527
transactivation O 0 0.006267522927373648
region O 0 0.0005752350552938879
of O 0 0.000900093640666455
PAX6 O 1 0.9998522996902466
result O 0 0.0006237321067601442
in O 0 0.0002673571289051324
dominant O 0 0.002700581680983305
- O 0 0.0014830520376563072
negative O 0 0.0006038123974576592
mutants O 0 0.003465584944933653
. O 0 0.0010343544417992234

PAX6 O 1 0.9429314732551575
is O 0 0.0006458086427301168
a O 0 0.0004324735782574862
transcription O 0 0.0007099829381331801
factor O 0 0.000256907194852829
with O 0 6.321213732007891e-05
two O 0 5.8555739087751135e-05
DNA O 0 0.00024283636594191194
- O 0 0.00025040487525984645
binding O 0 8.12105936347507e-05
domains O 0 0.00023745409271214157
( O 0 0.00014491598994936794
paired O 0 0.00037379900459200144
box O 0 0.0005813706084154546
and O 0 0.0001413942372892052
homeobox O 0 0.003052702872082591
) O 0 9.494475671090186e-05
and O 0 7.589686720166355e-05
a O 0 0.0002375969779677689
proline O 0 0.002596073318272829
- O 0 0.0012060978915542364
serine O 0 0.0022635573986917734
- O 0 0.0014829320134595037
threonine O 0 0.003174637444317341
( O 0 0.0009361712145619094
PST O 0 0.36660540103912354
) O 0 0.0004214688087813556
- O 0 0.0009891961235553026
rich O 0 0.001208149129524827
transactivation O 0 0.008422931656241417
domain O 0 0.0015640767524018884
. O 0 0.0010377370053902268

PAX6 O 1 0.9998356103897095
regulates O 0 0.4738612473011017
eye O 0 0.39073121547698975
development O 0 0.0016993468161672354
in O 0 0.00034714918001554906
animals O 0 0.00016944999515544623
ranging O 0 0.00023597870313096792
from O 0 0.00017341974307782948
jellyfish O 0 0.00040306654409505427
to O 0 0.00013349571963772178
Drosophila O 0 0.0007319592987187207
to O 0 0.0002746625104919076
humans O 0 0.0004989381413906813
. O 0 0.0006542060291394591

Heterozygous O 0 0.0028127904515713453
mutations O 0 0.0005794874159619212
in O 0 0.00021680766076315194
the O 0 0.0003510859969537705
human O 0 0.0013424174394458532
PAX6 O 1 0.9999414682388306
gene O 0 0.00029541694675572217
result O 0 0.00010385599307483062
in O 0 6.33415111224167e-05
various O 0 5.7438734074821696e-05
phenotypes O 0 0.0004226504825055599
, O 0 9.112046973314136e-05
including O 0 0.00019717731629498303
aniridia B-Disease 1 0.9999994039535522
, O 0 0.010098139755427837
Peters B-Disease 1 0.9999836683273315
anomaly I-Disease 1 0.9999955892562866
, O 0 0.002271211938932538
autosomal B-Disease 1 0.9639126658439636
dominant I-Disease 1 0.9999363422393799
keratitis I-Disease 1 0.9999996423721313
, O 0 0.33188825845718384
and O 0 0.36678242683410645
familial B-Disease 1 0.9999990463256836
foveal I-Disease 1 1.0
dysplasia I-Disease 1 1.0
. O 1 0.9842573404312134

It O 0 0.00111269426997751
is O 0 0.0003879641881212592
believed O 0 0.00038380458136089146
that O 0 8.055999205680564e-05
the O 0 0.00032284375629387796
mutated O 0 0.000631336763035506
allele O 0 0.00047250097850337625
of O 0 0.0007677049143239856
PAX6 O 1 0.9978528022766113
produces O 0 0.00043581993668340147
an O 0 0.00019167622667737305
inactive O 0 0.0009577239397913218
protein O 0 0.00033631574478931725
and O 0 0.00026517873629927635
aniridia B-Disease 1 0.999876856803894
is O 0 0.0004345584020484239
caused O 0 0.19974398612976074
due O 0 0.0005838322103954852
to O 0 0.0003279339289292693
genetic O 0 0.006496724672615528
haploinsufficiency O 1 0.9991973042488098
. O 0 0.0015951351961120963

However O 0 0.0013883084757253528
, O 0 0.0003592747962102294
several O 0 0.00020739903266075999
truncation O 0 0.00389268109574914
mutations O 0 0.00028297517565079033
have O 0 3.745956200873479e-05
been O 0 3.6935492971679196e-05
found O 0 2.5611510864109732e-05
to O 0 2.7566748030949384e-05
occur O 0 2.8832526368205436e-05
in O 0 3.7625890399795026e-05
the O 0 0.0001546375424368307
C O 0 0.0014328127726912498
- O 0 0.0005884345737285912
terminal O 0 0.0006455990951508284
half O 0 0.00011165478645125404
of O 0 0.00018954365805257112
PAX6 O 1 0.9846663475036621
in O 0 0.00026652999804355204
patients O 0 0.00031901008333079517
with O 0 0.0001538939686724916
Aniridia B-Disease 1 0.9999933242797852
resulting O 0 0.02665935643017292
in O 0 0.0002621193416416645
mutant O 0 0.0010113182943314314
proteins O 0 9.394339576829225e-05
that O 0 3.651954102679156e-05
retain O 0 0.000127280451124534
the O 0 0.0001486614637542516
DNA O 0 0.00034661058452911675
- O 0 0.0004354387638159096
binding O 0 9.537333971820772e-05
domains O 0 0.00016157350910361856
but O 0 6.454122922150418e-05
have O 0 3.641462171799503e-05
lost O 0 0.000207236735150218
most O 0 8.28995107440278e-05
of O 0 0.0002818958892021328
the O 0 0.0006814953521825373
transactivation O 0 0.021836120635271072
domain O 0 0.0015170368133112788
. O 0 0.0007462984067387879

It O 0 0.0009359523537568748
is O 0 0.00026752360281534493
not O 0 6.937118450878188e-05
clear O 0 0.00012870803766418248
whether O 0 9.443307499168441e-05
such O 0 0.00013865478103980422
mutants O 0 0.004555959720164537
really O 0 0.00054055021610111
behave O 0 0.00035755953285843134
as O 0 0.00018816466035787016
loss O 0 0.002012234413996339
- O 0 0.00043726727017201483
of O 0 0.00034849991789087653
- O 0 0.0014686888316646218
function O 0 0.00025430109235458076
mutants O 0 0.0008678499143570662
as O 0 0.00017140230920631438
predicted O 0 0.0005123736918903887
by O 0 0.0002673408016562462
haploinsufficiency O 0 0.08462769538164139
. O 0 0.0011524250730872154

Contrary O 0 0.00369802163913846
to O 0 0.00041155508370138705
this O 0 0.0002248130040243268
theory O 0 0.0003546619846019894
, O 0 0.00012491134111769497
our O 0 0.0001590453030075878
data O 0 9.223376400768757e-05
showed O 0 0.0001219918267452158
that O 0 3.957437729695812e-05
these O 0 2.8814822144340724e-05
mutants O 0 0.0003188556001987308
are O 0 2.647293877089396e-05
dominant O 0 0.0003566151426639408
- O 0 0.00037583999801427126
negative O 0 0.00017742085037752986
in O 0 0.0001789359812391922
transient O 0 0.0020848566200584173
transfection O 0 0.017147695645689964
assays O 0 0.000210812475415878
when O 0 7.025876402622089e-05
they O 0 2.333023257961031e-05
are O 0 1.6557456547161564e-05
coexpressed O 0 0.0009817078243941069
with O 0 0.00012131089169997722
wild O 0 0.0009132882696576416
- O 0 0.006688189692795277
type O 0 0.00710569741204381
PAX6 O 1 0.9979190230369568
. O 0 0.0014475280186161399

We O 0 0.0006678501376882195
found O 0 0.00016515800962224603
that O 0 6.584737275261432e-05
the O 0 0.0001442531356588006
dominant O 0 0.001127847470343113
- O 0 0.0008963505970314145
negative O 0 0.0002228049997938797
effects O 0 0.00047674166853539646
result O 0 0.00012138980673626065
from O 0 7.175597420427948e-05
the O 0 0.0001355238928226754
enhanced O 0 0.0002712828863877803
DNA O 0 0.0001786948851076886
binding O 0 7.929735875222832e-05
ability O 0 0.0001096711857826449
of O 0 0.0001944507093867287
these O 0 0.00013976209447719157
mutants O 0 0.004890167620033026
. O 0 0.000855189748108387

Kinetic O 0 0.006880579981952906
studies O 0 0.0006085289642214775
of O 0 0.00045060133561491966
binding O 0 0.0002975888201035559
and O 0 0.0002952587092295289
dissociation O 0 0.0019974177703261375
revealed O 0 0.000575288780964911
that O 0 7.444915536325425e-05
various O 0 5.827325367135927e-05
truncation O 0 0.0017413882305845618
mutants O 0 0.0009322765981778502
have O 0 4.887427712674253e-05
3 O 0 0.0001535979681648314
- O 0 0.0002739778137765825
5 O 0 0.00017048008157871664
- O 0 0.00021655643649864942
fold O 0 0.0001545710547361523
higher O 0 7.879842451075092e-05
affinity O 0 5.5657663324382156e-05
to O 0 2.5287055905209854e-05
various O 0 2.886889888031874e-05
DNA O 0 0.0001684884773567319
- O 0 0.0001651913917157799
binding O 0 3.8480833609355614e-05
sites O 0 3.906834535882808e-05
when O 0 5.061526098870672e-05
compared O 0 5.2529750973917544e-05
with O 0 3.3075124520109966e-05
the O 0 0.00015681971854064614
wild O 0 0.0009035367984324694
- O 0 0.005154910963028669
type O 0 0.0038117405492812395
PAX6 O 1 0.9967432618141174
. O 0 0.0026709765661507845

These O 0 0.000428124942118302
results O 0 0.000279332889476791
provide O 0 0.00011758482287405059
a O 0 0.0001679309643805027
new O 0 9.862222213996574e-05
insight O 0 0.00046753697097301483
into O 0 0.00011887080472661182
the O 0 0.00015114480629563332
role O 0 0.0002475283981766552
of O 0 0.000593063363339752
mutant O 1 0.9633974432945251
PAX6 O 1 0.9999873638153076
in O 0 0.019794484600424767
causing O 1 0.9998641014099121
aniridia B-Disease 1 0.9999959468841553
. O 0 0.0006530010141432285
. O 0 0.0008076337398961186

Reversal O 1 0.9904502034187317
of O 1 0.9995922446250916
severe O 1 1.0
hypertrophic B-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
and O 1 0.9999692440032959
excellent O 1 0.99968421459198
neuropsychologic O 1 0.9999452829360962
outcome O 0 0.0009816436795517802
in O 0 0.00016315605898853391
very B-Disease 0 0.0001621144183445722
- I-Disease 0 0.0006687408313155174
long I-Disease 0 0.00036931931390427053
- I-Disease 0 0.0010295649990439415
chain I-Disease 0 0.001416809274815023
acyl I-Disease 0 0.0027262642979621887
- I-Disease 0 0.004576941020786762
coenzyme I-Disease 0 0.008104038424789906
A I-Disease 1 0.98340904712677
dehydrogenase I-Disease 1 0.9999102354049683
deficiency I-Disease 1 0.9999982118606567
. O 0 0.0024273376911878586

Very B-Disease 0 0.003706247080117464
- I-Disease 0 0.0038267658092081547
long I-Disease 0 0.0013123787939548492
- I-Disease 0 0.002049307804554701
chain I-Disease 0 0.0015255152247846127
acyl I-Disease 0 0.0019274867372587323
- I-Disease 0 0.001637834357097745
coenzyme I-Disease 0 0.001670127734541893
A I-Disease 0 0.1168636754155159
dehydrogenase I-Disease 1 0.991884708404541
( I-Disease 0 0.028139356523752213
VLCAD I-Disease 1 0.9999991655349731
) I-Disease 0 0.04546310007572174
deficiency I-Disease 1 0.999996542930603
is O 0 0.0004822685441467911
a O 0 0.061065226793289185
disorder O 1 0.9999978542327881
of O 1 0.9982112646102905
fatty O 1 0.999948263168335
acid O 1 0.9832329154014587
beta O 0 0.0007944279350340366
oxidation O 0 0.00017899707017932087
that O 0 3.2469579309690744e-05
reportedly O 0 0.00019453896675258875
has O 0 5.229593807598576e-05
high O 0 0.00023217711714096367
rates O 0 9.839826088864356e-05
of O 0 0.00030871719354763627
morbidity O 0 0.097191721200943
and O 0 0.0007856336887925863
mortality O 0 0.009075464680790901
. O 0 0.0008533598738722503

We O 0 0.0007457159226760268
describe O 0 0.00045735432649962604
the O 0 0.0001894948654808104
outcome O 0 0.00013716956891585141
of O 0 8.798025373835117e-05
a O 0 0.00016982284432742745
5 O 0 0.00025548849953338504
- O 0 0.00037713494384661317
year O 0 0.00018541091412771493
- O 0 0.00048586894990876317
old O 0 0.0007912201108410954
girl O 0 0.005551351699978113
with O 0 0.008159729652106762
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
who O 0 0.0053153554908931255
was O 0 0.00479819905012846
first O 0 0.00020786483946722
seen O 0 0.00015454128151759505
at O 0 0.00012060845619998872
5 O 0 7.860157347749919e-05
months O 0 6.963616760913283e-05
of O 0 0.0001256249233847484
age O 0 0.0014085036236792803
with O 0 0.19426469504833221
severe O 1 1.0
hypertrophic B-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
, O 1 1.0
hepatomegaly B-Disease 1 1.0
, O 1 0.9999995231628418
encephalopathy B-Disease 1 1.0
, O 1 0.5856634974479675
and O 0 0.03857460990548134
hypotonia B-Disease 1 0.9996962547302246
. O 0 0.0019925932865589857

Biochemical O 0 0.3531147539615631
studies O 0 0.006020459346473217
indicated O 1 0.9987216591835022
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
caused O 1 0.9999872446060181
by O 0 0.0007352662505581975
a O 0 0.002479830291122198
stable O 0 0.046649906784296036
yet O 0 0.0007584033301100135
inactive O 0 0.002606869675219059
enzyme O 0 0.0018667519325390458
. O 0 0.0006186848622746766

Molecular O 0 0.004790797363966703
genetic O 0 0.0010536506306380033
analysis O 0 0.0003135055012535304
of O 0 0.0006361365667544305
her O 0 0.002656785538420081
VLCAD O 1 0.9999788999557495
gene O 0 0.0008530229097232223
revealed O 0 0.001227688044309616
a O 0 0.0009166381205432117
T1372C O 1 0.9961890578269958
( O 0 0.0007543661049567163
F458L O 1 0.5956121683120728
) O 0 0.0002852390753105283
missense O 0 0.001168356160633266
mutation O 0 0.00030817848164588213
and O 0 0.00019540007633622736
a O 0 0.0008747535175643861
1668 O 1 0.9636625051498413
ACAG O 1 0.9997206330299377
1669 O 1 0.9356017112731934
splice O 0 0.029780490323901176
site O 0 0.005448455922305584
mutation O 0 0.0027875511441379786
. O 0 0.0010794952977448702

After O 0 0.006931649520993233
initial O 0 0.003140080953016877
treatment O 0 0.022824713960289955
with O 0 0.0011897834483534098
intravenous O 1 0.99972003698349
glucose O 1 0.9800757169723511
and O 0 0.0016955811297520995
carnitine O 1 0.9995837807655334
, O 0 0.00016576857888139784
the O 0 0.00023277181026060134
patient O 0 0.00025418668519705534
has O 0 7.408513920381665e-05
thrived O 0 0.0004873347352258861
on O 0 9.321541438112035e-05
a O 0 0.00016719853738322854
low O 0 0.00037986933602951467
- O 0 0.0003730391326826066
fat O 0 0.000349178328178823
diet O 0 0.0002443334087729454
supplemented O 0 0.00016888223763089627
with O 0 6.552316335728392e-05
medium O 0 0.0004007833485957235
- O 0 0.0006892156088724732
chain O 0 0.0009351550252176821
triglyceride O 0 0.0026596614625304937
oil O 0 0.0010139704681932926
and O 0 0.0003252887981943786
carnitine O 0 0.1828199326992035
and O 0 0.0003502128238324076
avoidance O 0 0.04327213019132614
of O 0 0.017774121835827827
fasting O 0 0.25074899196624756
. O 0 0.0015098834410309792

Her O 1 0.9944239258766174
ventricular O 1 0.9999992847442627
hypertrophy O 1 0.9999924898147583
resolved O 0 0.011489038355648518
significantly O 0 0.0004940598737448454
over O 0 0.00021657790057361126
1 O 0 0.00020882452372461557
year O 0 0.000158216105774045
, O 0 6.925379420863464e-05
and O 0 9.916927956510335e-05
cognitively O 0 0.008285232819616795
, O 0 0.00010299991845386103
she O 0 0.00012072605022694916
is O 0 4.7367033403133973e-05
in O 0 5.7504996220814064e-05
the O 0 0.00013917824253439903
superior O 0 0.0004703612357843667
range O 0 0.00023716967552900314
for O 0 0.00013037523603998125
age O 0 0.0008074728539213538
. O 0 0.0007116955239325762

Clinical O 0 0.01146453246474266
recognition O 0 0.07276496291160583
of O 1 0.9999868869781494
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
is O 1 0.6663654446601868
important O 0 0.0007720253197476268
because O 0 6.995844159973785e-05
it O 0 2.1516932974918745e-05
is O 0 1.8834045476978645e-05
one O 0 1.885503479570616e-05
of O 0 5.761329157394357e-05
the O 0 0.00013420959294307977
few O 0 0.00022989917488303035
directly O 0 0.0010053511941805482
treatable O 1 0.9999967813491821
causes O 1 0.9998480081558228
of O 1 0.9999550580978394
cardiomyopathy B-Disease 1 1.0
in O 1 0.9969660639762878
children O 0 0.00636201212182641
. O 0 0.0003557892923709005
. O 0 0.000620007049292326

Cloning O 0 0.00504794716835022
of O 0 0.0008371466537937522
a O 0 0.0006154847797006369
novel O 0 0.0003150882839690894
member O 0 0.00011554567754501477
of O 0 0.00016347311611752957
the O 0 0.0003905206685885787
low O 0 0.002353777876123786
- O 0 0.002975394483655691
density O 0 0.0014395322650671005
lipoprotein O 1 0.6543377637863159
receptor O 0 0.0012354078935459256
family O 0 0.0007665476878173649
. O 0 0.0005930826882831752

A O 0 0.005611850880086422
gene O 0 0.0008998420089483261
encoding O 0 0.0003618252230808139
a O 0 0.0002885833091568202
novel O 0 0.0004779155715368688
transmembrane O 0 0.0010491107823327184
protein O 0 0.0002680914767552167
was O 0 0.00031495068105868995
identified O 0 9.13737530936487e-05
by O 0 4.003084541182034e-05
DNA O 0 9.242341911885887e-05
sequence O 0 6.541384209413081e-05
analysis O 0 3.528608795022592e-05
within O 0 8.361747313756496e-05
the O 0 0.0004568434087559581
insulin B-Disease 1 0.9737102389335632
- I-Disease 1 0.7136966586112976
dependent I-Disease 0 0.04052608460187912
diabetes I-Disease 1 0.9999991655349731
mellitus I-Disease 1 0.9999986886978149
( O 0 0.18601351976394653
IDDM B-Disease 1 0.9999780654907227
) O 0 0.0005124356248416007
locus O 0 0.0037856081034988165
IDDM4 O 1 0.9953526258468628
on O 0 0.0013574555050581694
chromosome O 0 0.0047607747837901115
11q13 O 1 0.6644760966300964
. O 0 0.0018856963142752647

Based O 0 0.0009993202984333038
on O 0 0.0004163116682320833
its O 0 0.00027040645363740623
chromosomal O 0 0.002016091486439109
position O 0 0.0005512012867256999
, O 0 0.00014542498684022576
this O 0 8.222737233154476e-05
gene O 0 0.0001222622231580317
is O 0 5.6648015743121505e-05
a O 0 0.00011879589146701619
candidate O 0 0.00025839192676357925
for O 0 0.0001694367383606732
conferring O 0 0.0019892873242497444
susceptibility O 1 0.9470587372779846
to O 0 0.002661464037373662
diabetes B-Disease 1 0.9999842643737793
. O 0 0.003037545131519437

The O 0 0.003180186729878187
gene O 0 0.0012098685838282108
, O 0 0.0004467663529794663
termed O 0 0.001770278438925743
low O 0 0.000985868857242167
- O 0 0.0007981741218827665
density O 0 0.00048281732597388327
lipoprotein O 0 0.005227182526141405
receptor O 0 0.0003088290977757424
related O 0 0.00014316481247078627
protein O 0 0.0001407492090947926
5 O 0 0.00013511432916857302
( O 0 0.00014449196169152856
LRP5 O 0 0.41949066519737244
) O 0 6.481927266577259e-05
, O 0 4.651687777368352e-05
encodes O 0 7.195791113190353e-05
a O 0 7.774163532303646e-05
protein O 0 0.00012745341518893838
of O 0 0.00023582328867632896
1615 O 0 0.0022580481600016356
amino O 0 0.0002247386146336794
acids O 0 0.00011700900358846411
that O 0 5.513914584298618e-05
contains O 0 9.236896585207433e-05
conserved O 0 0.0002009095042012632
modules O 0 0.0002916326920967549
which O 0 3.717518120538443e-05
are O 0 1.1228553375985939e-05
characteristic O 0 6.220465729711577e-05
of O 0 0.00010128791473107412
the O 0 0.0002563439484219998
low O 0 0.0008243332267738879
- O 0 0.0010151042370125651
density O 0 0.0005099506815895438
lipoprotein O 1 0.9822193384170532
( O 0 0.0008416476775892079
LDL O 1 0.9824521541595459
) O 0 0.0002839434309862554
receptor O 0 0.0005254811840131879
family O 0 0.0006030514487065375
. O 0 0.0008484659483656287

These O 0 0.0010175484931096435
modules O 0 0.0018702868837863207
include O 0 0.00027331174351274967
a O 0 0.00032940038363449275
putative O 0 0.0013929309789091349
signal O 0 0.0009217449696734548
peptide O 0 0.00038833756116218865
for O 0 6.669788126600906e-05
protein O 0 9.777422383194789e-05
export O 0 0.00019535089086275548
, O 0 6.13504380453378e-05
four O 0 0.0001490053255110979
epidermal O 1 0.5256852507591248
growth O 0 0.0013752954546362162
factor O 0 0.0010731896618381143
( O 0 0.00039695476880297065
EGF O 1 0.7526533007621765
) O 0 0.00013651947665493935
repeats O 0 0.00033181850449182093
with O 0 9.694322216091678e-05
associated O 0 0.00016540481010451913
spacer O 0 0.0014020716771483421
domains O 0 0.0004562854883261025
, O 0 0.00019797796267084777
three O 0 0.00025387766072526574
LDL O 1 0.9993053674697876
- O 0 0.03132832050323486
receptor O 0 0.0009201123612001538
( O 0 0.0003827059408649802
LDLR O 1 0.9298325777053833
) O 0 0.00014644063776358962
repeats O 0 0.00025079341139644384
, O 0 7.033880683593452e-05
a O 0 0.00011980357521679252
single O 0 0.0001928653073264286
transmembrane O 0 0.0010900622000917792
spanning O 0 0.0010257507674396038
domain O 0 0.00030761753441765904
, O 0 0.00015936318959575146
and O 0 0.0001047869081958197
a O 0 0.0003444785834290087
cytoplasmic O 0 0.0016542633529752493
domain O 0 0.0015382884303107858
. O 0 0.0010033806320279837

The O 0 0.001884688506834209
encoded O 0 0.0006949132075533271
protein O 0 0.0004158483643550426
has O 0 0.0001594017812749371
a O 0 0.00016662465350236744
unique O 0 0.00018422564608044922
organization O 0 0.0002922879357356578
of O 0 0.0011538941180333495
EGF O 1 0.9999052286148071
and O 0 0.00148296938277781
LDLR O 1 0.9999843835830688
repeats O 0 0.002859254367649555
; O 0 0.00015390569751616567
therefore O 0 0.00015482387971132994
, O 0 0.00016466504894196987
LRP5 O 1 0.9015889167785645
likely O 0 0.00015218429325614125
represents O 0 0.0001346123026451096
a O 0 0.00011250486568314955
new O 0 6.0512975323945284e-05
category O 0 0.0001644493022467941
of O 0 0.00022692994389217347
the O 0 0.0009658437338657677
LDLR O 1 0.9999710321426392
family O 0 0.002866035560145974
. O 0 0.0011270345421507955

Both O 0 0.00221921200864017
human O 0 0.0026922826655209064
and O 0 0.0019110561115667224
mouse O 1 0.932312548160553
LRP5 O 1 0.999998927116394
cDNAs O 1 0.9997934699058533
have O 0 0.00020587524340953678
been O 0 0.00015164313663262874
isolated O 0 0.00036268081748858094
and O 0 6.236015178728849e-05
the O 0 0.00011772213474614546
encoded O 0 9.65634681051597e-05
mature O 0 0.00011327909305691719
proteins O 0 4.4271488150116056e-05
are O 0 1.3798233339912258e-05
95 O 0 6.498391303466633e-05
% O 0 2.8594817194971256e-05
identical O 0 4.2319672502344474e-05
, O 0 3.471059972071089e-05
indicating O 0 9.523847256787121e-05
a O 0 0.00010669174662325531
high O 0 0.00018231634749099612
degree O 0 0.00014379649655893445
of O 0 0.00016653729835525155
evolutionary O 0 0.0008492719498462975
conservation O 0 0.0005606319755315781
. O 0 0.00019720286945812404
. O 0 0.0003620505449362099

The O 0 0.009479474276304245
APC B-Disease 1 0.9921541810035706
variants O 0 0.005329879000782967
I1307K O 1 0.9974803328514099
and O 0 0.0012805679580196738
E1317Q O 1 0.9946862459182739
are O 0 0.00016213994240388274
associated O 0 0.0015760221285745502
with O 1 0.9975482821464539
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 0.020875832065939903
but O 0 9.76543960859999e-05
not O 0 3.24864849972073e-05
always O 0 5.05174721183721e-05
with O 0 3.0233564757509157e-05
a O 0 0.0001915726315928623
family O 0 0.0004141086246818304
history O 0 0.0013701284769922495
. O 0 0.0006896533304825425

Classical O 1 0.6962666511535645
familial B-Disease 1 0.9999963045120239
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 1 0.9998568296432495
FAP B-Disease 1 0.999993085861206
) O 0 0.0009363988065160811
is O 0 0.0002745887031778693
a O 0 0.0007428454118780792
high O 0 0.4576992392539978
- O 1 0.9265944957733154
penetrance O 1 0.9996390342712402
autosomal B-Disease 1 0.9987205862998962
dominant I-Disease 1 0.9999855756759644
disease I-Disease 1 0.9999990463256836
that O 0 0.0007279813871718943
predisposes O 1 0.9078286290168762
to O 0 0.00012760076788254082
hundreds O 0 0.00034383489401079714
or O 0 0.00018000826821662486
thousands O 0 0.000926123175304383
of O 1 0.9991434812545776
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 0.9999189376831055
carcinoma I-Disease 1 1.0
and O 0 0.0018315118504688144
that O 0 0.00012801490083802491
results O 0 0.00013037673488724977
from O 0 0.00012664665700867772
truncating O 0 0.001446012407541275
mutations O 0 0.0001797372824512422
in O 0 0.00015779516252223402
the O 0 0.0005128273041918874
APC B-Disease 1 0.8910237550735474
gene O 0 0.0010806472273543477
. O 0 0.0006422866135835648

A O 0 0.014406939968466759
variant O 0 0.009648549370467663
of O 0 0.015490777790546417
FAP B-Disease 1 0.9999688863754272
is O 0 0.052523501217365265
attenuated B-Disease 1 0.9998496770858765
adenomatous I-Disease 1 0.9999998807907104
polyposis I-Disease 1 0.9999998807907104
coli I-Disease 1 0.999997615814209
, O 0 0.0006038505816832185
which O 0 7.80832560849376e-05
results O 0 0.00010073580051539466
from O 0 0.0002188859652960673
germ O 1 0.9996258020401001
- O 0 0.0017626145854592323
line O 0 0.0003282029356341809
mutations O 0 6.266320997383446e-05
in O 0 4.350583549239673e-05
the O 0 5.859064185642637e-05
5 O 0 6.0195106925675645e-05
and O 0 2.831717938533984e-05
3 O 0 5.614388282992877e-05
regions O 0 4.12644658354111e-05
of O 0 0.00016885323566384614
the O 0 0.0006534548592753708
APC B-Disease 1 0.9986226558685303
gene O 0 0.0012008956400677562
. O 0 0.0008001983514986932

Attenuated B-Disease 1 0.9999206066131592
adenomatous I-Disease 1 0.9999998807907104
polyposis I-Disease 1 1.0
coli I-Disease 1 0.9999998807907104
patients O 1 0.9967940449714661
have O 0 0.0005966085009276867
" O 0 0.00954160001128912
multiple O 0 0.23705460131168365
" O 1 0.9998186230659485
colorectal B-Disease 1 1.0
adenomas I-Disease 1 0.9999992847442627
( O 0 0.000720552634447813
typically O 0 7.690862548770383e-05
fewer O 0 3.821573409368284e-05
than O 0 1.7596565157873556e-05
100 O 0 5.2233135647838935e-05
) O 0 2.4354667402803898e-05
without O 0 3.4705899452092126e-05
the O 0 0.00011197337880730629
florid O 0 0.0038116539362818003
phenotype O 0 0.0010650686454027891
of O 0 0.000845622387714684
classical O 0 0.006332701537758112
FAP B-Disease 1 0.9982847571372986
. O 0 0.001700974185951054

Another O 0 0.0037093334831297398
group O 0 0.0007682245341129601
of O 0 0.0013605443527922034
patients O 0 0.004832997918128967
with O 0 0.0006077459547668695
multiple O 1 0.7451177835464478
adenomas B-Disease 1 0.9999842643737793
has O 0 0.00034861755557358265
no O 0 0.00014456942153628916
mutations O 0 6.191077409312129e-05
in O 0 6.925431807758287e-05
the O 0 0.00027478535776026547
APC B-Disease 1 0.9962252378463745
gene O 0 0.000150498075527139
, O 0 4.7936780902091414e-05
and O 0 4.1720690205693245e-05
their O 0 3.451933662290685e-05
phenotype O 0 0.0003100811445619911
probably O 0 0.00013413565466180444
results O 0 5.122925358591601e-05
from O 0 4.5652097469428554e-05
variation O 0 7.009099499555305e-05
at O 0 0.00011412499588914216
a O 0 0.00011003320832969621
locus O 0 0.0005479520186781883
, O 0 8.878029620973393e-05
or O 0 7.326887862291187e-05
loci O 0 0.0003066301578655839
, O 0 7.59365429985337e-05
elsewhere O 0 0.00013391072570811957
in O 0 8.47329429234378e-05
the O 0 0.00034525300725363195
genome O 0 0.0009092175168916583
. O 0 0.0006174438749440014

Recently O 0 0.005351950414478779
, O 0 0.0004808079975191504
however O 0 0.00014579652633983642
, O 0 0.00012370252807158977
a O 0 0.00024817496887408197
missense O 0 0.001201372710056603
variant O 0 0.0008217295398935676
of O 0 0.0016428501112386584
APC B-Disease 1 0.9999644756317139
( O 0 0.0021861304994672537
I1307K O 1 0.9952309727668762
) O 0 0.00012870128557551652
was O 0 0.00033691988210193813
described O 0 0.00019458422320894897
that O 0 4.376382639748044e-05
confers O 0 0.0003907999489456415
an O 0 0.00011670581443468109
increased O 0 0.0005817117053084075
risk O 0 0.12401950359344482
of O 1 0.999995231628418
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 1 0.5513929128646851
including O 0 0.020942915230989456
multiple O 0 0.23944422602653503
adenomas B-Disease 1 0.9999624490737915
, O 0 0.0005594074609689415
in O 0 0.0005669796955771744
Ashkenazim O 0 0.09841614216566086
. O 0 0.0011178007116541266

We O 0 0.000644451065454632
have O 0 0.00011824053945019841
studied O 0 0.00018493473180569708
a O 0 0.00010032215504907072
set O 0 0.00010941943764919415
of O 0 0.00018931771046482027
164 O 0 0.001683815149590373
patients O 0 0.0008263622876256704
with O 0 0.0007029155385680497
multiple O 1 0.9997463822364807
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 0.9992499947547913
/ I-Disease 1 0.9999539852142334
or I-Disease 1 0.5507646799087524
carcinoma I-Disease 1 0.9999991655349731
and O 0 0.0004131027963012457
analyzed O 0 0.0005560152349062264
codons O 0 0.001395864994265139
1263 O 0 0.009892602451145649
- O 0 0.0015335389180108905
1377 O 0 0.01363020483404398
( O 0 0.0004454001027625054
exon O 0 0.0017597952391952276
15G O 0 0.00225055986084044
) O 0 8.480060932924971e-05
of O 0 0.00011668622028082609
the O 0 0.0002812907623592764
APC B-Disease 1 0.5393080115318298
gene O 0 0.00033021095441654325
for O 0 0.0003713821934070438
germ O 1 0.9997039437294006
- O 0 0.017241938039660454
line O 0 0.0021876145619899035
variants O 0 0.0012854246888309717
. O 0 0.0008090421324595809

Three O 0 0.002126656472682953
patients O 0 0.0007033467991277575
with O 0 0.00013388096704147756
the O 0 0.0005910770851187408
I1307K O 1 0.9794014692306519
allele O 0 0.0004569191369228065
were O 0 0.00010311215010005981
detected O 0 0.0001821617188397795
, O 0 4.560823435895145e-05
each O 0 2.722611498029437e-05
of O 0 0.0001944243849720806
Ashkenazi O 0 0.003437393344938755
descent O 0 0.0038528756704181433
. O 0 0.0010681521380320191

Four O 0 0.002503030700609088
patients O 0 0.0011648518266156316
had O 0 0.0006009125499986112
a O 0 0.0015388759784400463
germ O 1 0.9999582767486572
- O 0 0.14023546874523163
line O 0 0.0026203577872365713
E1317Q O 0 0.24702589213848114
missense O 0 0.002051836811006069
variant O 0 0.0006714175688102841
of O 0 0.00035771599505096674
APC O 1 0.9789425730705261
that O 0 7.123671821318567e-05
was O 0 0.000268223142484203
not O 0 2.5961438950616866e-05
present O 0 4.0969323890749365e-05
in O 0 3.545247818692587e-05
controls O 0 8.158489072229713e-05
; O 0 2.4032811779761687e-05
one O 0 2.3928754671942443e-05
of O 0 5.220131788519211e-05
these O 0 1.3455460248223972e-05
individuals O 0 2.366342960158363e-05
had O 0 7.802600885042921e-05
an O 0 8.498226088704541e-05
unusually O 0 0.00021313595061656088
large O 0 8.210451778722927e-05
number O 0 5.399789733928628e-05
of O 0 0.0003086548240389675
metaplastic B-Disease 1 0.9995515942573547
polyps I-Disease 1 0.5222688913345337
of I-Disease 0 0.0007842047489248216
the I-Disease 0 0.0036539463326334953
colorectum I-Disease 1 0.9976314306259155
. O 0 0.0015962470788508654

There O 0 0.0011503515997901559
is O 0 0.0003263613907620311
increasing O 0 0.0002146055776393041
evidence O 0 0.00011716141307260841
that O 0 5.205402339925058e-05
there O 0 8.892204641597345e-05
exist O 0 0.0001473832526244223
germ O 1 0.9857456684112549
- O 0 0.0009935825364664197
line O 0 0.0003288735169917345
variants O 0 0.00010927263065241277
of O 0 0.00013541926455218345
the O 0 0.00041807544766925275
APC B-Disease 1 0.9818226099014282
gene O 0 0.00020073834457434714
that O 0 5.651118772220798e-05
predispose O 0 0.00027225897065363824
to O 0 4.32705637649633e-05
the O 0 0.0001114443875849247
development O 0 0.00032609302434138954
of O 0 0.12286016345024109
multiple O 1 0.9999833106994629
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 0.9999994039535522
carcinoma I-Disease 1 1.0
, O 0 0.00472625344991684
but O 0 9.533551201457158e-05
without O 0 8.38316700537689e-05
the O 0 0.0001891518768388778
florid O 0 0.005249012727290392
phenotype O 0 0.0004691366048064083
of O 0 0.0003114488208666444
classical O 0 0.019946154206991196
FAP B-Disease 1 0.999925971031189
, O 0 0.0001918817579280585
and O 0 0.00010636079969117418
possibly O 0 0.00017062024562619627
with O 0 8.436818461632356e-05
importance O 0 0.008685259148478508
for O 1 0.987218976020813
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
risk O 0 0.156356081366539
in O 0 0.00014412705786526203
the O 0 0.0002642305626068264
general O 0 0.00030989915831014514
population O 0 6.610040873056278e-05
. O 0 8.679801976541057e-05
. O 0 0.0002850305463653058

Genomic O 0 0.004540035035461187
structure O 0 0.0024550743401050568
of O 0 0.0039930520579218864
the O 1 0.997434675693512
human O 1 0.9999980926513672
congenital B-Disease 1 1.0
chloride I-Disease 1 1.0
diarrhea I-Disease 1 1.0
( O 1 0.9999980926513672
CLD B-Disease 1 0.9999998807907104
) O 0 0.0019944619853049517
gene O 0 0.0012638175394386053
. O 0 0.00063227245118469

Congenital B-Disease 1 1.0
chloride I-Disease 1 1.0
diarrhea I-Disease 1 1.0
( O 1 0.9999984502792358
CLD B-Disease 1 1.0
) O 0 0.013143331743776798
is O 0 0.0003751312615349889
caused O 0 0.027664145454764366
by O 0 5.544634768739343e-05
mutations O 0 5.0653023208724335e-05
in O 0 3.456875492702238e-05
a O 0 0.00011635655391728505
gene O 0 0.00010967610432999209
which O 0 6.06034736847505e-05
encodes O 0 0.00031860132003203034
an O 0 0.0005601715529337525
intestinal O 1 0.9999966621398926
anion O 1 0.9990612864494324
transporter O 1 0.9952211976051331
. O 0 0.0020082148257642984

We O 0 0.000982965575531125
report O 0 0.00040646924753673375
here O 0 0.00015836552483960986
the O 0 0.0001448904222343117
complete O 0 0.0003636129549704492
genomic O 0 0.0002793304738588631
organization O 0 0.000162828917382285
of O 0 0.00021242161164991558
the O 0 0.0005175868864171207
human O 0 0.0024872974026948214
CLD B-Disease 1 0.9999128580093384
gene O 0 0.00024320665397681296
which O 0 6.045743793947622e-05
spans O 0 0.0003160109044983983
approximately O 0 0.0002942232240457088
39kb O 0 0.04015671834349632
, O 0 9.561702609062195e-05
and O 0 6.73214890412055e-05
comprises O 0 0.0004182406992185861
21 O 0 0.0008134452509693801
exons O 0 0.0027600624598562717
. O 0 0.000660145131405443

All O 0 0.0030834677163511515
exon O 0 0.010505961254239082
/ O 0 0.003123258240520954
intron O 0 0.0036813272163271904
boundaries O 0 0.0003265839477535337
conform O 0 0.000504058669321239
to O 0 0.00020897372451145202
the O 0 0.0008498702081851661
GT O 1 0.9987714886665344
/ O 1 0.5653687119483948
AG O 1 0.9792385697364807
rule O 0 0.002846833784133196
. O 0 0.0014557794202119112

An O 0 0.0008298968314193189
analysis O 0 0.00023192157095763832
of O 0 0.00023941596737131476
the O 0 0.0003638504713308066
putative O 0 0.0026992387138307095
promoter O 0 0.005769574083387852
region O 0 0.00037658654036931694
sequence O 0 0.00017779394693206996
shows O 0 0.00022898301540408283
a O 0 0.00040435505798086524
putative O 0 0.048873815685510635
TATA O 1 0.9999700784683228
box O 0 0.0022703467402607203
and O 0 0.00020881238742731512
predicts O 0 0.0006643168744631112
multiple O 0 0.00018034153617918491
transcription O 0 0.0008048663148656487
factor O 0 0.0006025544716976583
binding O 0 0.000319114129524678
sites O 0 0.0005519428523257375
. O 0 0.0008126104949042201

The O 0 0.0028331326320767403
genomic O 0 0.002106405794620514
structure O 0 0.0013013266725465655
was O 0 0.0008266008808277547
determined O 0 0.00018962174362968653
using O 0 6.277696957113221e-05
DNA O 0 9.832257637754083e-05
from O 0 3.3022173738572747e-05
several O 0 2.3961547412909567e-05
sources O 0 5.377262277761474e-05
including O 0 5.315292582963593e-05
multiple O 0 0.00011772347352234647
large O 0 0.0003433327074162662
- O 0 0.0027257315814495087
insert O 0 0.0018419903935864568
libaries O 0 0.007927599363029003
and O 0 0.0001301042502745986
genomic O 0 0.0004747327766381204
DNA O 0 0.0004766925994772464
from O 0 0.000296049693133682
Finnish O 1 0.9851257801055908
CLD B-Disease 1 0.9999971389770508
patients O 0 0.005038138013333082
and O 0 0.0003857545671053231
controls O 0 0.0009853560477495193
. O 0 0.0008800983196124434

Exon O 0 0.03975903242826462
- O 0 0.00409295316785574
specific O 0 0.0004068237612955272
primers O 0 0.0015045423060655594
developed O 0 0.00030695454915985465
in O 0 9.25700951484032e-05
this O 0 4.317856291891076e-05
study O 0 5.632246029563248e-05
will O 0 6.181236676638946e-05
facilitate O 0 0.0001998342777369544
mutation O 0 0.00017201300943270326
screening O 0 0.00014821672812104225
studies O 0 8.356094622286037e-05
of O 0 0.0002646641805768013
patients O 0 0.0006183600053191185
with O 0 0.000288373208604753
the O 1 0.9318303465843201
disease O 1 0.9999959468841553
. O 0 0.0018522973405197263

Genomic O 0 0.005293612834066153
sequencing O 0 0.002083083614706993
of O 0 0.0009046109626069665
a O 0 0.0021352749317884445
BAC O 1 0.99907386302948
clone O 1 0.9969915151596069
H O 1 0.9997236132621765
_ O 0 0.0009734714403748512
RG364P16 O 0 0.02202083170413971
revealed O 0 0.0007236206438392401
the O 0 0.00013064865197520703
presence O 0 0.0001449097617296502
of O 0 0.0001428534887963906
another O 0 0.00023256307758856565
, O 0 9.267494169762358e-05
highly O 0 9.724374831421301e-05
homologous O 0 0.00018901954172179103
gene O 0 6.102776023908518e-05
3 O 0 7.155304047046229e-05
of O 0 0.00012047488417010754
the O 0 0.0002958425902761519
CLD B-Disease 1 0.9998966455459595
gene O 0 0.0001173912241938524
, O 0 3.609932537074201e-05
with O 0 2.916064659075346e-05
a O 0 7.479636406060308e-05
similar O 0 6.837120599811897e-05
genomic O 0 0.00018638900655787438
structure O 0 0.00033218314638361335
, O 0 6.541371840285137e-05
recently O 0 0.00017978974210564047
identified O 0 9.486087219556794e-05
as O 0 0.00011131948849651963
the O 0 0.0024453934747725725
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
gene O 1 0.9965558052062988
( O 0 0.3216671347618103
PDS B-Disease 1 0.9999923706054688
) O 0 0.0004916584002785385
. O 0 0.0003102654009126127
. O 0 0.0005560294957831502

The O 0 0.021390046924352646
APCI1307K O 1 0.9999685287475586
allele O 0 0.05654197931289673
and O 0 0.014085303992033005
cancer B-Disease 1 0.9992824196815491
risk O 0 0.0004889281699433923
in O 0 0.00016664309077896178
a O 0 0.0002554559032432735
community O 0 0.00017585621390026063
- O 0 0.00019108573906123638
based O 0 4.992109825252555e-05
study O 0 3.983146234531887e-05
of O 0 0.00016363094619009644
Ashkenazi O 0 0.00213653314858675
Jews O 0 0.0015116436406970024
. O 0 0.0006422948790714145

Mutations O 0 0.009387840516865253
in O 0 0.0024243376683443785
APC O 1 0.9936983585357666
are O 0 0.00031119619961827993
classically O 0 0.04924403131008148
associated O 0 0.0008880537352524698
with O 0 0.0012255008332431316
familial B-Disease 1 0.9999997615814209
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 1 0.9999934434890747
FAP B-Disease 1 0.9999992847442627
) O 0 0.0006859919521957636
, O 0 0.00024520859005860984
a O 0 0.0007847871165722609
highly O 0 0.2814413905143738
penetrant O 1 0.999997615814209
autosomal B-Disease 1 0.999998927116394
dominant I-Disease 1 0.9999998807907104
disorder I-Disease 1 1.0
characterized O 1 0.9999997615814209
by O 1 0.9999198913574219
multiple O 1 0.9999992847442627
intestinal O 1 1.0
polyps B-Disease 1 0.9999998807907104
and O 0 0.2247508317232132
, O 0 0.0003220275975763798
without O 0 0.00014946454029995948
surgical O 1 0.9337896704673767
intervention O 0 0.0014840227086097002
, O 0 8.433617767877877e-05
the O 0 0.0001516171032562852
development O 0 0.0009558001183904707
of O 1 0.9997902512550354
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 1 0.9932233095169067
CRC B-Disease 1 0.9998086094856262
) O 0 0.0005855268100276589
. O 0 0.0006295491475611925

APC B-Disease 1 0.78196781873703
is O 0 0.002287130570039153
a O 0 0.008864779025316238
tumour O 1 0.9999997615814209
- O 1 0.9976426959037781
suppressor O 1 0.9952974915504456
gene O 0 0.0004851562553085387
, O 0 0.0001420783664798364
and O 0 0.00013620468962471932
somatic O 0 0.005338235292583704
loss O 1 0.887081503868103
occurs O 0 0.002797965193167329
in O 0 0.0022982966620475054
tumours B-Disease 1 0.999983549118042
. O 0 0.001768317073583603

The O 0 0.011766682378947735
germline O 1 0.9887169599533081
T O 1 0.8972522020339966
- O 0 0.0011003001127392054
to O 0 0.00019458051247056574
- O 0 0.0005889069871045649
A O 0 0.0006621007923968136
transversion O 0 0.01196294091641903
responsible O 0 0.0005168021307326853
for O 0 0.00014765192463528365
the O 0 0.0004339258885011077
APC O 1 0.8918188810348511
I1307K O 0 0.4865540862083435
allele O 0 0.0005205547204241157
converts O 0 0.0002293216675752774
the O 0 0.00011313724826322868
wild O 0 0.00017648140783421695
- O 0 0.0001860271586338058
type O 0 0.00010622679837979376
sequence O 0 7.713669037912041e-05
to O 0 9.429863712284714e-05
a O 0 0.0006343350978568196
homopolymer O 1 0.9999173879623413
tract O 1 0.9999812841415405
( O 0 0.011715673841536045
A8 O 1 0.9999001026153564
) O 0 0.00017379253404214978
that O 0 8.654725388623774e-05
is O 0 0.00015617419558111578
genetically O 0 0.0005951332859694958
unstable O 0 0.3711155354976654
and O 0 0.00045110739301890135
prone O 1 0.7659797668457031
to O 0 0.0008904497954063118
somatic O 0 0.11744900792837143
mutation O 0 0.00255298032425344
. O 0 0.0008598488057032228

The O 0 0.007031864020973444
I1307K O 1 0.8248850107192993
allele O 0 0.0013722804142162204
was O 0 0.0009133644052781165
found O 0 0.0002613863907754421
in O 0 0.00029149703914299607
6 O 0 0.0011295010335743427
. O 0 0.0008860044763423502

1 O 0 0.001398284686729312
% O 0 0.000360884761903435
of O 0 0.0008642473840154707
unselected O 0 0.027523787692189217
Ashkenazi O 0 0.0034113163128495216
Jews O 0 0.0008550410275347531
and O 0 0.0002137733536073938
higher O 0 0.0002221668983111158
proportions O 0 0.000653339026030153
of O 0 0.00041997525840997696
Ashkenazim O 0 0.014502434059977531
with O 0 0.00014258378359954804
family O 0 0.00028046625084243715
or O 0 0.00014933932106941938
personal O 0 0.00032386163366027176
histories O 0 0.00033413039636798203
of O 0 0.004342038184404373
CRC B-Disease 1 0.9999815225601196
( O 0 0.002635580487549305
ref O 0 0.35505881905555725
. O 0 0.00016594761109445244
2 O 0 0.00031337462132796645
) O 0 0.00026466292911209166
. O 0 0.000584268884267658

To O 0 0.000994557049125433
evaluate O 0 0.0007928986451588571
the O 0 0.0005040975520387292
role O 0 0.0007562742102891207
of O 0 0.0015283141983672976
I1307K O 1 0.9999616146087646
in O 0 0.10417824983596802
cancer B-Disease 1 0.9997004270553589
, O 0 0.0002651021641213447
we O 0 0.00017611747898627073
genotyped O 0 0.03874639794230461
5 O 0 0.0004302017914596945
, O 0 0.0003424344176892191
081 O 0 0.008758229203522205
Ashkenazi O 0 0.001980711007490754
volunteers O 0 0.0006489144288934767
in O 0 0.0002001676184590906
a O 0 0.00035795001895166934
community O 0 0.00040083262138068676
survey O 0 0.0005951046478003263
. O 0 0.00066020229132846

Risk O 0 0.030413411557674408
of O 1 0.5263182520866394
developing O 1 0.9999287128448486
colorectal B-Disease 1 1.0
, I-Disease 1 0.9912115931510925
breast I-Disease 1 0.9999767541885376
and I-Disease 0 0.000915682699996978
other I-Disease 0 0.00020225763728376478
cancers I-Disease 1 0.6058629751205444
were O 0 0.00013707792095374316
compared O 0 0.00028680183459073305
between O 0 0.0003471778181847185
genotyped O 1 0.9995580315589905
I1307K O 1 0.9988553524017334
carriers O 0 0.0006511726533062756
and O 0 0.0001039354465319775
non O 0 0.00031948063406161964
- O 0 0.0003757060330826789
carriers O 0 8.130521018756554e-05
and O 0 1.9289867850602604e-05
their O 0 1.958448046934791e-05
first O 0 0.00013402786862570792
- O 0 0.0003363931900821626
degree O 0 0.00045761073124594986
relatives O 0 0.0006101893959566951
. O 0 0.0003847842162940651

Sperm O 0 0.002935346681624651
DNA O 0 0.0010404076892882586
analysis O 0 0.00021957620629109442
in O 0 0.00034624830004759133
a O 0 0.00226807314902544
Friedreich B-Disease 1 0.9999253749847412
ataxia I-Disease 1 0.999991774559021
premutation O 1 0.9999849796295166
carrier O 0 0.4624657928943634
suggests O 0 0.0014927760930731893
both O 0 0.0004186074947938323
meiotic O 0 0.2080633044242859
and O 0 0.0003979569301009178
mitotic O 0 0.0056512788869440556
expansion O 0 0.0012120093451812863
in O 0 0.00022391750826500356
the O 0 0.0008067294838838279
FRDA B-Disease 1 0.999859094619751
gene O 0 0.0013011780101805925
. O 0 0.0007334264228120446

Friedreich B-Disease 1 0.9999768733978271
ataxia I-Disease 1 0.9999738931655884
is O 0 0.0065973238088190556
usually O 0 0.0008920055697672069
caused O 0 0.02744286134839058
by O 0 0.0001424457150278613
an O 0 0.00011254435958107933
expansion O 0 0.0004965300904586911
of O 0 0.0003236671909689903
a O 0 0.0005410033045336604
GAA O 0 0.006121559534221888
trinucleotide O 0 0.02327163703739643
repeat O 0 0.0006251742015592754
in O 0 0.00014310597907751799
intron O 0 0.0010637675877660513
1 O 0 0.0001908342819660902
of O 0 0.0002521316637285054
the O 0 0.0010181638645008206
FRDA B-Disease 1 0.9998683929443359
gene O 0 0.0018077302956953645
. O 0 0.000788344070315361

Occasionally O 0 0.0024170763790607452
, O 0 0.00042741725337691605
a O 0 0.000419500662246719
fully O 0 0.0004590100725181401
expanded O 0 0.0002685747167561203
allele O 0 0.00017661743913777173
has O 0 4.33575150964316e-05
been O 0 3.485608613118529e-05
found O 0 3.411208308534697e-05
to O 0 4.495868051890284e-05
arise O 0 9.238852362614125e-05
from O 0 6.798761751269922e-05
a O 0 0.00017095411021728069
premutation O 0 0.010692102834582329
of O 0 0.0003324990102555603
100 O 0 0.0005174092948436737
or O 0 0.000184618475032039
less O 0 0.0002458411327097565
triplet O 0 0.0060128821060061455
repeats O 0 0.0025701711419969797
. O 0 0.001022318028844893

We O 0 0.0011251599062234163
have O 0 0.000274430844001472
examined O 0 0.00039208028465509415
the O 0 0.00023514500935561955
sperm O 0 0.00034556665923446417
DNA O 0 0.00036014203215017915
of O 0 0.00047898321645334363
a O 0 0.0013999028597027063
premutation O 1 0.9936768412590027
carrier O 0 0.010802497155964375
. O 0 0.0014390710275620222

This O 0 0.002251091180369258
mans O 0 0.012704476714134216
leucocyte O 1 0.5311504602432251
DNA O 0 0.0014373657759279013
showed O 0 0.0005224351771175861
one O 0 0.00017596255929674953
normal O 0 0.0001956028863787651
allele O 0 0.0001522348029538989
and O 0 3.309373641968705e-05
one O 0 3.1617903005098924e-05
allele O 0 9.417354158358648e-05
of O 0 0.00011872116010636091
approximately O 0 0.00021074576943647116
100 O 0 0.0005075959488749504
repeats O 0 0.0012091104872524738
. O 0 0.0005715324659831822

His O 0 0.004680722951889038
sperm O 0 0.0011826993431895971
showed O 0 0.000569905445445329
an O 0 0.00013989835861139
expanded O 0 0.00021220157213974744
allele O 0 0.00011717806773958728
in O 0 5.0704737077467144e-05
a O 0 0.0001300985604757443
tight O 0 0.0002512634382583201
range O 0 0.00011297606397420168
centering O 0 0.0002932003408204764
on O 0 9.2410555225797e-05
a O 0 0.00013051180576439947
size O 0 0.00013782012683805078
of O 0 0.00019438803428784013
approximately O 0 0.0004230857884977013
320 O 0 0.0021654798183590174
trinucleotide O 0 0.041835516691207886
repeats O 0 0.003967354539781809
. O 0 0.0012881584698334336

His O 0 0.010734057985246181
affected O 0 0.005672163795679808
son O 0 0.09599612653255463
has O 0 0.0006061975727789104
repeat O 0 0.0009525129571557045
sizes O 0 0.00027164185303263366
of O 0 0.0007093279855325818
1040 O 0 0.011685682460665703
and O 0 0.0007488774717785418
540 O 0 0.006367916706949472
. O 0 0.0013177256332710385

These O 0 0.0006063932087272406
data O 0 0.00018337670189794153
suggest O 0 0.00016883006901480258
that O 0 5.1357907068450004e-05
expansion O 0 0.0003325538127683103
occurs O 0 7.639106479473412e-05
in O 0 3.42231614922639e-05
two O 0 3.0013143259566277e-05
stages O 0 0.0001878624316304922
, O 0 4.676390381064266e-05
the O 0 5.601857992587611e-05
first O 0 0.00011851259478135034
during O 0 0.0002695022849366069
meiosis O 0 0.0009668109705671668
followed O 0 0.00015870927018113434
by O 0 4.2749506974359974e-05
a O 0 0.00019866930961143225
second O 0 0.0006695009651593864
mitotic O 0 0.006626551039516926
expansion O 0 0.0037242486141622066
. O 0 0.0008138061966747046

We O 0 0.0011963470606133342
also O 0 0.00031592565937899053
show O 0 0.00029503446421585977
that O 0 3.939559974242002e-05
in O 0 4.665877713705413e-05
all O 0 5.0519491196610034e-05
informative O 0 0.00022141657245811075
carrier O 0 0.00043819090933538973
father O 0 0.0004528499557636678
to O 0 0.00011947616440011188
affected O 0 0.000453085929621011
child O 0 0.0008419985533691943
transmissions O 0 0.00039464517612941563
, O 0 5.454701749840751e-05
with O 0 2.5119099518633448e-05
the O 0 8.405549306189641e-05
notable O 0 0.00011468989396234974
exception O 0 7.246244786074385e-05
of O 0 0.00012084767513442785
the O 0 0.00030098369461484253
premutation O 1 0.6909592747688293
carrier O 0 0.0004796379362232983
, O 0 6.669063441222534e-05
the O 0 0.0001126467832364142
expansion O 0 0.0005146389012224972
size O 0 0.00034650290035642684
decreases O 0 0.0007808576920069754
. O 0 0.00018747823196463287
. O 0 0.00042777496855705976

The O 0 0.004939384292811155
R496H O 1 0.9689487814903259
mutation O 0 0.0011848531430587173
of O 0 0.0015386538580060005
arylsulfatase O 1 0.9996277093887329
A O 1 0.7574077844619751
does O 0 0.00044477934716269374
not O 0 0.0002693294081836939
cause O 1 0.988952100276947
metachromatic B-Disease 1 0.9999988079071045
leukodystrophy I-Disease 1 0.9999986886978149
. O 0 0.004423938225954771

Deficiency B-Disease 1 0.9999926090240479
of I-Disease 0 0.3856838345527649
arylsulfatase I-Disease 1 0.9999663829803467
A I-Disease 1 0.9981845021247864
( O 0 0.014707004651427269
ARSA O 1 0.9997639060020447
) O 0 0.0008157262345775962
enzyme O 0 0.002147500868886709
activity O 0 0.003085538512095809
causes O 1 0.9983674883842468
metachromatic B-Disease 1 0.9999995231628418
leukodystrophy I-Disease 1 0.9999998807907104
( O 1 0.9761799573898315
MLD B-Disease 1 0.9999970197677612
) O 0 0.0020614296663552523
. O 0 0.0014394246973097324

A O 0 0.003617867361754179
number O 0 0.0005002750549465418
of O 0 0.001569557236507535
ARSA O 1 0.9999451637268066
gene O 0 0.0013292200164869428
mutations O 0 0.0005455969367176294
responsible O 0 0.0008658773731440306
for O 0 0.0006845776224508882
MLD B-Disease 1 0.9999955892562866
have O 0 0.0004021975619252771
been O 0 0.000442435615696013
identified O 0 0.0006923832697793841
. O 0 0.0005379553767852485

Recently O 0 0.0042478530667722225
, O 0 0.0006003904272802174
the O 0 0.0006021351437084377
R496H O 1 0.68277508020401
mutation O 0 0.0007613163907080889
of O 0 0.0011051701148971915
ARSA O 1 0.9998350143432617
was O 0 0.0011107514146715403
proposed O 0 0.0001574879279360175
to O 0 4.628862734534778e-05
be O 0 4.002916466561146e-05
a O 0 0.00012152206909377128
cause O 0 0.00037965283263474703
of O 0 0.0008359094499610364
MLD B-Disease 1 0.9999996423721313
( O 0 0.002645152620971203
Draghia O 1 0.995429515838623
et O 0 0.0036508888006210327
al O 0 0.002098553115502
. O 0 0.0001530244917375967
, O 0 0.0001643076102482155
1997 O 0 0.0006507114158011973
) O 0 0.0002434177731629461
. O 0 0.00043952371925115585

We O 0 0.0011595742544159293
have O 0 0.00024155199935194105
investigated O 0 0.0007785526104271412
the O 0 0.0005674830754287541
R496H O 1 0.9604824781417847
mutation O 0 0.00028986032702960074
and O 0 7.528818241553381e-05
found O 0 5.068960308562964e-05
this O 0 3.2791147532407194e-05
mutation O 0 5.716539817512967e-05
at O 0 8.365175744984299e-05
a O 0 8.053678902797401e-05
relatively O 0 4.893555887974799e-05
high O 0 8.665501809446141e-05
frequency O 0 2.936598684755154e-05
in O 0 1.6386860806960613e-05
an O 0 2.34700164583046e-05
African O 0 0.00010484146332601085
American O 0 0.00012158269237261266
population O 0 2.8547929105116054e-05
( O 0 4.272090154699981e-05
f O 0 0.00018433317018207163
= O 0 0.00018482771702110767
0 O 0 0.00011883000115631148
. O 0 7.736490806564689e-05
09 O 0 0.0008107203175313771
, O 0 0.00014643352187704295
n O 0 0.0003859616699628532
= O 0 0.0004720793222077191
61 O 0 0.0005363936652429402
subjects O 0 0.0005970809143036604
) O 0 0.00034202105598524213
. O 0 0.0006899418658576906

The O 0 0.009993690066039562
ARSA O 1 0.9991430044174194
enzyme O 0 0.002137476811185479
activity O 0 0.000321326864650473
in O 0 8.356015314348042e-05
subjects O 0 0.00016509283159393817
with O 0 4.4605931179830804e-05
and O 0 4.149495725869201e-05
without O 0 6.272616883506998e-05
the O 0 0.00021766620920971036
R496H O 1 0.9787063002586365
mutation O 0 0.00023591505305375904
was O 0 0.0002766989346127957
determined O 0 8.822068775771186e-05
and O 0 4.734526373795234e-05
found O 0 5.2063551265746355e-05
to O 0 6.54507166473195e-05
be O 0 0.00011940667172893882
normal O 0 0.0005517166573554277
. O 0 0.00046826174366287887

It O 0 0.0008371648727916181
is O 0 0.0003920750750694424
therefore O 0 0.00021413933427538723
concluded O 0 0.00032158123212866485
that O 0 7.032659777905792e-05
the O 0 0.00027194528956897557
R496H O 1 0.7611628770828247
mutation O 0 0.0005840806988999248
of O 0 0.0012735071359202266
ARSA O 1 0.9999080896377563
does O 0 0.0001169947354355827
not O 0 4.187482409179211e-05
negatively O 0 0.0001169442039099522
influence O 0 0.00012439295824151486
the O 0 0.00015781291585881263
activity O 0 0.0002363549720030278
of O 0 0.000537328131031245
ARSA O 1 0.9999324083328247
and O 0 0.00024631363339722157
is O 0 0.00012187207175884396
not O 0 5.7167140766978264e-05
a O 0 0.00033034602529369295
cause O 0 0.008903983980417252
of O 0 0.05063134804368019
MLD B-Disease 1 0.9999971389770508

Down O 0 0.015589389950037003
- O 0 0.0023801494389772415
regulation O 0 0.0006358280661515892
of O 0 0.0005971620557829738
transmembrane O 1 0.5763396620750427
carbonic O 1 0.9998514652252197
anhydrases O 1 0.9999899864196777
in O 1 0.9975201487541199
renal B-Disease 1 1.0
cell I-Disease 1 0.9999996423721313
carcinoma I-Disease 1 1.0
cell O 1 0.7899959683418274
lines O 0 0.0006142017664387822
by O 0 0.00010508829291211441
wild O 0 0.0003314403584226966
- O 0 0.0007073341985233128
type O 0 0.0008211127133108675
von B-Disease 0 0.05416029319167137
Hippel I-Disease 1 0.9981397390365601
- I-Disease 0 0.24648736417293549
Lindau I-Disease 1 0.9166305661201477
transgenes O 0 0.10378529131412506
. O 0 0.001897158334031701

To O 0 0.001681694877333939
discover O 0 0.0014532364439219236
genes O 0 0.00029139674734324217
involved O 0 0.0002926889283116907
in O 0 0.0002529078919906169
von B-Disease 0 0.19959434866905212
Hippel I-Disease 1 0.9995803236961365
- I-Disease 1 0.960838794708252
Lindau I-Disease 1 0.9993903636932373
( O 0 0.00557631766423583
VHL B-Disease 1 0.9999350309371948
) O 0 0.000624750042334199
- O 0 0.0029318486340343952
mediated O 0 0.011268426664173603
carcinogenesis O 1 0.9991729855537415
, O 0 0.0004347570356912911
we O 0 0.000443751341663301
used O 0 0.0036034269724041224
renal B-Disease 1 1.0
cell I-Disease 1 0.9999980926513672
carcinoma I-Disease 1 1.0
cell O 1 0.9869171380996704
lines O 0 0.0019227517768740654
stably O 0 0.006458267569541931
transfected O 0 0.0030302084051072598
with O 0 0.0001575373171363026
wild O 0 0.0006071233074180782
- O 0 0.0018831733614206314
type O 0 0.004877136554569006
VHL O 1 0.9998983144760132
- O 0 0.008951457217335701
expressing O 0 0.00220678374171257
transgenes O 0 0.014986129477620125
. O 0 0.001256470219232142

Large O 0 0.003143067704513669
- O 0 0.002000743756070733
scale O 0 0.0019004857167601585
RNA O 0 0.0009608778054825962
differential O 0 0.0009768801974132657
display O 0 0.0006146535160951316
technology O 0 0.00026258386787958443
applied O 0 7.138632645364851e-05
to O 0 3.943521369365044e-05
these O 0 3.275751441833563e-05
cell O 0 0.00020270940149202943
lines O 0 0.00014019962691236287
identified O 0 6.54432296869345e-05
several O 0 5.575035902438685e-05
differentially O 0 0.00038946408312767744
expressed O 0 0.00010331232624594122
genes O 0 5.6990134908119217e-05
, O 0 3.9774527976987883e-05
including O 0 5.268618042464368e-05
an O 0 0.00021839610417373478
alpha O 0 0.001763528329320252
carbonic O 0 0.3158469498157501
anhydrase O 1 0.989884614944458
gene O 0 0.001103821792639792
, O 0 0.0006813164800405502
termed O 0 0.014067714102566242
CA12 O 1 0.9994021654129028
. O 0 0.0023968222085386515

The O 0 0.001960810273885727
deduced O 0 0.0013828855007886887
protein O 0 0.0003521465987432748
sequence O 0 0.00017535021470393986
was O 0 0.00028766749892383814
classified O 0 0.00013616248907055706
as O 0 6.145876977825537e-05
a O 0 9.376046364195645e-05
one O 0 0.00011798398190876469
- O 0 0.00044011088903062046
pass O 0 0.0004055531171616167
transmembrane O 0 0.0028615216724574566
CA O 0 0.0015310439048334956
possessing O 0 0.0006032331148162484
an O 0 0.0002092680224450305
apparently O 0 0.0004466896934900433
intact O 0 0.0004498787457123399
catalytic O 0 0.0005845047999173403
domain O 0 0.00017762958304956555
in O 0 0.00011241436004638672
the O 0 0.000372208101907745
extracellular O 0 0.005205714609473944
CA O 0 0.06866036355495453
module O 0 0.01863826811313629
. O 0 0.0007801774190738797

Reintroduced O 0 0.01831533946096897
wild O 0 0.006773679982870817
- O 0 0.011836611665785313
type O 0 0.007472170051187277
VHL B-Disease 1 0.9977824091911316
strongly O 0 0.0006364840664900839
inhibited O 0 0.0006791952764615417
the O 0 0.0002859767118934542
overexpression O 0 0.000607533729635179
of O 0 0.00027102979947812855
the O 0 0.0005190950469113886
CA12 O 1 0.9996423721313477
gene O 0 0.00021409668261185288
in O 0 8.663882181281224e-05
the O 0 0.0005329054547473788
parental O 0 0.1574450582265854
renal B-Disease 1 1.0
cell I-Disease 1 0.9999996423721313
carcinoma I-Disease 1 1.0
cell O 1 0.9996024966239929
lines O 0 0.004540185444056988
. O 0 0.0009249934228137136

Similar O 0 0.001088881166651845
results O 0 0.00031957810278981924
were O 0 0.0001278658164665103
obtained O 0 0.00018307255231775343
with O 0 0.0001379651512252167
CA9 O 1 0.8132548332214355
, O 0 0.00016381374734919518
encoding O 0 0.0001311873202212155
another O 0 0.0002550319768488407
transmembrane O 0 0.001767558977007866
CA O 0 0.0006460669101215899
with O 0 9.181475616060197e-05
an O 0 0.00022075891320127994
intact O 0 0.0027541141025722027
catalytic O 0 0.003855573944747448
domain O 0 0.001445392263121903
. O 0 0.0008036585059016943

Although O 0 0.0012621405767276883
both O 0 0.0003091301186941564
domains O 0 0.0006395703530870378
of O 0 0.0005952629144303501
the O 0 0.0020653903484344482
VHL B-Disease 1 0.9998905658721924
protein O 0 0.0005564640159718692
contribute O 0 0.0002266067313030362
to O 0 6.806416058680043e-05
regulation O 0 0.0001604740391485393
of O 0 0.00034982673241756856
CA12 O 1 0.9995822310447693
expression O 0 0.00034829298965632915
, O 0 8.879028609953821e-05
the O 0 0.00021859379194211215
elongin O 0 0.005282867234200239
binding O 0 0.00017742966883815825
domain O 0 0.00022470499970950186
alone O 0 0.0003876041155308485
could O 0 0.0002659218152984977
effectively O 0 0.0007299588178284466
regulate O 0 0.0011525441659614444
CA9 O 1 0.9962792992591858
expression O 0 0.002048240276053548
. O 0 0.0012418364640325308

We O 0 0.003194141900166869
mapped O 0 0.007860226556658745
CA12 O 1 0.9982873797416687
and O 0 0.0014571857172995806
CA9 O 1 0.9940187931060791
loci O 0 0.00350498897023499
to O 0 0.0004478651680983603
chromosome O 0 0.0016166315181180835
bands O 0 0.004438705276697874
15q22 O 1 0.9970343112945557
and O 0 0.0015211825957521796
17q21 O 1 0.9927431344985962
. O 0 0.0017128655454143882

2 O 0 0.0031571004074066877
respectively O 0 0.0013281924184411764
, O 0 0.00039090096834115684
regions O 0 0.00026163997245021164
prone O 0 0.0019175646593794227
to O 0 0.00026414691819809377
amplification O 0 0.001683651003986597
in O 0 0.00029455582262016833
some O 0 0.000264681875705719
human O 0 0.003544116159901023
cancers B-Disease 1 0.9636154770851135
. O 0 0.0008581614238210022

Additional O 0 0.0017166152829304338
experiments O 0 0.0008693458512425423
are O 0 5.669465826940723e-05
needed O 0 0.0001482785155531019
to O 0 4.084476677235216e-05
define O 0 0.00010705658496590331
the O 0 0.00013674500223714858
role O 0 0.00035056855995208025
of O 0 0.003933645319193602
CA O 1 0.9910417199134827
IX O 1 0.9999581575393677
and O 0 0.001127044204622507
CA O 0 0.0760183185338974
XII O 1 0.9843305945396423
enzymes O 0 0.00021422674763016403
in O 0 6.379287515301257e-05
the O 0 0.00010504753299755976
regulation O 0 0.00011855496268253773
of O 0 0.00018360662215854973
pH O 0 0.0004933002055622637
in O 0 0.00010055622988147661
the O 0 0.0002665376232471317
extracellular O 0 0.0008230401435866952
microenvironment O 0 0.0020497101359069347
and O 0 9.240702638635412e-05
its O 0 7.767982606310397e-05
potential O 0 0.00028386464691720903
impact O 0 0.000561706256121397
on O 0 0.001459561986848712
cancer B-Disease 1 0.9999032020568848
cell O 1 0.6271898746490479
growth O 0 0.0029317494481801987
. O 0 0.0008229895611293614

A O 0 0.003606571350246668
gene O 0 0.0007408902747556567
encoding O 0 0.00032983903656713665
a O 0 0.0003080794704146683
transmembrane O 0 0.001779958140105009
protein O 0 0.0004938972415402532
is O 0 0.0002148854691768065
mutated O 0 0.000607843860052526
in O 0 0.00030772079480811954
patients O 0 0.2089754045009613
with O 1 0.9740602970123291
diabetes B-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 1 1.0
optic B-Disease 1 1.0
atrophy I-Disease 1 1.0
( O 1 0.9999995231628418
Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
) O 0 0.010863271541893482
. O 0 0.0016357679851353168

Wolfram B-Disease 1 0.9999996423721313
syndrome I-Disease 1 1.0
( O 1 0.9997134804725647
WFS B-Disease 1 0.9999982118606567
; O 0 0.25003156065940857
OMIM O 1 0.9999947547912598
222300 O 1 0.9999340772628784
) O 0 0.0008752895519137383
is O 0 0.0004485831595957279
an O 0 0.002003370551392436
autosomal B-Disease 1 0.9999469518661499
recessive I-Disease 1 1.0
neurodegenerative I-Disease 1 1.0
disorder I-Disease 1 1.0
defined O 1 0.9993784427642822
by O 0 0.4621284306049347
young O 1 0.9965850114822388
- O 1 0.9990689158439636
onset O 1 0.9999985694885254
non O 1 0.9998714923858643
- O 1 0.9999845027923584
immune O 1 0.9999983310699463
insulin B-Disease 1 0.9999964237213135
- I-Disease 1 0.9999704360961914
dependent I-Disease 1 0.9990014433860779
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 1 0.9999891519546509
progressive O 1 1.0
optic B-Disease 1 1.0
atrophy I-Disease 1 1.0
. O 1 0.9438993334770203

Linkage O 0 0.009412677958607674
to O 0 0.000783012539613992
markers O 0 0.0017924918793141842
on O 0 0.0009821997955441475
chromosome O 0 0.004211698658764362
4p O 1 0.9994922876358032
was O 0 0.0020488931331783533
confirmed O 0 0.00027573879924602807
in O 0 0.00012146877270424739
five O 0 0.00019921408966183662
families O 0 0.0003891619562637061
. O 0 0.0006373509531840682

On O 0 0.0019910705741494894
the O 0 0.0009232333395630121
basis O 0 0.0005047076265327632
of O 0 0.0017625750042498112
meiotic O 1 0.9999710321426392
recombinants O 1 0.9999990463256836
and O 1 0.9991636276245117
disease O 1 0.9999998807907104
- O 1 0.9983465671539307
associated O 0 0.0009001335129141808
haplotypes O 0 0.001617135014384985
, O 0 0.0002868409501388669
the O 0 0.0007541238446719944
WFS B-Disease 1 0.9993971586227417
gene O 0 0.0006660246872343123
was O 0 0.0007542619132436812
localized O 0 0.0005025058053433895
to O 0 0.00011950463522225618
a O 0 0.0005350543069653213
BAC O 1 0.9432737231254578
/ O 0 0.004499990027397871
P1 O 0 0.22443124651908875
contig O 0 0.007586125284433365
of O 0 0.0005210665403865278
less O 0 0.00016276712995022535
than O 0 0.000156518115545623
250 O 0 0.0006331058102659881
kb O 0 0.004192451946437359
. O 0 0.0010035315062850714

Mutations O 0 0.0033006148878484964
in O 0 0.0006836723769083619
a O 0 0.0007063927478156984
novel O 0 0.0007860343321226537
gene O 0 0.00039265782106667757
( O 0 0.00037685211282223463
WFS1 O 1 0.8332072496414185
) O 0 0.00012445502215996385
encoding O 0 0.00010859639587579295
a O 0 0.0001737885468173772
putative O 0 0.0010472473222762346
transmembrane O 0 0.0009754442726261914
protein O 0 0.0001326869532931596
were O 0 4.919786806567572e-05
found O 0 4.9234949983656406e-05
in O 0 3.895796544384211e-05
all O 0 2.491979830665514e-05
affected O 0 8.696561417309567e-05
individuals O 0 2.7905254682991654e-05
in O 0 8.556586544727907e-05
six O 0 0.00033224833896383643
WFS B-Disease 1 0.9982981085777283
families O 0 0.00011548904149094597
, O 0 7.169332820922136e-05
and O 0 6.085226414143108e-05
these O 0 2.764158671197947e-05
mutations O 0 5.925412551732734e-05
were O 0 5.229877569945529e-05
associated O 0 0.00011154665844514966
with O 0 0.00016727173351682723
the O 1 0.9212234020233154
disease O 1 0.9999991655349731
phenotype O 1 0.9603135585784912
. O 0 0.001286940067075193

WFS1 O 1 0.9994367957115173
appears O 0 0.002174470340833068
to O 0 0.00033149594673886895
function O 0 0.0002494110376574099
in O 0 0.0001366997603327036
survival O 0 0.0006482969038188457
of O 0 0.0005341024952940643
islet O 1 0.970207691192627
beta O 0 0.33149489760398865
- O 0 0.4117240905761719
cells O 0 0.0005779691855423152
and O 0 0.00018696214829105884
neurons O 0 0.0007982334354892373
. O 0 0.0001685080787865445
. O 0 0.00042626456706784666

Stable O 0 0.01146591454744339
interaction O 0 0.001544031547382474
between O 0 0.00045958117698319256
the O 0 0.0003780928673222661
products O 0 0.0002445089048705995
of O 0 0.0003501232131384313
the O 0 0.002696277806535363
BRCA1 O 1 0.9987131357192993
and O 0 0.0018327415455132723
BRCA2 O 1 0.9997642636299133
tumor B-Disease 1 0.9999809265136719
suppressor O 1 0.8243975043296814
genes O 0 0.00034618808422237635
in O 0 0.00029238240676932037
mitotic O 0 0.1020795926451683
and O 0 0.001221795566380024
meiotic O 1 0.9996098875999451
cells O 0 0.0068944357335567474
. O 0 0.0011700417380779982

BRCA1 O 1 0.9964901804924011
and O 0 0.0022351257503032684
BRCA2 O 0 0.010417857207357883
account O 0 0.00019859470194205642
for O 0 6.645516259595752e-05
most O 0 6.364715954987332e-05
cases O 0 8.560113201383501e-05
of O 0 0.0004458049079403281
familial O 1 0.9957494735717773
, O 0 0.010605085641145706
early O 1 0.9686236381530762
onset O 1 1.0
breast B-Disease 1 0.9999992847442627
and I-Disease 1 0.9930813908576965
/ I-Disease 1 0.9999979734420776
or I-Disease 1 0.9999818801879883
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999983310699463
and O 0 0.0003836853720713407
encode O 0 0.0001883951626950875
products O 0 0.00011203425674466416
that O 0 3.859464777633548e-05
each O 0 4.279613131075166e-05
interact O 0 0.00012539704039227217
with O 0 0.00020041702373418957
hRAD51 O 0 0.16378596425056458
. O 0 0.001330848317593336

Results O 0 0.0025645641144365072
presented O 0 0.0011305388761684299
here O 0 0.0005690738908015192
show O 0 0.000553532037883997
that O 0 0.0002430962776998058
BRCA1 O 0 0.21245791018009186
and O 0 0.0004547004064079374
BRCA2 O 0 0.06472495198249817
coexist O 0 0.0003971712721977383
in O 0 0.00012306439748499542
a O 0 0.0003606282116379589
biochemical O 0 0.0019065557280555367
complex O 0 0.0011094798101112247
and O 0 0.0001873086584964767
colocalize O 1 0.7784634232521057
in O 0 0.0003838668344542384
subnuclear O 1 0.9140744805335999
foci O 0 0.00483858585357666
in O 0 0.0003324444987811148
somatic O 0 0.0024284531828016043
cells O 0 0.00017197051784023643
and O 0 4.0960028854897246e-05
on O 0 6.430900248233229e-05
the O 0 8.410471491515636e-05
axial O 0 0.00028059675241820514
elements O 0 0.0002607695641927421
of O 0 0.0007145320996642113
developing O 0 0.002215511631220579
synaptonemal O 1 0.9991157650947571
complexes O 0 0.037639372050762177
. O 0 0.0014580782735720277

Like O 0 0.07347036153078079
BRCA1 O 1 0.9977325201034546
and O 0 0.003957152832299471
RAD51 O 1 0.9997909665107727
, O 0 0.0020898666698485613
BRCA2 O 0 0.06938159465789795
relocates O 0 0.008775084279477596
to O 0 0.0008128927438519895
PCNA O 1 0.9368166923522949
+ O 0 0.001456752885133028
replication O 0 0.0005376296467147768
sites O 0 0.00017384653619956225
following O 0 0.000115389542770572
exposure O 0 0.00019150707521475852
of O 0 0.0003118951281066984
S O 1 0.6528676748275757
phase O 0 0.08392681926488876
cells O 0 0.0005258970195427537
to O 0 0.0002649813541211188
hydroxyurea O 0 0.018404429778456688
or O 0 0.0015100769232958555
UV O 1 0.9407866597175598
irradiation O 0 0.008121488615870476
. O 0 0.0012829320039600134

Thus O 0 0.006450892426073551
, O 0 0.0025357273407280445
BRCA1 O 1 0.969350278377533
and O 0 0.0007755454280413687
BRCA2 O 0 0.1760798990726471
participate O 0 0.00023099823738448322
, O 0 6.691901944577694e-05
together O 0 6.311071047093719e-05
, O 0 5.06682918057777e-05
in O 0 7.548717985628173e-05
a O 0 0.0002587928611319512
pathway O 0 0.035241708159446716
( O 0 0.0001979235967155546
s O 0 0.0005411743186414242
) O 0 5.5439151765313e-05
associated O 0 5.190774390939623e-05
with O 0 1.7398017007508315e-05
the O 0 0.00010559899965301156
activation O 0 0.00021165476937312633
of O 0 0.0002587447233963758
double O 0 0.006315142847597599
- O 0 0.001577878836542368
strand O 0 0.0010898971231654286
break O 0 0.0013815198326483369
repair O 0 0.4643566608428955
and O 0 0.0005026229191571474
/ O 0 0.002197085879743099
or O 0 0.0005691337864845991
homologous O 0 0.003982909023761749
recombination O 0 0.005295031704008579
. O 0 0.001277418457902968

Dysfunction O 1 0.9995998740196228
of O 0 0.007226287852972746
this O 0 0.0012524572666734457
pathway O 1 0.6023572087287903
may O 0 0.00018546362116467208
be O 0 4.01567158405669e-05
a O 0 0.00011688968515954912
general O 0 0.000245829374762252
phenomenon O 0 0.0002135398972313851
in O 0 3.0228460673242807e-05
the O 0 4.5478984247893095e-05
majority O 0 3.5074092011200264e-05
of O 0 9.954152483260259e-05
cases O 0 0.00010364921763539314
of O 0 0.10654783993959427
hereditary B-Disease 1 0.9999996423721313
breast I-Disease 1 0.9999998807907104
and I-Disease 1 0.999885082244873
/ I-Disease 1 0.9999995231628418
or I-Disease 1 0.9999974966049194
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
. O 0 0.0011531799100339413
. O 0 0.0009576172451488674

A O 0 0.015152443200349808
novel O 0 0.006231619510799646
Arg362Ser O 1 0.6094057559967041
mutation O 0 0.0005143588641658425
in O 0 0.00013450515689328313
the O 0 0.00031709010363556445
sterol O 0 0.005381639115512371
27 O 0 0.0025363604072481394
- O 0 0.002897483529523015
hydroxylase O 0 0.007602411322295666
gene O 0 0.0006715404451824725
( O 0 0.0004887923132628202
CYP27 O 1 0.9462444186210632
) O 0 0.00010294934327248484
: O 0 9.400271665072069e-05
its O 0 6.369112816173583e-05
effects O 0 0.000212623635889031
on O 0 0.00013903713261242956
pre O 0 0.0008288038661703467
- O 0 0.0005750944255851209
mRNA O 0 0.0004873395955655724
splicing O 0 0.0004898777115158737
and O 0 0.00019937369506806135
enzyme O 0 0.0007216662634164095
activity O 0 0.000803715200163424
. O 0 0.0004914278397336602

A O 0 0.007467231713235378
novel O 0 0.0018477309495210648
C O 0 0.0011902290862053633
to O 0 0.0001712565717753023
A O 0 0.0006394311785697937
mutation O 0 0.00020967787713743746
in O 0 0.00010566930723143741
the O 0 0.00023036125639919192
sterol O 0 0.0022709225304424763
27 O 0 0.001417978317476809
- O 0 0.001598543138243258
hydroxylase O 0 0.004663898143917322
gene O 0 0.00033366563729941845
( O 0 0.00031184899853542447
CYP27 O 1 0.9703824520111084
) O 0 0.0001290067593799904
was O 0 0.0003705520066432655
identified O 0 0.00015522446483373642
by O 0 0.00011489052121760324
sequencing O 0 0.0009299146477133036
amplified O 0 0.001957070315256715
CYP27 O 1 0.9898606538772583
gene O 0 0.00045951767242513597
products O 0 0.00021064875181764364
from O 0 0.00011238027946092188
a O 0 0.0003891118976753205
patient O 0 0.0011075922520831227
with O 0 0.0007316762348636985
cerebrotendinous B-Disease 1 0.999998927116394
xanthomatosis I-Disease 1 0.9999997615814209
( O 1 0.9248833656311035
CTX B-Disease 1 0.9999790191650391
) O 0 0.0018859968986362219
. O 0 0.0014203611062839627

The O 0 0.0035211406648159027
mutation O 0 0.001485126675106585
changed O 0 0.0008895628270693123
the O 0 0.0008267388329841197
adrenodoxin O 0 0.06995806843042374
cofactor O 0 0.011093273758888245
binding O 0 0.0005759688792750239
residue O 0 0.004890503361821175
362Arg O 0 0.06751375645399094
to O 0 0.0007668223115615547
362Ser O 1 0.771016538143158
( O 0 0.0018402000423520803
CGT O 1 0.9945300221443176
362Arg O 1 0.8641987442970276
to O 0 0.001420048763975501
AGT O 1 0.9999798536300659
362Ser O 1 0.9975793957710266
) O 0 0.00035835173912346363
, O 0 0.00014148364425636828
and O 0 0.00011704851931426674
was O 0 0.0005307354149408638
responsible O 0 0.0006592252757400274
for O 0 0.00040035948040895164
deficiency O 1 0.9999943971633911
in O 0 0.00021834028302691877
the O 0 0.0007513220771215856
sterol O 0 0.37639230489730835
27 O 0 0.0022264441940933466
- O 0 0.0013644982827827334
hydroxylase O 0 0.0013789100339636207
activity O 0 0.00013451014820020646
, O 0 5.607165439869277e-05
as O 0 4.5573502575280145e-05
confirmed O 0 7.060122152324766e-05
by O 0 4.34612957178615e-05
expression O 0 8.122616418404505e-05
of O 0 0.00019136503397021443
mutant O 0 0.0008664960041642189
cDNA O 0 0.0010490777203813195
into O 0 0.0004782758478540927
COS O 1 0.9988094568252563
- O 0 0.003653927007690072
1 O 0 0.0010562882525846362
cells O 0 0.0009176640305668116
. O 0 0.00042568673961795866

Quantitative O 0 0.0024336394853889942
analysis O 0 0.0005239579477347434
showed O 0 0.00041283349855802953
that O 0 7.477346662199125e-05
the O 0 0.00013125789701007307
expression O 0 0.00021720037329941988
of O 0 0.00033319200156256557
CYP27 O 1 0.9998506307601929
gene O 0 0.00021021493012085557
mRNA O 0 0.0001854798902058974
in O 0 5.2257852075854316e-05
the O 0 0.000115723189082928
patient O 0 0.0003059215086977929
represented O 0 0.0004408776294440031
52 O 0 0.0012562936171889305
. O 0 0.0006743437261320651

5 O 0 0.0014373821904882789
% O 0 0.0002880165702663362
of O 0 0.00041531838360242546
the O 0 0.0005400998634286225
normal O 0 0.0007558391080237925
level O 0 0.001069827238097787
. O 0 0.0004901859792880714

As O 0 0.0014364320086315274
the O 0 0.0005614619003608823
mutation O 0 0.00029080838430672884
occurred O 0 0.0005892416229471564
at O 0 0.000229984667384997
the O 0 0.00014830369036644697
penultimate O 0 0.0017489775782451034
nucleotide O 0 0.00017077942902687937
of O 0 0.00011476055078674108
exon O 0 0.0006238858331926167
6 O 0 0.0002077027747873217
( O 0 7.261048449436203e-05
- O 0 0.00010170730092795566
2 O 0 4.718021227745339e-05
position O 0 6.146515806904063e-05
of O 0 9.173511352855712e-05
exon O 0 0.0007472663419321179
6 O 0 0.0003771658812183887
- O 0 0.0004331555392127484
intron O 0 0.0014668095391243696
6 O 0 0.00040588402771390975
splice O 0 0.0007039664196781814
site O 0 0.00021001721324864775
) O 0 3.238243516534567e-05
of O 0 5.446193608804606e-05
the O 0 0.00016829307423904538
gene O 0 0.00015819921100046486
, O 0 6.968265370232984e-05
we O 0 3.3787553547881544e-05
hypothesized O 0 0.00014537367678713053
that O 0 3.364995791343972e-05
the O 0 0.00010958861093968153
mutation O 0 0.0002376221091253683
may O 0 0.0001515948388259858
partially O 0 0.0004659921978600323
affect O 0 0.0001229789777426049
the O 0 0.0001232716895174235
normal O 0 0.00018552409892436117
splicing O 0 0.00039626762736588717
efficiency O 0 0.0002697498712223023
in O 0 6.336894148262218e-05
exon O 0 0.0005639566807076335
6 O 0 0.0003592638240661472
and O 0 0.00012772688933182508
cause O 0 0.00044073749450035393
alternative O 0 0.00016589032020419836
splicing O 0 0.0003564425278455019
elsewhere O 0 9.536524885334074e-05
, O 0 3.672086677397601e-05
which O 0 2.5380624720128253e-05
resulted O 0 0.00016186728316824883
in O 0 8.397136843996122e-05
decreased O 0 0.000451294967206195
transcript O 0 0.0003524542262312025
in O 0 0.00010026783274952322
the O 0 0.0003026566992048174
patient O 0 0.0014743049396201968
. O 0 0.0007741993758827448

Transfection O 0 0.0645323395729065
of O 0 0.006222171243280172
constructed O 1 0.9462460875511169
minigenes O 1 0.9990712404251099
, O 0 0.0003674282052088529
with O 0 0.00010647464659996331
or O 0 8.349293057108298e-05
without O 0 5.687199518433772e-05
the O 0 0.00011891296890098602
mutation O 0 0.00014348229160532355
, O 0 7.068077684380114e-05
into O 0 0.0001562526886118576
COS O 1 0.9986405968666077
- O 0 0.0013883250067010522
1 O 0 0.00019478863396216184
cells O 0 0.00011962434655288234
confirmed O 0 6.0972091887379065e-05
that O 0 3.2219086278928444e-05
the O 0 0.0001078755667549558
mutant O 0 0.0011937448289245367
minigene O 1 0.6946629285812378
was O 0 0.000591126037761569
responsible O 0 0.00014997991092968732
for O 0 5.323515142663382e-05
a O 0 9.702506940811872e-05
mRNA O 0 0.00013584097905550152
species O 0 2.514337575121317e-05
alternatively O 0 9.636110189603642e-05
spliced O 0 0.00019274801888968796
at O 0 0.00020640848379116505
an O 0 0.0001257616822840646
activated O 0 0.0009088880033232272
cryptic O 0 0.0008341938955709338
5 O 0 0.0002447505248710513
splice O 0 0.0008452731417492032
site O 0 0.00042321812361478806
88 O 0 0.0005297132302075624
bp O 0 0.0008185394108295441
upstream O 0 0.0002512227219995111
from O 0 5.6314402172574773e-05
the O 0 8.578572305850685e-05
3 O 0 0.00014013159670867026
end O 0 0.00026217379490844905
of O 0 0.00030388348386622965
exon O 0 0.0032376598101109266
6 O 0 0.0015490384539589286
. O 0 0.0007489534909836948

Our O 0 0.001699401531368494
data O 0 0.00023415456234943122
suggest O 0 0.00017737114103510976
that O 0 3.476625352050178e-05
the O 0 7.102129166014493e-05
C O 0 0.0001688912307145074
to O 0 3.7380690628197044e-05
A O 0 0.00016617261280771345
mutation O 0 8.302544301841408e-05
at O 0 0.0001285357284359634
the O 0 0.00014673206896986812
penultimate O 0 0.0025878942105919123
nucleotide O 0 0.000314354314468801
of O 0 0.0001824777282308787
exon O 0 0.0007445889059454203
6 O 0 0.00022022511984687299
of O 0 0.0001709964853944257
the O 0 0.0004003762733191252
CYP27 O 1 0.9998084902763367
gene O 0 0.00027893605874851346
not O 0 5.358245471143164e-05
only O 0 6.91673340043053e-05
causes O 0 0.0016765320906415582
the O 0 0.004435860551893711
deficiency B-Disease 1 0.9999921321868896
in I-Disease 0 0.00017309100076090544
the I-Disease 0 0.00046730952453799546
sterol I-Disease 0 0.1051197201013565
27 I-Disease 0 0.0014975600643083453
- I-Disease 0 0.0018307631835341454
hydroxylase I-Disease 0 0.002344073262065649
activity I-Disease 0 0.00021847149764653295
, O 0 6.86253042658791e-05
but O 0 4.5389206206891686e-05
also O 0 7.475292659364641e-05
partially O 0 0.0002757272159215063
leads O 0 0.00019446774967946112
to O 0 6.904581096023321e-05
alternative O 0 0.0001790233509382233
pre O 0 0.0006147894891910255
- O 0 0.0003611335705500096
mRNA O 0 0.00022590412118006498
splicing O 0 0.0003849273198284209
of O 0 0.00015852416981942952
the O 0 0.0003315183857921511
gene O 0 0.0005627938662655652
. O 0 0.00056363211479038

To O 0 0.0009671531151980162
our O 0 0.000557227001991123
knowledge O 0 0.0003540761535987258
, O 0 0.00012008539488306269
this O 0 5.489381874212995e-05
is O 0 5.8550547691993415e-05
the O 0 7.079221541061997e-05
first O 0 0.0001146987488027662
report O 0 7.010938134044409e-05
regarding O 0 0.00011129507038276643
effects O 0 0.0001666971220402047
on O 0 0.00012336234794929624
pre O 0 0.0006467843195423484
- O 0 0.00018169301620218903
mRNA O 0 8.851637539919466e-05
splicing O 0 0.00010335490514989942
of O 0 4.374667696538381e-05
a O 0 6.0592494264710695e-05
mutation O 0 5.688046076102182e-05
at O 0 8.230630919570103e-05
the O 0 6.03697553742677e-05
- O 0 0.00011566715693334118
2 O 0 6.194182788021863e-05
position O 0 6.408193439710885e-05
of O 0 6.512659456348047e-05
a O 0 0.0001279469288419932
5 O 0 0.0002783025265671313
splice O 0 0.0017017979407683015
site O 0 0.0018691166769713163
. O 0 0.000718441151548177

ATM O 1 0.6366795897483826
germline O 1 0.6226841807365417
mutations O 0 0.002603969071060419
in O 0 0.0013830034295096993
classical O 1 0.9580591917037964
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999971389770508
telangiectasia I-Disease 1 0.9999984502792358
patients O 0 0.049099747091531754
in O 0 0.00033909641206264496
the O 0 0.000607802125159651
Dutch O 0 0.0018904937896877527
population O 0 0.00025371479569002986
. O 0 0.00035162491258233786

Germline O 0 0.463706910610199
mutations O 0 0.0016089442651718855
in O 0 0.00038035670877434313
the O 0 0.000544570735655725
ATM O 0 0.00310511514544487
gene O 0 0.00019742376753129065
are O 0 2.949933877971489e-05
responsible O 0 0.0001789670204743743
for O 0 0.00017937635129783303
the O 0 0.49791550636291504
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 1 0.9998940229415894
A B-Disease 1 0.9999994039535522
- I-Disease 1 0.9999738931655884
T I-Disease 1 0.9998986721038818
) O 0 0.0004413915448822081
. O 0 0.0003874445683322847

In O 0 0.0011683076154440641
our O 0 0.0006360493134707212
study O 0 0.00014812829613219947
, O 0 7.407581142615527e-05
we O 0 3.435156759223901e-05
have O 0 1.7036734789144248e-05
determined O 0 7.547414861619473e-05
the O 0 0.00015067856293171644
ATM O 0 0.0008247063960880041
mutation O 0 0.0001032463478622958
spectrum O 0 0.00011021665704902261
in O 0 6.262617534957826e-05
19 O 0 0.0002269883843837306
classical O 0 0.0008469602325931191
A B-Disease 1 0.9999262094497681
- I-Disease 1 0.9999289512634277
T I-Disease 1 0.9999904632568359
patients O 0 0.0001892388245323673
, O 0 2.8308677428867668e-05
including O 0 1.7871809177449904e-05
some O 0 2.8230360840098e-05
immigrant O 0 0.00010097807535203174
populations O 0 2.7622114430414513e-05
, O 0 3.321146868984215e-05
as O 0 4.954476753482595e-05
well O 0 2.9581738999695517e-05
as O 0 5.674826024915092e-05
12 O 0 0.00012156657612649724
of O 0 0.00016626199067104608
Dutch O 0 0.0005151203367859125
ethnic O 0 0.0002713454596232623
origin O 0 0.00038122176192700863
. O 0 0.0004969678120687604

Both O 0 0.0012479150900617242
the O 0 0.0008749727276153862
protein O 0 0.0010099159553647041
truncation O 0 0.004691596142947674
test O 0 0.0006780188996344805
( O 0 0.0003458256833255291
PTT O 0 0.002502134535461664
) O 0 8.526872989023104e-05
and O 0 5.59818945475854e-05
the O 0 0.00010213706991635263
restriction O 0 0.00022786790214013308
endonuclease O 0 0.0018608378013595939
fingerprinting O 0 0.0012466148473322392
( O 0 0.00029059217195026577
REF O 0 0.15246708691120148
) O 0 6.287415453698486e-05
method O 0 5.567534390138462e-05
were O 0 3.5300494346302e-05
used O 0 3.6199362511979416e-05
and O 0 2.8753667720593512e-05
compared O 0 4.9817896069725975e-05
for O 0 2.763950396911241e-05
their O 0 2.8609902074094862e-05
detection O 0 0.00019135228649247438
efficiency O 0 0.00021017066319473088
, O 0 4.790058665093966e-05
identifying O 0 8.4820254414808e-05
76 O 0 0.00010757632117019966
% O 0 2.4626051526865922e-05
and O 0 2.5230156097677536e-05
60 O 0 4.610104952007532e-05
% O 0 2.493401370884385e-05
of O 0 7.667247700737789e-05
the O 0 0.00024799659149721265
mutations O 0 0.0003383881994523108
, O 0 0.00019379214791115373
respectively O 0 0.0006382488645613194
. O 0 0.00046626722905784845

Most O 0 0.0021545016206800938
patients O 0 0.000741085154004395
were O 0 0.00019853275443892926
found O 0 0.0001282332232221961
to O 0 0.0001210431510116905
be O 0 0.00028787844348698854
compound O 0 0.01685635931789875
heterozygote O 0 0.01649637334048748
. O 0 0.001441409345716238

Seventeen O 0 0.009570783004164696
mutations O 0 0.0008595952531322837
were O 0 0.00014528525935020298
distinct O 0 9.454137762077153e-05
, O 0 6.233552994672209e-05
of O 0 7.218464452307671e-05
which O 0 4.555659688776359e-05
10 O 0 8.001624519238248e-05
were O 0 5.667936056852341e-05
not O 0 3.9898066461319104e-05
reported O 0 0.0001898880727821961
previously O 0 0.0002633532858453691
. O 0 0.00043746616574935615

Mutations O 0 0.002584414556622505
are O 0 0.00015195518790278584
small O 0 0.00023716808937024325
deletions O 0 0.0009748339653015137
or O 0 0.0002826976706273854
point O 0 0.0005590602522715926
mutations O 0 0.0004178025992587209
frequently O 0 0.00031376536935567856
affecting O 0 0.0009927862556651235
splice O 0 0.0036315929610282183
sites O 0 0.0009661083458922803
. O 0 0.0009036314440891147

Moreover O 0 0.005362441297620535
, O 0 0.0007210533949546516
a O 0 0.000963750237133354
16 O 0 0.001926147728227079
. O 0 0.0013303484302014112

7 O 0 0.006617425940930843
- O 0 0.0033741802908480167
kb O 0 0.0027861834969371557
genomic O 0 0.0005236059660091996
deletion O 0 0.000280555832432583
of O 0 0.000123728605103679
the O 0 0.00011925114085897803
3 O 0 0.00011354122398188338
end O 0 0.0001389736426062882
of O 0 7.481682405341417e-05
the O 0 0.00010760454460978508
gene O 0 7.20231982995756e-05
, O 0 3.637154804891907e-05
most O 0 2.4015333110583015e-05
likely O 0 3.703626134665683e-05
a O 0 4.2766467231558636e-05
result O 0 4.5688597310800105e-05
of O 0 8.794250607024878e-05
recombination O 0 0.0002450753818266094
between O 0 0.00012099480954930186
two O 0 6.982767808949575e-05
LINE O 0 0.001405456569045782
elements O 0 0.00041278236312791705
, O 0 0.00017203859169967473
was O 0 0.0006416655378416181
identified O 0 0.0005674062995240092
. O 0 0.0005919435643590987

The O 0 0.0015728416619822383
most O 0 0.0002712226123549044
frequently O 0 0.00021755894704256207
found O 0 0.0001547309075249359
mutation O 0 0.00016259975382126868
, O 0 5.5904856708366424e-05
identified O 0 9.61800615186803e-05
in O 0 5.5402793805114925e-05
three O 0 6.06403591518756e-05
unrelated O 0 0.00029150841874070466
Turkish O 0 0.0009292671456933022
A B-Disease 1 0.9999674558639526
- I-Disease 1 0.9999158382415771
T I-Disease 1 0.9999264478683472
individuals O 0 5.277583477436565e-05
, O 0 6.33111922070384e-05
was O 0 0.00026450579753145576
previously O 0 6.929620576556772e-05
described O 0 6.933321856195107e-05
to O 0 2.3901886379462667e-05
be O 0 2.7928179406444542e-05
a O 0 7.989654113771394e-05
Turkish O 0 0.0003977155138272792
A B-Disease 1 0.9996628761291504
- I-Disease 1 0.9990097284317017
T I-Disease 1 0.9998519420623779
founder O 0 0.26044145226478577
mutation O 0 0.0017085056751966476
. O 0 0.0008536779787391424

The O 0 0.0024896811228245497
presence O 0 0.0006682633538730443
of O 0 0.0004458856419660151
a O 0 0.0008187273633666337
founder O 1 0.6043173670768738
mutation O 0 0.0002724942460190505
among O 0 7.484108209609985e-05
relatively O 0 4.812861152458936e-05
small O 0 2.9816445021424443e-05
ethnic O 0 4.870194607065059e-05
population O 0 1.684538619883824e-05
groups O 0 1.1698256457748357e-05
in O 0 2.2049292965675704e-05
Western O 0 0.00012025934120174497
Europe O 0 0.0001227548491442576
could O 0 6.386957102222368e-05
indicate O 0 6.814813241362572e-05
a O 0 0.00010641617700457573
high O 0 0.00021758423827122897
carrier O 0 0.0002571520453784615
frequency O 0 6.134095747256652e-05
in O 0 5.918420720263384e-05
such O 0 7.339055446209386e-05
communities O 0 0.0002591123047750443
. O 0 0.0005586340557783842

In O 0 0.0018354930216446519
patients O 0 0.0006161438650451601
of O 0 0.0002986145264003426
Dutch O 0 0.0007401675684377551
ethnic O 0 0.0001547775318613276
origin O 0 0.0001236520620295778
, O 0 6.005623799865134e-05
however O 0 4.142785837757401e-05
, O 0 3.783675128943287e-05
no O 0 5.429873272078112e-05
significant O 0 0.00012683110253419727
founder O 0 0.0028800510335713625
effect O 0 0.00022682959388475865
could O 0 0.0001367361401207745
be O 0 0.00012490645167417824
identified O 0 0.0005774640012532473
. O 0 0.0005949648912064731

The O 0 0.0035602450370788574
observed O 0 0.0012087891809642315
genetic O 0 0.000586960872169584
heterogeneity O 0 0.0009116780711337924
including O 0 0.0001191313422168605
the O 0 0.00016810382658150047
relative O 0 0.0002113752270815894
high O 0 0.00020743462664540857
percentage O 0 9.774532372830436e-05
of O 0 0.00014574272790923715
splice O 0 0.0038928771391510963
- O 0 0.0007890959968790412
site O 0 0.00040837295819073915
mutations O 0 0.0001429682451998815
had O 0 8.309484110213816e-05
no O 0 0.00010291470971424133
reflection O 0 0.00038074309122748673
on O 0 0.000166137600899674
the O 0 0.0006300575332716107
phenotype O 0 0.003832197980955243
. O 0 0.0009640642674639821

All O 0 0.0020998890977352858
patients O 0 0.0023719333112239838
manifested O 0 0.016640186309814453
classical O 0 0.00547085190191865
A B-Disease 1 0.9999518394470215
- I-Disease 1 0.9994159936904907
T I-Disease 1 0.9988083839416504
and O 0 0.00025209851446561515
increased O 0 0.0005228745867498219
cellular O 0 0.0022224169224500656
radioresistant O 1 0.6390540599822998
DNA O 0 0.0015771391335874796
synthesis O 0 0.002332762349396944
. O 0 0.0007152940379455686

Determination O 0 0.0038862021174281836
of O 0 0.0009269997826777399
the O 0 0.0004394410061649978
genomic O 0 0.0004318144347053021
structure O 0 0.0005357476184144616
of O 0 0.00040666668792255223
the O 0 0.0019054906442761421
COL4A4 O 1 0.9999833106994629
gene O 0 0.0003134744765702635
and O 0 0.00014600604481529444
of O 0 0.0004371730610728264
novel O 0 0.11270058900117874
mutations O 1 0.9085684418678284
causing O 1 0.9999884366989136
autosomal B-Disease 1 0.9999985694885254
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.9936495423316956

Autosomal B-Disease 1 0.9999929666519165
recessive I-Disease 1 0.9999998807907104
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 1 0.9988657236099243
a O 1 0.9996250867843628
progressive O 1 0.9999995231628418
hematuric B-Disease 1 1.0
glomerulonephritis I-Disease 1 1.0
characterized O 1 0.999974250793457
by O 1 0.8995081782341003
glomerular B-Disease 1 0.9999998807907104
basement I-Disease 1 0.9999997615814209
membrane I-Disease 1 0.9999856948852539
abnormalities I-Disease 1 0.9999792575836182
and O 0 0.00029979689861647785
associated O 0 0.00016063063230831176
with O 0 8.850541053107008e-05
mutations O 0 8.564130257582292e-05
in O 0 6.541240873048082e-05
either O 0 7.013566209934652e-05
the O 0 0.00017719263269100338
COL4A3 O 1 0.9997990727424622
or O 0 0.00019102831720374525
the O 0 0.0005489211762323976
COL4A4 O 1 0.9996165037155151
gene O 0 0.00016779682482592762
, O 0 5.464021523948759e-05
which O 0 3.5903151001548395e-05
encode O 0 9.004395542433485e-05
the O 0 0.00028602415113709867
alpha3 O 0 0.20119628310203552
and O 0 0.0006498591974377632
alpha4 O 1 0.9997503161430359
type O 1 0.9996453523635864
IV O 1 1.0
collagen O 1 0.9999992847442627
chains O 1 0.6970621347427368
, O 0 0.0006048292270861566
respectively O 0 0.0008671989198774099
. O 0 0.0005619520088657737

To O 0 0.0008397379424422979
date O 0 0.0007801303872838616
, O 0 0.00018262430967297405
mutation O 0 0.00019653070194181055
screening O 0 9.878089622361585e-05
in O 0 4.026293026981875e-05
the O 0 6.799060065532103e-05
two O 0 3.5800989280687645e-05
genes O 0 4.956083284923807e-05
has O 0 5.3565960115520284e-05
been O 0 8.256058936240152e-05
hampered O 0 0.0008729650289751589
by O 0 5.959390546195209e-05
the O 0 0.00018392725905869156
lack O 0 0.00032900492078624666
of O 0 0.0005151042132638395
genomic O 0 0.000813387508969754
structure O 0 0.0016392648685723543
information O 0 0.00020947442681062967
. O 0 0.0003629954007919878

We O 0 0.0010642396518960595
report O 0 0.0003248790744692087
here O 0 0.00017359346384182572
the O 0 9.905463230097666e-05
complete O 0 0.00022189633455127478
characterization O 0 0.0003404978197067976
of O 0 0.00016121893713716418
the O 0 0.00019263777357991785
48 O 0 0.0002934354997705668
exons O 0 0.0004241733404342085
of O 0 0.00017530974582768977
the O 0 0.0005330202402547002
COL4A4 O 1 0.9999247789382935
gene O 0 0.00024669483536854386
, O 0 7.480398198822513e-05
a O 0 0.00013111929001752287
comprehensive O 0 0.0002372476737946272
gene O 0 0.00014767530956305563
screen O 0 0.00012379291001707315
, O 0 3.811698479694314e-05
and O 0 2.6222056476399302e-05
the O 0 5.201100793783553e-05
subsequent O 0 0.00012034491373924538
detection O 0 0.00015959095617290586
of O 0 0.00012733120820485055
10 O 0 0.0002140454453183338
novel O 0 0.0002764521341305226
mutations O 0 0.0001333752297796309
in O 0 0.00012162222992628813
eight O 0 0.001058418769389391
patients O 1 0.8949780464172363
diagnosed O 1 0.9999986886978149
with O 1 0.9984639883041382
autosomal B-Disease 1 0.9999998807907104
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.9993404746055603

Furthermore O 0 0.004822485148906708
, O 0 0.0006287717260420322
we O 0 0.00013941842189524323
identified O 0 0.00014168601774144918
a O 0 0.00019601921667344868
glycine O 0 0.00048671028343960643
to O 0 0.00017069251043722034
alanine O 0 0.0006943597109057009
substitution O 0 0.0004297513223718852
in O 0 9.754792699823156e-05
the O 0 0.0002272941783303395
collagenous O 0 0.23342373967170715
domain O 0 0.00023427471751347184
that O 0 6.53993702144362e-05
is O 0 4.955356052960269e-05
apparently O 0 0.00018312930478714406
silent O 0 0.0003586178063414991
in O 0 5.421625974122435e-05
the O 0 9.362324635731056e-05
heterozygous O 0 0.0001322183816228062
carriers O 0 0.0001440332125639543
, O 0 6.191183638293296e-05
in O 0 0.00013895124720875174
11 O 0 0.0005770551506429911
. O 0 0.0006090454407967627

5 O 0 0.00132520473562181
% O 0 0.0001767967187333852
of O 0 0.0002096958487527445
all O 0 8.015897765289992e-05
control O 0 0.0002506016753613949
individuals O 0 4.138868462177925e-05
, O 0 4.498007911024615e-05
and O 0 3.964663847000338e-05
in O 0 5.798119673272595e-05
one O 0 9.44629791774787e-05
control O 0 0.00013236420636530966
individual O 0 6.330720498226583e-05
homozygous O 0 0.00022875891590956599
for O 0 9.036980191012844e-05
this O 0 0.00011664116755127907
glycine O 0 0.0014113292563706636
substitution O 0 0.002064893487840891
. O 0 0.000796089821960777

There O 0 0.0008337202598340809
has O 0 0.00021182071941439062
been O 0 0.00011711774277500808
no O 0 5.6844342907425016e-05
previous O 0 7.22268596291542e-05
finding O 0 7.297539559658617e-05
of O 0 0.00010702156578190625
a O 0 0.0001617617381270975
glycine O 0 0.0005580143188126385
substitution O 0 0.0002694357535801828
that O 0 3.8920010410947725e-05
is O 0 3.9426751754945144e-05
not O 0 2.1521405869862065e-05
associated O 0 4.328889190219343e-05
with O 0 3.2752795959822834e-05
any O 0 0.00012229780259076506
obvious O 0 0.0011433903127908707
phenotype O 0 0.001645278069190681
in O 0 0.0004307269991841167
homozygous O 0 0.0011239327723160386
individuals O 0 0.0002713203721214086
. O 0 0.0008839532965794206

Founder O 1 0.9953296184539795
BRCA1 O 1 0.9978010058403015
and O 0 0.002650519600138068
BRCA2 O 1 0.877845823764801
mutations O 0 0.0005884700221940875
in O 0 0.00035418960032984614
French O 0 0.11782001703977585
Canadian O 1 0.9993340373039246
breast B-Disease 1 0.9999996423721313
and I-Disease 1 0.9999779462814331
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
families O 0 0.01423422247171402
. O 0 0.0021223491057753563

We O 0 0.0007446712697856128
have O 0 9.93270514300093e-05
identified O 0 0.00013779988512396812
four O 0 9.812092321226373e-05
mutations O 0 8.717036689631641e-05
in O 0 5.2352072088979185e-05
each O 0 2.8355743779684417e-05
of O 0 0.00021362178085837513
the O 1 0.5262770056724548
breast B-Disease 1 0.9999995231628418
cancer I-Disease 1 0.9999994039535522
- O 1 0.9995085000991821
susceptibility O 1 0.9863929152488708
genes O 0 0.0006369216716848314
, O 0 0.000310434348648414
BRCA1 O 1 0.700084388256073
and O 0 0.00032599971746094525
BRCA2 O 0 0.03426029533147812
, O 0 0.00010815801215358078
in O 0 0.0001293985260417685
French O 0 0.003977595362812281
Canadian O 1 0.994748055934906
breast B-Disease 1 0.9999986886978149
cancer I-Disease 1 0.9999995231628418
and O 1 0.9997747540473938
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
families O 0 0.0008999041747301817
from O 0 0.0007737302221357822
Quebec O 0 0.0208708718419075
. O 0 0.001027432968840003

To O 0 0.0010945742251351476
identify O 0 0.0013100559590384364
founder O 0 0.2942611575126648
effects O 0 0.015642400830984116
, O 0 0.00019557417545001954
we O 0 0.0001102398891816847
examined O 0 0.00021980829478707165
independently O 0 0.00010458385804668069
ascertained O 0 0.0007857707678340375
French O 0 0.0012224108213558793
Canadian O 0 0.003457621904090047
cancer B-Disease 0 0.006128488574177027
families O 0 7.350934902206063e-05
for O 0 3.6411667679203674e-05
the O 0 7.316401752177626e-05
distribution O 0 4.372244075057097e-05
of O 0 0.00012714120384771377
these O 0 5.8152461861027405e-05
eight O 0 0.00025256621302105486
mutations O 0 0.0005340480711311102
. O 0 0.00041585590224713087

Mutations O 0 0.0014489981113001704
were O 0 0.000301601568935439
found O 0 0.00013998204667586833
in O 0 0.00014245683269109577
41 O 0 0.0003789191832765937
of O 0 0.00043025342165492475
97 O 0 0.0024603535421192646
families O 0 0.0006806785240769386
. O 0 0.0006772238411940634

Six O 0 0.0011422426905483007
of O 0 0.00047022587386891246
eight O 0 0.0003788673784583807
mutations O 0 0.00016326468903571367
were O 0 0.0001313721004407853
observed O 0 0.00018785671272780746
at O 0 0.0004153205081820488
least O 0 0.00029136589728295803
twice O 0 0.0006956698489375412
. O 0 0.0005662890034727752

The O 0 0.014332124032080173
BRCA1 O 1 0.9979348182678223
C4446T O 1 0.9992393255233765
mutation O 0 0.0014993150252848864
was O 0 0.0009833223884925246
the O 0 0.00019379399600438774
most O 0 9.467083145864308e-05
common O 0 0.00012552720727398992
mutation O 0 0.0001045411845552735
found O 0 6.424512685043737e-05
, O 0 7.109882426448166e-05
followed O 0 0.0001714876270852983
by O 0 7.616847142344341e-05
the O 0 0.00046375172678381205
BRCA2 O 1 0.9445701837539673
8765delAG O 1 0.9983042478561401
mutation O 0 0.0028931857086718082
. O 0 0.0009420696296729147

Together O 0 0.002564673777669668
, O 0 0.0005653893458656967
these O 0 8.227804937632754e-05
mutations O 0 8.386389527004212e-05
were O 0 3.798483157879673e-05
found O 0 2.8991336876060814e-05
in O 0 3.355126682436094e-05
28 O 0 9.139833127846941e-05
of O 0 9.013072121888399e-05
41 O 0 0.0001782323670340702
families O 0 4.5173816033639014e-05
identified O 0 4.7104465920710936e-05
to O 0 3.538937744451687e-05
have O 0 3.7327474274206907e-05
a O 0 0.0003878256829921156
mutation O 0 0.000842136621940881
. O 0 0.0006955634453333914

The O 0 0.0022123116068542004
odds O 0 0.001770244911313057
of O 0 0.0005073029897175729
detection O 0 0.0006807073368690908
of O 0 0.00021191647101659328
any O 0 7.90320846135728e-05
of O 0 0.00015570060350000858
the O 0 0.00021413770446088165
four O 0 0.0002508044126443565
BRCA1 O 0 0.10249132663011551
mutations O 0 0.00019666229491122067
was O 0 0.0008948492468334734
18 O 0 0.0006956728175282478
. O 0 0.0005784017266705632

7x O 1 0.8973689079284668
greater O 0 0.002194109605625272
if O 0 0.00023681603488512337
one O 0 0.00011331430141581222
or O 0 7.29666935512796e-05
more O 0 4.9559697799850255e-05
cases O 0 0.00017545826267451048
of O 1 0.9996005892753601
ovarian B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
were O 0 0.0006643472006544471
also O 0 0.0001222020946443081
present O 0 0.00016842309560161084
in O 0 0.00014296796871349216
the O 0 0.0003536212898325175
family O 0 0.0006718675722368062
. O 0 0.0006987196393311024

The O 0 0.0025647126603871584
odds O 0 0.0020153853110969067
of O 0 0.0006105285719968379
detection O 0 0.0005323112709447742
of O 0 0.00017498995293863118
any O 0 7.315871334867552e-05
of O 0 0.00016793800750747323
the O 0 0.0002975411480292678
four O 0 0.0003063937765546143
BRCA2 O 0 0.031115200370550156
mutations O 0 0.00031258902163244784
was O 0 0.000904240005183965
5 O 0 0.0006990106776356697
. O 0 0.0004881976346950978

3x O 0 0.041439253836870193
greater O 0 0.0011050591710954905
if O 0 0.00014101789565756917
there O 0 4.9816757382359356e-05
were O 0 4.4285836338531226e-05
at O 0 8.057874219957739e-05
least O 0 2.4489845600328408e-05
five O 0 4.212997737340629e-05
cases O 0 5.713695281883702e-05
of O 0 0.010343761183321476
breast B-Disease 1 0.9999972581863403
cancer I-Disease 1 0.9998455047607422
in O 0 0.0003808302280958742
the O 0 0.0007373912958428264
family O 0 0.0008930123294703662
. O 0 0.0005345615791156888

Interestingly O 0 0.005034111440181732
, O 0 0.000496909546200186
the O 0 0.0002380307560088113
presence O 0 0.0003094665880780667
of O 0 0.0004902420332655311
a O 1 0.6266742944717407
breast B-Disease 1 0.9999918937683105
cancer I-Disease 1 0.9991777539253235
case O 0 0.00042787345591932535
< O 0 0.000529944954905659
36 O 0 0.00010064813977805898
years O 0 4.998612712370232e-05
of O 0 7.90166377555579e-05
age O 0 0.00017287376977037638
was O 0 0.0002784699900075793
strongly O 0 8.26641044113785e-05
predictive O 0 0.00011056583025492728
of O 0 6.560869951499626e-05
the O 0 7.567543798359111e-05
presence O 0 9.292820323025808e-05
of O 0 7.882600766606629e-05
any O 0 4.460976197151467e-05
of O 0 0.00012627420073840767
the O 0 0.00023568930919282138
eight O 0 0.00031956163002178073
mutations O 0 0.0005219675367698073
screened O 0 0.001004451303742826
. O 0 0.0005161174922250211

Carriers O 0 0.0026106340810656548
of O 0 0.00044936168706044555
the O 0 0.00036706775426864624
same O 0 0.00018987106159329414
mutation O 0 0.00013239411055110395
, O 0 3.764563371078111e-05
from O 0 3.5644690797198564e-05
different O 0 1.5445719327544793e-05
families O 0 3.570946864783764e-05
, O 0 4.176993388682604e-05
shared O 0 7.088462734827772e-05
similar O 0 0.00010560766531853005
haplotypes O 0 0.0005207147914916277
, O 0 9.828937618294731e-05
indicating O 0 0.0002530217170715332
that O 0 3.897977148881182e-05
the O 0 0.00014392983575817198
mutant O 0 0.0006097767618484795
alleles O 0 0.00010661770647857338
were O 0 4.5792497985530645e-05
likely O 0 4.907959373667836e-05
to O 0 2.6406902179587632e-05
be O 0 1.9639654055936262e-05
identical O 0 4.0270959289046004e-05
by O 0 2.3315085854846984e-05
descent O 0 0.00011342932702973485
for O 0 4.908736445941031e-05
a O 0 0.00015314214397221804
mutation O 0 0.00016427566879428923
in O 0 9.616932948119938e-05
the O 0 0.0003211225848644972
founder O 0 0.003066820790991187
population O 0 0.000305153924273327
. O 0 0.000688091095071286

The O 0 0.0013281607534736395
identification O 0 0.0007748318603262305
of O 0 0.0014858716167509556
common O 0 0.06074697896838188
BRCA1 O 1 0.999961256980896
and O 0 0.018947528675198555
BRCA2 O 1 0.9782214760780334
mutations O 0 0.0002424782287562266
will O 0 8.556358079658821e-05
facilitate O 0 0.00021676672622561455
carrier O 0 0.0004145383427385241
detection O 0 0.00021432930952869356
in O 0 0.00014247940271161497
French O 0 0.0022162029054015875
Canadian O 1 0.9307628273963928
breast B-Disease 1 0.9999972581863403
cancer I-Disease 1 0.9999985694885254
and O 1 0.9997608065605164
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
families O 0 0.003655259031802416
. O 0 0.0013046793173998594

Are O 0 0.002762635936960578
Dp71 O 1 0.9978840947151184
and O 0 0.00906609557569027
Dp140 O 1 0.9999815225601196
brain O 1 0.9998685121536255
dystrophin O 1 0.9502701759338379
isoforms O 0 0.001366104232147336
related O 0 0.0007280874415300786
to O 0 0.0007410155958496034
cognitive B-Disease 1 0.9999377727508545
impairment I-Disease 1 0.9999998807907104
in O 1 0.9999954700469971
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
? O 1 0.9998098015785217

Molecular O 0 0.005964754149317741
study O 0 0.000841644883621484
and O 0 0.00036583124892786145
neuropsychological O 0 0.0015630710404366255
analysis O 0 9.93505454971455e-05
were O 0 9.391402272740379e-05
performed O 0 0.00026032913592644036
concurrently O 0 0.0005962537252344191
on O 0 0.0003556167066562921
49 O 0 0.0014689852250739932
patients O 0 0.04940737038850784
with O 1 0.7222301363945007
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999971389770508
DMD B-Disease 1 1.0
) O 0 0.00030693988082930446
in O 0 0.00011007497960235924
order O 0 5.5461787269450724e-05
to O 0 2.8367889171931893e-05
find O 0 5.536535172723234e-05
a O 0 8.893256017472595e-05
molecular O 0 0.0001243145961780101
explanation O 0 0.0001548917789477855
for O 0 5.317893737810664e-05
the O 0 0.0003377752145752311
cognitive B-Disease 1 0.6997467875480652
impairment I-Disease 1 0.9959738850593567
observed O 0 0.0004493377055041492
in O 0 0.00046963884960860014
most O 0 0.0014657966094091535
DMD B-Disease 1 0.9999980926513672
patients O 0 0.023157423362135887
. O 0 0.0011048270389437675

Complete O 0 0.0020631253719329834
analysis O 0 0.00023050012532621622
of O 0 0.00043311898480169475
the O 0 0.0006409321213141084
dystrophin O 1 0.8901488780975342
gene O 0 0.0003239734214730561
was O 0 0.00031998418853618205
performed O 0 0.00013791372475679964
to O 0 3.805415690294467e-05
define O 0 7.926529360702261e-05
the O 0 0.00012411040370352566
localization O 0 0.0008644393528811634
of O 0 0.0002542955335229635
deletions O 0 0.0005735884769819677
and O 0 0.00014736276352778077
duplications O 0 0.000791091239079833
in O 0 0.00013265885354485363
relation O 0 0.00016722470172680914
to O 0 8.87578644324094e-05
the O 0 0.0002553365775384009
different O 0 0.0002951140922959894
DMD B-Disease 1 0.9999873638153076
promoters O 1 0.5193618535995483
. O 0 0.0012342585250735283

Qualitative O 0 0.0033936353866010904
analysis O 0 0.0005329902633093297
of O 0 0.00044564492418430746
the O 0 0.0006501059979200363
Dp71 O 1 0.9854021072387695
transcript O 0 0.0012714952463284135
and O 0 0.0001070986472768709
testing O 0 9.24364649108611e-05
for O 0 3.013353853020817e-05
the O 0 7.890135748311877e-05
specific O 0 3.792185816564597e-05
first O 0 0.00011929491301998496
exon O 0 0.0006294494960457087
of O 0 0.00027138792211189866
Dp140 O 0 0.040693193674087524
were O 0 0.00013713294174522161
also O 0 0.00011314803850837052
carried O 0 0.0001898339542094618
out O 0 0.000256864121183753
. O 0 0.00042552503873594105

Neuropsychological O 0 0.02831658534705639
analysis O 0 0.0015601455233991146
assessed O 0 0.001856085262261331
verbal O 0 0.0036170841194689274
and O 0 0.0009205906535498798
visuospatial O 1 0.9654800295829773
intelligence O 0 0.0012951978715136647
, O 0 0.0004526151460595429
verbal O 0 0.007115073502063751
memory O 1 0.9606582522392273
, O 0 0.0003253837348893285
and O 0 0.0002829983422998339
reading O 0 0.0011402565287426114
skills O 0 0.0024398991372436285
. O 0 0.0008363867527805269

Comparison O 0 0.0022163947578519583
of O 0 0.0010469360277056694
molecular O 0 0.0011878138175234199
and O 0 0.00041809139656834304
psychometric O 0 0.008329520933330059
findings O 0 0.0004566113348118961
demonstrated O 0 0.0007123007671907544
that O 0 0.00013782565656583756
deletions O 0 0.0005629811203107238
and O 0 0.00010881728667300195
duplications O 0 0.0008198023424483836
that O 0 5.093066283734515e-05
were O 0 5.0588725571287796e-05
localized O 0 0.00021502668096218258
in O 0 8.842247916618362e-05
the O 0 0.0001675461244303733
distal O 0 0.004950392059981823
part O 0 0.0002511149796191603
of O 0 0.00024553562980145216
the O 0 0.00043825001921504736
gene O 0 0.00018426182214170694
seemed O 0 0.00017510527686681598
to O 0 4.627503585652448e-05
be O 0 5.809204594697803e-05
preferentially O 0 0.00019965239334851503
associated O 0 0.00021892938821110874
with O 0 0.000358807563316077
cognitive B-Disease 1 0.9994522929191589
impairment I-Disease 1 0.9999897480010986
. O 0 0.004327676258981228

Two O 0 0.0021707129199057817
altered O 0 0.0033772385213524103
Dp71 O 0 0.30123603343963623
transcripts O 0 0.0008157401462085545
and O 0 9.847514593275264e-05
two O 0 6.145126826595515e-05
deleted O 0 0.00031314048101194203
Dp140 O 0 0.002828072290867567
DNA O 0 0.00015796707884874195
sequences O 0 6.582798232557252e-05
were O 0 3.660154470708221e-05
found O 0 4.2455205402802676e-05
in O 0 7.421425107168034e-05
four O 0 0.0002630411181598902
patients O 0 0.026661353185772896
with O 1 0.6096625328063965
severe O 1 1.0
cerebral B-Disease 1 1.0
dysfunction I-Disease 1 1.0
. O 1 0.9982011318206787

These O 0 0.0005132300429977477
findings O 0 0.00039680986083112657
suggest O 0 0.00014465601998381317
that O 0 3.647095218184404e-05
some O 0 2.500745358702261e-05
sequences O 0 4.759297371492721e-05
located O 0 0.0001492184674134478
in O 0 5.781367508461699e-05
the O 0 0.00013558025239035487
distal O 0 0.0008250193204730749
part O 0 0.00012213789159432054
of O 0 0.0001620301918592304
the O 0 0.0002932528732344508
gene O 0 0.00011799928324762732
and O 0 3.341791307320818e-05
, O 0 3.41485720127821e-05
in O 0 3.32651034113951e-05
particular O 0 3.831430149148218e-05
, O 0 5.5015090765664354e-05
some O 0 7.076467591105029e-05
DMD B-Disease 1 0.9819542169570923
isoforms O 0 0.00015868387708906084
expressed O 0 9.362824494019151e-05
in O 0 6.713410402880982e-05
the O 0 0.0012311208993196487
brain O 1 0.9858074188232422
may O 0 0.00011057742085540667
be O 0 5.857858559465967e-05
related O 0 9.598262840881944e-05
to O 0 0.00010169314191443846
the O 0 0.0013170525198802352
cognitive B-Disease 1 0.9994310736656189
impairment I-Disease 1 0.9999793767929077
associated O 0 0.027973761782050133
with O 0 0.11330810189247131
DMD B-Disease 1 0.9999998807907104
. O 0 0.0012413539225235581
. O 0 0.0008654798730276525

I1307K O 1 0.9989205598831177
APC O 1 0.9983141422271729
and O 0 0.0024275663308799267
hMLH1 O 1 0.9647554159164429
mutations O 0 0.0005163399619050324
in O 0 0.00020109157776460052
a O 0 0.0003979136818088591
non O 0 0.0004130925517529249
- O 0 0.0002960979181807488
Jewish O 0 0.0002664847415871918
family O 0 0.00022240320686250925
with O 0 0.0001905024837469682
hereditary B-Disease 1 0.9999877214431763
non I-Disease 1 0.9999963045120239
- I-Disease 1 0.9999998807907104
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.05750712752342224

We O 0 0.0013007286470383406
describe O 0 0.0012522186152637005
a O 0 0.0004828582750633359
French O 0 0.0016376660205423832
Canadian O 0 0.0066298977471888065
hereditary B-Disease 1 0.9999765157699585
non I-Disease 1 0.9999852180480957
- I-Disease 1 0.9999998807907104
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
( O 1 0.9999862909317017
HNPCC B-Disease 1 0.9999998807907104
) O 0 0.0008738804026506841
kindred O 0 0.006044749170541763
which O 0 0.00010157257202081382
carries O 0 0.00021842523710802197
a O 0 0.00031863743788562715
novel O 0 0.0008394134929403663
truncating O 0 0.004572179634124041
mutation O 0 0.0008872472681105137
in O 0 0.0007387593504972756
hMLH1 O 1 0.6225870251655579
. O 0 0.0018759560771286488

Interestingly O 0 0.00800821278244257
, O 0 0.0010840905597433448
the O 0 0.0012745216954499483
I1307K O 1 0.998077392578125
APC O 1 0.998042106628418
polymorphism O 0 0.0014005369739606977
, O 0 0.0001802036858862266
associated O 0 0.00013041750935371965
with O 0 3.964277857448906e-05
an O 0 0.00012520850577857345
increased O 0 0.0010426378576084971
risk O 0 0.14896070957183838
of O 1 0.9999790191650391
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 0.0077035557478666306
is O 0 7.342219760175794e-05
also O 0 6.0529135225806385e-05
present O 0 8.673305273987353e-05
in O 0 7.753485260764137e-05
this O 0 0.00012016260006930679
family O 0 0.000658761418890208
. O 0 0.0006750451866537333

The O 0 0.005468870047479868
I1307K O 1 0.8501404523849487
polymorphism O 0 0.0019320491701364517
has O 0 0.00018512245151214302
previously O 0 0.00013705190212931484
only O 0 4.0451439417665824e-05
been O 0 3.761362313525751e-05
identified O 0 5.964365482213907e-05
in O 0 4.0155187889467925e-05
individuals O 0 3.839124838123098e-05
of O 0 0.00043929103412665427
self O 0 0.2640451490879059
- O 0 0.05650893971323967
reported O 0 0.00041685273754410446
Ashkenazi O 0 0.0009078700095415115
Jewish O 0 0.0008180239819921553
origins O 0 0.0020175788085907698
. O 0 0.0007579473895020783

In O 0 0.0008918138919398189
addition O 0 0.0003562161000445485
, O 0 0.00010044487135019153
in O 0 6.20379505562596e-05
this O 0 4.645963781513274e-05
family O 0 0.00011278608872089535
, O 0 7.243273284984753e-05
there O 0 6.270362791838124e-05
appears O 0 0.0001105238770833239
to O 0 3.709875818458386e-05
be O 0 2.9840653951396234e-05
no O 0 4.140475357417017e-05
relationship O 0 0.00010111181472893804
between O 0 0.00011406277189962566
the O 0 0.00047286119661293924
I1307K O 1 0.990100085735321
polymorphism O 0 0.0003795348748099059
and O 0 7.587653090013191e-05
the O 0 0.0001641412964090705
presence O 0 0.0003020928124897182
or O 0 0.00017204384494107217
absence O 0 0.002683569910004735
of O 1 0.8552570343017578
cancer B-Disease 1 0.9999449253082275
. O 0 0.000516348285600543
. O 0 0.0007014698348939419

Identification O 0 0.0016506165266036987
of O 0 0.0005950099439360201
a O 0 0.0004883555811829865
novel O 0 0.0004489544953685254
mutation O 0 0.0001943694951478392
of O 0 0.00021135913266334683
the O 0 0.0006010986980982125
CPO O 0 0.33595824241638184
gene O 0 0.00015376137162093073
in O 0 9.248698188457638e-05
a O 0 0.00027462822617962956
Japanese O 0 0.009367072954773903
hereditary B-Disease 1 0.9997712969779968
coproporphyria I-Disease 1 0.9999452829360962
family O 0 0.008139509707689285
. O 0 0.0017001249361783266

Hereditary B-Disease 1 0.9999821186065674
coproporphyria I-Disease 1 0.999997615814209
( O 1 0.9920492768287659
HCP B-Disease 1 0.9999840259552002
) O 0 0.0006236405461095273
is O 0 0.00029093786724843085
an O 0 0.0006195598980411887
autosomal B-Disease 1 0.9961456060409546
dominant I-Disease 1 0.9999892711639404
disease I-Disease 1 0.9999996423721313
characterized O 1 0.9994725584983826
by O 0 0.006398437544703484
a O 1 0.9730312824249268
deficiency B-Disease 1 0.9999998807907104
of I-Disease 1 0.9994981288909912
coproporphyrinogen I-Disease 1 0.9999998807907104
oxidase I-Disease 1 0.9991589784622192
( O 0 0.0009653042652644217
CPO O 1 0.5962305665016174
) O 0 9.488259092904627e-05
caused O 0 0.0003191667783539742
by O 0 3.639229908003472e-05
a O 0 9.349244646728039e-05
mutation O 0 0.00013657129602506757
in O 0 0.0001110622615669854
the O 0 0.000684562954120338
CPO O 1 0.689777672290802
gene O 0 0.000896952988114208
. O 0 0.0005591470398940146

Only O 0 0.0006076544523239136
11 O 0 0.0008734334842301905
mutations O 0 0.00022402001195587218
of O 0 0.00022800829901825637
the O 0 0.0003771201882045716
gene O 0 0.00013492417929228395
have O 0 3.4349832276348025e-05
been O 0 8.615849947091192e-05
reported O 0 0.00022581321536563337
in O 0 0.0006754677160643041
HCP B-Disease 1 0.9998455047607422
patients O 0 0.005651686806231737
. O 0 0.001043454627506435

We O 0 0.0008843365940265357
report O 0 0.00032839353661984205
another O 0 0.00024644003133289516
mutation O 0 0.00010949144780170172
in O 0 8.371615695068613e-05
a O 0 0.00027205212973058224
Japanese O 0 0.002223697956651449
family O 0 0.0007860924815759063
. O 0 0.0005444347043521702

Polymerase O 0 0.025698306038975716
chain O 0 0.00739640835672617
reaction O 0 0.0021777660585939884
- O 0 0.0010832351399585605
single O 0 0.00036710817948915064
strand O 0 0.0006453299429267645
conformational O 0 0.00044036898179911077
polymorphism O 0 0.00021228047262411565
and O 0 4.248258483130485e-05
direct O 0 3.745034700841643e-05
sequence O 0 6.639012281084433e-05
analyses O 0 5.62202803848777e-05
demonstrated O 0 0.0001229846093337983
a O 0 9.620364289730787e-05
C O 0 0.00024192540149670094
to O 0 8.942698332248256e-05
T O 0 0.0007704642484895885
substitution O 0 0.0002480079419910908
in O 0 6.682539969915524e-05
exon O 0 0.0003727787407115102
1 O 0 7.365592318819836e-05
of O 0 7.419034227496013e-05
the O 0 0.00014275600551627576
CPO O 0 0.001466747373342514
gene O 0 7.519684731960297e-05
at O 0 0.0001111582459998317
nucleotide O 0 0.00010384807683294639
position O 0 0.0001037631300278008
85 O 0 0.00015234312741085887
, O 0 4.541423186310567e-05
which O 0 2.721147393458523e-05
lies O 0 0.00015362008707597852
in O 0 9.420463175047189e-05
the O 0 0.0002276171144330874
putative O 0 0.0011565600289031863
presequence O 0 0.005738649982959032
for O 0 0.00014069568715058267
targeting O 0 0.0002870814350899309
to O 0 0.0002713015419431031
mitochondria O 0 0.0026809037663042545
. O 0 0.0006836085813120008

This O 0 0.0007929598796181381
mutation O 0 0.0005191450472921133
changes O 0 0.00013939422206021845
the O 0 0.00012617667380254716
codon O 0 0.00030164243071340024
for O 0 5.4589068895438686e-05
glutamine O 0 0.00021206725796218961
to O 0 4.6539949835278094e-05
a O 0 0.00011576193355722353
termination O 0 0.0006742904661223292
codon O 0 0.000697652401868254
at O 0 0.00029409871785901487
amino O 0 0.00021443990408442914
acid O 0 0.00035536388168111444
position O 0 0.0003682431415654719
29 O 0 0.0008090979536063969
. O 0 0.0006736060604453087

MaeI O 1 0.6864378452301025
restriction O 0 0.0015438065165653825
analysis O 0 0.0003212809097021818
showed O 0 0.0003086765937041491
two O 0 4.6496516006300226e-05
other O 0 3.6058725527254865e-05
carriers O 0 0.0001079275316442363
in O 0 8.439338125754148e-05
the O 0 0.00022445105423685163
family O 0 0.0009919970761984587
. O 0 0.0008883241098374128

The O 0 0.005835759919136763
C O 1 0.957488477230072
- O 1 0.9454734325408936
T O 1 0.84136563539505
mutation O 0 0.00017732547712512314
is O 0 4.645534136216156e-05
located O 0 0.00011054137576138601
within O 0 5.598071948043071e-05
a O 0 0.00010375918645877391
recently O 0 0.00018502380407880992
proposed O 0 0.00016931237769313157
putative O 0 0.00044230592902749777
alternative O 0 0.0001977888896362856
translation O 0 0.00026559949037618935
initiation O 0 0.0009677989291958511
codon O 0 0.0011284896172583103
( O 0 0.0002819114597514272
TIC O 0 0.03295786306262016
- O 0 0.000424678873969242
1 O 0 0.00010355635458836332
) O 0 3.163956353091635e-05
, O 0 2.407382635283284e-05
supporting O 0 7.690642814850435e-05
that O 0 5.791758303530514e-05
TIC O 1 0.8701479434967041
- O 0 0.00042590306838974357
1 O 0 0.00014043913688510656
is O 0 6.214524910319597e-05
the O 0 0.00010253668733639643
real O 0 0.0005638531874865294
TIC O 0 0.0564378947019577
rather O 0 0.0002207420620834455
than O 0 0.0001706742768874392
TIC O 1 0.9016337394714355
- O 0 0.0010002709459513426
2 O 0 0.0004041559877805412
. O 0 0.00017350756388623267
. O 0 0.0005016335635446012

Human B-Disease 0 0.01923096738755703
complement I-Disease 1 0.8802956342697144
factor I-Disease 1 0.9999558925628662
H I-Disease 1 1.0
deficiency I-Disease 1 1.0
associated O 1 0.9999512434005737
with O 1 0.9999982118606567
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.9999014139175415

This O 0 0.0003329189494252205
study O 0 0.00017885409761220217
reports O 0 0.00011104944132966921
on O 0 6.242594827199355e-05
six O 0 0.00010548367572482675
cases O 0 0.00011976838868577033
of O 0 0.09268737584352493
deficiency B-Disease 1 0.9999997615814209
in I-Disease 0 0.00025168975116685033
the I-Disease 0 0.00025457111769355834
human I-Disease 0 0.00017073108756449074
complement I-Disease 0 0.0002398935321252793
regulatory I-Disease 0 0.0002360896614845842
protein I-Disease 0 0.0005106634926050901
Factor I-Disease 0 0.00303563941270113
H I-Disease 1 0.9992081522941589
( O 0 0.000295696227112785
FH O 0 0.011717948131263256
) O 0 4.3620409996947274e-05
in O 0 2.8832249881816097e-05
the O 0 6.677004421362653e-05
context O 0 0.00013400601164903492
of O 0 0.0008682945044711232
an O 1 0.9994210004806519
acute B-Disease 1 1.0
renal I-Disease 1 1.0
disease I-Disease 1 1.0
. O 1 0.999011754989624

Five O 0 0.0006055950652807951
of O 0 0.00041025911923497915
the O 0 0.0002511728962417692
cases O 0 0.00015515343693550676
were O 0 9.857068653218448e-05
observed O 0 0.0001302381861023605
in O 0 0.00010331074736313894
children O 0 0.00025099480990320444
presenting O 0 0.0022739656269550323
with O 1 0.9780634641647339
idiopathic O 1 1.0
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 1.0
HUS B-Disease 1 1.0
) O 1 0.8210422396659851
. O 0 0.0031827769707888365

Two O 0 0.0007317134877666831
of O 0 0.0006641693762503564
the O 0 0.0006751205655746162
children O 0 0.0005062205600552261
exhibited O 0 0.2058480978012085
a O 1 0.9353703260421753
homozygous O 1 0.9995904564857483
deficiency O 1 0.9999995231628418
characterized O 0 0.13932958245277405
by O 0 0.0001473055745009333
the O 0 0.00029916022322140634
absence O 0 0.0003921898314729333
of O 0 0.00014886345888953656
the O 0 0.00016784916806500405
150 O 0 0.00021635273878928274
- O 0 0.00023585835879202932
kD O 0 0.0009381321724504232
form O 0 8.740676275920123e-05
of O 0 0.00019526504911482334
Factor O 0 0.005023783538490534
H O 1 0.9523090124130249
and O 0 8.95544872037135e-05
the O 0 0.0001215329539263621
presence O 0 0.00016182406398002058
, O 0 5.8124627685174346e-05
upon O 0 0.00015054226969368756
immunoblotting O 0 0.002872156212106347
, O 0 4.7443070798181e-05
of O 0 8.861697278916836e-05
the O 0 0.00016176406643353403
42 O 0 0.000580624386202544
- O 0 0.0010572165483608842
kD O 0 0.005762248765677214
Factor O 0 0.0016422807238996029
H O 1 0.6176020503044128
- O 0 0.0004980129306204617
like O 0 0.00015060602163430303
protein O 0 0.00016377829888369888
1 O 0 0.000182847332325764
( O 0 0.00012886474723927677
FHL O 0 0.040390968322753906
- O 0 0.0003348635509610176
1 O 0 0.00013025023508816957
) O 0 4.1770574171096087e-05
and O 0 4.213246575091034e-05
other O 0 7.542378443758935e-05
FH O 1 0.5812070965766907
- O 0 0.001295864232815802
related O 0 0.000665428233332932
protein O 0 0.0009636501781642437
( O 0 0.0007308065542019904
FHR O 1 0.9993041753768921
) O 0 0.0005965613527223468
bands O 0 0.002009140094742179
. O 0 0.0009069172665476799

Southern O 0 0.0078098708763718605
blot O 0 0.01112276315689087
and O 0 0.0006738169468007982
PCR O 0 0.0011389945866540074
analysis O 0 8.601893205195665e-05
of O 0 0.00011039810488000512
DNA O 0 0.00023190210049506277
of O 0 0.00021619167819153517
one O 0 0.00025309022748842835
patient O 0 0.0012914875987917185
with O 0 0.000581414089538157
homozygous O 1 0.8351004123687744
deficiency O 1 0.9999980926513672
ruled O 0 0.0010661320993676782
out O 0 8.763176447246224e-05
the O 0 8.500244439346716e-05
presence O 0 0.00010309002391295508
of O 0 9.664204117143527e-05
a O 0 0.00010656484664650634
large O 0 0.0001044444361468777
deletion O 0 0.00016619321831967682
of O 0 0.00014191505033522844
the O 0 0.00039892850327305496
FH O 1 0.9065514802932739
gene O 0 0.000127271210658364
as O 0 0.00011856773926410824
the O 0 0.0002972598886117339
underlying O 0 0.47561097145080566
defect O 1 0.999944806098938
for O 0 0.005710161756724119
the O 1 0.9979245662689209
deficiency O 1 0.9999998807907104
. O 0 0.004065073095262051

The O 0 0.00173025147523731
other O 0 0.0002902626583818346
four O 0 0.00028917359304614365
children O 0 0.00021436772658489645
presented O 0 0.0005779460188932717
with O 0 0.0005746629321947694
heterozygous O 0 0.31360581517219543
deficiency O 1 0.9999996423721313
and O 0 0.0011083362624049187
exhibited O 0 0.26892220973968506
a O 0 0.001938704983331263
normal O 0 0.0011343980440869927
immunoblotting O 0 0.330337256193161
pattern O 0 0.0003313534543849528
of O 0 0.0002240516187157482
proteins O 0 0.00010891186684602872
of O 0 0.00026964902644976974
the O 0 0.0008679082384333014
FH O 1 0.9956282377243042
family O 0 0.001828035106882453
. O 0 0.0009018599521368742

Factor B-Disease 1 0.9998487234115601
H I-Disease 1 0.9999996423721313
deficiency I-Disease 1 0.9999995231628418
is O 0 0.0009551215334795415
the O 0 0.003642404917627573
only O 0 0.005588063970208168
complement B-Disease 1 0.9999706745147705
deficiency I-Disease 1 1.0
associated O 1 0.9037961363792419
with O 0 0.2125452756881714
HUS B-Disease 1 0.9999998807907104
. O 0 0.008379521779716015

These O 0 0.0007719013374298811
observations O 0 0.0005858156946487725
suggest O 0 0.00025180040393024683
a O 0 0.00030216824961826205
role O 0 0.0006111102411523461
for O 0 0.0002297477622050792
FH O 1 0.9990911483764648
and O 0 0.0007376429275609553
/ O 0 0.05385701730847359
or O 0 0.0007423366187140346
FH O 1 0.9954311847686768
receptors O 0 0.0003749006718862802
in O 0 0.00021993198606651276
the O 0 0.0006971916882321239
pathogenesis O 1 0.9995675683021545
of O 1 0.9986357092857361
idiopathic O 1 1.0
HUS B-Disease 1 1.0
. O 0 0.11707393825054169
. O 0 0.0023191417567431927

Further O 0 0.0015406558522954583
evidence O 0 0.000483997369883582
for O 0 0.00013082727673463523
a O 0 0.0004026709939353168
major O 0 0.0015335214557126164
ancient O 0 0.4976327121257782
mutation O 1 0.9597269892692566
underlying O 1 0.9999794960021973
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
from O 1 0.9377250671386719
linkage O 1 0.9987938404083252
disequilibrium O 1 0.9982925057411194
studies O 0 0.00024975393898785114
in O 0 0.00011715907021425664
the O 0 0.00019443828205112368
Japanese O 0 0.0012900670990347862
population O 0 0.0002422256802674383
. O 0 0.0003740153624676168

The O 1 0.9982441663742065
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999486207962036
DM B-Disease 1 1.0
) O 0 0.001935375272296369
mutation O 0 0.0006491498206742108
is O 0 0.00022214697673916817
an O 0 0.000300137820886448
unstable O 1 0.6622020602226257
( O 0 0.0009875567629933357
CTG O 1 0.98734050989151
) O 0 0.00022339337738230824
n O 0 0.0004182468692306429
repeat O 0 0.00026887425337918103
, O 0 4.312169039621949e-05
present O 0 6.0896261857124045e-05
at O 0 9.284530096920207e-05
a O 0 6.94250556989573e-05
copy O 0 6.926277274033055e-05
number O 0 1.3599636986327823e-05
of O 0 4.290764991310425e-05
5 O 0 9.300445526605472e-05
- O 0 0.00012293443433009088
37 O 0 0.00015264193643815815
repeats O 0 0.0001730634248815477
on O 0 7.883262151153758e-05
normal O 0 9.212388977175578e-05
chromosomes O 0 0.00011545854067662731
but O 0 4.599302337737754e-05
amplified O 0 0.0001855577138485387
to O 0 4.377844015834853e-05
50 O 0 0.00015662740042898804
- O 0 0.00044597109081223607
3000 O 0 0.0012388946488499641
copies O 0 0.00039120682049542665
on O 0 0.000612481904681772
DM B-Disease 1 0.9991247057914734
chromosomes O 0 0.002786068245768547
. O 0 0.001029573380947113

Previous O 0 0.0023721579927951097
findings O 0 0.0006934646517038345
in O 0 0.0002063087304122746
Caucasian O 0 0.0011390174040570855
populations O 0 0.00015239702770486474
of O 0 0.00029429170535877347
a O 0 0.012061208486557007
DM B-Disease 1 0.9999998807907104
founder O 1 0.9851279854774475
chromosome O 0 0.00041798740858212113
raise O 0 0.00016150667215697467
a O 0 7.743635069346055e-05
question O 0 5.5528573284391314e-05
about O 0 4.214186628814787e-05
the O 0 9.071930981008336e-05
molecular O 0 0.0001748196518747136
events O 0 0.00011258525046287104
involved O 0 8.560978312743828e-05
in O 0 7.025956438155845e-05
the O 0 0.000239842789596878
expansion O 0 0.0021712903399020433
mutation O 0 0.0007469843258149922
. O 0 0.0005895298672839999

To O 0 0.0009556536679156125
investigate O 0 0.0009293424664065242
whether O 0 0.0002171504747821018
a O 0 0.000386271218303591
founder O 0 0.0033320272341370583
chromosome O 0 0.0005499544786289334
for O 0 0.00015739767695777118
the O 0 0.0008157397387549281
DM B-Disease 1 0.999998927116394
mutation O 0 0.000309993076371029
exists O 0 9.783801215235144e-05
in O 0 4.340852683526464e-05
the O 0 6.938527076272294e-05
Japanese O 0 0.00033146151690743864
population O 0 2.981192483275663e-05
, O 0 4.49080289399717e-05
we O 0 6.740262324456125e-05
genotyped O 0 0.001028647879138589
families O 0 8.522077405359596e-05
using O 0 6.863015005365014e-05
polymorphic O 0 0.0003445470938459039
markers O 0 0.00045723680523224175
near O 0 0.0010392561089247465
the O 0 0.00032838195329532027
( O 0 0.00035389207187108696
CTG O 0 0.1753624677658081
) O 0 0.00017049862071871758
n O 0 0.0004681334539782256
repeat O 0 0.0007480856729671359
region O 0 0.00045798884821124375
and O 0 0.00032719256705604494
constructed O 0 0.003657739609479904
haplotypes O 0 0.004156431648880243
. O 0 0.0012164214858785272

Six O 0 0.0020530889742076397
different O 0 0.0004382205370347947
haplotypes O 0 0.0016678537940606475
were O 0 0.0004259989073034376
found O 0 0.0005297967582009733
and O 0 0.0008369212737306952
DM B-Disease 1 0.9999803304672241
alleles O 0 0.0012050782097503543
were O 0 0.000514698214828968
always O 0 0.0007224056171253324
haplotype O 0 0.0029842513613402843
A O 0 0.0028531160205602646
. O 0 0.001132528530433774

To O 0 0.0008188223000615835
find O 0 0.0003605472156777978
an O 0 0.00011200443987036124
origin O 0 9.033316746354103e-05
of O 0 0.00016644963761791587
the O 0 0.00028253087657503784
( O 0 0.00036797364009544253
CTG O 1 0.9600568413734436
) O 0 0.0002545339521020651
n O 0 0.00043615326285362244
repeat O 0 0.0004232599167153239
mutation O 0 9.078888251679018e-05
and O 0 2.375343865423929e-05
to O 0 2.4620672775199637e-05
investigate O 0 9.056916314875707e-05
the O 0 0.00010367955837864429
mechanism O 0 0.00015895826800260693
of O 0 0.00015572317352052778
the O 0 0.0001376394066028297
expansion O 0 0.00042743684025481343
mutation O 0 6.941671017557383e-05
in O 0 2.7564698029891588e-05
the O 0 4.767141581396572e-05
Japanese O 0 0.00019163676188327372
population O 0 1.759512088028714e-05
we O 0 1.7908148947753944e-05
have O 0 1.3369582120503765e-05
studied O 0 6.798230606364086e-05
90 O 0 0.00023025303380563855
Japanese O 0 0.001416047103703022
DM B-Disease 1 0.9977586269378662
families O 0 0.00016844413767103106
comprising O 0 0.00018740443920250982
190 O 0 0.00048314413288608193
affected O 0 0.00030578006408177316
and O 0 0.00019914761651307344
130 O 0 0.0007097271736711264
unaffected O 0 0.001637618406675756
members O 0 0.00038771406980231404
. O 0 0.0005304787191562355

The O 0 0.0023413964081555605
results O 0 0.0005429210723377764
suggest O 0 0.0002769272541627288
that O 0 4.3518946768017486e-05
a O 0 0.00010989636211888865
few O 0 0.00010428659152239561
common O 0 0.00012960575986653566
ancestral O 0 0.009606130421161652
mutations O 0 0.00017601203580852598
in O 0 9.853159281192347e-05
both O 0 8.26574832899496e-05
Caucasian O 0 0.0021268357522785664
and O 0 0.00015201620408333838
Japanese O 0 0.002775776432827115
populations O 0 4.997735231881961e-05
have O 0 1.651412276260089e-05
originated O 0 7.289310451596975e-05
by O 0 2.2737591280019842e-05
expansion O 0 0.00010110293806064874
of O 0 6.3316932937596e-05
an O 0 4.9922433390747756e-05
ancestral O 0 0.00045201778993941844
n O 0 0.00021350124734453857
= O 0 0.00018592787091620266
5 O 0 7.68381796660833e-05
repeat O 0 0.000129456035210751
to O 0 3.92334841308184e-05
n O 0 0.00013650568143930286
= O 0 0.00024070388462860137
19 O 0 0.0004556539061013609
- O 0 0.0005195544217713177
37 O 0 0.0006578485481441021
copies O 0 0.00038990945904515684
. O 0 0.0004458509502001107

These O 0 0.0006010057986713946
data O 0 0.00025917059974744916
support O 0 0.00023617970873601735
multistep O 0 0.0012416495010256767
models O 0 0.00034200347727164626
of O 0 0.0004922644584439695
triplet O 1 0.8734804391860962
repeat O 0 0.002157288370653987
expansion O 0 0.000753136700950563
that O 0 4.830928082810715e-05
have O 0 2.145143116649706e-05
been O 0 4.5648357627214864e-05
proposed O 0 7.456354069290683e-05
for O 0 8.974914817372337e-05
both O 0 0.0002722202625591308
DM B-Disease 1 0.9999996423721313
and O 0 0.17890313267707825
Friedreichs B-Disease 1 0.9999967813491821
ataxia I-Disease 1 0.9999791383743286
. O 0 0.0026989637408405542
. O 0 0.0013220235705375671

The O 0 0.001955773215740919
molecular O 0 0.0020059968810528517
basis O 0 0.00072816590545699
of O 1 0.8076215982437134
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 0.0011664394987747073
the O 0 0.000716913549695164
western O 0 0.0006383074796758592
Cape O 0 0.0039027633611112833
, O 0 0.00017630044021643698
South O 0 0.0007569000590592623
Africa O 0 0.0011844332329928875
. O 0 0.0005964793963357806

Deficiency B-Disease 1 0.9999526739120483
of I-Disease 0 0.003992983140051365
the I-Disease 0 0.002992187160998583
sixth I-Disease 1 0.986467182636261
component I-Disease 0 0.00639465032145381
of I-Disease 0 0.0008260391768999398
human I-Disease 0 0.0006833330262452364
complement I-Disease 0 0.002861971966922283
( O 0 0.0013382170582190156
C6 O 1 0.9999562501907349
) O 0 9.636229515308514e-05
has O 0 3.362769348314032e-05
been O 0 2.4627084712847136e-05
reported O 0 2.451856380503159e-05
in O 0 1.3348356333153788e-05
a O 0 3.698836371768266e-05
number O 0 1.6511965441168286e-05
of O 0 6.13236625213176e-05
families O 0 5.1017133955610916e-05
from O 0 5.95100864302367e-05
the O 0 0.0001274828246096149
western O 0 0.00028890848625451326
Cape O 0 0.001782790175639093
, O 0 0.00031811691587790847
South O 0 0.001247221021912992
Africa O 0 0.0012082537868991494
. O 0 0.0008371014846488833

Meningococcal B-Disease 1 0.9999995231628418
disease I-Disease 1 0.9999980926513672
is O 0 0.002118582371622324
endemic O 0 0.029855677857995033
in O 0 0.00030163407791405916
the O 0 0.00048206080100499094
Cape O 0 0.0013617019867524505
and O 0 5.038376912125386e-05
almost O 0 4.218859248794615e-05
all O 0 2.6840396458283067e-05
pedigrees O 0 0.00023884416441433132
of O 0 0.0005283212522044778
total O 1 0.9951642751693726
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 1 0.9776676893234253
C6Q0 O 1 0.9999972581863403
) O 0 0.00015558114682789892
have O 0 4.36055997852236e-05
been O 0 0.00012078870349796489
ascertained O 0 0.0006484310142695904
because O 0 0.0002113814844051376
of O 0 0.009442981332540512
recurrent O 1 0.9999991655349731
disease O 1 0.9999997615814209
. O 0 0.03444468230009079

We O 0 0.0011909020831808448
have O 0 0.00021885427122469991
sequenced O 0 0.0007913045701570809
the O 0 0.00026324030477553606
expressed O 0 0.00021730850858148187
exons O 0 0.0006146376836113632
of O 0 0.00043402769370004535
the O 0 0.0010068253614008427
C6 O 1 0.999968409538269
gene O 0 0.00020516605582088232
from O 0 7.88960896898061e-05
selected O 0 8.22422734927386e-05
cases O 0 4.1119317756965756e-05
and O 0 2.3631499061593786e-05
have O 0 1.7759573893272318e-05
found O 0 2.650777605595067e-05
three O 0 5.177906132303178e-05
molecular O 0 0.002794397994875908
defects O 1 0.9998618364334106
leading O 0 0.1053297147154808
to O 0 0.0003675917978398502
total O 1 0.9102192521095276
deficiency O 1 1.0
879delG O 1 0.9999866485595703
, O 0 0.00018064287723973393
which O 0 4.416740557644516e-05
is O 0 3.7675876228604466e-05
the O 0 0.00010436886077513918
common O 0 0.00020204139582347125
defect O 1 0.9930275082588196
in O 0 0.00019026269728783518
the O 0 0.0004030370037071407
Cape O 0 0.007001828867942095
and O 0 0.00010009272227762267
hitherto O 0 0.0006450630025938153
unreported O 0 0.0005749138072133064
, O 0 0.00012461829464882612
and O 0 0.00014611188089475036
1195delC O 1 0.5591869950294495
and O 0 0.00029567195451818407
1936delG O 1 0.9923658967018127
, O 0 0.00014329292753245682
which O 0 3.103424751316197e-05
have O 0 2.0443038010853343e-05
been O 0 3.301089964224957e-05
previously O 0 8.560006972402334e-05
reported O 0 0.00011286451626801863
in O 0 0.00012170134868938476
African O 0 0.0014017978683114052
- O 0 0.0021111369132995605
Americans O 0 0.0007197603117674589
. O 0 0.0006935165147297084

We O 0 0.0013311899965628982
also O 0 0.0003501090104691684
show O 0 0.00033511201036162674
that O 0 0.0001078525310731493
the O 0 0.0004938560887239873
879delG O 1 0.9981790781021118
and O 0 0.03370392695069313
1195delC O 1 0.9999959468841553
defects O 1 0.999984622001648
are O 0 0.0001264763850485906
associated O 0 0.0002864286070689559
with O 0 0.00035236182156950235
characteristic O 1 0.9996989965438843
C6 O 1 1.0
/ O 1 0.9997871518135071
C7 O 1 0.9999732971191406
region O 0 0.0017591736977919936
DNA O 0 0.001371191581711173
marker O 0 0.0029222143348306417
haplotypes O 0 0.0007431163103319705
, O 0 9.57272422965616e-05
although O 0 6.924731860635802e-05
small O 0 6.248301360756159e-05
variations O 0 0.00011959880794165656
were O 0 0.00017535958613734692
observed O 0 0.0005288049578666687
. O 0 0.0005542231374420226

The O 0 0.019572773948311806
1936delG O 1 0.9998440742492676
defect O 1 0.9998862743377686
was O 0 0.06521077454090118
observed O 0 0.0002711088745854795
only O 0 6.024265894666314e-05
once O 0 0.00013663082791026682
in O 0 6.036503327777609e-05
the O 0 0.00015135854482650757
Cape O 0 0.0006181366625241935
, O 0 4.7710665967315435e-05
but O 0 2.923739157267846e-05
its O 0 4.184648423688486e-05
associated O 0 0.00010664942237781361
haplotype O 0 0.0007564760744571686
could O 0 0.00011814181925728917
be O 0 0.00014299058238975704
deduced O 0 0.0019716338720172644
. O 0 0.0007840858888812363

The O 0 0.001508956542238593
data O 0 0.00026653939858078957
from O 0 0.00017275249410886317
the O 0 0.0002736987080425024
haplotypes O 0 0.0005915462970733643
indicate O 0 0.00012082555622328073
that O 0 3.8970145396888256e-05
these O 0 2.503024006728083e-05
three O 0 0.00011149095371365547
molecular O 0 0.0019626570865511894
defects O 1 0.97196364402771
account O 0 0.00015200127381831408
for O 0 0.0001062615483533591
the O 0 0.0009449830977246165
defects O 1 0.9923503994941711
in O 0 7.998893124749884e-05
all O 0 5.4244497732724994e-05
the O 0 0.00013328688510227948
38 O 0 0.0004724804894067347
unrelated O 0 0.0014927390730008483
C6Q0 O 1 0.9997934699058533
individuals O 0 8.002403046702966e-05
we O 0 7.27515944163315e-05
have O 0 2.421418685116805e-05
studied O 0 0.0001322365424130112
from O 0 0.00014281536277849227
the O 0 0.0004000577318947762
Cape O 0 0.0047257691621780396
. O 0 0.0009866711916401982

We O 0 0.0013013200368732214
have O 0 0.00019530692952685058
also O 0 0.00016484083607792854
observed O 0 0.0001544382976135239
the O 0 0.00040864921174943447
879delG O 1 0.927528977394104
defect O 1 0.9802322387695312
in O 0 0.00033737742342054844
two O 0 0.00031285136356018484
Dutch O 1 0.9536424279212952
C6 B-Disease 1 1.0
- I-Disease 1 0.9996919631958008
deficient I-Disease 1 0.9997053742408752
kindreds O 0 0.04604347050189972
, O 0 0.00014404994726646692
but O 0 4.8037825763458386e-05
the O 0 0.0001617157831788063
879delG O 1 0.9989607334136963
defect O 1 0.9989629983901978
in O 0 0.00028645285055972636
the O 0 0.00046499428572133183
Cape O 0 0.006426120642572641
probably O 0 0.0003265033010393381
did O 0 6.649021815974265e-05
not O 0 1.4637008462159429e-05
come O 0 3.233263487345539e-05
from O 0 4.5611541281687096e-05
The O 0 0.00015046076441649348
Netherlands O 0 0.0005154680693522096
. O 0 0.00028253087657503784
. O 0 0.00044942315435037017

Complement B-Disease 1 0.9997870326042175
C7 I-Disease 1 1.0
deficiency I-Disease 1 1.0
: O 0 0.001969679491594434
seven O 0 0.0012410583440214396
further O 0 0.00123304664157331
molecular O 1 0.5569035410881042
defects O 1 0.9999130964279175
and O 0 0.0003693242324516177
their O 0 0.00018759768863674253
associated O 0 0.0008317468455061316
marker O 0 0.2741227149963379
haplotypes O 0 0.009019896388053894
. O 0 0.0020987431053072214

Seven O 0 0.0034048042725771666
further O 0 0.001351826824247837
molecular O 0 0.0017620382132008672
bases O 0 0.0035105424467474222
of O 1 0.9983421564102173
C7 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 0.0012054616818204522
described O 0 0.004197527188807726
. O 0 0.0009289378067478538

All O 0 0.0006360162515193224
these O 0 0.00018392936908639967
new O 0 0.00026089168386533856
molecular O 0 0.0017460130620747805
defects O 1 0.9501233696937561
involve O 0 0.0005284849321469665
single O 0 0.0006649895804002881
- O 0 0.00111814693082124
nucleotide O 0 0.00031810838845558465
events O 0 0.00012074712140019983
, O 0 7.008751708781347e-05
deletions O 0 0.0002565963368397206
and O 0 8.360814535990357e-05
substitutions O 0 0.0002669261593837291
, O 0 7.391225517494604e-05
some O 0 3.3369000448146835e-05
of O 0 9.407751349499449e-05
which O 0 6.29898568149656e-05
alter O 0 0.00043242963147349656
splice O 0 0.0009756023064255714
sites O 0 0.0002657484437804669
, O 0 0.0001573099143570289
and O 0 0.00013289789785631
others O 0 0.00029605365125462413
codons O 0 0.001960163936018944
. O 0 0.0007819351740181446

They O 0 0.0005250861286185682
are O 0 7.888134132372215e-05
distributed O 0 9.175216837320477e-05
along O 0 0.00015966492355801165
the O 0 0.00038492088788188994
C7 O 1 0.9999592304229736
gene O 0 0.0003417169791646302
, O 0 8.386589615838602e-05
but O 0 2.7223881261306815e-05
predominantly O 0 5.6937111367005855e-05
towards O 0 0.00019983731908723712
the O 0 0.00024942937307059765
3 O 0 0.0005466439761221409
end O 0 0.0010389882372692227
. O 0 0.0006036178092472255

All O 0 0.0007021346245892346
were O 0 0.0004040941712446511
found O 0 0.0002573273959569633
in O 0 0.0003597511677071452
compound O 0 0.02329564467072487
heterozygous O 0 0.0008219612645916641
individuals O 0 0.0003348852915223688
. O 0 0.0006834990927018225

The O 1 0.5360424518585205
C6 O 1 0.9999967813491821
/ O 1 0.9994608759880066
C7 O 1 0.99998939037323
marker O 1 0.9011387825012207
haplotypes O 0 0.005344885867089033
associated O 0 0.0005873010959476233
with O 0 0.00042792322346940637
most O 0 0.047851622104644775
C7 B-Disease 1 1.0
defects I-Disease 1 0.9999970197677612
are O 0 0.0002155897964257747
tabulated O 0 0.0013112600427120924
. O 0 0.000302066036965698
. O 0 0.0005453702178783715

A O 0 0.007452012039721012
genome O 0 0.002061194274574518
- O 0 0.0012323556002229452
wide O 0 0.0005012155743315816
search O 0 0.00046809023478999734
for O 0 0.0002818010398186743
chromosomal O 0 0.22968925535678864
loci O 0 0.02498016506433487
linked O 0 0.043205853551626205
to O 0 0.0013122063828632236
mental O 1 0.9999762773513794
health O 1 0.713435173034668
wellness O 1 0.6727855801582336
in O 0 0.0002469650062266737
relatives O 0 0.0006177847390063107
at O 0 0.003334111999720335
high O 0 0.10059189796447754
risk O 0 0.019948452711105347
for O 0 0.123407281935215
bipolar B-Disease 1 1.0
affective I-Disease 1 1.0
disorder I-Disease 1 1.0
among O 0 0.39439913630485535
the O 0 0.05365316942334175
Old O 1 0.7723247408866882
Order O 0 0.001652511302381754
Amish O 0 0.006667794194072485
. O 0 0.0009759750682860613

Bipolar B-Disease 1 1.0
affective I-Disease 1 1.0
disorder I-Disease 1 1.0
( O 1 0.9999996423721313
BPAD B-Disease 1 1.0
; O 1 0.9999959468841553
manic B-Disease 1 1.0
- I-Disease 1 1.0
depressive I-Disease 1 1.0
illness I-Disease 1 1.0
) O 0 0.005005029030144215
is O 0 0.00029882017406634986
characterized O 0 0.0006910707452334464
by O 0 0.00012535089626908302
episodes O 0 0.0004237100074533373
of O 0 0.017555110156536102
mania B-Disease 1 0.9999994039535522
and O 0 0.064853236079216
/ O 1 0.9630804657936096
or O 0 0.0013587579596787691
hypomania B-Disease 1 0.9994673132896423
interspersed O 0 0.0010813834378495812
with O 0 0.0001446500828024
periods O 0 0.000820743094664067
of O 0 0.004260939080268145
depression B-Disease 1 0.9999825954437256
. O 0 0.0015728470170870423

Compelling O 0 0.006129240617156029
evidence O 0 0.0013738973066210747
supports O 0 0.0006466178456321359
a O 0 0.0003490883100312203
significant O 0 0.0002528051845729351
genetic O 0 0.0003122545313090086
component O 0 0.0006050954107195139
in O 0 8.136361429933459e-05
the O 0 0.0003935943532269448
susceptibility O 0 0.007891506887972355
to O 0 0.00035769588430412114
develop O 0 0.01379439141601324
BPAD B-Disease 1 0.9999949932098389
. O 0 0.0019395854324102402

To O 0 0.0010254658991470933
date O 0 0.001059865695424378
, O 0 0.00021747846039943397
however O 0 0.00012685540423262864
, O 0 0.00011249059753026813
linkage O 0 0.0006551470141857862
studies O 0 7.283718150574714e-05
have O 0 3.1756488169776276e-05
attempted O 0 0.00018335609638597816
only O 0 4.6457913413178176e-05
to O 0 8.332018478540704e-05
identify O 0 0.0003065518685616553
chromosomal O 0 0.1789131909608841
loci O 0 0.0033542821183800697
that O 0 0.00021314610785339028
cause O 0 0.08384869247674942
or O 0 0.00020097331434953958
increase O 0 0.00015941668243613094
the O 0 0.00028783566085621715
risk O 0 0.00040375706157647073
of O 0 0.0027416041120886803
developing O 1 0.6937658190727234
BPAD B-Disease 1 0.9999994039535522
. O 0 0.0025766175240278244

To O 0 0.0007145460695028305
determine O 0 0.0002830787852872163
whether O 0 0.00017460808157920837
there O 0 0.0001287074264837429
could O 0 0.0001247963373316452
be O 0 8.09214761829935e-05
protective O 0 0.003431975608691573
alleles O 0 0.00029506091959774494
that O 0 8.36198523757048e-05
prevent O 0 0.00038895776378922164
or O 0 0.00013464412768371403
reduce O 0 0.00019533711019903421
the O 0 0.00016924395458772779
risk O 0 0.00027205419610254467
of O 0 0.0007679793634451926
developing O 1 0.5493856072425842
BPAD B-Disease 1 0.9999998807907104
, O 0 0.00014428434951696545
similar O 0 4.900037674815394e-05
to O 0 2.443133962515276e-05
what O 0 3.56150594598148e-05
is O 0 3.500912862364203e-05
observed O 0 5.8659188653109595e-05
in O 0 7.532164454460144e-05
other O 0 0.0001418093015672639
genetic B-Disease 1 0.99996018409729
disorders I-Disease 1 1.0
, O 0 0.026058359071612358
we O 0 0.0003678677312564105
used O 0 0.0008354021701961756
mental O 1 0.9999134540557861
health O 0 0.48834773898124695
wellness O 1 0.9988297820091248
( O 0 0.0003199475759174675
absence O 0 0.0004411408444866538
of O 0 0.0008833571919240057
any O 0 0.024749774485826492
psychiatric B-Disease 1 0.9999996423721313
disorder I-Disease 1 0.9999998807907104
) O 0 0.00022037951566744596
as O 0 0.00015298379003070295
the O 0 0.00022607864229939878
phenotype O 0 0.0002519572153687477
in O 0 6.495441630249843e-05
our O 0 0.00014757072494830936
genome O 0 0.00020951520127709955
- O 0 0.00024821184342727065
wide O 0 0.00018924009054899216
linkage O 0 0.0005785577814094722
scan O 0 0.00035564351128414273
of O 0 0.00014752823335584253
several O 0 0.00012351111217867583
large O 0 0.00022283960424829274
multigeneration O 0 0.2502657473087311
Old O 0 0.001698301755823195
Order O 0 0.0007004624349065125
Amish O 0 0.002595505677163601
pedigrees O 0 0.001115401042625308
exhibiting O 0 0.0007900275522843003
an O 0 0.000333567732013762
extremely O 0 0.0008462769910693169
high O 0 0.0053812614642083645
incidence O 1 0.8548390865325928
of O 1 0.6025153398513794
BPAD B-Disease 1 0.9999996423721313
. O 0 0.0030949634965509176

We O 0 0.0009468906209804118
have O 0 9.194092126563191e-05
found O 0 7.989699952304363e-05
strong O 0 0.0001489066198701039
evidence O 0 0.00011351417197147384
for O 0 6.306426075752825e-05
a O 0 0.00020295869035180658
locus O 0 0.0007455762242898345
on O 0 0.0003539651515893638
chromosome O 0 0.001236298936419189
4p O 1 0.9927075505256653
at O 0 0.0016468544490635395
D4S2949 O 0 0.12967924773693085
( O 0 0.0004909888957627118
maximum O 0 0.0008870603633113205
GENEHUNTER O 1 0.963697612285614
- O 0 0.0014716085279360414
PLUS O 0 0.0008838109788484871
nonparametric O 0 0.001582272700034082
linkage O 0 0.0007545655244030058
score O 0 0.0001768661750247702
= O 0 0.00020383490482345223
4 O 0 0.00014854187611490488
. O 0 6.469983782153577e-05
05 O 0 0.0008398807840421796
, O 0 0.00011376449401723221
P O 0 0.0005785550456494093
= O 0 0.00017238834698218852
5 O 0 7.728674972895533e-05
. O 0 2.3309770767809823e-05
22 O 0 7.820501195965335e-05
x O 0 9.93073481367901e-05
10 O 0 9.597109601600096e-05
( O 0 7.896925671957433e-05
- O 0 0.00017005892004817724
4 O 0 0.00015710304433014244
) O 0 6.117914745118469e-05
; O 0 6.484147161245346e-05
SIBPAL O 0 0.007163260132074356
Pempirical O 0 0.002743999706581235
value O 0 0.00019240299297962338
< O 0 0.00039337415364570916
3 O 0 8.949360926635563e-05
x O 0 8.808694110484794e-05
10 O 0 6.294277409324422e-05
( O 0 7.29266248526983e-05
- O 0 0.00010580038360785693
5 O 0 0.00011763034854084253
) O 0 4.975584670319222e-05
) O 0 4.269801138434559e-05
and O 0 5.955453161732294e-05
suggestive O 0 0.0002524674928281456
evidence O 0 8.37762127048336e-05
for O 0 4.8765199608169496e-05
a O 0 0.00016178720397874713
locus O 0 0.0006182662327773869
on O 0 0.0002662455372046679
chromosome O 0 0.0011155583197250962
4q O 0 0.38217586278915405
at O 0 0.0012158897006884217
D4S397 O 0 0.25287318229675293
( O 0 0.00032457755878567696
maximum O 0 0.0006260763038881123
GENEHUNTER O 1 0.7474124431610107
- O 0 0.0012966925278306007
PLUS O 0 0.0008334855083376169
nonparametric O 0 0.0017757606692612171
linkage O 0 0.0009355056681670249
score O 0 0.0001713444507913664
= O 0 0.00022921542404219508
3 O 0 9.104012133320794e-05
. O 0 3.473136530374177e-05
29 O 0 0.0001844770013121888
, O 0 7.724445458734408e-05
P O 0 0.0005226353532634676
= O 0 0.00020981347188353539
2 O 0 9.206576942233369e-05
. O 0 2.3217478883452713e-05
57 O 0 9.777962259249762e-05
x O 0 0.00012171063281130046
10 O 0 0.0001085941112251021
( O 0 0.00010417676094220951
- O 0 0.00020730117103084922
3 O 0 0.000139312629471533
) O 0 8.144799357978627e-05
; O 0 0.00012419609993230551
SIBPAL O 0 0.008145015686750412
Pempirical O 0 0.003788067726418376
value O 0 0.00020417860650923103
< O 0 0.0003335782093927264
1 O 0 8.763677760725841e-05
x O 0 9.221601067110896e-05
10 O 0 6.340967956930399e-05
( O 0 4.748290666611865e-05
- O 0 0.00011797801562352106
3 O 0 8.162238373188302e-05
) O 0 2.5992529117502272e-05
) O 0 2.145542202924844e-05
that O 0 2.4575892894063145e-05
are O 0 2.4216404199250974e-05
linked O 0 0.0004002434725407511
to O 0 0.00029519907548092306
mental O 1 0.999983549118042
health O 1 0.9933928847312927
wellness O 1 0.9996770620346069
. O 0 0.003788420232012868

These O 0 0.0006600560154765844
findings O 0 0.000392067595385015
are O 0 3.612515138229355e-05
consistent O 0 9.82328929239884e-05
with O 0 4.388812158140354e-05
the O 0 0.00015493582759518176
hypothesis O 0 0.00015841959975659847
that O 0 4.255824751453474e-05
certain O 0 5.878529555047862e-05
alleles O 0 0.00014919371460564435
could O 0 9.874661918729544e-05
prevent O 0 0.00026798105682246387
or O 0 0.00011958079267060384
modify O 0 0.00019958023040089756
the O 0 0.00016544549725949764
clinical O 0 0.0005746141541749239
manifestations O 1 0.5858451128005981
of O 1 0.98457932472229
BPAD B-Disease 1 1.0
and O 0 0.022534267976880074
perhaps O 0 0.0014998078113421798
other O 0 0.00030179633176885545
related O 1 0.7351341843605042
affective B-Disease 1 0.9999997615814209
disorders I-Disease 1 0.9999998807907104
. O 0 0.45055991411209106

Segregation O 1 0.9996274709701538
distortion O 1 0.9999020099639893
in O 1 0.9977454543113708
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 0.420166939496994

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999575614929199
DM B-Disease 1 1.0
) O 0 0.0015361651312559843
is O 0 0.00031029645469971
an O 0 0.0005072024650871754
autosomal B-Disease 1 0.979864239692688
dominant I-Disease 1 0.9999874830245972
disease I-Disease 1 0.9999996423721313
which O 0 0.00032773922430351377
, O 0 9.047861385624856e-05
in O 0 5.8671608712757006e-05
the O 0 0.00012345128925517201
typical O 0 0.00026097026420757174
pedigree O 0 0.0005688293022103608
, O 0 8.564537711208686e-05
shows O 0 9.211880387738347e-05
a O 0 0.0001776653080014512
three O 0 0.0002887944574467838
generation O 0 0.003532733768224716
anticipation O 0 0.004392797127366066
cascade O 0 0.07545545697212219
. O 0 0.0010166681604459882

This O 0 0.002165711484849453
results O 0 0.0018943415489047766
in O 0 0.021176587790250778
infertility B-Disease 1 0.9999994039535522
and O 1 0.9999953508377075
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999967813491821
CDM B-Disease 1 0.9999910593032837
) O 0 0.00026869639987125993
with O 0 5.5048887588782236e-05
the O 0 0.00018220304627902806
disappearance O 0 0.0010842066258192062
of O 0 0.00457487627863884
DM B-Disease 1 0.9999995231628418
in O 0 0.0005397350178100169
that O 0 0.00031657962244935334
pedigree O 0 0.0038069237489253283
. O 0 0.0010265817400068045

The O 0 0.002581167034804821
concept O 0 0.0021048469934612513
of O 0 0.0024975971318781376
segregation O 1 0.9995033740997314
distortion O 1 0.9994032382965088
, O 0 0.00020058010704815388
where O 0 0.00010020818444900215
there O 0 5.141789006302133e-05
is O 0 3.911080784746446e-05
preferential O 0 0.0001154652563855052
transmission O 0 0.0001534128241473809
of O 0 0.00010641414701240137
the O 0 0.00011705365614034235
larger O 0 8.377972699236125e-05
allele O 0 0.00014195512630976737
at O 0 0.00020243783365003765
the O 0 0.00033560022711753845
DM B-Disease 1 0.9999986886978149
locus O 0 0.0032620790880173445
, O 0 0.00013882383063901216
has O 0 4.78941947221756e-05
been O 0 5.3384614147944376e-05
put O 0 0.00010570257290964946
forward O 0 0.00012982716725673527
to O 0 7.163892587414011e-05
explain O 0 0.00020065756689291447
partially O 0 0.0006237725028768182
the O 0 0.00023629232600796968
maintenance O 0 0.001956274500116706
of O 0 0.001956329680979252
DM B-Disease 1 0.9999970197677612
in O 0 0.000372844107914716
the O 0 0.00043327611638233066
population O 0 0.0002631023235153407
. O 0 0.00045941778807900846

In O 0 0.0010511495638638735
a O 0 0.0006901735905557871
survey O 0 0.00038488602149300277
of O 0 0.000463537173345685
DM B-Disease 1 0.9999822378158569
in O 0 0.00029455526964738965
Northern O 0 0.00041860208148136735
Ireland O 0 0.0003819063422270119
, O 0 0.00022538860503118485
59 O 0 0.0007434481522068381
pedigrees O 0 0.0012340741232037544
were O 0 0.0003767633461393416
ascertained O 0 0.0044455151073634624
. O 0 0.0011827923590317369

Sibships O 1 0.7123803496360779
where O 0 0.0009976550936698914
the O 0 0.00039889808977022767
status O 0 0.00012912599777337164
of O 0 0.0001118554500862956
all O 0 3.9293841837206855e-05
the O 0 6.429194763768464e-05
members O 0 4.2643805500119925e-05
had O 0 9.123967174673453e-05
been O 0 4.219985567033291e-05
identified O 0 4.759746661875397e-05
were O 0 5.052016786066815e-05
examined O 0 9.298104851040989e-05
to O 0 3.940562964999117e-05
determine O 0 5.1309834816493094e-05
the O 0 0.0001128000658354722
transmission O 0 0.0002516657405067235
of O 0 0.0001537865900900215
the O 0 0.0010957010090351105
DM B-Disease 1 0.9999995231628418
expansion O 0 0.0021586541552096605
from O 0 0.00016499085177201778
affected O 0 0.00016312448133248836
parents O 0 5.4855361668160185e-05
to O 0 6.540005415445194e-05
their O 0 0.00012065654300386086
offspring O 0 0.0008819611393846571
. O 0 0.000493838859256357

Where O 0 0.002600649371743202
the O 0 0.0017910676542669535
transmitting O 0 0.005206653382629156
parent O 0 0.001282015349715948
was O 0 0.0014297127490863204
male O 0 0.000787992961704731
, O 0 0.0004663825675379485
58 O 0 0.0019562942907214165
. O 0 0.0009245441178791225

3 O 0 0.0010110402945429087
% O 0 0.00017123599536716938
of O 0 0.00023013165628071874
the O 0 0.0003083583724219352
offspring O 0 0.00031148470588959754
were O 0 7.440472836606205e-05
affected O 0 9.86449740594253e-05
, O 0 4.165426071267575e-05
and O 0 2.0459028746699914e-05
in O 0 2.2913101929589175e-05
the O 0 5.913693530601449e-05
case O 0 8.087512105703354e-05
of O 0 0.00010122459207195789
a O 0 0.0002617400314193219
female O 0 0.0006163247744552791
transmitting O 0 0.002269917633384466
parent O 0 0.00041339825838804245
, O 0 0.00020259077427908778
68 O 0 0.0009569583344273269
. O 0 0.0005688914097845554

7 O 0 0.005061892792582512
% O 0 0.0012223252560943365
were O 0 0.0010693054646253586
affected O 0 0.002066632267087698
. O 0 0.0011511353077366948

Studies O 0 0.002117910422384739
on O 0 0.0022991583682596684
meiotic O 1 0.9497746229171753
drive O 0 0.006206875666975975
in O 0 0.0011721579357981682
DM B-Disease 1 0.9999951124191284
have O 0 0.00015898040146566927
shown O 0 0.0001849803957156837
increased O 0 0.000171907406183891
transmission O 0 0.00021471772924996912
of O 0 9.522339678369462e-05
the O 0 0.00014608848141506314
larger O 0 0.00014316767919808626
allele O 0 0.00015823179273866117
at O 0 0.00018558390729594976
the O 0 0.00025244872085750103
DM B-Disease 1 0.9998475313186646
locus O 0 0.0012339535169303417
in O 0 0.00042480340925976634
non O 0 0.0018464835593476892
- O 0 0.1995411068201065
DM O 1 0.9999890327453613
heterozygotes O 0 0.01755620166659355
for O 0 0.0011119075352326035
CTGn O 1 0.9761167764663696
. O 0 0.0021612842101603746

This O 0 0.0006643981905654073
study O 0 0.0002612764947116375
provides O 0 0.00011360967619111761
further O 0 0.00011581525905057788
evidence O 0 0.00015255944163072854
that O 0 9.210246207658201e-05
the O 0 0.0005121146095916629
DM B-Disease 1 0.9999935626983643
expansion O 0 0.003621855517849326
tends O 0 0.0005096726818010211
to O 0 8.498395618516952e-05
be O 0 0.00013363263860810548
transmitted O 0 0.0005557206459343433
preferentially O 0 0.0014326089294627309
. O 0 0.0005756400641985238

Diagnosis O 1 0.9984115362167358
of O 1 0.9948668479919434
hemochromatosis B-Disease 1 1.0
. O 0 0.20903517305850983

If O 1 0.6021315455436707
untreated O 1 0.9999991655349731
, O 1 0.9990422129631042
hemochromatosis B-Disease 1 1.0
can O 1 0.9377926588058472
cause O 1 0.9999933242797852
serious O 1 0.9999970197677612
illness O 1 0.9999997615814209
and O 0 0.10520113259553909
early B-Disease 1 0.8337815403938293
death I-Disease 1 0.9607701301574707
, O 0 0.00014287147496361285
but O 0 5.786767724202946e-05
the O 0 0.0003725357528310269
disease O 1 0.9991587400436401
is O 0 0.00010668737377272919
still O 0 0.00014944658323656768
substantially O 0 0.0008493868517689407
under O 0 0.0018258907366544008
- O 1 0.9723745584487915
diagnosed O 1 0.9989829659461975
. O 0 0.0011570686474442482

The O 0 0.0032668921630829573
cornerstone O 0 0.3473300635814667
of O 0 0.001224264269694686
screening O 0 0.0005126027972437441
and O 0 0.00010146608838113025
case O 0 0.00017085715080611408
detection O 0 0.00030755769694224
is O 0 6.105576903792098e-05
the O 0 0.00010357837891206145
measurement O 0 0.0003015291295014322
of O 0 0.00038921055966056883
serum O 1 0.7930246591567993
transferrin O 1 0.7260417938232422
saturation O 0 0.0017833386082202196
and O 0 0.00018484816246200353
the O 0 0.000675036630127579
serum O 0 0.16005778312683105
ferritin O 1 0.6348465085029602
level O 0 0.0030929010827094316
. O 0 0.0013489529956132174

Once O 0 0.006728516425937414
the O 0 0.0023303173948079348
diagnosis O 0 0.2592065632343292
is O 0 0.0004756790294777602
suspected O 0 0.0018999801250174642
, O 0 0.00033593905391171575
physicians O 0 0.0003832030051853508
must O 0 0.00018873641965910792
use O 0 0.0002350932190893218
serum O 1 0.9485130906105042
ferritin O 1 0.9996839761734009
levels O 0 0.010970886796712875
and O 0 0.00062534463359043
hepatic O 1 0.9999582767486572
iron O 1 0.999997615814209
stores O 0 0.0019112416775897145
on O 0 0.002681632060557604
liver O 1 0.9991588592529297
biopsy O 0 0.053921882063150406
specimens O 0 0.00028885388746857643
to O 0 0.00010330937220714986
assess O 0 0.00033800877281464636
patients O 0 0.00011986938625341281
for O 0 6.49557841825299e-05
the O 0 0.00023221896844916046
presence O 0 0.000835804792586714
of O 0 0.29216834902763367
iron B-Disease 1 0.9999998807907104
overload I-Disease 1 0.9999982118606567
. O 0 0.0039320774376392365

Liver O 1 0.9999910593032837
biopsy O 1 0.9982942938804626
is O 0 0.0008285657386295497
also O 0 0.0001814021816244349
used O 0 7.817787263775244e-05
to O 0 4.116765921935439e-05
establish O 0 0.00011228858056711033
the O 0 0.00012705466360785067
presence O 0 0.0002801473892759532
or O 0 0.00016597751528024673
absence O 0 0.0007401394541375339
of O 0 0.16825802624225616
cirrhosis B-Disease 1 1.0
, O 0 0.013208519667387009
which O 0 0.000376916432287544
can O 0 0.00016552204033359885
affect O 0 0.000642533297650516
prognosis O 1 0.9860680103302002
and O 0 0.0005252808332443237
management O 0 0.002511960454285145
. O 0 0.0012349019525572658

A O 0 0.004315616097301245
DNA O 0 0.0013071544235572219
- O 0 0.0004691070644184947
based O 0 6.243630923563614e-05
test O 0 6.650861178059131e-05
for O 0 3.575503433239646e-05
the O 0 0.0002407498104730621
HFE O 1 0.9995757937431335
gene O 0 0.00018894387176260352
is O 0 5.653167318087071e-05
commercially O 0 9.256338671548292e-05
available O 0 1.5511674064327963e-05
, O 0 1.2942969988216646e-05
but O 0 6.4100331655936316e-06
its O 0 1.122487083193846e-05
place O 0 3.769664908759296e-05
in O 0 5.867821164429188e-05
the O 0 0.00026238110149279237
diagnosis O 0 0.49324849247932434
of O 1 0.9295164346694946
hemochromatosis B-Disease 1 1.0
is O 0 0.017192155122756958
still O 0 0.00044768975931219757
being O 0 0.0004067777772434056
evaluated O 0 0.0007985549164004624
. O 0 0.0005591324297711253

Currently O 0 0.0014807364204898477
, O 0 0.0003175381280016154
the O 0 0.00018552869732957333
most O 0 6.499655864899978e-05
useful O 0 6.762480916222557e-05
role O 0 0.00014231292880140245
for O 0 4.335850462666713e-05
this O 0 3.511294926283881e-05
test O 0 5.7273115089628845e-05
is O 0 2.292678618687205e-05
in O 0 3.265539635322057e-05
the O 0 0.0001268525084014982
detection O 0 0.0005917720845900476
of O 0 0.003879580879583955
hemochromatosis B-Disease 1 0.9999998807907104
in O 0 0.0002553215017542243
the O 0 0.0001864611986093223
family O 0 8.553665975341573e-05
members O 0 3.633851156337187e-05
of O 0 8.310149132739753e-05
patients O 0 9.225171379512176e-05
with O 0 3.5412333090789616e-05
a O 0 0.0001889759296318516
proven O 0 0.0025445662904530764
case O 0 0.0002487577439751476
of O 0 0.0009741603280417621
the O 1 0.6555150747299194
disease O 1 0.9999544620513916
. O 0 0.0011876317439600825

It O 0 0.0010115100303664804
is O 0 0.0005657939473167062
crucial O 0 0.0013749642530456185
to O 0 0.001995558850467205
diagnose O 1 0.9999985694885254
hemochromatosis B-Disease 1 1.0
before O 1 0.9999992847442627
hepatic B-Disease 1 1.0
cirrhosis I-Disease 1 1.0
develops O 1 0.9999984502792358
because O 1 0.9988435506820679
phlebotomy O 1 0.9999994039535522
therapy O 1 0.9999772310256958
can O 0 0.002383005805313587
avert O 1 0.9999940395355225
serious O 1 1.0
chronic O 1 1.0
disease O 1 1.0
and O 1 0.9967156648635864
can O 0 0.0002251557889394462
even O 0 0.00012821599375456572
lead O 0 0.00021553759870585054
to O 0 7.364244083873928e-05
normal O 0 0.00026743460330180824
life O 0 0.0006018358981236815
expectancy O 0 0.0011472227051854134
. O 0 0.0001921170187415555
. O 0 0.0004097376950085163

Prevalence O 0 0.007680496200919151
of O 0 0.0016809080261737108
the O 0 0.004416572395712137
I1307K O 1 0.9999288320541382
APC B-Disease 1 0.9997768998146057
gene O 0 0.0006460585282184184
variant O 0 0.0003983406350016594
in O 0 9.796414087759331e-05
Israeli O 0 0.00023541669361293316
Jews O 0 0.00014748857938684523
of O 0 8.576193067710847e-05
differing O 0 4.768887811223976e-05
ethnic O 0 7.720718713244423e-05
origin O 0 0.00012640836939681321
and O 0 0.0004758547293022275
risk O 1 0.8435125350952148
for O 1 0.9959986209869385
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.13606315851211548

BACKGROUND O 0 0.06474749743938446
& O 0 0.18962040543556213
AIMS O 0 0.005279164761304855
Israeli O 0 0.0017232905374839902
Jews O 0 0.0007596111972816288
of O 0 0.0004241375718265772
European O 0 0.0002563674352131784
birth O 0 0.0022151554003357887
, O 0 0.00017377728363499045
i O 0 0.00037029499071650207
. O 0 9.889927605399862e-05
e O 0 0.000145482670632191
. O 0 4.4831442210124806e-05
, O 0 8.504088327754289e-05
Ashkenazim O 0 0.001008251798339188
, O 0 0.00010626751463860273
have O 0 5.8734192862175405e-05
the O 0 0.000632821989711374
highest O 1 0.9999313354492188
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
incidence O 1 0.9994530081748962
of O 0 0.005260834936052561
any O 0 0.00020678789587691426
Israeli O 0 0.0006883358000777662
ethnic O 0 0.0002891123294830322
group O 0 0.00033917726250365376
. O 0 0.00036055530654266477

The O 0 0.010920137166976929
I1307K O 1 0.9979795813560486
APC B-Disease 1 0.9969555139541626
gene O 0 0.0020960732363164425
variant O 0 0.001343936542980373
was O 0 0.0009614831069484353
found O 0 0.00017605519678909332
in O 0 0.00022832414833828807
6 O 0 0.0010558617068454623
. O 0 0.0006846804171800613

1 O 0 0.0009976631263270974
% O 0 0.00018345541320741177
of O 0 0.0001811014662962407
American O 0 0.0002160037838621065
Jews O 0 0.00023056429927237332
, O 0 5.269286339171231e-05
28 O 0 0.00014951043704058975
% O 0 5.4446980357170105e-05
of O 0 0.00021141112665645778
their O 0 0.0005670164828188717
familial O 1 0.9999998807907104
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
cases O 1 0.9400082230567932
, O 0 0.00025433360133320093
but O 0 4.931012517772615e-05
not O 0 3.4498440072638914e-05
in O 0 8.221522148232907e-05
non O 0 0.0002666621294338256
- O 0 0.0004907056572847068
Jews O 0 0.00077129399869591
. O 0 0.0005580561701208353

We O 0 0.002195201814174652
assessed O 0 0.0016221953555941582
the O 0 0.000744469347409904
I1307K O 1 0.7609754204750061
prevalence O 0 0.0013845578068867326
in O 0 0.00010101582302013412
Israeli O 0 0.0002872947370633483
Jews O 0 0.00017673501861281693
of O 0 8.924433495849371e-05
differing O 0 4.007355164503679e-05
ethnic O 0 9.393837535753846e-05
origin O 0 0.0001978069922188297
and O 0 0.00035857129842042923
risk O 1 0.8636376261711121
for O 1 0.9978545308113098
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.04238317161798477

METHODS O 0 0.003099928144365549
DNA O 0 0.0008947188034653664
samples O 0 0.00020611647050827742
from O 0 0.00014402154192794114
500 O 0 0.0003420363937038928
unrelated O 0 0.00018792548507917672
Jews O 0 0.00017987236788030714
of O 0 0.0001272129884455353
European O 0 8.248221274698153e-05
or O 0 8.714143768884242e-05
non O 0 0.00018533544789534062
- O 0 0.00011736178566934541
European O 0 2.892889460781589e-05
origin O 0 4.109026849619113e-05
, O 0 2.7612313715508208e-05
with O 0 1.5008192349341698e-05
or O 0 3.59761506842915e-05
without O 0 3.8136258808663115e-05
a O 0 0.00010723404557211325
personal O 0 0.0002865722344722599
and O 0 0.00015838787658140063
/ O 0 0.0011808060808107257
or O 0 9.670261351857334e-05
family O 0 0.00012096019781893119
history O 0 0.00023852648155298084
of O 0 0.0012043598107993603
neoplasia B-Disease 1 0.9999185800552368
, O 0 0.00012366031296551228
were O 0 6.050761294318363e-05
examined O 0 0.00012964135385118425
for O 0 5.993140075588599e-05
the O 0 0.0001478541234973818
I1307K O 0 0.19842258095741272
variant O 0 0.0002669582609087229
by O 0 4.5944281737320125e-05
the O 0 0.00013451233098749071
allele O 0 0.00013921118807047606
- O 0 0.00021572632249444723
specific O 0 0.00011216573329875246
oligonucleotide O 0 0.0019222870469093323
( O 0 0.000546822149772197
ASO O 1 0.9203587770462036
) O 0 0.00046503549674525857
method O 0 0.000548464129678905
. O 0 0.0007309256470762193

RESULTS O 0 0.002205316675826907
In O 0 0.00047228747280314565
persons O 0 0.0003348817699588835
at O 0 0.000763812568038702
average O 0 0.0006802112911827862
risk O 0 0.002112548565492034
for O 0 0.09867865592241287
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 0.022213570773601532
I1307K O 1 0.9997590184211731
was O 0 0.004209859296679497
found O 0 0.00012681985390372574
in O 0 0.00016675848746672273
5 O 0 0.00040976039599627256
. O 0 0.0004658442921936512

0 O 0 0.0009163827053271234
% O 0 0.00028206605929881334
of O 0 0.0003188607806805521
120 O 0 0.0005404840339906514
European O 0 0.0002982949954457581
and O 0 0.0002851052850019187
1 O 0 0.0008764704689383507
. O 0 0.0008907552692107856

6 O 0 0.001987059134989977
% O 0 0.0002654532145243138
of O 0 0.0002957089163828641
188 O 0 0.0010335181141272187
non O 0 0.00042401268729008734
- O 0 0.0003006799961440265
European O 0 0.00010778612340800464
Jews O 0 0.00017935688083525747
( O 0 0.00011442814866313711
P O 0 0.0009677785565145314
= O 0 0.0003171372809447348
0 O 0 0.0001704960159258917
. O 0 0.00012537337897811085
08 O 0 0.0017516418593004346
) O 0 0.00039856473449617624
. O 0 0.000496621651109308

It O 0 0.001176719437353313
occurred O 0 0.0031403466127812862
in O 0 0.00041993721970357
15 O 0 0.0007947853300720453
. O 0 0.0011404509423300624

4 O 0 0.001184543943963945
% O 0 0.00018583251221571118
of O 0 0.00029074595659039915
52 O 0 0.0004979317891411483
Ashkenazi O 0 0.0010678920662030578
Israelis O 0 0.0006696901982650161
with O 0 0.0002643590560182929
familial O 1 0.9991952776908875
cancer B-Disease 1 0.9999620914459229
( O 0 0.0020657444838434458
P O 0 0.37220683693885803
= O 0 0.0006150302942842245
0 O 0 0.00018645086674951017
. O 0 8.605569746578112e-05
02 O 0 0.0014858100330457091
) O 0 8.483335113851354e-05
and O 0 6.970711547182873e-05
was O 0 0.00019193558546248823
not O 0 3.2256375561701134e-05
detected O 0 0.000114865877549164
in O 0 6.65233310428448e-05
51 O 0 0.00029739143792539835
non O 0 0.00029537250520661473
- O 0 0.0003373262588866055
European O 0 0.0001210064729093574
Jews O 0 0.00045849295565858483
at O 0 0.006768741179257631
increased O 0 0.060177993029356
cancer B-Disease 1 0.9990442395210266
risk O 0 0.001888805185444653
. O 0 0.0008150502108037472

Colorectal B-Disease 1 0.9999972581863403
neoplasia I-Disease 1 0.999992847442627
occurred O 1 0.998636782169342
personally O 0 0.008738958276808262
or O 0 0.00020074754138477147
in O 0 7.793663098709658e-05
the O 0 8.253524720203131e-05
families O 0 3.4598106140038e-05
of O 0 7.876544259488583e-05
13 O 0 0.00011897536023752764
of O 0 0.00013470345584210008
20 O 0 0.00029318692395463586
Ashkenazi O 0 0.0014369990676641464
I1307K O 0 0.24907822906970978
carriers O 0 0.00022109593555796891
, O 0 6.118778401287273e-05
8 O 0 0.00010663457214832306
of O 0 0.00010066752292914316
whom O 0 0.00011797497427323833
also O 0 5.4299049224937335e-05
had O 0 0.00010806108912220225
a O 0 0.00017152295913547277
personal O 0 0.0003364474105183035
or O 0 0.00016682335990481079
family O 0 0.00046710314927622676
history O 0 0.0020878957584500313
of O 0 0.43487581610679626
noncolonic O 1 0.9999899864196777
neoplasia B-Disease 1 0.9999409914016724
. O 0 0.0031895150896161795

CONCLUSIONS O 0 0.008799448609352112
The O 0 0.004672696813941002
I1307K O 1 0.9989563226699829
APC O 1 0.9989857077598572
variant O 0 0.003999166656285524
may O 0 0.0002696456795092672
represent O 0 0.00023673679970670491
a O 0 0.00043471253593452275
susceptibility O 0 0.048958197236061096
gene O 0 0.0006586154922842979
for O 0 0.000601711159106344
colorectal B-Disease 1 0.9999995231628418
, I-Disease 0 0.00031724522705189884
or I-Disease 0 0.0001577501680003479
other I-Disease 0 9.910263906931505e-05
, I-Disease 0 0.00034033897100016475
cancers I-Disease 0 0.26197490096092224
in O 0 0.00016126139962580055
Ashkenazi O 0 0.004367610905319452
Jews O 0 0.0005751692224293947
, O 0 0.00010976796329487115
and O 0 9.009445057017729e-05
partially O 0 0.0004869163385592401
explains O 0 0.00028040207689628005
the O 0 0.00020895260968245566
higher O 0 0.00063535594381392
incidence O 1 0.9985228180885315
of O 1 0.9999759197235107
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
in O 0 0.0015668455744162202
European O 0 0.0005545559688471258
Israelis O 0 0.0012722694082185626
. O 0 0.0005644390475936234

Systematic O 0 0.004537238273769617
analysis O 0 0.000934845011215657
of O 0 0.00545413326472044
coproporphyrinogen O 1 0.9999895095825195
oxidase O 1 0.999626636505127
gene O 0 0.30304065346717834
defects O 1 0.9998282194137573
in O 0 0.0018328531878069043
hereditary B-Disease 1 0.9999905824661255
coproporphyria I-Disease 1 0.999997615814209
and O 0 0.10656172782182693
mutation O 0 0.004763615783303976
update O 0 0.002869952004402876
. O 0 0.0008287035743705928

Hereditary B-Disease 1 0.9999678134918213
coproporphyria I-Disease 1 0.9999943971633911
( O 1 0.9504474997520447
HC B-Disease 1 0.9999960660934448
) O 0 0.0035861367359757423
is O 0 0.0014127269387245178
an O 0 0.3943042457103729
acute O 1 1.0
hepatic B-Disease 1 1.0
porphyria I-Disease 1 1.0
with O 1 0.9996283054351807
autosomal O 1 0.9999767541885376
dominant O 1 0.9999828338623047
inheritance O 1 0.9999421834945679
caused O 1 0.9999912977218628
by O 0 0.0016241664998233318
deficient B-Disease 1 0.9337202310562134
activity I-Disease 0 0.0006952271796762943
of I-Disease 0 0.004481878597289324
coproporphyrinogen I-Disease 1 0.9999841451644897
III I-Disease 1 0.999997615814209
oxidase I-Disease 1 0.9769342541694641
( O 0 0.0015803499845787883
CPO O 0 0.02797524817287922
) O 0 0.0005442986148409545
. O 0 0.0005477890954352915

Clinical O 0 0.014504008926451206
manifestations O 1 0.8856058120727539
of O 1 0.8480223417282104
the O 1 0.999927282333374
disease O 1 0.9999998807907104
are O 0 0.00013090568245388567
characterized O 1 0.6147727966308594
by O 0 0.0010628565214574337
acute O 1 0.9999990463256836
attacks O 1 0.9993013143539429
of O 1 0.9999985694885254
neurological B-Disease 1 1.0
dysfunction I-Disease 1 1.0
often O 1 0.9964543581008911
precipitated O 1 0.9999978542327881
by O 0 0.001752002164721489
drugs O 0 0.008193093352019787
, O 0 0.00035947145079262555
fasting O 0 0.0026381597854197025
, O 0 0.000506014097481966
cyclical O 1 0.9622065424919128
hormonal O 1 0.9979372024536133
changes O 0 0.0015260179061442614
, O 0 0.004544009920209646
or O 1 0.9445015788078308
infectious B-Disease 1 0.9999996423721313
diseases I-Disease 1 0.9999990463256836
. O 0 0.010544279590249062

Skin O 1 0.9999991655349731
photosensitivity O 1 0.9999958276748657
may O 0 0.13812175393104553
also O 0 0.00041916692862287164
be O 0 0.00028737119282595813
present O 0 0.0006104077911004424
. O 0 0.0007975525804795325

The O 0 0.002262466587126255
seven O 0 0.0012232628650963306
exons O 0 0.002296829828992486
, O 0 0.00033269429695792496
the O 0 0.00045884159044362605
exon O 0 0.003977714106440544
/ O 0 0.0011115019442513585
intron O 0 0.0014723206404596567
boundaries O 0 0.00012616538151632994
and O 0 5.8420817367732525e-05
part O 0 0.00011271941912127659
of O 0 0.00013062584912404418
3 O 0 0.00014632102102041245
noncoding O 0 0.0002906935987994075
sequence O 0 7.279613782884553e-05
of O 0 0.00012280883674975485
the O 0 0.0002979638520628214
CPO O 0 0.005015335511416197
gene O 0 7.17719885869883e-05
were O 0 3.06224828818813e-05
systematically O 0 0.00010928242409136146
analyzed O 0 3.8338341255439445e-05
by O 0 2.2753945813747123e-05
an O 0 6.751636101398617e-05
exon O 0 0.0010370081290602684
- O 0 0.00036712639848701656
by O 0 0.00014358673070091754
- O 0 0.000854159239679575
exon O 0 0.0033467933535575867
denaturing O 0 0.016842244192957878
gradient O 0 0.04961620643734932
gel O 0 0.1869334578514099
electrophoresis O 0 0.011270706541836262
( O 0 0.0011591347865760326
DGGE O 1 0.9866932034492493
) O 0 0.00019166125275660306
strategy O 0 0.00026950432220473886
followed O 0 0.00016248569590970874
by O 0 4.199864633847028e-05
direct O 0 6.285400741035119e-05
sequencing O 0 0.00013764570758212358
in O 0 7.069156708894297e-05
seven O 0 0.00020466979185584933
unrelated O 0 0.0005952172796241939
heterozygous O 0 0.0008558370172977448
HC B-Disease 1 0.9999667406082153
patients O 0 0.005994110833853483
from O 0 0.0004460928903426975
France O 0 0.001247658277861774
, O 0 0.00020836052135564387
Holland O 0 0.0010640419786795974
, O 0 0.00012350110046099871
and O 0 8.400325168622658e-05
Czech O 0 0.0016440581530332565
Republic O 0 0.0017640463775023818
. O 0 0.0011611483059823513

Seven O 0 0.0033826190046966076
novel O 0 0.0019992950838059187
mutations O 0 0.00024443454458378255
and O 0 0.00013003555068280548
two O 0 8.530483319191262e-05
new O 0 0.0002734311274252832
polymorphisms O 0 0.0013422787887975574
were O 0 0.00038274863618426025
detected O 0 0.0020019912626594305
. O 0 0.0007990672020241618

Among O 0 0.0011303297942504287
these O 0 0.000161560601554811
mutations O 0 0.00012927076022606343
two O 0 4.093278039363213e-05
are O 0 3.3959888241952285e-05
missense O 0 0.0008923803688958287
( O 0 0.00041974728810600936
G197W O 1 0.9956177473068237
, O 0 0.0003632318403106183
W427R O 1 0.6885055899620056
) O 0 0.00011661893950076774
, O 0 5.477762533701025e-05
two O 0 2.721505552472081e-05
are O 0 2.1009005649830215e-05
nonsense O 0 0.0007702139555476606
( O 0 0.00035992104676552117
Q306X O 1 0.9403446912765503
, O 0 0.0002555304381530732
Q385X O 1 0.618121325969696
) O 0 0.00011491868644952774
, O 0 4.310388976591639e-05
two O 0 2.937144563475158e-05
are O 0 1.80070310307201e-05
small O 0 8.349245763383806e-05
deletions O 0 0.0004991543246433139
( O 0 0.0002826470008585602
662de14bp O 0 0.08836627751588821
; O 0 0.00013725971803069115
1168del3bp O 0 0.0047007338143885136
removing O 0 0.0006930084782652557
a O 0 0.0001627710007596761
glycine O 0 0.0003033566172234714
at O 0 0.0001561743556521833
position O 0 0.00018416559032630175
390 O 0 0.0005169766955077648
) O 0 5.165886250324547e-05
, O 0 3.219012432964519e-05
and O 0 2.830929952324368e-05
one O 0 2.7856172891915776e-05
is O 0 3.515616845106706e-05
a O 0 0.0001229961053468287
splicing O 0 0.000552742276340723
mutation O 0 0.0003104305069427937
( O 0 0.00027771148597821593
IVS1 O 1 0.9967435598373413
- O 0 0.0018176981247961521
15c O 0 0.01239027176052332
- O 0 0.0014232071116566658
- O 0 0.0009815908269956708
> O 0 0.0008167856140062213
g O 0 0.0003532410191837698
) O 0 6.234944885363802e-05
which O 0 3.8530404708581045e-05
creates O 0 0.00016515140305273235
a O 0 0.00014801281213294715
new O 0 0.0001724787725834176
acceptor O 0 0.0010535325855016708
splice O 0 0.0041729360818862915
site O 0 0.002647669753059745
. O 0 0.0011841593077406287

The O 0 0.0029871980659663677
pathological O 0 0.005339195020496845
significance O 0 0.0014078436652198434
of O 0 0.0005874987691640854
the O 0 0.0004953113384544849
point O 0 0.0010935880709439516
mutations O 0 0.0003243402752559632
G197W O 1 0.9553767442703247
, O 0 0.0002136018156306818
W427R O 0 0.25475525856018066
, O 0 8.230402454501018e-05
and O 0 5.824875188409351e-05
the O 0 0.00012290490849409252
in O 0 0.0001969518489204347
- O 0 0.0007393519626930356
frame O 0 0.001955644926056266
deletion O 0 0.0011860996019095182
390delGly O 0 0.013564905151724815
were O 0 0.00013373972615227103
assessed O 0 0.00014274237037170678
by O 0 2.5543458832544275e-05
their O 0 2.362025588809047e-05
respective O 0 9.20134480111301e-05
expression O 0 9.835577657213435e-05
in O 0 7.350626401603222e-05
a O 0 0.00017976023082155734
prokaryotic O 0 0.0005237372242845595
system O 0 0.00014877009380143136
using O 0 0.00010521172953303903
site O 0 0.0005989769124425948
- O 0 0.0008360700448974967
directed O 0 0.0006194291054271162
mutagenesis O 0 0.002940382109954953
. O 0 0.0007446439121849835

These O 0 0.0009394703083671629
mutations O 0 0.0006021893350407481
resulted O 0 0.0007483252556994557
in O 0 0.00018195234588347375
the O 0 0.00024574995040893555
absence O 0 0.0006641278741881251
or O 0 9.808555478230119e-05
a O 0 0.00022809658548794687
dramatic O 0 0.0009805808076635003
decrease O 0 0.000583488610573113
of O 0 0.0008228886872529984
CPO O 1 0.8313785791397095
activity O 0 0.0011695291614159942
. O 0 0.00046874789404682815

The O 0 0.0017885444685816765
two O 0 0.000376207783119753
polymorphisms O 0 0.0008097876561805606
were O 0 0.00014813055167905986
localized O 0 0.0003698745567817241
in O 0 0.00010922805086011067
noncoding O 0 0.00025893421843647957
part O 0 8.407248969888315e-05
of O 0 8.036471990635619e-05
the O 0 7.86776072345674e-05
gene O 0 6.319429667200893e-05
1 O 0 5.984408198855817e-05
) O 0 3.096996806561947e-05
a O 0 0.0001184572174679488
C O 0 0.0004509238642640412
/ O 0 0.0004506234254222363
G O 0 0.0008140841964632273
polymorphism O 0 0.0002469810133334249
in O 0 0.00011062235716963187
the O 0 0.00030544615583494306
promotor O 0 0.008005818352103233
region O 0 0.000499606248922646
, O 0 0.00017471134196966887
142 O 0 0.0008540900307707489
bp O 0 0.0012069821823388338
upstream O 0 0.00042181950993835926
from O 0 0.00012218310439493507
the O 0 0.00017296196892857552
transcriptional O 0 0.0006319778622128069
initiation O 0 0.0013698694529011846
site O 0 0.0006810457562096417
( O 0 0.0002732252178248018
- O 0 0.0007537818746641278
142C O 0 0.21206791698932648
/ O 0 0.001972030848264694
G O 0 0.0015578365419059992
) O 0 5.512065035873093e-05
, O 0 3.957490480388515e-05
and O 0 2.8423672119970433e-05
2 O 0 4.490237552090548e-05
) O 0 1.906281067931559e-05
a O 0 6.495689740404487e-05
6 O 0 0.00019102849182672799
bp O 0 0.0008017354994080961
deletion O 0 0.00024206015223171562
polymorphism O 0 0.00010600559471640736
in O 0 4.564739720080979e-05
the O 0 0.00010092453885590658
3 O 0 0.00017234659753739834
noncoding O 0 0.0004009622207377106
part O 0 0.00014977797400206327
of O 0 0.00013632381160277873
the O 0 0.00036868680035695434
CPO O 0 0.10238974541425705
gene O 0 0.0002039618557319045
, O 0 0.00010763513273559511
574 O 0 0.0010156763019040227
bp O 0 0.0007086282130330801
downstream O 0 0.00021407197345979512
of O 0 6.793790817027912e-05
the O 0 7.133270992198959e-05
last O 0 8.703397907083854e-05
base O 0 0.00014856824418529868
of O 0 0.00012202602374600247
the O 0 0.00020919241069350392
normal O 0 0.0003285350976511836
termination O 0 0.0011191138764843345
codon O 0 0.0012119399616494775
( O 0 0.0004555294872261584
+ O 0 0.001326937461271882
574 O 0 0.0070992643013596535
delATTCTT O 0 0.049271319061517715
) O 0 0.0006724685081280768
. O 0 0.000777214125264436

Five O 0 0.009909715503454208
intragenic O 1 0.9995349645614624
dimorphisms O 1 0.9973486661911011
are O 0 0.00018429997726343572
now O 0 0.0002561553556006402
well O 0 0.00012928407522849739
characterized O 0 0.00031031243270263076
and O 0 8.69260766194202e-05
the O 0 0.0001825266663217917
high O 0 0.0003407465701457113
degree O 0 0.0002032156626228243
of O 0 0.00025872892001643777
allelic O 0 0.028533149510622025
heterogeneity O 0 0.002868042327463627
in O 0 0.0004068349953740835
HC B-Disease 1 0.9999727010726929
is O 0 0.0002355195174459368
demonstrated O 0 0.00027629538089968264
with O 0 2.6854784664465114e-05
seven O 0 6.05213463131804e-05
new O 0 2.8027936423313804e-05
different O 0 1.1853070645884145e-05
mutations O 0 2.9069906304357573e-05
making O 0 3.787732930504717e-05
a O 0 4.6931654651416466e-05
total O 0 7.382927287835628e-05
of O 0 0.00022263338905759156
nineteen O 0 0.0063534090295434
CPO O 1 0.9991531372070312
gene B-Disease 0 0.003951319493353367
defects I-Disease 1 0.9976028800010681
reported O 0 0.0002387485292274505
so O 0 9.129658428719267e-05
far O 0 0.00015566973888780922
. O 0 0.00016505946405231953
. O 0 0.0003385082527529448

Coincidence O 0 0.006847888231277466
of O 0 0.001327333739027381
two O 0 0.0004888189723715186
novel O 0 0.0022286877501755953
arylsulfatase O 0 0.447438508272171
A O 0 0.0023517634253948927
alleles O 0 0.000840731430798769
and O 0 0.0003756043442990631
mutation O 0 0.000641208840534091
459 O 0 0.01176249049603939
+ O 0 0.0031831928063184023
1G O 0 0.17303748428821564
> O 0 0.0008010077872313559
A O 0 0.0003410071658436209
within O 0 0.0001323778269579634
a O 0 0.00017234199913218617
family O 0 0.0002671670517884195
with O 0 0.00040334791992790997
metachromatic B-Disease 1 0.9999970197677612
leukodystrophy I-Disease 1 0.9999915361404419
: O 0 0.00043128622928634286
molecular O 0 0.00029751393594779074
basis O 0 0.00012980883184354752
of O 0 0.000404516002163291
phenotypic O 0 0.0030253054574131966
heterogeneity O 0 0.004779902286827564
. O 0 0.0008466815343126655

In O 0 0.0013619245728477836
a O 0 0.0006654057651758194
family O 0 0.0003629372513387352
with O 0 9.015891555463895e-05
three O 0 0.0001244460145244375
siblings O 0 0.000635959324426949
, O 0 0.00010937937622657046
one O 0 0.00011913327034562826
developed O 0 0.00044439686462283134
classical O 0 0.0016628671437501907
late O 1 0.8800941109657288
infantile O 1 0.9999990463256836
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 0.9999998807907104
( O 1 0.7089405059814453
MLD B-Disease 1 0.9999977350234985
) O 0 0.00028512917924672365
, O 0 0.00012741549289785326
fatal O 0 0.05016100034117699
at O 0 0.0003524149360600859
age O 0 0.00021419243421405554
5 O 0 0.00013649214815814048
years O 0 9.121340553974733e-05
, O 0 6.23261439613998e-05
with O 0 9.188507829094306e-05
deficient O 1 0.6303618550300598
arylsulfatase O 1 0.9984496831893921
A O 0 0.3015403747558594
( O 0 0.000678280892316252
ARSA O 1 0.9818159341812134
) O 0 0.00011517364328028634
activity O 0 0.00019156478811055422
and O 0 0.00011775177699746564
increased O 0 0.0004745151672977954
galactosylsulfatide O 1 0.9985384941101074
( O 0 0.006816990673542023
GS O 1 0.9999912977218628
) O 0 0.0012229379499331117
excretion O 0 0.004702380392700434
. O 0 0.0008221931057050824

The O 0 0.0016150468727573752
two O 0 0.00020363149815239012
other O 0 0.0001258772099390626
siblings O 0 0.0004835374129470438
, O 0 0.00014839775394648314
apparently O 0 0.00033833857742138207
healthy O 0 0.00017223783652298152
at O 0 0.00014299740723799914
12 O 0 9.680548100732267e-05
( O 0 4.7171979531412944e-05
1 O 0 0.00011146246833959594
/ O 0 0.00020063231931999326
2 O 0 5.8059256843989715e-05
) O 0 2.465848228894174e-05
and O 0 1.895426248665899e-05
15 O 0 3.9652873965678737e-05
years O 0 4.8649868404027075e-05
, O 0 4.81709030282218e-05
respectively O 0 7.226818706840277e-05
, O 0 3.976094740210101e-05
and O 0 3.5866087273461744e-05
their O 0 3.9482816646341234e-05
father O 0 0.0018657714826986194
, O 0 0.00020675220002885908
apparently O 0 0.00046503415796905756
healthy O 0 0.0004353208641987294
as O 0 0.00013004595530219376
well O 0 0.00010588809527689591
, O 0 9.146686352323741e-05
presented O 0 0.0006319297244772315
ARSA O 1 0.9975191354751587
and O 0 0.0005398919456638396
GS O 1 0.9996639490127563
values O 0 0.0001637689274502918
within O 0 9.936549759004265e-05
the O 0 0.00018180460028816015
range O 0 0.0003237758355680853
of O 0 0.00193622091319412
MLD B-Disease 1 0.9999988079071045
patients O 0 0.042919378727674484
. O 0 0.0013787299394607544

Mutation O 0 0.003173572476953268
screening O 0 0.0007582543767057359
and O 0 0.00013721693539991975
sequence O 0 0.00017422855307813734
analysis O 0 0.0001011982312775217
disclosed O 0 0.00026044182595796883
the O 0 0.0001053451414918527
involvement O 0 0.00027909036725759506
of O 0 0.00016105317627079785
three O 0 0.0001169364113593474
different O 0 9.550858521834016e-05
ARSA O 1 0.9977523684501648
mutations O 0 0.0001568707375554368
being O 0 9.646802936913446e-05
the O 0 9.920938464347273e-05
molecular O 0 0.0002025749272434041
basis O 0 0.00014319281035568565
of O 0 0.0006743813282810152
intrafamilial O 1 0.9069138169288635
phenotypic O 0 0.006851919926702976
heterogeneity O 0 0.00929649081081152
. O 0 0.0022871773689985275

The O 0 0.0072130546905100346
late O 1 0.7336203455924988
infantile O 1 0.9999881982803345
patient O 1 0.9761180281639099
inherited O 1 0.9997426867485046
from O 0 0.0010905348462983966
his O 0 0.0016310317441821098
mother O 0 0.0007817723671905696
the O 0 0.0002075962838716805
frequent O 0 0.00018800543330144137
0 O 0 0.00023431135923601687
- O 0 0.0005100138951092958
type O 0 0.0003322996781207621
mutation O 0 0.00026269775116816163
459 O 0 0.0032390037085860968
+ O 0 0.0018682382069528103
1G O 0 0.05662400647997856
> O 0 0.0005748480907641351
A O 0 0.0004022688663098961
, O 0 4.895983511232771e-05
and O 0 3.661047958303243e-05
from O 0 6.950162787688896e-05
his O 0 0.0002039626269834116
father O 0 0.0005802266532555223
a O 0 0.00029024886316619813
novel O 0 0.0003944417694583535
, O 0 0.00012209423584863544
single O 0 0.00022474999423138797
basepair O 0 0.004702641628682613
microdeletion O 0 0.002562045119702816
of O 0 0.00023740473261568695
guanine O 0 0.0005515223601832986
at O 0 0.00021761786774732172
nucleotide O 0 0.00019833883561659604
7 O 0 0.00014238811854738742
in O 0 7.103565440047532e-05
exon O 0 0.0009707955177873373
1 O 0 0.00042213546112179756
( O 0 0.0004631791962310672
7delG O 0 0.010620173998177052
) O 0 0.0005220023449510336
. O 0 0.0006692269234918058

The O 0 0.00323387049138546
two O 0 0.0011154265375807881
clinically O 0 0.46384918689727783
unaffected O 0 0.005548832938075066
siblings O 0 0.0012887095799669623
carried O 0 0.000748859194573015
the O 0 0.0008235096465796232
maternal O 0 0.004500288981944323
mutation O 0 0.0011445791460573673
459 O 0 0.041687577962875366
+ O 0 0.004802399314939976
1G O 0 0.3923357129096985
> O 0 0.0007105055265128613
A O 0 0.0003844058373942971
and O 0 5.677792432834394e-05
, O 0 3.713949627126567e-05
on O 0 4.599627209245227e-05
their O 0 4.510924918577075e-05
paternal O 0 0.0004152482724748552
allele O 0 0.0001368910016026348
, O 0 5.5209129641298205e-05
a O 0 0.00011577727855183184
novel O 0 0.0002517055836506188
cytosine O 0 0.0003263878170400858
to O 0 7.536203338531777e-05
thymidine O 0 0.0005505743320100009
transition O 0 0.0006814193911850452
at O 0 0.0003579121839720756
nucleotide O 0 0.0005157619598321617
2435 O 0 0.006136759649962187
in O 0 0.0002086471940856427
exon O 0 0.001052763545885682
8 O 0 0.00030282814987003803
, O 0 0.00012072167737642303
resulting O 0 0.0001553746114950627
in O 0 8.281827467726544e-05
substitution O 0 0.00024544436018913984
of O 0 0.0002992612135130912
alanine O 0 0.0011619653087109327
464 O 0 0.005704449024051428
by O 0 0.00044848868856206536
valine O 0 0.028604302555322647
( O 0 0.0013062533689662814
A464V O 0 0.3953343331813812
) O 0 0.0006931748939678073
. O 0 0.0008233410189859569

The O 0 0.003884469158947468
fathers O 0 0.00486788572743535
genotype O 0 0.003106040647253394
thus O 0 0.0012541403993964195
was O 0 0.010466092266142368
7delG O 1 0.999006450176239
/ O 1 0.7385250329971313
A464V O 1 0.9936296343803406
. O 0 0.0024005554150789976

Mutation O 0 0.015952369198203087
A464V O 1 0.9292952418327332
was O 0 0.0016368234064429998
not O 0 0.00010265575110679492
found O 0 0.00011368530977051705
in O 0 0.00017020558880176395
18 O 0 0.0010280846618115902
unrelated O 0 0.3184407651424408
MLD B-Disease 1 0.9999994039535522
patients O 0 0.00357434363104403
and O 0 0.00035678825224749744
50 O 0 0.0008732129354029894
controls O 0 0.0009230354917235672
. O 0 0.0005240468890406191

A464V O 1 0.9886273741722107
, O 0 0.0018877014517784119
although O 0 0.0008505786536261439
clearly O 0 0.0014375252649188042
modifying O 0 0.0052130878902971745
ARSA O 1 0.9999048709869385
and O 0 0.020399389788508415
GS O 1 0.999998927116394
levels O 0 0.003134464845061302
, O 0 0.00015503409667871892
apparently O 0 0.00024475730606354773
bears O 0 0.00027036803658120334
little O 0 0.00019933607836719602
significance O 0 0.00030062836594879627
for O 0 0.0001341573806712404
clinical O 0 0.0014465275453403592
manifestation O 1 0.9997561573982239
of O 1 0.9980989098548889
MLD B-Disease 1 0.9999998807907104
, O 0 0.00159975525457412
mimicking O 0 0.006136405281722546
the O 0 0.0010599353117868304
frequent O 0 0.0029679210856556892
ARSA O 1 0.9996213912963867
pseudodeficiency O 1 0.9965037107467651
allele O 0 0.005386334378272295
. O 0 0.0015267243143171072

Our O 0 0.002474240493029356
results O 0 0.0005559140117838979
demonstrate O 0 0.00042260371265001595
that O 0 7.47329686419107e-05
in O 0 0.00012587913079187274
certain O 0 0.00018082986935041845
genetic O 0 0.0012656376929953694
conditions O 1 0.98527991771698
MLD B-Disease 1 1.0
- O 1 0.9992462396621704
like O 0 0.005659038666635752
ARSA O 1 0.999687910079956
and O 0 0.000722810800652951
GS O 1 0.9999257326126099
values O 0 0.000171759762451984
need O 0 6.973677955102175e-05
not O 0 2.943119761766866e-05
be O 0 3.091287726419978e-05
paralleled O 0 0.0004712750087492168
by O 0 0.000184946897206828
clinical O 1 0.5498324036598206
disease O 1 0.9999802112579346
, O 0 0.00022424310736823827
a O 0 0.0002686500665731728
finding O 0 0.0002723009674809873
with O 0 0.0001990978780668229
serious O 1 0.9837391376495361
diagnostic O 1 0.7247382998466492
and O 0 0.001559306401759386
prognostic O 1 0.998954176902771
implications O 0 0.018769890069961548
. O 0 0.0014117627870291471

Moreover O 0 0.006423112936317921
, O 0 0.0012836018577218056
further O 0 0.0015802551060914993
ARSA O 1 0.9949512481689453
alleles O 0 0.0009211935102939606
functionally O 0 0.001294260728172958
similar O 0 0.00016241379489656538
to O 0 0.0001376678847009316
A464V O 1 0.9499053955078125
might O 0 0.00018423495930619538
exist O 0 7.47278390917927e-05
which O 0 3.172560900566168e-05
, O 0 2.6888508728006855e-05
together O 0 3.39092111971695e-05
with O 0 3.5329223464941606e-05
0 O 0 0.00017400378419551998
- O 0 0.0006709391018375754
type O 0 0.0005184497567825019
mutations O 0 0.00023671763483434916
, O 0 0.00013772606325801462
may O 0 0.00036649376852437854
cause O 1 0.8203869462013245
pathological O 1 0.9999886751174927
ARSA O 1 0.9999996423721313
and O 1 0.9622097611427307
GS O 1 1.0
levels O 0 0.00583325931802392
, O 0 9.808649338083342e-05
but O 0 2.9145301596145146e-05
not O 0 2.0067689547431655e-05
clinical O 0 0.00020499477977864444
outbreak O 0 0.23744331300258636
of O 0 0.062190942466259
the O 1 0.999139666557312
disease O 1 0.9999986886978149
. O 0 0.0006825909949839115
. O 0 0.0007366600912064314

Human O 1 0.9996570348739624
MLH1 O 1 0.9999990463256836
deficiency O 1 1.0
predisposes O 1 0.9999566078186035
to O 1 0.5754982233047485
hematological B-Disease 1 0.999998927116394
malignancy I-Disease 1 0.9999998807907104
and O 1 0.9911671280860901
neurofibromatosis B-Disease 1 0.9999997615814209
type I-Disease 1 0.9988483190536499
1 I-Disease 0 0.03603203222155571
. O 0 0.0012797681847587228

Heterozygous O 0 0.015331053175032139
germ O 1 0.9993382096290588
- O 0 0.012667221017181873
line O 0 0.0014524947619065642
mutations O 0 0.00019353583047632128
in O 0 0.00014178710989654064
the O 0 0.0003232620074413717
DNA O 0 0.0026043083053082228
mismatch O 1 0.9997732043266296
repair O 1 0.9998075366020203
genes O 0 0.0007907339604571462
lead O 0 0.001744424575008452
to O 0 0.0011487441370263696
hereditary B-Disease 1 0.9999996423721313
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.038421109318733215

The O 1 0.9380544424057007
disease O 1 0.9999948740005493
susceptibility O 1 0.8848596215248108
of O 0 0.21068225800991058
individuals O 0 0.00032587326131761074
who O 0 0.0006301722605712712
constitutionally O 0 0.0011450136080384254
lack O 0 0.0005579082062467933
both O 0 0.00012659982894547284
wild O 0 0.0008581733563914895
- O 0 0.0017674688715487719
type O 0 0.0006349442410282791
alleles O 0 0.0002636919671203941
is O 0 0.0001516194170108065
unknown O 0 0.0005958090187050402
. O 0 0.00045564433094114065

We O 0 0.0011306807864457369
have O 0 0.00012587697710841894
identified O 0 0.00018637016182765365
three O 0 8.687178342370316e-05
offspring O 0 0.00024974156985990703
in O 0 0.00013932008005212992
a O 0 0.005309751722961664
hereditary B-Disease 1 1.0
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 1 0.9982016086578369
who O 1 0.5758298635482788
developed O 1 0.9814385771751404
hematological B-Disease 1 0.9999922513961792
malignancy I-Disease 1 0.9999949932098389
at O 0 0.00780436722561717
a O 0 0.00016460241749882698
very O 0 5.069748658570461e-05
early O 0 0.00012472721573431045
age O 0 0.00011842604726552963
, O 0 4.237544271745719e-05
and O 0 3.68918408639729e-05
at O 0 6.941697938600555e-05
least O 0 2.7796202630270272e-05
two O 0 1.3598262739833444e-05
of O 0 6.0938029491808265e-05
them O 0 5.7909684983314946e-05
displayed O 0 0.00040219182847067714
signs O 0 0.0008683411870151758
of O 0 0.0015064325416460633
neurofibromatosis B-Disease 1 0.9999977350234985
type I-Disease 1 0.9271184206008911
1 I-Disease 0 0.012161092832684517
( O 0 0.000921751547139138
NF1 B-Disease 1 0.7745640873908997
) O 0 0.0003912696847692132
. O 0 0.000454777356935665

DNA O 0 0.0030134476255625486
sequence O 0 0.0007877282332628965
analysis O 0 0.00016738071280997247
and O 0 0.00016374439292121679
allele O 0 0.0002678196760825813
- O 0 0.00022533531591761857
specific O 0 6.652700540143996e-05
amplification O 0 0.0004190830222796649
in O 0 8.628067007521167e-05
two O 0 0.00010286603355780244
siblings O 0 0.0005583511665463448
revealed O 0 0.0006006822804920375
a O 0 0.0006061469903215766
homozygous O 0 0.0017554496880620718
MLH1 O 1 0.9981427192687988
mutation O 0 0.0012693757889792323
( O 0 0.0006479299627244473
C676T O 1 0.9948284029960632
- O 0 0.15834785997867584
- O 0 0.005282263271510601
> O 0 0.0040027848444879055
Arg226Stop O 0 0.4957570731639862
) O 0 0.0008418052457273006
. O 0 0.0007897688774392009

Thus O 0 0.003338753478601575
, O 0 0.0008904879214242101
a O 0 0.001342358416877687
homozygous O 0 0.004795226734131575
germ O 1 0.9997791647911072
- O 1 0.7598906755447388
line O 0 0.10403087735176086
MLH1 O 1 0.9999181032180786
mutation O 0 0.002452295273542404
and O 0 0.0014180748257786036
consequent O 1 0.9999860525131226
mismatch O 1 1.0
repair O 1 1.0
deficiency O 1 1.0
results O 0 0.0017429686849936843
in O 0 0.0004945501568727195
a O 0 0.0025343229062855244
mutator O 1 0.9999030828475952
phenotype O 0 0.2905345857143402
characterized O 0 0.203841432929039
by O 0 0.004002533387392759
leukemia B-Disease 1 0.9999998807907104
and O 1 0.9852494597434998
/ O 1 0.9999866485595703
or O 1 0.9997572302818298
lymphoma B-Disease 1 1.0
associated O 0 0.04591472074389458
with O 0 0.0076233092695474625
neurofibromatosis B-Disease 1 0.9999998807907104
type I-Disease 1 0.9990173578262329
1 I-Disease 0 0.017443332821130753
. O 0 0.00035403718356974423
. O 0 0.0006241805385798216

Missense O 0 0.015568050555884838
mutations O 0 0.0008938670507632196
in O 0 0.00024283681705128402
the O 0 0.00029125146102160215
most O 0 0.00012954272096976638
ancient O 0 0.0005886881845071912
residues O 0 0.0004902761429548264
of O 0 0.0003779641992878169
the O 0 0.0010814010165631771
PAX6 O 1 0.9957915544509888
paired O 0 0.0011786168906837702
domain O 0 0.0005627453792840242
underlie O 0 0.0032304618507623672
a O 0 0.001229477347806096
spectrum O 0 0.011008372530341148
of O 1 0.9958414435386658
human O 1 0.9999992847442627
congenital B-Disease 1 1.0
eye I-Disease 1 1.0
malformations I-Disease 1 1.0
. O 1 0.9944537281990051

Mutations O 0 0.0022913890425115824
of O 0 0.0010574295883998275
the O 0 0.0024627118837088346
human O 0 0.27500906586647034
PAX6 O 1 0.9999979734420776
gene O 1 0.9707186818122864
underlie O 1 0.9999892711639404
aniridia B-Disease 1 1.0
( O 1 0.9997567534446716
congenital B-Disease 1 1.0
absence I-Disease 1 0.9909781217575073
of I-Disease 1 0.8059823513031006
the I-Disease 1 0.9663469791412354
iris I-Disease 1 0.9992566704750061
) O 0 0.00017044950800482184
, O 0 7.969032594701275e-05
a O 0 0.0002654572599567473
rare O 0 0.0011879665544256568
dominant O 1 0.7518975138664246
malformation B-Disease 1 0.9999978542327881
of I-Disease 1 0.9863213896751404
the I-Disease 1 0.9977715015411377
eye I-Disease 1 0.9998517036437988
. O 0 0.0015171908307820559

The O 0 0.003441660664975643
spectrum O 0 0.0027646152302622795
of O 0 0.004009723663330078
PAX6 O 1 0.9999747276306152
mutations O 0 0.003956899046897888
in O 0 0.002837549429386854
aniridia B-Disease 1 0.9999994039535522
patients O 0 0.011057435534894466
is O 0 9.35966381803155e-05
highly O 0 0.00015893735690042377
biased O 0 0.00010113804455613717
, O 0 3.7341287679737434e-05
with O 0 2.3741324184811674e-05
92 O 0 0.00015342071128543466
% O 0 2.4371256586164236e-05
of O 0 7.615626964252442e-05
all O 0 4.456800525076687e-05
reported O 0 0.00014139221457298845
mutations O 0 8.717751916265115e-05
leading O 0 0.0002736475726123899
to O 0 0.00010278897389071062
premature O 0 0.0005925094592384994
truncation O 0 0.0008775438764132559
of O 0 0.00022533317678608
the O 0 0.00018366087169852108
protein O 0 0.0001544057740829885
( O 0 0.00011504039139254019
nonsense O 0 0.0010179883101955056
, O 0 0.00011616652773227543
splicing O 0 0.000290318566840142
, O 0 8.238450391218066e-05
insertions O 0 0.0005742769571952522
and O 0 0.00010841160110430792
deletions O 0 0.00033238809555768967
) O 0 3.2869102142285556e-05
and O 0 2.6421816073707305e-05
just O 0 6.295237835729495e-05
2 O 0 7.88324759923853e-05
% O 0 2.7337235223967582e-05
leading O 0 6.658679922111332e-05
to O 0 2.532578946556896e-05
substitution O 0 9.30143942241557e-05
of O 0 6.757715891581029e-05
one O 0 6.699455843772739e-05
amino O 0 9.591454727342352e-05
acid O 0 0.00019337038975208998
by O 0 6.799540278734639e-05
another O 0 0.0002721836790442467
( O 0 0.00027620582841336727
missense O 0 0.001570122200064361
) O 0 0.0002457651717122644
. O 0 0.0005753825535066426

The O 0 0.002312291879206896
extraordinary O 0 0.0024788901209831238
conservation O 0 0.000895690347533673
of O 0 0.00045516336103901267
the O 0 0.0005773233133368194
PAX6 O 1 0.9131547212600708
protein O 0 0.00038165118894539773
at O 0 0.00043910558451898396
the O 0 0.00020904786651954055
amino O 0 0.0003234475734643638
acid O 0 0.0008126933244057
level O 0 0.0005284801591187716
amongst O 0 0.0008079643012024462
vertebrates O 0 0.002453872002661228
predicts O 0 0.0010999349178746343
that O 0 0.0001674368977546692
pathological O 0 0.015709511935710907
missense O 0 0.004871086683124304
mutations O 0 0.00032503149122931063
should O 0 8.565199095755816e-05
in O 0 7.791224925313145e-05
fact O 0 9.326609142590314e-05
be O 0 3.6078501580050215e-05
common O 0 4.931709190714173e-05
even O 0 4.8679103201720864e-05
though O 0 3.547986852936447e-05
they O 0 1.9040153347305022e-05
are O 0 1.5380222976091318e-05
hardly O 0 0.0002136735274689272
ever O 0 0.00034307289752177894
seen O 0 0.000602974439971149
in O 0 0.0008374504977837205
aniridia B-Disease 1 0.9999879598617554
patients O 0 0.007273691240698099
. O 0 0.001211337512359023

This O 0 0.000645642401650548
indicates O 0 0.0005148204509168863
that O 0 5.94892590015661e-05
there O 0 8.112567593343556e-05
is O 0 5.9097415942233056e-05
a O 0 0.00021142723562661558
heavy O 0 0.0057618990540504456
ascertainment O 1 0.9856032133102417
bias O 0 0.00047526316484436393
in O 0 0.00011240696767345071
the O 0 0.0001100535664591007
selection O 0 0.00017298012971878052
of O 0 0.0002620928571559489
patients O 0 0.00028299292898736894
for O 0 0.0001749790826579556
PAX6 O 1 0.9996010661125183
mutation O 0 0.0002394762559561059
analysis O 0 6.042503810022026e-05
and O 0 4.943952080793679e-05
that O 0 5.582793164649047e-05
the O 0 0.00021865485177841038
missing O 0 0.0019236120861023664
PAX6 O 1 0.9997060894966125
missense O 0 0.06747373193502426
mutations O 0 0.0009943974437192082
frequently O 0 0.0005049945320934057
may O 0 0.0004658633843064308
underlie O 0 0.01835450530052185
phenotypes O 0 0.0024263656232506037
distinct O 0 0.0006078635342419147
from O 0 0.002280230401083827
textbook O 1 0.9788230061531067
aniridia B-Disease 1 0.999955415725708
. O 0 0.0030516001861542463

Here O 0 0.002445619087666273
we O 0 0.0002810159930959344
present O 0 0.00026980999973602593
four O 0 0.00036998672294430435
novel O 0 0.0015588172245770693
PAX6 O 1 0.9973852038383484
missense O 0 0.005827728658914566
mutations O 0 0.0002446303842589259
, O 0 8.277201413875446e-05
two O 0 4.7472356527578086e-05
in O 0 0.00013354628754314035
association O 0 0.0004084552638232708
with O 0 0.0002583234163466841
atypical O 1 0.9999712705612183
phenotypes O 1 0.9999110698699951
ectopia B-Disease 1 0.9999990463256836
pupillae I-Disease 1 0.9999982118606567
( O 0 0.0031094620935618877
displaced B-Disease 0 0.034313417971134186
pupils I-Disease 0 0.003847412997856736
) O 0 0.0005863899714313447
and O 0 0.007192773744463921
congenital B-Disease 1 1.0
nystagmus I-Disease 1 0.9999973773956299
( O 0 0.00532466359436512
searching B-Disease 0 0.0013168700970709324
gaze I-Disease 0 0.08088093250989914
) O 0 0.00010624776768963784
, O 0 4.75867091154214e-05
and O 0 2.6071797037729993e-05
two O 0 2.8621529054362327e-05
in O 0 6.64429462631233e-05
association O 0 0.0001828539534471929
with O 0 0.00010837191803148016
more O 0 0.00020276567374821752
recognizable O 1 0.9523209929466248
aniridia B-Disease 1 0.9999974966049194
phenotypes O 0 0.2660675048828125
. O 0 0.0016227661399170756

Strikingly O 0 0.008629671297967434
, O 0 0.0005325058591552079
all O 0 0.00017567990289535373
four O 0 0.0001496587647125125
mutations O 0 0.00013210911129135638
are O 0 1.847882231231779e-05
located O 0 0.00013968508574180305
within O 0 0.00011299234029138461
the O 0 0.00033067906042560935
PAX6 O 1 0.9367230534553528
paired O 0 0.0004235571250319481
domain O 0 0.00022945509408600628
and O 0 0.0001305892365053296
affect O 0 0.00013822152686771005
amino O 0 0.0001259156415471807
acids O 0 7.724158786004409e-05
which O 0 3.107060547336005e-05
are O 0 1.0044739610748366e-05
highly O 0 5.9231526392977685e-05
conserved O 0 9.471607336308807e-05
in O 0 4.91869832330849e-05
all O 0 7.326524792006239e-05
known O 0 0.0001799722231226042
paired O 0 0.000353398296283558
domain O 0 0.0004797527508344501
proteins O 0 0.000532856211066246
. O 0 0.0006597859901376069

Our O 0 0.001629269914701581
results O 0 0.00027806704747490585
support O 0 0.0001380213361699134
the O 0 0.00014408252900466323
hypothesis O 0 0.000125770311569795
that O 0 2.972891161334701e-05
the O 0 6.838894478278235e-05
under O 0 0.00011597682896535844
- O 0 0.000173238615388982
representation O 0 8.263604831881821e-05
of O 0 0.0002877248334698379
missense O 0 0.005196794867515564
mutations O 0 0.0005243711639195681
is O 0 0.00026380864437669516
caused O 0 0.07733798027038574
by O 0 0.00023115200747270137
ascertainment O 1 0.999413251876831
bias O 0 0.001847381005063653
and O 0 0.0001646002201596275
suggest O 0 0.00013561101513914764
that O 0 3.478787766653113e-05
a O 0 0.00010802134056575596
substantial O 0 0.00027864877483807504
burden O 0 0.0028188638389110565
of O 0 0.3980836868286133
PAX6 B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999212026596069
related I-Disease 1 0.7948906421661377
disease I-Disease 1 0.9999674558639526
remains O 0 0.01712069846689701
to O 0 0.00010952988668577746
be O 0 9.859052806859836e-05
uncovered O 0 0.001152951386757195
. O 0 0.00026662045274861157
. O 0 0.00045224622590467334

The O 0 0.003056672867387533
chromosomal O 0 0.004369279835373163
order O 0 0.000596705183852464
of O 0 0.0006597513565793633
genes O 0 0.0002982949954457581
controlling O 0 0.0008416087366640568
the O 0 0.0007133209728635848
major O 1 0.7891586422920227
histocompatibility O 1 0.9999985694885254
complex O 1 0.664793074131012
, O 0 0.0005644780467264354
properdin O 1 0.9939759373664856
factor O 0 0.0036643280182033777
B O 0 0.0025543433148413897
, O 0 0.00014057713269721717
and O 0 0.00023321520711760968
deficiency B-Disease 1 0.9995517134666443
of I-Disease 0 0.0006826866301707923
the I-Disease 0 0.0017467112047597766
second I-Disease 0 0.008782378397881985
component I-Disease 0 0.0028897279407829046
of I-Disease 0 0.0009297201759181917
complement I-Disease 0 0.002946721389889717
. O 0 0.0010134417098015547

The O 0 0.0019428576342761517
relationship O 0 0.0006240811781026423
of O 0 0.0003613519365899265
the O 0 0.0004237678076606244
genes O 0 0.000320356892189011
coding O 0 0.0006690427544526756
for O 0 0.00017956150986719877
HLA O 0 0.3105616867542267
to O 0 0.00010910645505646244
those O 0 5.265322397463024e-05
coding O 0 0.00022407982032746077
for O 0 0.00012792435882147402
properdin O 1 0.9593467116355896
Factor O 0 0.017825542017817497
B O 0 0.016396164894104004
allotypes O 1 0.7665091156959534
and O 0 0.00021490473591256887
for O 0 0.00026923391851596534
deficiency B-Disease 1 0.9991152882575989
of I-Disease 0 0.00041816660086624324
the I-Disease 0 0.0005982264410704374
second I-Disease 0 0.0009987781522795558
component I-Disease 0 0.0009097907459363341
of I-Disease 0 0.000257231731666252
complement I-Disease 0 0.0013051347341388464
( O 0 0.0004766648926306516
C2 O 1 0.9207656979560852
) O 0 5.977609544061124e-05
was O 0 0.00012252552551217377
studied O 0 0.00010056600876851007
in O 0 5.2521281759254634e-05
families O 0 5.8279703807784244e-05
of O 0 0.0005822220700792968
patients O 1 0.8671123385429382
with O 1 0.9973885416984558
connective O 1 1.0
tissue O 1 1.0
disorders O 1 1.0
. O 1 0.9198575615882874

Patients O 0 0.004798913840204477
were O 0 0.0006089415401220322
selected O 0 0.0004510744765866548
because O 0 0.0001562103716423735
they O 0 7.615532376803458e-05
were O 0 0.00014862234820611775
heterozygous O 0 0.0002424916165182367
or O 0 0.00036254929727874696
homozygous O 0 0.00336088496260345
for O 0 0.0791168212890625
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 0.010781199671328068

12 O 0 0.001682195346802473
families O 0 0.00044097471982240677
with O 0 0.00021229566482361406
15 O 0 0.0008463345584459603
matings O 0 0.004651757422834635
informative O 0 0.0027984215412288904
for O 0 0.05586432293057442
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
were O 0 0.0033971560187637806
found O 0 0.0010959233622998
. O 0 0.000981904100626707

Of O 0 0.0031741096172481775
57 O 0 0.0037482900079339743
informative O 0 0.0023640007711946964
meioses O 0 0.49749213457107544
, O 0 0.0002695662551559508
two O 0 0.0001081729496945627
crossovers O 0 0.0005803012754768133
were O 0 0.00012277874338906258
noted O 0 0.00017460042727179825
between O 0 0.00037993292789906263
the O 1 0.6272900104522705
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
gene O 0 0.000793981016613543
and O 0 0.00017273503181058913
the O 0 0.0036624730564653873
HLA O 1 0.9999972581863403
- O 0 0.11665964126586914
B O 0 0.0008447703439742327
gene O 0 6.488434155471623e-05
, O 0 2.1395964722614735e-05
with O 0 1.3486009265761822e-05
a O 0 7.908908446552232e-05
recombinant O 0 0.0003519666497595608
fraction O 0 0.000274098536465317
of O 0 0.00027384120039641857
0 O 0 0.0004163513658568263
. O 0 0.00038326712092384696

035 O 1 0.8999170064926147
. O 0 0.014688359573483467

A O 0 0.00541622145101428
lod O 0 0.0077737909741699696
score O 0 0.0004873440193478018
of O 0 0.00032728465157561004
13 O 0 0.0004369626985862851
was O 0 0.000690041168127209
calculated O 0 0.00028202630346640944
for O 0 0.00013685158046428114
linkage O 0 0.0035886152181774378
between O 1 0.7732976675033569
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 1 0.9925557971000671
HLA O 1 0.9999997615814209
- O 1 0.6229197978973389
B O 0 0.0009732904727570713
at O 0 0.00018539537268225104
a O 0 9.631167631596327e-05
maximum O 0 6.830239726696163e-05
likelihood O 0 5.7470071624265984e-05
value O 0 2.3726817744318396e-05
of O 0 4.663982326746918e-05
the O 0 8.64579196786508e-05
recombinant O 0 0.0003551525587681681
fraction O 0 0.000182586009032093
of O 0 0.00023356259043794125
0 O 0 0.0003745391732081771
. O 0 0.0003486411296762526

04 O 1 0.6699516773223877
. O 0 0.013764680363237858

18 O 0 0.002330204239115119
families O 0 0.000447418395197019
with O 0 0.00015612252173013985
21 O 0 0.000612345349509269
informative O 0 0.0005964575684629381
matings O 0 0.0012680002255365252
for O 0 0.00011640805314527825
both O 0 0.00017795590974856168
properdin O 1 0.9589110016822815
Factor O 0 0.007635306101292372
B O 0 0.14908923208713531
allotype O 1 0.9958716034889221
and O 0 0.0008696954464539886
HLA O 1 0.9999873638153076
- O 0 0.03428556025028229
B O 0 0.0011468917364254594
were O 0 0.00013648667663801461
found O 0 0.00019600837549660355
. O 0 0.00040971703128889203

Of O 0 0.0039940569549798965
72 O 0 0.004094415344297886
informative O 0 0.0024360662791877985
meioses O 0 0.23835675418376923
, O 0 0.00032885061227716506
three O 0 0.00026577780954539776
recombinants O 0 0.017876971513032913
were O 0 0.00012468999193515629
found O 0 6.518692680401728e-05
, O 0 4.03427256969735e-05
giving O 0 9.516857971902937e-05
a O 0 0.0001753806573105976
recombinant O 0 0.0005191108793951571
fraction O 0 0.00025761951110325754
of O 0 0.0002968401531688869
0 O 0 0.0005052273045293987
. O 0 0.0005512196803465486

042 O 1 0.9855085015296936
. O 0 0.0127762695774436

A O 0 0.0038860708009451628
lod O 0 0.006730087101459503
score O 0 0.00040639389771968126
of O 0 0.0003334027132950723
16 O 0 0.0005913655622862279
between O 0 0.0009865090250968933
HLA O 1 0.9999680519104004
- O 0 0.020901834592223167
B O 0 0.0015882236184552312
and O 0 0.0001690070639597252
Factor O 0 0.000742061180062592
B O 0 0.001538979122415185
allotypes O 0 0.01458143349736929
was O 0 0.00025469856336712837
calculated O 0 5.800064900540747e-05
at O 0 8.295501174870878e-05
a O 0 4.801492104888894e-05
maximum O 0 5.871028042747639e-05
likelihood O 0 8.921397238736972e-05
value O 0 3.340039256727323e-05
of O 0 4.5297714677872136e-05
the O 0 0.0001068884739652276
recombinant O 0 0.0004244510200805962
fraction O 0 0.00024500247673131526
of O 0 0.00030825016438029706
0 O 0 0.0004076533659826964
. O 0 0.0004261552821844816

04 O 1 0.5542231798171997
. O 0 0.013182614929974079

A O 0 0.00619996665045619
crossover O 0 0.00491120433434844
was O 0 0.0014778050826862454
shown O 0 0.00020994432270526886
to O 0 5.127099939272739e-05
have O 0 3.360361370141618e-05
occurred O 0 0.00027670105919241905
between O 0 9.170250268653035e-05
genes O 0 6.321888940874487e-05
for O 0 5.7786724937614053e-05
Factor O 0 0.0004127634456381202
B O 0 0.000712114735506475
and O 0 0.0002190124650951475
HLA O 1 0.9999500513076782
- O 0 0.017270740121603012
D O 0 0.0016178040532395244
, O 0 8.747747051529586e-05
in O 0 0.00011266161891398951
which O 0 0.00020509175374172628
HLA O 1 0.9993413090705872
- O 0 0.01340033020824194
D O 0 0.013375130482017994
segregared O 0 0.33602678775787354
with O 0 0.0007640294497832656
HLA O 1 0.9999277591705322
- O 0 0.004141595680266619
A O 0 0.00232511293143034
and O 0 0.00034854875411838293
B O 0 0.002977825701236725
. O 0 0.0005975196254439652

These O 0 0.000517597480211407
studies O 0 0.00031248797313310206
suggest O 0 0.00018910426297225058
that O 0 3.505593485897407e-05
the O 0 7.678192923776805e-05
genes O 0 5.766484537161887e-05
for O 0 7.086029654601589e-05
Factor O 0 0.011462198570370674
B O 1 0.9817122220993042
and O 1 0.5122860074043274
C2 B-Disease 1 1.0
deficiency I-Disease 1 0.9999998807907104
are O 0 4.677987453760579e-05
located O 0 0.00013695470988750458
outside O 0 0.00015104538761079311
those O 0 3.829449997283518e-05
for O 0 8.576796972192824e-05
HLA O 1 0.955000102519989
, O 0 7.160702807595953e-05
that O 0 2.3121960111893713e-05
the O 0 4.813044870388694e-05
order O 0 8.731844718568027e-05
of O 0 0.00023943698033690453
genese O 1 0.9639214277267456
is O 0 0.00044680380960926414
HLA O 1 0.9996562004089355
- O 0 0.0005734337610192597
A O 0 0.00041802049963735044
, O 0 0.00010362787725171074
- O 0 0.0003549237735569477
B O 0 0.0005093443905934691
, O 0 0.00011662237375276163
- O 0 0.0005037608207203448
D O 0 0.001143482862971723
, O 0 0.00016627104196231812
Factor O 0 0.0014121283311396837
B O 0 0.39402464032173157
allotype O 1 0.9999663829803467
, O 1 0.8161446452140808
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
, O 0 0.0003442829183768481
that O 0 5.78731887799222e-05
the O 0 0.0001662127033341676
genes O 0 0.0001959538203664124
coding O 0 0.0017381286015734076
for O 0 0.0037659555673599243
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 0 0.010617048479616642
Factor O 0 0.34356749057769775
B O 0 0.0031030860263854265
allotypes O 0 0.0025654362980276346
are O 0 1.5124054698389955e-05
approximately O 0 5.7840425142785534e-05
3 O 0 9.27975052036345e-05
- O 0 0.0002169126964872703
- O 0 0.00016566019621677697
5 O 0 0.00014590221690014005
centimorgans O 0 0.000706590071786195
from O 0 0.00010503420344321057
the O 0 0.00033300594077445567
HLA O 1 0.999286949634552
- O 0 0.001133809215389192
A O 0 0.0020005591213703156
and O 0 0.0007089794962666929
HLA O 1 0.9999794960021973
- O 0 0.21009840071201324
B O 0 0.019206780940294266
loci O 0 0.00047736329725012183
, O 0 4.78078582091257e-05
and O 0 3.1298259273171425e-05
that O 0 1.7980089978664182e-05
the O 0 7.289985660463572e-05
apparent O 0 0.0006071542738936841
lack O 0 0.0003183671797160059
of O 0 0.0007438789471052587
recombinants O 1 0.9972387552261353
between O 0 0.0004364718624856323
the O 0 0.0005647145444527268
Factor O 0 0.030023349449038506
B O 0 0.3758191466331482
gene O 0 0.0012285191332921386
and O 0 0.01722891815006733
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
gene O 0 0.0009681502124294639
suggests O 0 0.00015322159742936492
that O 0 2.341028994123917e-05
these O 0 7.693980478507001e-06
two O 0 2.276199847983662e-05
genes O 0 3.783249485422857e-05
lie O 0 0.0001294274115934968
in O 0 5.1108487241435796e-05
close O 0 0.00014002487296238542
proximity O 0 0.0001933266903506592
to O 0 5.5495696869911626e-05
one O 0 0.00015367269224952906
another O 0 0.00047021021600812674
. O 0 0.000536025152541697

Distribution O 0 0.0032953149639070034
of O 0 0.0026376142632216215
emerin O 1 0.997180700302124
and O 0 0.0010320108849555254
lamins O 1 0.8783808946609497
in O 0 0.00048768651322461665
the O 0 0.0036261517088860273
heart O 1 0.9994077682495117
and O 0 0.00039002695120871067
implications O 0 0.0022944053635001183
for O 0 0.0009598482865840197
Emery B-Disease 1 0.999873161315918
- I-Disease 1 0.9999785423278809
Dreifuss I-Disease 1 0.9999996423721313
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 0.43640899658203125

Emerin O 1 0.787103533744812
is O 0 0.0011894210474565625
a O 0 0.0009023607126437128
nuclear O 0 0.0023560200352221727
membrane O 0 0.00099245086312294
protein O 0 0.00031387549825012684
which O 0 6.88459986122325e-05
is O 0 8.084350702119991e-05
missing O 0 0.0003628632111940533
or O 0 0.0003410872013773769
defective O 1 0.9088703393936157
in O 0 0.0016880790935829282
Emery B-Disease 1 0.9996671676635742
- I-Disease 1 0.9999778270721436
Dreifuss I-Disease 1 0.9999998807907104
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.999976396560669
EDMD B-Disease 1 1.0
) O 0 0.0034264728892594576
. O 0 0.0015040424186736345

It O 0 0.00040829781210049987
is O 0 0.00013708550250157714
one O 0 7.099041977198794e-05
member O 0 0.00012268360296729952
of O 0 0.00013313839735928923
a O 0 0.00022306089522317052
family O 0 0.0003283177793491632
of O 0 0.004801969043910503
lamina O 1 0.9999923706054688
- O 1 0.7958449125289917
associated O 0 0.0002634976990520954
proteins O 0 0.00013296646648086607
which O 0 7.862091297283769e-05
includes O 0 0.00026375032030045986
LAP1 O 1 0.999392032623291
, O 0 0.0004632917698472738
LAP2 O 1 0.9965110421180725
and O 0 0.0005040946998633444
lamin O 0 0.08971608430147171
B O 0 0.19262997806072235
receptor O 0 0.002898800652474165
( O 0 0.0012522676261141896
LBR O 1 0.9910405278205872
) O 0 0.0007049062987789512
. O 0 0.001001597847789526

A O 0 0.0025794398970901966
panel O 0 0.001195603283122182
of O 0 0.0007563225808553398
16 O 0 0.0015705677215009928
monoclonal O 0 0.00329163228161633
antibodies O 0 0.0009280364029109478
( O 0 0.0003059267473872751
mAbs O 0 0.0019766686018556356
) O 0 7.716877007624134e-05
has O 0 4.809099482372403e-05
been O 0 4.0298964449902996e-05
mapped O 0 0.00013141543604433537
to O 0 4.76871027785819e-05
six O 0 6.602128996746615e-05
specific O 0 3.6310968425823376e-05
sites O 0 7.411792466882616e-05
throughout O 0 7.166570867411792e-05
the O 0 0.0001968827418750152
emerin O 0 0.037692341953516006
molecule O 0 0.0005157602136023343
using O 0 0.00017926898726727813
phage O 0 0.002160670468583703
- O 0 0.0006508630467578769
displayed O 0 0.0005411722231656313
peptide O 0 0.0004413791175466031
libraries O 0 0.00013218029926065356
and O 0 6.0194532125024125e-05
has O 0 4.8331126890843734e-05
been O 0 3.6468518374022096e-05
used O 0 5.449929085443728e-05
to O 0 7.022868521744385e-05
localize O 0 0.002587184077128768
emerin O 1 0.866221010684967
in O 0 0.00037978641921654344
human O 0 0.0007435160805471241
and O 0 0.0006176420138217509
rabbit O 1 0.9972670078277588
heart O 1 0.9998258948326111
. O 0 0.0014357215259224176

Several O 0 0.0022022235207259655
mAbs O 0 0.010507537983357906
against O 0 0.0009853335795924067
different O 0 0.000338337937137112
emerin O 1 0.9065565466880798
epitopes O 0 0.004893758334219456
did O 0 0.0002069492475129664
not O 0 5.9792680985992774e-05
recognize O 0 0.00024174002464860678
intercalated O 0 0.021216347813606262
discs O 0 0.0010681521380320191
in O 0 0.00018365109281148762
the O 0 0.0015226142713800073
heart O 1 0.9988836646080017
, O 0 0.00013612431939691305
though O 0 5.796975165139884e-05
they O 0 3.4051790862577036e-05
recognized O 0 0.00014774981536902487
cardiomyocyte O 0 0.444320946931839
nuclei O 0 0.000995825626887381
strongly O 0 0.00018044318130705506
, O 0 6.428128108382225e-05
both O 0 4.956906195729971e-05
at O 0 0.0001882745127659291
the O 0 0.00022408667427953333
rim O 0 0.002091912319883704
and O 0 0.0001690720091573894
in O 0 0.00028770725475624204
intranuclear O 1 0.9625827074050903
spots O 0 0.001207267981953919
or O 0 0.0003976925800088793
channels O 0 0.00041541215614415705
. O 0 0.0005765738897025585

A O 0 0.019382117316126823
polyclonal O 0 0.1500372290611267
rabbit O 0 0.02261148951947689
antiserum O 0 0.029044268652796745
against O 0 0.003256805706769228
emerin O 1 0.9760923385620117
did O 0 0.0003852542140521109
recognize O 0 0.00034625458647497
both O 0 0.0002613083634059876
nuclear O 0 0.003236915450543165
membrane O 0 0.001164669869467616
and O 0 0.00023184950987342745
intercalated O 0 0.1900029480457306
discs O 0 0.0006475743721239269
but O 0 5.143142334418371e-05
, O 0 4.652139978134073e-05
after O 0 8.959085971582681e-05
affinity O 0 0.00013792818936053663
purification O 0 0.0021838610991835594
against O 0 0.0002493794308975339
a O 0 0.0002991670626215637
pure O 0 0.014643770642578602
- O 0 0.0017016244819387794
emerin O 0 0.006876118015497923
band O 0 0.00028667200240306556
on O 0 5.997473999741487e-05
a O 0 7.99146801000461e-05
western O 0 0.00023014657199382782
blot O 0 0.0016508034896105528
, O 0 0.00014994417142588645
it O 0 7.658989488845691e-05
stained O 0 0.002319266553968191
only O 0 0.00012270407751202583
the O 0 0.0003341224801260978
nuclear O 0 0.002353199291974306
membrane O 0 0.001865958794951439
. O 0 0.0005168853094801307

These O 0 0.0004735339607577771
results O 0 0.0002891944895964116
would O 0 7.807536167092621e-05
not O 0 3.200792707502842e-05
be O 0 3.5878434573533013e-05
expected O 0 7.371840911218897e-05
if O 0 9.96313538053073e-05
immunostaining O 0 0.012390890158712864
at O 0 0.0007814197451807559
intercalated O 0 0.03121853992342949
discs O 0 0.000588924391195178
were O 0 7.409842510242015e-05
due O 0 7.245290908031166e-05
to O 0 3.1050469260662794e-05
a O 0 6.338477396639064e-05
product O 0 6.919167208252475e-05
of O 0 8.67035414557904e-05
the O 0 0.0005410984740592539
emerin O 1 0.9998971223831177
gene O 0 0.00024205853696912527
and O 0 6.628131814068183e-05
, O 0 6.0711990954587236e-05
therefore O 0 4.8359936045017093e-05
, O 0 3.2147821912076324e-05
cast O 0 5.9788239013869315e-05
some O 0 2.9086269933031872e-05
doubt O 0 0.0001170969771919772
upon O 0 0.00010414487041998655
the O 0 0.00022222026018425822
hypothesis O 0 0.0004749801300931722
that O 0 0.0007124738185666502
cardiac B-Disease 1 0.9999997615814209
defects I-Disease 1 0.9999997615814209
in O 1 0.9967272281646729
EDMD B-Disease 1 1.0
are O 0 0.00023098589736036956
caused O 0 0.40841469168663025
by O 0 0.00013980221410747617
absence O 0 0.001094408449716866
of O 0 0.0032741695176810026
emerin O 1 0.9996838569641113
from O 0 0.003224871354177594
intercalated O 1 0.9912775754928589
discs O 0 0.01006254181265831
. O 0 0.0013195977080613375

Although O 0 0.004884221125394106
emerin O 1 0.9200747609138489
was O 0 0.0022253531496971846
abundant O 0 0.000903676322195679
in O 0 0.00019519186753313988
the O 0 0.00027582902112044394
membranes O 0 0.0006231314619071782
of O 0 0.0009061464807018638
cardiomyocyte O 1 0.9998488426208496
nuclei O 0 0.014441058039665222
, O 0 0.0001265007449546829
it O 0 5.413463804870844e-05
was O 0 0.00022024758800398558
absent O 0 0.0002217489090980962
from O 0 6.633228622376919e-05
many O 0 7.252841169247404e-05
non O 0 0.0006844103336334229
- O 0 0.008969791233539581
myocyte O 1 0.9989373087882996
cells O 0 0.0007192096672952175
in O 0 0.00027473768568597734
the O 0 0.0011105409357696772
heart O 1 0.9821027517318726
. O 0 0.001188113121315837

This O 0 0.0010180854005739093
distribution O 0 0.00039101761649362743
of O 0 0.0006954873097129166
emerin O 1 0.9857075810432434
was O 0 0.0008700887556187809
similar O 0 8.687112858751789e-05
to O 0 3.825858220807277e-05
that O 0 4.1061641240958124e-05
of O 0 0.0001457300822949037
lamin O 0 0.0053815655410289764
A O 0 0.0006323290872387588
, O 0 5.311902714311145e-05
a O 0 7.151558384066448e-05
candidate O 0 0.00013012398267164826
gene O 0 8.538899419363588e-05
for O 0 3.691823440021835e-05
an O 0 9.27545188460499e-05
autosomal O 0 0.0008119112462736666
form O 0 0.0009525038185529411
of O 1 0.9870737791061401
EDMD B-Disease 1 1.0
. O 0 0.007110496051609516

In O 0 0.002528876531869173
contrast O 0 0.0034426944330334663
, O 0 0.001389572280459106
lamin O 1 0.9052854180335999
B1 O 1 0.9997925162315369
was O 0 0.02870413102209568
absent O 0 0.0025162536185234785
from O 0 0.0006158186588436365
cardiomyocyte O 1 0.9983745813369751
nuclei O 0 0.005467365495860577
, O 0 0.0003075737913604826
showing O 0 0.0006107788649387658
that O 0 0.0002158691204385832
lamin O 1 0.9304904937744141
B1 O 1 0.999175488948822
is O 0 0.0001480893261032179
not O 0 4.553948383545503e-05
essential O 0 0.00016039707406889647
for O 0 7.754837861284614e-05
localization O 0 0.0009159683831967413
of O 0 0.0003620722854975611
emerin O 0 0.08579900115728378
to O 0 0.00020582244906108826
the O 0 0.0006966849905438721
nuclear O 0 0.006215101573616266
lamina O 1 0.8600954413414001
. O 0 0.0013027206296101213

Lamin O 1 0.999104917049408
B1 O 1 0.9998681545257568
is O 0 0.0010018807370215654
also O 0 0.00041007966501638293
almost O 0 0.00035408191615715623
completely O 0 0.0014140319544821978
absent O 0 0.00692546833306551
from O 0 0.012249649502336979
skeletal O 1 0.9999979734420776
muscle O 1 0.9999891519546509
nuclei O 1 0.9966789484024048
. O 0 0.0026424042880535126

In O 0 0.004797418136149645
EDMD B-Disease 1 0.9999775886535645
, O 0 0.0005222315085120499
the O 0 0.0003280405653640628
additional O 0 0.00019221613183617592
absence O 0 0.0007878073956817389
of O 0 0.0034771959763020277
lamin O 1 0.9999217987060547
B1 O 1 0.9999990463256836
from O 1 0.9721087217330933
heart O 1 0.9999994039535522
and O 1 0.9907891154289246
skeletal O 1 1.0
muscle O 1 0.9999998807907104
nuclei O 1 0.9998883008956909
which O 0 0.000549713266082108
already O 0 0.0002270281984237954
lack O 0 0.0012500759912654757
emerin O 1 0.994277834892273
may O 0 0.00010897980973822996
offer O 0 4.6655306505272165e-05
an O 0 4.211764462525025e-05
alternative O 0 5.7037115766434e-05
explanation O 0 9.879917342914268e-05
of O 0 0.00014658998406957835
why O 0 0.0002745907986536622
these O 0 7.45389552321285e-05
tissues O 0 0.0010818472364917397
are O 0 4.4444412196753547e-05
particularly O 0 0.0003457772545516491
affected O 0 0.0005253659910522401
. O 0 0.00021514995023608208
. O 0 0.00042666291119530797

Genetic O 0 0.003972811624407768
mapping O 0 0.0015195409068837762
of O 0 0.0014930354664102197
the O 0 0.0038731954991817474
copper B-Disease 1 0.9999561309814453
toxicosis I-Disease 1 0.9999450445175171
locus O 0 0.0051222979091107845
in O 0 0.00032895413460209966
Bedlington O 0 0.1200602725148201
terriers O 0 0.0019105778774246573
to O 0 0.00016872561536729336
dog O 0 0.0010084558743983507
chromosome O 0 0.00029698965954594314
10 O 0 0.00010870518599404022
, O 0 4.536363485385664e-05
in O 0 3.5607114114100114e-05
a O 0 8.503910066792741e-05
region O 0 0.00020195625256747007
syntenic O 0 0.06223473697900772
to O 0 0.00014130608178675175
human O 0 0.0003371140919625759
chromosome O 0 0.0008406228735111654
region O 0 0.0019310768693685532
2p13 O 1 0.9997028708457947
- O 0 0.2403711974620819
p16 O 0 0.05922839045524597
. O 0 0.001166586298495531

Abnormal O 1 0.9999879598617554
hepatic B-Disease 1 0.9999996423721313
copper I-Disease 1 0.9999986886978149
accumulation I-Disease 1 0.9997979998588562
is O 0 0.0006567144300788641
recognized O 0 0.00026008699205704033
as O 0 0.0003324590506963432
an O 0 0.012291190214455128
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
in O 1 0.9724447727203369
man O 1 0.999661922454834
, O 0 0.0005721385241486132
mouse O 0 0.0010051049757748842
, O 0 0.00025903276400640607
rat O 0 0.013717557303607464
and O 0 0.0003528273955453187
dog O 0 0.004030176438391209
. O 0 0.0009411940118297935

The O 0 0.004927591420710087
major O 0 0.4486568868160248
cause O 1 0.9975128173828125
of O 1 0.9994932413101196
hepatic B-Disease 1 1.0
copper I-Disease 1 0.9999998807907104
accumulation I-Disease 1 0.999984860420227
in O 0 0.003458815161138773
man O 0 0.007300483528524637
is O 0 0.00011190270015504211
a O 0 0.00035219910205341876
dysfunctional O 1 0.5913058519363403
ATP7B O 1 0.9999945163726807
gene O 0 0.0020143690053373575
, O 0 0.0006910575903020799
causing O 1 0.9998010993003845
Wilson B-Disease 1 0.9999455213546753
disease I-Disease 1 0.9999991655349731
( O 1 0.6671401858329773
WD B-Disease 1 0.9999061822891235
) O 0 0.000891735777258873
. O 0 0.0009640523348934948

Mutations O 0 0.003023291239514947
in O 0 0.000714381574653089
the O 0 0.0018390277400612831
ATP7B O 1 0.999953031539917
genes O 0 0.0003189197741448879
have O 0 8.369412535103038e-05
also O 0 5.931342820986174e-05
been O 0 9.968572703655809e-05
demonstrated O 0 0.0003967052907682955
in O 0 0.0002464329591020942
mouse O 0 0.0017183044692501426
and O 0 0.000750226725358516
rat O 0 0.1535419523715973
. O 0 0.0012943847104907036

The O 0 0.010306972078979015
ATP7B O 1 0.9999231100082397
gene O 0 0.0009235817124135792
has O 0 0.0001486244727857411
been O 0 0.00010196775110671297
excluded O 0 0.0001503210951341316
in O 0 6.931272218935192e-05
the O 0 0.0001969069562619552
much O 0 0.0004863682552240789
rarer O 1 0.8482900261878967
human O 1 0.9850703477859497
copper B-Disease 1 1.0
overload I-Disease 1 1.0
disease O 1 0.9999997615814209
non B-Disease 1 0.9340031147003174
- I-Disease 1 0.6482352614402771
Indian I-Disease 0 0.01375754363834858
childhood I-Disease 1 0.999708354473114
cirrhosis I-Disease 1 0.9999998807907104
, O 0 0.001662077964283526
indicating O 0 0.01948482170701027
genetic O 0 0.002753357170149684
heterogeneity O 0 0.012268448248505592
. O 0 0.0012464997125789523

By O 0 0.0011149834608659148
investigating O 0 0.0012721653329208493
the O 0 0.0011823204113170505
common O 0 0.0057353675365448
autosomal O 1 0.9996439218521118
recessive O 1 0.9999990463256836
copper B-Disease 1 1.0
toxicosis I-Disease 1 1.0
( O 1 0.9504042267799377
CT B-Disease 1 0.9785897135734558
) O 0 0.00012931786477565765
in O 0 0.00017706191283650696
Bedlington O 0 0.29452452063560486
terriers O 0 0.007675664033740759
, O 0 9.993623098125681e-05
we O 0 2.93112298095366e-05
have O 0 1.2145292203058489e-05
identified O 0 2.9257193091325462e-05
a O 0 7.92333303252235e-05
new O 0 0.00012642741785384715
locus O 0 0.0008734301081858575
involved O 0 0.000727889477275312
in O 0 0.09947242587804794
progressive O 1 0.9999997615814209
liver B-Disease 1 1.0
disease I-Disease 1 1.0
. O 1 0.7395520210266113

We O 0 0.001599011244252324
examined O 0 0.0009864899329841137
whether O 0 0.0003491843235678971
the O 0 0.0008705370128154755
WD B-Disease 1 0.9990371465682983
gene O 0 0.002055325312539935
ATP7B O 1 0.9998806715011597
was O 0 0.006758480798453093
also O 0 0.0002790613507386297
causative O 0 0.0020148232579231262
for O 0 0.0002285441296407953
CT B-Disease 0 0.003680553985759616
by O 0 0.0001284046593355015
investigating O 0 0.000535419094376266
the O 0 0.0005476238438859582
chromosomal O 0 0.06556135416030884
co O 0 0.0036265752278268337
- O 0 0.002090079477056861
localization O 0 0.003081059083342552
of O 0 0.0014454005286097527
ATP7B O 1 0.9999849796295166
and O 0 0.0005193177494220436
C04107 O 1 0.5779879689216614
, O 0 0.00017821895016822964
using O 0 0.00010673733777366579
fluorescence O 0 0.0002882847038563341
in O 0 0.00017196100088767707
situ O 0 0.002053565578535199
hybridization O 0 0.000792376755271107
( O 0 0.0004905079840682447
FISH O 0 0.001179020619019866
) O 0 0.0004306161717977375
. O 0 0.0006848634220659733

C04107 O 1 0.8972413539886475
is O 0 0.001194748212583363
an O 0 0.000713742570951581
anonymous O 0 0.0017090279143303633
microsatellite O 0 0.01018038671463728
marker O 0 0.003772270865738392
closely O 0 0.0006086070206947625
linked O 0 0.0016352813690900803
to O 0 0.0007294726674444973
CT B-Disease 1 0.5842828750610352
. O 0 0.00117354781832546

However O 0 0.0037007806822657585
, O 0 0.0024701182264834642
BAC O 1 0.9857926964759827
clones O 0 0.019575821235775948
containing O 0 0.0024189569521695375
ATP7B O 1 0.9991037249565125
and O 0 0.0006116030854173005
C04107 O 0 0.04432833939790726
mapped O 0 0.00042250080150552094
to O 0 0.0001483428495703265
the O 0 0.00030678545590490103
canine O 0 0.007371112238615751
chromosome O 0 0.0012422723229974508
regions O 0 0.0003868566418532282
CFA22q11 O 1 0.9997596144676208
and O 0 0.0012485209153965116
CFA10q26 O 1 0.9998940229415894
, O 0 0.0002769494312815368
respectively O 0 0.00026373472064733505
, O 0 0.00012744076957460493
demonstrating O 0 0.000764282129239291
that O 0 0.00020856187620665878
WD B-Disease 1 0.5191026926040649
cannot O 0 0.00026096703368239105
be O 0 0.00013275022502057254
homologous O 0 0.001023853663355112
to O 0 0.00044659283594228327
CT B-Disease 0 0.03633960336446762
. O 0 0.0014456667704507709

The O 0 0.009551695547997952
copper O 1 0.9979051351547241
transport O 0 0.05218749865889549
genes O 0 0.0031078278552740812
CTR1 O 1 0.9999370574951172
and O 0 0.0011109146289527416
CTR2 O 1 0.999839186668396
were O 0 0.0002160025469493121
also O 0 8.237075235228986e-05
excluded O 0 0.00013813744590152055
as O 0 5.13698578288313e-05
candidate O 0 0.00010424889478599653
genes O 0 9.994252468459308e-05
for O 0 0.00010116880730492994
CT B-Disease 0 0.010574309155344963
since O 0 0.00011095883382949978
they O 0 2.5431698304601014e-05
both O 0 4.5011958718532696e-05
mapped O 0 0.0002473561908118427
to O 0 0.0002270936092827469
canine O 0 0.009837154299020767
chromosome O 0 0.003737896680831909
region O 0 0.0042474824003875256
CFA11q22 O 1 0.9989528656005859
. O 0 0.0027772155590355396

2 O 0 0.005383859854191542
- O 0 0.006837130058556795
22 O 0 0.004204902797937393
. O 0 0.001321171410381794

5 O 0 0.015707233920693398
. O 0 0.0054554264061152935

A O 0 0.004318797029554844
transcribed O 0 0.0011428294237703085
sequence O 0 0.00034439124283380806
identified O 0 0.00022633832122664899
from O 0 0.0001682325964793563
the O 0 0.00038980430690571666
C04107 O 1 0.9719794988632202
- O 0 0.00253706774674356
containing O 0 0.0009548277594149113
BAC O 0 0.33919966220855713
was O 0 0.0004647142195608467
found O 0 5.5115287977969274e-05
to O 0 3.831999856629409e-05
be O 0 2.3726295694359578e-05
homologous O 0 8.427042484981939e-05
to O 0 3.5821001802105457e-05
a O 0 0.00011699005699483678
gene O 0 8.294797589769587e-05
expressed O 0 9.825640881899744e-05
from O 0 0.0001621822884771973
human O 0 0.0005161094013601542
chromosome O 0 0.019881848245859146
2p13 O 1 0.9998526573181152
- O 0 0.07605372369289398
p16 O 0 0.005768707487732172
, O 0 0.0001280990254599601
a O 0 0.00022760516731068492
region O 0 0.0003185922105330974
devoid O 0 0.0010817400179803371
of O 0 0.0003170864947605878
any O 0 0.0002607610949780792
positional O 0 0.00328871700912714
candidate O 0 0.0011739725014194846
genes O 0 0.0007448376854881644
. O 0 0.0006769199972040951

Molecular O 0 0.0021428167819976807
analysis O 0 0.0002811057784128934
of O 0 0.00037049816455692053
the O 0 0.0005648351507261395
APC B-Disease 1 0.8031469583511353
gene O 0 0.00023037753999233246
in O 0 9.167967073153704e-05
205 O 0 0.0005584900500252843
families O 0 9.167119424091652e-05
: O 0 0.00011199109576409683
extended O 0 0.0002748385595623404
genotype O 0 0.001352972351014614
- O 0 0.0010819584131240845
phenotype O 0 0.0007894288282841444
correlations O 0 0.000553979305550456
in O 0 0.0003454797260928899
FAP B-Disease 1 0.7315699458122253
and O 0 0.00014760451449546963
evidence O 0 0.00011823107342934236
for O 0 3.911797102773562e-05
the O 0 0.00010125075641553849
role O 0 0.000247653282713145
of O 0 0.0004655431257560849
APC B-Disease 1 0.9942875504493713
amino O 0 0.0009063410689122975
acid O 0 0.00459866039454937
changes O 0 0.0006822205614298582
in O 1 0.7913098931312561
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
predisposition O 1 0.9999743700027466
. O 0 0.0060206991620361805

BACKGROUND O 0 0.01865040510892868
/ O 0 0.011499669402837753
AIMS O 0 0.004399533849209547
The O 0 0.0007131863967515528
development O 0 0.003924858756363392
of O 1 0.99982088804245
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
and O 0 0.0007292656227946281
a O 0 0.0003279661468695849
variable O 0 0.00012804676953237504
range O 0 0.0001491452130721882
of O 0 0.00040983714279718697
extracolonic O 1 0.9911717772483826
manifestations O 1 0.9119769334793091
in O 0 0.00610515009611845
familial B-Disease 1 0.9999986886978149
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 1 0.9998522996902466
FAP B-Disease 1 0.9999927282333374
) O 0 0.00025141870719380677
is O 0 0.00010911124263657257
the O 0 0.00011611980880843475
result O 0 6.633626617258415e-05
of O 0 0.00013921728532295674
the O 0 0.0003615697205532342
dominant O 0 0.002180582145228982
inheritance O 0 0.010317678563296795
of O 1 0.982073187828064
adenomatous B-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
( O 1 0.9992583394050598
APC B-Disease 1 0.9999926090240479
) O 0 0.0012319819070398808
gene O 0 0.0008609416545368731
mutations O 0 0.0007083707023411989
. O 0 0.0008421674720011652

In O 0 0.0008201352902688086
this O 0 0.0002558070991653949
study O 0 0.00015236261242534965
, O 0 8.421819802606478e-05
direct O 0 0.00011635567352641374
mutation O 0 8.585995237808675e-05
analysis O 0 3.681023736135103e-05
of O 0 0.0001238618860952556
the O 0 0.00044172952766530216
APC B-Disease 1 0.9971862435340881
gene O 0 0.0002574537938926369
was O 0 0.0004783612967003137
performed O 0 0.0002730530977714807
to O 0 6.535018474096432e-05
determine O 0 0.00017744151409715414
genotype O 0 0.0007142763934098184
- O 0 0.0006512334221042693
phenotype O 0 0.0004400869947858155
correlations O 0 0.00023305519425775856
for O 0 0.00010899872722802684
nine O 0 0.0006875921972095966
extracolonic O 1 0.9955573678016663
manifestations O 0 0.34472882747650146
and O 0 0.00015938383876346052
to O 0 0.00010975069017149508
investigate O 0 0.0003770991461351514
the O 0 0.00043757795356214046
incidence O 0 0.014381124638020992
of O 0 0.0043213628232479095
APC B-Disease 1 0.9999375343322754
mutations O 0 0.000818098895251751
in O 0 0.000609199283644557
non O 1 0.9813053011894226
- O 1 0.9999884366989136
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
. O 0 0.0033952598460018635

METHODS O 0 0.004718799144029617
The O 0 0.001997609855607152
APC B-Disease 1 0.9833880662918091
gene O 0 0.0005834336625412107
was O 0 0.000526443007402122
analysed O 0 0.00044479567441157997
in O 0 9.763093112269416e-05
190 O 0 0.0004997277283109725
unrelated O 0 0.0007710657664574683
FAP B-Disease 0 0.3220156133174896
and O 0 0.00026536863879300654
15 O 0 0.0014245467027649283
non O 1 0.8909328579902649
- O 1 0.9999656677246094
FAP O 1 0.9999998807907104
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999996423721313
patients O 0 0.023955054581165314
using O 0 0.0006678514182567596
denaturing O 1 0.8535930514335632
gradient O 0 0.36401450634002686
gel O 0 0.07387863099575043
electrophoresis O 0 0.001557644340209663
, O 0 0.0001495306787546724
the O 0 0.00025968061527237296
protein O 0 0.000368432403774932
truncation O 0 0.0024514882825315
test O 0 0.00032395616290159523
, O 0 0.0001044040109263733
and O 0 7.257005199790001e-05
direct O 0 0.00021561179892159998
sequencing O 0 0.0008714101277291775
. O 0 0.0005378071800805628

RESULTS O 0 0.006982874125242233
Chain O 0 0.004055535886436701
terminating O 0 0.002568785334005952
signals O 0 0.0006153706926852465
were O 0 0.00010263009608024731
only O 0 5.931574560236186e-05
identified O 0 8.762993093114346e-05
in O 0 8.801365038380027e-05
patients O 0 0.00010289940109942108
belonging O 0 0.0002577136328909546
to O 0 0.00010479050251888111
the O 0 0.0003642523370217532
FAP B-Disease 1 0.9914395809173584
group O 0 0.0002673545677680522
( O 0 0.00027304087416268885
105 O 0 0.0011135388631373644
patients O 0 0.0004573462065309286
) O 0 0.00026662860182113945
. O 0 0.0005750875570811331

Amino O 0 0.004017407540231943
acid O 0 0.0022776545956730843
changes O 0 0.00024510949151590466
were O 0 8.174444519681856e-05
identified O 0 9.632352157495916e-05
in O 0 5.872511974303052e-05
four O 0 9.330674220109358e-05
patients O 0 0.00010768369247671217
, O 0 3.435160033404827e-05
three O 0 4.217370951664634e-05
of O 0 0.0001248956104973331
whom O 0 0.00018543530313763767
belonged O 0 0.0004862354544457048
to O 0 7.51245315768756e-05
the O 0 0.00019713859364856035
non O 0 0.0008984737214632332
- O 0 0.0074644084088504314
FAP O 1 0.9980083107948303
group O 0 0.001165779773145914
of O 1 0.9998815059661865
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 1 0.9995949864387512
. O 0 0.00217293668538332

Genotype O 0 0.4671439826488495
- O 0 0.11113855987787247
phenotype O 0 0.0037520453333854675
correlations O 0 0.0008192870300263166
identified O 0 0.00031822946039028466
significant O 0 0.00023381657956633717
differences O 0 0.00017541709530632943
in O 0 0.0001185424262075685
the O 0 0.00016653920465614647
nature O 0 0.0002381846570642665
of O 0 0.00031209050212055445
certain O 0 0.0003242713282816112
extracolonic O 1 0.999782145023346
manifestations O 1 0.9974291920661926
in O 0 0.012883259914815426
FAP B-Disease 1 0.9999532699584961
patients O 0 0.0006921961903572083
belonging O 0 0.00045550710638053715
to O 0 0.0001180357503471896
three O 0 0.00024364484124816954
mutation O 0 0.0004793774278368801
subgroups O 0 0.0010345160262659192
. O 0 0.0005792141309939325

CONCLUSIONS O 0 0.006614070385694504
Extended O 0 0.004560425877571106
genotype O 0 0.005265785381197929
- O 0 0.00341536826454103
phenotype O 0 0.0012408934999257326
correlations O 0 0.0003732565091922879
made O 0 0.00015435484237968922
in O 0 7.27421574993059e-05
this O 0 3.782997009693645e-05
study O 0 3.88287371606566e-05
may O 0 3.806591485044919e-05
have O 0 1.060664089891361e-05
the O 0 4.237596658640541e-05
potential O 0 7.402666960842907e-05
to O 0 2.6776964659802616e-05
determine O 0 3.059276787098497e-05
the O 0 6.161416240502149e-05
most O 0 3.7327263271436095e-05
appropriate O 0 0.00011216840357519686
surveillance O 0 0.0002576863334979862
and O 0 0.00020290937391109765
prophylactic O 1 0.8246248364448547
treatment O 1 0.7360522747039795
regimens O 0 0.06530175358057022
for O 0 0.00020260621386114508
those O 0 0.00010366660717409104
patients O 0 0.00016001866606529802
with O 0 7.530197035521269e-05
mutations O 0 0.0002594114048406482
associated O 0 0.00019717523537110537
with O 0 0.00021139701129868627
life O 0 0.16572247445583344
threatening O 1 0.9968444108963013
conditions O 0 0.23216137290000916
. O 0 0.0007647097227163613

This O 0 0.0007024564547464252
study O 0 0.0002465290599502623
also O 0 0.00013169919839128852
provided O 0 9.650721040088683e-05
evidence O 0 0.00010993934120051563
for O 0 5.503786451299675e-05
the O 0 0.00017099191609304398
pathological O 0 0.011470668017864227
nature O 0 0.0005464254645630717
of O 0 0.0007263144361786544
amino O 0 0.0003563256177585572
acid O 0 0.0004987409920431674
changes O 0 0.0001303759781876579
in O 0 0.0001262827281607315
APC O 0 0.0866585522890091
associated O 0 0.00016756803961470723
with O 0 9.046178456628695e-05
both O 0 0.0002162489981856197
FAP B-Disease 1 0.9994088411331177
and O 0 0.0022314093075692654
non O 1 0.9996727705001831
- O 1 0.9999991655349731
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 1 0.9985260963439941
. O 0 0.0010987530695274472
. O 0 0.001373367733322084

Inherited B-Disease 1 0.9999995231628418
colorectal I-Disease 1 1.0
polyposis I-Disease 1 1.0
and O 1 0.9999306201934814
cancer B-Disease 1 0.9999988079071045
risk O 1 0.5269985795021057
of O 1 0.5270506143569946
the O 1 0.9954248070716858
APC O 1 0.9999927282333374
I1307K O 1 0.9997527003288269
polymorphism O 0 0.005310164764523506
. O 0 0.0011204620823264122

Germ O 1 0.9998064637184143
- O 0 0.0821041464805603
line O 0 0.002974857110530138
and O 0 0.0005180332809686661
somatic O 0 0.0015410593478009105
truncating O 0 0.0026804909575730562
mutations O 0 0.0002082608116324991
of O 0 0.0002591933589428663
the O 0 0.0007275496027432382
APC B-Disease 1 0.9964523315429688
gene O 0 0.00016662210691720247
are O 0 1.9840783352265134e-05
thought O 0 0.00014487717999145389
to O 0 0.00016382732428610325
initiate O 0 0.022232063114643097
colorectal B-Disease 1 0.9999996423721313
tumor I-Disease 1 0.9999983310699463
formation O 1 0.9999676942825317
in O 1 0.9989486336708069
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 1 0.9999988079071045
sporadic O 1 1.0
colorectal O 1 1.0
carcinogenesis O 1 1.0
, O 1 0.5591851472854614
respectively O 0 0.007310805842280388
. O 0 0.0011958378599956632

Recently O 0 0.004003830719739199
, O 0 0.0007224156288430095
an O 0 0.0008446126012131572
isoleucine O 1 0.8668619990348816
- O 0 0.008534076623618603
- O 0 0.0028899849858134985
> O 0 0.002038508653640747
lysine O 0 0.0022292209323495626
polymorphism O 0 0.0007420915644615889
at O 0 0.0006755252834409475
codon O 0 0.00182831019628793
1307 O 0 0.007883833721280098
( O 0 0.00041002591024152935
I1307K O 0 0.003332502441480756
) O 0 7.897015166236088e-05
of O 0 0.00017675693379715085
the O 0 0.0002863297413568944
APC B-Disease 1 0.9325061440467834
gene O 0 0.00012699386570602655
has O 0 3.6692130379378796e-05
been O 0 1.7676558854873292e-05
identified O 0 3.104478673776612e-05
in O 0 2.8330225177342072e-05
6 O 0 9.075184061657637e-05
% O 0 3.845922401524149e-05
- O 0 0.00011879838712047786
7 O 0 9.228049020748585e-05
% O 0 2.4623139324830845e-05
of O 0 6.789217877667397e-05
the O 0 0.00018226420797873288
Ashkenazi O 0 0.0009970349492505193
Jewish O 0 0.0008860352681949735
population O 0 0.0003763265267480165
. O 0 0.0005961264832876623

To O 0 0.0012500403681769967
assess O 0 0.0010263698641210794
the O 0 0.00047676829854026437
risk O 0 0.00027467901236377656
of O 0 0.000271251832600683
this O 0 0.00014522502897307277
common O 0 0.0007402678020298481
APC B-Disease 1 0.9997270703315735
allelic O 1 0.9895015358924866
variant O 1 0.9348013401031494
in O 1 0.6538464426994324
colorectal O 1 1.0
carcinogenesis O 1 0.9999969005584717
, O 0 0.00037837610580027103
we O 0 6.893699173815548e-05
have O 0 1.830027758842334e-05
analyzed O 0 3.7989466363796964e-05
a O 0 6.308218144113198e-05
large O 0 0.00011355010065017268
cohort O 0 0.0005325076635926962
of O 0 0.00026803731452673674
unselected O 0 0.009646176360547543
Ashkenazi O 0 0.002017454942688346
Jewish O 0 0.0009915923001244664
subjects O 0 0.000846008479129523
with O 0 0.0005141684086993337
adenomatous B-Disease 1 0.999997615814209
polyps I-Disease 1 0.9999443292617798
and O 0 0.0021509493235498667
. O 0 0.0026168283075094223
or O 1 0.9992249011993408
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999992847442627
, I-Disease 0 0.0005459451931528747
for O 0 0.000244291964918375
the O 0 0.0009503282490186393
APC O 1 0.9983263611793518
I1307K O 1 0.9943746328353882
polymorphism O 0 0.0032175194937735796
. O 0 0.000636340060736984

The O 0 0.010311963967978954
APC O 1 0.9965676069259644
I1307K O 1 0.9679286479949951
allele O 0 0.0012209847336634994
was O 0 0.0004884834052063525
identified O 0 8.863639959599823e-05
in O 0 5.6882847275119275e-05
48 O 0 9.020964353112504e-05
( O 0 4.218859248794615e-05
10 O 0 4.868226096732542e-05
. O 0 2.621490421006456e-05
1 O 0 7.337144779739901e-05
% O 0 5.15332976647187e-05
) O 0 8.333686855621636e-05
of O 0 0.0003682547539938241
476 O 0 0.03443719819188118
patients O 0 0.0025726978201419115
. O 0 0.0010682599386200309

Compared O 0 0.001638592453673482
with O 0 0.00021998691954649985
the O 0 0.00018524445476941764
frequency O 0 8.622080349596217e-05
in O 0 3.6389174056239426e-05
two O 0 2.558612141001504e-05
separate O 0 2.9079114028718323e-05
population O 0 2.471003790560644e-05
control O 0 8.961786807049066e-05
groups O 0 3.206316250725649e-05
, O 0 7.35728899599053e-05
the O 0 0.00033838837407529354
APC O 1 0.973289966583252
I1307K O 1 0.9742251038551331
allele O 0 0.0005004017148166895
is O 0 0.00010069076233776286
associated O 0 6.187216786202043e-05
with O 0 2.3680564481765032e-05
an O 0 5.364703247323632e-05
estimated O 0 0.0001516434276709333
relative O 0 0.0002650745736900717
risk O 0 0.00025846288190223277
of O 0 0.00042125993059016764
1 O 0 0.0012552386615425348
. O 0 0.0006541096954606473

5 O 0 0.00806775875389576
- O 0 0.008671090006828308
1 O 0 0.0029558686073869467
. O 0 0.002284940332174301

7 O 0 0.011802932247519493
for O 0 0.005535939242690802
colorectal B-Disease 1 0.9999954700469971
neoplasia I-Disease 1 0.9999433755874634
( O 0 0.001318889670073986
both O 0 0.0005414632032625377
P O 1 0.6276988387107849
= O 0 0.0017296652076765895
. O 0 0.0003088305820710957
01 O 0 0.009676733985543251
) O 0 0.0003277098585385829
. O 0 0.0005066494341008365

Furthermore O 0 0.004672100301831961
, O 0 0.0008677473524585366
compared O 0 0.0005677254521287978
with O 0 0.0003161953645758331
noncarriers O 1 0.9972214698791504
, O 0 0.0010805747006088495
APC O 1 0.9982402324676514
I1307K O 1 0.9945573806762695
carriers O 0 0.0007841891492716968
had O 0 0.0002159335563192144
increased O 0 0.00014102341083344072
numbers O 0 7.872467540437356e-05
of O 0 0.0005801246734336019
adenomas B-Disease 1 0.9999779462814331
and O 1 0.7945489883422852
colorectal B-Disease 1 1.0
cancers I-Disease 1 0.9999644756317139
per O 0 0.0007466028910130262
patient O 0 0.0008997965487651527
( O 0 0.00018930379883386195
P O 0 0.002104604383930564
= O 0 0.00031045565265230834
. O 0 6.927109643584117e-05
03 O 0 0.0008760715136304498
) O 0 4.702542719314806e-05
, O 0 4.3395859393058345e-05
as O 0 5.442927431431599e-05
well O 0 3.078892768826336e-05
as O 0 6.210093124536797e-05
a O 0 0.00012201695062685758
younger O 0 0.0006351025658659637
age O 0 0.0008486110018566251
at O 0 0.007739265449345112
diagnosis O 1 0.783176600933075
. O 0 0.0009893713286146522

We O 0 0.0013715337263420224
conclude O 0 0.0016825557686388493
that O 0 0.0002873854245990515
the O 0 0.0005799363716505468
APC O 1 0.9653154611587524
I1307K O 1 0.9953059554100037
variant O 0 0.0033856299705803394
leads O 0 0.0012228538980707526
to O 0 0.0002576617698650807
increased O 0 0.005562223494052887
adenoma B-Disease 1 0.9999994039535522
formation O 1 0.7550972700119019
and O 0 0.00018731277668848634
directly O 0 0.0001058314592228271
contributes O 0 8.874111517798156e-05
to O 0 2.6054993213620037e-05
3 O 0 5.320084892446175e-05
% O 0 2.6507423172006384e-05
- O 0 8.28998236102052e-05
4 O 0 6.122385093476623e-05
% O 0 2.967588443425484e-05
of O 0 9.243223030352965e-05
all O 0 0.000135723952553235
Ashkenazi O 0 0.0683402493596077
Jewish O 1 0.992544412612915
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999991655349731
. O 0 0.004127285443246365

The O 0 0.0031432644464075565
estimated O 0 0.001364243682473898
relative O 0 0.0007756962440907955
risk O 0 0.0005071969353593886
for O 0 0.0001414300932083279
carriers O 0 0.0003539055760484189
may O 0 0.00013457969180308282
justify O 0 0.0004249469784554094
specific O 0 7.490569987567142e-05
clinical O 0 0.00020948161545675248
screening O 0 0.00012243092351127416
for O 0 4.0444807382300496e-05
the O 0 0.00011847485438920557
360 O 0 0.0003256394120398909
, O 0 4.7378103772643954e-05
000 O 0 0.00014639610890299082
Americans O 0 4.2567098716972396e-05
expected O 0 4.4780757889384404e-05
to O 0 2.731417043833062e-05
harbor O 0 0.00044280118891038
this O 0 6.359250255627558e-05
allele O 0 0.00012072143726982176
, O 0 6.372829375322908e-05
and O 0 4.151791654294357e-05
genetic O 0 7.375566201517358e-05
testing O 0 8.450024324702099e-05
in O 0 3.645172546384856e-05
the O 0 5.2439758292166516e-05
setting O 0 8.639973384561017e-05
of O 0 0.00011351113789714873
long O 0 0.00018017909314949065
- O 0 0.00026740808971226215
term O 0 0.00013754192332271487
- O 0 0.00018855422968044877
outcome O 0 0.00010566640412434936
studies O 0 5.119737033965066e-05
may O 0 6.285700510488823e-05
impact O 0 0.00034134776797145605
significantly O 0 0.0006800848059356213
on O 0 0.19080723822116852
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
prevention O 1 0.9998327493667603
in O 0 0.0005564526654779911
this O 0 0.00016487951506860554
population O 0 0.00021420388657134026
. O 0 0.0004591108881868422

Localization O 0 0.024434812366962433
of O 0 0.00315019185654819
human O 0 0.002485003089532256
BRCA1 O 0 0.01379148568958044
and O 0 0.00015942883328534663
its O 0 0.0001295012334594503
loss O 0 0.0008879232918843627
in O 0 0.00023189415514934808
high O 0 0.002831442980095744
- O 0 0.002376219257712364
grade O 0 0.015923626720905304
, O 0 0.00042097692494280636
non B-Disease 0 0.003150681499391794
- I-Disease 1 0.9511023759841919
inherited I-Disease 1 0.999991774559021
breast I-Disease 1 0.9999973773956299
carcinomas I-Disease 1 0.9999961853027344
. O 0 0.003933634143322706

Although O 0 0.0011069440515711904
the O 0 0.0005336953327059746
link O 0 0.0006935237906873226
between O 0 0.0005136337131261826
the O 0 0.00458315247669816
BRCA1 O 1 0.99998939037323
tumour B-Disease 1 1.0
- O 1 0.9997326731681824
suppressor O 1 0.9992959499359131
gene O 0 0.0012664528330788016
and O 0 0.001008623163215816
hereditary B-Disease 1 0.9999995231628418
breast I-Disease 1 1.0
and I-Disease 1 0.9999997615814209
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
is O 0 0.013293149881064892
established O 0 0.0003018717106897384
, O 0 7.088543497957289e-05
the O 0 0.00010578526416793466
role O 0 0.0002007571019930765
, O 0 5.162207526154816e-05
if O 0 2.7761443561757915e-05
any O 0 2.662513179529924e-05
, O 0 4.610157702700235e-05
of O 0 0.00021619106701109558
BRCA1 O 0 0.33011022210121155
in O 0 0.0006342429551295936
non B-Disease 0 0.34357428550720215
- I-Disease 1 0.9919871091842651
familial I-Disease 1 0.999805748462677
cancers I-Disease 1 0.999937891960144
is O 0 0.0010144582483917475
unclear O 0 0.0012992380652576685
. O 0 0.000881421787198633

BRCA1 O 1 0.9973419308662415
mutations O 0 0.0016379053704440594
are O 0 0.0001275389950023964
rare O 0 0.0005288373795337975
in O 0 0.0003152772260364145
sporadic B-Disease 1 0.9614163637161255
cancers I-Disease 1 0.9996742010116577
, O 0 0.00015622496721334755
but O 0 7.480340718757361e-05
loss O 0 0.0012280985247343779
of O 0 0.0011775789316743612
BRCA1 O 1 0.9931545257568359
resulting O 0 0.001025779522024095
from O 0 0.00019992004672531039
reduced O 0 0.0002842739340849221
expression O 0 0.00016500643687322736
or O 0 7.352799730142578e-05
incorrect O 0 0.00025648821610957384
subcellular O 0 0.001322081545367837
localization O 0 0.0014142104191705585
is O 0 0.00011426567652961239
postulated O 0 0.00023759176838211715
to O 0 3.751998156076297e-05
be O 0 3.322528209537268e-05
important O 0 7.75744192651473e-05
in O 0 9.281537495553493e-05
non B-Disease 0 0.001481462735682726
- I-Disease 1 0.9198746085166931
familial I-Disease 1 0.9999954700469971
breast I-Disease 1 1.0
and I-Disease 1 0.9999994039535522
ovarian I-Disease 1 1.0
cancers I-Disease 1 1.0
. O 0 0.08190738409757614

Epigenetic O 1 0.9521327018737793
loss O 1 0.9980104565620422
, O 0 0.0008577184053137898
however O 0 0.00022469749092124403
, O 0 0.00012799732212442905
has O 0 6.717751239193603e-05
not O 0 2.0502311599557288e-05
received O 0 8.656450518174097e-05
general O 0 0.0002940978738479316
acceptance O 0 0.0005898881936445832
due O 0 0.00024668447440490127
to O 0 9.671118459664285e-05
controversy O 0 0.0003657391935121268
regarding O 0 0.00012436165707185864
the O 0 0.00019069276459049433
subcellular O 0 0.0015774528728798032
localization O 0 0.0016875192523002625
of O 0 0.0008431514725089073
BRCA1 O 0 0.05821312963962555
proteins O 0 0.00015266916307155043
, O 0 4.458492185221985e-05
reports O 0 3.8162965211085975e-05
of O 0 5.9944202803308144e-05
which O 0 3.137258318020031e-05
have O 0 1.7572101569385268e-05
ranged O 0 0.00017828642739914358
from O 0 5.884789061383344e-05
exclusively O 0 7.574915798613802e-05
nuclear O 0 0.0002614688710309565
, O 0 5.421672904049046e-05
to O 0 4.536359119811095e-05
conditionally O 0 0.0003328408638481051
nuclear O 0 0.00032084810663945973
, O 0 6.395537639036775e-05
to O 0 4.9610822316026315e-05
the O 0 0.00037016032729297876
ER O 1 0.9968892931938171
/ O 0 0.0026555918157100677
golgi O 0 0.011562654748558998
, O 0 0.00015549185627605766
to O 0 0.00014886089775245637
cytoplasmic O 0 0.0007552242605015635
invaginations O 0 0.005869749002158642
into O 0 0.0005688987439498305
the O 0 0.0009132848354056478
nucleus O 0 0.0049896263517439365
. O 0 0.0008175151888281107

In O 0 0.0012475085677579045
an O 0 0.0003686191630549729
attempt O 0 0.0004820925241801888
to O 0 0.00011310962145216763
resolve O 0 0.00041479943320155144
this O 0 7.620363612659276e-05
issue O 0 0.0001391778641846031
, O 0 7.828738307580352e-05
we O 0 4.329054354457185e-05
have O 0 3.267595820943825e-05
comprehensively O 0 0.0008179281139746308
characterized O 0 0.0007266387692652643
19 O 0 0.0022781735751777887
anti O 1 0.9809601306915283
- O 1 0.974662721157074
BRCA1 O 1 0.9774501323699951
antibodies O 0 0.0026069071609526873
. O 0 0.0011828616261482239

These O 0 0.001024487428367138
reagents O 0 0.004200709518045187
detect O 0 0.0012701153755187988
a O 0 0.0005994520615786314
220 O 0 0.0017278518062084913
- O 0 0.0014884000411257148
kD O 0 0.004492029547691345
protein O 0 0.0004130663874093443
localized O 0 0.0005332311848178506
in O 0 0.00017514367937110364
discrete O 0 0.00040707550942897797
nuclear O 0 0.0011496247025206685
foci O 0 0.0012785972794517875
in O 0 0.00013406849757302552
all O 0 0.0001890842686407268
epithelial O 1 0.9987425208091736
cell O 0 0.0033874481450766325
lines O 0 0.00022672451450489461
, O 0 6.450258661061525e-05
including O 0 4.885685120825656e-05
those O 0 4.366835855762474e-05
derived O 0 0.0002748487750068307
from O 0 0.0009442163864150643
breast B-Disease 1 0.9987195730209351
malignancies I-Disease 1 0.997177004814148
. O 0 0.0021920371800661087

Immunohistochemical O 1 0.9830589294433594
staining O 1 0.858928382396698
of O 0 0.25036704540252686
human O 1 0.9588428139686584
breast O 1 0.9997233748435974
specimens O 0 0.0013409715611487627
also O 0 0.0003304004785604775
revealed O 0 0.002087922766804695
BRCA1 O 0 0.1187208965420723
nuclear O 0 0.003811914473772049
foci O 0 0.059511035680770874
in O 0 0.0027827606536448
benign O 1 0.9999822378158569
breast O 1 0.9999845027923584
, O 0 0.33042246103286743
invasive B-Disease 1 0.9999897480010986
lobular I-Disease 1 0.9999998807907104
cancers I-Disease 1 0.9999868869781494
and O 0 0.02572852373123169
low B-Disease 1 0.8898133039474487
- I-Disease 1 0.9848173260688782
grade I-Disease 1 0.9994717240333557
ductal I-Disease 1 0.9999970197677612
carcinomas I-Disease 1 0.9999804496765137
. O 0 0.0031624624971300364

Conversely O 0 0.023829281330108643
, O 0 0.0017885231645777822
BRCA1 O 1 0.5274850130081177
expression O 0 0.0009053684188984334
was O 0 0.0023467042483389378
reduced O 0 0.00042436423245817423
or O 0 0.0001702325389487669
undetectable O 0 0.0006659440696239471
in O 0 4.716581679531373e-05
the O 0 4.883290966972709e-05
majority O 0 3.1455561838811263e-05
of O 0 0.00015047138731461018
high O 0 0.021778885275125504
- O 0 0.05527374893426895
grade O 1 0.9439506530761719
, O 0 0.0008192592649720609
ductal B-Disease 1 0.9999967813491821
carcinomas I-Disease 1 0.9999862909317017
, O 0 0.0002501619455870241
suggesting O 0 0.000291861331788823
that O 0 5.795139441033825e-05
absence O 0 0.0003342008567415178
of O 0 0.0019846248906105757
BRCA1 O 1 0.9990890026092529
may O 0 0.00024317906354553998
contribute O 0 0.00016251295164693147
to O 0 8.266694203484803e-05
the O 0 0.0002453781489748508
pathogenesis O 0 0.012447934597730637
of O 0 0.00021737191127613187
a O 0 0.00022174595505930483
significant O 0 0.0001951954182004556
percentage O 0 0.00022871309192851186
of O 0 0.0005573384696617723
sporadic B-Disease 1 0.9994933605194092
breast I-Disease 1 0.9999992847442627
cancers I-Disease 1 0.999887228012085
. O 0 0.0005427620490081608
. O 0 0.0006435810355469584

